,Date,Title,Url
0,2020-01-01,대웅제약토종주름약나보타중국임상시험본격착수,https://www.ajunews.com/view/20191231110518871
1,2020-01-01,대웅제약경구용장티푸스백신비보티프발매,http://www.viva100.com/main/view.php?key=20200101010000048
2,2020-01-01,대웅제약경구용장티푸스백신비보티프발매,http://www.dailymedi.com/detail.php?number=851357&thread=22r05
3,2020-01-01,대웅제약나보타中임상3상진행,http://www.fnnews.com/news/202001011831390931
4,2020-01-01,대웅제약나보타중국임상3상착수,http://www.dt.co.kr/contents.html?article_no=2020010202101531102001&ref=naver
5,2020-01-02,대웅제약경구용장티푸스백신비보티프국내출시,http://www.g-enews.com/ko-kr/news/article/news_all/20191231170805749569d76442fa_1/article.html
6,2020-01-02,대웅제약경구용장티푸스백신비보티프발매,http://www.bokuennews.com/news/article.html?no=185225
7,2020-01-02,대웅제약나보타중국임상3상본격착수,https://www.paxnetnews.com/articles/55445
8,2020-01-02,2020신년사대웅제약혁신신약성과창출이어질것”,http://www.mhj21.com/126636
9,2020-01-02,전승호대웅제약대표글로벌2025비전위해전사적역량집중”,http://www.viva100.com/main/view.php?key=20200102010000419
10,2020-01-02,대웅제약2020년혁신신약개발성과창출이어지는원년,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239185
11,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://medipana.com/news/news_viewer.asp?NewsNum=251065&MainKind=A&NewsKind=5&vCount=12&vKind=1
12,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.nbnnews.co.kr/news/articleView.html?idxno=355429
13,2020-01-02,2020재계신년사전승호대웅제약사장글로벌2025비전위해전사적역량집중,http://www.newslock.co.kr/news/articleView.html?idxno=24769
14,2020-01-02,신년사전승호대웅제약사장펙수프라잔글로벌에서인정받는약될것,http://moneys.mt.co.kr/news/mwView.php?no=2020010211068077678
15,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성원년,http://www.newspim.com/news/view/20200102000461
16,2020-01-02,신년사2020대웅제약올해혁신신약성과창출원년”,https://www.paxnetnews.com/articles/55452
17,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.g-enews.com/ko-kr/news/article/news_all/202001021122224974aca1a8c21a_1/article.html
18,2020-01-02,대웅제약글로벌2025비전달성위한변화와혁신이룰것”,http://sports.hankooki.com/lpage/economy/202001/sp20200102112307137020.htm
19,2020-01-02,대웅제약전승호사장글로벌2025비전달성에전사적역량집중,http://www.medisobizanews.com/news/articleView.html?idxno=65441
20,2020-01-02,대웅제약2일036변화종목그래프살펴보기,http://www.gokorea.kr/news/articleView.html?idxno=618509
21,2020-01-02,대웅제약2020년혁신신약성과창출원년될것,http://www.biospectator.com/view/news_view.php?varAtcId=9234
22,2020-01-02,전승호대웅제약대표2025년100개국수출망구축”,http://news.mt.co.kr/mtview.php?no=2020010211203711544
23,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.sporbiz.co.kr/news/articleView.html?idxno=405518
24,2020-01-02,대웅제약경구용장티푸스백신비보티프국내판매,http://www.ekn.kr/news/article.html?no=473400
25,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.ekn.kr/news/article.html?no=473448
26,2020-01-02,글로벌2025비전달성위해전사적역량집중하자대웅제약시무식개최항상준비하고도전하라,http://www.updownnews.co.kr/news/articleView.html?idxno=213188
27,2020-01-02,신년사대웅제약글로벌2025비전달성위해전사적역량집중,http://www.dailysmart.co.kr/news/articleView.html?idxno=20475
28,2020-01-02,신년메시지전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.ceoscoredaily.com/news/article.html?no=64441
29,2020-01-02,전승호대웅제약사장2020년글로벌비전달성위한변화와혁신의원년,http://www.newsprime.co.kr/news/article.html?no=488857
30,2020-01-02,신년사전승호대웅제약사장2020년혁신신약개발성과창출원년,http://www.edaily.co.kr/news/newspath.asp?newsid=02656806625633784
31,2020-01-02,전승호대웅제약대표올해신약개발성과본격창출하는한해될것,https://www.sedaily.com/NewsView/1YXHOAZ0AV
32,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.bosa.co.kr/news/articleView.html?idxno=2119158
33,2020-01-02,대웅제약종목검색2일현재137000원,http://nbntv.co.kr/news/view/793531
34,2020-01-02,대웅제약2020년RD성과창출의원년,http://www.newsis.com/view/?id=NISX20200102_0000877406&cID=13001&pID=13000
35,2020-01-02,대웅제약나보타中임상3상착수,http://www.monews.co.kr/news/articleView.html?idxno=207386
36,2020-01-02,2일데일리주가정보대웅제약069620오후12시12분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=92277
37,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.newsway.co.kr/news/view?tp=1&ud=2020010211524339382
38,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59030
39,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.metroseoul.co.kr/news/newsview?newscd=2020010200093
40,2020-01-02,대웅제약글로벌2025비전달성위해역량집중”,http://www.econovill.com/news/articleView.html?idxno=381617
41,2020-01-02,대웅제약올해는혁신신약성과창출의원년,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89807
42,2020-01-02,신년사전승호대웅제약대표올해신약개발성과창출하는한해될것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010212420043166
43,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.etnews.com/20200102000099
44,2020-01-02,대웅제약전승호사장글로벌블록버스터되도록역량강화,http://health.chosun.com/site/data/html_dir/2020/01/02/2020010201873.html
45,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중,https://asiatime.co.kr/news/newsview.php?ncode=1065584943481021
46,2020-01-02,대웅제약글로벌2025비전달성전사적역량집중”,http://www.bokuennews.com/news/article.html?no=185255
47,2020-01-02,전승호대웅제약사장글로벌사업확대,http://www.finomy.com/news/articleView.html?idxno=73684
48,2020-01-02,전승호대웅제약사장글로벌2025비전달성위해전사적역량집중,http://www.pressm.kr/news/articleView.html?idxno=26929
49,2020-01-02,대웅제약글로벌2025비전달성목표전사적역량집중,http://kormedi.com/?p=1308788
50,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”,http://www.mdtoday.co.kr/mdtoday/index.html?no=374134
51,2020-01-02,전승호대웅제약시무식에서신약개발성과본격창출하는한해,http://www.businesspost.co.kr/BP?command=article_view&num=157724
52,2020-01-02,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.wsobi.com/news/articleView.html?idxno=87726
53,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”다짐,http://www.getnews.co.kr/view.php?ud=20200102144727387441d0c69529_16
54,2020-01-02,대웅제약글로벌2025비전달성위해역량집중,http://www.ebn.co.kr/news/view/1015880/?sc=naver
55,2020-01-02,전승호대웅제약사장신약개발의성과창출하는해만들겠다,http://www.newsworks.co.kr/news/articleView.html?idxno=422898
56,2020-01-02,2020년신년사전승호대웅제약사장글로벌사업확대미래성장동력육성”,http://inthenews.co.kr/article-30370/
57,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.wikileaks-kr.org/news/articleView.html?idxno=73931
58,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중,http://www.newswatch.kr/news/articleView.html?idxno=26239
59,2020-01-02,신년사전승호대웅제약사장글로벌2025비전에전사적역량집중”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1840733
60,2020-01-02,대웅제약비전달성위해혁신도전이어갈것”올해혁신신약성과가시화,http://www.donga.com/news/article/all/20200102/99059459/1
61,2020-01-02,대웅제약2020년대웅제약혁신신약개발성과창출로이어지는원년될것,http://www.medigatenews.com/news/1064712562
62,2020-01-02,전승호대웅제약대표신약개발성과창출할것,https://view.asiae.co.kr/article/2020010216150074453
63,2020-01-02,전승호대웅제약2025년까지10위권100개국수출달성,http://www.dt.co.kr/contents.html?article_no=2020010202109931102008&ref=naver
64,2020-01-02,대웅제약불확실한미래속에서지속성장도모,http://www.sisaon.co.kr/news/articleView.html?idxno=107079
65,2020-01-02,대웅제약경구용장티푸스백신비보티프발매,http://www.monews.co.kr/news/articleView.html?idxno=207387
66,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”,http://www.lawissue.co.kr/view.php?ud=202001021647208438204ead0791_12
67,2020-01-02,전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.segyebiz.com/newsView/20200102512895?OutUrl=naver
68,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.economytalk.kr/news/articleView.html?idxno=202710
69,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”,http://newsbrite.net/132215
70,2020-01-02,전승호대웅제약사장글로벌사업확대미래성장동력육성,http://www.100ssd.co.kr/news/articleView.html?idxno=66411
71,2020-01-02,신년사전승호대웅제약사장글로벌사업확대와미래성장동력육성해야”,http://news.mk.co.kr/newsRead.php?no=6399&year=2020
72,2020-01-02,신년사전승호대웅제약사장2020년신약개발성과를창출하는한해가될것,http://www.seoulwire.com/news/articleView.html?idxno=265123
73,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.newscj.com/news/articleView.html?idxno=696381
74,2020-01-02,대웅제약보툴리눔톡신제재나보타중국3상착수2022년중국출시목표,http://www.econonews.co.kr/news/articleView.html?idxno=101624
75,2020-01-03,대웅제약글로벌 2025비전달성위해전사적역량집중,http://www.businesskorea.co.kr/news/articleView.html?idxno=39779
76,2020-01-03,대웅제약시무식개최글로벌2025비전달성위해전사적역량집중,http://www.thefirstmedia.net/news/articleView.html?idxno=52614
77,2020-01-03,신년사와직장인의과제18대웅제약유한양행동아쏘시오홀딩스올해키워드는능동적자세,http://www.news2day.co.kr/145636
78,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.bosa.co.kr/news/articleView.html?idxno=2119220
79,2020-01-03,대웅제약마케팅영업총괄부사장에40대이창재승진,http://medipana.com/news/news_viewer.asp?NewsNum=251121&MainKind=A&NewsKind=5&vCount=12&vKind=1
80,2020-01-03,대웅제약이창재본부장과대웅바이오진성곤본부장각각마케팅영업총괄부사장으로승진,http://www.g-enews.com/ko-kr/news/article/news_all/202001030725111007aca1a8c21a_1/article.html
81,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://www.viva100.com/main/view.php?key=20200103010000815
82,2020-01-03,나이아닌성과중심40대부사장인사낸대웅제약,https://view.asiae.co.kr/article/2020010307505723830
83,2020-01-03,대웅제약이창재본부장 마케팅영업총괄부사장으로승진  ,http://www.businesskorea.co.kr/news/articleView.html?idxno=39784
84,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장승진,http://www.medisobizanews.com/news/articleView.html?idxno=65478
85,2020-01-03,대웅제약그룹임원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89833
86,2020-01-03,대웅제약마케팅영업부사장에43세이창재본부장,http://www.dailypharm.com/Users/News/NewsView.html?ID=260579&REFERER=NP
87,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://www.wikileaks-kr.org/news/articleView.html?idxno=73978
88,2020-01-03,대웅제약총괄부사장에이창재본부장세대교체속도,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010308244279825
89,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.newsway.co.kr/news/view?tp=1&ud=2020010308263516916
90,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장승진,http://news.mt.co.kr/mtview.php?no=2020010308145992397
91,2020-01-03,40대젊은피수혈대웅제약신임부사장에이창재본부장선임,http://moneys.mt.co.kr/news/mwView.php?no=2020010308298061169
92,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장,https://www.kpanews.co.kr/article/show.asp?idx=209926&category=D
93,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://www.newspim.com/news/view/20200103000061
94,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239229
95,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.segyebiz.com/newsView/20200103502247?OutUrl=naver
96,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장승진,https://asiatime.co.kr/news/newsview.php?ncode=1065569603257530
97,2020-01-03,대웅제약이창재마케팅영업부사장승진40대젊은리더,http://www.newsis.com/view/?id=NISX20200103_0000878307&cID=13001&pID=13000
98,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://news1.kr/articles/?3807867
99,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://biz.newdaily.co.kr/site/data/html/2020/01/03/2020010300009.html
100,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.dailysmart.co.kr/news/articleView.html?idxno=20535
101,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.seoulwire.com/news/articleView.html?idxno=265168
102,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.ebn.co.kr/news/view/1016007/?sc=naver
103,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.etoday.co.kr/news/section/newsview.php?idxno=1841001
104,2020-01-03,인사대웅제약,http://daily.hankooki.com/lpage/society/202001/dh20200103091929137910.htm
105,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.econovill.com/news/articleView.html?idxno=381715
106,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,https://www.sedaily.com/NewsView/1YXI3Y45TU
107,2020-01-03,대웅제약젊은리더눈길40대이창재진성곤본부장부사장으로승진,http://www.paxetv.com/news/articleView.html?idxno=84105
108,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.ajunews.com/view/20200103092703673
109,2020-01-03,인사대웅제약,https://www.youthdaily.co.kr/news/article.html?no=25976
110,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.mdtoday.co.kr/mdtoday/index.html?no=374198
111,2020-01-03,인사대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.todaykorea.co.kr/news/view.php?no=267098
112,2020-01-03,인사대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.medicaltimes.com/Users/Inform/index.html?mode=View&ID=8853
113,2020-01-03,인사대웅제약이창재본부장부사장승진마케팅영업총괄,http://www.monews.co.kr/news/articleView.html?idxno=207415
114,2020-01-03,인사대웅제약,http://www.fnnews.com/news/202001030944429574
115,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://kormedi.com/?p=1308845
116,2020-01-03,대웅제약대웅바이오마케팅영업부사장에각각이창재진성곤본부장임명,http://inthenews.co.kr/article-30496/
117,2020-01-03,인사대웅제약,http://www.asiatoday.co.kr/view.php?key=20200103010001342
118,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.lawissue.co.kr/view.php?ud=202001030948281525204ead0791_12
119,2020-01-03,인사중앙그룹신한금융투자세계일보대웅제약,https://biz.seoul.co.kr/news/newsView.php?id=20200103500022&wlog_tag3=naver
120,2020-01-03,인사대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.nbnnews.co.kr/news/articleView.html?idxno=355771
121,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진40대젊은리더배치,http://www.ceoscoredaily.com/news/article.html?no=64531
122,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59055
123,2020-01-03,대웅제약이창재마케팅영업총괄부사장승진,https://www.paxnetnews.com/articles/55528
124,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.m-i.kr/news/articleView.html?idxno=669535
125,2020-01-03,대웅제약신임이창재마케팅영업총괄부사장선임,http://www.newstomato.com/ReadNews.aspx?no=943423
126,2020-01-03,제약산업대웅제약경구용장티푸스백신비보티프발매外,http://www.kukinews.com/news/article.html?no=733981
127,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장승진젊은리더발탁,http://www.ekn.kr/news/article.html?no=473658
128,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.medigatenews.com/board/people/view/708
129,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.newspost.kr/news/articleView.html?idxno=75048
130,2020-01-03,대웅제약성과중심인재중용”40대이창재부사장승진,http://www.sporbiz.co.kr/news/articleView.html?idxno=405839
131,2020-01-03,능력과성과중심으로인재중용대웅제약마케팅영업총괄부사장으로이창재본부장선임,http://www.updownnews.co.kr/news/articleView.html?idxno=213251
132,2020-01-03,대웅제약정기임원인사,http://www.bokuennews.com/news/article.html?no=185317
133,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.economytalk.kr/news/articleView.html?idxno=202740
134,2020-01-03,인사대웅제약,http://www.joongboo.com/news/articleView.html?idxno=363390155
135,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.newsprime.co.kr/news/article.html?no=489032
136,2020-01-03,젊어진대웅제약40대리더부사장승진,http://www.sisaweek.com/news/articleView.html?idxno=129602
137,2020-01-03,대웅제약사장이어부사장도40대파격배치철저한성과위주,http://news1.kr/articles/?3808104
138,2020-01-03,대웅제약부사장으로이창재대웅바이오부사장으로진성곤승진,http://www.businesspost.co.kr/BP?command=article_view&num=157955
139,2020-01-03,1월3일대웅제약주식종목시세134500원147,http://nbntv.co.kr/news/view/795546
140,2020-01-03,젊어지는대웅제약40대이창재본부장부사장승진,http://www.donga.com/news/article/all/20200103/99069890/1
141,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장승진,http://www.etnews.com/20200103000091
142,2020-01-03,인사세계일보대웅제약한국청소년정책연구원광주동구,http://www.businesspost.co.kr/BP?command=article_view&num=157981
143,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.newswatch.kr/news/articleView.html?idxno=26260
144,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://newsbrite.net/132241
145,2020-01-03,대웅제약대웅바이오성별나이상관없이인재중용,http://www.newslock.co.kr/news/articleView.html?idxno=24803
146,2020-01-03,나이보다성과40대부사장선택한대웅제약,https://biz.chosun.com/site/data/html_dir/2020/01/03/2020010301706.html?utm_source=naver&utm_medium=original&utm_campaign=biz
147,2020-01-03,대웅제약인사40대이창재마케팅∙영업총괄부사장,http://www.thevaluenews.co.kr/news/view.php?idx=157961
148,2020-01-03,대웅제약40대본부장부사장으로발탁,http://www.edaily.co.kr/news/newspath.asp?newsid=02669926625634112
149,2020-01-03,이창재대웅제약본부장부사장승진마케팅영업총괄,http://www.finomy.com/news/articleView.html?idxno=73743
150,2020-01-03,대웅제약대표이어부사장도40대선임나이보단능력,http://www.upinews.kr/newsView/upi202001030068
151,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.koreastocknews.com/news/articleView.html?idxno=49340
152,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.sisafocus.co.kr/news/articleView.html?idxno=229208
153,2020-01-03,오늘의인사대웅제약웰컴금융그룹외,http://www.ajunews.com/view/20200103135732858
154,2020-01-03,인사대웅제약,http://www.fetv.co.kr/news/article.html?no=44346
155,2020-01-03,대웅제약정기임원인사이창재본부장총괄부사장승진,http://www.mediapen.com/news/view/489946
156,2020-01-03,대웅제약젊은피전진배치이창재본부장부사장승진,http://www.shinailbo.co.kr/news/articleView.html?idxno=1239000
157,2020-01-03,전승호대웅제약대표글로벌2025달성위해역량집중,http://www.shinailbo.co.kr/news/articleView.html?idxno=1239014
158,2020-01-03,대웅제약이창재본부장부사장으로승진40대젊은리더,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001030372&t=NN
159,2020-01-03,인사대웅제약;화성산업;웰컴금융그룹등,https://www.hankyung.com/society/article/2020010315621
160,2020-01-03,대웅제약인사,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4025275
161,2020-01-03,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.wsobi.com/news/articleView.html?idxno=87874
162,2020-01-03,1월3일인사대웅제약한국청소년정책연구원外,http://www.news2day.co.kr/145758
163,2020-01-03,대웅제약정기임원인사단행이창재본부장마케팅영업총괄부사장승진,http://www.ftoday.co.kr/news/articleView.html?idxno=113637
164,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.newscj.com/news/articleView.html?idxno=696677
165,2020-01-04,인사대웅제약,https://www.ajunews.com/view/20200103160052998
166,2020-01-04,대웅제약이창재본부장마케팅영업총괄부사장으로승진발표,http://www.thefirstmedia.net/news/articleView.html?idxno=52682
167,2020-01-04,경제계인사대웅제약외,https://biz.chosun.com/site/data/html_dir/2020/01/04/2020010400127.html?utm_source=naver&utm_medium=original&utm_campaign=biz
168,2020-01-04,대웅제약이창재마케팅영업총괄부사장승진대웅바이오진성곤본부장도부사장승진,http://www.econonews.co.kr/news/articleView.html?idxno=101889
169,2020-01-04,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.getnews.co.kr/view.php?ud=20200104164921668941d0c69529_16
170,2020-01-06,CEO신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.cnbnews.com/news/article.html?no=432824
171,2020-01-06,대웅제약40대젊은리더십주목역동적인조직으로탈바꿈,http://www.rapportian.com/news/articleView.html?idxno=122529
172,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239276
173,2020-01-06,대웅제약빈혈치료제에포디온할랄인증,https://www.sedaily.com/NewsView/1YXJHS9XU0
174,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1841651
175,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.ebn.co.kr/news/view/1016295/?sc=naver
176,2020-01-06,대웅제약인도네시아합작법인대웅인피온통해바이오의약품할랄인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=20635
177,2020-01-06,대웅제약인도네시아법인빈혈치료제할랄인증,http://yna.kr/AKR20200106038900017?did=1195m
178,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=356202
179,2020-01-06,대웅제약인도네시아합작사적혈구생성인자제제할랄인증받아,http://news.mk.co.kr/newsRead.php?no=14107&year=2020
180,2020-01-06,대웅제약인도네시아합작법인바이오시밀러할랄인증획득,http://www.newspim.com/news/view/20200106000238
181,2020-01-06,대웅제약세계첫동물세포유래바이오의약품에포디온할랄인증,http://www.medisobizanews.com/news/articleView.html?idxno=65541
182,2020-01-06,대웅제약EPO제제인도네시아할랄인증,http://www.biospectator.com/view/news_view.php?varAtcId=9258
183,2020-01-06,대웅제약인도네시아법인빈혈치료제할랄인증,http://yna.kr/PYH20200106041600017?did=1196m
184,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020010609541703882
185,2020-01-06,대웅제약인도네시아합작법인대웅인피온통해세계최초동물세포유래바이오의약품할랄인증획득,http://newsbrite.net/132300
186,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.sisafocus.co.kr/news/articleView.html?idxno=229289
187,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1359797
188,2020-01-06,대웅제약동물세포유래바이오시밀러할랄인증,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001060144&t=NN
189,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.bokuennews.com/news/article.html?no=185350
190,2020-01-06,대웅제약대웅인포인통해바이오의약품할랄인증회득,http://medipana.com/news/news_viewer.asp?NewsNum=251191&MainKind=A&NewsKind=5&vCount=12&vKind=1
191,2020-01-06,대웅제약인도네시아합작법인바이오의약품할랄인증획득,http://weekly.cnbnews.com/news/article.html?no=131968
192,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.m-i.kr/news/articleView.html?idxno=670025
193,2020-01-06,대웅제약印尼법인빈혈치료제할랄인증,https://view.asiae.co.kr/article/2020010610202941024
194,2020-01-06,대웅제약인도네시아법인빈혈치료제에포디온할랄인증,http://www.pressm.kr/news/articleView.html?idxno=26971
195,2020-01-06,대웅제약인니합작법인통해동물세포유래바이오의약품할랄인증획득,http://www.newstomato.com/ReadNews.aspx?no=943754
196,2020-01-06,대웅제약인도네시아합작대웅인피온할랄인증,http://www.fnnews.com/news/202001061036454649
197,2020-01-06,대웅제약인도네시아법인에포디온할랄인증받아,https://cnbc.sbs.co.kr/article_hub/10000968266?division=NAVER
198,2020-01-06,대웅제약동물세포유래바이오의약품글로벌최초할랄인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020010610428026929
199,2020-01-06,대웅제약대웅인피온통해동물세포유래바이오의약품할랄인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59083
200,2020-01-06,대웅제약적혈구생성인자제제할랄인증획득,http://www.mhj21.com/126709
201,2020-01-06,대웅제약인니합작법인서에포디온동물세포유래바이오의약품할랄인증,http://www.newslock.co.kr/news/articleView.html?idxno=24838
202,2020-01-06,대웅제약동물세포유래바이오약최초할랄인증,http://www.bosa.co.kr/news/articleView.html?idxno=2119330
203,2020-01-06,대웅제약인도네시아법인빈혈치료제에포디온할랄인증,http://kormedi.com/?p=1308946
204,2020-01-06,대웅제약합작법인대웅인피온세계최초할랄인증,http://daily.hankooki.com/lpage/ittech/202001/dh20200106114430145630.htm
205,2020-01-06,대웅제약인도네시아법인적혈구생성인자제제할랄인증획득,http://www.seoulwire.com/news/articleView.html?idxno=265461
206,2020-01-06,대웅제약인도네시아에서바이오의약품할랄인증획득,http://www.joseilbo.com/news/news_read.php?uid=389980&class=27&grp=
207,2020-01-06,1월6일대웅제약증권매매221132500원,http://nbntv.co.kr/news/view/796773
208,2020-01-06,대웅제약인니합작법인대웅인피온세계최초동물세포유래바이오의약품할랄인증획득,http://www.g-enews.com/ko-kr/news/article/news_all/202001061313188500aca1a8c21a_1/article.html
209,2020-01-06,대웅제약인니합작대웅인피온바이오의약품할랄인증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2020010600091
210,2020-01-06,대웅제약인도네시아합작법인세계최초동물세포유래바이오의약품할랄인증획득,http://www.koreaittimes.com/news/articleView.html?idxno=94922
211,2020-01-06,대웅제약인도네시아합작법인동물세포유래바이오의약품할랄인증획득,http://news.mk.co.kr/newsRead.php?no=15427&year=2020
212,2020-01-06,대웅제약빈혈치료제할랄인증,https://www.hankyung.com/it/article/202001065597i
213,2020-01-06,대웅제약인도네시아합작법인에포디온할랄인증획득,http://inthenews.co.kr/article-30698/
214,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.wsobi.com/news/articleView.html?idxno=87948
215,2020-01-06,대웅제약인도네시아합작법인대웅인피온통해동물세포유래바이오의약품할랄인증획득,http://www.lawissue.co.kr/view.php?ud=202001061420323236204ead0791_12
216,2020-01-06,대웅제약인도네시아법인빈혈치료제바이오시밀러할랄인증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010614302158839
217,2020-01-06,대웅제약인도네시아법인빈혈치료제바이오시밀러할랄인증,https://biz.chosun.com/site/data/html_dir/2020/01/06/2020010602174.html?utm_source=naver&utm_medium=original&utm_campaign=biz
218,2020-01-06,대웅제약동물세포유래바이오의약품으로인도네시아할랄인증받아,http://www.businesspost.co.kr/BP?command=article_view&num=158220
219,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증,https://www.nocutnews.co.kr/news/5268460
220,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증,http://www.wikileaks-kr.org/news/articleView.html?idxno=74212
221,2020-01-06,대웅제약빈혈치료제에포디온할랄인증,http://www.seoulfn.com/news/articleView.html?idxno=367990
222,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.ekn.kr/news/article.html?no=474114
223,2020-01-06,대웅제약중동의약품시장진출청신호대웅인피온통해세계최초동물세포유래바이오의약품할랄인증획득,http://www.updownnews.co.kr/news/articleView.html?idxno=213344
224,2020-01-06,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.kukinews.com/news/article.html?no=734841
225,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.medigatenews.com/news/3384340765
226,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.dailian.co.kr/news/view/858933/?sc=naver
227,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=374358
228,2020-01-06,대웅제약대웅인피온통해바이오의약품할랄인증획득,http://www.newsian.co.kr/news/articleView.html?idxno=39232
229,2020-01-06,대웅제약세계최초바이오의약품할랄인증획득,http://www.donga.com/news/article/all/20200106/99105613/1
230,2020-01-06,대웅제약인도네시아합작법인대웅인피온바이오의약품할랄인증,http://news1.kr/articles/?3810105
231,2020-01-06,대웅제약印尼합작사대웅인피온빈혈치료제에포디온할랄인증,http://www.dt.co.kr/contents.html?article_no=2020010702101931102002&ref=naver
232,2020-01-06,대웅제약인도네시아합작법인대웅인피온바이오의약품할랄인증획득,http://www.newscj.com/news/articleView.html?idxno=697343
233,2020-01-06,대웅제약인도네시아법인빈혈치료제할랄인증,http://www.edaily.co.kr/news/newspath.asp?newsid=03899926625635096
234,2020-01-07,대웅제약인도네시아합작법인대웅인피온통해동물세포유래바이오의약품할랄인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=52733
235,2020-01-07,보톡스보툴리눔톡신테마오전시황상승률상위종목메디톡스195휴온스132대웅제약114등,http://www.gokorea.kr/news/articleView.html?idxno=621952
236,2020-01-07,대웅제약주식실시간7일현재134000원,http://nbntv.co.kr/news/view/797787
237,2020-01-07,보톡스보툴리눔톡신테마오후시황상승률상위종목메디톡스523휴젤247대웅제약227등,http://www.gokorea.kr/news/articleView.html?idxno=623405
238,2020-01-07,13시28분보톡스보툴리눔톡신오후의테마종목메디톡스대웅제약등이주도,http://nbntv.co.kr/news/view/798575
239,2020-01-07,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목메디톡스17000원563휴젤9300원245대웅제약3000원227상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156000
240,2020-01-07,대웅제약vs메디톡스보톡스전쟁끝이보인다,http://www.edaily.co.kr/news/newspath.asp?newsid=03663766625635424
241,2020-01-07,보톡스보툴리눔톡신테마마감시황상승률상위종목메디톡스699휴젤289대웅제약152등,http://www.gokorea.kr/news/articleView.html?idxno=623779
242,2020-01-08,★주식인사이드대웅제약주가132000원1월8일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1056185
243,2020-01-08,대웅제약인니합작법인대웅인피온적혈구제제에포디온할랄인증획득,http://www.cnbnews.com/news/article.html?no=433112
244,2020-01-08,대웅제약0696208일336변동종목그래프및거래동향,http://www.gokorea.kr/news/articleView.html?idxno=624479
245,2020-01-08,대웅제약영국아박타사와줄기세포기반면역질환치료제개발박차,http://www.getnews.co.kr/view.php?ud=2020010810410640241d0c69529_16
246,2020-01-08,대웅제약英아박타와줄기세포기반면역질환치료제개발위한JV설립키로,http://news.mk.co.kr/newsRead.php?no=23164&year=2020
247,2020-01-08,대웅제약英아박타사와조인트벤처설립면역질환치료제개발박차,http://www.segye.com/content/html/2020/01/08/20200108505902.html?OutUrl=naver
248,2020-01-08,대웅제약英아박타와조인트벤처설립파트너십,http://www.newspim.com/news/view/20200108000369
249,2020-01-08,대웅제약英바이오텍과조인트벤처,https://www.sedaily.com/NewsView/1YXKFJG4ZW
250,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.medisobizanews.com/news/articleView.html?idxno=65638
251,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.newsway.co.kr/news/view?tp=1&ud=2020010810501400847
252,2020-01-08,대웅제약영국아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.lawissue.co.kr/view.php?ud=202001081053119987204ead0791_12
253,2020-01-08,대웅제약아박타JV설립면역질환치료제개발,http://www.etnews.com/20200108000087
254,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환약개발,http://www.newsis.com/view/?id=NISX20200108_0000882656&cID=13001&pID=13000
255,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.bosa.co.kr/news/articleView.html?idxno=2119467
256,2020-01-08,​​대웅제약면역질환치료제개발속도英아박타와조인트벤처설립,http://www.etoday.co.kr/news/section/newsview.php?idxno=1842745
257,2020-01-08,대웅제약영국아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.nbnnews.co.kr/news/articleView.html?idxno=356973
258,2020-01-08,대웅제약영국아박타와조인트벤처설립계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=251327&MainKind=A&NewsKind=5&vCount=12&vKind=1
259,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.edaily.co.kr/news/newspath.asp?newsid=02719126625635752
260,2020-01-08,대웅제약英바이오기업과합작법인면역질환치료제개발,https://view.asiae.co.kr/article/2020010811050188307
261,2020-01-08,대웅제약英아박타사와조인트벤처설립세포치료제개발박차,http://www.viva100.com/main/view.php?key=20200108010002522
262,2020-01-08,대웅제약英기업과JV설립면역질환치료제개발,http://news.mt.co.kr/mtview.php?no=2020010811004015718
263,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발박차,http://daily.hankooki.com/lpage/ittech/202001/dh20200108110737145630.htm
264,2020-01-08,대웅제약영국아박타JV설립면역질환치료제개발,http://yna.kr/AKR20200108077400017?did=1195m
265,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.newsprime.co.kr/news/article.html?no=489510
266,2020-01-08,대웅제약면역질환치료제개발맞손英아박타와조인트벤처설립,http://www.ezyeconomy.com/news/articleView.html?idxno=96901
267,2020-01-08,1월8일대웅제약주식추천주336129500원,http://nbntv.co.kr/news/view/800118
268,2020-01-08,대웅제약영국아박타와조인트벤처설립,http://www.fnnews.com/news/202001081114351298
269,2020-01-08,국민연금셀트리온유한양행대웅제약품었다,http://news.mt.co.kr/mtview.php?no=2020010710520870343
270,2020-01-08,대웅제약 영국 아박타사와 조인트벤처 설립 통해 면역질환 치료제 개발 박차 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=39931
271,2020-01-08,대웅제약영국아박타사와조인트벤처설립면역질환치료제개발박차,http://www.ceoscoredaily.com/news/article.html?no=64700
272,2020-01-08,대웅제약英아박타손잡고면역질환치료제개발한다,https://www.hankyung.com/it/article/202001081499i
273,2020-01-08,대웅제약英아박타와JV설립면역질환신약개발,http://www.biospectator.com/view/news_view.php?varAtcId=9273
274,2020-01-08,대웅제약英아박타와합작기업신설,http://www.dt.co.kr/contents.html?article_no=2020010802109931102002&ref=naver
275,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,http://www.metroseoul.co.kr/news/newsview?newscd=2020010800068
276,2020-01-08,​​대웅제약英아박타조인트벤처설립면역질환치료제개발,http://kormedi.com/?p=1309102
277,2020-01-08,대웅제약英아박타와면역질환치료제개발박차,http://www.dailysmart.co.kr/news/articleView.html?idxno=20765
278,2020-01-08,대웅제약아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59119
279,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239377
280,2020-01-08,데일리주식정보대웅제약069620오후12시25분기준외매매동향,https://www.dailysecu.com/news/articleView.html?idxno=94339
281,2020-01-08,대웅제약英아박타사와조인트벤처설립면역질환치료제개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075895
282,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,http://www.mediapen.com/news/view/491077
283,2020-01-08,대웅제약아박타조인트벤처설립면역질환치료제개발,http://www.pressm.kr/news/articleView.html?idxno=27017
284,2020-01-08,대웅제약英아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.medigatenews.com/news/3683394603
285,2020-01-08,대웅제약英바이오텍아박타와조인트벤처설립계약면역질환치료제개발,http://www.donga.com/news/article/all/20200108/99135298/1
286,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.econovill.com/news/articleView.html?idxno=382189
287,2020-01-08,대웅제약英아박타社와조인트벤처설립면역질환신약개발착수,http://www.newswatch.kr/news/articleView.html?idxno=26392
288,2020-01-08,대웅제약영국바이오기업과JV설립면역질환치료제개발,http://moneys.mt.co.kr/news/mwView.php?no=2020010813578032687
289,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.economytalk.kr/news/articleView.html?idxno=202891
290,2020-01-08,대웅제약영국바이오회사와합작사전승호면역질환치료제개발,http://www.businesspost.co.kr/BP?command=article_view&num=158603
291,2020-01-08,대웅제약영국바이오텍과JV설립면역질환치료제개발박차,http://www.newstomato.com/ReadNews.aspx?no=944421
292,2020-01-08,대웅제약英아박타와조인트벤처설립통해면역질환치료제개발박차,http://www.m-i.kr/news/articleView.html?idxno=670988
293,2020-01-08,대웅제약조인트벤처통해면역질환치료제개발,http://www.mhj21.com/126758
294,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,https://asiatime.co.kr/news/newsview.php?ncode=1065588195441979
295,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,http://www.seoulwire.com/news/articleView.html?idxno=265905
296,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발박차”,http://sports.hankooki.com/lpage/economy/202001/sp20200108144230137020.htm
297,2020-01-08,대웅제약영국아박타와조인트벤처설립,http://news.bizwatch.co.kr/article/consumer/2020/01/08/0011/naver
298,2020-01-08,대웅제약아박타사와면역질환치료제개발,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001080263&t=NN
299,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.newsian.co.kr/news/articleView.html?idxno=39307
300,2020-01-08,대웅제약영국아박타사와조인트벤처면역질환치료제개발박차,http://www.enewstoday.co.kr/news/articleView.html?idxno=1360410
301,2020-01-08,대웅제약영국아박타와조인트벤처설립,http://www.ebn.co.kr/news/view/1016802/?sc=naver
302,2020-01-08,심상찮은대웅제약의글로벌행보,http://www.wikileaks-kr.org/news/articleView.html?idxno=74415
303,2020-01-08,대웅제약英아박타조인트벤처설립통해면역질환치료제개발박차,http://www.ftoday.co.kr/news/articleView.html?idxno=113723
304,2020-01-08,대웅제약영국아박타사와조인트벤처통해면역질환치료제개발나서,http://www.thefirstmedia.net/news/articleView.html?idxno=52806
305,2020-01-08,대웅제약英아박타와조인트벤처설립세포치료제연구,https://biz.chosun.com/site/data/html_dir/2020/01/08/2020010802414.html?utm_source=naver&utm_medium=original&utm_campaign=biz
306,2020-01-08,대웅제약영국아박타와JV설립면역질환치료제개발,http://www.monews.co.kr/news/articleView.html?idxno=207536
307,2020-01-08,대웅제약면역질환치료제개발박차영국아박타와조인트벤처설립,http://www.g-enews.com/ko-kr/news/article/news_all/20200108151455537069d76442fa_1/article.html
308,2020-01-08,Bio톡스메디톡스vs대웅제약균주소송전3가지시나리오,http://www.newspim.com/news/view/20200108000874
309,2020-01-08,대웅제약아박타와면역질환제개발조인트벤처설립,http://www.shinailbo.co.kr/news/articleView.html?idxno=1240320
310,2020-01-08,대웅제약영국아박타사와함께면역질환치료제개발박차,http://www.ekn.kr/news/article.html?no=474605
311,2020-01-08,면역질환치료제개발박차대웅제약아박타社와조인트벤처설립,http://kpenews.com/View.aspx?No=647218
312,2020-01-08,대웅제약영국기업과조인트벤처설립면역질환신약개발,http://news1.kr/articles/?3812078
313,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발박차,http://www.mdtoday.co.kr/mdtoday/index.html?no=374550
314,2020-01-08,대웅제약오너처벌해야”청와대청원등장대체무슨일이,http://www.ajunews.com/view/20200108171616267
315,2020-01-08,대웅제약아박타면역질환치료제개발위해조인트벤처설립,http://www.k-health.com/news/articleView.html?idxno=46852
316,2020-01-08,대웅제약영국아박타사와조인트벤처설립통해면역질환치료제개발박차,http://newsbrite.net/132427
317,2020-01-08,대웅제약면역질환치료제개발위해영국아박타와JV설립,http://www.seoulfn.com/news/articleView.html?idxno=368264
318,2020-01-08,대웅제약 영국 아박타와 조인트벤처 설립면역질환 치료제 개발 박차,http://www.newslock.co.kr/news/articleView.html?idxno=24910
319,2020-01-08,대웅제약英아박타와조인트벤처설립,http://www.fnnews.com/news/202001081903450882
320,2020-01-08,대웅제약영국아박타와면역질환치료제개발박차,http://www.wsobi.com/news/articleView.html?idxno=88139
321,2020-01-08,대웅제약영국아박타사와조인트벤처설립면역질환치료제개발박차,http://www.newscj.com/news/articleView.html?idxno=698003
322,2020-01-09,메디톡스vs대웅제약보톡스전쟁6월판가름난다,http://www.mdtoday.co.kr/mdtoday/index.html?no=374575
323,2020-01-09,대웅제약4분기영업익컨센서스하회전망목표가↓삼성증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1843131
324,2020-01-09,대웅제약영국바이오텍과함께면역질환치료제개발,http://news.heraldcorp.com/view.php?ud=20200109000041
325,2020-01-09,★주식인사이드대웅제약주가131000원1월9일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1056484
326,2020-01-09,대웅제약▲1500주가목표액210000원삼성증권소송리스크가관건,http://nbntv.co.kr/news/view/801838
327,2020-01-09,대웅제약줄기세포면역질환치료제개발나서,http://www.bokuennews.com/news/article.html?no=185503
328,2020-01-09,대웅제약4Q실적컨센서스밑돌듯목표주가87하향,http://www.econovill.com/news/articleView.html?idxno=382270
329,2020-01-09,1월9일대웅제약종목정보039변동,http://www.gokorea.kr/news/articleView.html?idxno=626488
330,2020-01-09,대웅제약아박타조인트벤처설립면역질환치료제개발박차,http://www.cnbnews.com/news/article.html?no=433251
331,2020-01-09,1월9일대웅제약주식증권039130000원,http://nbntv.co.kr/news/view/802396
332,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.getnews.co.kr/view.php?ud=20200109110305376741d0c69529_16
333,2020-01-09,대웅제약글로벌빅파마와RD로드맵공유,http://www.dailypharm.com/Users/News/NewsView.html?ID=260762&REFERER=NP
334,2020-01-09,대웅제약JP모건컨퍼런스에서해외진출전략공개,https://www.sedaily.com/NewsView/1YXKVYYUX9
335,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가신약개발로드맵제시,http://www.viva100.com/main/view.php?key=20200109010003002
336,2020-01-09,대웅제약JP모건컨퍼런스서글로벌사업RD로드맵제시,http://www.medisobizanews.com/news/articleView.html?idxno=65684
337,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과 R로드맵제시,http://www.businesskorea.co.kr/news/articleView.html?idxno=39974
338,2020-01-09,대웅제약글로벌사업RD로드맵제시,http://www.bosa.co.kr/news/articleView.html?idxno=2119555
339,2020-01-09,대웅제약JP모건서연구개발해외진출전략로드맵공개,http://www.newspim.com/news/view/20200109000820
340,2020-01-09,대웅제약JP모건컨퍼런스서신약로드맵공개,http://news.mt.co.kr/mtview.php?no=2020010911220101552
341,2020-01-09,대웅제약美JP모건서글로벌RD전략공개한다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010911255683952
342,2020-01-09,대웅제약비용부담늘어4분기영업이익기대이하추정,http://www.businesspost.co.kr/BP?command=article_view&num=158761
343,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업RD로드맵발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1843288
344,2020-01-09,대웅제약JP모건컨퍼런스통해신약개발로드맵공개,http://www.rapportian.com/news/articleView.html?idxno=122654
345,2020-01-09,대웅제약나보타ITC소송상반기일단락되나,http://medipana.com/news/news_viewer.asp?NewsNum=251382&MainKind=A&NewsKind=5&vCount=12&vKind=1
346,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.dailysmart.co.kr/news/articleView.html?idxno=20820
347,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업RD로드맵제시,http://www.mdtoday.co.kr/mdtoday/index.html?no=374634
348,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.newslock.co.kr/news/articleView.html?idxno=24943
349,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참석RD로드맵공개,http://www.metroseoul.co.kr/news/newsview?newscd=2020010900091
350,2020-01-09,대웅제약JP모건컨퍼런스서RD로드맵제시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075935
351,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서RD로드맵제시,http://www.newsway.co.kr/news/view?tp=1&ud=2020010913080455025
352,2020-01-09,윤제승대웅제약전회장분식회계및허위공시의혹경영복귀설솔솔,http://www.newsworker.co.kr/news/articleView.html?idxno=57100
353,2020-01-09,대웅제약JP모건참가RD로드맵제시,https://www.paxnetnews.com/articles/55706
354,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.nbnnews.co.kr/news/articleView.html?idxno=357438
355,2020-01-09,대웅제약JP모건컨퍼런스서나보타펙수프라잔로드맵발표,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001090483&t=NN
356,2020-01-09,글로벌사업과RD로드맵제시대웅제약JP모건헬스케어컨퍼런스에서자사우수성발표,http://www.updownnews.co.kr/news/articleView.html?idxno=213512
357,2020-01-09,대웅제약오는15일美서글로벌전략발표한국제약경쟁력각인시킬것”,http://www.donga.com/news/article/all/20200109/99155096/1
358,2020-01-09,대웅제약해외진출전략RD로드맵제시,http://www.newsprime.co.kr/news/article.html?no=489653
359,2020-01-09,대웅제약전승호사장JP모건헬스케어컨퍼런스서글로벌전략발표,http://www.koreaittimes.com/news/articleView.html?idxno=94990
360,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌∙RD전략발표,http://www.pressm.kr/news/articleView.html?idxno=27040
361,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가,http://www.whosaeng.com/115205
362,2020-01-09,대웅제약美서신약개발전략발표,https://view.asiae.co.kr/article/2020010914411403223
363,2020-01-09,대웅제약JP모건헬스케어컨퍼런스글로벌사업및RD로드맵제시,http://www.ekn.kr/news/article.html?no=474806
364,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서RD로드맵공개,http://www.segyebiz.com/newsView/20200109509802?OutUrl=naver
365,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.wikileaks-kr.org/news/articleView.html?idxno=74502
366,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가,http://www.ebn.co.kr/news/view/1017005/?sc=naver
367,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.medigatenews.com/news/2994010038
368,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서해외진출전략신약로드맵공개,http://it.chosun.com/site/data/html_dir/2020/01/09/2020010902581.html
369,2020-01-09,대웅제약이지듀메이크업라인할인이벤트진행,http://moneys.mt.co.kr/news/mwView.php?no=2020010915008054059
370,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서해외진출및신약개발전략발표,http://news.mk.co.kr/newsRead.php?no=30043&year=2020
371,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가글로벌사업및RD로드맵제시,http://www.ezyeconomy.com/news/articleView.html?idxno=96945
372,2020-01-09,대웅제약미국서신약개발로드맵공개,http://news.mk.co.kr/newsRead.php?no=30134&year=2020
373,2020-01-09,JP모건헬스케어전승호사장대웅제약가치확실히알린다,http://www.econovill.com/news/articleView.html?idxno=382310
374,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://newsbrite.net/132472
375,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59138
376,2020-01-09,대웅제약JP모건서글로벌사업RD로드맵제시,http://www.newstomato.com/ReadNews.aspx?no=944788
377,2020-01-09,대웅제약JP모건헬스케어콘퍼런스참가글로벌사업과RD로드맵제시,http://sports.hankooki.com/lpage/economy/202001/sp20200109160600137020.htm
378,2020-01-09,대웅제약JP모건컨퍼런스서글로벌사업RD로드맵공개,http://inthenews.co.kr/article-31389/
379,2020-01-09,靑국민청원인윤재승전대웅제약회장이135억원횡령증거도다수확보,http://www.sisajournal-e.com/news/articleView.html?idxno=211867
380,2020-01-09,윤재승대웅제약회장130억원회삿돈횡령불기소청원檢외압의혹제기,http://www.beyondpost.co.kr/view.php?ud=202001081927184295c5c1bde209_30
381,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.dailian.co.kr/news/view/859992/?sc=naver
382,2020-01-09,대웅제약JP모건헬스케어콘퍼런스서글로벌RD전략발표,http://www.asiatoday.co.kr/view.php?key=20200109010005276
383,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.m-i.kr/news/articleView.html?idxno=671525
384,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서신약개발계획발표한다,http://www.sisafocus.co.kr/news/articleView.html?idxno=229598
385,2020-01-09,대웅제약JP모건헬스케어컨퍼런스글로벌사업과RD로드맵제시,http://www.segye.com/content/html/2020/01/09/20200109515063.html?OutUrl=naver
386,2020-01-09,대웅제약메디톡스균주분쟁종착역보여진쪽은치명적타격불가피,http://www.businesspost.co.kr/BP?command=article_view&num=158887
387,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.newscj.com/news/articleView.html?idxno=698374
388,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.lawissue.co.kr/view.php?ud=202001092107362534204ead0791_12
389,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.thefirstmedia.net/news/articleView.html?idxno=52874
390,2020-01-09,대웅제약15일美서신약개발로드맵공개,http://www.seoulwire.com/news/articleView.html?idxno=266162
391,2020-01-09,대웅제약아박타면역질환치료제위한조인트벤처세워,https://www.kpanews.co.kr/article/show.asp?idx=210030&category=D
392,2020-01-10,영업강자대웅제약펙수프라잔케이캡의대항마될까,http://www.newsis.com/view/?id=NISX20200109_0000884632&cID=13001&pID=13000
393,2020-01-10,★주식인사이드대웅제약주가130000원1월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1056781
394,2020-01-10,대웅제약전일대비536이시각1만8952주거래,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001100177&t=NN
395,2020-01-10,대웅제약5이상상승주가20일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202001107698L
396,2020-01-10,대웅제약06962010일651변화증권그래프및종목분석,http://www.gokorea.kr/news/articleView.html?idxno=628527
397,2020-01-10,대웅제약JP모건컨퍼런스서글로벌사업RD로드맵공개,http://www.cnbnews.com/news/article.html?no=433381
398,2020-01-10,대웅제약오늘증권시세10일현재138000원,http://nbntv.co.kr/news/view/804841
399,2020-01-10,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.kukinews.com/news/article.html?no=736342
400,2020-01-10,대웅제약728상승중하락추세중이평선뚫고급등,http://www.newspim.com/news/view/20200110000651
401,2020-01-10,바이오시밀러복제바이오의약품테마오후시황상승률상위종목한올바이오파마977대웅제약766알테오젠562등,http://www.gokorea.kr/news/articleView.html?idxno=628940
402,2020-01-10,바이오시밀러복제바이오의약품테마오후시황상승률상위종목한올바이오파마977대웅제약766알테오젠562등,http://www.gokorea.kr/news/articleView.html?idxno=628940
403,2020-01-10,치매관련주테마오후시황상승률상위종목대웅제약766리메드618SK케미칼599등,http://www.gokorea.kr/news/articleView.html?idxno=628977
404,2020-01-10,제약업종13시현재주식시황상승률상위종목한올바이오파마3100원891대웅제약9500원728티움바이오1100원683,http://www.cctvnews.co.kr/news/articleView.html?idxno=156710
405,2020-01-10,10일13시바이오시밀러복제바이오의약품테마주시황오후한올바이오파마대웅제약등이상승세견인중,http://nbntv.co.kr/news/view/805271
406,2020-01-10,13시24분보톡스보툴리눔톡신테마주오후시황대웅제약제테마등이상승세주도,http://nbntv.co.kr/news/view/805276
407,2020-01-10,제약업종돋보기제약견인종목에이프로젠제약870상승한올바이오파마862대웅제약728상승,http://nbntv.co.kr/news/view/805302
408,2020-01-10,10일13시치매관련주테마주시황오후대웅제약리메드등이주도,http://nbntv.co.kr/news/view/805341
409,2020-01-10,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목대웅제약9000원690제테마1150원556메디톡스8400원255상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156779
410,2020-01-10,바이오시밀러복제바이오의약품테마13시현재주식시황상승률상위종목에이프로젠제약125원988한올바이오파마2950원848대웅제약9000원690상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156775
411,2020-01-10,치매관련주테마13시현재주식시황상승률상위종목에이프로젠제약125원988대웅제약9000원690리메드850원656상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156800
412,2020-01-10,제약업종오후시황상승률상위종목한올바이오파마805대웅제약651에이프로젠제약632등,http://www.gokorea.kr/news/articleView.html?idxno=629142
413,2020-01-10,보톡스보툴리눔톡신테마주시황마감제테마대웅제약등이주도,http://nbntv.co.kr/news/view/805903
414,2020-01-10,바이오시밀러복제바이오의약품테마주마감한올바이오파마대웅제약등이주도,http://nbntv.co.kr/news/view/805921
415,2020-01-10,치매관련주테마주시황마감리메드대웅제약등이주도,http://nbntv.co.kr/news/view/805961
416,2020-01-10,업종이슈제약업주요종목10일종가티움바이오1600원994상승한올바이오파마2700원776상승대웅제약8500원651상승,http://nbntv.co.kr/news/view/805991
417,2020-01-10,제약업종마감시황상승률상위종목티움바이오994한올바이오파마776대웅제약651등,http://www.gokorea.kr/news/articleView.html?idxno=629659
418,2020-01-10,보톡스보툴리눔톡신테마마감시황상승률상위종목제테마870대웅제약651메디톡스446등,http://www.gokorea.kr/news/articleView.html?idxno=629701
419,2020-01-10,바이오시밀러복제바이오의약품테마마감시황상승률상위종목한올바이오파마776대웅제약651LG화학604등,http://www.gokorea.kr/news/articleView.html?idxno=629719
420,2020-01-10,치매관련주테마마감시황상승률상위종목리메드772대웅제약651SK케미칼599등,http://www.gokorea.kr/news/articleView.html?idxno=629752
421,2020-01-10,대웅제약JP모건헬스케어컨퍼런스서글로벌사업RD로드맵제시,http://www.newsian.co.kr/news/articleView.html?idxno=39380
422,2020-01-12,대웅제약JP모건헬스케어컨퍼런스신약로드맵공개,http://weekly.cnbnews.com/news/article.html?no=132056
423,2020-01-13,★주식인사이드대웅제약주가140500원1월13일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1057231
424,2020-01-13,보톡스보툴리눔톡신테마09시현재주식시황상승률상위종목파마리서치프로덕트1200원339메디톡스8300원241대웅제약2500원180상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156918
425,2020-01-13,대웅제약주가06962013일216변화,http://www.gokorea.kr/news/articleView.html?idxno=630556
426,2020-01-13,대웅제약주식현황13일현재143000원,http://nbntv.co.kr/news/view/807336
427,2020-01-13,삼성바이오셀트리온대웅제약등JP모건서KBIO눈도장찍는다,http://daily.hankooki.com/lpage/ittech/202001/dh20200113143154145630.htm
428,2020-01-13,대웅제약메디톡스보톡스소송올해끝나나,http://www.newsian.co.kr/news/articleView.html?idxno=39421
429,2020-01-13,제약바이오CEO미국총집결한미약품셀트리온삼성바이오로직스JW중외제약대웅제약등JP모건컨퍼런스참가,https://www.sisa-news.com/news/article.html?no=123122
430,2020-01-14,SK대웅제약뛰어든다줄기세포치료제시장볼륨업,http://www.viva100.com/main/view.php?key=20200112010003690
431,2020-01-14,전승호윤재춘대웅제약대표매출늘리고영업이익개선,http://www.datanews.co.kr/news/article.html?no=105754
432,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구,http://www.viva100.com/main/view.php?key=20200114010004456
433,2020-01-14,대웅제약AI결합된신약설계플랫폼가진美A2A와항암제공동개발키로,http://news.mk.co.kr/newsRead.php?no=42882&year=2020
434,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입 ,http://www.dailian.co.kr/news/view/861067?sc=Naver
435,2020-01-14,대웅제약美바이오기업과AI기반항암신약공동연구,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020011409081164856
436,2020-01-14,대웅제약미국A2A파마와맞손AI기반항암신약공동연구,http://www.etoday.co.kr/news/section/newsview.php?idxno=1844756
437,2020-01-14,대웅제약미국기업과항암신약공동연구나서,http://moneys.mt.co.kr/news/mwView.php?no=2020011409048083936
438,2020-01-14,대웅제약美A2A와항암신약공동연구파트너십,http://news.mt.co.kr/mtview.php?no=2020011409031644062
439,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239544
440,2020-01-14,대웅제약美A2A파마사와AI기반항암신약공동연구돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=20994
441,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구,http://medipana.com/news/news_viewer.asp?NewsNum=251550&MainKind=A&NewsKind=5&vCount=12&vKind=1
442,2020-01-14,대웅제약A2A파마社와AI기반항암신약공동연구,http://www.consumuch.com/news/articleView.html?idxno=47212
443,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.getnews.co.kr/view.php?ud=20200114091832454441d0c69529_16
444,2020-01-14,대웅제약美A2A파마와AI항암신약공동연구계약,http://www.biospectator.com/view/news_view.php?varAtcId=9312
445,2020-01-14,대웅제약美바이오기업과AI항암신약공동연구개발,http://www.newspim.com/news/view/20200114000148
446,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2020011400014
447,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2020011409234410159
448,2020-01-14,대웅제약미국바이오텍과AI연구돌입항암신약개발,http://www.newsis.com/view/?id=NISX20200114_0000887953&cID=13001&pID=13000
449,2020-01-14,대웅제약 미국 A2A 파마社와 AI 기반항암신약공동연구  ,http://www.medisobizanews.com/news/articleView.html?idxno=65811
450,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=358700
451,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구돌입,http://www.asiatoday.co.kr/view.php?key=20200114010007378
452,2020-01-14,대웅제약A2A파마AI기반항암신약공동연구돌입,https://asiatime.co.kr/news/newsview.php?ncode=1065571496000768
453,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,https://www.sedaily.com/NewsView/1YXN6TIZS2
454,2020-01-14,JP모건첫희소식대웅제약AI신약개발파트너찾다,http://www.bosa.co.kr/news/articleView.html?idxno=2119805
455,2020-01-14,대웅제약미국AI기반신약개발기업과공동연구,http://yna.kr/AKR20200114047800017?did=1195m
456,2020-01-14,대웅제약미국벤처와AI기반항암제개발제휴,http://www.dailypharm.com/Users/News/NewsView.html?ID=260894&REFERER=NP
457,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구돌입,http://www.m-i.kr/news/articleView.html?idxno=672433
458,2020-01-14,대웅제약美A2A파마와맞손AI기반항암신약공동연구,http://www.seoulwire.com/news/articleView.html?idxno=266646
459,2020-01-14,대웅제약미국AI기반신약개발기업과공동연구,http://yna.kr/PYH20200114031600017?did=1196m
460,2020-01-14,대웅제약미국A2A파마와AI기반항암신약연구돌입,http://www.news2day.co.kr/146425
461,2020-01-14,대웅제약AI로항암신약개발한다美바이오기업과파트너십체결,http://it.chosun.com/site/data/html_dir/2020/01/14/2020011401256.html
462,2020-01-14,대웅제약미국A2A와AI기반항암신약공동연구돌입,http://www.newstomato.com/ReadNews.aspx?no=945530
463,2020-01-14,대웅제약미국A2A파마사와AI기반항암신약공동연구돌입,http://www.ezyeconomy.com/news/articleView.html?idxno=97045
464,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구돌입,http://inthenews.co.kr/article-31761/
465,2020-01-14,대웅제약AI활용항암제개발 돌입,http://www.seoulfn.com/news/articleView.html?idxno=368735
466,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=374970
467,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.newsfc.co.kr/news/articleView.html?idxno=39412
468,2020-01-14,대웅제약 A2A 파마사와 AI 기반항암신약공동연구돌입  ,http://www.newslock.co.kr/news/articleView.html?idxno=25031
469,2020-01-14,대웅제약美바이오기업과항암신약공동개발추진,http://www.rapportian.com/news/articleView.html?idxno=122739
470,2020-01-14,대웅제약미국신약설계플랫폼기업과항암파트너십,http://health.chosun.com/site/data/html_dir/2020/01/14/2020011401375.html
471,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구,http://www.etnews.com/20200114000037
472,2020-01-14,대웅제약AI기반항암신약개발나선다,http://www.whosaeng.com/115283
473,2020-01-14,대웅제약JP모건서AI기반항암신약물질개발협약오픈이노베이션강화,http://news1.kr/articles/?3816186
474,2020-01-14,대웅제약A2A파마사와AI기반항암신약개발JP모건헬스케어컨퍼런스2020,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001140201&t=NN
475,2020-01-14,대웅제약미국A2A파마社와AI활용신약개발돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=02489526625637720
476,2020-01-14,AI기반연구통해신약개발성공가능성UP대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.updownnews.co.kr/news/articleView.html?idxno=213691
477,2020-01-14,대웅제약美A2A파마사와AI항암신약공동연구,https://biz.chosun.com/site/data/html_dir/2020/01/14/2020011401495.html?utm_source=naver&utm_medium=original&utm_campaign=biz
478,2020-01-14,대웅제약인공지능기반항암제연구돌입,https://www.paxnetnews.com/articles/55829
479,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://newsbrite.net/132653
480,2020-01-14,대웅제약06962014일071변화,http://www.gokorea.kr/news/articleView.html?idxno=632425
481,2020-01-14,대웅제약미국바이오기업A2A파마사와AI기반항암신약공동연구,http://www.paxetv.com/news/articleView.html?idxno=84732
482,2020-01-14,대웅제약미국인공지능기반바이오사와항암신약공동개발,https://cnbc.sbs.co.kr/article_hub/10000969288?division=NAVER
483,2020-01-14,대웅제약美A2A파마AI기반항암신약공동연구,http://www.dailymedi.com/detail.php?number=851787&thread=22r05
484,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,http://www.ceoscoredaily.com/news/article.html?no=64905
485,2020-01-14,대웅제약증권플러스14일현재140500원,http://nbntv.co.kr/news/view/809660
486,2020-01-14,대웅제약美AI기반바이오기업과항암신약공동연구,http://www.dt.co.kr/contents.html?article_no=2020011402109931102003&ref=naver
487,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구,http://www.econovill.com/news/articleView.html?idxno=382666
488,2020-01-14,대웅제약미AI기반신약개발기업과공동연구,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4033459
489,2020-01-14,대웅제약A2A와AI기반항암신약공동연구,http://www.finomy.com/news/articleView.html?idxno=74104
490,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구돌입,http://www.cnbnews.com/news/article.html?no=433729
491,2020-01-14,대웅제약美기업과AI기반항암신약공동연구나서,http://www.newswatch.kr/news/articleView.html?idxno=26564
492,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59212
493,2020-01-14,대웅제약美A2A파마사와AI기반항암신약공동연구돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=113812
494,2020-01-14,대웅제약미국바이오기업과AI기반항암신약공동연구”,http://sports.hankooki.com/lpage/economy/202001/sp20200114135418137020.htm
495,2020-01-14,대웅제약美A2A파마와항암신약공동연구들어간다,http://news.mk.co.kr/newsRead.php?no=45074&year=2020
496,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구계약체결,http://www.pressm.kr/news/articleView.html?idxno=27116
497,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.lawissue.co.kr/view.php?ud=202001141433045133204ead0791_12
498,2020-01-14,대웅제약미국A2A파마사와AI기반항암신약공동연구돌입,http://www.ekn.kr/news/article.html?no=475619
499,2020-01-14,대웅제약美A2A파마와항암신약공동연구개발,http://www.newsprime.co.kr/news/article.html?no=490160
500,2020-01-14,대웅제약A2A파마와AI기반항암신약공동연구,http://www.ebn.co.kr/news/view/1017655/?sc=naver
501,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,http://www.medigatenews.com/news/2284229536
502,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.wikileaks-kr.org/news/articleView.html?idxno=74854
503,2020-01-14,대웅제약미국바이오회사와인공지능기반항암신약공동연구시작,http://www.businesspost.co.kr/BP?command=article_view&num=159455
504,2020-01-14,대웅제약A2A파마AI기반항암신약연구개발돌입,http://www.mediapen.com/news/view/492546
505,2020-01-14,대웅제약美A2A파마와인공지능기반항암신약공동연구,https://www.hankyung.com/finance/article/2020011465676
506,2020-01-14,대웅제약A2A파마와AI기반항암신약공동연구파트너십계약,http://digitalchosun.dizzo.com/site/data/html_dir/2020/01/14/2020011480146.html
507,2020-01-14,대웅제약AI기반항암신약공동연구돌입,http://www.bokuennews.com/news/article.html?no=185671
508,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.joseilbo.com/news/news_read.php?uid=390469&class=27&grp=
509,2020-01-14,대웅제약A2A파마맞손AI기반항암신약연구,http://www.mhj21.com/126853
510,2020-01-14,대웅제약미국A2A파마와AI기반항암제개발나선다,https://www.kpanews.co.kr/article/show.asp?idx=210149&category=D
511,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구계약,http://www.sporbiz.co.kr/news/articleView.html?idxno=408382
512,2020-01-14,대웅제약A2A파마항암신약공동연구개발파트너십체결,http://www.k-health.com/news/articleView.html?idxno=46898
513,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.businesskorea.co.kr/news/articleView.html?idxno=40155
514,2020-01-14,대웅제약미국A2A파마사와AI기반항암신약공동연구돌입,http://www.newsian.co.kr/news/articleView.html?idxno=39458
515,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.newscj.com/news/articleView.html?idxno=699634
516,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=53079
517,2020-01-15,종근당대웅제약도1조클럽진입유력신약개발글로벌진출가속,https://biz.chosun.com/site/data/html_dir/2020/01/14/2020011403631.html?utm_source=naver&utm_medium=original&utm_campaign=biz
518,2020-01-15,뉴스브리핑1월15일노트북2020영상편집자저임금종근당대웅제약도1조클럽,http://it.chosun.com/site/data/html_dir/2020/01/15/2020011500370.html
519,2020-01-15,대웅제약소송비용축소로올해영업이익개선전망SK증권,http://www.ajunews.com/view/20200115083253204
520,2020-01-15,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.kukinews.com/news/article.html?no=737614
521,2020-01-15,대웅제약美A2A파마와항암신약개발맞손,http://www.monews.co.kr/news/articleView.html?idxno=207639
522,2020-01-15,대웅제약AI이용한항암신약개발착수,http://news.heraldcorp.com/view.php?ud=20200115000069
523,2020-01-15,리포트브리핑대웅제약나보타소송비용은점진적으로축소중목표가220000원SK증권,http://www.newspim.com/news/view/20200115000198
524,2020-01-15,대웅제약15일000변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=634139
525,2020-01-15,1월15일대웅제약실시간주식현황139500원036,http://nbntv.co.kr/news/view/811660
526,2020-01-15,데일리주식정보대웅제약069620오후12시23분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=97432
527,2020-01-15,대웅제약美바이오기업과항암신약공동개발,http://www.shinailbo.co.kr/news/articleView.html?idxno=1242016
528,2020-01-15,국민청원에등장한윤재승전대웅제약회장왜,http://www.sisaon.co.kr/news/articleView.html?idxno=107709
529,2020-01-16,더벨2020승부수대웅제약개방형협력강조파이프라인확대주력,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202001141304442000108196
530,2020-01-16,★주식인사이드대웅제약주가140500원1월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1057972
531,2020-01-16,한올바이오대웅제약안구건조증신약임상3상Topline결과발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239635
532,2020-01-16,한올바이오대웅제약HL0363상Topline결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=251645&MainKind=A&NewsKind=5&vCount=12&vKind=1
533,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상톱라인결과발표,https://www.sedaily.com/NewsView/1YXO3XM0RY
534,2020-01-16,한올바이오파마대웅제약안구건조증신약글로벌임상3상성공,http://www.newspim.com/news/view/20200116000285
535,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상VELOS2성공적인Topline결과”발표,http://newsbrite.net/132722
536,2020-01-16,대웅제약주가16일143변화,http://www.gokorea.kr/news/articleView.html?idxno=636152
537,2020-01-16,한올바이오파마대웅제약안구건조증신약美임상3상효과확인,http://news1.kr/articles/?3818270
538,2020-01-16,1월16일대웅제약주식현황036140000원,http://nbntv.co.kr/news/view/814070
539,2020-01-16,유한양행대웅제약올해영업이익대폭증가전망,http://medipana.com/news/news_viewer.asp?NewsNum=251665&MainKind=A&NewsKind=5&vCount=12&vKind=1
540,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상탑라인결과공개,http://www.dailian.co.kr/news/view/861765?sc=Naver
541,2020-01-16,한올바이오파마대웅제약안구건조신약3상성공적,http://www.newsis.com/view/?id=NISX20200116_0000890983&cID=13001&pID=13000
542,2020-01-16,한올바이오파마대웅제약안구건조증신약미국임상3상성공적”,http://www.mdtoday.co.kr/mdtoday/index.html?no=375202
543,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상성공적인탑라인결과발표,http://www.medigatenews.com/news/2090598891
544,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상의성공적인Topline결과발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59259
545,2020-01-16,대웅제약피로회복에너지생성큰도움,http://www.dt.co.kr/contents.html?article_no=2020011702101931033002&ref=naver
546,2020-01-17,한올바이오파마대웅제약안구건조증신약3상탑라인결과성공적,https://www.kpanews.co.kr/article/show.asp?idx=210219&category=D
547,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://daily.hankooki.com/lpage/ittech/202001/dh20200117085143145630.htm
548,2020-01-17,대웅제약신약개발현황글로벌사업전략제시,http://www.ebn.co.kr/news/view/1018149/?sc=naver
549,2020-01-17,전승호대웅제약사장올해펙수프라잔글로벌임상성과주목,http://news.mk.co.kr/newsRead.php?no=56133&year=2020
550,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.getnews.co.kr/view.php?ud=20200117090407784941d0c69529_16
551,2020-01-17,대웅제약JP모건서오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1846271
552,2020-01-17,대웅제약오픈콜라보레이션으로희귀질환치료제개발할것,https://www.sedaily.com/NewsView/1YXOKEJ675
553,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://news.mk.co.kr/newsRead.php?no=56222&year=2020
554,2020-01-17,대웅제약펙수프라잔올해국내허가美中임상진입,http://www.biospectator.com/view/news_view.php?varAtcId=9344
555,2020-01-17,대웅제약JP모건헬스케어컨퍼런스서신약개발로드맵제시,http://www.dailian.co.kr/news/view/862058?sc=Naver
556,2020-01-17,대웅제약희귀난치성질환치료제개발에역량집중,http://www.medisobizanews.com/news/articleView.html?idxno=65946
557,2020-01-17,대웅제약펙수프라잔연내미국중국임상시험진입,http://www.newspim.com/news/view/20200117000151
558,2020-01-17,대웅제약올해RD성과나와희귀질환약로드맵제시,http://www.newsis.com/view/?id=NISX20200117_0000891835&cID=13001&pID=13000
559,2020-01-17,대웅제약희귀난치성질환치료제개발에집중할것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020011709291048638
560,2020-01-17,대웅제약JP모건서RD성과발표로드맵제시,http://www.mhj21.com/126891
561,2020-01-17,전승호대웅제약대표2020년은RD성과가가시화되는한해가될것”,http://www.ceoscoredaily.com/news/article.html?no=65063
562,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.segye.com/content/html/2020/01/17/20200117503683.html?OutUrl=naver
563,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://medipana.com/news/news_viewer.asp?NewsNum=251714&MainKind=A&NewsKind=5&vCount=12&vKind=1
564,2020-01-17,JP모건헬스케어대웅제약희귀난치질환치료제개발로드맵제시,http://www.econovill.com/news/articleView.html?idxno=382978
565,2020-01-17,대웅제약JP모간서혁신신약글로벌로드맵공개,http://news.mt.co.kr/mtview.php?no=2020011709092954619
566,2020-01-17,대웅제약 오픈콜라보레이션통한 희귀난치성질환치료제개발로드맵제시,http://www.businesskorea.co.kr/news/articleView.html?idxno=40260
567,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.mdtoday.co.kr/mdtoday/index.html?no=375292
568,2020-01-17,대웅제약올해글로벌사업전략및신약RD로드맵공개,http://www.sisaweek.com/news/articleView.html?idxno=130115
569,2020-01-17,대웅제약위식도역류질환치료제美中임상진행,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90050
570,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.nbnnews.co.kr/news/articleView.html?idxno=359880
571,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.dailysmart.co.kr/news/articleView.html?idxno=21156
572,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://newsbrite.net/132776
573,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.bosa.co.kr/news/articleView.html?idxno=2120040
574,2020-01-17,대웅제약펙수프라잔올해美中임상진입,http://www.etnews.com/20200117000054
575,2020-01-17,대웅제약올해미국중국서펙수프라잔임상진입JP모건헬스케어컨퍼런스2020,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001170197&t=NN
576,2020-01-17,대웅제약06962017일073변동,http://www.gokorea.kr/news/articleView.html?idxno=638188
577,2020-01-17,전승호대표올해대웅제약RD성과가시화”,https://www.paxnetnews.com/articles/55995
578,2020-01-17,대웅제약오픈콜라보레이션으로희귀질환치료제개발로드맵제시,http://www.metroseoul.co.kr/news/newsview?newscd=2020011700046
579,2020-01-17,대웅제약희귀난치성질환치료제개발청사진,http://news1.kr/articles/?3819263
580,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59276
581,2020-01-17,1월17일대웅제약오늘증시073138500원,http://nbntv.co.kr/news/view/816397
582,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.asiatoday.co.kr/view.php?key=20200117010009854
583,2020-01-17,대웅제약전승호대표희귀난치성질환치료제개발로드맵제시,http://www.insightkorea.co.kr/news/articleView.html?idxno=75623
584,2020-01-17,대웅제약펙수프라잔희귀질환치료제등글로벌로드맵제시차별화오픈콜라보중요,http://www.newslock.co.kr/news/articleView.html?idxno=25146
585,2020-01-17,대웅제약희귀난치성질환치료제개발현황발표,http://www.pressm.kr/news/articleView.html?idxno=27188
586,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.newstomato.com/ReadNews.aspx?no=946443
587,2020-01-17,전승호대웅제약은개방형협력으로난치성질환신약개발집중,http://www.businesspost.co.kr/BP?command=article_view&num=160027
588,2020-01-17,대웅제약올해美中서펙수프라잔임상진입,http://www.ezyeconomy.com/news/articleView.html?idxno=97179
589,2020-01-17,대웅제약희귀난치성질환혁신신약개발역량집중,http://www.newsprime.co.kr/news/article.html?no=490683
590,2020-01-17,전승호대웅제약대표올해주요RD성과가시화”2020년사업전략발표,http://www.donga.com/news/article/all/20200117/99270681/1
591,2020-01-17,대웅제약펙수프라잔연내美中임상시험진입JPM컨퍼런스서밝혀,http://inthenews.co.kr/article-32285/
592,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵발표,http://www.joseilbo.com/news/news_read.php?uid=390673&class=27&grp=
593,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.newswatch.kr/news/articleView.html?idxno=26717
594,2020-01-17,대웅제약글로벌오픈콜라보네이션으로연구개발고도화,https://jhealthmedia.joins.com/article/article_view.asp?pno=21297
595,2020-01-17,대웅제약올해는글로벌오픈콜라보레이션고도화에집중할것,http://kormedi.com/?p=1309763
596,2020-01-17,대웅제약희귀난치질환치료제개발역량집중,http://www.monews.co.kr/news/articleView.html?idxno=207715
597,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.medigatenews.com/news/1488923959
598,2020-01-17,대웅제약펙수프라잔美中임상시험추진,http://www.edaily.co.kr/news/newspath.asp?newsid=03378406625638704
599,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.lawissue.co.kr/view.php?ud=202001171654136688204ead0791_12
600,2020-01-17,전승호대웅제약대표RD성과가시화될것,http://www.shinailbo.co.kr/news/articleView.html?idxno=1242897
601,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.newscj.com/news/articleView.html?idxno=700562
602,2020-01-18,전승호사장대웅제약글로벌도약이끌까,http://moneys.mt.co.kr/news/mwView.php?no=2020011515358056632
603,2020-01-18,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.newsian.co.kr/news/articleView.html?idxno=39542
604,2020-01-19,대웅제약글로벌오픈콜라보레이션고도화집중”,http://www.fetv.co.kr/news/article.html?no=45464
605,2020-01-19,대웅제약올해연구개발RD성과나와난치성질환치료제등희귀질환약로드맵제시,http://www.econonews.co.kr/news/articleView.html?idxno=104273
606,2020-01-19,대웅제약美바이오기업과AI기반항암신약공동연구,http://weekly.cnbnews.com/news/article.html?no=132181
607,2020-01-20,대웅제약실적개선에도주가부진속타는소액주주,http://www.asiatoday.co.kr/view.php?key=20200119010010379
608,2020-01-20,대웅제약20일108변화,http://www.gokorea.kr/news/articleView.html?idxno=640258
609,2020-01-20,대웅제약주식추천주20일현재137500원,http://nbntv.co.kr/news/view/818966
610,2020-01-20,20일데일리증권대웅제약069620오후12시37분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=99463
611,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://medipana.com/news/news_viewer.asp?NewsNum=251809&MainKind=A&NewsKind=5&vCount=12&vKind=1
612,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.metroseoul.co.kr/news/newsview?newscd=2020012000157
613,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단식,http://www.medisobizanews.com/news/articleView.html?idxno=66027
614,2020-01-20,대웅제약참치마요프로젝트2기봉사단창단식개최,http://news.mk.co.kr/newsRead.php?no=65032&year=2020
615,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.nbnnews.co.kr/news/articleView.html?idxno=360689
616,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newswatch.kr/news/articleView.html?idxno=26793
617,2020-01-20,청와대국민청원게시판에윤재승전대웅제약회장횡령혐의처벌청원,http://nbntv.co.kr/news/view/819845
618,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.etoday.co.kr/news/section/newsview.php?idxno=1847133
619,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newspim.com/news/view/20200120000900
620,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.businesskorea.co.kr/news/articleView.html?idxno=40369
621,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.wikileaks-kr.org/news/articleView.html?idxno=75441
622,2020-01-20,대웅제약발달장애인위한참지마요프로젝트교육봉사단창단,http://www.donga.com/news/article/all/20200120/99326175/1
623,2020-01-20,대웅제약발달장애인위한참지마요제2기교육봉사단창단,http://www.kpinews.co.kr/news/articleView.html?idxno=109539
624,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239770
625,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59308
626,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단식진행,http://www.cnbnews.com/news/article.html?no=434491
627,2020-01-20,대웅제약참지마요프로젝트2기교육봉사단창단,http://www.dailian.co.kr/news/view/862836?sc=Naver
628,2020-01-20,반등노리는바이오제약대웅제약역류성식도염등난치성질환치료제개발매진,https://www.sedaily.com/NewsView/1YXPY0LZYV
629,2020-01-20,대웅제약참지마요제2기교육봉사단창단,http://www.ekn.kr/news/article.html?no=476761
630,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.getnews.co.kr/view.php?ud=20200120174913831441d0c69529_16
631,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://newsbrite.net/132913
632,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.lawissue.co.kr/view.php?ud=20200120180217883204ead0791_12
633,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.mdtoday.co.kr/mdtoday/index.html?no=375497
634,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.econovill.com/news/articleView.html?idxno=383266
635,2020-01-20,뉴스투데이L대웅제약 건강한삶을위한참지마요프로젝트제2기교육봉사단창단,http://www.news2day.co.kr/146917
636,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단발달장애인의건강한삶위해,http://www.thefirstmedia.net/news/articleView.html?idxno=53299
637,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,https://www.kpanews.co.kr/article/show.asp?idx=210294&category=D
638,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newscj.com/news/articleView.html?idxno=701158
639,2020-01-20,대웅제약건강한삶과소통의프로젝트참지마요봉사단22일부터활동시작,http://www.paxetv.com/news/articleView.html?idxno=85210
640,2020-01-21,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.dailymedi.com/detail.php?number=852035&thread=22r05
641,2020-01-21,대웅제약나보타8개월간미국서400억원어치팔려,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1076301
642,2020-01-21,대웅제약한국머크의심혈관질환치료제콩코르영업돌입,http://news.mk.co.kr/newsRead.php?no=67205&year=2020
643,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newstomato.com/ReadNews.aspx?no=947040
644,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.ebn.co.kr/news/view/1018653/?sc=naver
645,2020-01-21,09시14분바이오시밀러복제바이오의약품오전테마시황에이프로젠제약대웅제약등이주도,http://nbntv.co.kr/news/view/820338
646,2020-01-21,21일09시보톡스보툴리눔톡신테마주시황오전대웅제약디에스케이등이주도,http://nbntv.co.kr/news/view/820389
647,2020-01-21,바이오시밀러복제바이오의약품테마오전시황상승률상위종목에이프로젠제약226대웅제약147셀트리온145등,http://www.gokorea.kr/news/articleView.html?idxno=641609
648,2020-01-21,대웅제약한국머크바이오파마와콩코르국내판권계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239789
649,2020-01-21,대웅제약심혈관치료제콩고르국내판매실시,https://asiatime.co.kr/news/newsview.php?ncode=1065571817392869
650,2020-01-21,대웅제약심혈관치료제콩코르판매돌입순환기계시장경쟁력강화,http://www.getnews.co.kr/view.php?ud=20200121092431120941d0c69529_16
651,2020-01-21,대웅제약콩코르국내판매돌입순환기치료제막강라인업,http://www.medisobizanews.com/news/articleView.html?idxno=66041
652,2020-01-21,대웅제약심혈관치료제콩코르국내판매‥순환기계강화,http://medipana.com/news/news_viewer.asp?NewsNum=251837&MainKind=A&NewsKind=5&vCount=12&vKind=1
653,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020012109323248190
654,2020-01-21,대웅제약순환기계시장최강자입지강화나서심혈관치료제콩코르국내판매돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=113989
655,2020-01-21,대웅제약심혈관치료제콩코르국내판권계약순환기계라인업확대,http://www.pressm.kr/news/articleView.html?idxno=27238
656,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.metroseoul.co.kr/news/newsview?newscd=2020012100029
657,2020-01-21,대웅제약심혈관치료제콩코르판매돌입,http://www.skyedaily.com/news/news_view.html?ID=97966
658,2020-01-21,대웅제약한국머크심혈관치료제콩코르국내판매돌입,http://www.fnnews.com/news/202001210944447294
659,2020-01-21,대웅제약한국머크심혈관치료제콩코르국내판매돌입,https://www.sedaily.com/NewsView/1YXQDY3XRP
660,2020-01-21,대웅제약머크社심혈관치료제콩코르국내판매,http://www.newspim.com/news/view/20200121000222
661,2020-01-21,대웅제약심혈관치료제콩코르판매,https://www.paxnetnews.com/articles/56124
662,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.etnews.com/20200121000033
663,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newsis.com/view/?id=NISX20200121_0000894964&cID=13001&pID=13000
664,2020-01-21,대웅제약심혈관치료제콩코르국내판매개시,http://it.chosun.com/site/data/html_dir/2020/01/21/2020012101099.html
665,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.seoulwire.com/news/articleView.html?idxno=267773
666,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=360969
667,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1362944
668,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.dailian.co.kr/news/view/862966?sc=Naver
669,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,https://biz.chosun.com/site/data/html_dir/2020/01/21/2020012101291.html?utm_source=naver&utm_medium=original&utm_campaign=biz
670,2020-01-21,대웅제약주가06962021일074변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=642142
671,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://news.mk.co.kr/newsRead.php?no=67976&year=2020
672,2020-01-21,대웅제약참지마요프로젝트2기교육봉사단창단,http://www.bosa.co.kr/news/articleView.html?idxno=2120223
673,2020-01-21,실시간주식현황대웅제약주가21일현재137000원,http://nbntv.co.kr/news/view/821088
674,2020-01-21,대웅제약심혈관치료제콩코르국내판권획득순환기계약물라인업확대,http://www.paxetv.com/news/articleView.html?idxno=85266
675,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.lawissue.co.kr/view.php?ud=202001211107489363204ead0791_12
676,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59321
677,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=21377
678,2020-01-21,대웅제약종근당할랄인증획득80조원할랄시장뛰어든다,http://www.segyebiz.com/newsView/20200121505797?OutUrl=naver
679,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입한국머크바이오파마와판권계약,http://www.updownnews.co.kr/news/articleView.html?idxno=214023
680,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.insightkorea.co.kr/news/articleView.html?idxno=75756
681,2020-01-21,대웅제약심혈관치료제콩코르국내판매시작,http://www.newslock.co.kr/news/articleView.html?idxno=25209
682,2020-01-21,성공적이라더니대웅제약한올임상3상미충족,https://www.sedaily.com/NewsView/1YXQDPIKKQ
683,2020-01-21,대웅제약심혈관치료제콩코르韓판매돌입순환기계시장경쟁력강화,http://www.segye.com/content/html/2020/01/21/20200121507060.html?OutUrl=naver
684,2020-01-21,대웅제약한국머크바이오파마심혈관질환치료제의국내판매시작,http://www.businesspost.co.kr/BP?command=article_view&num=160446
685,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://newsbrite.net/132933
686,2020-01-21,대웅제약심혈관치료제콩코르판매개시,http://www.koreaittimes.com/news/articleView.html?idxno=95168
687,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.dailymedi.com/detail.php?number=852059&thread=22r05
688,2020-01-21,콩코르판매나선대웅제약순환기계경쟁력강화,http://www.monews.co.kr/news/articleView.html?idxno=207778
689,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.ekn.kr/news/article.html?no=476961
690,2020-01-21,​​대웅제약심혈관치료제콩코르국내판매순환기계시장입지강화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1847616
691,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newswatch.kr/news/articleView.html?idxno=26819
692,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.bosa.co.kr/news/articleView.html?idxno=2120241
693,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.joseilbo.com/news/news_read.php?uid=390860&class=27&grp=
694,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=375570
695,2020-01-21,대웅제약장중하락세전일대비1029이시각거래량9만8479주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001210307&t=NN
696,2020-01-21,대웅제약1029VI발동,https://biz.chosun.com/site/data/html_dir/2020/01/21/2020012101963.html?utm_source=naver&utm_medium=original&utm_campaign=biz
697,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.econovill.com/news/articleView.html?idxno=383347
698,2020-01-21,대웅제약오후갑자기11급락에투자자들당황12만원선마저무너지나,http://www.econonews.co.kr/news/articleView.html?idxno=104645
699,2020-01-21,주식한올바이오파마임상평가지표달성못해30가까이하락대웅제약은,http://www.ggilbo.com/news/articleView.html?idxno=739982
700,2020-01-21,대웅제약순환기계시장경쟁력강화,http://www.m-i.kr/news/articleView.html?idxno=674931
701,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.wikileaks-kr.org/news/articleView.html?idxno=75576
702,2020-01-21,대웅제약콩코르국내판매돌입순환기계시장경쟁력강화,http://www.bokuennews.com/news/article.html?no=185890
703,2020-01-21,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.wsobi.com/news/articleView.html?idxno=88954
704,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.wsobi.com/news/articleView.html?idxno=88945
705,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.koreastocknews.com/news/articleView.html?idxno=49825
706,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.medigatenews.com/news/3716867888
707,2020-01-21,표21일코스피주가Top50하락률한올바이오파마주가하락률1위2559내려장마감체시스백광소재대웅제약까뮤이앤씨주가순으로상위기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=99509
708,2020-01-21,뉴스투데이L대웅제약심혈관치료제콩코르국내판매,http://www.news2day.co.kr/147002
709,2020-01-21,한올바이오대웅제약안구건조증신약임상3상실패에주가도출렁,http://www.asiatoday.co.kr/view.php?key=20200121010012263
710,2020-01-21,대웅제약1조클럽가입2020년에는확실하다,http://www.insightkorea.co.kr/news/articleView.html?idxno=75785
711,2020-01-21,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newsian.co.kr/news/articleView.html?idxno=39597
712,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newscj.com/news/articleView.html?idxno=701537
713,2020-01-21,대웅제약한국머크바이오파마콩코르품목판권계약,https://www.kpanews.co.kr/article/show.asp?idx=210341&category=D
714,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.thefirstmedia.net/news/articleView.html?idxno=53387
715,2020-01-22,출근길신약1차평가지표미충족한올바이오파마대웅제약주춤,http://moneys.mt.co.kr/news/mwView.php?no=2020012116458075806
716,2020-01-22,대웅제약나보타사각턱개선임상3상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=375625
717,2020-01-22,대웅제약임상실패여파로파이프라인가치하락목표가↓삼성증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1847988
718,2020-01-22,대웅제약차별화전략으로글로벌헬스케어그룹도약,http://www.dailysmart.co.kr/news/articleView.html?idxno=21419
719,2020-01-22,대웅제약목표주가하향안구건조증치료제임상지연돼가치하락,http://www.businesspost.co.kr/BP?command=article_view&num=160613
720,2020-01-22,대웅제약전날9급락딛고상승세로급락여파벗어나나,http://www.econonews.co.kr/news/articleView.html?idxno=104785
721,2020-01-22,리포트브리핑대웅제약지연되었을뿐끝이아닌HL036목표가180000원삼성증권,http://www.newspim.com/news/view/20200122000584
722,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.getnews.co.kr/view.php?ud=20200122112003608741d0c69529_16
723,2020-01-22,대웅제약펙수프라잔5000만달러규모멕시코수출계약,http://www.fnnews.com/news/202001221121528915
724,2020-01-22,대웅제약펙수프라잔5천만달러멕시코수출계약,http://www.consumuch.com/news/articleView.html?idxno=47317
725,2020-01-22,대웅제약주가06962022일121변동,http://www.gokorea.kr/news/articleView.html?idxno=644079
726,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239866
727,2020-01-22,1월22일대웅제약주가차트161126000원,http://nbntv.co.kr/news/view/823438
728,2020-01-22,대웅제약펙수프라잔멕시코5천만弗수출계약,http://www.biospectator.com/view/news_view.php?varAtcId=9383
729,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약582억규모,http://www.ceoscoredaily.com/news/article.html?no=65266
730,2020-01-22,대웅제약차세대항궤양제펙수프라잔글로벌첫진출,http://www.newsis.com/view/?id=NISX20200122_0000896679&cID=13001&pID=13000
731,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결글로벌진출신호탄,http://www.metroseoul.co.kr/news/newsview?newscd=2020012200085
732,2020-01-22,대웅제약펙수프라잔글로벌진출신호탄쏘아올려,http://www.bosa.co.kr/news/articleView.html?idxno=2120321
733,2020-01-22,대웅제약펙수프라잔글로벌진출포문멕시코수출계약,http://www.donga.com/news/article/all/20200122/99358867/1
734,2020-01-22,대웅제약펙수프라잔5000만달러규모중남미수출계약,http://www.newswatch.kr/news/articleView.html?idxno=26875
735,2020-01-22,대웅제약 펙수프라잔Fexuprazan멕시코수출계약,http://www.businesskorea.co.kr/news/articleView.html?idxno=40466
736,2020-01-22,대웅제약펙수프라잔멕시코수출글로벌시장진출신호탄,http://www.medisobizanews.com/news/articleView.html?idxno=66113
737,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://yna.kr/AKR20200122094600017?did=1195m
738,2020-01-22,대웅제약펙수프라잔멕시코수출글로벌시장진출신호탄,http://www.ezyeconomy.com/news/articleView.html?idxno=97286
739,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=261173&REFERER=NP
740,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=375682
741,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=61010
742,2020-01-22,대웅제약멕시코에펙수프라잔수출계약체결,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001220236&t=NN
743,2020-01-22,보톡스보툴리눔톡신테마오후시황상승률상위종목휴젤824파마리서치프로덕트420대웅제약242등,http://www.gokorea.kr/news/articleView.html?idxno=644445
744,2020-01-22,​​대웅제약멕시코에펙수프라잔5000만달러규모수출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1848199
745,2020-01-22,대웅제약펙수프라잔글로벌진출멕시코5000만달러수출계약,https://biz.chosun.com/site/data/html_dir/2020/01/22/2020012201832.html?utm_source=naver&utm_medium=original&utm_campaign=biz
746,2020-01-22,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목휴젤34800원839파마리서치프로덕트1400원367대웅제약3000원242상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=158775
747,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약,http://www.insightkorea.co.kr/news/articleView.html?idxno=75802
748,2020-01-22,대웅제약자체개발펙수프라잔글로벌시장진출신호탄,http://medipana.com/news/news_viewer.asp?NewsNum=251919&MainKind=A&NewsKind=5&vCount=12&vKind=1
749,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://newsbrite.net/132986
750,2020-01-22,대웅제약멕시코에펙수프라잔수출계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2020012213364006671
751,2020-01-22,대웅제약차세대항궤양제펙수프라잔글로벌시장첫진출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020012213335385152
752,2020-01-22,대웅제약위식도역류치료제첫해외수출,https://www.nocutnews.co.kr/news/5277312
753,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔으로중남미시장노크,https://www.sedaily.com/NewsView/1YXQUFQAPF
754,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.m-i.kr/news/articleView.html?idxno=675265
755,2020-01-22,대웅제약펙수프라잔멕시코시장진출한다,http://www.etnews.com/20200122000170
756,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://news.mk.co.kr/newsRead.php?no=73654&year=2020
757,2020-01-22,대웅제약멕시코제약사에580억규모펙수프라잔수출,http://www.newspim.com/news/view/20200122000822
758,2020-01-22,대웅제약위식도역류질환치료제를멕시코에5천만달러수출계약,http://www.businesspost.co.kr/BP?command=article_view&num=160674
759,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://www.seoulwire.com/news/articleView.html?idxno=268026
760,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약”,http://sports.hankooki.com/lpage/economy/202001/sp20200122135556137020.htm
761,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://www.rapportian.com/news/articleView.html?idxno=122953
762,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.nbnnews.co.kr/news/articleView.html?idxno=361577
763,2020-01-22,대웅제약펙수프라잔멕시코수출계약약580억원규모,http://inthenews.co.kr/article-32886/
764,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.newstomato.com/ReadNews.aspx?no=947422
765,2020-01-22,대웅제약펙수프라잔멕시코수출계약글로벌시장진출포문,http://www.ajunews.com/view/20200122143335860
766,2020-01-22,대웅제약멕시코목샤8과펙수프라잔수출계약체결,http://news.mk.co.kr/newsRead.php?no=73987&year=2020
767,2020-01-22,대웅제약멕시코에위식도역류질환치료제펙수프라잔수출,http://www.finomy.com/news/articleView.html?idxno=74435
768,2020-01-22,대웅제약위식도역류치료제펙수프라잔첫수출,http://news.mt.co.kr/mtview.php?no=2020012214170510904
769,2020-01-22,대웅제약위식도역류치료제멕시코수출580억원규모,http://it.chosun.com/site/data/html_dir/2020/01/22/2020012202237.html
770,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,https://asiatime.co.kr/news/newsview.php?ncode=1065591714045074
771,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.dailian.co.kr/news/view/863434?sc=Naver
772,2020-01-22,대웅제약펙수프라잔5000만달러규모멕시코수출계약,http://www.asiatoday.co.kr/view.php?key=20200122010012917
773,2020-01-22,대웅제약식도역류질환치료제멕시코에5000만弗규모수출,https://www.hankyung.com/it/article/202001224178i
774,2020-01-22,대웅제약멕시코에5천만달러수출계약,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90127
775,2020-01-22,전세계시장확대나선대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려멕시코수출계약체결,http://www.updownnews.co.kr/news/articleView.html?idxno=214122
776,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.wikileaks-kr.org/news/articleView.html?idxno=75686
777,2020-01-22,대웅제약위식도역류질환치료제로멕시코진출,https://cnbc.sbs.co.kr/article_hub/10000970313?division=NAVER
778,2020-01-22,대웅제약멕시코에위식도역류질환치료제수출계약2020년현지발매목표,http://www.paxetv.com/news/articleView.html?idxno=85368
779,2020-01-22,대웅제약펙수프라잔580억멕시코수출계약글로벌진출신호탄,http://news1.kr/articles/?3823365
780,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.economytalk.kr/news/articleView.html?idxno=203326
781,2020-01-22,대웅제약글로벌시장진출본격화,https://jhealthmedia.joins.com/article/article_view.asp?pno=21313
782,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.dailysmart.co.kr/news/articleView.html?idxno=21480
783,2020-01-22,대웅제약안구건조증치료제HL0363상1차지표충족실패”,http://www.wikitree.co.kr/main/news_view.php?id=499190
784,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.ebn.co.kr/news/view/1018998/?sc=naver
785,2020-01-22,대웅제약펙수프라잔중남미2위멕시코시장진출글로벌진출본격화,http://www.ekn.kr/news/article.html?no=477261
786,2020-01-22,보톡스보툴리눔톡신테마마감시황상승률상위종목휴젤964파마리서치프로덕트696대웅제약242등,http://www.gokorea.kr/news/articleView.html?idxno=645289
787,2020-01-22,대웅제약위식도역류질환치료제5천만달러기술수출,http://www.edaily.co.kr/news/newspath.asp?newsid=03909766625640344
788,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결글로벌시장진출본격화,http://www.newslock.co.kr/news/articleView.html?idxno=25275
789,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59362
790,2020-01-22,대웅제약펙수프라잔멕시코5000만달러수출계약체결,https://www.kpanews.co.kr/article/show.asp?idx=210373&category=D
791,2020-01-22,대웅제약펙수프라잔글로벌시장진출본격화중남미2위시장멕시코수출,http://www.pressm.kr/news/articleView.html?idxno=27280
792,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.wsobi.com/news/articleView.html?idxno=89033
793,2020-01-22,대웅제약펙수프라잔5000만불수출계약,http://www.dailymedi.com/detail.php?number=852119&thread=22r05
794,2020-01-22,대웅제약멕시코목샤8과펙수프라잔수출계약,http://www.shinailbo.co.kr/news/articleView.html?idxno=1244476
795,2020-01-22,대웅제약위식도역류질환신약글로벌진출첫발,http://www.monews.co.kr/news/articleView.html?idxno=207817
796,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.bokuennews.com/news/article.html?no=185951
797,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려최고의제약사들과제휴통해전세계시장확대나설것,http://www.segye.com/content/html/2020/01/22/20200122515958.html?OutUrl=naver
798,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.lawissue.co.kr/view.php?ud=202001221833139977204ead0791_12
799,2020-01-22,대웅제약펙수프라잔글로벌시장진출본격화,https://www.paxnetnews.com/articles/56222
800,2020-01-22,대웅제약위식도역류치료제글로벌진출첫신호탄,http://www.econovill.com/news/articleView.html?idxno=383533
801,2020-01-22,대웅제약펙수프라잔멕시코수출계약거점확보,http://www.mhj21.com/127035
802,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.newscj.com/news/articleView.html?idxno=701766
803,2020-01-23,대웅제약펙수프라잔멕시코수출계약체결중남미두번째큰의약품시장,http://www.thefirstmedia.net/news/articleView.html?idxno=53456
804,2020-01-23,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.medigatenews.com/news/3191661129
805,2020-01-23,★주식인사이드대웅제약주가128000원1월23일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1059257
806,2020-01-23,대웅제약중남미2위규모멕시코의약품시장진출,http://news.heraldcorp.com/view.php?ud=20200123000075
807,2020-01-23,09시18분보톡스보툴리눔톡신테마주오전시황대웅제약디에스케이등이주도,http://nbntv.co.kr/news/view/825086
808,2020-01-23,주간추천종목SK증권대웅제약애경산업아비코전자,http://www.greened.kr/news/articleView.html?idxno=234167
809,2020-01-23,대웅제약주가06962023일157변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=646047
810,2020-01-23,대웅제약종목검색23일현재125500원,http://nbntv.co.kr/news/view/825781
811,2020-01-23,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newsian.co.kr/news/articleView.html?idxno=39646
812,2020-01-24,대웅제약주식그래프24일현재126000원,http://nbntv.co.kr/news/view/828115
813,2020-01-25,이번주추천종목SK증권대웅제약애경산업등,http://www.asiatoday.co.kr/view.php?key=20200123010013350
814,2020-01-25,주간추천종목현대차BNK금융지주케이엠더블유대웅제약애경산업아비코전자,http://www.lawissue.co.kr/view.php?ud=2020012512044141519817d053b9_12
815,2020-01-26,주간추천종목SK증권대웅제약애경산업아비코전자,http://www.fntimes.com/html/view.php?ud=2020012613282722816c0eb6f11e_18
816,2020-01-26,대웅제약위식도역류질환치료제펙수프라잔멕시코진출,http://weekly.cnbnews.com/news/article.html?no=132257
817,2020-01-27,대웅제약영업활동현금흐름전년비6배개선으로작년잉여현금흐름흑자전환,http://www.ceoscoredaily.com/news/article.html?no=65140
818,2020-01-27,대웅제약06962027일079변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=649781
819,2020-01-27,1월27일대웅제약오늘주식장079126000원,http://nbntv.co.kr/news/view/830605
820,2020-01-28,SK증권대웅제약애경산업아비코전자,http://www.seoulfn.com/news/articleView.html?idxno=369934
821,2020-01-28,대웅제약06962028일159변화,http://www.gokorea.kr/news/articleView.html?idxno=651223
822,2020-01-28,대웅제약주가차트28일현재125000원,http://nbntv.co.kr/news/view/832606
823,2020-01-28,바른의료연구소대웅제약이제기한명예훼손업무방해금지가처분소송승소,http://www.medigatenews.com/news/1687535917
824,2020-01-28,바른의료연구소대웅제약명예훼손등소송서승소,http://www.ftoday.co.kr/news/articleView.html?idxno=114132
825,2020-01-28,우루사과대광고의혹대웅제약의료단체상대소송에서패소,http://www.todaykorea.co.kr/news/view.php?no=267769
826,2020-01-29,제약남방시대②대웅제약이인도네시아시장석권한비결,http://www.edaily.co.kr/news/newspath.asp?newsid=01338246625642640
827,2020-01-29,★주식인사이드대웅제약주가124000원1월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1059967
828,2020-01-29,대웅제약주가29일120변화,http://www.gokorea.kr/news/articleView.html?idxno=653159
829,2020-01-29,주식시세현황대웅제약주가29일현재123000원,http://nbntv.co.kr/news/view/834936
830,2020-01-29,29일데일리주가정보대웅제약069620오후12시28분기준외매매동향,https://www.dailysecu.com/news/articleView.html?idxno=103644
831,2020-01-29,법원우루사대웅제약간수치개선임상입증안됐다판결,http://www.wolyo.co.kr/news/articleView.html?idxno=100148
832,2020-01-30,대웅제약나보타수출균주소송자신감UP5년내5천억도전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240019
833,2020-01-30,이인영대웅제약현대자동차등민간차원에서도中국민돕는자발적운동시작”,http://www.kukinews.com/news/article.html?no=742537
834,2020-01-30,★주식인사이드대웅제약주가124500원1월30일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1060257
835,2020-01-30,대웅제약나보타출시11개월만에500억원매출달성올해는800억원목표”,http://www.thepublic.kr/news/newsview.php?ncode=1065577131453842
836,2020-01-30,주식증권대웅제약주가30일현재122500원,http://nbntv.co.kr/news/view/837352
837,2020-01-30,전승호號대웅제약글로벌도약막아서는소송리스크,http://www.wikileaks-kr.org/news/articleView.html?idxno=76164
838,2020-01-31,★주식인사이드대웅제약주가121500원1월31일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1060581
839,2020-02-03,나보타성공신화대웅제약글로벌시장가시적성과기대,http://www.bosa.co.kr/news/articleView.html?idxno=2120797
840,2020-02-03,대웅제약전승호사장창사이래가장화려한파이프라인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240125
841,2020-02-03,★주식인사이드대웅제약주가116000원2월3일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1060976
842,2020-02-03,대웅제약목표주가하향자체개발보톨리눔톡신유럽출시는기대,http://www.businesspost.co.kr/BP?command=article_view&num=161934
843,2020-02-03,대웅제약0696203일254변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=658896
844,2020-02-03,2월3일대웅제약금일증시085117000원,http://nbntv.co.kr/news/view/842113
845,2020-02-03,리포트브리핑대웅제약반기나보타유럽출시기대목표가170000원NH투자증권,http://www.newspim.com/news/view/20200203000555
846,2020-02-04,★주식인사이드대웅제약주가117500원2월4일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1061317
847,2020-02-04,2월4일대웅제약오늘주식시세120500원212,http://nbntv.co.kr/news/view/844426
848,2020-02-04,대웅제약글로벌학술교류나보타프로그램개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=364777
849,2020-02-04,대웅제약나보타프랑스서글로벌학술교류프로그램개최,http://www.ekn.kr/news/article.html?no=479405
850,2020-02-04,대웅제약나보타글로벌학술교류포럼서차별화된제품력전파,http://www.medisobizanews.com/news/articleView.html?idxno=66482
851,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼개최,http://www.bosa.co.kr/news/articleView.html?idxno=2120904
852,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.lawissue.co.kr/view.php?ud=202002041201498801204ead0791_12
853,2020-02-04,대웅제약0696204일169변화,http://www.gokorea.kr/news/articleView.html?idxno=660741
854,2020-02-04,대웅제약 프랑스에서 나보타에스테틱포럼 개최차별화된제품력전파,http://www.businesskorea.co.kr/news/articleView.html?idxno=40849
855,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.ezyeconomy.com/news/articleView.html?idxno=97610
856,2020-02-04,대웅제약나보타글로벌학술교류프로그램통해제품전파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240221
857,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.newsway.co.kr/news/view?tp=1&ud=2020020411464311429
858,2020-02-04,대웅제약프랑스파리서나보타글로벌학술교류개최자체개발제품알리다,http://www.paxetv.com/news/articleView.html?idxno=85886
859,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.dailysmart.co.kr/news/articleView.html?idxno=21909
860,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼개최,http://www.insightkorea.co.kr/news/articleView.html?idxno=76154
861,2020-02-04,대웅제약프랑스서나보타에스테틱포럼개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=376611
862,2020-02-04,대웅제약佛서나보타글로벌포럼개최차별화된제품력전파,http://www.viva100.com/main/view.php?key=20200204010001192
863,2020-02-04,대웅제약글로벌학술교류행사열어보툴리눔톡신제품경쟁력알려,http://www.businesspost.co.kr/BP?command=article_view&num=162197
864,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼차별화된제품력전파,http://www.newsprime.co.kr/news/article.html?no=492047
865,2020-02-04,대웅제약제8회나보타에스테틱포럼NAFNABOTAAestheticForum개최,http://www.pressm.kr/news/articleView.html?idxno=27428
866,2020-02-04,대웅제약글로벌포럼서보툴리눔톡신제품력전파,http://kormedi.com/?p=1310645
867,2020-02-04,차별화된제품력전파대웅제약나보타파리에서글로벌학술교류프로그램개최,http://www.updownnews.co.kr/news/articleView.html?idxno=214602
868,2020-02-04,대웅제약나보타글로벌학술교류가져차별화된제품력전파,http://www.metroseoul.co.kr/news/newsview?newscd=2020020400112
869,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.g-enews.com/ko-kr/news/article/news_all/20200204140112456869d76442fa_1/article.html
870,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59512
871,2020-02-04,대웅제약프랑스서포럼열고나보타경쟁력알려,http://www.koreastocknews.com/news/articleView.html?idxno=50142
872,2020-02-04,대웅제약나보타제8회나보타에스테틱포럼서차별화된제품력전파,http://www.cnbnews.com/news/article.html?no=435855
873,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://medipana.com/news/news_viewer.asp?NewsNum=252414&MainKind=A&NewsKind=5&vCount=12&vKind=1
874,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최7개국의사참가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1852476
875,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://news.mt.co.kr/mtview.php?no=2020020414352126515
876,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼개최,http://news.mk.co.kr/newsRead.php?no=113978&year=2020
877,2020-02-04,제약오늘대웅제약나보타글로벌학술교류프로그램개최휴메딕스남성비뇨기필러시장진출선언,http://www.sisaon.co.kr/news/articleView.html?idxno=108628
878,2020-02-04,대웅제약나보타에스테틱포럼개최,http://www.ebn.co.kr/news/view/1020516/?sc=naver
879,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.wikileaks-kr.org/news/articleView.html?idxno=76575
880,2020-02-04,대웅제약프랑스에서나보타학술교류프로그램개최,http://www.mediapen.com/news/view/497662
881,2020-02-04,대웅제약나보타글로벌학술교류프로그램성료,http://www.dailymedi.com/detail.php?number=852472&thread=22r05
882,2020-02-04,대웅제약나보타글로벌포럼개최신제품경쟁력전파,https://www.youthdaily.co.kr/news/article.html?no=27794
883,2020-02-04,대웅제약나보타글로벌학술교류프로그램차별화된제품력전파,http://www.newswatch.kr/news/articleView.html?idxno=27300
884,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.segye.com/content/html/2020/02/04/20200204512057.html?OutUrl=naver
885,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.medigatenews.com/news/1612547858
886,2020-02-04,대웅제약프랑스제8회나보타에스테틱포럼서나보타경쟁력알려,http://www.newslock.co.kr/news/articleView.html?idxno=25532
887,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.dailian.co.kr/news/view/866207?sc=Naver
888,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://newsbrite.net/133346
889,2020-02-04,뉴스투데이L대웅제약글로벌학술프로그램에서나보타경쟁력알려,http://www.news2day.co.kr/147668
890,2020-02-04,대웅제약나보타글로벌학술교류행사서경쟁력강조,http://www.econovill.com/news/articleView.html?idxno=384608
891,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.newscj.com/news/articleView.html?idxno=705267
892,2020-02-04,대웅제약제8회나보타에스테틱포럼개최차별화된제품력전파,http://www.ftoday.co.kr/news/articleView.html?idxno=114327
893,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4049962
894,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.thefirstmedia.net/news/articleView.html?idxno=53886
895,2020-02-05,막바지향하는메디톡스대웅제약균주전쟁ITC심리시작,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1076798
896,2020-02-05,★주식인사이드대웅제약주가117500원2월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1061625
897,2020-02-05,대웅제약NAF개최나보타차별점홍보 ,http://www.monews.co.kr/news/articleView.html?idxno=208059
898,2020-02-05,대웅제약佛서나보타학술교류프로그램진행,http://www.whosaeng.com/115652
899,2020-02-06,대웅제약도진통제가격인상이지엔6공급가8↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=261534&REFERER=NP
900,2020-02-06,메디톡스VS대웅제약보툴리눔톡신균주두고美재판진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=376766
901,2020-02-06,대웅제약vs메디톡스보톡스균주분쟁마무리국면ITC심리中,http://www.greened.kr/news/articleView.html?idxno=235930
902,2020-02-06,제약산업대웅제약나보타프랑스파리학술교류포럼개최外,http://www.kukinews.com/news/article.html?no=745658
903,2020-02-06,대웅제약우루사피로회복효과논란확산식약처제재할까,http://www.wolyo.co.kr/news/articleView.html?idxno=100364
904,2020-02-06,보톡스보툴리눔톡신테마마감시황상승률상위종목디에스케이994대웅제약343메디톡스300등,http://www.gokorea.kr/news/articleView.html?idxno=662871
905,2020-02-07,더벨RD힘싣는대웅제약1300억돌파추산,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202002051547301240103057
906,2020-02-07,★주식인사이드대웅제약주가121500원2월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1062161
907,2020-02-07,돌풍일으킨대웅제약올로맥스신규용량추가,http://medipana.com/news/news_viewer.asp?NewsNum=252549&MainKind=A&NewsKind=5&vCount=12&vKind=1
908,2020-02-07,대웅제약올래맥스신규용량식약처허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=376987
909,2020-02-09,대웅제약파리에서나보타포럼개최,http://weekly.cnbnews.com/news/article.html?no=132461
910,2020-02-09,유유광동대웅제약조직체계수직→수평개편,http://www.dailymedi.com/detail.php?number=852627&thread=22r05
911,2020-02-10,★주식인사이드대웅제약주가118500원2월10일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1062527
912,2020-02-11,★주식인사이드대웅제약주가119500원2월11일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1062845
913,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240461
914,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.wsobi.com/news/articleView.html?idxno=90161
915,2020-02-11,대웅제약美바이오업계와항암신약공동연구로주가상승세견인중,http://nbntv.co.kr/news/view/846679
916,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.viva100.com/main/view.php?key=20200211010003547
917,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2121250
918,2020-02-11,대웅제약덴티가드랩iF디자인어워드서본상수상,https://asiatime.co.kr/news/newsview.php?ncode=1065572710862219
919,2020-02-11,대웅제약덴티가드랩국제디자인상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90428
920,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://medipana.com/news/news_viewer.asp?NewsNum=252665&MainKind=A&NewsKind=5&vCount=12&vKind=1
921,2020-02-11,대웅제약맞춤치약덴티가드랩세계3대디자인상수상,http://www.medisobizanews.com/news/articleView.html?idxno=66703
922,2020-02-11,대웅제약덴티가드랩패키지디자인우수성인정받아iF디자인어워드에서본상수상,http://www.updownnews.co.kr/news/articleView.html?idxno=214908
923,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.m-i.kr/news/articleView.html?idxno=680400
924,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=377210
925,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.dailysmart.co.kr/news/articleView.html?idxno=22185
926,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.newspim.com/news/view/20200211000277
927,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://news.mt.co.kr/mtview.php?no=2020021110011762886
928,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.newsway.co.kr/news/view?tp=1&ud=2020021110110801999
929,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.seoulwire.com/news/articleView.html?idxno=270484
930,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://newsbrite.net/133562
931,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.nbnnews.co.kr/news/articleView.html?idxno=367012
932,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.metroseoul.co.kr/news/newsview?newscd=2020021100040
933,2020-02-11,대웅제약덴티가드랩獨iF디자인어워드본상수상,http://news.mk.co.kr/newsRead.php?no=139374&year=2020
934,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수장,http://www.dailian.co.kr/news/view/867645?sc=Naver
935,2020-02-11,대웅제약덴티가드랩치약iF디자인어워드본상,http://www.newstomato.com/ReadNews.aspx?no=951224
936,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.newslock.co.kr/news/articleView.html?idxno=25665
937,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.ekn.kr/news/article.html?no=480763
938,2020-02-11,대웅제약 덴티가드랩iF 디자인어워드 본상글로벌디자인우수성인정,http://www.businesskorea.co.kr/news/articleView.html?idxno=41114
939,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.asiatoday.co.kr/view.php?key=20200211010006060
940,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.youthdaily.co.kr/news/article.html?no=28386
941,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.ebn.co.kr/news/view/1021447/?sc=naver
942,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.cnbnews.com/news/article.html?no=436575
943,2020-02-11,대웅제약덴티가드랩iF디자인어워드인정받아,http://www.whosaeng.com/115741
944,2020-02-11,제약워치대웅제약덴티가드랩iF디자인어워드본상外,http://www.newswatch.kr/news/articleView.html?idxno=27606
945,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.bokuennews.com/news/article.html?no=186518
946,2020-02-11,대웅제약덴티가드랩디자인상수상,http://www.dailymedi.com/detail.php?number=852718&thread=22r05
947,2020-02-11,대웅제약맞춤치약덴티가드랩iF디자인어워드본상수상,http://www.insightkorea.co.kr/news/articleView.html?idxno=76334
948,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.lawissue.co.kr/view.php?ud=202002111219235796204ead0791_12
949,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1855577
950,2020-02-11,제약오늘대웅제약덴티가드랩iF디자인어워드본상한미LAPSTripleAgonst글로벌시장게임체인저예고,http://www.sisaon.co.kr/news/articleView.html?idxno=108970
951,2020-02-11,뉴스투데이L대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.news2day.co.kr/148007
952,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.donga.com/news/article/all/20200211/99637475/1
953,2020-02-11,대웅제약맞춤치약덴티가드랩if디자인어워드본상수상글로벌디자인우수성인정,http://www.paxetv.com/news/articleView.html?idxno=86272
954,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.mediapen.com/news/view/499542
955,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.pressm.kr/news/articleView.html?idxno=27540
956,2020-02-11,제약산업대웅제약덴티가드랩iF디자인어워드본상外,http://www.kukinews.com/news/article.html?no=747595
957,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.wikileaks-kr.org/news/articleView.html?idxno=77125
958,2020-02-11,대웅제약덴티가드랩글로벌디자인우수성인정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59614
959,2020-02-11,대웅제약덴티가드랩글로벌서디자인우수성인정,http://www.econovill.com/news/articleView.html?idxno=385286
960,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드패키지부문수상,http://www.greened.kr/news/articleView.html?idxno=236756
961,2020-02-11,대웅제약덴티가드랩獨iF디자인어워드본상수상,http://www.ezyeconomy.com/news/articleView.html?idxno=97821
962,2020-02-11,대웅제약덴티가드랩iF디자인어워드패키지부문본상수상,http://www.g-enews.com/ko-kr/news/article/news_all/2020021116415922869d76442fa_1/article.html
963,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.thepublic.kr/news/newsview.php?ncode=1065597324432327
964,2020-02-11,대웅제약덴티가드랩iF디자인어워드서본상,http://www.mhj21.com/127500
965,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.sporbiz.co.kr/news/articleView.html?idxno=414496
966,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.ajunews.com/view/20200211183455499
967,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.newscj.com/news/articleView.html?idxno=707642
968,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상영예,https://www.kpanews.co.kr/article/show.asp?idx=210790&category=D
969,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.thefirstmedia.net/news/articleView.html?idxno=54210
970,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4056432
971,2020-02-12,★주식인사이드대웅제약주가119500원2월12일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1063184
972,2020-02-12,대웅제약글로벌신약개발가속화에이디엠코리아와협약,http://medipana.com/news/news_viewer.asp?NewsNum=252704&MainKind=A&NewsKind=5&vCount=12&vKind=1
973,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.medisobizanews.com/news/articleView.html?idxno=66748
974,2020-02-12,대웅제약에이디엠코리아와맞손글로벌신약개발가속화,http://www.seoulwire.com/news/articleView.html?idxno=270673
975,2020-02-12,대웅제약에이디엠코리아와공동임상개발협약,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202002120117&t=NN
976,2020-02-12,대웅제약에이디엠코리아와협약글로벌신약개발앞당긴다,http://www.mediapen.com/news/view/499716
977,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.nbnnews.co.kr/news/articleView.html?idxno=367388
978,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축글로벌신약개발가속화,http://www.viva100.com/main/view.php?key=20200212010003969
979,2020-02-12,대웅제약국내CRO와손잡고글로벌신약개발가속,http://www.econovill.com/news/articleView.html?idxno=385341
980,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.newsway.co.kr/news/view?tp=1&ud=2020021209240128860
981,2020-02-12,대웅제약에이디엠코리아와공동임상개발MOU체결,https://asiatime.co.kr/news/newsview.php?ncode=1065572204511774
982,2020-02-12,대웅제약에이디엠코리아와글로벌임상연구MOU,http://moneys.mt.co.kr/news/mwView.php?no=2020021209318014082
983,2020-02-12,대웅제약신약개발가속화공동임상체계구축글로벌진출강화,http://www.newswatch.kr/news/articleView.html?idxno=27674
984,2020-02-12,대웅제약에이디엠코리아글로벌임상연구개발MOU체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=377360
985,2020-02-12,대웅제약에이디엠코리아와공동임상개발MOU,http://www.bosa.co.kr/news/articleView.html?idxno=2121323
986,2020-02-12,대웅제약 에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.businesskorea.co.kr/news/articleView.html?idxno=41176
987,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.dailian.co.kr/news/view/867963?sc=Naver
988,2020-02-12,대웅제약에이디엠코리아와공동임상개발MOU체결,http://www.newspim.com/news/view/20200212000365
989,2020-02-12,대웅제약임상시험기관과MOU임상성공글로벌진출기대,http://news.mt.co.kr/mtview.php?no=2020021209580154181
990,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축MOU,http://news.mk.co.kr/newsRead.php?no=144071&year=2020
991,2020-02-12,대웅제약에이디엠코리아공동임상개발체계구축MOU체결글로벌신약개발가속화,http://www.greened.kr/news/articleView.html?idxno=236857
992,2020-02-12,대웅제약노련한CRO와손잡고신약개발박차,http://www.edaily.co.kr/news/newspath.asp?newsid=02378006625669864
993,2020-02-12,대웅제약에이디엠코리아글로벌신약개발위해MOU체결,http://www.k-health.com/news/articleView.html?idxno=47224
994,2020-02-12,대웅제약에이디엠코리아MOU체결신약개발및글로벌진출가속화,http://www.paxetv.com/news/articleView.html?idxno=86307
995,2020-02-12,대웅제약에이디엠코리아와맞손글로벌신약개발가속화,http://www.ezyeconomy.com/news/articleView.html?idxno=97841
996,2020-02-12,대웅제약에이디엠코리아글로벌신약개발가속화위한MOU체결,http://www.ekn.kr/news/article.html?no=481010
997,2020-02-12,대웅제약CRO에이디엠코리아와글로벌신약개발협약,http://www.newsis.com/view/?id=NISX20200212_0000916264&cID=13001&pID=13000
998,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://newsbrite.net/133613
999,2020-02-12,대웅제약글로벌신약개발가속화,http://www.ebn.co.kr/news/view/1021629/?sc=naver
1000,2020-02-12,대웅제약ADM코리아와공동임상체계구축,http://www.dailypharm.com/Users/News/NewsView.html?ID=261762&REFERER=NP
1001,2020-02-12,대웅제약에이디엠코리아와공동임상개발협약,http://www.metroseoul.co.kr/news/newsview?newscd=2020021200060
1002,2020-02-12,제약오늘대웅제약에이디엠코리아와공동임상개발체계구축업무협약체결동성제약이지엔신규컬러2종출시,http://www.sisaon.co.kr/news/articleView.html?idxno=109011
1003,2020-02-12,대웅제약에이디엠코리아와MOU공동임상체계구축,http://www.bokuennews.com/news/article.html?no=186557
1004,2020-02-12,대웅제약에이디엠코리아와협약체결글로벌신약개발가속화,http://www.pressm.kr/news/articleView.html?idxno=27569
1005,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.lawissue.co.kr/view.php?ud=20200212111600595204ead0791_12
1006,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축,http://www.newstomato.com/ReadNews.aspx?no=951563
1007,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축업무협약,http://www.insightkorea.co.kr/news/articleView.html?idxno=76369
1008,2020-02-12,대웅제약에이디엠코리아와글로벌임상MOU,https://www.hankyung.com/it/article/202002129894i
1009,2020-02-12,대웅제약공동임상개발체계구축나선다,http://www.monews.co.kr/news/articleView.html?idxno=208238
1010,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.dailysmart.co.kr/news/articleView.html?idxno=22257
1011,2020-02-12,대웅제약에이디엠코리아글로벌임상연구맞손,http://www.newsprime.co.kr/news/article.html?no=492959
1012,2020-02-12,대웅제약에이디엠코리아공동임상MOU체결글로벌신약개발가속화,http://www.newslock.co.kr/news/articleView.html?idxno=25697
1013,2020-02-12,대웅제약에이디엠코리아와손잡고글로벌신약개발가속화,http://www.etnews.com/20200212000211
1014,2020-02-12,대웅제약임상시험인프라구축에이디엠코리아와협약,http://www.100ssd.co.kr/news/articleView.html?idxno=67139
1015,2020-02-12,대웅제약에이디엠코리아와손잡고글로벌신약개발속도,http://www.etoday.co.kr/news/section/newsview.php?idxno=1856108
1016,2020-02-12,2월12일대웅제약실시간증시121000원126,http://nbntv.co.kr/news/view/847270
1017,2020-02-12,대웅제약에이디엠코리아와협약통해글로벌신약개발가속화전략적인공동임상체계구축해임상성공극대화할것,http://www.segye.com/content/html/2020/02/12/20200212510171.html?OutUrl=naver
1018,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59637
1019,2020-02-12,대웅제약임상시험성공높이기위해임상시험수탁기관과손잡아,http://www.businesspost.co.kr/BP?command=article_view&num=163515
1020,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.wikileaks-kr.org/news/articleView.html?idxno=77225
1021,2020-02-12,대웅제약전문임상수탁기관과MOU신약개발가속화,http://www.upinews.kr/newsView/upi202002120101
1022,2020-02-12,대웅제약에이디엠코리아와협약체결,http://www.wsobi.com/news/articleView.html?idxno=90335
1023,2020-02-12,대웅제약에이디엠코리아와협약통해글로벌신약개발가속화,http://www.medigatenews.com/news/2282273147
1024,2020-02-12,대웅제약에이디엠코리아와협약체결글로벌신약개발가속화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1367503
1025,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축업무협약,http://www.donga.com/news/article/all/20200212/99660098/1
1026,2020-02-12,대웅제약에이디엠코리아와MOU신약개발가속화,http://sports.hankooki.com/lpage/economy/202002/sp20200212163129137020.htm
1027,2020-02-12,대웅제약국내임상시험수탁기관에이디엠코리아와신약개발위한MOU체결,http://www.g-enews.com/ko-kr/news/article/news_all/2020021216494439969d76442fa_1/article.html
1028,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.m-i.kr/news/articleView.html?idxno=681108
1029,2020-02-12,대웅제약에이디엠코리아와공동임상개발협약,http://www.newscj.com/news/articleView.html?idxno=708005
1030,2020-02-12,대웅제약에이디엠코리아공동임상체계구축협약,https://www.kpanews.co.kr/article/show.asp?idx=210821&category=D
1031,2020-02-12,대웅제약에이디엠코리아와임상성공극대화협약,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4057520
1032,2020-02-13,대웅제약에이디엠코리아와협약을통해글로벌신약개발가속화,http://www.thefirstmedia.net/news/articleView.html?idxno=54263
1033,2020-02-13,★주식인사이드대웅제약주가119500원2월13일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1063566
1034,2020-02-13,대웅제약주식종목13일현재119000원,http://nbntv.co.kr/news/view/848025
1035,2020-02-13,대웅제약맞춤치약덴티가드랩獨iF디자인어워드본상수상,http://www.munhwa.com/news/view.html?no=2020021301032603000001
1036,2020-02-13,종근당대웅제약셀트리온첫매출1조클럽,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202002130343&t=NNv
1037,2020-02-13,코스피대웅제약2019년매출액1조52억원영업이익314억원,http://news.kmib.co.kr/article/view.asp?arcid=0014236268&code=61141211&cp=nv
1038,2020-02-13,실적속보잠정대웅제약별도20194Q영업이익1354억원,http://www.fntimes.com/html/view.php?ud=2020021317000992465dfa8bd265_18
1039,2020-02-13,대웅제약지난해영업익314억원전년比22증가,http://www.ftoday.co.kr/news/articleView.html?idxno=114587
1040,2020-02-13,대웅제약사상첫1조원돌파나보타임팩타민성장견인,http://news.mt.co.kr/mtview.php?no=2020021317083597665
1041,2020-02-13,대웅제약매출1조52억영업이익314억첫1조클럽가입,http://www.wikileaks-kr.org/news/articleView.html?idxno=77371
1042,2020-02-13,악재불구전승호사장의대웅제약매출1조돌파,http://www.whosaeng.com/115803
1043,2020-02-13,대웅제약작년매출액사상첫1조원돌파,http://www.asiatoday.co.kr/view.php?key=20200213010008225
1044,2020-02-13,대웅제약지난해영업익314원전년비22↑,http://www.ebn.co.kr/news/view/1021896/?sc=naver
1045,2020-02-13,대웅제약별도기준매출사상첫1조원돌파,http://medipana.com/news/news_viewer.asp?NewsNum=252801&MainKind=A&NewsKind=5&vCount=12&vKind=1
1046,2020-02-13,대웅제약지난해매출액1조52억원기록사상첫1조클럽입성,http://www.newslock.co.kr/news/articleView.html?idxno=25770
1047,2020-02-13,대웅제약2019년별도매출기준사상첫1조원돌파,http://www.koreaittimes.com/news/articleView.html?idxno=95532
1048,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.lawissue.co.kr/view.php?ud=202002131726167702204ead0791_12
1049,2020-02-13,대웅제약지난해매출액1조돌파영업익22↑,http://www.newspim.com/news/view/20200213001426
1050,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.mdtoday.co.kr/mdtoday/index.html?no=377564
1051,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.sisaon.co.kr/news/articleView.html?idxno=109127
1052,2020-02-13,대웅제약작년영업이익314억원전년동기대비22↑,http://news.mk.co.kr/newsRead.php?no=152153&year=2020
1053,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.etnews.com/20200213000400
1054,2020-02-13,대웅제약지난해매출1조52억원1조클럽진입성공,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020021317320247085
1055,2020-02-13,대웅제약별도매출기준첫1조돌파,http://www.dailypharm.com/Users/News/NewsView.html?ID=261833&REFERER=NP
1056,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.newsway.co.kr/news/view?tp=1&ud=2020021317370087491
1057,2020-02-13,대웅제약첫매출1조클럽가입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202002130476&t=NN
1058,2020-02-13,대웅제약지난해영업익314억전년比22증가,http://www.ajunews.com/view/20200213173723741
1059,2020-02-13,대웅제약지난해사상최대실적달성별도기준첫1조돌파,http://www.greened.kr/news/articleView.html?idxno=237166
1060,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://moneys.mt.co.kr/news/mwView.php?no=2020021317408068068
1061,2020-02-13,대웅제약별도기준매출사상첫1조돌파,http://www.newstomato.com/ReadNews.aspx?no=952114
1062,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.medigatenews.com/news/177827538
1063,2020-02-13,대웅제약사상첫매출1조원돌파의약품성장견인,http://sports.hankooki.com/lpage/economy/202002/sp20200213174642137020.htm
1064,2020-02-13,대웅제약사상첫별도매출1조돌파악재불구선방,http://www.newsis.com/view/?id=NISX20200213_0000918611&cID=13001&pID=13000
1065,2020-02-13,대웅제약별도매출기준사상첫1조원돌파전년대비65성장,http://www.consumernews.co.kr/news/articleView.html?idxno=601246
1066,2020-02-13,대웅제약별도기준매출첫1조돌파전문일반약사업고루성장,http://news1.kr/articles/?3842107
1067,2020-02-13,대웅제약별도매출기준사상첫1조원돌파전년대비매출액65상승,http://www.paxetv.com/news/articleView.html?idxno=86454
1068,2020-02-13,대웅제약작년별도매출첫1조원돌파,http://www.biospectator.com/view/news_view.php?varAtcId=9539
1069,2020-02-13,대웅제약사상처음으로1조클럽진입,http://www.mhj21.com/127564
1070,2020-02-13,대웅제약지난해매출별도기준첫1조돌파,https://www.ajunews.com/view/20200213172633712
1071,2020-02-13,대웅제약작년별도기준매출1조돌파,http://www.finomy.com/news/articleView.html?idxno=75128
1072,2020-02-13,대웅제약소송악재에도1조클럽가입,https://www.paxnetnews.com/articles/57065
1073,2020-02-13,대웅제약별도매출기준사상첫1조돌파작년영업익314억,http://www.newsprime.co.kr/news/article.html?no=493251
1074,2020-02-13,대웅제약지난해매출1조원첫돌파나보타수출효과,http://yna.kr/AKR20200213164800017?did=1195m
1075,2020-02-13,대웅제약별도재무제표기준매출사상첫1조원돌파,http://www.seoulfn.com/news/articleView.html?idxno=371906
1076,2020-02-13,대웅제약작년매출1조원첫돌파나보타실적견인,https://view.asiae.co.kr/article/2020021318050464491
1077,2020-02-13,대웅제약사상첫1조클럽진입나보타수출영향,http://www.getnews.co.kr/view.php?ud=2020021318091492707f7a2feaf6_16
1078,2020-02-13,대웅제약작년매출첫1조원돌파영업이익은314억원,http://sports.chosun.com/news/ntype.htm?id=202002140100102170006583&servicedate=20200213
1079,2020-02-13,대웅제약매출사상첫1조원돌파나보타및주력제품성과,http://www.ekn.kr/news/article.html?no=481504
1080,2020-02-13,대웅제약전승호號별도기준매출사상첫1조원돌파,http://www.sisaweek.com/news/articleView.html?idxno=130995
1081,2020-02-13,대웅제약지난해영업익314억전년比22증가,http://biz.newdaily.co.kr/site/data/html/2020/02/13/2020021300249.html
1082,2020-02-13,대웅제약별도기준첫매출1조원돌파,http://www.dailymedi.com/detail.php?number=852820&thread=22r05
1083,2020-02-13,대웅제약사상첫매출1조원돌파영업익22증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240622
1084,2020-02-13,대웅제약사상첫매출1조원돌파쾌거나보다미국진출덕분”,http://www.thepublic.kr/news/newsview.php?ncode=1065603638054432
1085,2020-02-13,대웅제약지난해매출1조52억영업익도소폭성장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1856927
1086,2020-02-13,대웅제약사상첫1조매출달성ETCOTC고른성장,http://www.koreastocknews.com/news/articleView.html?idxno=50437
1087,2020-02-13,대웅제약매출기준사상첫1조원돌파,http://www.nbnnews.co.kr/news/articleView.html?idxno=368160
1088,2020-02-13,대웅제약별도매출기준사상첫1조원돌파1조클럽가입,http://it.chosun.com/site/data/html_dir/2020/02/13/2020021303621.html
1089,2020-02-13,대웅제약작년매출1조52억원영업이익314억원달성별도매출기준사상첫1조원돌파,http://www.thefirstmedia.net/news/articleView.html?idxno=54313
1090,2020-02-13,대웅제약사상첫매출1조돌파,http://www.m-i.kr/news/articleView.html?idxno=681542
1091,2020-02-13,대웅제약사상첫매출1조원클럽멤버신고합니다,http://www.medisobizanews.com/news/articleView.html?idxno=66834
1092,2020-02-13,대웅제약개별매출기준첫1조원돌파1조클럽가입,https://biz.chosun.com/site/data/html_dir/2020/02/13/2020021303760.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1093,2020-02-13,대웅제약1조클럽가입매출영업이익314억달성,http://www.k-health.com/news/articleView.html?idxno=47273
1094,2020-02-13,대웅제약작년매출1조신기록영업이익은소송비용탓에약간늘어,http://www.businesspost.co.kr/BP?command=article_view&num=163846
1095,2020-02-13,대웅제약연간매출1조원돌파악재불구견고해진수익구조”,http://www.donga.com/news/article/all/20200213/99682098/1
1096,2020-02-13,대웅제약지난해매출1조클럽발디뎠다,http://www.mediapen.com/news/view/500277
1097,2020-02-13,대웅제약매출1조클럽가입오너공백극복,http://www.straightnews.co.kr/news/articleView.html?idxno=66612
1098,2020-02-13,대웅제약별도매출기준사상첫1조돌파나보타美수출성과,http://www.segyebiz.com/newsView/20200213516799?OutUrl=naver
1099,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://daily.hankooki.com/lpage/industry/202002/dh20200213203101147950.htm
1100,2020-02-13,대웅제약지난해별도영업익314억원기록전년대비22증가,http://www.econovill.com/news/articleView.html?idxno=385573
1101,2020-02-13,대웅제약2019년매출1조52억별도첫1조원달성,https://www.kpanews.co.kr/article/show.asp?idx=210863&category=D
1102,2020-02-14,대웅제약의뒷심악재뚫고하이킥,http://www.newsclaim.co.kr/news/articleView.html?idxno=3978
1103,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59669
1104,2020-02-14,대웅제약별도매출기준사상첫1조돌파,http://www.bosa.co.kr/news/articleView.html?idxno=2121446
1105,2020-02-14,대웅제약대표품목의빈자리목표가↓대신,http://news.mt.co.kr/mtview.php?no=2020021408111691566
1106,2020-02-14,리포트브리핑대웅제약지금은실적개선보다는불확실성해소가보고싶다목표가140000원한국투자증권,http://www.newspim.com/news/view/20200214000069
1107,2020-02-14,하이로우대웅제약불확실성여전목표가22↓한국투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020021408513272504
1108,2020-02-14,리포트브리핑대웅제약내우외환으로고전하는실적상반기까지감내필요목표가180000원KTB투자증권,http://www.newspim.com/news/view/20200214000140
1109,2020-02-14,★주식인사이드대웅제약주가118000원2월14일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1063897
1110,2020-02-14,바이오시밀러복제바이오의약품테마오전시황상승률상위종목알테오젠310대웅제약299LG화학146등,http://www.gokorea.kr/news/articleView.html?idxno=666315
1111,2020-02-14,대웅제약지난해별도매출기준사상첫1조원돌파,http://www.dailian.co.kr/news/view/868486?sc=Naver
1112,2020-02-14,대웅제약작년사상첫매출1조원돌파영업익은314억원,http://www.viva100.com/main/view.php?key=20200214010004890
1113,2020-02-14,뉴스락주식네비2월14일대웅제약메디톡스소송리스크해소여부가열쇠,http://www.newslock.co.kr/news/articleView.html?idxno=25779
1114,2020-02-14,대웅제약지난해1조52억원매출영업이익314억원달성,http://www.bokuennews.com/news/article.html?no=186648
1115,2020-02-14,대웅제약첫매출1조클럽가입1조52억매출,http://www.newswatch.kr/news/articleView.html?idxno=27756
1116,2020-02-14,대웅제약별도매출기준사상첫1조원돌파나보다미국진출쾌거,http://www.businesskorea.co.kr/news/articleView.html?idxno=41293
1117,2020-02-14,대웅제약미국수출된나보타덕별도매출기준사상첫1조원돌파,http://www.ceoscoredaily.com/news/article.html?no=66125
1118,2020-02-14,주식실시간대웅제약주가14일현재119500원,http://nbntv.co.kr/news/view/849163
1119,2020-02-14,NH투자증권대웅제약실적개선보다불확실성해소가보고싶다”,http://www.econovill.com/news/articleView.html?idxno=385603
1120,2020-02-14,대웅제약별도매출기준사상첫1조원돌파기염RD주요신약파이프라인성과가시화기대,http://www.segye.com/content/html/2020/02/14/20200214504682.html?OutUrl=naver
1121,2020-02-14,대웅제약지난해별도기준사상첫1조원돌파매출액1조52억영업익314억,http://www.g-enews.com/ko-kr/news/article/news_all/2020021410100646369d76442fa_1/article.html
1122,2020-02-14,대웅제약지난해별도기준사상첫1조원돌파매출액1조52억영업익314억,http://www.g-enews.com/ko-kr/news/article/news_all/2020021410100646369d76442fa_1/article.html
1123,2020-02-14,리포트브리핑대웅제약소송의피로감만덜어진다면목표가190000원DB금융투자,http://www.newspim.com/news/view/20200214000517
1124,2020-02-14,대웅제약매출1조52억원1조클럽첫가입,http://www.monews.co.kr/news/articleView.html?idxno=208297
1125,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://newsbrite.net/133725
1126,2020-02-14,리포트브리핑대웅제약4Q19Reveiw끝나지않았던알비스영향목표가160000원유안타증권,http://www.newspim.com/news/view/20200214000602
1127,2020-02-14,대웅제약사상첫매출1조클럽가입연구개발성과에주목,http://www.joseilbo.com/news/news_read.php?uid=392051&class=17&grp=
1128,2020-02-14,대웅제약소송비에다위장약매출감소로이익개선은하반기나가능,http://www.businesspost.co.kr/BP?command=article_view&num=163964
1129,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://www.enewstoday.co.kr/news/articleView.html?idxno=1368021
1130,2020-02-14,리포트브리핑대웅제약4Q19Review알비스의공백을감안하면선방NotRated미래에셋대우,http://www.newspim.com/news/view/20200214000698
1131,2020-02-14,알비스공백컸나대웅제약4분기어닝쇼크,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1077180
1132,2020-02-14,리포트브리핑대웅제약대표품목의빈자리목표가170000원대신증권,http://www.newspim.com/news/view/20200214000798
1133,2020-02-14,대웅제약사상첫매출1조돌파영업익314억달성,http://www.pressm.kr/news/articleView.html?idxno=27614
1134,2020-02-14,대웅제약메디톡스와진행중인소송의피로감반영”,http://www.wikitree.co.kr/main/news_view.php?id=505412
1135,2020-02-14,대웅제약발암물질악재에도사상첫별도기준매출1조돌파,https://asiatime.co.kr/news/newsview.php?ncode=1065583052352053
1136,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://www.wsobi.com/news/articleView.html?idxno=90556
1137,2020-02-14,보툴리눔전쟁승자는대웅제약소송불확실성에올해도실적타격,http://www.whitepaper.co.kr/news/articleView.html?idxno=189236
1138,2020-02-14,대웅제약지난해매출65증가,http://www.kukinews.com/news/article.html?no=749316
1139,2020-02-14,대웅제약지난해영업익314억전년比22↑,http://www.cnbnews.com/news/article.html?no=437077
1140,2020-02-17,★주식인사이드대웅제약주가119500원2월17일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1064239
1141,2020-02-17,대웅제약첫1조매출달성,http://news.heraldcorp.com/view.php?ud=20200217000120
1142,2020-02-17,대웅제약주식추천주17일현재117500원,http://nbntv.co.kr/news/view/850293
1143,2020-02-17,대웅제약알비스판매중단에4분기어닝쇼크빈자리메울수있을까,http://www.greened.kr/news/articleView.html?idxno=237687
1144,2020-02-18,★주식인사이드대웅제약주가117500원2월18일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1064545
1145,2020-02-18,대웅제약06962018일042변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=668762
1146,2020-02-18,보톡스보툴리눔톡신테마오후시황상승률상위종목파마리서치프로덕트1263제테마020대웅제약042등,http://www.gokorea.kr/news/articleView.html?idxno=669260
1147,2020-02-18,보톡스보툴리눔톡신테마마감시황상승률상위종목파마리서치프로덕트1302대웅제약보합세디에스케이080등,http://www.gokorea.kr/news/articleView.html?idxno=669424
1148,2020-02-18,종근당대웅제약1조클럽가입적극적인RD투자결실,http://www.newsprime.co.kr/news/article.html?no=493804
1149,2020-02-19,대웅제약VS메디톡스보툴리눔톡신균주전쟁최후승자는,http://www.g-enews.com/ko-kr/news/article/news_all/20200217105655757269d76442fa_1/article.html
1150,2020-02-19,위탁생산위주파모티딘제제대웅제약자체생산움직임,http://medipana.com/news/news_viewer.asp?NewsNum=252954&MainKind=A&NewsKind=5&vCount=12&vKind=1
1151,2020-02-19,★주식인사이드대웅제약주가118500원2월19일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1064870
1152,2020-02-19,노갑용전대웅제약부사장휴먼스헬스케어설립,http://www.bosa.co.kr/news/articleView.html?idxno=2121738
1153,2020-02-19,잠정실적대웅제약4Q실적매출액2876억원전년동기대비56증가영업이익73감소연결,http://www.newspim.com/news/view/20200219000945
1154,2020-02-19,잠정실적대웅제약3년중가장낮은영업이익매출액은직전대비68↑연결,https://www.hankyung.com/finance/article/202002198034L
1155,2020-02-19,대웅제약작년영업익446억전년비819↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859123
1156,2020-02-19,대웅제약지난해영업익447억전년비819↑,http://news.heraldcorp.com/view.php?ud=20200219000740
1157,2020-02-19,대웅제약작년영업익446억전년比819↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03706406625672160
1158,2020-02-19,공시대웅제약지난해영업익447억원전년비819↑,http://www.newsway.co.kr/news/view?tp=1&ud=2020021915341276606
1159,2020-02-19,대웅제약작년영업익446억전년비819↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859155
1160,2020-02-19,실적발표대웅제약화천기공브릿지바이오코오롱플라스틱,http://www.businesspost.co.kr/BP?command=article_view&num=164651
1161,2020-02-19,대웅제약작년영업익447억전년비819↑,http://www.asiatoday.co.kr/view.php?key=20200219010011464
1162,2020-02-19,대웅제약지난해영업익446억8709만원전년比819증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=378088
1163,2020-02-19,대웅제약라니티딘나보타소송한올3상등계속된악재에도흑자전환성공,http://www.medigatenews.com/news/627445548
1164,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.businesskorea.co.kr/news/articleView.html?idxno=41593
1165,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240826
1166,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.newspim.com/news/view/20200220000100
1167,2020-02-20,대웅제약나보타브라질판매허가,http://www.hankookilbo.com/news/npath/202002200930790267?did=NA
1168,2020-02-20,대웅제약보톡스나보타중남미최대브라질시장뚫었다,http://www.edaily.co.kr/news/newspath.asp?newsid=01823686625672488
1169,2020-02-20,대웅제약나보타중남미최대시장브라질진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859390
1170,2020-02-20,★주식인사이드대웅제약주가120000원2월20일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1065083
1171,2020-02-20,게시판대웅제약나보타브라질품목허가획득,http://yna.kr/AKR20200220039700017?did=1195m
1172,2020-02-20,대웅제약나보타브라질품목허가중남미최대시장진출,http://www.medisobizanews.com/news/articleView.html?idxno=67043
1173,2020-02-20,대웅제약나보타브라질서품목허가획득,https://asiatime.co.kr/news/newsview.php?ncode=1065571171042938
1174,2020-02-20,대웅제약나보타브라질서품목허가획득,https://asiatime.co.kr/news/newsview.php?ncode=1065571171042938
1175,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.m-i.kr/news/articleView.html?idxno=683366
1176,2020-02-20,대웅제약나보타브라질진출중남미공략나서,http://moneys.mt.co.kr/news/mwView.php?no=2020022009158091431
1177,2020-02-20,대웅제약나보타브라질서품목허가취득,http://www.mhj21.com/127758
1178,2020-02-20,대웅제약브라질서나보타품목허가획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020022009214443360
1179,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.metroseoul.co.kr/news/newsview?newscd=2020022000010
1180,2020-02-20,대웅제약보툴리눔톡신나보타브라질품목허가승인,http://www.consumuch.com/news/articleView.html?idxno=47660
1181,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.enewstoday.co.kr/news/articleView.html?idxno=1369097
1182,2020-02-20,대웅제약브라질서나보타시판허가받아,http://news.mk.co.kr/newsRead.php?no=174464&year=2020
1183,2020-02-20,대웅제약나보타브라질서품목허가획득중남미최대시장진출,http://www.greened.kr/news/articleView.html?idxno=238150
1184,2020-02-20,대웅제약나보타브라질서품목허가획득중남미시장입지강화,http://www.newslock.co.kr/news/articleView.html?idxno=25914
1185,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.ezyeconomy.com/news/articleView.html?idxno=98101
1186,2020-02-20,대웅제약나보타중남미최대시장브라질품목허가획득,http://www.ftoday.co.kr/news/articleView.html?idxno=114724
1187,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.biospectator.com/view/news_view.php?varAtcId=9585
1188,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.etnews.com/20200220000037
1189,2020-02-20,대웅제약나보타중남미시장공략브라질품목허가획득,http://www.newsprime.co.kr/news/article.html?no=494069
1190,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.dailian.co.kr/news/view/869789?sc=Naver
1191,2020-02-20,대웅제약나보타중남미최대브라질품목허가획득,http://www.medigatenews.com/news/832748802
1192,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.ekn.kr/news/article.html?no=482712
1193,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.mediapen.com/news/view/501909
1194,2020-02-20,대웅제약나보타중남미최대시장진출,http://www.nbnnews.co.kr/news/articleView.html?idxno=370120
1195,2020-02-20,대웅제약나보타중남미시장공략본격화,http://www.koreastocknews.com/news/articleView.html?idxno=50676
1196,2020-02-20,대웅제약나보타브라질허가중남미최대시장진출,http://www.newsis.com/view/?id=NISX20200220_0000925221&cID=13001&pID=13000
1197,2020-02-20,대웅제약나보타중남미최대시장브라질서품목허가,http://www.consumernews.co.kr/news/articleView.html?idxno=601472
1198,2020-02-20,대웅제약나보타브라질품목허가중남미최대시장진출,http://www.newstomato.com/ReadNews.aspx?no=953474
1199,2020-02-20,대웅제약나보타브라질시장진출,http://www.monews.co.kr/news/articleView.html?idxno=208432
1200,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미시장진출,http://www.asiatoday.co.kr/view.php?key=20200220010011852
1201,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.rapportian.com/news/articleView.html?idxno=123532
1202,2020-02-20,대웅제약나보타브라질에품목허가획득중남미시장입지강화계획,http://www.paxetv.com/news/articleView.html?idxno=86741
1203,2020-02-20,대웅제약나보타브라질품목허가획득,https://www.paxnetnews.com/articles/57320
1204,2020-02-20,대웅제약나보타중남미최대시장브라질진출,http://www.sisaweek.com/news/articleView.html?idxno=131151
1205,2020-02-20,대웅제약나보타브라질허가획득중남미최대시장진출,http://www.viva100.com/main/view.php?key=20200220010007193
1206,2020-02-20,대웅제약나보타브라질품목허가획득중남미시장진출,http://news.mt.co.kr/mtview.php?no=2020022011062758448
1207,2020-02-20,대웅제약나보타로중남미시장공략본격화,https://jhealthmedia.joins.com/article/article_view.asp?pno=21413
1208,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.ebn.co.kr/news/view/1022804/?sc=naver
1209,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=378149
1210,2020-02-20,대웅제약보툴리눔톡신제제나보타브라질진출,https://cnbc.sbs.co.kr/article_hub/10000973606?division=NAVER
1211,2020-02-20,대웅제약나보타중남미최대시장브라질서품목허가획득,http://www.insightkorea.co.kr/news/articleView.html?idxno=76715
1212,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.ceoscoredaily.com/news/article.html?no=66324
1213,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2121800
1214,2020-02-20,대웅제약나보타브라질진출중남미본격공략,http://www.upinews.kr/newsView/upi202002200058
1215,2020-02-20,대웅제약브라질에서보툴리눔톡신품목허가얻어중남미공략,http://www.businesspost.co.kr/BP?command=article_view&num=164774
1216,2020-02-20,대웅제약보톡스나보타중남미시장진출본격화브라질시판허가,http://www.ntoday.co.kr/news/articleView.html?idxno=70985
1217,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.lawissue.co.kr/view.php?ud=202002201320482770204ead0791_12
1218,2020-02-20,대웅제약나보타브라질품목허가획득중남미공략박차,http://www.donga.com/news/article/all/20200220/99793600/1
1219,2020-02-20,제약오늘대웅제약나보타브라질품목허가획득으로중남미최대시장진출유한양행아임뉴런社플랫폼기술활용한신약개발공동연구진행,http://www.sisaon.co.kr/news/articleView.html?idxno=109375
1220,2020-02-20,대웅제약나보타브라질서품목허가획득중남미최대시장진출,http://www.cnbnews.com/news/article.html?no=437663
1221,2020-02-20,대웅제약자체개발보툴리눔톡신제제나보타브라질품목허가획득,http://www.pressm.kr/news/articleView.html?idxno=27707
1222,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.updownnews.co.kr/news/articleView.html?idxno=215322
1223,2020-02-20,대웅제약나보타중남미시장본격공략브라질서품목허가획득,http://kpenews.com/View.aspx?No=755293
1224,2020-02-20,대웅제약나보타브라질품목허가획득중남미시장진출,http://www.dailysmart.co.kr/news/articleView.html?idxno=22636
1225,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.dailymedi.com/detail.php?number=853042&thread=22r05
1226,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출미용적응증치료적응증동시허가획득으로빠른성장기대,http://www.segye.com/content/html/2020/02/20/20200220512794.html?OutUrl=naver
1227,2020-02-20,대웅제약브라질서나보타품목허가획득,http://www.seoulfn.com/news/articleView.html?idxno=372573
1228,2020-02-20,대웅제약브라질서나보타판매허가획득,http://www.finomy.com/news/articleView.html?idxno=75338
1229,2020-02-20,대웅제약보툴리눔톡신나보타브라질진출,https://view.asiae.co.kr/article/2020022016163400270
1230,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장,http://www.econovill.com/news/articleView.html?idxno=386166
1231,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.thefirstmedia.net/news/articleView.html?idxno=54618
1232,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://newsbrite.net/133951
1233,2020-02-20,대웅제약나보타글로벌영토확장에박차브라질서품목허가획득,http://www.g-enews.com/ko-kr/news/article/news_all/20200220165102389369d76442fa_1/article.html
1234,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.newscj.com/news/articleView.html?idxno=710544
1235,2020-02-21,오늘기업사람MH에탄올주LS대웅제약서울옥션현대차,https://cnbc.sbs.co.kr/article_hub/10000973735?division=NAVER
1236,2020-02-21,★주식인사이드대웅제약주가118500원2월21일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1065411
1237,2020-02-21,대웅제약우루사지난해매출882억원역대최대,http://www.ceoscoredaily.com/news/article.html?no=66368
1238,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://medipana.com/news/news_viewer.asp?NewsNum=253083&MainKind=A&NewsKind=5&vCount=12&vKind=1
1239,2020-02-21,대웅제약우루사3년연속역대최고매출경신,http://www.consumuch.com/news/articleView.html?idxno=47678
1240,2020-02-21,대웅제약우루사지난해882억원어치팔렸다,http://www.econovill.com/news/articleView.html?idxno=386203
1241,2020-02-21,대웅제약우루사3년연속최고매출882억원기록,http://moneys.mt.co.kr/news/mwView.php?no=2020022109258024397
1242,2020-02-21,대웅제약우루사지난해매출882억3년연속최대치,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859999
1243,2020-02-21,대웅제약우루사작년882억매출3년연속최대,http://www.edaily.co.kr/news/newspath.asp?newsid=01886006625672816
1244,2020-02-21,대웅제약우루사폭풍성장3년연속최고매출기록경신,http://www.medisobizanews.com/news/articleView.html?idxno=67089
1245,2020-02-21,대웅제약대표품목우루사3년연속최고매출기록경신,http://daily.hankooki.com/lpage/ittech/202002/dh20200221093528145630.htm
1246,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240883
1247,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.bosa.co.kr/news/articleView.html?idxno=2121860
1248,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newspim.com/news/view/20200221000255
1249,2020-02-21,대웅제약주가21일042변화,http://www.gokorea.kr/news/articleView.html?idxno=671815
1250,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.mediapen.com/news/view/502214
1251,2020-02-21,대웅제약우루사매출882억원최고매출기록경신,http://www.viva100.com/main/view.php?key=20200221010007566
1252,2020-02-21,대웅제약우루사3년연속최고매출갱신,https://asiatime.co.kr/news/newsview.php?ncode=1065572164488824
1253,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newsway.co.kr/news/view?tp=1&ud=2020022109535678573
1254,2020-02-21,대웅제약우루사3년연속매출기록경신,http://www.ebn.co.kr/news/view/1022963/?sc=naver
1255,2020-02-21,대웅제약우루사매출882억3년연속최고기록경신,http://www.newsis.com/view/?id=NISX20200221_0000926759&cID=13001&pID=13000
1256,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.dailysmart.co.kr/news/articleView.html?idxno=22658
1257,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.enewstoday.co.kr/news/articleView.html?idxno=1369450
1258,2020-02-21,대웅제약우루사3년연속역대최고매출경신,http://www.koreastocknews.com/news/articleView.html?idxno=50737
1259,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.m-i.kr/news/articleView.html?idxno=683796
1260,2020-02-21,대웅제약의효자우루사3년연속최고매출,http://www.mhj21.com/127810
1261,2020-02-21,대웅제약우루사지난해매출882억3년연속최고기록,http://www.mdtoday.co.kr/mdtoday/index.html?no=378269
1262,2020-02-21,대웅제약우루사3년연속최고매출기록경신900억원달성눈앞,http://www.ezyeconomy.com/news/articleView.html?idxno=98148
1263,2020-02-21,대웅제약우루사지난해매출882억원3년연속최고기록경신,http://www.metroseoul.co.kr/news/newsview?newscd=2020022100023
1264,2020-02-21,대웅제약우루사매출일신우일신,http://www.whosaeng.com/115948
1265,2020-02-21,대웅제약우루사매출일신우일신,http://www.whosaeng.com/115948
1266,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.dailian.co.kr/news/view/870165?sc=Naver
1267,2020-02-21,대웅제약우루사2019년매출800억원돌파3년연속최고매출경신,http://www.sisaweek.com/news/articleView.html?idxno=131186
1268,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.nbnnews.co.kr/news/articleView.html?idxno=370594
1269,2020-02-21,대웅제약우루사매출882억3년연속최고매출,http://news.mt.co.kr/mtview.php?no=2020022110251284679
1270,2020-02-21,뉴스투데이L대웅제약우루사3년연속최고매출기록조제용연간매출최초500억원돌파,http://www.news2day.co.kr/148536
1271,2020-02-21,대웅제약우루사작년매출882억달성,http://www.rapportian.com/news/articleView.html?idxno=123566
1272,2020-02-21,대웅제약우루사3년연속최고매출경신전년대비11↑,http://www.businesskorea.co.kr/news/articleView.html?idxno=41654
1273,2020-02-21,대웅제약우루사전년대비약11성장최고매출기록,http://www.pressm.kr/news/articleView.html?idxno=27732
1274,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.lawissue.co.kr/view.php?ud=20200221112342302204ead0791_12
1275,2020-02-21,대웅제약간판제품우루사공격적마케팅으로3년연속최고매출,http://www.medigatenews.com/news/1915290430
1276,2020-02-21,대웅제약우루사3년연속역대최고매출기록경신,http://www.newsprime.co.kr/news/article.html?no=494222
1277,2020-02-21,대웅제약우루사연매출800억돌파,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1077493
1278,2020-02-21,대웅제약우루사매출최고치경신900억원눈앞,http://sports.hankooki.com/lpage/economy/202002/sp20200221131242137020.htm
1279,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newslock.co.kr/news/articleView.html?idxno=25956
1280,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.bokuennews.com/news/article.html?no=186899
1281,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59781
1282,2020-02-21,대웅제약우루사작년매출882억신기록,http://www.finomy.com/news/articleView.html?idxno=75369
1283,2020-02-21,대웅제약우루사파워브랜드입증3년연속두자릿수성장률,http://www.seoulfn.com/news/articleView.html?idxno=372718
1284,2020-02-21,대웅제약우루사매출신기록3년째달성전승호처방영역확대,http://www.businesspost.co.kr/BP?command=article_view&num=165005
1285,2020-02-21,대웅제약우루사작년882억원어치팔려3년연속최대매출기록경신,http://news.mk.co.kr/newsRead.php?no=181285&year=2020
1286,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://newsbrite.net/133995
1287,2020-02-21,대웅제약간판제품우루사3년연속최고매출경신약882억원기록경신,http://www.paxetv.com/news/articleView.html?idxno=86809
1288,2020-02-21,대웅제약우루사지난해매출882억3년연속최고매출기록경신,http://www.cnbnews.com/news/article.html?no=437781
1289,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.sisaon.co.kr/news/articleView.html?idxno=109436
1290,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.wikileaks-kr.org/news/articleView.html?idxno=78126
1291,2020-02-21,대웅제약우루사작년매출882억3년연속최고매출경신,http://www.asiatoday.co.kr/view.php?key=20200221010012711
1292,2020-02-21,대웅제약우루사3년연속최고매출기록경신최초500억돌파,http://www.newswatch.kr/news/articleView.html?idxno=28022
1293,2020-02-21,대웅제약우루사작년매출882억3년연속최대,http://inthenews.co.kr/article-36647/
1294,2020-02-21,대웅제약우루사3년연속최고매출기록경신조제용우루사연간매출최초500억원돌파,http://www.segye.com/content/html/2020/02/21/20200221513137.html?OutUrl=naver
1295,2020-02-21,대웅제약우루사3년연속매출신기록경신900억고지눈앞,http://www.donga.com/news/article/all/20200221/99815438/1
1296,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.updownnews.co.kr/news/articleView.html?idxno=215384
1297,2020-02-21,대웅제약우루사2019년매출882억3년째경신,http://health.chosun.com/site/data/html_dir/2020/02/21/2020022102830.html
1298,2020-02-21,대웅제약우루사3년연속최고매출기록경신,https://www.vop.co.kr/A00001469967.html
1299,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newscj.com/news/articleView.html?idxno=710876
1300,2020-02-21,대웅제약우루사3년연속최고매출기록경신,https://www.kpanews.co.kr/article/show.asp?idx=211054&category=D
1301,2020-02-22,유한종근당대웅제약등대구경북재택근무전환,http://www.dailymedi.com/detail.php?number=853101&thread=22r05
1302,2020-02-22,대웅제약우루사작년매출882억원전년대비약11성장,http://www.thefirstmedia.net/news/articleView.html?idxno=54725
1303,2020-02-23,대웅제약우루사3년연속최고매출기록경신,http://www.segyebiz.com/newsView/20200223503868?OutUrl=naver
1304,2020-02-24,★주식인사이드대웅제약주가116000원2월24일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1065827
1305,2020-02-24,대웅제약의료진대상WECARE캠페인시행위질환치료정보제공,http://www.viva100.com/main/view.php?key=20200224010008337
1306,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.m-i.kr/news/articleView.html?idxno=684364
1307,2020-02-24,대웅제약의료진대상WECARE캠페인시행위질환치료정보제공,http://www.dailian.co.kr/news/view/870597?sc=Naver
1308,2020-02-24,대웅제약위질환치료정보제공온라인캠페인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90692
1309,2020-02-24,대웅제약의료진대상WECARE캠페인시행위질환치료정보제공,http://www.pressm.kr/news/articleView.html?idxno=27747
1310,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240945
1311,2020-02-24,대웅제약의료진대상WECARE캠페인위장관손상예방정보제공,http://www.medisobizanews.com/news/articleView.html?idxno=67142
1312,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.nbnnews.co.kr/news/articleView.html?idxno=371257
1313,2020-02-24,대웅제약의료진대상WECARE캠페인위질환치료정보제공,http://www.newsway.co.kr/news/view?tp=1&ud=2020022409494303206
1314,2020-02-24,대웅제약위질환치료정보WECARE캠페인시행,http://www.dailysmart.co.kr/news/articleView.html?idxno=22714
1315,2020-02-24,대웅제약의료진대상위케어캠페인진행위질환치료온라인강의제공,http://www.greened.kr/news/articleView.html?idxno=238692
1316,2020-02-24,대웅제약NSAIDs로인한위질환치료정보공유캠페인나서,http://news.mk.co.kr/newsRead.php?no=187998&year=2020
1317,2020-02-24,대웅제약06962024일298변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=672979
1318,2020-02-24,대웅제약의료진대상WECARE캠페인진행,http://www.bosa.co.kr/news/articleView.html?idxno=2121960
1319,2020-02-24,대웅제약의료진에위질환치료정보제공하는WECARE캠페인,http://www.insightkorea.co.kr/news/articleView.html?idxno=77091
1320,2020-02-24,대웅제약WECARE캠페인통해위질환치료정보제공,http://www.newspim.com/news/view/20200224000287
1321,2020-02-24,대웅제약의료진대상WECARE캠페인실시,http://medipana.com/news/news_viewer.asp?NewsNum=253152&MainKind=A&NewsKind=5&vCount=12&vKind=1
1322,2020-02-24,대웅제약의료진대상위케어캠페인실시,https://asiatime.co.kr/news/newsview.php?ncode=1065573532766848
1323,2020-02-24,대웅제약의료진대상WECARE캠페인위질환치료정보공유,http://www.asiatoday.co.kr/view.php?key=20200224010013614
1324,2020-02-24,대웅제약의료진대상위질환치료정보제공,http://news.mt.co.kr/mtview.php?no=2020022410260358524
1325,2020-02-24,대웅제약의료진대상위질환치료정보온라인세미나,http://www.etoday.co.kr/news/section/newsview.php?idxno=1860797
1326,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://newsbrite.net/134033
1327,2020-02-24,대웅제약WECARE캠페인의료진대상위치료정보제공,http://www.medigatenews.com/news/2623427131
1328,2020-02-24,대웅제약WECARE캠페인전개,http://www.monews.co.kr/news/articleView.html?idxno=208510
1329,2020-02-24,대웅제약우루사3년연속최고매출기록경신,http://www.monews.co.kr/news/articleView.html?idxno=208505
1330,2020-02-24,대웅제약오늘부터의료진대상WECARE캠페인진행,http://www.ekn.kr/news/article.html?no=483436
1331,2020-02-24,뉴스투데이L대웅제약WECARE캠페인으로의료진대상위질환치료정보제공,http://www.news2day.co.kr/148600
1332,2020-02-24,대웅제약WECARE캠페인통해위질환치료정보제공,http://www.ebn.co.kr/news/view/1023232/?sc=naver
1333,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.bokuennews.com/news/article.html?no=186971
1334,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.updownnews.co.kr/news/articleView.html?idxno=215421
1335,2020-02-24,대웅제약의료진대상위질환치료온라인세미나,http://www.mediapen.com/news/view/502870
1336,2020-02-24,대웅제약 의료진대상4주간 WECARE 캠페인 통해위질환치료정보제공,http://www.newslock.co.kr/news/articleView.html?idxno=25992
1337,2020-02-24,대웅제약의료진대상WECARE캠페인위질환치료정보제공,http://www.metroseoul.co.kr/article/20200224500190
1338,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59798
1339,2020-02-24,대웅제약의료진대상WECARE캠페인실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=378435
1340,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.businesskorea.co.kr/news/articleView.html?idxno=41746
1341,2020-02-24,대웅제약의료진대상WECARE캠페인위질환치료정보제공,http://www.ezyeconomy.com/news/articleView.html?idxno=98221
1342,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.thepublic.kr/news/newsview.php?ncode=1065579447826599
1343,2020-02-24,대웅제약의료진대상최신위질환치료정보제공,http://www.donga.com/news/article/all/20200224/99846564/1
1344,2020-02-24,대웅제약WECARE캠페인위질환치료정보제공,http://www.whosaeng.com/115980
1345,2020-02-24,대웅제약의료진대상최신위질환치료정보제공위케어캠페인시행,http://www.newswatch.kr/news/articleView.html?idxno=28062
1346,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.lawissue.co.kr/view.php?ud=202002241427379480204ead0791_12
1347,2020-02-24,제약오늘대웅제약의료진대상WECARE캠페인시행동성제약모발건강도움주는프로비올출시,http://www.sisaon.co.kr/news/articleView.html?idxno=109505
1348,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.cnbnews.com/news/article.html?no=437951
1349,2020-02-24,대웅제약의료진대상WECARE캠페인실시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1370050
1350,2020-02-24,대웅제약의료진대상위케어캠페인시행약제로인한위질환치료정보제공,http://www.paxetv.com/news/articleView.html?idxno=86933
1351,2020-02-24,대웅제약위장관손상최신지견공유WECARE캠페인시행,http://www.iminju.net/news/articleView.html?idxno=52171
1352,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.thefirstmedia.net/news/articleView.html?idxno=54777
1353,2020-02-24,대웅제약의료진대상WECARE캠페인열어,http://www.econovill.com/news/articleView.html?idxno=386553
1354,2020-02-24,대웅제약의료진대상WECARE캠페인진행,http://www.k-health.com/news/articleView.html?idxno=47393
1355,2020-02-24,전승호대웅제약사장2년연속1조클럽가입비결,http://www.insightkorea.co.kr/news/articleView.html?idxno=77102
1356,2020-02-24,대웅제약WECARE캠페인실시,http://www.wsobi.com/news/articleView.html?idxno=91028
1357,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.newscj.com/news/articleView.html?idxno=711649
1358,2020-02-25,★주식인사이드대웅제약주가109000원2월25일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1066162
1359,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240993
1360,2020-02-25,대웅제약올로맥스신규용량추가시장확대,http://news.mt.co.kr/mtview.php?no=2020022509090255675
1361,2020-02-25,대웅제약올로맥스로고혈압치료제라인업강화,http://www.newspim.com/news/view/20200225000187
1362,2020-02-25,대웅제약올로맥스신규용량추가로제품군강화,http://www.edaily.co.kr/news/newspath.asp?newsid=01945046625674128
1363,2020-02-25,대웅제약올로맥스신규용량출시라인업강화,http://www.dailypharm.com/Users/News/NewsView.html?ID=262146&REFERER=NP
1364,2020-02-25,대웅제약올로맥스신규용량추가고혈압치료제라인업강화,http://www.etnews.com/20200225000040
1365,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나서나,https://www.dailian.co.kr/news/view/870908?sc=Naver
1366,2020-02-25,대웅제약올로맥스시장확대박차신규용량라인업강화,http://medipana.com/news/news_viewer.asp?NewsNum=253203&MainKind=A&NewsKind=5&vCount=12&vKind=1
1367,2020-02-25,대웅제약올로맥스신규용량추가시장확대가속,http://www.etoday.co.kr/news/section/newsview.php?idxno=1861358
1368,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.bokuennews.com/news/article.html?no=187010
1369,2020-02-25,대웅제약올로맥스신규용량출시시장확대나선다,http://www.mediapen.com/news/view/503126
1370,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.dailysmart.co.kr/news/articleView.html?idxno=22769
1371,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.ebn.co.kr/news/view/1023379/?sc=naver
1372,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,http://www.mhj21.com/127861
1373,2020-02-25,대웅제약고혈압치료제올로맥스신규용량추가로라인업강화,http://www.medisobizanews.com/news/articleView.html?idxno=67181
1374,2020-02-25,대웅제약올로맥스신규용량추가,https://www.paxnetnews.com/articles/57489
1375,2020-02-25,대웅제약고혈압이상지질혈증치료제올로맥스용량추가라인업강화,http://www.newslock.co.kr/news/articleView.html?idxno=26006
1376,2020-02-25,대웅제약올로맥스고혈압치료제완벽라인업구축,http://www.pressm.kr/news/articleView.html?idxno=27776
1377,2020-02-25,대웅제약올로맥스신규용량추가로시장확대나서,http://www.nbnnews.co.kr/news/articleView.html?idxno=371689
1378,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.mdtoday.co.kr/mdtoday/index.html?no=378537
1379,2020-02-25,대웅제약고혈압치료제올로맥스라인업강화시장확대나서,http://www.greened.kr/news/articleView.html?idxno=238904
1380,2020-02-25,대웅제약개량신약올로맥스신규용량추가5월출시예정,http://www.ceoscoredaily.com/news/article.html?no=66472
1381,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,https://asiatime.co.kr/news/newsview.php?ncode=1065572413529182
1382,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.bosa.co.kr/news/articleView.html?idxno=2122054
1383,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.segyebiz.com/newsView/20200225504291?OutUrl=naver
1384,2020-02-25,대웅제약고혈압고지혈증복합제올로맥스신규용량허가받아,http://news.mk.co.kr/newsRead.php?no=192867&year=2020
1385,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.ezyeconomy.com/news/articleView.html?idxno=98256
1386,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.newsis.com/view/?id=NISX20200225_0000930932&cID=13001&pID=13000
1387,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.newsway.co.kr/news/view?tp=1&ud=2020022510080851493
1388,2020-02-25,대웅제약올로맥스신규용량추가고혈압치료제라인업강화,http://sports.hankooki.com/lpage/economy/202002/sp20200225102641137020.htm
1389,2020-02-25,대웅제약고혈압이상지질혈증치료제올로맥스용량추가고혈압치료제완벽라인업구축,http://www.paxetv.com/news/articleView.html?idxno=86992
1390,2020-02-25,대웅제약올로맥스신용량2종추가라인업확대,http://www.biospectator.com/view/news_view.php?varAtcId=9625
1391,2020-02-25,대웅제약올로맥스신규용량출시고혈압치료제라인업강화,http://www.cnbnews.com/news/article.html?no=438007
1392,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화나서,http://www.ekn.kr/news/article.html?no=483649
1393,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대,http://www.m-i.kr/news/articleView.html?idxno=684870
1394,2020-02-25,대웅제약고혈압이상지질혈증올로맥스신규용량추가,http://health.chosun.com/site/data/html_dir/2020/02/25/2020022501728.html
1395,2020-02-25,대웅제약올로맥스라인업강화신규용량추가러시장확대나서,http://www.ftoday.co.kr/news/articleView.html?idxno=114868
1396,2020-02-25,대웅제약3제복합제올로맥스신규용량추가,http://www.medigatenews.com/news/3437745735
1397,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59807
1398,2020-02-25,대웅제약올로맥스신규용량추가시장확대나선다,http://www.metroseoul.co.kr/article/20200225500112
1399,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1370222
1400,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,http://www.newsprime.co.kr/news/article.html?no=494590
1401,2020-02-25,대웅제약고혈압이상지질혈증치료제용량추가해제품군넓혀,http://www.businesspost.co.kr/BP?command=article_view&num=165446
1402,2020-02-25,대웅제약올로맥스신규용량추가고혈압치료라인업강화,http://moneys.mt.co.kr/news/mwView.php?no=2020022512168058293
1403,2020-02-25,제약산업대웅제약위질환치료정보알려,http://www.kukinews.com/news/article.html?no=753568
1404,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://newsbrite.net/134094
1405,2020-02-25,대웅제약올로맥스신규용량허가고혈압치료제시장확대,http://www.viva100.com/main/view.php?key=20200225010009122
1406,2020-02-25,뉴스투데이L대웅제약올로맥스용량추가로라인업강화,https://www.news2day.co.kr/148659
1407,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,http://www.dailymedi.com/detail.php?number=853230&thread=22r05
1408,2020-02-25,제약오늘한미약품짜먹는맥시부펜출시대웅제약올로맥스신규용량추가로라인업강화,http://www.sisaon.co.kr/news/articleView.html?idxno=109595
1409,2020-02-25,대웅제약올로맥스신규용량추가시장확대나선다 ,http://www.monews.co.kr/news/articleView.html?idxno=208540
1410,2020-02-25,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.g-enews.com/ko-kr/news/article/news_all/202002251515335431aca1a8c21a_1/article.html
1411,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.wikileaks-kr.org/news/articleView.html?idxno=78397
1412,2020-02-25,대웅제약올로맥스용량추가로고혈압치료제라인업확대,http://www.econovill.com/news/articleView.html?idxno=386687
1413,2020-02-25,대웅제약올로맥스라인업강화신규용량식약처허가완료로4종갖추게돼,http://kpenews.com/View.aspx?No=758908
1414,2020-02-25,제약사1조클럽새내기셀트리온대웅제약도약비결은,http://www.wikileaks-kr.org/news/articleView.html?idxno=78394
1415,2020-02-25,대웅제약고혈압치료제올로맥스용량추가라인업강화,http://www.100ssd.co.kr/news/articleView.html?idxno=67404
1416,2020-02-25,종근당대웅제약셀트리온등제약사3곳1조클럽입성올해는신약개발성과등으로수익성개선도기대,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003883783
1417,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.lawissue.co.kr/view.php?ud=202002251803294416204ead0791_12
1418,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.thepublic.kr/news/newsview.php?ncode=1065598507067000
1419,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.thefirstmedia.net/news/articleView.html?idxno=54840
1420,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.newscj.com/news/articleView.html?idxno=712070
1421,2020-02-26,대웅제약올로맥스신규용량추가,https://www.kpanews.co.kr/article/show.asp?idx=211137&category=D
1422,2020-02-26,의료제약업계단신용인세브란스병원대웅제약알보젠코리아에스디랩코리아,http://www.g-enews.com/ko-kr/news/article/news_all/20200224143512505269d76442fa_1/article.html
1423,2020-02-26,대웅제약작년최대매출낸원동력은우루사수익성도개선,http://www.consumernews.co.kr/news/articleView.html?idxno=601710
1424,2020-02-26,★주식인사이드대웅제약주가111000원2월26일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1066515
1425,2020-02-26,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.wsobi.com/news/articleView.html?idxno=91244
1426,2020-02-26,시경Today제약대웅제약올로맥스신규용량추가로라인업강화外,http://www.meconomynews.com/news/articleView.html?idxno=38492
1427,2020-02-27,더벨대웅제약아박타JV아피셀테라퓨틱스사업윤곽,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202002260744164200107821
1428,2020-02-27,대웅제약임직원들건강위해코로나19대응재택근무확대시행,http://www.mdtoday.co.kr/mdtoday/index.html?no=378802
1429,2020-02-27,대웅제약코로나19대응영업판매직원전원재택근무,http://www.medisobizanews.com/news/articleView.html?idxno=67287
1430,2020-02-27,대웅제약코로나19로재택근무확대시행,http://www.ebn.co.kr/news/view/1023780/?sc=naver
1431,2020-02-27,대웅제약전체영업마케팅재택근무,http://www.edaily.co.kr/news/newspath.asp?newsid=01908966625674784
1432,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.newspim.com/news/view/20200227000127
1433,2020-02-27,★주식인사이드대웅제약주가110000원2월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1066851
1434,2020-02-27,대웅제약임직원건강위해코로나19대응재택근무시행,http://www.mediapen.com/news/view/503747
1435,2020-02-27,대웅제약코로나19확산에재택근무확대시행,http://daily.hankooki.com/lpage/ittech/202002/dh20200227091207145630.htm
1436,2020-02-27,대웅제약코로나19사태로재택근무확대시행”,http://www.viva100.com/main/view.php?key=20200227010009863
1437,2020-02-27,대웅제약임직원들건강위해코로나19대응재택근무확대시행,https://www.dailian.co.kr/news/view/871480?sc=Naver
1438,2020-02-27,대웅제약코로나19확산방지위해임직원자택근무확대,https://asiatime.co.kr/news/newsview.php?ncode=1065571199836950
1439,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://medipana.com/news/news_viewer.asp?NewsNum=253305&MainKind=A&NewsKind=5&vCount=12&vKind=1
1440,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.newsway.co.kr/news/view?tp=1&ud=2020022709242341859
1441,2020-02-27,대웅제약코로나19대응위해임직원재택근무확대시행,http://www.greened.kr/news/articleView.html?idxno=239307
1442,2020-02-27,대웅제약오늘부터전체영업마케팅직원재택근무실시,http://moneys.mt.co.kr/news/mwView.php?no=2020022708508015062
1443,2020-02-27,대웅제약재택근무확대시행임직원건강이최우선,http://www.newsis.com/view/?id=NISX20200227_0000934161&cID=13001&pID=13000
1444,2020-02-27,대웅제약코로나19예방재택근무시차출근제확대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1862551
1445,2020-02-27,대웅제약사내코로나19확산저지위해재택근무시차출근제시행,http://news.mk.co.kr/newsRead.php?no=202466&year=2020
1446,2020-02-27,코로나19비상대웅제약확산방지위해임직원재택근무확대,http://www.m-i.kr/news/articleView.html?idxno=685664
1447,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.etnews.com/20200227000048
1448,2020-02-27,대웅제약코로나19대응임직원들건강위한재택근무시행,http://www.pressm.kr/news/articleView.html?idxno=27822
1449,2020-02-27,대웅제약코로나19대응재택근무시차출근제시행,http://www.seoulwire.com/news/articleView.html?idxno=400894
1450,2020-02-27,대웅제약임직원들건강위해코로나19대응재택근무확대시행,http://www.segyebiz.com/newsView/20200227505022?OutUrl=naver
1451,2020-02-27,대웅제약코로나19방지재택근무확대시행,http://www.medigatenews.com/news/1136471727
1452,2020-02-27,대웅제약임직원건강위해코로나19대응재택근무확대,http://www.metroseoul.co.kr/article/20200227500112
1453,2020-02-27,대웅제약코로나19확산재택근무확대,http://www.dailymedi.com/detail.php?number=853309&thread=22r05
1454,2020-02-27,대웅제약코로나19여파에임직원재택근무시차출근확대시행,http://www.sisaweek.com/news/articleView.html?idxno=131366
1455,2020-02-27,코로나19대웅제약재택근무시차출근제시행,http://www.ftoday.co.kr/news/articleView.html?idxno=114964
1456,2020-02-27,대웅제약코로나19확산에재택근무확대,http://www.mhj21.com/127956
1457,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.dailysmart.co.kr/news/articleView.html?idxno=22916
1458,2020-02-27,대웅제약코로나19예방위해재택근무확대시행,http://www.ekn.kr/news/article.html?no=484192
1459,2020-02-27,대웅제약코로나19확산관련재택근무확대시행,http://www.donga.com/news/article/all/20200227/99901681/1
1460,2020-02-27,대웅제약재택근무확대시행임직원건강지키기,http://www.bosa.co.kr/news/articleView.html?idxno=2122243
1461,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://www.nbnnews.co.kr/news/articleView.html?idxno=372783
1462,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.newslock.co.kr/news/articleView.html?idxno=26074
1463,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.asiatoday.co.kr/view.php?key=20200227010016158
1464,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://newsbrite.net/134204
1465,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.bokuennews.com/news/article.html?no=187149
1466,2020-02-27,대웅제약재택근무확대코로나19대응,http://www.monews.co.kr/news/articleView.html?idxno=208627
1467,2020-02-27,대웅제약임직원건강위해코로나19대응재택근무확대시행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59863
1468,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://www.lawissue.co.kr/view.php?ud=202002271350015985204ead0791_12
1469,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://www.wikileaks-kr.org/news/articleView.html?idxno=78648
1470,2020-02-27,대웅제약임직원들의건강위해재택근무확대시행스마트워크환경구축,http://www.paxetv.com/news/articleView.html?idxno=87171
1471,2020-02-27,대웅제약코로나19확산방지위해27일부터무기한재택근무,http://www.businesspost.co.kr/BP?command=article_view&num=165912
1472,2020-02-27,대웅제약코로나19확산에재택근무확대시행,http://www.koreastocknews.com/news/articleView.html?idxno=51026
1473,2020-02-27,코로나19대웅제약임직원건강위해재택근무확대,http://www.econovill.com/news/articleView.html?idxno=387068
1474,2020-02-27,대웅제약재택근무시차출근제시행,http://www.finomy.com/news/articleView.html?idxno=75584
1475,2020-02-27,대웅제약주당600원현금배당결정,http://news.kmib.co.kr/article/view.asp?arcid=0014292285&code=61141211&cp=nv
1476,2020-02-27,대웅제약코로나19선제적예방나서재택근무확대시행”,http://sports.hankooki.com/lpage/economy/202002/sp20200227173518137020.htm
1477,2020-02-27,유가증권시장공시에스원대웅제약코스맥스,http://news.mk.co.kr/newsRead.php?no=206059&year=2020
1478,2020-02-27,대웅제약코로나19로재택근무확대시행,http://www.g-enews.com/ko-kr/news/article/news_all/20200227174213553569d76442fa_1/article.html
1479,2020-02-27,대웅제약코로나19대응임직원들건강위해재택근무확대시행,http://www.thefirstmedia.net/news/articleView.html?idxno=54994
1480,2020-02-27,대웅제약재택근무확대시행코로나19확산대응,http://www.newscj.com/news/articleView.html?idxno=712861
1481,2020-02-27,대웅제약보통주1주당600원총62억현금배당,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241164
1482,2020-02-28,★주식인사이드대웅제약주가106500원2월28일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1067164
1483,2020-02-28,대웅제약06962028일369변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=677022
1484,2020-02-28,대웅제약주당600원현금배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=378990
1485,2020-02-28,대웅제약코로나19대응재택근무확대시행,http://www.newswatch.kr/news/articleView.html?idxno=28229
1486,2020-03-01,전승호대웅제약신약개발에인공지능접목해시간과비용줄인다,http://www.businesspost.co.kr/BP?command=article_view&num=166284
1487,2020-03-02,대웅제약골다공증치료제졸레드론산새품목허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=379082
1488,2020-03-02,대웅제약전일대비524이시각거래량3만1924주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003020281&t=NN
1489,2020-03-02,대웅제약5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003029097L
1490,2020-03-02,대웅제약보합출발후꾸준히올라714↑차트하락세중상승전환,http://www.newspim.com/news/view/20200302001113
1491,2020-03-02,대웅제약952VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/02/2020030202873.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1492,2020-03-02,보톡스보툴리눔톡신테마마감시황상승률상위종목파마리서치프로덕트1021대웅제약952휴젤718등,http://www.gokorea.kr/news/articleView.html?idxno=679102
1493,2020-03-02,대웅제약메디톡스보톡스분쟁합의로마무리되나,http://www.upinews.kr/newsView/upi202003020124
1494,2020-03-03,휴온스대웅제약엑셀러레이터新사업에주목,http://www.mdtoday.co.kr/mdtoday/index.html?no=379207
1495,2020-03-03,★주식인사이드대웅제약주가114000원3월3일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1067810
1496,2020-03-03,3월3일대웅제약금일증시112000원261,http://nbntv.co.kr/news/view/862958
1497,2020-03-03,대웅제약지주사대웅200억원규모자사주매입결정,http://www.insightkorea.co.kr/news/articleView.html?idxno=77882
1498,2020-03-03,대웅제약200억원규모자사주매입결정주주가치제고차원,http://www.newswatch.kr/news/articleView.html?idxno=28346
1499,2020-03-03,대웅제약매출1조원돌파에도주가부진자사주매입으로주가부양나서,http://www.asiatoday.co.kr/view.php?key=20200303010001680
1500,2020-03-04,빅데이터MSI시장심리톱5KB금융삼성화재SK이노베이션LS대웅제약,http://www.newsis.com/view/?id=NISX20200304_0000941694&cID=10401&pID=10400
1501,2020-03-04,연중기획기업과나눔대웅제약느린학습자의징검다리되다,http://www.cnbnews.com/news/article.html?no=438831
1502,2020-03-04,★주식인사이드대웅제약주가112000원3월4일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1068149
1503,2020-03-04,美ITC소속변호사대웅제약이메디톡스균주사용”의견제출,http://www.edaily.co.kr/news/newspath.asp?newsid=03129126625700040
1504,2020-03-04,메디톡스美ITC소속변호사대웅제약이메디톡스균주사용의견제출,http://www.greened.kr/news/articleView.html?idxno=240386
1505,2020-03-04,대웅제약991VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/04/2020030401941.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1506,2020-03-04,美ITC변호사대웅제약메디톡스균주사용의견제출,http://news.mt.co.kr/mtview.php?no=2020030412511016353
1507,2020-03-04,대웅제약전일대비1063이시각13만3101주거래,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003040243&t=NN
1508,2020-03-04,메디톡스대웅제약보툴리눔균주가메디톡스균주입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241387
1509,2020-03-04,대웅제약낮부터갑작스런12급락에투자자들당황10만원선붕괴,http://www.econonews.co.kr/news/articleView.html?idxno=110884
1510,2020-03-04,특징주메디톡스대웅제약균주사용동의에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020030413538028069
1511,2020-03-04,메디톡스美ITC소속변호사대웅제약이메디톡스균주사용한다의견서제출,http://news.mk.co.kr/newsRead.php?no=228182&year=2020
1512,2020-03-04,美ITC변호사대웅제약메디톡스균주도용,http://www.finomy.com/news/articleView.html?idxno=75798
1513,2020-03-04,특징주메디톡스대웅제약美ITC소속변호사의견에희비교차,http://news.mk.co.kr/newsRead.php?no=228530&year=2020
1514,2020-03-04,메디톡스는ITC에제출한자료모두공개하라대웅제약美ITC승소확신,http://www.segye.com/content/html/2020/03/04/20200304512590.html?OutUrl=naver
1515,2020-03-04,대웅제약메디톡스와의美ITC소송승리확신,http://news.mk.co.kr/newsRead.php?no=228660&year=2020
1516,2020-03-04,대웅제약ITC승소확신메디톡스허위자료냈다반격,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020030414491078505
1517,2020-03-04,대웅제약美ITC승소확신메디톡스증거다수허위,http://www.ebn.co.kr/news/view/1024822/?sc=naver
1518,2020-03-04,대웅제약보툴리눔톡신균주미국ITC승소확신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241400
1519,2020-03-04,대웅제약미국ITC승소확신소송성립되지않을수도,http://www.newspim.com/news/view/20200304001231
1520,2020-03-04,메디톡스대웅제약보톡수균주출처놓고법정공방팽팽종합,http://www.newspim.com/news/view/20200304001268
1521,2020-03-04,대웅제약메디톡스주장반박메디톡스가합의제안했지만거절”,http://daily.hankooki.com/lpage/ittech/202003/dh20200304150510145630.htm
1522,2020-03-04,메디톡스대웅제약보툴리눔균주다툼기술도용”vs아니다”,http://www.edaily.co.kr/news/newspath.asp?newsid=03834326625700040
1523,2020-03-04,대웅제약메디톡스ITC재판허위자료제출합의도먼저제안”,http://www.viva100.com/main/view.php?key=20200304010001817
1524,2020-03-04,다시불붙은대웅제약과메디톡스美ITC소송전첨예한대립,http://www.metroseoul.co.kr/article/20200304500372
1525,2020-03-04,대웅제약미국ITC승소확신메디톡스ITC제출자료모두공개요구,http://newsclaim.co.kr/View.aspx?No=767198
1526,2020-03-04,대웅제약ITC승소확신메디톡스허위자료냈다반박,http://www.mediapen.com/news/view/505590
1527,2020-03-04,대웅제약美ITC승소확신메디톡스증거허위반박,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003040312&t=NN
1528,2020-03-04,대웅제약메디톡스의균주소유권침해사실등증명된것없어,http://www.medisobizanews.com/news/articleView.html?idxno=67501
1529,2020-03-04,대웅제약메디톡스설전ITC승소확신동상이몽,http://www.upinews.kr/newsView/upi202003040111
1530,2020-03-04,대웅제약메디톡스는ITC제출자료전부공개하라,http://news.mk.co.kr/newsRead.php?no=229218&year=2020
1531,2020-03-04,메디톡스미국국제무역위변호사도편들어”대웅제약무모한주장”,http://www.businesspost.co.kr/BP?command=article_view&num=166848
1532,2020-03-04,대웅제약미ITC변호사의견재판영향없다주장ITC승소확신한다,http://www.lawissue.co.kr/view.php?ud=20200304152714293204ead0791_12
1533,2020-03-04,대웅제약미국ITC승소확신메디톡스는ITC에제출한자료모두를공개하라요구,http://www.nbnnews.co.kr/news/articleView.html?idxno=374871
1534,2020-03-04,메디톡스대웅제약미국ITC서보툴리눔공방격화,http://www.econovill.com/news/articleView.html?idxno=387799
1535,2020-03-04,대웅제약메디톡스서로美ITC승소확신5년째진실게임종합,https://www.hankyung.com/finance/article/2020030461306
1536,2020-03-04,대웅제약메디톡스美ICT재판서균주관련허위자료제출”,http://www.donga.com/news/article/all/20200304/100005614/1
1537,2020-03-04,대웅제약메디톡스ITC제출자료모두공개하라,http://www.finomy.com/news/articleView.html?idxno=75805
1538,2020-03-04,대웅제약메디톡스와의보툴리눔소송에급락,http://www.newstomato.com/ReadNews.aspx?no=956837
1539,2020-03-04,메디톡스대웅제약보툴리눔톡신치열한공방전,http://www.asiatoday.co.kr/view.php?key=20200304010002805
1540,2020-03-04,메디톡스대웅제약보툴리눔톡신치열한공방전,http://www.asiatoday.co.kr/view.php?key=20200304010002805
1541,2020-03-04,보톡스전쟁재점화메디톡스선제공격에대웅제약즉각반박,http://www.etoday.co.kr/news/section/newsview.php?idxno=1865630
1542,2020-03-04,美ITC변호사대웅제약메디톡스균주사용의견제출,https://biz.chosun.com/site/data/html_dir/2020/03/04/2020030403070.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1543,2020-03-04,대웅제약메디톡스다시불붙은보톡스균주공방서로美ITC승소확신,http://www.ekn.kr/news/article.html?no=485580
1544,2020-03-04,메디톡스vs대웅제약美ITC소송최종판결앞두고재격돌,http://biz.newdaily.co.kr/site/data/html/2020/03/04/2020030400183.html
1545,2020-03-04,대웅제약미국ITC승소확신메디톡스ITC에제출한자료모두공개하라”요구,http://www.thepublic.kr/news/newsview.php?ncode=1065592774331626
1546,2020-03-04,대웅제약메디톡스ITC제출자료모두공개하라강력요구,http://www.pressm.kr/news/articleView.html?idxno=27974
1547,2020-03-04,대웅제약 미국 ITC 승소 확신메디톡스는 ITC에 제출한 자료 모두를 공개하라 요구,http://newsbrite.net/134451
1548,2020-03-04,대웅제약메디톡스는ITC제출자료전부공개하라”,http://www.newsway.co.kr/news/view?tp=1&ud=2020030416512245963
1549,2020-03-04,대웅제약VS메디톡스끝이보이지않는균주전쟁,http://www.pinpointnews.co.kr/view.php?ud=202003041700299439f090c8dbcb_45
1550,2020-03-04,표4일코스피주가Top50하락률대양금속주가하락률1위1224내려장마감대웅제약신풍제약신한인버스2X금선물ETN신한인버스2X천연가스선물ETN주가순으로상위,http://www.fintechpost.co.kr/news/articleView.html?idxno=103537
1551,2020-03-04,대웅제약vs메디톡스美ITC승소최종판결앞두고재공방,http://www.m-i.kr/news/articleView.html?idxno=687991
1552,2020-03-04,대웅제약메디톡스증거허위ITC승소가능성주장반박,https://www.dailian.co.kr/news/view/873242?sc=Naver
1553,2020-03-04,대웅제약메디톡스는ITC에제출한자료모두를공개하라요구,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60004
1554,2020-03-04,대웅제약 미국 ITC 승소 확신메디톡스는 ITC에 제출한 자료 모두를 공개하라 요구,http://www.businesskorea.co.kr/news/articleView.html?idxno=42230
1555,2020-03-04,메디톡스美소송자신vs대웅제약허위사실주장,http://www.dailymedi.com/detail.php?number=853592&thread=22r05
1556,2020-03-04,대웅제약메디톡스美ITC에허위자료제출모든자료공개해야”,http://www.ajunews.com/view/20200304174649332
1557,2020-03-04,메디톡스대웅제약美ITC소속변호사의견에엇갈린주가,http://www.mdtoday.co.kr/mdtoday/index.html?no=379501
1558,2020-03-04,대웅제약미국ITC승소확신메디톡스는ITC에제출한자료모두를공개하라,http://www.thevaluenews.co.kr/news/view.php?idx=158577
1559,2020-03-04,대웅제약메디톡스는ITC에제출한자료모두를공개하라美ITC승소확신,http://www.newscj.com/news/articleView.html?idxno=714791
1560,2020-03-04,대웅제약메디톡스는ITC에제출한자료를모두공개하라반격나서,http://www.greened.kr/news/articleView.html?idxno=240479
1561,2020-03-04,대웅제약美ITC승소확신메디톡스ITC제출한자료공개요구,http://www.thefirstmedia.net/news/articleView.html?idxno=55284
1562,2020-03-05,대웅제약vs메디톡스보툴리눔균주법적공방또다시시작,http://medicalworldnews.co.kr/news/view.php?idx=1510934529
1563,2020-03-05,대웅제약메디톡스ITC판결앞두고또다시공방,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1078106
1564,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://medipana.com/news/news_viewer.asp?NewsNum=253656&MainKind=A&NewsKind=5&vCount=12&vKind=1
1565,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.dailysmart.co.kr/news/articleView.html?idxno=23253
1566,2020-03-05,★주식인사이드대웅제약주가100000원3월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1068473
1567,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.medisobizanews.com/news/articleView.html?idxno=67514
1568,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241425
1569,2020-03-05,대웅제약발달장애인지원코로나19예방도서배포,http://www.greened.kr/news/articleView.html?idxno=240521
1570,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.newsis.com/view/?id=NISX20200305_0000943449&cID=13001&pID=13000
1571,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.newsway.co.kr/news/view?tp=1&ud=2020030509185208759
1572,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.mediapen.com/news/view/505751
1573,2020-03-05,대웅제약발달장애인위한코로나19도서배포,https://asiatime.co.kr/news/newsview.php?ncode=1065571198417937
1574,2020-03-05,대웅제약발달장애인위해코로나19쉬운글도서배포,http://www.viva100.com/main/view.php?key=20200305010002068
1575,2020-03-05,대웅제약참지마요코로나19정보담은쉬운글도서제작배포,http://news.mk.co.kr/newsRead.php?no=231699&year=2020
1576,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60008
1577,2020-03-05,대웅제약발달장애인눈높이맞춘코로나19도서배포,http://moneys.mt.co.kr/news/mwView.php?no=2020030509108025187
1578,2020-03-05,대웅제약발달장애인이해돕는코로나19안내도서배포,https://www.news1.kr/articles/?3863360
1579,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.mdtoday.co.kr/mdtoday/index.html?no=379528
1580,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://news.mt.co.kr/mtview.php?no=2020030509492697585
1581,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.newsfc.co.kr/news/articleView.html?idxno=40090
1582,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.asiatoday.co.kr/view.php?key=20200305010003159
1583,2020-03-05,대웅제약참지마요발달장애인위한코로나예방법도서제작배포,http://www.100ssd.co.kr/news/articleView.html?idxno=67565
1584,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.koreaittimes.com/news/articleView.html?idxno=95924
1585,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.ekn.kr/news/article.html?no=485683
1586,2020-03-05,대웅제약발달장애인을위한코로나19도서무료배포,http://sports.hankooki.com/lpage/economy/202003/sp20200305102505137020.htm
1587,2020-03-05,대한민국이좋다대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.m-i.kr/news/articleView.html?idxno=688207
1588,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.metroseoul.co.kr/article/20200305500104
1589,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.bokuennews.com/news/article.html?no=187446
1590,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.nbnnews.co.kr/news/articleView.html?idxno=375096
1591,2020-03-05,대웅제약전날10급락딛고보합10만원선회복하나,http://www.econonews.co.kr/news/articleView.html?idxno=110993
1592,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,https://www.dailian.co.kr/news/view/873400?sc=Naver
1593,2020-03-05,美ITC변호사대웅제약메디톡스균주사용”의견제출,http://www.sportsworldi.com/content/html/2020/03/05/20200305506641.html
1594,2020-03-05,대웅제약 발달장애인위한 코로나19 쉬운글도서제작배포,http://www.ntoday.co.kr/news/articleView.html?idxno=71289
1595,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://daily.hankooki.com/lpage/ittech/202003/dh20200305105632145630.htm
1596,2020-03-05,힘을내요대한민국대웅제약 발달장애인위해 코로나19 쉬운글도서배포,http://www.newslock.co.kr/news/articleView.html?idxno=26259
1597,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.ebn.co.kr/news/view/1024970/?sc=naver
1598,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.thevaluenews.co.kr/news/view.php?idx=158587
1599,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.insightkorea.co.kr/news/articleView.html?idxno=77931
1600,2020-03-05,대웅제약美파트너사보톡스균주戰변수부각,http://www.ebn.co.kr/news/view/1024963/?sc=naver
1601,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.sportsseoul.com/news/read/890818
1602,2020-03-05,장애인도코로나19알아야한다”대웅제약코로나19쉬운글도서배포,http://www.donga.com/news/article/all/20200305/100018898/1
1603,2020-03-05,대웅제약코로나19쉬운글도서배포,http://www.bosa.co.kr/news/articleView.html?idxno=2122747
1604,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://newsbrite.net/134478
1605,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1372639
1606,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.lawissue.co.kr/view.php?ud=202003051240185925204ead0791_12
1607,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.cnbnews.com/news/article.html?no=439002
1608,2020-03-05,에볼루스대웅제약파트너사로서보툴리눔톡신지식재산에확신”,http://www.businesspost.co.kr/BP?command=article_view&num=167005
1609,2020-03-05,대웅제약발달장애인위해코로나19쉽게설명한책만들어배포,http://www.businesspost.co.kr/BP?command=article_view&num=167033
1610,2020-03-05,대웅제약발달장애인쉬운이해코로나19도서배포,http://www.pressm.kr/news/articleView.html?idxno=28005
1611,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.updownnews.co.kr/news/articleView.html?idxno=215911
1612,2020-03-05,대웅제약코로나19이해위한발달장애인용도서배포,http://www.finomy.com/news/articleView.html?idxno=75831
1613,2020-03-05,대웅제약라니티딘이어메트포르민회수가능성↑매출타격우려,http://biz.newdaily.co.kr/site/data/html/2020/03/05/2020030500192.html
1614,2020-03-05,뉴스투데이L대웅제약발달장애인용코로나19쉬운글도서배포,https://www.news2day.co.kr/149222
1615,2020-03-05,거짓말ITC승소자신등대웅제약메디톡스공방5년째평행선,http://www.betanews.net:8080/article/1143967.html
1616,2020-03-05,메디톡스대웅제약보톡스전쟁미ITC6월예비판결승자는,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003894383
1617,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,https://www.kpanews.co.kr/article/show.asp?idx=211443&category=D
1618,2020-03-05,대웅제약전국특수학교등을위한코로나19쉬운글도서배포,http://www.thepublic.kr/news/newsview.php?ncode=1065588596128566
1619,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.econovill.com/news/articleView.html?idxno=388018
1620,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.newscj.com/news/articleView.html?idxno=715221
1621,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.wsobi.com/news/articleView.html?idxno=91967
1622,2020-03-06,대웅제약메디톡스보톡스균주분쟁법정밖난타전승자없는진흙탕싸움,http://www.greened.kr/news/articleView.html?idxno=240714
1623,2020-03-06,제약CEO오너리스크잠재운대웅제약전승호보톡스소송전도이길까,http://isplus.live.joins.com/news/article/article.asp?total_id=23723583
1624,2020-03-06,★주식인사이드대웅제약주가100500원3월6일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1068825
1625,2020-03-06,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.mhj21.com/128143
1626,2020-03-06,대웅제약vs메디톡스보톡스전쟁결말이다가오고있다,http://www.insightkorea.co.kr/news/articleView.html?idxno=77952
1627,2020-03-06,공시대웅제약전승호대표1000주장내매수,http://www.newsway.co.kr/news/view?tp=1&ud=2020030611483593410
1628,2020-03-06,대웅제약경영진4억원규모자사주장내매수,http://www.medigatenews.com/news/987634611
1629,2020-03-06,대웅대웅제약경영진4억원어치자사주매입자신감책임경영,http://www.upinews.kr/newsView/upi202003060103
1630,2020-03-06,대웅제약그룹윤재춘전승호이창재등경영진이4억원어치자사주매입,http://news.mk.co.kr/newsRead.php?no=239681&year=2020
1631,2020-03-06,대웅대웅제약경영진자사주4억원매입,http://www.shinailbo.co.kr/news/articleView.html?idxno=1256831
1632,2020-03-06,윤재춘전승호대웅과대웅제약주식각각2억과1억사들여,http://www.businesspost.co.kr/BP?command=article_view&num=167328
1633,2020-03-07,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.thefirstmedia.net/news/articleView.html?idxno=55394
1634,2020-03-07,박일경의바이오돋보기메디톡스vs대웅제약보톡스전쟁왜,http://www.edaily.co.kr/news/newspath.asp?newsid=01558006625701024
1635,2020-03-09,대웅제약특별관계자지분변동,http://news.kmib.co.kr/article/view.asp?arcid=0014336061&code=61141211&cp=nv
1636,2020-03-09,대웅제약특별관계자지분변동,http://www.mdtoday.co.kr/mdtoday/index.html?no=379918
1637,2020-03-09,걱정말아요대웅제약전승호사장자사주1000주매입,http://www.wikileaks-kr.org/news/articleView.html?idxno=79813
1638,2020-03-11,일동제약보령컨슈머메디팜일양약품칸젠대웅제약임신테스트기민감도기준미달,http://medicalworldnews.co.kr/news/view.php?idx=1510934620
1639,2020-03-11,메디톡스vs대웅제약ITC소송승패따라벌어질결과는,https://www.dailian.co.kr/news/view/874828?sc=Naver
1640,2020-03-11,대웅제약신약DWP16001병용투여임상돌입,http://www.finomy.com/news/articleView.html?idxno=76027
1641,2020-03-11,전승호대웅제약신약개발경쟁력키우기위해스타트업투자본격화,http://www.businesspost.co.kr/BP?command=article_view&num=168037
1642,2020-03-12,대웅제약vs메디톡스판박이제2의균주전쟁,http://www.edaily.co.kr/news/newspath.asp?newsid=04070486625702664
1643,2020-03-13,양윤선메디포스트대표대웅제약사외이사퇴임줄기세포치료제협업끝,http://www.consumernews.co.kr/news/articleView.html?idxno=602518
1644,2020-03-13,더벨보톡스열전대웅제약2조미국시장가장먼저연다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202003052227002560108434
1645,2020-03-13,하이로우대웅제약ITC소송부담목표가↓한화투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020031308493712965
1646,2020-03-13,대웅제약전일대비1024하락이시각거래량1만2683주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003130106&t=NN
1647,2020-03-13,대웅제약목표주가낮아져영업위축에나보타소송도불확실,http://www.businesspost.co.kr/BP?command=article_view&num=168337
1648,2020-03-13,리포트브리핑대웅제약최악의시나리오기반영중목표가120000원삼성증권,http://www.newspim.com/news/view/20200313000287
1649,2020-03-13,리포트브리핑대웅제약업황업데이트목표가120000원한화투자증권,http://www.newspim.com/news/view/20200313000329
1650,2020-03-13,대웅제약연결대상종속기업매출기여도1위한올,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241766
1651,2020-03-13,대웅제약메디톡스와의ITC소송이슈에관심집중”,http://www.wikitree.co.kr/articles/513629
1652,2020-03-13,대웅제약하락출발후꾸준히올라976↑차트하락세중상승전환,http://www.newspim.com/news/view/20200313000621
1653,2020-03-13,특징주대웅제약79000원13일13시0분장시작대비647상승,http://www.getnews.co.kr/view.php?ud=202003131301404290c20b927e9b_16
1654,2020-03-13,대웅제약5이상상승전일기관대량순매도,https://www.hankyung.com/finance/article/202003139214L
1655,2020-03-13,일양약품대웅제약희비엇갈려일양약품상한가반해대웅제약4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=112173
1656,2020-03-13,대웅제약코로나19치료효과일양약품슈펙트판권보유↑,http://www.sentv.co.kr/news/view/569845
1657,2020-03-13,대웅제약나보타미국ITC결정기반영영향제한적,http://www.beyondpost.co.kr/view.php?ud=202003131439321443c5c1bde209_30
1658,2020-03-13,주식대웅제약1488급등코로나19치료효과슈펙트가뭐길래,http://www.ggilbo.com/news/articleView.html?idxno=752634
1659,2020-03-13,일양약품슈펙트코로나19치료효과에대웅제약주가상승왜,http://moneys.mt.co.kr/news/mwView.php?no=2020031314588048055
1660,2020-03-13,특징주일양약품녹십자셀대웅제약상한가서킷브레이커장세뚫고급등,http://www.thevaluenews.co.kr/news/view.php?idx=158736
1661,2020-03-13,일양약품슈펙트코로나19치료제개발기대대웅제약도주가상승,http://sports.hankooki.com/lpage/economy/202003/sp20200313175652137020.htm
1662,2020-03-13,일양약품슈펙트코로나19치료효과에상한가국내판권가진대웅제약5↑,http://www.segye.com/content/html/2020/03/13/20200313512136.html?OutUrl=naver
1663,2020-03-13,대웅제약전략적오픈콜라보레이션통한미래가치창출신약개발박차,http://www.ftoday.co.kr/news/articleView.html?idxno=115592
1664,2020-03-13,양윤선메디포스트대표대웅제약사외이사물러나,http://www.dailymedi.com/detail.php?number=853962&thread=22r12
1665,2020-03-16,대웅제약747상승출발,http://www.newspim.com/news/view/20200316000198
1666,2020-03-16,일양약품대웅제약급등에상한가까지특히일양약품2거래일연속상한가,http://www.econonews.co.kr/news/articleView.html?idxno=112440
1667,2020-03-16,대웅제약5이상상승업황업데이트한화투자증권BUY유지,https://www.hankyung.com/finance/article/202003163150L
1668,2020-03-16,대웅제약상승출발후현재554이시각거래량30만5649주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003160210&t=NN
1669,2020-03-16,주식대웅제약305하락후반등슈펙트코로나19치료제개발기대,http://www.ggilbo.com/news/articleView.html?idxno=753044
1670,2020-03-16,대웅제약000VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/16/2020031601637.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1671,2020-03-17,대웅제약의불확실성ITC소송경우의수3가지,http://moneys.mt.co.kr/news/mwView.php?no=2020031611398065243
1672,2020-03-17,明약이야기④피로는간때문이야국내대표간장약대웅제약우루사,http://www.asiatoday.co.kr/view.php?key=20200316010009983
1673,2020-03-17,일양약품대웅제약급락에무너지는주가특히일양약품갑작스런10급락,http://www.econonews.co.kr/news/articleView.html?idxno=112607
1674,2020-03-17,일양약품대웅제약하락에급락까지특히일양약품가파른하락세로7급락,http://www.econonews.co.kr/news/articleView.html?idxno=112708
1675,2020-03-18,제약대웅제약혁신적연구기술로넥스트나보타만든다,http://news.mk.co.kr/newsRead.php?no=278665&year=2020
1676,2020-03-18,일양약품대웅제약희비엇갈려특히일양약품하락부진이어지나,http://www.econonews.co.kr/news/articleView.html?idxno=112764
1677,2020-03-18,대웅제약상승흐름전일대비528이평선역배열상황에서반등시도,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003180142&t=NN
1678,2020-03-18,대웅제약5이상상승업황업데이트한화투자증권BUY유지,https://www.hankyung.com/finance/article/202003180174L
1679,2020-03-18,대웅제약세계최초코로나19감염동반폐섬유증신약개발↑,http://www.sentv.co.kr/news/view/570053
1680,2020-03-18,대웅제약상승출발후현재는1121↑긴하락구간에서주가급등,http://www.newspim.com/news/view/20200318000688
1681,2020-03-18,대웅제약462VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/18/2020031802144.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1682,2020-03-18,특징주대웅제약85900원18일11시0분장시작대비1199상승,http://www.getnews.co.kr/view.php?ud=202003181101394233c20b93777c_16
1683,2020-03-18,일양약품대웅제약엇갈리는주가여전특히일양약품오후가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=112830
1684,2020-03-19,일양약품대웅제약하락부진딛고상승세로특히일양약품19폭락벗어나3만원선회복하나,http://www.econonews.co.kr/news/articleView.html?idxno=112881
1685,2020-03-19,대웅제약790VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/19/2020031903946.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1686,2020-03-19,대웅제약전일대비1008하락중이시각11만9986주거래,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003190334&t=NN
1687,2020-03-19,일양약품대웅제약급락에폭락까지특히일양약품12폭락에투자자들어떡하나,http://www.econonews.co.kr/news/articleView.html?idxno=112961
1688,2020-03-20,대웅제약코로나19에도성장세위기서빛났다,http://www.bosa.co.kr/news/articleView.html?idxno=2123709
1689,2020-03-20,일양약품대웅제약급락벗어나상승세로특히대웅제약가파른상승세로4상승,http://www.econonews.co.kr/news/articleView.html?idxno=113000
1690,2020-03-20,대웅제약5이상상승최근5일간기관대량순매도,https://www.hankyung.com/finance/article/202003206320L
1691,2020-03-20,대웅제60기 대웅제약제18기주주총회개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=42997
1692,2020-03-20,대웅대웅제약전우방감사신규선임이충우감사재선임,https://www.fetv.co.kr/news/article.html?no=50554
1693,2020-03-20,대웅제약매출1조52억원달성파이프라인순항,http://www.dailypharm.com/Users/News/NewsView.html?ID=263021&REFERER=NP
1694,2020-03-20,대웅제약나보타미국유럽포함선진국진출본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242073
1695,2020-03-20,대웅대웅제약정우방감사신규선임등주주총회개최,http://www.ftoday.co.kr/news/articleView.html?idxno=115819
1696,2020-03-20,주총대웅제약매출1조원첫돌파나보타글로벌진출확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020032013123789042
1697,2020-03-20,대웅대웅제약정기주총개최윤재춘대표이사글로벌사업영역확대”,http://www.mdtoday.co.kr/mdtoday/index.html?no=381178
1698,2020-03-20,대웅대웅제약주총신약개발성과가시화원년,http://www.newsis.com/view/?id=NISX20200320_0000963681&cID=13001&pID=13000
1699,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://medipana.com/news/news_viewer.asp?NewsNum=254432&MainKind=A&NewsKind=5&vCount=12&vKind=1
1700,2020-03-20,주총현장전승호대웅제약대표올해본격적으로성과나타날것,http://news.mk.co.kr/newsRead.php?no=290596&year=2020
1701,2020-03-20,대웅대웅제약정기주총성과가시화원년될것,http://www.mediapen.com/news/view/510164
1702,2020-03-20,대웅대웅제약주주총회개최글로벌사업확대통해건실한성과창출”,http://www.donga.com/news/article/all/20200320/100254454/1
1703,2020-03-20,대웅대웅제약정기주주총회개최책임경영으로실적창출계속하겠다,http://www.sporbiz.co.kr/news/articleView.html?idxno=423515
1704,2020-03-20,대웅제약첫매출1조원신약개발성과본격화기대,http://news.mt.co.kr/mtview.php?no=2020032013474388208
1705,2020-03-20,대웅대웅제약주주총회글로벌사업확대나보타성과본격화”,http://www.viva100.com/main/view.php?key=20200320010008460
1706,2020-03-20,대웅제약전우방감사신규선임글로벌사업확대다양한파이프확보,http://www.medisobizanews.com/news/articleView.html?idxno=68037
1707,2020-03-20,대웅대웅제약주주총회개최경영진책임경영체제구축,http://www.newsprime.co.kr/news/article.html?no=498012
1708,2020-03-20,전승호대웅제약대표이사나보타미국유럽등선진국본격진출,http://www.m-i.kr/news/articleView.html?idxno=693546
1709,2020-03-20,대웅제약594상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/20/2020032003565.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1710,2020-03-20,주식대웅제약281소폭상승백혈병신약슈펙트는무엇,http://www.ggilbo.com/news/articleView.html?idxno=754282
1711,2020-03-20,대웅대웅제약2020년주주총회개최대웅제약사상처음으로별도매출기준1조원돌파,http://www.updownnews.co.kr/news/articleView.html?idxno=216585
1712,2020-03-20,주총전승호대웅제약대표미국유럽진출등신약개발성과나타날것,http://moneys.mt.co.kr/news/mwView.php?no=2020032013358084981
1713,2020-03-20,대웅제약엑셀러레이터사업착수벤처기업키운다,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003200386&t=NN
1714,2020-03-20,주총대웅대웅제약주주총회개최글로벌사업영역확대할것,https://www.dailian.co.kr/news/view/877599?sc=Naver
1715,2020-03-20,대웅제약사상처음으로별도매출기준1조원돌파신기록,http://www.segye.com/content/html/2020/03/20/20200320509337.html?OutUrl=naver
1716,2020-03-20,주총대웅대웅제약책임경영체제구축글로벌사업확대,http://www.dailysmart.co.kr/news/articleView.html?idxno=23976
1717,2020-03-20,2020주총대웅대웅제약글로벌사업영역확대”,http://www.newsway.co.kr/news/view?tp=1&ud=2020032014374259041
1718,2020-03-20,대웅대웅제약정기주총개최엑셀레이터사업추가,http://www.kpinews.co.kr/news/articleView.html?idxno=112935
1719,2020-03-20,주총대웅대웅제약주주총회개최글로벌사업확대,http://www.newspim.com/news/view/20200320002294
1720,2020-03-20,대웅대웅제약주주총회개최감사선임정관변경등의결,http://www.greened.kr/news/articleView.html?idxno=243174
1721,2020-03-20,전승호대웅제약대표올해신약개발성과본격화,http://www.asiatoday.co.kr/view.php?key=20200320010013047
1722,2020-03-20,대웅제약전승호대표글로벌사업영역확대파이프라인확보통해글로벌2025비전달성할것”,https://www.news2day.co.kr/149917
1723,2020-03-20,대웅대웅제약정기주주총회개최,http://www.ebn.co.kr/news/view/1027392/?sc=naver
1724,2020-03-20,전승호대웅제약대표올해신약개발성과본격화글로벌사업확대”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873000
1725,2020-03-20,대웅대웅제약주주총회개최19년실적보고및신규사업위한정관변경등안건의결,http://www.paxetv.com/news/articleView.html?idxno=88607
1726,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=379478
1727,2020-03-20,대웅대웅제약정기주주총회대웅윤재춘대표자회사성장힘입어건실한경영성과지속”,http://www.thepublic.kr/news/newsview.php?ncode=1065591392128812
1728,2020-03-20,18기주총대웅제약나보타선진시장진출본격화강조,http://www.bosa.co.kr/news/articleView.html?idxno=2123796
1729,2020-03-20,대웅제약신규사업추가전우방감사선임신약개발본격화,http://www.medigatenews.com/news/2331461074
1730,2020-03-20,대웅대웅제약매출1조원돌파주총서보고비전2025박차,http://www.econovill.com/news/articleView.html?idxno=390060
1731,2020-03-20,대웅대웅제약주총글로벌사업확대할것,http://health.chosun.com/site/data/html_dir/2020/03/20/2020032004594.html
1732,2020-03-20,대웅제약매출1조원돌파신약개발성과본격화될것,http://sports.hankooki.com/lpage/economy/202003/sp20200320154800137020.htm
1733,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60299
1734,2020-03-20,대웅제약지난해1조원돌파보툴리눔진출본격화할것,http://kormedi.com/?p=1313753
1735,2020-03-20,대웅대웅제약정기주주총회개최올해신약개발성과본격화될것,http://www.ekn.kr/news/article.html?no=488945
1736,2020-03-20,대웅제약사상처음으로별도매출기준1조원돌파,http://www.fnnews.com/news/202003201611334420
1737,2020-03-20,대웅제약별도기준매출1조돌파,http://www.whosaeng.com/116553
1738,2020-03-20,2020주총대웅제약글로벌사업영역확대및다양한파이프라인확보의지재천명,http://www.newslock.co.kr/news/articleView.html?idxno=26611
1739,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://newsbrite.net/135005
1740,2020-03-20,㈜대웅대웅제약정기주주총회개최,http://www.g-enews.com/ko-kr/news/article/news_all/20200320151543906769d76442fa_1/article.html
1741,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.lawissue.co.kr/view.php?ud=202003201704329954204ead0791_12
1742,2020-03-20,대웅대웅제약주주총회개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1376000
1743,2020-03-20,대웅대웅제약주총해외사업집중방침,http://www.economytalk.kr/news/articleView.html?idxno=204961
1744,2020-03-20,대웅대웅제약주총사업고도화로글로벌사업확대,http://www.meconomynews.com/news/articleView.html?idxno=39344
1745,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.thefirstmedia.net/news/articleView.html?idxno=55951
1746,2020-03-22,대웅제약보툴리눔톡신품질자신전승호싼가격으로유럽들어간다,http://www.businesspost.co.kr/BP?command=article_view&num=169637
1747,2020-03-22,대웅대웅제약정기주주총회개최,http://www.cnbnews.com/news/article.html?no=440729
1748,2020-03-23,단독메디톡스균주절취거짓인줄알면서도대웅제약소송이용하려고허위주장”,http://www.segye.com/content/html/2020/03/22/20200322506999.html?OutUrl=naver
1749,2020-03-23,일양약품대웅제약하락세로부진특히일양약품다시하락수렁빠지나,http://www.econonews.co.kr/news/articleView.html?idxno=113382
1750,2020-03-23,거짓알고서도소송메디톡스대웅제약균주분쟁점입가경,http://news.mt.co.kr/mtview.php?no=2020032308031313668
1751,2020-03-23,지노믹트리대웅제약얼리텍®대장암검사마케팅및판매협력MOU체결,http://news.heraldcorp.com/view.php?ud=20200323000197
1752,2020-03-23,대웅제약지노믹트리얼리텍대장암검사마케팅판매MOU,http://www.medisobizanews.com/news/articleView.html?idxno=68074
1753,2020-03-23,지노믹트리대웅제약대장암검사MOU,http://www.medical-tribune.co.kr/news/articleView.html?idxno=91349
1754,2020-03-23,지노믹트리대웅제약얼리텍대장암검사판매협력MOU,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873644
1755,2020-03-23,지노믹트리대웅제약대장암조기진단마케팅판매협약,http://www.biospectator.com/view/news_view.php?varAtcId=9848
1756,2020-03-23,지노믹트리대웅제약얼리텍®대장암검사마케팅및판매맞손,http://www.viva100.com/main/view.php?key=20200323010009137
1757,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅판매MOU체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242120
1758,2020-03-23,지노믹트리대웅제약과얼리텍®판매협력MOU체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873635
1759,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사마케팅협약체결,http://www.fnnews.com/news/202003231040308142
1760,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅판매협력MOU체결,https://sports.donga.com/article/all/20200323/100301424/1
1761,2020-03-23,대웅제60기대웅제약제18기주주총회성황리개최,http://www.pressm.kr/news/articleView.html?idxno=28386
1762,2020-03-23,지노믹트리대웅제약과대장암조기검사마케팅맞손,http://www.edaily.co.kr/news/newspath.asp?newsid=02492806625706272
1763,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사마케팅판매협력,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020032311061566189
1764,2020-03-23,지노믹트리대웅제약과대장암검사MOU체결,http://www.newsis.com/view/?id=NISX20200323_0000965939&cID=10401&pID=10400
1765,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅및판매협력MOU체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60305
1766,2020-03-23,지노믹트리대웅제약대장암검사공동마케팅나서,http://www.monews.co.kr/news/articleView.html?idxno=209331
1767,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅MOU,http://medipana.com/news/news_viewer.asp?NewsNum=254513&MainKind=A&NewsKind=5&vCount=12&vKind=1
1768,2020-03-23,지노믹트리대웅제약과손잡고대장암조기진단검사공동판매,http://www.businesspost.co.kr/BP?command=article_view&num=169746
1769,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅및판매협력MOU체결,http://sports.chosun.com/news/ntype.htm?id=202003240100180360011364&servicedate=20200323
1770,2020-03-23,대웅제약대장암검사얼리텍판다,http://www.whosaeng.com/116586
1771,2020-03-23,지노믹트리대웅제약대장암키트판매협력,https://www.hankyung.com/it/article/202003232730i
1772,2020-03-23,대웅제약나보타미국캐나다진출올해유럽눈앞,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241899
1773,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사협력MOU체결,http://news.mk.co.kr/newsRead.php?no=298096&year=2020
1774,2020-03-23,대웅제약571상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/23/2020032303112.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1775,2020-03-23,대웅제약전일대비571상승이시각거래량10만4690주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003230361&t=NN
1776,2020-03-23,대웅제약5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003233111L
1777,2020-03-23,대웅제약586VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/23/2020032303125.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1778,2020-03-23,면역력이답이다비타민B군8종에피로회복까지대웅제약임팩타민프리미엄,http://www.metroseoul.co.kr/article/20200323500253
1779,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사판매협력MOU체결,http://www.m-i.kr/news/articleView.html?idxno=694191
1780,2020-03-23,대웅제약하락출발후현재는796↑차트하락세중상승전환,http://www.newspim.com/news/view/20200323000712
1781,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅판매협력MOU,http://www.mdtoday.co.kr/mdtoday/index.html?no=381367
1782,2020-03-23,지노믹트리대웅제약판매협력MOU체결대장암체외분자진단검사시장확대,http://www.paxetv.com/news/articleView.html?idxno=88694
1783,2020-03-23,SR제약바이오지노믹트리대웅제약과대장암검사마케팅및판매협력,http://www.srtimes.kr/news/articleView.html?idxno=57911
1784,2020-03-23,대웅자회사대웅제약주식300억원에추가취득,http://yna.kr/AKR20200323157000008?did=1195m
1785,2020-03-23,대웅자회사대웅제약주식300억원에추가취득,http://news.einfomax.co.kr/news/articleView.html?idxno=4078430
1786,2020-03-23,공시대웅자회사대웅제약주식44만1826주추가취득,http://www.newsway.co.kr/news/view?tp=1&ud=2020032317355175682
1787,2020-03-23,대웅제약자기주식처분결정,http://news.kmib.co.kr/article/view.asp?arcid=0014394646&code=61141211&cp=nv
1788,2020-03-23,대웅제약300억원자사주처분으로미래성정동력투자확대,http://www.metroseoul.co.kr/article/20200323500410
1789,2020-03-23,대웅제약자회사한올바이오파마주식100억원에추가취득,http://yna.kr/AKR20200323161700008?did=1195m
1790,2020-03-23,대웅제약100억규모한올바이오파마지분취득결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873993
1791,2020-03-23,대웅자회사대웅제약주식300억원에추가취득,http://www.asiatoday.co.kr/view.php?key=20200323010014466
1792,2020-03-23,대웅제약자사주처분통해미래성장동력투자확대,https://www.fetv.co.kr/news/article.html?no=50756
1793,2020-03-23,대웅제약자회사한올바이오파마주식100억원에추가취득,http://news.einfomax.co.kr/news/articleView.html?idxno=4078435
1794,2020-03-23,대웅제약자사주처분한올바이오파마100억원주식취득등미래성장동력투자,http://www.etnews.com/20200323000264
1795,2020-03-23,공시대웅제약자회사한올바이오파마주식100억원에추가취득,http://www.newsway.co.kr/news/view?tp=1&ud=2020032317575951861
1796,2020-03-23,대웅제약자사주처분300억원현금확보미래성장동력투자확대,http://www.businesskorea.co.kr/news/articleView.html?idxno=43115
1797,2020-03-23,대웅제약㈜대웅에자사주처분300억원현금확보,http://daily.hankooki.com/lpage/ittech/202003/dh20200323175516145630.htm
1798,2020-03-23,대웅제약지주사에지분39처분해현금300억원확보,http://www.donga.com/news/article/all/20200323/100311091/1
1799,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.nbnnews.co.kr/news/articleView.html?idxno=380009
1800,2020-03-23,대웅300억원규모대웅제약주식추가취득,http://moneys.mt.co.kr/news/mwView.php?no=2020032317518084188
1801,2020-03-23,대웅제약자사주39처분300억현금확보,http://www.edaily.co.kr/news/newspath.asp?newsid=04372246625706272
1802,2020-03-23,대웅제약자사주처분통해미래성장동력투자확대,http://www.kpinews.co.kr/news/articleView.html?idxno=113084
1803,2020-03-23,대웅제약자사주처분통해미래성장동력투자확대,http://www.ebn.co.kr/news/view/1027718/?sc=naver
1804,2020-03-23,대웅제약자사주처분현금300억원확보미래성장동력에투자,http://www.mediapen.com/news/view/510931
1805,2020-03-23,대웅제약300억규모자사주처분미래성장동력투자확대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874001
1806,2020-03-23,대웅제약자사주300억원처분미래성장동력에투자확대,http://sports.hankooki.com/lpage/economy/202003/sp20200323181351137020.htm
1807,2020-03-23,대웅제약지주사대웅에자사주처분300억원확보,http://www.econovill.com/news/articleView.html?idxno=390425
1808,2020-03-23,대웅제약지주사에지분39처분300억원현금확보,http://www.seoulwire.com/news/articleView.html?idxno=404466
1809,2020-03-23,대웅제약자사주처분으로300억확보미래성장동력에투자,http://www.newsway.co.kr/news/view?tp=1&ud=2020032318191494618
1810,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.lawissue.co.kr/view.php?ud=202003231824401306204ead0791_12
1811,2020-03-23,대웅제약지주사대웅에자사주처분300억원현금확보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242155
1812,2020-03-23,대웅제약미래성장동력확보위해300억원규모자사주처분”,http://news.mk.co.kr/newsRead.php?no=300394&year=2020
1813,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.pressm.kr/news/articleView.html?idxno=28400
1814,2020-03-23,대웅제약자사주39처분300억규모현금확보,http://www.newsprime.co.kr/news/article.html?no=498242
1815,2020-03-23,대웅제약300억규모자사주처분미래성장동력투자,http://news.mt.co.kr/mtview.php?no=2020032318185671685
1816,2020-03-23,대웅제약자사주처분현금300억확보RD에통큰투자,http://www.medisobizanews.com/news/articleView.html?idxno=68112
1817,2020-03-23,대웅제약자사주처분전승호300억확보해성장동력에투자”,http://www.businesspost.co.kr/BP?command=article_view&num=169880
1818,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://newsbrite.net/135067
1819,2020-03-23,대웅제약대웅에자사주처분현금확보로투자확대,http://medipana.com/news/news_viewer.asp?NewsNum=254544&MainKind=A&NewsKind=5&vCount=12&vKind=1
1820,2020-03-23,대웅제약자사주처분통해미래성장동력에투자확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=381462
1821,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅판매협력MOU,https://www.kpanews.co.kr/article/show.asp?idx=211922&category=D
1822,2020-03-24,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60336
1823,2020-03-24,대웅제약지주사㈜대웅에자사주처분미래성장동력에대한투자확대,http://www.thefirstmedia.net/news/articleView.html?idxno=56031
1824,2020-03-24,희망RD대웅제약창사이래가장화려한신약라인업보유,http://www.newsis.com/view/?id=NISX20200320_0000964379&cID=13001&pID=13000
1825,2020-03-24,노갑용전대웅제약부사장모친상,http://www.bosa.co.kr/news/articleView.html?idxno=2123938
1826,2020-03-24,지노믹트리대웅제약얼리텍대장암검사마케팅MOU체결,http://www.bosa.co.kr/news/articleView.html?idxno=2123933
1827,2020-03-24,대웅제약지주사대웅에자사주39처분,http://www.bosa.co.kr/news/articleView.html?idxno=2123940
1828,2020-03-24,대웅제약300억확보RD확대한올바이오지분확대,http://www.biospectator.com/view/news_view.php?varAtcId=9857
1829,2020-03-24,코스피코스닥23일주요공시대웅제약자회사한올바이오파마주식100억원에추가취득”등,http://www.betanews.net:8080/article/1152851.html
1830,2020-03-24,전일주요공시대웅제약인터로조클리오등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874014
1831,2020-03-24,대웅제약한올바이오파마주식100억원추가취득,http://www.medisobizanews.com/news/articleView.html?idxno=68117
1832,2020-03-24,대웅제약한올바이오파마주식100억원추가취득,http://www.ebn.co.kr/news/view/1027737/?sc=naver
1833,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈편의성접근성개선,http://news.mt.co.kr/mtview.php?no=2020032408411188284
1834,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242164
1835,2020-03-24,대웅제약한올바이오파마주식100억원추가매수결정,http://www.koreastocknews.com/news/articleView.html?idxno=52135
1836,2020-03-24,대웅제약한올바이오파마주식100억추가투자,http://www.getnews.co.kr/view.php?ud=2020032408455426562fe691f917_16
1837,2020-03-24,장마감후공시대웅제약한올바이오파마주식100억추가취득결정外,http://www.ezyeconomy.com/news/articleView.html?idxno=99172
1838,2020-03-24,대웅제약지주사대웅에300억규모자사주처분,http://www.greened.kr/news/articleView.html?idxno=243603
1839,2020-03-24,대웅제약한올바이오파마주식100억어치추가매수,http://www.rapportian.com/news/articleView.html?idxno=124201
1840,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.nbnnews.co.kr/news/articleView.html?idxno=380059
1841,2020-03-24,대웅제약홈페이지사용자친화전면리뉴얼,http://www.medical-tribune.co.kr/news/articleView.html?idxno=91381
1842,2020-03-24,대웅제약5이상상승외국인기관각각3일6일연속순매수,https://www.hankyung.com/finance/article/202003245223L
1843,2020-03-24,대웅제약자사주처분에관계사주가에긍정적KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01781046625706600
1844,2020-03-24,대웅제약홈페이지리뉴얼글로벌헬스케어기업브랜드강화,http://www.kpinews.co.kr/news/articleView.html?idxno=113094
1845,2020-03-24,대웅제약공식웹사이트새단장편의성높였다,http://www.mediapen.com/news/view/511016
1846,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.dailysmart.co.kr/news/articleView.html?idxno=24068
1847,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,https://www.fetv.co.kr/news/article.html?no=50776
1848,2020-03-24,대웅제약공식웹사이트전면리뉴얼고객편의성접근성개선”,http://www.viva100.com/main/view.php?key=20200324010009613
1849,2020-03-24,대웅제약한올바이오파마주식100억추가취득,http://www.newsis.com/view/?id=NISX20200324_0000967315&cID=13001&pID=13000
1850,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성과접근성개선,http://www.m-i.kr/news/articleView.html?idxno=694449
1851,2020-03-24,한올바이오파마대웅제약이지분추가확보”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874172
1852,2020-03-24,대웅제약공식웹사이트전면리뉴얼고객편의성개선,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571703786319
1853,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.bosa.co.kr/news/articleView.html?idxno=2123954
1854,2020-03-24,대웅제약웹사이트전면리뉴얼편의성향상접근성개선 ,http://www.medisobizanews.com/news/articleView.html?idxno=68122
1855,2020-03-24,일양약품대웅제약모두3대상승특히대웅제약7만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=113539
1856,2020-03-24,대웅제약공식웹사이트리뉴얼편의접근성개선,http://www.newsis.com/view/?id=NISX20200324_0000967332&cID=13001&pID=13000
1857,2020-03-24,대웅제약공식웹사이트전면리뉴얼고객편의성접근성개선,http://www.asiatoday.co.kr/view.php?key=20200324010014696
1858,2020-03-24,대웅제약웹사이트리뉴얼오픈고객편의성및접근성개선,http://www.newspim.com/news/view/20200324000452
1859,2020-03-24,대웅제약공식웹사이트리뉴얼고객편의성접근성개선,http://medipana.com/news/news_viewer.asp?NewsNum=254554&MainKind=A&NewsKind=5&vCount=12&vKind=1
1860,2020-03-24,대웅제약공식웹사이트리뉴얼오픈고객편의성과접근성개선,http://www.sportsseoul.com/news/read/897202?ref=naver
1861,2020-03-24,대웅제약공식웹사이트리뉴얼편의성과접근성개선”,http://www.newsway.co.kr/news/view?tp=1&ud=2020032409425749811
1862,2020-03-24,한올바이오파마대웅제약이주식100억원추가취득,https://www.sedaily.com/NewsView/1Z0BNWBTJP
1863,2020-03-24,대웅제약자사주300억원처분한올바이오파마지분추가취득,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003240116&t=NN
1864,2020-03-24,대웅제약신약개발홈페이지서확인된다,http://www.sisafocus.co.kr/news/articleView.html?idxno=235318
1865,2020-03-24,공시한올바이오파마대웅제약이주식100억원추가취득,http://www.fnnews.com/news/202003241000486851
1866,2020-03-24,대웅제약연구개발현황전면배치등공식웹사이트리뉴얼,http://www.newslock.co.kr/news/articleView.html?idxno=26670
1867,2020-03-24,대웅제약전일대비515상승중이시각거래량4만290주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003240202&t=NN
1868,2020-03-24,대웅제약공식홈페이지리뉴얼오픈편의성접근성개선,http://sports.hankooki.com/lpage/economy/202003/sp20200324100710137020.htm
1869,2020-03-24,대웅제약지주사에자사주처분한올바이오파마지분확대RD투자,http://www.sisaweek.com/news/articleView.html?idxno=132243
1870,2020-03-24,지노믹트리대웅제약얼리텍대장암검사공동마케팅,http://www.doctorsnews.co.kr/news/articleView.html?idxno=133978
1871,2020-03-24,대웅제약공식웹사이트전면리뉴얼,http://www.newsfc.co.kr/news/articleView.html?idxno=40396
1872,2020-03-24,특징주대웅제약72200원24일10시20분등락률633,http://www.getnews.co.kr/view.php?ud=202003241022355654c20b962ac2_16
1873,2020-03-24,대웅제약공식홈페이지전면리뉴얼오픈편의성접근성개선,http://www.seoulwire.com/news/articleView.html?idxno=404544
1874,2020-03-24,대웅제약300억규모자사주처분통해미래성장동력확보한올바이오파마지분추가취득,http://www.ekn.kr/news/article.html?no=489491
1875,2020-03-24,대웅제약자사주처분하며미래성장RD에투자,http://health.chosun.com/site/data/html_dir/2020/03/24/2020032402229.html
1876,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성및접근성↑,http://www.ekn.kr/news/article.html?no=489496
1877,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼,http://www.etnews.com/20200324000086
1878,2020-03-24,대웅제약공식웹사이트리뉴얼고객편의성과접근성개선,http://www.econovill.com/news/articleView.html?idxno=390483
1879,2020-03-24,대웅제약자사주처분통해현금300억확보,http://www.wikileaks-kr.org/news/articleView.html?idxno=81323
1880,2020-03-24,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.bokuennews.com/news/article.html?no=188143
1881,2020-03-24,대웅제약지주사대웅에자사주39처분,http://www.cnbnews.com/news/article.html?no=440898
1882,2020-03-24,대웅제약공식웹사이트전면개편브랜드강화편의성향상,http://www.greened.kr/news/articleView.html?idxno=243663
1883,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.bokuennews.com/news/article.html?no=188147
1884,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.cstimes.com/news/articleView.html?idxno=407321
1885,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60346
1886,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60345
1887,2020-03-24,대웅제약고객편의성과접근성개선위해공식웹사이트전면리뉴얼오픈,http://www.updownnews.co.kr/news/articleView.html?idxno=216698
1888,2020-03-24,고객편의성과접근성강화대웅제약공식홈페이지전면개편,http://kpenews.com/View.aspx?No=785645
1889,2020-03-24,대웅제약자사주팔아미래성장동력에투자,http://www.whosaeng.com/116609
1890,2020-03-24,대웅제약사용자친화홈페이지로개편,https://www.news2day.co.kr/150031
1891,2020-03-24,지노믹트리대웅제약과얼리텍대장암검사국내영업협력,http://www.etnews.com/20200324000128
1892,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.lawissue.co.kr/view.php?ud=20200324125251907204ead0791_12
1893,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.ebn.co.kr/news/view/1027842/?sc=naver
1894,2020-03-24,대웅제약급등전일대비795↑하락흐름중단기급등발생,http://www.newspim.com/news/view/20200324001947
1895,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성접근성개선,http://www.mdtoday.co.kr/mdtoday/index.html?no=381530
1896,2020-03-24,대웅제약계열대웅바이오세무조사국세청리턴매치,http://www.topdaily.kr/news/articleView.html?idxno=65375
1897,2020-03-24,대웅제약고객편의성과정보접근성개선공식웹사이트리뉴얼오픈,http://www.pressm.kr/news/articleView.html?idxno=28429
1898,2020-03-24,대웅제약한올바이오파마주식100억원추가취득,http://www.ajunews.com/view/20200324135906356
1899,2020-03-24,대웅제약웹사이트전면개편고객편의성과접근성개선,http://www.koreaittimes.com/news/articleView.html?idxno=96337
1900,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://newsbrite.net/135097
1901,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://newsbrite.net/135100
1902,2020-03-24,효능성분으로약검색대웅제약공식웹사이트새단장,http://theviewers.co.kr/View.aspx?No=786169
1903,2020-03-24,대웅제약공식홈페이지리뉴얼오픈사용자친화적개선,http://www.100ssd.co.kr/news/articleView.html?idxno=67901
1904,2020-03-24,대웅제약자사주처분해미래성장동력투자확대,http://www.medigatenews.com/news/1634871408
1905,2020-03-24,메디톡스대웅제약나란히자사주매입러시왜,http://moneys.mt.co.kr/news/mwView.php?no=2020032414068085694
1906,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://www.sportsseoul.com/news/read/897444?ref=naver
1907,2020-03-24,대웅제약미래성장동력투자확대 ,http://www.monews.co.kr/news/articleView.html?idxno=209373
1908,2020-03-24,대웅제약한올바이오파마주식100억추가취득,http://www.skyedaily.com/news/news_view.html?ID=101392
1909,2020-03-24,대웅제약공식웹사이트전면리뉴얼편의성과접근성개선”,http://www.sporbiz.co.kr/news/articleView.html?idxno=424721
1910,2020-03-24,대웅제약편의접근성높인공식웹사이트공개,http://www.economytalk.kr/news/articleView.html?idxno=205045
1911,2020-03-24,대웅제약자사주처분통해미래성장동력에대한투자확대,https://www.thepublic.kr/news/newsview.php?ncode=1065592432827135
1912,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성접근성개선,https://www.thepublic.kr/news/newsview.php?ncode=1065592313604773
1913,2020-03-24,대웅제약기업브랜드강화공식웹사이트리뉴얼,http://newsclaim.co.kr/View.aspx?No=786219
1914,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://www.medigatenews.com/news/2090542604
1915,2020-03-24,대웅제약홈페이지편의성개선,http://www.seoulfn.com/news/articleView.html?idxno=376541
1916,2020-03-24,미래성장동력투자확대VS주가안정목적대웅제약지주회사에자사주300억규모처분,http://theviewers.co.kr/View.aspx?No=786466
1917,2020-03-24,대웅제약편의성․접근성개선웹사이트전면손질,http://www.whosaeng.com/116625
1918,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.enewstoday.co.kr/news/articleView.html?idxno=1376721
1919,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.wsobi.com/news/articleView.html?idxno=93569
1920,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,https://www.kpanews.co.kr/article/show.asp?idx=211955&category=D
1921,2020-03-25,대웅제약턱밑지방개선주사제시장뛰어드나,https://www.paxnetnews.com/articles/58525
1922,2020-03-25,일양약품대웅제약모두상승흐름특히대웅제약가파른상승세로5상승,http://www.econonews.co.kr/news/articleView.html?idxno=113677
1923,2020-03-25,대웅제약급등전일대비1102↑긴하락구간에서주가급등,http://www.newspim.com/news/view/20200325001313
1924,2020-03-25,대웅제약1578VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/25/2020032501563.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1925,2020-03-25,중기부기술침해행정조사거부대웅제약에과태료500만원부과,http://www.fnnews.com/news/202003250828210691
1926,2020-03-25,대웅제약보톡스기술불법취득조사거부첫과태료부과처분,http://news.mt.co.kr/mtview.php?no=2020032508564823694
1927,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료첫사례,https://www.news1.kr/articles/?3884782
1928,2020-03-25,중기부대웅제약에첫과태료부과처분기술침해행정조사거부,http://www.asiatoday.co.kr/view.php?key=20200325010015439
1929,2020-03-25,중기부대웅제약에기술침해행정조사거부과태료첫부과,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003250106&t=NN
1930,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료부과,http://yna.kr/AKR20200325077800030?did=1195m
1931,2020-03-25,기술침해행정조사거부대웅제약에과태료500만원,http://www.newsis.com/view/?id=NISX20200325_0000969149&cID=13001&pID=13000
1932,2020-03-25,중기부대웅제약에과태료500만원부과기술침해행정조사거부,https://view.asiae.co.kr/article/2020032508300369251
1933,2020-03-25,중기부대웅제약에기술침해행정조사거부과태료첫부과,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003250106&t=NN
1934,2020-03-25,대웅제약중기부기술침해조사거부과태료500만원부과받아,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874873
1935,2020-03-25,中企기술침해대웅제약조사도거부해과태료부과,http://www.metroseoul.co.kr/article/20200325500073
1936,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료500만원부과,http://www.newstomato.com/ReadNews.aspx?no=961685
1937,2020-03-25,보톡스균주기술침해조사거부대웅제약에과태료,https://www.ytn.co.kr/_ln/0102_202003251202370556
1938,2020-03-25,중기부기술침해조사거부한대웅제약에과태료부과,http://www.ajunews.com/view/20200325084614966
1939,2020-03-25,중소기업기술침해의혹행정조사거부한대웅제약에과태료부과,http://news.kbs.co.kr/news/view.do?ncd=4409677&ref=A
1940,2020-03-25,메디톡스기술침해조사거부한대웅제약에과태료500만원,https://news.chosun.com/site/data/html_dir/2020/03/25/2020032502311.html?utm_source=naver&utm_medium=original&utm_campaign=news
1941,2020-03-25,기술침해행정조사거부한대웅제약중기부첫과태료처분내려,http://www.viva100.com/main/view.php?key=20200325010010336
1942,2020-03-25,중기부행정조사거부한대웅제약에500만원과태료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020032511524824192
1943,2020-03-25,중기부기술침해행정조사거부대웅제약에과태료500만원첫부과,http://www.etnews.com/20200325000149
1944,2020-03-25,중기부대웅제약에기술침해행정조사거부과태료500만원부과,http://news.kbiz.or.kr/news/articleView.html?idxno=65548
1945,2020-03-25,중기부행정조사거부대웅제약에과태료부과,http://www.shinailbo.co.kr/news/articleView.html?idxno=1262891
1946,2020-03-25,대웅제약기술침해행정조사거부로첫과태료부과,http://www.dt.co.kr/contents.html?article_no=2020032502109931731004&ref=naver
1947,2020-03-25,대웅제약특별관계자지분변동,http://news.kmib.co.kr/article/view.asp?arcid=0014403328&code=61141211&cp=nv
1948,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료500만원부과,http://www.ekn.kr/news/article.html?no=489880
1949,2020-03-25,대웅제약메디톡스기술침해조사거부과태료500만원,http://moneys.mt.co.kr/news/mwView.php?no=2020032513578010444
1950,2020-03-25,기술침해조사거부한대웅제약에과태료500만원중기부행정조사첫제재,http://biz.newdaily.co.kr/site/data/html/2020/03/25/2020032500146.html
1951,2020-03-25,중기부메디톡스기술침해혐의조사거부한대웅제약에과태료부과,http://news.mk.co.kr/newsRead.php?no=309196&year=2020
1952,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료처분,https://www.hankyung.com/finance/article/2020032502386
1953,2020-03-25,중기부기술침해행정조사거부대웅제약에500만원과태료부과,http://www.econovill.com/news/articleView.html?idxno=390715
1954,2020-03-25,대웅제약중소기업기술침해과태료500만원부과받아,http://www.sisafocus.co.kr/news/articleView.html?idxno=235487
1955,2020-03-25,기술침해행정조사거부한대웅제약첫과태료부과처분,http://www.chungnamilbo.com/news/articleView.html?idxno=537231
1956,2020-03-25,중소벤처기업부대웅제약기술침해조사거부에과태료부과,http://www.mediapen.com/news/view/511565
1957,2020-03-25,중기부행정조사거부대웅제약에과태료500만원부과,http://www.ebn.co.kr/news/view/1028115/?sc=naver
1958,2020-03-25,조사안받는대신500만원”기술침해의혹대웅제약중기부과태료부과첫사례,http://theviewers.co.kr/View.aspx?No=787726
1959,2020-03-25,메디톡스소송비용충당대웅제약300억자사주매각,http://www.wikileaks-kr.org/news/articleView.html?idxno=81500
1960,2020-03-25,보톡스분쟁관련대웅제약기술침해행정조사거부과태료부과,http://www.kidd.co.kr/news/215244
1961,2020-03-25,중기부대웅제약에과태료500만원부과기술침해행정조사거부,http://www.newsworks.co.kr/news/articleView.html?idxno=443176
1962,2020-03-25,대웅제약특별관계자지분율변동,http://www.mdtoday.co.kr/mdtoday/index.html?no=381771
1963,2020-03-25,중기부대웅제약에과태료부과기술침해관련행정조사거부,https://www.hankyung.com/economy/article/2020032509141
1964,2020-03-25,기술침해행정조사거부한대웅제약에첫과태료부과,https://www.seoul.co.kr/news/newsView.php?id=20200325500209&wlog_tag3=naver
1965,2020-03-25,기술침해조사거부대웅제약첫과태료,https://www.sedaily.com/NewsView/1Z0C5KR5RA
1966,2020-03-25,보톡스분쟁허우적대는대웅제약중기부조사거부에제재,http://www.seouleconews.com/news/articleView.html?idxno=54034
1967,2020-03-25,보톡스균주기술침해조사거부대웅제약에과태료,https://www.ytn.co.kr/_ln/0102_202003251806276762
1968,2020-03-25,대웅제약중소기업기술침해행정조사거부해과태료500만원,http://www.businesspost.co.kr/BP?command=article_view&num=170319
1969,2020-03-25,중기부기술침해조사거부대웅제약에과태료500만원,http://www.seoulfn.com/news/articleView.html?idxno=376720
1970,2020-03-25,보톡스균주현장조사거부대웅제약에첫과태료,https://www.ytn.co.kr/_ln/0102_202003252336273858
1971,2020-03-26,대웅제약공식웹사이트전면리뉴얼오픈고객편의성과접근성개선,http://www.thefirstmedia.net/news/articleView.html?idxno=56129
1972,2020-03-26,대웅제약알비스원료변경통해재출시가능성대두,http://www.bosa.co.kr/news/articleView.html?idxno=2124080
1973,2020-03-26,기술침해행정조사거부한대웅제약에과태료500만원,http://www.mdtoday.co.kr/mdtoday/index.html?no=381798
1974,2020-03-26,대웅제약보톡스기술불법취득조사거부첫과태료부과,http://news.jtbc.joins.com/article/article.aspx?news_id=NB11942028
1975,2020-03-26,대웅제약기술침해조사거부했다500만원과태료,http://www.mhj21.com/128744
1976,2020-03-26,대웅제약브랜드서체DW임팩타민체무료배포,http://newsclaim.co.kr/View.aspx?No=788105
1977,2020-03-26,대웅제약DW임팩타민체서체무료배포,http://www.consumuch.com/news/articleView.html?idxno=48116
1978,2020-03-26,대웅제약브랜드서체DW임팩타민체개발BI강화,http://www.greened.kr/news/articleView.html?idxno=244058
1979,2020-03-26,대웅제약브랜드서체DW임팩타민체개발및무료배포소비자접점확대,http://www.ekn.kr/news/article.html?no=490045
1980,2020-03-26,대웅제약브랜드서체DW임팩타민체개발,http://www.ebn.co.kr/news/view/1028214/?sc=naver
1981,2020-03-26,대웅제약정부기술침해행정조사거부중기부과태료부과,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003917574
1982,2020-03-26,일양약품대웅제약희비엇갈려특히일양약품급등하루만에지지부진,http://www.econonews.co.kr/news/articleView.html?idxno=113814
1983,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,https://www.fetv.co.kr/news/article.html?no=51075
1984,2020-03-26,대웅제약DW임팩타민체개발해임팩타민BI강화,http://medipana.com/news/news_viewer.asp?NewsNum=254681&MainKind=A&NewsKind=5&vCount=12&vKind=1
1985,2020-03-26,대웅제약브랜드서체DW임팩타민체개발활기넘치고임팩트있는특징서체에표현,http://www.pressm.kr/news/articleView.html?idxno=28498
1986,2020-03-26,대웅제약비타민브랜드임팩타민특징살린서체무료배포,http://news.mk.co.kr/newsRead.php?no=312470&year=2020
1987,2020-03-26,대웅제약개발브랜드서체DW임팩타민체무료배포,http://www.medisobizanews.com/news/articleView.html?idxno=68231
1988,2020-03-26,대웅제약임팩타민글씨체로브랜드이미지강화,http://health.chosun.com/site/data/html_dir/2020/03/26/2020032602215.html
1989,2020-03-26,대웅제약브랜드서체개발로임팩타민BI강화,http://www.newsis.com/view/?id=NISX20200326_0000970881&cID=13001&pID=13000
1990,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.ezyeconomy.com/news/articleView.html?idxno=99272
1991,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60383
1992,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.ezyeconomy.com/news/articleView.html?idxno=99272
1993,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.cstimes.com/news/articleView.html?idxno=407644
1994,2020-03-26,대웅제약브랜드서체DW임팩타민체개발,http://www.dailymedi.com/detail.php?number=854417&thread=22r05
1995,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.viva100.com/main/view.php?key=20200326010010736
1996,2020-03-26,대웅제약브랜드서체DW임팩타민체개발브랜드이미지강화,http://www.seoulwire.com/news/articleView.html?idxno=404899
1997,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=381856
1998,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,https://www.dailian.co.kr/news/view/878894?sc=Naver
1999,2020-03-26,대웅제약임팩타민체무료배포브랜드가치강화,http://moneys.mt.co.kr/news/mwView.php?no=2020032610588041790
2000,2020-03-26,대웅제약DW임팩타민체무료배포하며소비자접점확대추진,http://www.g-enews.com/ko-kr/news/article/news_all/20200326105845769369d76442fa_1/article.html
2001,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.metroseoul.co.kr/article/20200326500157
2002,2020-03-26,대웅제약브랜드서체DW임팩타민체무료배포임팩타민BI강화,http://www.thepublic.kr/news/newsview.php?ncode=1065574945670411
2003,2020-03-26,대웅제약서체DW임팩타민체개발,http://www.econovill.com/news/articleView.html?idxno=390860
2004,2020-03-26,대웅제약브랜드서체개발통해임팩타민BI강화,http://www.dailysmart.co.kr/news/articleView.html?idxno=24216
2005,2020-03-26,중기부기술침해행정조사거부대웅제약에과태료500만원부과,http://www.betanews.net:8080/article/1154417.html
2006,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=380789
2007,2020-03-26,대웅제약상승흐름전일대비509이시각거래량8만7913주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003260196&t=NN
2008,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.sporbiz.co.kr/news/articleView.html?idxno=425365
2009,2020-03-26,대웅제약이종욱고문이달말회사떠난다,http://www.pharmnews.com/news/articleView.html?idxno=100206
2010,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.m-i.kr/news/articleView.html?idxno=695576
2011,2020-03-26,중기부기술침해대웅제약에과태료,http://www.naeil.com/news_view/?id_art=344835
2012,2020-03-26,기술침해행정조사거부한대웅제약첫과태료부과처분,http://www.korea.kr/news/pressReleaseView.do?newsId=156382250&call_from=naver_news
2013,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.lawissue.co.kr/view.php?ud=202003261434327688204ead0791_12
2014,2020-03-26,대웅제약브랜드서체DW임팩타민체개발배포,http://www.bosa.co.kr/news/articleView.html?idxno=2124143
2015,2020-03-26,대웅제약브랜드서체DW임팩타민체무료배포,http://www.mediapen.com/news/view/511933
2016,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242314
2017,2020-03-26,대웅제약브랜드서체DW임팩타민체로접점늘린다,http://www.mhj21.com/128763
2018,2020-03-26,대웅제약브랜드서체DW임팩타민체개발무료배포브랜드이미지강화,http://www.paxetv.com/news/articleView.html?idxno=88995
2019,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.updownnews.co.kr/news/articleView.html?idxno=216853
2020,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://newsbrite.net/135184
2021,2020-03-26,대웅제약DW임팩타민체개발통해임팩타민BI강화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065593238839722
2022,2020-03-26,대웅제약DW임팩타민브랜드서체개발무료배포,http://www.kpinews.co.kr/news/articleView.html?idxno=113401
2023,2020-03-26,대웅제약브랜드서체DW임팩타민체배포눈길,http://www.sisaweek.com/news/articleView.html?idxno=132358
2024,2020-03-26,대웅제약브랜드서체DW임팩타민체개발,https://www.kpanews.co.kr/article/show.asp?idx=212025&category=D
2025,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.cnbnews.com/news/article.html?no=441346
2026,2020-03-26,대웅제약임팩타민프리미엄비타민B군8종함유피로회복탁월,https://www.sedaily.com/NewsView/1Z0CKVWPWG
2027,2020-03-26,대웅제약메디톡스가중소기업과태료처분억울하다,http://www.mediapen.com/news/view/511873
2028,2020-03-26,뉴스투데이L대웅제약브랜드서체DW임팩타민체개발,https://www.news2day.co.kr/150267
2029,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.wsobi.com/news/articleView.html?idxno=93800
2030,2020-03-26,연속순매수기관대웅제약9일째매수,http://www.itooza.com/common/iview.php?no=2020032617004380576
2031,2020-03-26,메디톡스대웅제약의기술침해행정조사거부소식에上,http://www.mdtoday.co.kr/mdtoday/index.html?no=381971
2032,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.thevaluenews.co.kr/news/view.php?idx=158963
2033,2020-03-27,대웅제약브랜드서체DW임팩타민체무료배포,http://news.kbiz.or.kr/news/articleView.html?idxno=65627
2034,2020-03-27,대웅제약중기부행정조사거부로과태료부과,http://www.topdaily.kr/news/articleView.html?idxno=65455
2035,2020-03-27,대웅제약브랜드서체DW임팩타민체무료배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1377344
2036,2020-03-27,일양약품대웅제약모두상승세로특히일양약품가파른상승세로4상승,http://www.econonews.co.kr/news/articleView.html?idxno=113995
2037,2020-03-27,대웅제약서체DW임팩타민체개발통해브랜드이미지강화,http://www.newslock.co.kr/news/articleView.html?idxno=26773
2038,2020-03-27,대웅제약브랜드서체DW임팩타민체개발,http://kormedi.com/?p=1314191
2039,2020-03-27,메디톡스vs대웅제약보톡스전쟁끝날까,http://www.babytimes.co.kr/news/articleView.html?idxno=34524
2040,2020-03-27,대웅제약보톡스분쟁기술침해행정조사거부과태료부과,http://www.pinpointnews.co.kr/view.php?ud=202003271505295685f090c8dbcb_45
2041,2020-03-28,알비스판금대웅제약새로운항궤양제찾아라,http://www.dailypharm.com/Users/News/NewsView.html?ID=263266&REFERER=NP
2042,2020-03-30,이종욱경영고문퇴진대웅제약참장점많은회사,http://www.bosa.co.kr/news/articleView.html?idxno=2124252
2043,2020-03-30,대웅제약메디톡스관련중기부행정조사소송종결까지중지돼야,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242381
2044,2020-03-30,대웅제약코로나19소송비용이중고목표가29↓KB,http://www.edaily.co.kr/news/newspath.asp?newsid=01456326625708568
2045,2020-03-30,메디톡스관련중소벤처기업부의행정조사에대한대웅제약의입장,http://www.nbnnews.co.kr/news/articleView.html?idxno=381543
2046,2020-03-30,대웅제약성장세둔화소송비용증가로실적감소KB증권,http://www.ajunews.com/view/20200330080839357
2047,2020-03-30,대웅제약코로나19와소송이중고목표가↓,http://www.asiatoday.co.kr/view.php?key=20200330010018280
2048,2020-03-30,리포트브리핑대웅제약소송의피로감이만든주가목표가120000원하이투자증권,http://www.newspim.com/news/view/20200330000075
2049,2020-03-30,대웅제약중소벤처기업부행정조사중지해야,http://news.mt.co.kr/mtview.php?no=2020033008374376595
2050,2020-03-30,대웅제약메디톡스관련중기부행정조사소송종결까지중지돼야”,http://newsclaim.co.kr/View.aspx?No=790908
2051,2020-03-30,대웅제약중기부행정조사는부당균주소송종결까지중단해야,http://www.ajunews.com/view/20200330084517431
2052,2020-03-30,대웅제약소송종결시까지중기부행정조사중지돼야,http://www.enewstoday.co.kr/news/articleView.html?idxno=1377732
2053,2020-03-30,대웅제약중기부보톡스관련행정조사중단해달라,http://www.newspim.com/news/view/20200330000077
2054,2020-03-30,대웅제약중소벤처기업부에메디톡스관련행정조사중단요청,http://www.wikileaks-kr.org/news/articleView.html?idxno=81840
2055,2020-03-30,대웅제약메디톡스관련중기부행정조사중단돼야,http://www.medisobizanews.com/news/articleView.html?idxno=68320
2056,2020-03-30,하이로우대웅제약코로나19소송비용이중고목표가↓KB증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020033009125852715
2057,2020-03-30,대웅제약124상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/30/2020033001416.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2058,2020-03-30,대웅제약중기부행정조사소송종결시까지중지해야,http://www.newsis.com/view/?id=NISX20200330_0000974927&cID=13001&pID=13000
2059,2020-03-30,대웅제약코로나19에소송비용까지이중고목표가하향KB증권,http://www.newstomato.com/ReadNews.aspx?no=962635
2060,2020-03-30,대웅제약메디톡스관련중기부행정조사소송종결까지중지돼야,http://www.asiatoday.co.kr/view.php?key=20200330010018373
2061,2020-03-30,대웅제약행정조사소송종결시까지중지해야,http://medipana.com/news/news_viewer.asp?NewsNum=254809&MainKind=A&NewsKind=5&vCount=12&vKind=1
2062,2020-03-30,대웅제약메디톡스와소송종결시까지중기부행정조사중단돼야,http://www.etoday.co.kr/news/section/newsview.php?idxno=1876926
2063,2020-03-30,트라파코대웅제약제품생산확대올해1015개목표,https://www.theguru.co.kr/news/article.html?no=9773
2064,2020-03-30,이종욱대웅제약고문명예퇴진제3의인생RD돕는일하고싶다,http://www.wikileaks-kr.org/news/articleView.html?idxno=81859
2065,2020-03-30,대웅제약메디톡스와소송중행정조사중지요청한속내는,https://www.fetv.co.kr/news/article.html?no=51383
2066,2020-03-30,대웅제약일방적가해자로규정한행정조사중지돼야,http://www.shinailbo.co.kr/news/articleView.html?idxno=1264393
2067,2020-03-30,대웅제약메디톡스관련중기부행정조사는부당,http://www.bosa.co.kr/news/articleView.html?idxno=2124280
2068,2020-03-30,대웅제약행정조사부당메디톡스나약한피해자행세,http://www.upinews.kr/newsView/upi202003300031
2069,2020-03-30,대웅제약중기부행정조사메디톡스와소송종결까지중지돼야,https://www.hankyung.com/finance/article/2020033006006
2070,2020-03-30,메디톡스관련중소벤처기업부행정조사에대한대웅제약입장발표,http://www.pressm.kr/news/articleView.html?idxno=28562
2071,2020-03-30,일양약품대웅제약상승에급등까지특히일양약품갑작스런7급등,http://www.econonews.co.kr/news/articleView.html?idxno=114351
2072,2020-03-30,대웅제약메디톡스와소송종결시까지중기부행정조사중지해야,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003300181&t=NN
2073,2020-03-30,대웅제약메디톡스명백한거짓중소기업도아니야중기부행정조사부당,http://www.newslock.co.kr/news/articleView.html?idxno=26815
2074,2020-03-30,리포트브리핑대웅제약코로나19와소송비용의이중고목표가120000원KB증권,http://www.newspim.com/news/view/20200330000401
2075,2020-03-30,대웅제약중소벤처기업부행정조사중지돼야”,http://www.whosaeng.com/116717
2076,2020-03-30,대웅제약중기부과태료부과에반발일방적가해자로규정,http://www.newsprime.co.kr/news/article.html?no=499093
2077,2020-03-30,대웅제약중기부행정조사메디톡스소송종결시까지중지돼야,http://www.greened.kr/news/articleView.html?idxno=244582
2078,2020-03-30,중기부대웅제약주장사실과달라의견서접수후후속대응할것”,http://www.ajunews.com/view/20200330110417666
2079,2020-03-30,대웅제약중소벤처기업부행정조사메디톡스와의소송끝날때까지종결돼야,http://www.ceoscoredaily.com/news/article.html?no=67868
2080,2020-03-30,대웅제약중기부행정조사메디톡스와소송종결될때까지중단해야”,http://www.mdtoday.co.kr/mdtoday/index.html?no=382218
2081,2020-03-30,대웅제약중기부행정조사중단촉구,http://www.dailymedi.com/detail.php?number=854532&thread=22r05
2082,2020-03-30,대웅제약중기부메디톡스소송종결까지행정조사중지해야,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1079141
2083,2020-03-30,대웅제약중기부행정조사반발메디톡스와소송종결까지중단돼야,http://www.sisaweek.com/news/articleView.html?idxno=132432
2084,2020-03-30,대웅제약중기부행정조사종결까지중지돼야메디톡스중소기업아냐”,http://www.econovill.com/news/articleView.html?idxno=391352
2085,2020-03-30,메디톡스관련중소벤처기업부의행정조사에대한대웅제약의입장,http://newsbrite.net/135272
2086,2020-03-30,대웅제약중기부기술침해행정조사중지해야,http://www.mediapen.com/news/view/512874
2087,2020-03-30,대웅제약메디톡스간막장보톡스균주전쟁출혈가시화,http://www.metroseoul.co.kr/article/20200330500341
2088,2020-03-30,대웅제약메디톡스기술침해절대아냐”,http://theviewers.co.kr/View.aspx?No=791719
2089,2020-03-30,대웅제약메디톡스와소송종결될때까지중기부기술침해조사중단돼야,http://news.mk.co.kr/newsRead.php?no=328819&year=2020
2090,2020-03-30,대웅제약보툴리눔톡신미국점유율확대로매출늘어실적에긍정적,http://www.businesspost.co.kr/BP?command=article_view&num=170998
2091,2020-03-30,대웅제약중기부행정조사소송종결시까지중단돼야,http://www.ebn.co.kr/news/view/1028817/?sc=naver
2092,2020-03-30,대웅제약중기부행정조사에반발메디톡스중소기업아냐,http://www.updownnews.co.kr/news/articleView.html?idxno=216968
2093,2020-03-30,동아에스티대웅제약삼일제약은코로나19왕따제약사제약업종강세속하락거듭하며자사주매입까지,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003922125
2094,2020-03-30,대웅제약보톡스행정조사처분에부당한처사,http://www.pharmnews.com/news/articleView.html?idxno=100223
2095,2020-03-30,대웅제약중기부행정조사소송종결시까지중지돼야”,http://www.cnbnews.com/news/article.html?no=441638
2096,2020-03-30,대웅제약중기부부당한행정조사중단하라,http://www.finomy.com/news/articleView.html?idxno=76675
2097,2020-03-30,대웅제약정부현장조사끝내거부메디톡스와소송戰끝날때까지미루자”,http://www.edaily.co.kr/news/newspath.asp?newsid=04168886625708568
2098,2020-03-31,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.thefirstmedia.net/news/articleView.html?idxno=56284
2099,2020-03-31,메디톡스vs대웅제약보톡스전쟁韓제약산업경쟁력발목잡나,http://www.asiatoday.co.kr/view.php?key=20200330010018868
2100,2020-03-31,보톡스전쟁중대웅제약중기부에이유있는항변,http://isplus.live.joins.com/news/article/article.asp?total_id=23743269
2101,2020-03-31,5대제약사RD크게늘렸다대웅제약505최고증가율,http://www.medisobizanews.com/news/articleView.html?idxno=68366
2102,2020-03-31,일양약품대웅제약상승에급등까지특히일양약품갑작스런13급등,http://www.econonews.co.kr/news/articleView.html?idxno=114483
2103,2020-03-31,대웅제약중소벤처기업부행정조사거부,http://www.betanews.net:8080/article/1156412.html
2104,2020-03-31,셀트리온한미약품대웅제약유한양행종근당JW중외제약보령제약RD투자광동제약꼴찌,http://www.globale.co.kr/view.php?ud=202003311356207183084e0343a0_36
2105,2020-03-31,중기부대웅제약기술침해행정조사ITC소송과는독립적절차,http://biz.newdaily.co.kr/site/data/html/2020/03/31/2020033100245.html
2106,2020-04-01,대웅제약라니티딘원료수급해안정성분석한다알비스판매재개되나,http://www.mdtoday.co.kr/mdtoday/index.html?no=382470
2107,2020-04-01,일양약품대웅제약희비엇갈려특히일양약품갑작스런12폭락에투자자들당황,http://www.econonews.co.kr/news/articleView.html?idxno=114632
2108,2020-04-01,메디톡스사면초가대웅제약과보톡스전쟁불리해지나,http://www.insightkorea.co.kr/news/articleView.html?idxno=78650
2109,2020-04-01,라니티딘제제허가갱신판매재개는미지수대웅제약안전성분석중,http://theviewers.co.kr/View.aspx?No=797369
2110,2020-04-01,대웅제약임팩타민서체개발을통한브랜드임팩트전달,https://www.jungle.co.kr/magazine/201635
2111,2020-04-01,메디톡스vs대웅제약美ITC결과국내소송에미칠영향두고상반된해석,http://biz.newdaily.co.kr/site/data/html/2020/04/01/2020040100311.html
2112,2020-04-01,보톡스분쟁메디톡스대웅제약ITC보고서갈등일단락,http://www.finomy.com/news/articleView.html?idxno=76797
2113,2020-04-02,4년째절차공방중인메디톡스대웅제약보톡스균주소송전,http://www.nongaek.com/news/articleView.html?idxno=68314
2114,2020-04-02,일양약품대웅제약가파른하락세특히일양약품전날17폭락이어5하락,http://www.econonews.co.kr/news/articleView.html?idxno=114772
2115,2020-04-02,균주전쟁5년차대웅제약메디톡스보고서제출방식에서또결렬,http://theviewers.co.kr/View.aspx?No=798818
2116,2020-04-02,공시한올바이오파마최대주주대웅제약보통주6만8010주취득”,http://www.newsway.co.kr/news/view?tp=1&ud=2020040215515274546
2117,2020-04-03,대웅제약위식도역류질환치료제DWP14012임상3상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=382875
2118,2020-04-03,일양약품대웅제약모두상승세로특히일양약품매수세쏟아지며3상승,http://www.econonews.co.kr/news/articleView.html?idxno=114901
2119,2020-04-03,공시국민연금대웅제약지분율819로감소,http://www.newsway.co.kr/news/view?tp=1&ud=2020040311102790487
2120,2020-04-03,FDA모든라니티딘시장퇴출대웅제약어쩌나,http://theviewers.co.kr/View.aspx?No=801414
2121,2020-04-03,대웅제약효자항궤양제판매재개추진전승호안전성입증이열쇠,http://www.businesspost.co.kr/BP?command=article_view&num=172021
2122,2020-04-06,제약사급여유한종근당한미광동대웅제약順,http://www.dailymedi.com/detail.php?number=854786&thread=22r05
2123,2020-04-06,대웅제약1일1회복용치매약메만틴서방정개발,http://www.dailypharm.com/Users/News/NewsView.html?ID=263508&REFERER=NP
2124,2020-04-06,2020PowerProduct대웅제약나보타,http://www.bosa.co.kr/news/articleView.html?idxno=2124707
2125,2020-04-06,대웅제약메만틴해외수출용임상돌입자체개발진행,http://medipana.com/news/news_viewer.asp?NewsNum=255146&MainKind=A&NewsKind=5&vCount=12&vKind=1
2126,2020-04-06,대웅제약치매치료제메만틴서방정임상1상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=383062
2127,2020-04-06,일양약품대웅제약모두상승세로일양약품3상승이어대웅제약4상승,http://www.econonews.co.kr/news/articleView.html?idxno=115169
2128,2020-04-06,보톡스기술유출갈등조사요구하는정부버티는대웅제약,http://health.chosun.com/site/data/html_dir/2020/04/06/2020040603368.html
2129,2020-04-07,도네페질에이어메만틴까지대웅제약치매치료제개발속도,http://www.mdtoday.co.kr/mdtoday/index.html?no=383187
2130,2020-04-07,의사들이꼽은디지털마케팅잘하는기업은한미약품대웅제약에이치케이이노엔,http://www.etoday.co.kr/news/section/newsview.php?idxno=1880606
2131,2020-04-07,일양약품대웅제약희비엇갈려일양약품3하락반해대웅제약3상승,http://www.econonews.co.kr/news/articleView.html?idxno=115360
2132,2020-04-07,대웅제약전일대비51상승최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004070320&t=NN
2133,2020-04-08,디지털마케팅활동잘하고있는회사는한미약품대웅제약HK이노엔GSK순,http://medicalworldnews.co.kr/news/view.php?idx=1510935051
2134,2020-04-08,일양약품대웅제약모두하락부진특히일양약품2하락,http://www.econonews.co.kr/news/articleView.html?idxno=115510
2135,2020-04-10,대웅제약과도한소송비용지출목표가↓NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01443206625734808
2136,2020-04-10,대웅제약코로나19로영업타격소송비용까지목표가↓,http://www.asiatoday.co.kr/view.php?key=20200410010006111
2137,2020-04-10,HotLine대웅제약소송및코로나19영향에실적부진할것목표가↓,http://news.mk.co.kr/newsRead.php?no=375868&year=2020
2138,2020-04-10,하이로우과도한소송비용대웅제약1분기도실적부진NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020041008505610459
2139,2020-04-10,대웅제약코로나19소송비용악재1분기실적부진NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1882194
2140,2020-04-10,1분기실적컨센서스하회예상NH투자證대웅제약목표가↓,http://www.whitepaper.co.kr/news/articleView.html?idxno=191954
2141,2020-04-10,리포트브리핑대웅제약과도한소송비용지출로부진한실적목표가110000원NH투자증권,http://www.newspim.com/news/view/20200410000104
2142,2020-04-10,대웅제약코로나영향등으로1분기실적부진목표가↓,http://www.seoulfn.com/news/articleView.html?idxno=378736
2143,2020-04-10,NH투자증권대웅제약과도한소송비지출로실적↓목표가하향,http://www.straightnews.co.kr/news/articleView.html?idxno=71810
2144,2020-04-10,증시현황대웅제약과도한소송비용지출부진한실적하반기반등,http://www.newscape.co.kr/news/view.php?idx=45049
2145,2020-04-10,특징주대웅제약과도한소송비용1Q20실적부진전망,http://www.sisaon.co.kr/news/articleView.html?idxno=111511
2146,2020-04-10,제약세금1위유한양행종근당대웅제약순,https://www.taxwatch.co.kr/article/tax/2020/04/10/0002/naver
2147,2020-04-10,대웅제약과도한소송비용지출과우루사매출감소실적부진전망,http://www.sisafocus.co.kr/news/articleView.html?idxno=236815
2148,2020-04-10,대웅제약120억원의소송비용반영으로1분기부진한실적예상”,http://www.wikitree.co.kr/articles/522622
2149,2020-04-13,10대제약사대표약품매출호조대웅제약비처방우루사24감소,http://www.consumernews.co.kr/news/articleView.html?idxno=603858
2150,2020-04-13,대웅제약소송비용매출감소목표가하향SK,http://www.ebn.co.kr/news/view/1424015/?sc=naver
2151,2020-04-13,리포트브리핑대웅제약나보타소송비용은2분기부터축소전망목표가140000원SK증권,http://www.newspim.com/news/view/20200413000094
2152,2020-04-13,대웅제약파트너아박타10분만에코로나판정진단키트개발추진,https://www.theguru.co.kr/news/article.html?no=10110
2153,2020-04-13,메디톡스대웅제약과의ITC소송노이즈는언제든주가폭락으로”,http://www.wikitree.co.kr/articles/523108
2154,2020-04-13,대웅제약2분기전문의약품매출회복가능소송비용도감소예상,http://www.businesspost.co.kr/BP?command=article_view&num=173550
2155,2020-04-13,3중고대웅제약알비스ETC매출감소에소송비용증가,http://www.inews24.com/view/1257547
2156,2020-04-14,KBiz리뷰대웅제약파트너아박타간편코로나진단키트개발추진4월14일,https://www.theguru.co.kr/news/article.html?no=10124
2157,2020-04-14,대웅제약목표가29하향소송불확실성해소필요키움證,http://news.mt.co.kr/mtview.php?no=2020041408063626990
2158,2020-04-14,키움證대웅제약소송이쥔주가방향,http://www.newsis.com/view/?id=NISX20200414_0000993362&cID=10401&pID=10400
2159,2020-04-14,대웅제약1분기실적시장기대치밑돌것목표가↓”,https://www.sedaily.com/NewsView/1Z1GYXKV9C
2160,2020-04-14,대웅제약1분기컨센서스하회가능성소송결과주목”키움,http://www.etoday.co.kr/news/section/newsview.php?idxno=1883399
2161,2020-04-14,대웅제약목표주가낮아져코로나19로영업위축에소송비용도늘어,http://www.businesspost.co.kr/BP?command=article_view&num=173709
2162,2020-04-14,키움증권대웅제약나보타관련소송실적투자심리발목,http://www.kpinews.co.kr/news/articleView.html?idxno=114719
2163,2020-04-14,2020파워기업대웅제약2025년까지100개국에수출한다,http://moneys.mt.co.kr/news/mwView.php?no=2020032714538013023
2164,2020-04-14,대웅제약코로나19영향과소송비용증가로1분기실적은기대이하”,http://www.wikitree.co.kr/articles/523452
2165,2020-04-14,리포트브리핑대웅제약소송불확실성해소만이해답목표가120000원키움증권,http://www.newspim.com/news/view/20200414000372
2166,2020-04-14,파스퇴르硏대웅제약코로나19치료제임상착수,https://www.zdnet.co.kr/view/?no=20200414101240
2167,2020-04-14,대웅제약347상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041401403.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2168,2020-04-14,대웅제약그룹한국파스퇴르연구소와코로나19치료제개발나서,http://news.mk.co.kr/newsRead.php?no=390276&year=2020
2169,2020-04-14,대웅제약파스퇴르연구소와구충제로코로나19임상한다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020041410375588650
2170,2020-04-14,대웅제약전일대비515상승중최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004140198&t=NN
2171,2020-04-14,대웅제약5이상상승소송불확실성해소만이해답키움증권BUY상향,https://www.hankyung.com/finance/article/202004148615L
2172,2020-04-14,대웅제약988VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041401483.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2173,2020-04-14,키움증권대웅제약목표주가하향나보타관련소송결과주목,http://www.m-i.kr/news/articleView.html?idxno=701779
2174,2020-04-14,대웅제약알비스판매중단여파1Q영업익하락,http://www.press9.kr/news/articleView.html?idxno=44306
2175,2020-04-14,파스퇴르硏대웅제약코로나19치료제임상시험에맞손,http://www.dt.co.kr/contents.html?article_no=2020041402109931731001&ref=naver
2176,2020-04-14,특징주대웅제약렘데시비르대비40배항바이러스효과니클로사마이드코로나19개발부각,http://www.etoday.co.kr/news/section/newsview.php?idxno=1883518
2177,2020-04-14,시황분석대웅제약전일대비568상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004141101354363edd30d18f7_45
2178,2020-04-14,한국파스퇴르대웅제약구충제코로나19치료제로개발,http://moneys.mt.co.kr/news/mwView.php?no=2020041410168043124
2179,2020-04-14,강세토픽2020년임상예정제약바이오테마대웅제약2671젬백스696,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041402137.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2180,2020-04-14,대웅제약코로나19치료제임상시험준비소식에주가강세,http://www.whitepaper.co.kr/news/articleView.html?idxno=192136
2181,2020-04-14,부광약품대웅제약제약주갑작스런급등부광약품24급등이어대웅제약13급등,http://www.econonews.co.kr/news/articleView.html?idxno=116358
2182,2020-04-14,파스퇴르대웅코로나19치료제임상준비대웅제약주가꿈틀,http://sports.hankooki.com/lpage/economy/202004/sp20200414135236137020.htm
2183,2020-04-14,대웅제약신풍제약희비엇갈려대웅제약11급등반해신풍제약12폭락,http://www.econonews.co.kr/news/articleView.html?idxno=116363
2184,2020-04-14,대웅제약대웅주가장중급등구충제성분코로나19치료제개발,http://www.businesspost.co.kr/BP?command=article_view&num=173796
2185,2020-04-14,강세토픽치매치료테마대웅제약936젬백스591,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041402641.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2186,2020-04-14,14일기관순매도Top10KODEX200선물인버스2X1782억대웅제약72억하나금융지주40억KODEX골드선물H27억기관순매도나서코스닥시장에서는에스티팜압타바이오CJ,http://www.fintechpost.co.kr/news/articleView.html?idxno=109400
2187,2020-04-15,시황분석대웅제약전일대비1146상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004150932272731edd30fbd99_45
2188,2020-04-16,대웅제약5이상상승소송불확실성해소만이해답키움증권BUY상향,https://www.hankyung.com/finance/article/202004163130L
2189,2020-04-16,대웅제약708상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/16/2020041600892.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2190,2020-04-16,시황분석대웅제약전일대비519상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004160926425649edd308ffdd_45
2191,2020-04-16,대웅제약신사업확장속도낸다,http://newsclaim.co.kr/View.aspx?No=810895
2192,2020-04-16,대웅제약건강기능식품군강화간장눈등효과6종출시,https://www.sedaily.com/NewsView/1Z1HXCCP8K
2193,2020-04-16,대웅제약건강기능식품6종출시,http://www.newsis.com/view/?id=NISX20200416_0000996066&cID=13001&pID=13000
2194,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.econovill.com/news/articleView.html?idxno=393443
2195,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.segye.com/content/html/2020/04/16/20200416511320.html?OutUrl=naver
2196,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.metroseoul.co.kr/article/20200416500117
2197,2020-04-16,대웅제약생활습관맞춤건강기능식품6종출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=83553
2198,2020-04-16,대웅제약에너씨슬등건강기능식품6종출시,http://www.kpinews.co.kr/news/articleView.html?idxno=114829
2199,2020-04-16,대웅제약건강기능식품6종출시,http://www.newspim.com/news/view/20200416000460
2200,2020-04-16,대웅제약건강기능식품사업확장건기식6종출시,http://www.viva100.com/main/view.php?key=20200416010005956
2201,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.etnews.com/20200416000097
2202,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,https://www.fetv.co.kr/news/article.html?no=52741
2203,2020-04-16,대웅제약건강기능식품6종출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60745
2204,2020-04-16,대웅제약예방관리필수간장눈혈행특화건기식6종출시,http://theviewers.co.kr/View.aspx?No=810921
2205,2020-04-16,대웅제약건강기능식품6종으로新사업확장,http://health.chosun.com/site/data/html_dir/2020/04/16/2020041601590.html
2206,2020-04-16,대웅제약건강기능식품으로사업영역확대,http://www.koreastocknews.com/news/articleView.html?idxno=52889
2207,2020-04-16,대웅제약고품질건강기능식품6종출시신사업확장나서,http://www.pressm.kr/news/articleView.html?idxno=29020
2208,2020-04-16,대웅제약건강기능식품6종출시헬스케어사업확장나선다,http://www.greened.kr/news/articleView.html?idxno=247317
2209,2020-04-16,대웅제약건강기능식품6종출시간장눈건강을위한고품질제품라인업구성,http://www.paxetv.com/news/articleView.html?idxno=90383
2210,2020-04-16,대웅제약건강기능식품6종으로신사업확장,http://www.fnnews.com/news/202004161052298653
2211,2020-04-16,대웅제약간기능개선등건기식6종출시신사업확장,http://moneys.mt.co.kr/news/mwView.php?no=2020041610488094545
2212,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.edaily.co.kr/news/newspath.asp?newsid=02522326625736776
2213,2020-04-16,대웅제약신사업확장건기식6종출시,http://daily.hankooki.com/lpage/industry/202004/dh20200416105957148390.htm
2214,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.thepublic.kr/news/newsview.php?ncode=1065576780641047
2215,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.segyebiz.com/newsView/20200416511874?OutUrl=naver
2216,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.bosa.co.kr/news/articleView.html?idxno=2125317
2217,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.mdtoday.co.kr/mdtoday/index.html?no=384124
2218,2020-04-16,대웅제약증상별맞춤건강기능식품6종출시,http://www.insightkorea.co.kr/news/articleView.html?idxno=79133
2219,2020-04-16,대웅제약건강기능식품6종출시사업영역확장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1884295
2220,2020-04-16,대웅제약맞춤건기식6종출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065576789158594
2221,2020-04-16,대웅제약가정의달앞두고6종건기식승부수,http://www.press9.kr/news/articleView.html?idxno=44321
2222,2020-04-16,대웅제약소비자생활습관맞춤건기식6종출시신사업확장나선다,http://www.ekn.kr/news/article.html?no=494182
2223,2020-04-16,대웅제약신사업확장건기식품6종출시,http://www.medical-tribune.co.kr/news/articleView.html?idxno=91879
2224,2020-04-16,대웅제약간장눈혈행챙기는건강기능식품6종출시,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003941289
2225,2020-04-16,대웅제약신사업영역확장나서건강기능식품6종출시,http://medipana.com/news/news_viewer.asp?NewsNum=255612&MainKind=A&NewsKind=5&vCount=12&vKind=1
2226,2020-04-16,건강기능식품강화나선대웅제약에너씨슬등신제품6종출시,http://www.donga.com/news/article/all/20200416/100685750/1
2227,2020-04-16,대웅제약건강기능식품6종출시사업영역확대,http://news.mt.co.kr/mtview.php?no=2020041611451835267
2228,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://newsbrite.net/135853
2229,2020-04-16,대웅제약간장눈혈행등건강기능식품6종출시,http://www.asiatoday.co.kr/view.php?key=20200416010009745
2230,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.businesskorea.co.kr/news/articleView.html?idxno=44282
2231,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243126
2232,2020-04-16,에너씨슬세노메가출시대웅제약건식분야눈독,http://www.whosaeng.com/117112
2233,2020-04-16,대웅제약건강기능식품6종출시신사업확대에속도,http://www.ajunews.com/view/20200416123911321
2234,2020-04-16,부광약품대웅제약제약주상승에급등까지부광약품6급등이어대웅제약2상승,http://www.econonews.co.kr/news/articleView.html?idxno=116601
2235,2020-04-16,대웅제약신풍제약희비엇갈려대웅제약2상승반해신풍제약12폭락,http://www.econonews.co.kr/news/articleView.html?idxno=116602
2236,2020-04-16,대웅제약건기식6종출시신사업확장나선다,http://www.dailysmart.co.kr/news/articleView.html?idxno=25159
2237,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.ceoscoredaily.com/news/article.html?no=68531
2238,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.nbnnews.co.kr/news/articleView.html?idxno=386108
2239,2020-04-16,대웅제약건강기능식품6종출시,http://www.ebn.co.kr/news/view/1429783/?sc=naver
2240,2020-04-16,대웅제약건강기능식품6종출시신사업확장추진,http://www.enewstoday.co.kr/news/articleView.html?idxno=1381760
2241,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.pharmnews.com/news/articleView.html?idxno=100315
2242,2020-04-16,대웅제약신개념건강기능식품6종선뵈,http://www.g-enews.com/ko-kr/news/article/news_all/20200416140217529951638db705_1/article.html
2243,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.m-i.kr/news/articleView.html?idxno=702451
2244,2020-04-16,대웅제약맞춤형건강기능식품6종출시,http://www.finomy.com/news/articleView.html?idxno=77265
2245,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.mediapen.com/news/view/518153
2246,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.pinpointnews.co.kr/view.php?ud=202004161425189054f090c8dbcb_45
2247,2020-04-16,대웅제약고품질건강기능식품6종내놓으며신사업진출,http://www.businesspost.co.kr/BP?command=article_view&num=174040
2248,2020-04-16,대웅제약건강기능식품6종출시신사업확장,https://www.dailian.co.kr/news/view/884559?sc=Naver
2249,2020-04-16,대웅제약건강기능식품으로사업영역확대소비자증상별제품6종출시,http://kpenews.com/View.aspx?No=811400
2250,2020-04-16,뉴스투데이L대웅제약증상별맞춤건기식6종출시로신사업확장,https://www.news2day.co.kr/151327
2251,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.upinews.kr/newsView/upi202004160114
2252,2020-04-16,대웅제약건강기능식품6종출시신사업확대,http://www.dailymedi.com/detail.php?number=855202&thread=22r05
2253,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.sporbiz.co.kr/news/articleView.html?idxno=431114
2254,2020-04-16,대웅제약건강기능식품6종출시신사업확장나서,https://jhealthmedia.joins.com/article/article_view.asp?pno=21661
2255,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.lawissue.co.kr/view.php?ud=202004161557456753204ead0791_12
2256,2020-04-16,대웅제약신사업확장나선다소비자생활습관과증상별맞춤건강기능식품6종출시,http://www.updownnews.co.kr/news/articleView.html?idxno=217643
2257,2020-04-16,대웅제약건강기능식품6종출시,http://www.joseilbo.com/news/news_read.php?uid=396322&class=27&grp=
2258,2020-04-16,대웅제약간장눈혈행챙기는건강기능식품6종출시,http://www.100ssd.co.kr/news/articleView.html?idxno=68265
2259,2020-04-16,코로나에울고웃고대웅제약부광약품주가고공행진,http://www.whitepaper.co.kr/news/articleView.html?idxno=192228
2260,2020-04-16,대웅제약건기식신제품출시카테고리확대,http://www.meconomynews.com/news/articleView.html?idxno=40401
2261,2020-04-16,대웅제약건강기능식품사업확장,http://www.seoulfn.com/news/articleView.html?idxno=379457
2262,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.wsobi.com/news/articleView.html?idxno=95513
2263,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.thevaluenews.co.kr/news/view.php?idx=159205
2264,2020-04-16,대웅제약간장눈등건강기능식품6종라인업출시,https://www.kpanews.co.kr/article/show.asp?idx=212569&category=D
2265,2020-04-17,대웅제약신풍제약희비엇갈려대웅제약4하락반해신풍제약8급등,http://www.econonews.co.kr/news/articleView.html?idxno=116740
2266,2020-04-17,대웅제약건기식사업확장신제품6종출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1270730
2267,2020-04-17,RD투자한미약품유한양행녹십자종근당대웅제약순,http://www.wikileaks-kr.org/news/articleView.html?idxno=83702
2268,2020-04-17,대웅제약맞춤건강기능식품6종출시신사업확장본격화,http://www.newslock.co.kr/news/articleView.html?idxno=27263
2269,2020-04-18,니클로사마이드최대수혜주대웅제약외국인매수전환땐상승폭발가능성,http://www.thekpm.com/view.php?ud=202004180701286922861beb2d9d_17
2270,2020-04-18,대웅제약나보타코로나19로유럽발매지연,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1079849
2271,2020-04-19,전승호대웅제약인도네시아할랄인증앞세워이슬람권으로간다,http://www.businesspost.co.kr/BP?command=article_view&num=174394
2272,2020-04-19,대웅제약과소송에도영향,https://www.hankyung.com/it/article/2020041999261
2273,2020-04-20,대웅제약20이상상승소송불확실성해소만이해답키움증권BUY상향,https://www.hankyung.com/finance/article/202004200636L
2274,2020-04-20,특징주대웅제약메디톡스제재소식에급등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004200086&t=NN
2275,2020-04-20,특징주국내1위보톡스메디톡신퇴출에휴젤대웅제약급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1885321
2276,2020-04-20,특징주대웅제약휴젤메디톡신품목허가취소반사이익기대감에강세,http://news.mk.co.kr/newsRead.php?no=408743&year=2020
2277,2020-04-20,대웅제약신풍제약희비엇갈려대웅제약갑작스런12급등반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=116957
2278,2020-04-20,특징주대웅제약휴젤메디톡스판매중지에급등,http://www.inews24.com/view/1258925
2279,2020-04-20,대웅제약15강세메디톡스와분쟁서유리한고지전망,http://news.mt.co.kr/mtview.php?no=2020042008345252245
2280,2020-04-20,시황분석대웅제약전일대비1579상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004200924478738edd30b65ed_45
2281,2020-04-20,특징주대웅제약메디톡신판매중지반사이익기대감에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020042009258088439
2282,2020-04-20,헬스케어주관심집중휴젤엔지켐생명과학대웅제약강세,http://www.g-enews.com/ko-kr/news/article/news_all/202004200925497741edf69f862c_1/article.html
2283,2020-04-20,특징주대웅제약휴젤메디톡신품목허가취소반사이익기대감에↑,http://www.viva100.com/main/view.php?key=20200420010006974
2284,2020-04-20,메디톡스下경쟁사대웅제약휴젤은두자릿수상승,http://news.mt.co.kr/mtview.php?no=2020042009333920363
2285,2020-04-20,코스피코스닥동반상승출발대웅제약네이처셀휴젤에넥스급등,http://www.businesspost.co.kr/BP?command=article_view&num=174469
2286,2020-04-20,TF특징주대웅제약메디톡스톡신제품허가취소소식에급등,http://news.tf.co.kr/read/economy/1790644.htm
2287,2020-04-20,특징주대웅제약보톡스경쟁사메디톡스악재소식에급등,http://www.asiatoday.co.kr/view.php?key=20200420010011352
2288,2020-04-20,주식대웅제약1244휴젤1842급등메디톡신품목허가취소에반사이익기대감부각,http://www.ggilbo.com/news/articleView.html?idxno=761832
2289,2020-04-20,대웅제약상승흐름전일대비134최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004200150&t=NN
2290,2020-04-20,메디톡스메디톡신이슈속장중급락vs휴젤대웅제약은장중급등,http://www.choicenews.co.kr/news/articleView.html?idxno=70114
2291,2020-04-20,메디톡스판매중지명령에하한가대웅제약등경쟁사급등,https://biz.chosun.com/site/data/html_dir/2020/04/20/2020042001583.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2292,2020-04-20,메디톡스메디톡신허가취소가능성휴젤대웅제약웃는다,https://www.news1.kr/articles/?3912049
2293,2020-04-20,TF특징주메디톡스제품판매중단에급락휴젤대웅제약반사이익,http://news.tf.co.kr/read/economy/1790666.htm
2294,2020-04-20,메디톡스주가제조금지에초반하한가경쟁사휴젤대웅제약은급등,http://www.businesspost.co.kr/BP?command=article_view&num=174489
2295,2020-04-20,허가취소메디톡스下반사이익기대감에대웅제약휴젤급등,http://news.mt.co.kr/mtview.php?no=2020042014441104893
2296,2020-04-20,대웅제약과소송에검찰식약처압박까지메디톡스에무슨일이,http://www.opinionnews.co.kr/news/articleView.html?idxno=32618
2297,2020-04-20,보톡스株희비메디톡스하한가휴젤대웅제약급등,http://www.edaily.co.kr/news/newspath.asp?newsid=04040966625738088
2298,2020-04-20,특징주메디톡스제품판매중지소식에하한가휴젤대웅제약강세,http://www.seoulwire.com/news/articleView.html?idxno=408534
2299,2020-04-20,메디톡스메디톡신악재에하한가휴젤대웅제약반사이익종합,https://www.news1.kr/articles/?3912696
2300,2020-04-20,메디톡스추락에경쟁사휴젤대웅제약껑충,https://www.hankyung.com/finance/article/202004202273i
2301,2020-04-20,메디톡스판매중단위기대웅제약휴젤반사익보나,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004200341&t=NNv
2302,2020-04-20,휴젤보톡스경쟁반사이익대웅제약도매출향상기대,https://www.hankyung.com/it/article/2020042028791
2303,2020-04-20,메디톡스외국인매수에도하한가충격왜경쟁사인대웅제약휴젤주가는폭등,http://www.smartfn.co.kr/view.php?ud=202004201855491661861beb2d9d_46
2304,2020-04-21,메디톡스잇단악재휴젤대웅제약휴온스호재,http://www.dailymedi.com/detail.php?number=855328&thread=22r05
2305,2020-04-21,이슈돋보기보톡스3중고겪는메디톡스대웅제약과소송향방은,http://www.asiatoday.co.kr/view.php?key=20200420010011912
2306,2020-04-21,빅데이터MSI시장심리톱5CJ현대로템대웅제약SK포스코,http://www.newsis.com/view/?id=NISX20200421_0001000385&cID=10401&pID=10400
2307,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전붙이세요”,http://daily.hankooki.com/lpage/industry/202004/dh20200421091907148390.htm
2308,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.viva100.com/main/view.php?key=20200421010007493
2309,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.fnnews.com/news/202004210923346165
2310,2020-04-21,대웅제약신풍제약희비엇갈려대웅제약3하락반해신풍제약소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=117153
2311,2020-04-21,대웅제약”여드름짜기전미리붙이세요”,http://newsclaim.co.kr/View.aspx?No=814280
2312,2020-04-21,대웅제약여드름에붙이는이지덤뷰티릴리프출시,http://www.m-i.kr/news/articleView.html?idxno=703710
2313,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전붙이세요”,https://www.fetv.co.kr/news/article.html?no=53011
2314,2020-04-21,대웅제약여드름진정제패치이지덤뷰티릴리프시판,http://www.g-enews.com/ko-kr/news/article/news_all/20200421093119349351638db705_1/article.html
2315,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.greened.kr/news/articleView.html?idxno=248003
2316,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572936656693
2317,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,https://www.sedaily.com/NewsView/1Z1K7KPEQY
2318,2020-04-21,티안나게여드름케어대웅제약새로운이지덤뷰티릴리프패치출시,http://theviewers.co.kr/View.aspx?No=814368
2319,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.newslock.co.kr/news/articleView.html?idxno=27346
2320,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.dailymedi.com/detail.php?number=855338&thread=22r05
2321,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.ekn.kr/news/article.html?no=495014
2322,2020-04-21,대웅제약여드름짜기전붙이세요,http://www.bosa.co.kr/news/articleView.html?idxno=2125566
2323,2020-04-21,대웅제약여드름짜기전붙이는패치출시,http://www.newsis.com/view/?id=NISX20200421_0001000573&cID=13001&pID=13000
2324,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://moneys.mt.co.kr/news/mwView.php?no=2020042110018059081
2325,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.press9.kr/news/articleView.html?idxno=44367
2326,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60807
2327,2020-04-21,대웅제약여드름짜기전에붙이는이지덤뷰티릴리프출시,http://www.kpinews.co.kr/news/articleView.html?idxno=115094
2328,2020-04-21,리포트브리핑대웅제약이벤트가주도하는상반기목표가140000원DB금융투자,http://www.newspim.com/news/view/20200421000350
2329,2020-04-21,여드름짜지말고붙이세요대웅제약패치출시,http://news.mt.co.kr/mtview.php?no=2020042110213598412
2330,2020-04-21,대웅제약여드름짜기전에붙이는이지덤뷰티릴리프출시,http://www.thepublic.kr/news/newsview.php?ncode=1065575137118496
2331,2020-04-21,대웅제약여드름짜기전붙이는이지덤뷰티릴리프출시,http://medipana.com/news/news_viewer.asp?NewsNum=255839&MainKind=A&NewsKind=5&vCount=12&vKind=1
2332,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://sports.hankooki.com/lpage/economy/202004/sp20200421104058136980.htm
2333,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=384511
2334,2020-04-21,대웅제약여드름짜기전붙이는이지덤뷰티릴리프선봬,http://www.insightkorea.co.kr/news/articleView.html?idxno=79281
2335,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.100ssd.co.kr/news/articleView.html?idxno=68346
2336,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=25343
2337,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.segyebiz.com/newsView/20200421510964?OutUrl=naver
2338,2020-04-21,대웅제약보톡스시장강자로급부상하나,http://www.m-i.kr/news/articleView.html?idxno=703785
2339,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전미리붙이세요,http://www.nbnnews.co.kr/news/articleView.html?idxno=387077
2340,2020-04-21,대웅제약이지덤뷰티릴리프출시”여드름짜기전미리붙이세요”,http://newsbrite.net/136017
2341,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜지말고붙이세요,http://www.metroseoul.co.kr/article/20200421500227
2342,2020-04-21,대웅제약ITC소송불확실성해소기대”,http://www.wikitree.co.kr/articles/525534
2343,2020-04-21,오늘의신상품대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.econovill.com/news/articleView.html?idxno=393988
2344,2020-04-21,대웅제약여드름진정돕는이지덤뷰티릴리프출시,http://news.mk.co.kr/newsRead.php?no=415114&year=2020
2345,2020-04-21,메디톡스제보자위법증언자대웅제약출신말고도많다,http://www.upinews.kr/newsView/upi202004210065
2346,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.asiatoday.co.kr/view.php?key=20200421010012634
2347,2020-04-21,대웅제약여드름패치이지덤출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=84047
2348,2020-04-21,신상품대웅제약이지덤여드름패치,http://www.seoulfn.com/news/articleView.html?idxno=379978
2349,2020-04-21,대웅제약여드름진정도움이지덤뷰티릴리프선보여,http://www.pressm.kr/news/articleView.html?idxno=29168
2350,2020-04-21,대웅제약이지덤뷰티릴리프출시”여드름짜기전미리붙이세요”,http://www.lawissue.co.kr/view.php?ud=20200421162446169204ead0791_12
2351,2020-04-21,시황분석대웅제약전일대비573하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004211631324078edd300bd09_45
2352,2020-04-21,대웅제약여드름짜기전붙이는패치내놔,http://www.economytalk.kr/news/articleView.html?idxno=205589
2353,2020-04-21,대웅제약여드름진정돕는이지덤뷰티릴리프출시,http://kormedi.com/?p=1315811
2354,2020-04-21,뉴스투데이L대웅제약여드름진정패치이지덤뷰티릴리프출시,https://www.news2day.co.kr/151573
2355,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.donga.com/news/article/all/20200421/100750389/1
2356,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전미리붙이세요,http://www.businesskorea.co.kr/news/articleView.html?idxno=44564
2357,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.k-health.com/news/articleView.html?idxno=48152
2358,2020-04-22,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.thefirstmedia.net/news/articleView.html?idxno=57173
2359,2020-04-22,제약대웅제약난치병질환신약에집중올해부터결실기대,http://news.mk.co.kr/newsRead.php?no=416980&year=2020
2360,2020-04-22,우정바이오이종욱전대웅제약CEO영입드림팀완성,http://www.bosa.co.kr/news/articleView.html?idxno=2125608
2361,2020-04-22,종목DB금융투자대웅제약소송비용감소불확실성해소기대매수”,http://www.sporbiz.co.kr/news/articleView.html?idxno=432593
2362,2020-04-22,대웅제약신풍제약희비엇갈려대웅제약7급등반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=117350
2363,2020-04-22,대웅제약1075상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/22/2020042200989.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2364,2020-04-22,대웅제약5이상상승이벤트가주도하는상반기DB금융투자BUY유지,https://www.hankyung.com/finance/article/202004226996L
2365,2020-04-22,대웅제약1215VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/22/2020042201117.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2366,2020-04-22,시황분석대웅제약전일대비1963상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004220952486424edd3046faa_45
2367,2020-04-22,대웅제약전일대비1542상승중최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004220143&t=NN
2368,2020-04-22,주식대웅제약1495눈부신상승세메디톡스추락에반사이익계속될까,http://www.ggilbo.com/news/articleView.html?idxno=762541
2369,2020-04-22,대웅대웅제약주가초반급등코로나19치료효과약물보유,http://www.businesspost.co.kr/BP?command=article_view&num=174900
2370,2020-04-22,대웅제약코로나19수혜주주목에주가상승특징주,http://www.kukinews.com/news/article.html?no=779756
2371,2020-04-22,대웅제약메디톡스와균주소송의불확실성을올해해소가능,http://www.businesspost.co.kr/BP?command=article_view&num=174939
2372,2020-04-22,대웅제약나보타에쏠리는눈국내보톡스시장재편될까,http://www.opinionnews.co.kr/news/articleView.html?idxno=32731
2373,2020-04-22,메디톡스대웅제약과의균주제조기술도용소송끝나지않았다”,http://www.pinpointnews.co.kr/view.php?ud=202004221720048585f090c8dbcb_45
2374,2020-04-23,대웅제약신풍제약모두하락부진대웅제약1낙폭이어신풍제약2낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=117469
2375,2020-04-23,갑질회장윤재승떠나니대웅제약1조클럽가입1Q성적표는,http://www.inews24.com/view/1260076
2376,2020-04-23,시황분석대웅제약전일대비216하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004231633281904edd30908ea_45
2377,2020-04-24,대웅제약1013VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/24/2020042400903.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2378,2020-04-24,대웅제약5이상상승이벤트가주도하는상반기DB금융투자BUY유지,https://www.hankyung.com/finance/article/202004245462L
2379,2020-04-24,특징주대웅제약125000원24일9시20분장시작대비965상승,http://www.getnews.co.kr/view.php?ud=202004240921454262c20b972990_16
2380,2020-04-24,대웅제약신풍제약희비엇갈려대웅제약3상승반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=117588
2381,2020-04-24,2020제약RD대웅제약희귀난치성질환치료신약개발에역량집중,http://daily.hankooki.com/lpage/column/202004/dh20200424100010148550.htm?s_ref=nv
2382,2020-04-24,대웅제약264상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/24/2020042402240.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2383,2020-04-24,시황분석대웅제약전일대비088하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=20200424163930195edd3032c8b_45
2384,2020-04-24,전승호대웅제약코로나19치료제로연구개발능력증명하고싶다,http://www.businesspost.co.kr/BP?command=article_view&num=175392
2385,2020-04-26,대웅제약메디톡스판매금지코로나치료제개발로승승장구,http://www.mediapen.com/news/view/520616
2386,2020-04-27,대웅제약신풍제약모두상승세로대웅제약하락수렁벗어나나,http://www.econonews.co.kr/news/articleView.html?idxno=117971
2387,2020-04-28,대웅제약신풍제약모두하락부진대웅제약하락이어신풍제약가파른하락세로5하락,http://www.econonews.co.kr/news/articleView.html?idxno=118093
2388,2020-04-29,모사프리드후발주자에문열어준대웅제약성공할까,http://www.dailypharm.com/Users/News/NewsView.html?ID=264171&REFERER=NP
2389,2020-04-29,대웅제약신풍제약모두하락부진대웅제약2하락이어신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=118283
2390,2020-04-29,대웅제약모사프리드서방정시장판도바꾸나,http://medipana.com/news/news_viewer.asp?NewsNum=256263&MainKind=A&NewsKind=5&vCount=12&vKind=1
2391,2020-04-29,안아파도약먹는다식약처대웅제약구취제거약일반의약품허가,http://theviewers.co.kr/View.aspx?No=832743
2392,2020-05-01,대웅제약모사프리드성분서방제제수탁생산확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=385474
2393,2020-05-04,대웅제약파트너아박타코로나진단키트개발속도,https://www.theguru.co.kr/news/article.html?no=10603
2394,2020-05-04,대웅제약신풍제약희비엇갈려대웅제약2하락반해신풍제약14급등,http://www.econonews.co.kr/news/articleView.html?idxno=118746
2395,2020-05-06,제약대웅제약임팩타민길어진집콕에부쩍약해진부모님비타민B어때요,http://news.mk.co.kr/newsRead.php?no=459670&year=2020
2396,2020-05-06,대웅제약연구개발에연간1천억투입,http://www.g-enews.com/ko-kr/news/article/news_all/20200504140425850951638db705_1/article.html
2397,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,https://www.fetv.co.kr/news/article.html?no=53855
2398,2020-05-06,대웅제약펙수프라잔3상임상데이터최초공개,http://newsclaim.co.kr/View.aspx?No=835169
2399,2020-05-06,대웅제약펙수프라잔임상3상데이터최초공개,http://medipana.com/news/news_viewer.asp?NewsNum=256388&MainKind=A&NewsKind=5&vCount=12&vKind=1
2400,2020-05-06,대웅제약 위식도역류질환치료제펙수프라잔 3상임상데이터최초공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=45279
2401,2020-05-06,대웅제약펙수프라잔3상임상데이터공개안전성확인”,http://www.ajunews.com/view/20200506091509021
2402,2020-05-06,신풍제약대웅제약희비엇갈려신풍제약갑작스런7급락반해대웅제약상승,http://www.econonews.co.kr/news/articleView.html?idxno=119040
2403,2020-05-06,대웅제약위식도역류치료제펙수프라잔3상데이터공개,http://www.press9.kr/news/articleView.html?idxno=44519
2404,2020-05-06,대웅제약역류성식도염신약펙수프라잔3상결과최초공개점막결손치료율99,https://www.sedaily.com/NewsView/1Z2N9EMLN3
2405,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상결과최초공개,http://www.ezyeconomy.com/news/articleView.html?idxno=100537
2406,2020-05-06,대웅제약차세대위식도역류질환치료제글로벌시장상업화속도,http://moneys.mt.co.kr/news/mwView.php?no=2020050609098052610
2407,2020-05-06,대웅제약펙수프라잔임상3상데이터공개,https://www.ebn.co.kr/news/view/1432242?sc=Naver
2408,2020-05-06,대웅제약위식도역류질환치료제임상3상서효과입증,http://news.mt.co.kr/mtview.php?no=2020050609173261143
2409,2020-05-06,대웅제약펙수프라잔3상데이터최초공개유효성안전성입증”,http://www.viva100.com/main/view.php?key=20200506010000947
2410,2020-05-06,대웅제약차세대위식도역류질환치료제펙수프라잔3상임상결과공개,http://www.donga.com/news/article/all/20200506/100921015/1
2411,2020-05-06,대웅제약위식도역류질환신약펙수프라잔임상3상결과발표,http://news.mk.co.kr/newsRead.php?no=460190&year=2020
2412,2020-05-06,대웅제약위식도역류질환신약3상데이터최초공개,http://www.newsis.com/view/?id=NISX20200506_0001014799&cID=13001&pID=13000
2413,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.fnnews.com/news/202005060933298471
2414,2020-05-06,대웅제약펙수프라잔3상데이터공개점막결손99치료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020050609331751887
2415,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=25917
2416,2020-05-06,대웅제약美소화기학회서펙수프라잔3상임상데이터최초공개,http://www.ekn.kr/news/article.html?no=497467
2417,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상공개,http://www.mediapen.com/news/view/522564
2418,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.lawissue.co.kr/view.php?ud=202005060941573191204ead0791_12
2419,2020-05-06,대웅제약펙수프라잔국내3상임상데이터공개,http://www.consumuch.com/news/articleView.html?idxno=48586
2420,2020-05-06,대웅제약위식도역류질환치료제로글로벌40조시장진출한다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=116978
2421,2020-05-06,대웅제약美소화기학회서우수포스터펙수프라잔3상임상데이터최초공개,http://www.pressm.kr/news/articleView.html?idxno=29452
2422,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.youthdaily.co.kr/news/article.html?no=36277
2423,2020-05-06,가슴쓰림개선효과톡톡대웅제약펙수프라잔3상임상데이터공개,http://theviewers.co.kr/View.aspx?No=835292
2424,2020-05-06,대웅제약위식도역류질환치료제3상임상데이터공개,http://www.ftoday.co.kr/news/articleView.html?idxno=201452
2425,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상서우수,http://www.econovill.com/news/articleView.html?idxno=395415
2426,2020-05-06,대웅제약위식도역류질환치료제임상3상결과공개,http://www.newspim.com/news/view/20200506000227
2427,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.medigatenews.com/news/2525772930
2428,2020-05-06,대웅제약펙수프라잔임상3상데이터공개,http://www.mhj21.com/129938
2429,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243843
2430,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.edaily.co.kr/news/newspath.asp?newsid=02181206625766296
2431,2020-05-06,대웅제약펙수프라잔3상임상데이터공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571858529785
2432,2020-05-06,대웅제약PCAB신약점막결손치료율99,http://www.monews.co.kr/news/articleView.html?idxno=210368
2433,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.thepublic.kr/news/newsview.php?ncode=1065575732247136
2434,2020-05-06,대웅제약위식도역류질환신약3상서효과입증”,http://www.newsway.co.kr/news/view?tp=1&ud=2020050610414095226
2435,2020-05-06,대웅제약미국소화기학회서펙수프라잔임상3상데이터공개,http://www.kpinews.co.kr/news/articleView.html?idxno=116098
2436,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상공개,http://sports.hankooki.com/lpage/economy/202005/sp20200506104605137020.htm?s_ref=nv
2437,2020-05-06,대웅제약위식도역류질환신약3상임상데이터공개,http://kormedi.com/?p=1316561
2438,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,https://www.fetv.co.kr/news/article.html?no=53899
2439,2020-05-06,대웅제약美소화기학회서펙수프라잔3상임상데이터최초공개,http://www.asiatoday.co.kr/view.php?key=20200506010001827
2440,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.g-enews.com/ko-kr/news/article/news_all/20200506110626434751638db705_1/article.html
2441,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.press9.kr/news/articleView.html?idxno=44528
2442,2020-05-06,대웅제약펙수프라잔치료효과안전성확인임상3상결과첫공개,http://www.metroseoul.co.kr/article/20200506500147
2443,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.mhj21.com/129952
2444,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.ekn.kr/news/article.html?no=497554
2445,2020-05-06,대웅제약40조위식도역류질환치료제시장공략,http://www.m-i.kr/news/articleView.html?idxno=707610
2446,2020-05-06,대웅제약올로맥스신규함량출시라인업4개로확대,http://www.metroseoul.co.kr/article/20200506500150
2447,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243855
2448,2020-05-06,대웅제약위식도역류질환치료제3상임상데이터발표,http://www.newsfc.co.kr/news/articleView.html?idxno=40915
2449,2020-05-06,대웅제약올로맥스환자위해고함량제품개발,http://newsclaim.co.kr/View.aspx?No=835546
2450,2020-05-06,대웅제약올로맥스신규함량출시4개라인업구축,http://medipana.com/news/news_viewer.asp?NewsNum=256417&MainKind=A&NewsKind=5&vCount=12&vKind=1
2451,2020-05-06,대웅제약올로맥스신규함량출시4개라인업구축,http://news.mt.co.kr/mtview.php?no=2020050611200081579
2452,2020-05-06,더강한효과대웅제약고혈압약올로맥스신규함량출시,http://theviewers.co.kr/View.aspx?No=835567
2453,2020-05-06,대웅제약올로맥스신규함량출시처방영역넓혀,http://www.insightkorea.co.kr/news/articleView.html?idxno=79662
2454,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.edaily.co.kr/news/newspath.asp?newsid=02712566625766296
2455,2020-05-06,대웅제약올로맥스새용량2종출시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1133508&REFERER=NP
2456,2020-05-06,대웅제약올메사르탄함량두배늘린올로맥스2종출시,http://inthenews.co.kr/article-48080/
2457,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.newsis.com/view/?id=NISX20200506_0001015154&cID=13001&pID=13000
2458,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1385421
2459,2020-05-06,대웅제약위식도역류질환신약의미국임상에서증상개선확인,http://www.businesspost.co.kr/BP?command=article_view&num=176702
2460,2020-05-06, 대웅제약위식도역류질환치료제펙수프라잔3상임상최초공개,http://www.newslock.co.kr/news/articleView.html?idxno=27683
2461,2020-05-06,대웅제약올로맥스2개신규제형추가,http://www.whosaeng.com/117528
2462,2020-05-06,대웅제약펙수프라잔3상임상데이터최초공개,http://www.bosa.co.kr/news/articleView.html?idxno=2126272
2463,2020-05-06,대웅제약소화기신약펙수프라잔3상결과첫공개,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1133513&REFERER=NP
2464,2020-05-06,4가지라인업구축대웅제약올로맥스신규함량출시로처방영역확대,http://www.koreaittimes.com/news/articleView.html?idxno=97290
2465,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.joseilbo.com/news/news_read.php?uid=397457&class=27&grp=
2466,2020-05-06,대웅제약PCAB신약펙수프라잔3상공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1080372
2467,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.businesskorea.co.kr/news/articleView.html?idxno=45308
2468,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.bosa.co.kr/news/articleView.html?idxno=2126282
2469,2020-05-06,대웅제약펙수프라잔내시경치료증상개선에효과,http://www.finomy.com/news/articleView.html?idxno=77765
2470,2020-05-06,대웅제약올로맥스처방확대신규함량출시,http://www.viva100.com/main/view.php?key=20200506010001135
2471,2020-05-06,대웅제약고혈압고지혈증치료복합제올로맥스신규용량출시,http://news.mk.co.kr/newsRead.php?no=461895&year=2020
2472,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.bokuennews.com/news/article.html?no=189636
2473,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.youthdaily.co.kr/news/article.html?no=36325
2474,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=390178
2475,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.nbnnews.co.kr/news/articleView.html?idxno=390171
2476,2020-05-06,대웅제약고혈압藥올로맥스高함량제품출시,https://www.sedaily.com/NewsView/1Z2N992UUV
2477,2020-05-06,대웅제약올로맥스신규함량출시 ,http://www.monews.co.kr/news/articleView.html?idxno=210386
2478,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,https://www.dailian.co.kr/news/view/888189?sc=Naver
2479,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시처방영역확대,http://sports.hankooki.com/lpage/economy/202005/sp20200506141646137020.htm?s_ref=nv
2480,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상데이터최초공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891203
2481,2020-05-06,대웅제약올로맥스신규함량출시처방영업강화,http://www.kpinews.co.kr/news/articleView.html?idxno=116124
2482,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.segye.com/content/html/2020/05/06/20200506514310.html?OutUrl=naver
2483,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://newsbrite.net/136517
2484,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://newsbrite.net/136514
2485,2020-05-06,대웅제약올로맥스신규함량출시처방영역본격확대,http://www.m-i.kr/news/articleView.html?idxno=707757
2486,2020-05-06,대웅제약펙수프라잔점막결손치료율99,http://www.seoulfn.com/news/articleView.html?idxno=381483
2487,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.newslock.co.kr/news/articleView.html?idxno=27699
2488,2020-05-06,대웅제약올로맥스4개라인업구축처방영역확대,http://www.economytalk.kr/news/articleView.html?idxno=205824
2489,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891234
2490,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시,http://www.mediapen.com/news/view/522755
2491,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.dailysmart.co.kr/news/articleView.html?idxno=25951
2492,2020-05-06,대웅제약고혈압이상지질혈증치료제올로맥스라인업강화처방영역확대,http://www.donga.com/news/article/all/20200506/100930492/1
2493,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.updownnews.co.kr/news/articleView.html?idxno=218359
2494,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61022
2495,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61015
2496,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시,http://www.100ssd.co.kr/news/articleView.html?idxno=68546
2497,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.lawissue.co.kr/view.php?ud=20200506164334854204ead0791_12
2498,2020-05-06,대웅제약고혈압이상지지혈증치료제올로맥스신규함량출시,http://www.newstomato.com/ReadNews.aspx?no=970245
2499,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.econovill.com/news/articleView.html?idxno=395509
2500,2020-05-06,대웅제약올로맥스신규함량출시4가지라인업구축,http://www.ajunews.com/view/20200506170059670
2501,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=385835
2502,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.dailymedi.com/detail.php?number=855798&thread=22r05
2503,2020-05-06,대웅제약올로맥스처방영역확대올메사르탄함량늘려신규출시,http://kpenews.com/View.aspx?No=836141
2504,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=385844
2505,2020-05-06,대웅제약올로맥스신규함량출시로처방영역을확대,http://www.paxetv.com/news/articleView.html?idxno=91548
2506,2020-05-06,대웅제약역류성식도염신약펙수프라잔임상3상99치요율달성,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005060392&t=NN
2507,2020-05-06,대웅제약올로맥스신규함량출시,http://www.k-health.com/news/articleView.html?idxno=48348
2508,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.thevaluenews.co.kr/news/view.php?idx=159374
2509,2020-05-07,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,https://www.news2day.co.kr/152326
2510,2020-05-07,대웅제약신풍제약모두상승세로특히대웅제약1상승에11만원선눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=119246
2511,2020-05-07,대웅제약위식도역류질환치료신약펙수프라잔임상공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1276356
2512,2020-05-07,대웅제약펙수프라잔미국DDW약효안전성확인,http://www.doctorsnews.co.kr/news/articleView.html?idxno=134486
2513,2020-05-07,대웅제약올로맥스신규함량출시처방영역확대,http://www.doctorsnews.co.kr/news/articleView.html?idxno=134487
2514,2020-05-07,대웅제약계열사대웅바이오불법리베이트로검찰송치된중외제약전철밟나,http://www.datasom.co.kr/news/articleView.html?idxno=105707
2515,2020-05-07,코스피대웅제약2020년1분기누적매출액2284억원영업이익13억원,http://news.kmib.co.kr/article/view.asp?arcid=0014555695&code=61141211&cp=nv
2516,2020-05-07,대웅제약1Q영업익12억원전년比87↓,http://www.edaily.co.kr/news/newspath.asp?newsid=04083606625766624
2517,2020-05-07,대웅제약1Q영업익13억전년비88↓,http://www.dailypharm.com/Users/News/NewsView.html?ID=264380&REFERER=NP
2518,2020-05-07,실적속보잠정대웅제약별도20201Q영업이익1251억원,http://www.fntimes.com/html/view.php?ud=2020050717510011335dfa8341a5_18
2519,2020-05-07,대웅제약1분기영업익13억원전년比88↓,https://view.asiae.co.kr/article/2020050717551272504
2520,2020-05-07,공시대웅제약1분기영업익12억5100만원전년比877↓,http://www.newsway.co.kr/news/view?tp=1&ud=2020050717572613605
2521,2020-05-07,대웅제약1분기매출액2283억원전년대비41↓,https://www.sedaily.com/NewsView/1Z2NQJ4DHJ
2522,2020-05-07,대웅제약1분기매출액2284억원전년비41↓,http://www.mediapen.com/news/view/523136
2523,2020-05-07,대웅제약1분기매출2284억원영업익13억원,http://newsclaim.co.kr/View.aspx?No=837521
2524,2020-05-07,대웅제약2020년1분기실적발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61050
2525,2020-05-07,대웅제약1분기영업이익13억원전년동기대비877↓,http://news.mk.co.kr/newsRead.php?no=468709&year=2020
2526,2020-05-07,대웅제약1분기영업이익13억전년比88↓,http://www.asiatoday.co.kr/view.php?key=20200507010003117
2527,2020-05-07,대웅제약나보타수출증가에도소송비로1분기매출↓,http://www.medigatenews.com/news/569963298
2528,2020-05-07,대웅제약나보타소송비용코로나로1Q영업익88↓,http://www.newsis.com/view/?id=NISX20200507_0001017325&cID=13001&pID=13000
2529,2020-05-07,대웅제약1Q영업익전년比88↓코로나19소송비용탓,http://news.mt.co.kr/mtview.php?no=2020050719001934499
2530,2020-05-07,대웅제약1분기영업익13억전년比877급감,http://biz.newdaily.co.kr/site/data/html/2020/05/07/2020050700258.html
2531,2020-05-07,대웅제약1분기영업이익13억원전년比88급감,http://www.edaily.co.kr/news/newspath.asp?newsid=04270566625766624
2532,2020-05-07,대웅제약1분기12억원전년비877↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891980
2533,2020-05-07,대웅제약1분기영업익12억5100만원전년比88↓,http://www.newspim.com/news/view/20200507001066
2534,2020-05-07,대웅제약1분기영업이익13억원전년동기대비88↓,http://www.econovill.com/news/articleView.html?idxno=395683
2535,2020-05-07,대웅제약2020년1분기매출액2284억원영업이익13억원,http://newsbrite.net/136599
2536,2020-05-07,대웅제약올로맥스신규함량출시로처방영역확대,http://www.wsobi.com/news/articleView.html?idxno=96971
2537,2020-05-07,대웅제약1분기영업이익13억원전년비88↓,https://www.dailian.co.kr/news/view/888661?sc=Naver
2538,2020-05-07,대웅제약1분기영업익13억원전년동기대비88감소,https://www.news2day.co.kr/152403
2539,2020-05-07,대웅제약1분기영업익전년比88↓나보타OTC매출은늘어,http://www.seoulwire.com/news/articleView.html?idxno=410821
2540,2020-05-07,실적발표JW홀딩스JW중외제약JW생명과학대웅제약,http://www.businesspost.co.kr/BP?command=article_view&num=177094
2541,2020-05-07,대웅제약나보타대미수출액96억원증가글로벌시장공략가속화,http://www.businesskorea.co.kr/news/articleView.html?idxno=45389
2542,2020-05-07,대웅제약코로나19에소송비용겹쳐1분기영업이익급감,http://www.businesspost.co.kr/BP?command=article_view&num=177090
2543,2020-05-07,대웅제약나보타對美수출96억↗‥글로벌시장가속화,http://medipana.com/news/news_viewer.asp?NewsNum=256517&MainKind=A&NewsKind=5&vCount=12&vKind=1
2544,2020-05-07,대웅제약1분기영업이익88↓나보타소송비용137억원영향,http://www.donga.com/news/article/all/20200507/100953434/1
2545,2020-05-07,대웅제약1분기영업이익13억전년比88감소,https://www.fetv.co.kr/news/article.html?no=54068
2546,2020-05-07,대웅제약1분기매출2284억전년비4줄어,https://www.kpanews.co.kr/article/show.asp?idx=213004&category=D
2547,2020-05-08,대웅제약2020년1분기실적발표,http://www.lawissue.co.kr/view.php?ud=202005080018303215204ead0791_12
2548,2020-05-08,대웅제약라니티딘사태에코로나19직격탄,http://www.bosa.co.kr/news/articleView.html?idxno=2126396
2549,2020-05-08,대웅제약나보타소송비용코로나19등손익영향영업익감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243954
2550,2020-05-08,대웅제약나보타수출300늘었는데손해소송비용탓,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1080454
2551,2020-05-08,전일주요공시대웅제약카카오한진중공업홀딩스,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891988
2552,2020-05-08,대웅제약1분기영업익13억원전년비88↓,https://www.ebn.co.kr/news/view/1432728?sc=Naver
2553,2020-05-08,대웅제약1Q영업익13억원전년比88↓나보타소송비용직격탄,http://moneys.mt.co.kr/news/mwView.php?no=2020050808218078936
2554,2020-05-08,나보타소송비용영향대웅제약1분기영업익13억전년比88↓,http://www.newsprime.co.kr/news/article.html?no=503593
2555,2020-05-08,리포트브리핑대웅제약소송비용제외시실적양호2Q부터실적긍정적기대목표가170000원KTB투자증권,http://www.newspim.com/news/view/20200508000129
2556,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.youthdaily.co.kr/news/article.html?no=36486
2557,2020-05-08,코로나영향대웅제약1분기영업익13억전년比88↓,http://www.wikileaks-kr.org/news/articleView.html?idxno=85534
2558,2020-05-08,대웅제약11일안플원출시5주년웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=116271
2559,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61052
2560,2020-05-08,대웅제약2020년1분기실적발표나보타소송코로나19까지손익에영향컸다,http://www.paxetv.com/news/articleView.html?idxno=91646
2561,2020-05-08,대웅제약항혈전제안플원출시5주년맞이웹심포지엄,https://www.sedaily.com/NewsView/1Z2O6ASD4D
2562,2020-05-08,대웅제약안플원출시5주년웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=256529&MainKind=A&NewsKind=5&vCount=12&vKind=1
2563,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=44555
2564,2020-05-08,대웅제약안플원출시5주년맞아심포지엄개최,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572459035538
2565,2020-05-08,대웅제약1분기영업이익88↓메디톡스소송영향,http://www.upinews.kr/newsView/upi202005080016
2566,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.koreaittimes.com/news/articleView.html?idxno=97351
2567,2020-05-08,대웅제약신풍제약지지부진한주가신풍제약소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=119427
2568,2020-05-08,대웅제약1분기영업이익전년비88감소한13억원,http://www.ceoscoredaily.com/news/article.html?no=69244
2569,2020-05-08,종목삼성증권대웅제약소송비용점차감소될것매수,http://www.sporbiz.co.kr/news/articleView.html?idxno=436818
2570,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.medigatenews.com/news/2097804961
2571,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.ekn.kr/news/article.html?no=498003
2572,2020-05-08,대웅제약나보타美수출300↑껑충,http://www.whosaeng.com/117597
2573,2020-05-08,대웅제약장기지속형당뇨병바이오신약본격개발,http://www.medisobizanews.com/news/articleView.html?idxno=69516
2574,2020-05-08,5번째생일파티는웹에서대웅제약인플원5주년기념심포지엄웹개최,http://theviewers.co.kr/View.aspx?No=837808
2575,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=26056
2576,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최사포그릴레이트성분재조명,http://www.segye.com/content/html/2020/05/08/20200508507801.html?OutUrl=naver
2577,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최사포그릴레이트성분재조명,http://www.segye.com/content/html/2020/05/08/20200508507801.html?OutUrl=naver
2578,2020-05-08,대웅제약안플원5周기념웹심포지엄,http://www.dailymedi.com/detail.php?number=855863&thread=22r05
2579,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.newsis.com/view/?id=NISX20200508_0001017691&cID=13001&pID=13000
2580,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=54099
2581,2020-05-08,대웅제약나보타소송코로나19여파로1분기영업익전년대비88감소,http://sports.hankooki.com/lpage/economy/202005/sp20200508101218137020.htm?s_ref=nv
2582,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.viva100.com/main/view.php?key=20200508010001808
2583,2020-05-08,대웅제약안플원출시5주년웹심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=210456
2584,2020-05-08,대웅제약1분기영업익13억원라니티딘사태등으로전년比88↓,http://www.updownnews.co.kr/news/articleView.html?idxno=218450
2585,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.econovill.com/news/articleView.html?idxno=395746
2586,2020-05-08,대웅제약항혈전제안플원출시5주년맞이웹심포지엄개최,http://moneys.mt.co.kr/news/mwView.php?no=2020050809368082538
2587,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=708381
2588,2020-05-08,대웅제약안플원출시5주년기념포털사이트닥터빌서심포지엄개최,http://www.pressm.kr/news/articleView.html?idxno=29547
2589,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.greened.kr/news/articleView.html?idxno=250456
2590,2020-05-08,대웅제약2020년1분기실적발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1385888
2591,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2126423
2592,2020-05-08,대웅제약항혈전제안플원출시5주년웹심포지엄개최,http://news.mt.co.kr/mtview.php?no=2020050810583669009
2593,2020-05-08,대웅제약1분기나보타소송코로나19여파에고전,http://www.sisaweek.com/news/articleView.html?idxno=133611
2594,2020-05-08,대웅제약1분기영업이익88감소나보타소송코로나19등영향,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117067
2595,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1385891
2596,2020-05-08,대웅제약나보타대미수출액96억원증가글로벌시장공략가속화,http://www.wsobi.com/news/articleView.html?idxno=97041
2597,2020-05-08,대웅제약1분기영업익13억전년比88↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=386057
2598,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1892174
2599,2020-05-08,리포트브리핑대웅제약여전한소송비용부담다가오는ITC예비판정주목목표가120000원삼성증권,http://www.newspim.com/news/view/20200508000700
2600,2020-05-08,리포트브리핑대웅제약실적과모멘텀사이목표가140000원대신증권,http://www.newspim.com/news/view/20200508000727
2601,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=45433
2602,2020-05-08,대웅제약안플원출시5주년웹심포지엄개최,http://isplus.live.joins.com/news/article/article.asp?total_id=23772049
2603,2020-05-08,대웅제약보툴리눔톡신균주소송비용줄어2분기실적반등가능,http://www.businesspost.co.kr/BP?command=article_view&num=177164
2604,2020-05-08,코로나영향유한양행대웅제약1분기성적저조2분기전망은,http://www.wikileaks-kr.org/news/articleView.html?idxno=85592
2605,2020-05-08,대웅제약영업이익감소에도보톡스매출174↑,http://www.m-i.kr/news/articleView.html?idxno=708360
2606,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=390836
2607,2020-05-08,대웅제약2020년1분기실적발표,http://www.nbnnews.co.kr/news/articleView.html?idxno=390832
2608,2020-05-08,1Q대웅제약코로나19소송여파고전나보타글로벌시장공략가속화,http://www.thepublic.kr/news/newsview.php?ncode=1065589480858746
2609,2020-05-08,대웅제약항혈전제안플원출시5주년기념웹심포지엄개최키로,http://news.mk.co.kr/newsRead.php?no=471805&year=2020
2610,2020-05-08,대웅제약1분기2284억영업이익13억,http://www.g-enews.com/ko-kr/news/article/news_all/20200508143840200251638db705_1/article.html
2611,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,https://www.ebn.co.kr/news/view/1432864?sc=Naver
2612,2020-05-08,제약워치대웅제약안플원출시5주년기념웹심포지엄개최外,http://www.newswatch.kr/news/articleView.html?idxno=29756
2613,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=202005081521127175204ead0791_12
2614,2020-05-08,대웅제약올로맥스신규함량출시,http://weekly.hankooki.com/lpage/economy/202005/wk20200508153312146380.htm?s_ref=nv
2615,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.iminju.net/news/articleView.html?idxno=53569
2616,2020-05-08,보톡스전쟁타격대웅제약나보타소송비용영향1분기실적큰폭하락,http://theviewers.co.kr/View.aspx?No=838597
2617,2020-05-08,뉴스투데이L대웅제약안플원출시5주년기념웹심포지엄개최,https://www.news2day.co.kr/152457
2618,2020-05-08,주간신상태그헤라비욘드스파오대웅제약글래드호텔외,http://www.newsprime.co.kr/news/article.html?no=503718
2619,2020-05-08,뉴스워커_대웅제약안플원출시5주년기념웹심포지엄개최,http://www.newsworker.co.kr/news/articleView.html?idxno=70429
2620,2020-05-08,대웅제약안플원의료진과효능처방옵션공유자리마련,http://www.100ssd.co.kr/news/articleView.html?idxno=68622
2621,2020-05-08,대웅제약항혈전제안플원출시5주년기념웹심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=386133
2622,2020-05-08,대웅제약오는11일안플원출시5주년기념웹심포지엄열어,https://www.kpanews.co.kr/article/show.asp?idx=213047&category=D
2623,2020-05-09,대웅제약1Q영업익88↓먹구름ITC소송비부담여전,http://www.mediapen.com/news/view/523581
2624,2020-05-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.viva100.com/main/view.php?key=20200510010002169
2625,2020-05-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.thepublic.kr/news/newsview.php?ncode=1065602337506351
2626,2020-05-11,대웅제약1분기최악의영업실적에도선방평가이유는,http://www.pharmnews.com/news/articleView.html?idxno=100452
2627,2020-05-11,대웅제약지난해10대제약사가운데유일하게세금추징당해,http://www.consumernews.co.kr/news/articleView.html?idxno=604823
2628,2020-05-11,더벨CompanyWatch대웅제약톡신나보타로알비스빈자리채웠다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202005081531150320105381
2629,2020-05-11,대웅제약신풍제약희비엇갈려대웅제약하락반해신풍제약상승,http://www.econonews.co.kr/news/articleView.html?idxno=119708
2630,2020-05-11,100세시대건강기능식품에베팅한제약업계종근당대웅제약등맹활약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003967961
2631,2020-05-11,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=57878
2632,2020-05-11,대웅제약1분기경영실적매출액2284억원나보타대미수출액96억원증가,http://www.thefirstmedia.net/news/articleView.html?idxno=57879
2633,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈특별행사진행,http://www.econovill.com/news/articleView.html?idxno=396134
2634,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://medipana.com/news/news_viewer.asp?NewsNum=256676&MainKind=A&NewsKind=5&vCount=12&vKind=1
2635,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://newsclaim.co.kr/View.aspx?No=840688
2636,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩웹사이트오픈,http://www.viva100.com/main/view.php?key=20200512010002882
2637,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.bosa.co.kr/news/articleView.html?idxno=2126582
2638,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61103
2639,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://www.greened.kr/news/articleView.html?idxno=250943
2640,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩브랜드웹사이트오픈,http://www.kpinews.co.kr/news/articleView.html?idxno=116459
2641,2020-05-12,대웅제약덴티가드랩웹사이트오픈31일까지특별이벤트,http://www.metroseoul.co.kr/article/20200512500076
2642,2020-05-12,대웅제약생애주기별맞춤치약덴티가드랩이벤트팡팡,http://moneys.mt.co.kr/news/mwView.php?no=2020051209418069133
2643,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://www.updownnews.co.kr/news/articleView.html?idxno=218552
2644,2020-05-12,대웅제약덴티가드랩브랜드사이트오픈기념특별이벤트진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573763517491
2645,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈특별이벤트도실시,http://www.m-i.kr/news/articleView.html?idxno=709294
2646,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.youthdaily.co.kr/news/article.html?no=36737
2647,2020-05-12,대웅제약신풍제약모두하락부진대웅제약1하락이어신풍제약역시1하락,http://www.econonews.co.kr/news/articleView.html?idxno=119944
2648,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트,https://www.fetv.co.kr/news/article.html?no=54343
2649,2020-05-12,대웅제약덴티가드랩홈페이지에서구강건강챙기세요,https://www.sedaily.com/NewsView/1Z2Q0Y43RR
2650,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.dailysmart.co.kr/news/articleView.html?idxno=26196
2651,2020-05-12,대웅제약생애주기치약덴티가드랩홈페이지오픈이벤트,http://news.mt.co.kr/mtview.php?no=2020051210322218114
2652,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩브랜드웹사이트오픈,http://sports.hankooki.com/lpage/economy/202005/sp20200512103921136980.htm?s_ref=nv
2653,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.newspim.com/news/view/20200512000389
2654,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://newsbrite.net/136716
2655,2020-05-12,대웅제약덴비가드랩브랜드웹사이트오픈33가격할인,http://www.asiatoday.co.kr/view.php?key=20200512010005493
2656,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지최대33할인이벤트진행,http://www.ekn.kr/news/article.html?no=498702
2657,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.newsis.com/view/?id=NISX20200512_0001021644&cID=13001&pID=13000
2658,2020-05-12,대웅제약구강건강을위한정보와제품구매등토탈솔루션제공,http://www.g-enews.com/ko-kr/news/article/news_all/20200512114332787051638db705_1/article.html
2659,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩웹사이트오픈,http://www.mdtoday.co.kr/mdtoday/index.html?no=386342
2660,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.lawissue.co.kr/view.php?ud=202005121301487046204ead0791_12
2661,2020-05-12,대웅제약생애주기별구강건강웹사이트오픈토탈솔루션제공,http://www.100ssd.co.kr/news/articleView.html?idxno=68655
2662,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://www.nbnnews.co.kr/news/articleView.html?idxno=391519
2663,2020-05-12,대웅제약구강생애주기별맞춤치약사이트열고기념이벤트,http://www.businesspost.co.kr/BP?command=article_view&num=177661
2664,2020-05-12,뉴스투데이L대웅제약생애주기별맞춤치약덴티가드랩웹사이트오픈,https://www.news2day.co.kr/152617
2665,2020-05-12,대웅제약덴티가드랩웹사이트오픈기념이벤트진행,http://weekly.hankooki.com/lpage/economy/202005/wk20200512151741146380.htm?s_ref=nv
2666,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,https://www.ebn.co.kr/news/view/1433338?sc=Naver
2667,2020-05-12,오늘의장바구니롯데마트인터파크안다르대웅제약외,http://www.newsprime.co.kr/news/article.html?no=504149
2668,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈이벤트실시,http://daily.hankooki.com/lpage/industry/202005/dh20200512162004148390.htm?s_ref=nv
2669,2020-05-12,구강관리끝판왕대웅제약덴티가드랩브랜드웹사이트열었다,http://theviewers.co.kr/View.aspx?No=841666
2670,2020-05-12,대웅제약생애주기맞춤치약덴티가드랩브랜드웹사이트오픈,http://www.donga.com/news/article/all/20200512/101014447/1
2671,2020-05-12,대웅제약덴티가드랩브랜드웹사이트선봬,https://www.kpanews.co.kr/article/show.asp?idx=213137&category=D
2672,2020-05-13,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.thefirstmedia.net/news/articleView.html?idxno=57911
2673,2020-05-13,대웅제약신풍제약희비엇갈려대웅제약2하락반해신풍제약1상승,http://www.econonews.co.kr/news/articleView.html?idxno=120087
2674,2020-05-13,이제는K바이오시대④대웅제약넥스트나보타로제2의도약꿈꾼다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117165
2675,2020-05-13,대웅제약195상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/13/2020051301848.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2676,2020-05-14,1Q뒷걸음질대웅제약윤재춘전승호號2Q도가시밭길,http://www.inews24.com/view/1264250
2677,2020-05-14,대웅제약신풍제약상승에급등까지대웅제약소폭상승이어신풍제약8급등,http://www.econonews.co.kr/news/articleView.html?idxno=120252
2678,2020-05-14,오송팜대웅제약과일본시장공략제품공동개발협약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244219
2679,2020-05-14,오송팜대웅제약일본향제품공동개발협약체결,http://medipana.com/news/news_viewer.asp?NewsNum=256813&MainKind=A&NewsKind=5&vCount=12&vKind=1
2680,2020-05-14,오송팜대웅제약과일본향제품공동개발협약,http://www.mdtoday.co.kr/mdtoday/index.html?no=386601
2681,2020-05-14,오송팜대웅제약과일본시장공략제품공동개발협약,http://www.bosa.co.kr/news/articleView.html?idxno=2126769
2682,2020-05-14,오송팜대웅제약과손잡고日시장공략나서,http://www.whosaeng.com/117789
2683,2020-05-14,코로나에갈린제약사희비유한대웅제약어닝쇼크,http://www.whitepaper.co.kr/news/articleView.html?idxno=193361
2684,2020-05-14,오송팜대웅제약과일본향제품공동개발협약,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61175
2685,2020-05-14,오송팜대웅제약일본의약품시장공동공략,http://www.doctorsnews.co.kr/news/articleView.html?idxno=134590
2686,2020-05-15,오송팜대웅제약일본제품공동개발협약맺어,https://www.kpanews.co.kr/article/show.asp?idx=213207&category=D
2687,2020-05-15,대웅제약신풍제약희비엇갈려특히신풍제약가파른하락세로4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=120401
2688,2020-05-15,대웅제약장시작후꾸준히올라583최근단기조정후반등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005150218&t=NN
2689,2020-05-15,대웅제약5이상상승외국인3일연속순매수7857주,https://www.hankyung.com/finance/article/202005151964L
2690,2020-05-15,특징주대웅제약렘데시비르600배효과나파모스타트와유사한치료제생산부각,http://www.edaily.co.kr/news/newspath.asp?newsid=02758486625769248
2691,2020-05-15,대웅제약680VI발동,https://biz.chosun.com/site/data/html_dir/2020/05/15/2020051502220.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2692,2020-05-15,대웅제약728상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/15/2020051502231.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2693,2020-05-15,시황분석대웅제약전일대비534상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202005151443172867edd30d1253_45
2694,2020-05-15,대웅제약덴티가드랩브랜드사이트오픈해,http://www.cnbnews.com/news/article.html?no=446679
2695,2020-05-18,대웅제약1Q영업익55감소매출비RD비22,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244361
2696,2020-05-18,메디톡신보툴렉스자리노리는종근당휴온스와대웅제약,http://weekly.cnbnews.com/news/article.html?no=133948
2697,2020-05-18,대웅제약신풍제약모두하락부진대웅제약4하락이어신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=120791
2698,2020-05-18,시지바이오관상동맥용스텐트품목허가획득대웅제약통해출시,https://www.etoday.co.kr/news/view/1895564
2699,2020-05-18,시지바이오관상동맥용스텐트품목허가대웅제약통해출시,http://www.yakup.com/news/index.html?mode=view&cat=14&nid=244395
2700,2020-05-18,시지바이오관상동맥용스탠트식약처허가획득대웅제약판매,http://news.mt.co.kr/mtview.php?no=2020051816062982012
2701,2020-05-19,대웅제약유한양행위궤양개량신약공동개발2021년발매예정,http://www.ceoscoredaily.com/news/article.html?no=69591
2702,2020-05-19,10대제약사중8곳1분기매출증가유한양행대웅제약동반부진,http://www.consumernews.co.kr/news/articleView.html?idxno=605143
2703,2020-05-19,대웅제약신풍제약지지부진한주가대웅제약10만원선무너지나,http://www.econonews.co.kr/news/articleView.html?idxno=120907
2704,2020-05-19,뉴스투데이L대웅제약언택트마케팅으로포스트코로나시대경쟁력확보,https://www.news2day.co.kr/153003
2705,2020-05-19,시지바이오관상동맥용스텐트품목허가획득대웅제약통해출시,http://news.heraldcorp.com/view.php?ud=20200519000708
2706,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.lawissue.co.kr/view.php?ud=202005191457269320204ead0791_12
2707,2020-05-19,건강기능식품이름은대웅제약토스행운퀴즈이벤트진행,https://www.fetv.co.kr/news/article.html?no=54906
2708,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.g-enews.com/ko-kr/news/article/news_all/20200519150245913151638db705_1/article.html
2709,2020-05-19,대웅제약건강기능식품인지도높이는토스행운퀴즈진행,http://www.wsobi.com/news/articleView.html?idxno=97767
2710,2020-05-19,대웅제약20일토스행운퀴즈이벤트진행건기식이름을맞춰라,http://www.ekn.kr/news/article.html?no=500143
2711,2020-05-19,대웅제약건기식인지도제고토스행운퀴즈이벤트진행,http://medipana.com/news/news_viewer.asp?NewsNum=257095&MainKind=A&NewsKind=5&vCount=12&vKind=1
2712,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.bosa.co.kr/news/articleView.html?idxno=2127071
2713,2020-05-19,대웅제약토스행운퀴즈이벤트,http://newsclaim.co.kr/View.aspx?No=847982
2714,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=387162
2715,2020-05-19,대웅제약건강기능식품토스행운퀴즈이벤트진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244472
2716,2020-05-19,건기식인지도와체험의기회대웅제약토스에서행운퀴즈이벤트,http://kpenews.com/View.aspx?No=848040
2717,2020-05-19,대웅제약토스행운퀴즈이벤트진행건강기능식품의이름은무엇일까요,http://newsbrite.net/137055
2718,2020-05-19,대웅제약토스행운퀴즈진행정답자에토스머니증정,http://www.kpinews.co.kr/news/articleView.html?idxno=117007
2719,2020-05-19,대웅제약토스앱통해건강기능식품홍보이벤트나서,http://news.mk.co.kr/newsRead.php?no=512043&year=2020
2720,2020-05-19,대웅제약토스행운퀴즈이벤트실시건강기능식품이름은,http://www.m-i.kr/news/articleView.html?idxno=711737
2721,2020-05-19,대웅제약20일토스행운퀴즈이벤트진행20만명에게토스머니제공,http://sports.hankooki.com/lpage/economy/202005/sp20200519170604136980.htm?s_ref=nv
2722,2020-05-19,대웅제약토스서이벤트진행건기식이름맞추기,http://www.econovill.com/news/articleView.html?idxno=397239
2723,2020-05-19,대웅제약건강기능식품홍보이벤트진행,http://www.100ssd.co.kr/news/articleView.html?idxno=68829
2724,2020-05-19,대웅제약인지도↑토스행운퀴즈이벤트진행,http://www.whosaeng.com/117894
2725,2020-05-19,대웅제약토스행운퀴즈이벤트밀크씨슬제품이름은,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117381
2726,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.thefirstmedia.net/news/articleView.html?idxno=58264
2727,2020-05-20,대웅제약20일오전11시토스행운퀴즈이벤트정답은,http://www.bizwnews.com/news/articleView.html?idxno=13616
2728,2020-05-20,대웅제약몰에힌트대웅제약토스행운퀴즈이벤트진행,http://theviewers.co.kr/View.aspx?No=848472
2729,2020-05-20,대웅제약신풍제약모두하락부진특히신풍제약1낙폭에2만원선붕괴,http://www.econonews.co.kr/news/articleView.html?idxno=121093
2730,2020-05-20,대웅제약토스행운퀴즈이벤트진행건강기능식품의이름은,http://www.newsworker.co.kr/news/articleView.html?idxno=71642
2731,2020-05-20,대웅제약에너씨슬토스행운퀴즈정답은,http://www.ccreview.co.kr/news/articleView.html?idxno=260449
2732,2020-05-20,대웅제약토스행운퀴즈실시간정답업데이트,http://www.ggilbo.com/news/articleView.html?idxno=769318
2733,2020-05-20,대웅제약밀크씨슬이름은토스행운퀴즈정답은,http://www.newsworks.co.kr/news/articleView.html?idxno=456312
2734,2020-05-20,대웅제약에너씨슬토스행운퀴즈정답은,https://www.asiatime.co.kr/news/newsview.php?ncode=1065580023464686
2735,2020-05-20,대웅제약에너씨슬콜레다운토스행운퀴즈정답은,http://www.ccdn.co.kr/news/articleView.html?idxno=646294
2736,2020-05-20,대웅제약밀크씨슬토스행운퀴즈정답에쏠린관심선착순퀴즈이벤트,https://nc.asiae.co.kr/view.htm?idxno=2020052011311966649
2737,2020-05-20,대웅제약토스행운퀴즈이벤트진행건강기능식품의이름은무엇일까요,http://www.nbnnews.co.kr/news/articleView.html?idxno=393676
2738,2020-05-20,피곤한간대웅제약밀크씨슬어때요불순물엄격한시험통과한제품만제공,http://www.thekpm.com/view.php?ud=202005201401453333861beb2d9d_17
2739,2020-05-20,대웅제약밀크씨슬토스행운퀴즈정답총망라,http://www.joygm.com/news/articleView.html?idxno=84522
2740,2020-05-21,대웅제약신풍제약모두하락세로대웅제약소폭하락이어신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=121246
2741,2020-05-21,대웅제약올로스타제네릭나오나매출영향은미지수,http://medipana.com/news/news_viewer.asp?NewsNum=257216&MainKind=A&NewsKind=5&vCount=12&vKind=1
2742,2020-05-21,매출10RD투자하는대웅제약오픈이노베이션넘어오픈콜라보로미래성장,http://www.medigatenews.com/news/3541898120
2743,2020-05-21,대웅제약의언택트마케팅관심,http://www.lawissue.co.kr/view.php?ud=202005211545291353204ead0791_12
2744,2020-05-22,대웅제약올로스타특허방어실패후발약물나오나,http://www.mdtoday.co.kr/mdtoday/index.html?no=387487
2745,2020-05-22,대웅제약국제미용성형학회웨비나에서나보타우수성알렸다,http://www.getnews.co.kr/view.php?ud=2020052209043119132fe691f917_16
2746,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알려,http://newsclaim.co.kr/View.aspx?No=851047
2747,2020-05-22,대웅제약IMCAS아카데미웨비나성료나보타우수성알려,http://www.kpinews.co.kr/news/articleView.html?idxno=117213
2748,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성시술법소개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244626
2749,2020-05-22,대웅제약IMCAS웨비나서나보타우수성소개,http://www.press9.kr/news/articleView.html?idxno=44736
2750,2020-05-22,대웅제약세계의료진에게나보타우수성알려,http://www.koreastocknews.com/news/articleView.html?idxno=53788
2751,2020-05-22,대웅제약IMCAS 웨비나에서나보타우수성알렸다,http://www.businesskorea.co.kr/news/articleView.html?idxno=46189
2752,2020-05-22,한국보톡스대웅제약나보타우수성IMCAS웨비나통해소통,http://theviewers.co.kr/View.aspx?No=851101
2753,2020-05-22,대웅제약코로나속전세계미용성형전문가와소통확대,http://www.newsis.com/view/?id=NISX20200522_0001033388&cID=13001&pID=13000
2754,2020-05-22,대웅제약IMCAS웨비나서나보타우수성전파,http://www.dailysmart.co.kr/news/articleView.html?idxno=26776
2755,2020-05-22,대웅제약IMCAS웨비나서나보타우수성전파,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571948698815
2756,2020-05-22,대웅제약IMCAS웨비나서나보타우수성시술법알려,http://medipana.com/news/news_viewer.asp?NewsNum=257271&MainKind=A&NewsKind=5&vCount=12&vKind=1
2757,2020-05-22,대웅제약IMCAS웨비나서나보타우수성및시술법알려,http://www.ekn.kr/news/article.html?no=500754
2758,2020-05-22,대웅제약신풍제약희비엇갈려대웅제약1상승반해신풍제약소폭하락,http://www.econonews.co.kr/news/articleView.html?idxno=121381
2759,2020-05-22,대웅제약국제미용성형학회에서나보타우수성소개,http://www.youthdaily.co.kr/news/article.html?no=37737
2760,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알려,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117479
2761,2020-05-22,대웅제약전세계전문가1700명참석IMCAS웨비나서나보타우수성소개,http://www.pressm.kr/news/articleView.html?idxno=29900
2762,2020-05-22,주식대웅제약신풍제약주가희비엇갈려특히대웅제약1상승반해신풍제약매도세에소폭하락,http://www.ggilbo.com/news/articleView.html?idxno=770014
2763,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알렸다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61316
2764,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알렸다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61316
2765,2020-05-22,대웅제약웨비나쏠쏠하네전세계미용성형전문가에나보타소개,http://moneys.mt.co.kr/news/mwView.php?no=2020052209568074997
2766,2020-05-22,대웅제약국제미용성형학회에서나보타우수성알려,http://news.heraldcorp.com/view.php?ud=20200522000197
2767,2020-05-22,대웅제약전문가세미나서나보타우수성소개,http://www.upinews.kr/newsView/upi202005220025
2768,2020-05-22,대웅제약라이브웨비나시술법소개,http://www.g-enews.com/ko-kr/news/article/news_all/2020052210225772451638db705_1/article.html
2769,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알려,https://www.dailian.co.kr/news/view/891906?sc=Naver
2770,2020-05-22,대웅제약IMCAS웨비나서나보타시술법소개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1388910
2771,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.greened.kr/news/articleView.html?idxno=252628
2772,2020-05-22,대웅제약국제미용성형학회웨비나참석해나보타우수성알려,http://www.newslock.co.kr/news/articleView.html?idxno=28149
2773,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.mdtoday.co.kr/mdtoday/index.html?no=387541
2774,2020-05-22,대웅제약세계3대미용학회참가나보타우수성시술법소개,http://www.consumuch.com/news/articleView.html?idxno=48887
2775,2020-05-22,대웅제약IMCAS웨비나서나보타홍보나서,http://www.mhj21.com/130492
2776,2020-05-22,대웅제약국제미용성형학회웨비나통해나보타소개,https://www.etoday.co.kr/news/view/1897693
2777,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.bosa.co.kr/news/articleView.html?idxno=2127268
2778,2020-05-22,대웅제약국제미용성형학회플랫폼서나보타우수성알려,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052211144923979
2779,2020-05-22,대웅제약세계3대미용학회IMCAS웨비나서나보타우수성알려,http://www.updownnews.co.kr/news/articleView.html?idxno=219009
2780,2020-05-22,대웅제약보툴리눔톡신나보타우수성소개,http://www.pharmnews.com/news/articleView.html?idxno=100527
2781,2020-05-22,대웅제약IMCAS웨비나서나보타소개,http://www.sporbiz.co.kr/news/articleView.html?idxno=440931
2782,2020-05-22,글로벌톡신브랜드로입지대웅제약라이브웨비나열고나보타소개,http://kpenews.com/View.aspx?No=851386
2783,2020-05-22,대웅제약나보타우수성시술법소개효능과안전성입증,http://www.newsprime.co.kr/news/article.html?no=505276
2784,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.segye.com/content/html/2020/05/22/20200522510221.html?OutUrl=naver
2785,2020-05-22,대웅제약미용성형전문가1700여명에나보타우수성알려,http://daily.hankooki.com/lpage/industry/202005/dh20200522115307148390.htm?s_ref=nv
2786,2020-05-22,대웅제약국제미용성형학회에서자체보툴리눔톡신우수성알려,http://www.businesspost.co.kr/BP?command=article_view&num=179309
2787,2020-05-22,메디톡스메디톡신법원식약처명령집행정지소식에급등대웅제약휴젤등관련주주가는,http://www.topstarnews.net/news/articleView.html?idxno=788568
2788,2020-05-22,대웅제약나보타실시간온라인세미나개최전세계의료진소통확대,https://www.donga.com/news/article/all/20200522/101172172/1
2789,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.nbnnews.co.kr/news/articleView.html?idxno=394358
2790,2020-05-22,대웅제약전세계미용성형전문가와소통나보타우수성알려,http://sports.hankooki.com/lpage/economy/202005/sp20200522135835137020.htm?s_ref=nv
2791,2020-05-22,대웅제약IMCAS웨비나통해나보타시술법소개,http://www.medigatenews.com/news/2538070558
2792,2020-05-22,대웅제약국제미용성형학회웨비나서나보타우수성알렸다,http://www.sisaweek.com/news/articleView.html?idxno=134061
2793,2020-05-22,대웅제약국제미용성형학회온라인강의플랫폼서나보타홍보,http://news.mk.co.kr/newsRead.php?no=526104&year=2020
2794,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알렸다,http://www.m-i.kr/news/articleView.html?idxno=712746
2795,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.lawissue.co.kr/view.php?ud=202005221529344884204ead0791_12
2796,2020-05-22,대웅제약전문가1700명참석한자리서나보타우수성알렸다”,http://www.econovill.com/news/articleView.html?idxno=397775
2797,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알려,http://news.mt.co.kr/mtview.php?no=2020052209151086875
2798,2020-05-22,대웅제약IMCAS웨비나서나보타시술법소개,https://www.ebn.co.kr/news/view/1435013?sc=Naver
2799,2020-05-22,대웅제약IMCAS웨비나통해나보타우수성알렸다,http://www.mediapen.com/news/view/527192
2800,2020-05-22,대웅제약온라인라이브통해나보타우수성소개,http://www.economytalk.kr/news/articleView.html?idxno=206142
2801,2020-05-22,대웅제약세계의료진에나보타시술법소개,http://www.dailymedi.com/detail.php?number=856375&thread=22r05
2802,2020-05-22,뉴스투데이L대웅제약IMCAS웨비나에서나보타우수성알렸다,https://www.news2day.co.kr/153281
2803,2020-05-22,대웅제약IMCAS웨비나서나보타우수성전파,http://www.koreaittimes.com/news/articleView.html?idxno=97703
2804,2020-05-22,대웅제약공격마케팅주목경쟁사위기는기회,https://www.paxnetnews.com/articles/60835
2805,2020-05-22,대웅제약IMCAS웨비나열어나보타자랑,http://www.seoulfn.com/news/articleView.html?idxno=383476
2806,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.ybsn.tv/news/articleView.html?idxno=13894
2807,2020-05-23,대웅제약IMCASACADEMY에서라이브웨비나통해나보타우수성알리다,http://www.paxetv.com/news/articleView.html?idxno=92776
2808,2020-05-25,대웅제약이지에프외용액인니서할랄인증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=117324
2809,2020-05-25,대웅제약이지에프외용액할랄인증획득80조규모중동시장진출,http://news.mt.co.kr/mtview.php?no=2020052509024828544
2810,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증,https://www.etoday.co.kr/news/view/1898235
2811,2020-05-25,대웅제약당뇨병성족부궤양치료제할랄인증80조원무슬림공략,http://www.upinews.kr/newsView/upi202005250005
2812,2020-05-25,대웅제약이지에프외용액할랄인증획득,https://www.ebn.co.kr/news/view/1435116?sc=Naver
2813,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.viva100.com/main/view.php?key=20200525010006783
2814,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.lawissue.co.kr/view.php?ud=202005250911538565204ead0791_12
2815,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244700
2816,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,https://www.fetv.co.kr/news/article.html?no=55260
2817,2020-05-25,대웅제약이지에프외용액할랄인증획득중동의약품시장겨냥,http://www.econovill.com/news/articleView.html?idxno=397931
2818,2020-05-25,대웅제약 IMCAS 웨비나에서 나보타 우수성알렸다 ,http://www.greened.kr/news/articleView.html?idxno=252890
2819,2020-05-25,대웅제약중동신흥시장진출청신호이지에프외용액하랄인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020052509188057711
2820,2020-05-25,대웅제약국내1호바이오신약이지에프외용액할랄인증,http://www.ekn.kr/news/article.html?no=501090
2821,2020-05-25,대웅제약국내바이오신약1호할랄인증,http://www.edaily.co.kr/news/newspath.asp?newsid=01869606625772528
2822,2020-05-25,대웅제약대웅인피온통해이지에프외용액할랄인증획득,http://medipana.com/news/news_viewer.asp?NewsNum=257354&MainKind=A&NewsKind=5&vCount=12&vKind=1
2823,2020-05-25,대웅제약바이오신약1호이지에프외용액할랄인증,http://www.wikileaks-kr.org/news/articleView.html?idxno=87012
2824,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.m-i.kr/news/articleView.html?idxno=713212
2825,2020-05-25,대웅제약이지에프외용액할랄인증획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572178836651
2826,2020-05-25,인도네시아할랄인증대웅제약대웅인피온중동의약품시장진출,http://theviewers.co.kr/View.aspx?No=852511
2827,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://yna.kr/AKR20200525036800017?did=1195m
2828,2020-05-25,대웅제약인니법인당뇨발치료제할랄인증,https://www.sedaily.com/NewsView/1Z2W00DLXW
2829,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://newsbrite.net/137288
2830,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.newspim.com/news/view/20200525000133
2831,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1389248
2832,2020-05-25,대웅제약신풍제약희비엇갈려대웅제약소폭하락반해신풍제약1상승,http://www.econonews.co.kr/news/articleView.html?idxno=121654
2833,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://yna.kr/PYH20200525024300017?did=1196m
2834,2020-05-25,대웅제약이지에프외용액인도네시아할랄인증,http://www.bosa.co.kr/news/articleView.html?idxno=2127364
2835,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.ajunews.com/view/20200525094151364
2836,2020-05-25,대웅제약80조중동시장교두보마련,https://www.paxnetnews.com/articles/60847
2837,2020-05-25,대웅제약인니법인당뇨발치료제할랄인증획득,http://it.chosun.com/site/data/html_dir/2020/05/25/2020052501031.html
2838,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005250089&t=NN
2839,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.bokuennews.com/news/article.html?no=190353
2840,2020-05-25,할랄인증받은국내1호바이오신약대웅제약인도네시아서이지에프외용액인증획득,https://www.donga.com/news/article/all/20200525/101196523/1
2841,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=46301
2842,2020-05-25,대웅제약이지에프외용액할랄인증80조중동공략,http://www.newsis.com/view/?id=NISX20200525_0001035435&cID=13001&pID=13000
2843,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.g-enews.com/ko-kr/news/article/news_all/20200525100957536751638db705_1/article.html
2844,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.monews.co.kr/news/articleView.html?idxno=210883
2845,2020-05-25,대웅제약바이오신약1호로무슬림의약품시장첫발,http://health.chosun.com/site/data/html_dir/2020/05/25/2020052501152.html
2846,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,https://www.dailian.co.kr/news/view/892308?sc=Naver
2847,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://www.mediapen.com/news/view/527581
2848,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.fnnews.com/news/202005251029414111
2849,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.cnbnews.com/news/article.html?no=447605
2850,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득쾌거,http://www.pressm.kr/news/articleView.html?idxno=29936
2851,2020-05-25,대웅제약이지에프외용액인도네시아서할랄인증획득,http://www.sisaweek.com/news/articleView.html?idxno=134092
2852,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020052510555995202
2853,2020-05-25,인벤티지랩대웅제약장기지속형주사제공동개발,http://www.biospectator.com/view/news_view.php?varAtcId=10404
2854,2020-05-25,대웅제약당뇨병성족부궤양치료제이지에프외용액할랄인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=387696
2855,2020-05-25,대웅제약족부궤양치료제할랄인증,http://www.seoulfn.com/news/articleView.html?idxno=383554
2856,2020-05-25,대웅제약인벤티지랩과맞손장기지속형주사제사업확대,http://www.segye.com/content/html/2020/05/25/20200525505184.html?OutUrl=naver
2857,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.thepublic.kr/news/newsview.php?ncode=1065575706664605
2858,2020-05-25,인벤티지랩대웅제약과전략적파트너쉽협약체결,https://www.news1.kr/articles/?3944053
2859,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244723
2860,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052511062688631
2861,2020-05-25,인벤티지랩대웅제약과장기지속형주사제개발파트너십체결,http://www.metroseoul.co.kr/article/20200525500104
2862,2020-05-25,인벤티지랩대웅제약과장기지속형주사제공동개발맞손,http://it.chosun.com/site/data/html_dir/2020/05/25/2020052500801.html
2863,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.youthdaily.co.kr/news/article.html?no=37937
2864,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.press9.kr/news/articleView.html?idxno=44762
2865,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.kpinews.co.kr/news/articleView.html?idxno=117369
2866,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=26900
2867,2020-05-25,대웅제약장기지속형주사제사업확대인벤티지랩과파트너십,https://www.etoday.co.kr/news/view/1898346
2868,2020-05-25,대웅제약인벤티지랩과파트너십계약장기지속형주사제사업확대,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005250192&t=NN
2869,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업부문서맞손,http://www.econovill.com/news/articleView.html?idxno=397986
2870,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61342
2871,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61356
2872,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업확대,http://medipana.com/news/news_viewer.asp?NewsNum=257382&MainKind=A&NewsKind=5&vCount=12&vKind=1
2873,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://newsbrite.net/137309
2874,2020-05-25,대웅제약이지에프외용액할랄인증획득80조시장공략,http://www.metroseoul.co.kr/article/20200525500169
2875,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호할랄인증,http://www.medigatenews.com/news/1860915199
2876,2020-05-25,대웅제약중동의약품시장진출에탄력이지에프외용액印泥서할랄인증,http://kpenews.com/View.aspx?No=852813
2877,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=387728
2878,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.koreaittimes.com/news/articleView.html?idxno=97725
2879,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=387728
2880,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1133868&REFERER=NP
2881,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.ceoscoredaily.com/news/article.html?no=69815
2882,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.bosa.co.kr/news/articleView.html?idxno=2127416
2883,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업위해파트너십체결,http://www.k-health.com/news/articleView.html?idxno=48596
2884,2020-05-25,대웅제약인벤티지랩과장기지속형주사제RD협력파트너십체결,http://news.mk.co.kr/newsRead.php?no=532541&year=2020
2885,2020-05-25,대웅제약인벤티지랩파트너십계약,http://www.g-enews.com/ko-kr/news/article/news_all/2020052511450741551638db705_1/article.html
2886,2020-05-25,대웅제약인벤티지랩맞손장기지속형주사제사업확대,http://www.newsprime.co.kr/news/article.html?no=505398
2887,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.lawissue.co.kr/view.php?ud=202005251203204109204ead0791_12
2888,2020-05-25,대웅제약장기지속형주사제사업확대나서,http://www.bokuennews.com/news/article.html?no=190387
2889,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.dailymedi.com/detail.php?number=856432&thread=22r05
2890,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1081006
2891,2020-05-25,대웅제약인벤티지랩과파트너십장기지속형주사제사업확대,http://www.consumuch.com/news/articleView.html?idxno=48899
2892,2020-05-25,대웅제약인벤티지랩과장기지속형주사제공동개발맞손,http://www.ekn.kr/news/article.html?no=501190
2893,2020-05-25,대웅제약할랄인증으로무슬림시장공략본격화,http://www.sporbiz.co.kr/news/articleView.html?idxno=441399
2894,2020-05-25,대웅제약인벤티지랩장기지속형주사제개발파트너십,http://www.mediapen.com/news/view/527655
2895,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.m-i.kr/news/articleView.html?idxno=713370
2896,2020-05-25,대웅제약장기지속형주사제사업확대,https://www.paxnetnews.com/articles/60866
2897,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.newsis.com/view/?id=NISX20200525_0001035788&cID=13001&pID=13000
2898,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=394840
2899,2020-05-25,제약워치대웅제약인벤티지랩과맞손장기지속형주사제사업확대外,http://www.newswatch.kr/news/articleView.html?idxno=30177
2900,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.greened.kr/news/articleView.html?idxno=252971
2901,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.nbnnews.co.kr/news/articleView.html?idxno=394854
2902,2020-05-25,대웅제약인벤티지랩협업장기지속형주사제사업확대,http://www.newslock.co.kr/news/articleView.html?idxno=28200
2903,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증,http://www.newstomato.com/ReadNews.aspx?no=973892
2904,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,https://www.fetv.co.kr/news/article.html?no=55304
2905,2020-05-25,대웅제약장기지속형주사제사업정조준,http://www.whosaeng.com/118035
2906,2020-05-25,인벤티지랩대웅제약과장기지속형주사제전략적제휴,http://news.mk.co.kr/newsRead.php?no=533439&year=2020
2907,2020-05-25,대웅제약장기지속형주사제사업확대 ,http://www.monews.co.kr/news/articleView.html?idxno=210892
2908,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052514273759706
2909,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.getnews.co.kr/view.php?ud=2020052514470270662fe691f917_16
2910,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1081015
2911,2020-05-25,대웅제약인벤티지랩과파트너십체결장기지속형주사제사업확대,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117545
2912,2020-05-25,대웅제약대웅인피온통해바이오신약이지에프외용액할랄인증획득,http://www.getnews.co.kr/view.php?ud=2020052514530014942fe691f917_16
2913,2020-05-25,대웅제약나보타우수성전세계알렸다,http://www.whosaeng.com/118046
2914,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.mhj21.com/130563
2915,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,https://www.hankyung.com/it/article/202005253140i
2916,2020-05-25,뉴스투데이L대웅제약인벤티지랩과장기지속형주사제사업확대,https://www.news2day.co.kr/153336
2917,2020-05-25,게시판대웅제약인벤티지랩과장기지속형주사제공동연구,http://yna.kr/AKR20200525115900017?did=1195m
2918,2020-05-25,대웅제약인벤티지랩과장기지속형주사제공동연구,http://yna.kr/PYH20200525164400017?did=1196m
2919,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업확대나선다,http://www.paxetv.com/news/articleView.html?idxno=92874
2920,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.newstomato.com/ReadNews.aspx?no=974039
2921,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.businesspost.co.kr/BP?command=article_view&num=179634
2922,2020-05-25,대웅제약국내1호바이오신약이지에프외용액할랄인증,http://www.fnnews.com/news/202005251701062408
2923,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=58482
2924,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.thefirstmedia.net/news/articleView.html?idxno=58471
2925,2020-05-25,대웅제약1회주사로3개월효과가는장기지속형주사제확대,http://health.chosun.com/site/data/html_dir/2020/05/25/2020052503117.html
2926,2020-05-25,비즈피플대웅제약장기지속형주사제파이프라인발굴,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052516232128303
2927,2020-05-25,투약횟수뚝대웅제약인벤티지랩장기지속형주사제사업맞손,http://theviewers.co.kr/View.aspx?No=853450
2928,2020-05-25,대웅제약장기지속형주사제사업확대인벤티지랩과협업,http://www.edaily.co.kr/news/newspath.asp?newsid=03827766625772528
2929,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.koreastocknews.com/news/articleView.html?idxno=53868
2930,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.dailypharm.com/Users/News/NewsView.html?ID=264926&REFERER=NP
2931,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://news.kbiz.or.kr/news/articleView.html?idxno=67753
2932,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4162116
2933,2020-05-26,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.ybsn.tv/news/articleView.html?idxno=14166
2934,2020-05-26,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.ybsn.tv/news/articleView.html?idxno=14162
2935,2020-05-26,대웅제약인벤티지랩장기지속형주사제파트너십맺어,https://www.kpanews.co.kr/article/show.asp?idx=213449&category=D
2936,2020-05-26,대웅제약바이오신약이지에프외용액할랄인증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1282361
2937,2020-05-26,시판당뇨약발암물질검출대웅제약제일약품등31개제조판매중지,https://www.fetv.co.kr/news/article.html?no=55377
2938,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,https://www.fetv.co.kr/news/article.html?no=55380
2939,2020-05-26,대웅제약참지마요프로젝트온라인진행,https://www.ebn.co.kr/news/view/1435338?sc=Naver
2940,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.businesskorea.co.kr/news/articleView.html?idxno=46389
2941,2020-05-26,대웅제약발달장애인대상비대면봉사활동전개,http://www.wikileaks-kr.org/news/articleView.html?idxno=87126
2942,2020-05-26,대웅제약발달장애인멘토링비대면봉사활동지속전개,http://www.youthdaily.co.kr/news/article.html?no=38029
2943,2020-05-26,대웅제약온라인으로비대면봉사활동,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052609241792067
2944,2020-05-26,대웅제약온라인으로비대면봉사활동실시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571972910906
2945,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244763
2946,2020-05-26,코로나19사태의봉사활동은비대면이대세대웅제약 온라인으로 비대면봉사활동 전개 ,http://www.greened.kr/news/articleView.html?idxno=253109
2947,2020-05-26,대웅제약코로나위기속임직원비대면봉사활동실시,http://www.koreastocknews.com/news/articleView.html?idxno=53871
2948,2020-05-26,대웅제약신풍제약희비엇갈려대웅제약소폭상승반해신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=121827
2949,2020-05-26,발달장애인멘토링봉사대웅제약참지마요프로젝트온라인비대면방식으로지속,http://theviewers.co.kr/View.aspx?No=853878
2950,2020-05-26,대웅제약온라인통해비대면봉사활동지속전개,http://www.m-i.kr/news/articleView.html?idxno=713609
2951,2020-05-26,대웅제약사회공헌참지마요프로젝트온라인봉사활동펼쳐,http://www.kpinews.co.kr/news/articleView.html?idxno=117450
2952,2020-05-26,대웅제약참지마요프로젝트온라인으로봉사활동지속,http://www.metroseoul.co.kr/article/20200526500075
2953,2020-05-26,대웅제약참지마요프로젝트온라인으로봉사활동지속,http://www.metroseoul.co.kr/article/20200526500075
2954,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://newsbrite.net/137339
2955,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.newsway.co.kr/news/view?tp=1&ud=2020052609593184529
2956,2020-05-26,대웅제약봉사활동도온라인으로발달장애인의사소통카드제작,https://www.sedaily.com/NewsView/1Z2WFRJ04N
2957,2020-05-26,대웅제약발달장애인의사소통돕는참지마요프로젝트실시,http://www.rapportian.com/news/articleView.html?idxno=125419
2958,2020-05-26,대웅제약언택트봉사활동온라인참지마요프로젝트진행,http://moneys.mt.co.kr/news/mwView.php?no=2020052609128027149
2959,2020-05-26,대웅제약참지마요프로젝트온라인비대면봉사활동지속전개,http://www.pressm.kr/news/articleView.html?idxno=29983
2960,2020-05-26,대웅제약코로나19에온라인비대면봉사활동지속전개,http://medipana.com/news/news_viewer.asp?NewsNum=257439&MainKind=A&NewsKind=5&vCount=12&vKind=1
2961,2020-05-26,대웅제약참지마요프로젝트온라인비대면봉사활동으로지속,http://www.paxetv.com/news/articleView.html?idxno=92921
2962,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.dailysmart.co.kr/news/articleView.html?idxno=26970
2963,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61375
2964,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.bosa.co.kr/news/articleView.html?idxno=2127485
2965,2020-05-26,대웅제약온라인으로비대면봉사활동전개,http://www.bokuennews.com/news/article.html?no=190435
2966,2020-05-26,대웅제약발달장애인대상참지마요프로젝트봉사온라인으로이어가,http://news.mk.co.kr/newsRead.php?no=536634&year=2020
2967,2020-05-26,대웅제약코로나19에봉사활동도언택트,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005260202&t=NN
2968,2020-05-26,대웅제약온라인으로봉사활동지속전개,http://www.newsfc.co.kr/news/articleView.html?idxno=41243
2969,2020-05-26,대웅제약참지마요프로젝트온라인통한비대면봉사활동지속,http://www.newslock.co.kr/news/articleView.html?idxno=28225
2970,2020-05-26,대웅제약온라인으로발달장애인과함께하는임직원멘토링봉사활동진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=387873
2971,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.lawissue.co.kr/view.php?ud=202005261301526611204ead0791_12
2972,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.updownnews.co.kr/news/articleView.html?idxno=219129
2973,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.nbnnews.co.kr/news/articleView.html?idxno=395164
2974,2020-05-26,대웅제약참지마요프로젝트온라인활동전개,https://www.donga.com/news/article/all/20200526/101217835/1
2975,2020-05-26,대웅제약이즈에프외용액할랄인증획득80조규모중동시장공략나서,http://www.asiatoday.co.kr/view.php?key=20200525010013247
2976,2020-05-26,봉사활동도비대면대웅제약멘토링프로그램진행,http://weekly.hankooki.com/lpage/economy/202005/wk20200526143912146380.htm?s_ref=nv
2977,2020-05-26,코로나에도쉬지않는봉사대웅제약온라인으로비대면봉사활동,http://www.getnews.co.kr/view.php?ud=202005261447546692fe691f917_16
2978,2020-05-26,대웅제약참지마요프로젝트발달장애인위한봉사활동진행,http://sports.hankooki.com/lpage/economy/202005/sp20200526144818136980.htm?s_ref=nv
2979,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.medigatenews.com/news/2931646147
2980,2020-05-26,대웅제약온라인으로비대면봉사진행,http://www.segye.com/content/html/2020/05/26/20200526511137.html?OutUrl=naver
2981,2020-05-26,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://weekly.hankooki.com/lpage/economy/202005/wk20200526153942146380.htm?s_ref=nv
2982,2020-05-26,JW중외제약유한양행한미약품대웅제약당뇨약서발암추정물질검출31개제품제조판매중지,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003986133
2983,2020-05-26,대웅제약온라인으로장애인멘토링봉사활동,http://www.finomy.com/news/articleView.html?idxno=78386
2984,2020-05-26,시경Today제약대웅제약온라인으로비대면봉사활동지속전개外,http://www.meconomynews.com/news/articleView.html?idxno=41760
2985,2020-05-26,대웅제약코로나여파에온라인으로비대면봉사활동벌여,https://www.dailian.co.kr/news/view/892786?sc=Naver
2986,2020-05-26,대웅제약온라인비대면봉사활동지속,http://www.whosaeng.com/118092
2987,2020-05-26,대웅제약온라인통해발달장애인멘토링활동전개,http://www.100ssd.co.kr/news/articleView.html?idxno=68972
2988,2020-05-26,대웅제약온라인으로발달장애인봉사활동진행,http://www.cnbnews.com/news/article.html?no=447893
2989,2020-05-26,김창수의e뉴스브리핑시판당뇨약발암물질검출대웅제약제일약품등31개제조판매중지外,https://www.fetv.co.kr/news/article.html?no=55464
2990,2020-05-26,메트포르민암가능성낮다지만대웅제약그룹JW중외타격우려,http://www.sisajournal-e.com/news/articleView.html?idxno=218881
2991,2020-05-26,대웅제약온라인으로비대면봉사활동지속,http://www.ajunews.com/view/20200526172739973
2992,2020-05-26,대웅제약발달장애인증상표현교육온라인진행,http://news.mt.co.kr/mtview.php?no=2020052617404498781
2993,2020-05-26,대웅제약의사소통카드감수온라인봉사활동실시,http://www.mediapen.com/news/view/528101
2994,2020-05-26,비즈피플대웅제약발달장애멘토링온라인봉사활동진행외2건,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052616584174768
2995,2020-05-26,대웅제약봉사활동온라인비대면으로펼쳐,https://www.kpanews.co.kr/article/show.asp?idx=213482&category=D
2996,2020-05-27,뉴스투데이L대웅제약발달장애인임직원멘토링온라인진행,https://www.news2day.co.kr/153463
2997,2020-05-27,대웅제약온라인으로비대면봉사활동지속전개,http://www.thefirstmedia.net/news/articleView.html?idxno=58589
2998,2020-05-27,메디톡스vs대웅제약균주전쟁마무리단계상처뿐인결과,https://www.dailian.co.kr/news/view/892766?sc=Naver
2999,2020-05-27,대웅제약신풍제약지지부진특히신풍제약4거래일만에하락세로,http://www.econonews.co.kr/news/articleView.html?idxno=121999
3000,2020-05-27,e커머스에꽂힌제약업계동아제약대웅제약JW중외제약잇따라쇼핑몰오픈,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003987580
3001,2020-05-28,대웅제약신풍제약희비엇갈려대웅제약1하락반해신풍제약1상승,http://www.econonews.co.kr/news/articleView.html?idxno=122198
3002,2020-05-28,대웅제약베트남진출숨고르기코로나에기술이전지연,https://www.theguru.co.kr/news/article.html?no=11221
3003,2020-05-28,대웅제약142상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/28/2020052802475.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3004,2020-05-28,대웅제약전일대비569이시각거래량23만8501주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005280306&t=NN
3005,2020-05-28,대웅제약5이상상승주가상승세단기이평선역배열구간,https://www.hankyung.com/finance/article/202005286315L
3006,2020-05-29,대웅제약잼라이브퀴즈이벤트로제품인지도제고,https://www.ebn.co.kr/news/view/1435960?sc=Naver
3007,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://newsbrite.net/137501
3008,2020-05-29,대웅제약잼라이브이벤트진행장건강건기식은,http://www.press9.kr/news/articleView.html?idxno=44822
3009,2020-05-29,장건강도움되는건기식은”대웅제약잼라이브이벤트진행,https://www.fetv.co.kr/news/article.html?no=55732
3010,2020-05-29,대웅제약건기식체험기회확대잼라이브퀴즈이벤트실시,http://medipana.com/news/news_viewer.asp?NewsNum=257652&MainKind=A&NewsKind=5&vCount=12&vKind=1
3011,2020-05-29,대웅제약장건강에도움을주는건강기능식품은,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117696
3012,2020-05-29,대웅제약건강기능식품정보체험제공할퀴즈이벤트나서,http://news.mk.co.kr/newsRead.php?no=550470&year=2020
3013,2020-05-29,대웅제약잼라이브이벤트진행건강기능식품이름맞추기,http://sports.hankooki.com/lpage/economy/202005/sp20200529095910136980.htm?s_ref=nv
3014,2020-05-29,대웅제약잼라이브퀴즈이벤트진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244940
3015,2020-05-29,장건강에도움을주는건강기능식품은대웅제약잼라이브퀴즈이벤트진행,http://theviewers.co.kr/View.aspx?No=857828
3016,2020-05-29,장에좋은건강기능식품은대웅제약퀴즈쇼이벤트,http://news.mt.co.kr/mtview.php?no=2020052910193573150
3017,2020-05-29,대웅제약신풍제약희비엇갈려특히대웅제약가파른하락세로4하락,http://www.econonews.co.kr/news/articleView.html?idxno=122343
3018,2020-05-29,대웅제약장건강에도움주는건기식은,http://moneys.mt.co.kr/news/mwView.php?no=2020052910178017730
3019,2020-05-29,대웅제약소비자대상잼라이브이벤트진행,http://www.pressm.kr/news/articleView.html?idxno=30086
3020,2020-05-29,대웅제약건강기능식품6종잼라이브서퀴즈이벤트,http://www.kpinews.co.kr/news/articleView.html?idxno=117748
3021,2020-05-29,대웅제약잼라이브퀴즈이벤트진행,http://www.bosa.co.kr/news/articleView.html?idxno=2127745
3022,2020-05-29,대웅제약잼라이브이벤트진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61463
3023,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.businesskorea.co.kr/news/articleView.html?idxno=46638
3024,2020-05-29,11개제약사대웅제약올로스타제네릭우판권획득,http://medipana.com/news/news_viewer.asp?NewsNum=257664&MainKind=A&NewsKind=5&vCount=12&vKind=1
3025,2020-05-29,대웅제약잼라이브이벤트장건강에도움을주는건강기능식품진행,http://www.newslock.co.kr/news/articleView.html?idxno=28331
3026,2020-05-29,대웅제약잼라이브이벤트장건강에도움을주는건기식은,http://www.metroseoul.co.kr/article/20200529500086
3027,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.nbnnews.co.kr/news/articleView.html?idxno=396186
3028,2020-05-29,대웅제약잼라이브이벤트추진,http://www.g-enews.com/ko-kr/news/article/news_all/2020052913253954451638db705_1/article.html
3029,2020-05-29,대웅제약건강관련온라인퀴즈쇼이벤트진행,https://www.donga.com/news/article/all/20200529/101272473/1
3030,2020-05-29,대웅제약오는31일오후9시잼라이브이벤트진행,http://www.getnews.co.kr/view.php?ud=202005291335422362fe691f917_16
3031,2020-05-29,대웅제약잼라이브이벤트진행,http://www.lawissue.co.kr/view.php?ud=202005291354323528204ead0791_12
3032,2020-05-29,대웅제약잼라이브서건식체험이벤트진행,http://www.whosaeng.com/118217
3033,2020-05-29,뉴스투데이L대웅제약소비자대상잼라이브이벤트진행,https://www.news2day.co.kr/153652
3034,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건기식은,http://www.mdtoday.co.kr/mdtoday/index.html?no=388309
3035,2020-05-29,대웅제약잼라이브이벤트진행,http://daily.hankooki.com/lpage/industry/202005/dh20200529155030148390.htm?s_ref=nv
3036,2020-05-29,대웅제약잼라이브진행장건강에도움을주는건강기능식품은,http://www.paxetv.com/news/articleView.html?idxno=93208
3037,2020-05-29,대웅제약잼라이브서건기식퀴즈이벤트열어,https://www.kpanews.co.kr/article/show.asp?idx=213589&category=D
3038,2020-05-31,대웅제약라이브퀴즈쇼잼라이브진행,http://www.dailymedi.com/detail.php?number=856647&thread=22r05
3039,2020-05-31,대웅제약락피더스에너씨슬등잼라이브퀴즈이벤트,http://www.consumuch.com/news/articleView.html?idxno=48994
3040,2020-06-01,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.ybsn.tv/news/articleView.html?idxno=15097
3041,2020-06-01,대웅제약신풍제약모두지지부진대웅제약보합이어신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=122708
3042,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈서최초선보여,http://www.pressm.kr/news/articleView.html?idxno=30118
3043,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,https://www.fetv.co.kr/news/article.html?no=55884
3044,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏와디즈서공개,http://www.press9.kr/news/articleView.html?idxno=44846
3045,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈서최초공개,http://www.getnews.co.kr/view.php?ud=2020060110063819062fe691f917_16
3046,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서최초공개,http://medipana.com/news/news_viewer.asp?NewsNum=257744&MainKind=A&NewsKind=5&vCount=12&vKind=1
3047,2020-06-01,대웅제약양치힘좋은칫솔덴티가드랩그립핏공개,http://news.mt.co.kr/mtview.php?no=2020060110070340265
3048,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈에서공개,http://www.cnbnews.com/news/article.html?no=448514
3049,2020-06-01,대웅제약와디즈서덴티가드랩그립핏칫솔공개,http://www.kpinews.co.kr/news/articleView.html?idxno=117825
3050,2020-06-01,대웅제약와디즈통해덴티가드랩그립핏칫솔펀딩나서,http://news.mk.co.kr/newsRead.php?no=558003&year=2020
3051,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈최초공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245023
3052,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서최초공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574629619919
3053,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏최초공개,http://www.m-i.kr/news/articleView.html?idxno=715487
3054,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://newsbrite.net/137614
3055,2020-06-01,오늘의장바구니롯데백화점현대그린푸드CJ오쇼핑대웅제약외,http://www.newsprime.co.kr/news/article.html?no=506170
3056,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=388478
3057,2020-06-01,신제품홍보도펀딩으로대웅제약덴트가드랩그립핏칫솔공개,http://weekly.hankooki.com/lpage/economy/202006/wk20200601111934146380.htm?s_ref=nv
3058,2020-06-01,대웅제약양치힘이좋은특허칫솔,http://www.g-enews.com/ko-kr/news/article/news_all/20200601112316789951638db705_1/article.html
3059,2020-06-01,대웅제약양치힘이좋은특허칫솔개발,http://www.bosa.co.kr/news/articleView.html?idxno=2127871
3060,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈최초공개,http://www.viva100.com/main/view.php?key=20200601010000226
3061,2020-06-01,양치힘이남달라”대웅제약와디즈서덴티가드랩그립핏칫솔공개,http://www.asiatoday.co.kr/view.php?key=20200601010000530
3062,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.metroseoul.co.kr/article/20200601500260
3063,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서공개,http://www.whosaeng.com/118247
3064,2020-06-01,속보대웅제약부천소사구영업사원코로나19양성판정,http://moneys.mt.co.kr/news/mwView.php?no=2020060114198062269
3065,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서최초공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=27468
3066,2020-06-01,대웅제약경인지점직원코로나19확진판정,http://www.press9.kr/news/articleView.html?idxno=44851
3067,2020-06-01,대웅제약부천영업사원코로나19확진쿠팡물류센터발아냐,http://moneys.mt.co.kr/news/mwView.php?no=2020060114288079217
3068,2020-06-01,뉴스투데이L대웅제약덴티가드랩그립핏칫솔와디즈에서최초공개,https://www.news2day.co.kr/153762
3069,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=396636
3070,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=224378
3071,2020-06-01,대웅제약영업사원코로나19확진1명추가확진가능성,http://www.viva100.com/main/view.php?key=20200601010000291
3072,2020-06-01,대웅제약부천지점영업사원코로나19확진,http://www.dt.co.kr/contents.html?article_no=2020060102109931102002&ref=naver
3073,2020-06-01,대웅제약특허칫솔덴티카드랩그립핏와디즈서공개,http://www.econovill.com/news/articleView.html?idxno=399002
3074,2020-06-01,대웅제약부천영업사원코로나19확진판정감염경로미확인,http://www.ajunews.com/view/20200601151220114
3075,2020-06-01,대웅제약메디톡스보툴리눔균주공방이번주분수령,http://www.shinailbo.co.kr/news/articleView.html?idxno=1284554
3076,2020-06-01,대웅제약영업사원코로나19확진판정병의원불안감고조,http://www.medigatenews.com/news/2520834612
3077,2020-06-01,대웅제약영업사원코로나19확진영업소방역완료,http://www.dailypharm.com/Users/News/NewsView.html?ID=265127&REFERER=NP
3078,2020-06-01,대웅제약부천담당영맨코로나19확진,http://www.monews.co.kr/news/articleView.html?idxno=211110
3079,2020-06-01,대웅제약부천영업사원코로나19확진판정,http://www.newsway.co.kr/news/view?tp=1&ud=2020060116094563574
3080,2020-06-01,대웅제약영업사원코로나19확진자발생임직원들에입단속,http://www.wolyo.co.kr/news/articleView.html?idxno=105830
3081,2020-06-01,대웅제약덴티가드랩그립핏칫솔공개,http://www.lawissue.co.kr/view.php?ud=202006011623302945204ead0791_12
3082,2020-06-01,대웅제약영업사원코로나19확진영업인력첫사례,http://www.newstomato.com/ReadNews.aspx?no=975494
3083,2020-06-01,병의원코로나공포재점화대웅제약영업사원코로나19확진쿠팡과관계없어”,http://theviewers.co.kr/View.aspx?No=860151
3084,2020-06-01,대웅제약영업사원2명코로나19확진,http://www.newspim.com/news/view/20200601000994
3085,2020-06-01,대웅제약22일까지양치힘좋은덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.updownnews.co.kr/news/articleView.html?idxno=219371
3086,2020-06-01,대웅제약영업사원코로나확진,https://www.ebn.co.kr/news/view/1436325?sc=Naver
3087,2020-06-01,대웅제약양치힘좋은특허칫솔덴티가드랩그립핏칫솔와디즈서최초공개,http://www.newslock.co.kr/news/articleView.html?idxno=28370
3088,2020-06-01,제약사도뚫렸다대웅제약영업사원2명코로나19확진,http://news.heraldcorp.com/view.php?ud=20200601000940
3089,2020-06-01,대웅제약영업사원2인코로나19확진약국들르지않은듯,https://www.kpanews.co.kr/article/show.asp?idx=213618&category=D
3090,2020-06-01,대웅제약부천영업사원코로나19확진쿠팡근무자가족아냐,http://www.mediapen.com/news/view/529688
3091,2020-06-01,대웅제약양치힘좋은덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=46765
3092,2020-06-01,제약업계도코로나19엄습대웅제약영업사원코로나19확진,http://www.whitepaper.co.kr/news/articleView.html?idxno=194002
3093,2020-06-01,대웅제약영업사원코로나19확진거래처추가확진사례없어,http://www.asiatoday.co.kr/view.php?key=20200601010000797
3094,2020-06-01,대웅제약영업사원코로나19확진판정임직원들에함구령,http://www.newsfc.co.kr/news/articleView.html?idxno=41312
3095,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.ybsn.tv/news/articleView.html?idxno=15274
3096,2020-06-02,메디톡스대웅제약보톡스분쟁이번주누구의주름살이펴질까,http://www.hankookilbo.com/news/npath/202006011571350424?did=NA
3097,2020-06-02,대기업매출액감소속종근당∙대웅제약∙셀트리온매출1조클럽진입,http://www.g-enews.com/ko-kr/news/article/news_all/202006020605097193a218188523_1/article.html
3098,2020-06-02,이번주결판메디톡스대웅제약누가승리할까,http://moneys.mt.co.kr/news/mwView.php?no=2020060208508030878
3099,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.getnews.co.kr/view.php?ud=2020060209462498432fe691f917_16
3100,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.press9.kr/news/articleView.html?idxno=44862
3101,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.viva100.com/main/view.php?key=20200602010000471
3102,2020-06-02,대웅제약발달장애인위한ACC그림카드기부대상기관모집,http://www.mhj21.com/130893
3103,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.youthdaily.co.kr/news/article.html?no=38682
3104,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,https://www.fetv.co.kr/news/article.html?no=56040
3105,2020-06-02,대웅제약발달장애인질병표현그림카드기부대상기관모집,http://news.mt.co.kr/mtview.php?no=2020060209500721228
3106,2020-06-02,대웅제약질병표현AAC그림카드기부대상기관모집,http://www.koreastocknews.com/news/articleView.html?idxno=54117
3107,2020-06-02,대웅제약질병표현AAC카드기부대상기관모집,http://www.kpinews.co.kr/news/articleView.html?idxno=117947
3108,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.ekn.kr/news/article.html?no=502887
3109,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.g-enews.com/ko-kr/news/article/news_all/20200602100417856551638db705_1/article.html
3110,2020-06-02,그림카드로아픈곳표현대웅제약발달장애인위한AAC그림카드기부신청기관모집,http://theviewers.co.kr/View.aspx?No=860507
3111,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://medipana.com/news/news_viewer.asp?NewsNum=257820&MainKind=A&NewsKind=5&vCount=12&vKind=1
3112,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://newsbrite.net/137649
3113,2020-06-02,대웅제약발달장애인AAC그림카드기부대상기관모집,https://www.paxnetnews.com/articles/61196
3114,2020-06-02,대웅제약신풍제약희비엇갈려대웅제약2상승반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=122854
3115,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.m-i.kr/news/articleView.html?idxno=715897
3116,2020-06-02,종합신규16명2일경기도코로나19확진자총869명대웅제약관련확진자추가,http://digitalchosun.dizzo.com/site/data/html_dir/2020/06/02/2020060280072.html
3117,2020-06-02,대웅제약발달장애인위한AAC그림카드기부기관모집,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573837292432
3118,2020-06-02,대웅제약부천점영업사원코로나19확진지역감염의심,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574411463641
3119,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.cnbnews.com/news/article.html?no=448674
3120,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.metroseoul.co.kr/article/20200602500126
3121,2020-06-02,대웅제약전일대비583최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006020170&t=NN
3122,2020-06-02,대웅제약5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006021230L
3123,2020-06-02,대웅제약참지마요프로젝트발달장애인위한AAC그림카드기부대상기관모집,http://www.pressm.kr/news/articleView.html?idxno=30157
3124,2020-06-02,부천담당대웅제약영업사원코로나확진병원약국비상,https://www.news1.kr/articles/?3952534
3125,2020-06-02,대웅제약발달장애인 위한AAC그림카드기부 기관모집,http://www.economytalk.kr/news/articleView.html?idxno=206330
3126,2020-06-02,대웅제약참지마요프로젝트일환AAC그림카드기부대상기관모집,http://www.newsprime.co.kr/news/article.html?no=506341
3127,2020-06-02,대웅제약참지마요프로젝트보완대체의사소통카드지원받을기관모집나서,http://news.mk.co.kr/newsRead.php?no=562621&year=2020
3128,2020-06-02,대웅제약경인지역영업사원코로나19확진판정,http://www.wikileaks-kr.org/news/articleView.html?idxno=87857
3129,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.thepublic.kr/news/newsview.php?ncode=1065576837582848
3130,2020-06-02,확진영업사원동선숨기는대웅제약영업비밀,http://news.mt.co.kr/mtview.php?no=2020060211254752255
3131,2020-06-02,대웅제약발달장애인위한AAC그림카드제작기부,http://www.bosa.co.kr/news/articleView.html?idxno=2127960
3132,2020-06-02,뉴스투데이L대웅제약발달장애인위한AAC그림카드기부대상기관모집,https://www.news2day.co.kr/153831
3133,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.enewstoday.co.kr/news/articleView.html?idxno=1391134
3134,2020-06-02,대웅제약영업사원2명코로나19확진판정,https://www.sedaily.com/NewsView/1Z3VDKJZTW
3135,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61527
3136,2020-06-02,ITC대웅제약제출추가증거자료채택예비판결7월로연기,https://www.news1.kr/articles/?3952699
3137,2020-06-02,메디톡스대웅제약ITC판결다음달6일로연기,https://www.sedaily.com/NewsView/1Z3VDCC9N0
3138,2020-06-02,대웅제약발달장애인AAC그림카드기부대상기관모집,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245112
3139,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.wsobi.com/news/articleView.html?idxno=98617
3140,2020-06-02,대웅제약발달장애인위한의사소통그림카드기부대상기관모집,https://www.donga.com/news/article/all/20200602/101323359/1
3141,2020-06-02,대웅제약발달장애인위한질병표현그림카드기부기관모집,http://www.100ssd.co.kr/news/articleView.html?idxno=69130
3142,2020-06-02,美ITC메디톡스대웅제약예비판정내달6일로연기,https://www.paxnetnews.com/articles/61207
3143,2020-06-02,메디톡스대웅제약美ITC판결다음달6일로연기,https://www.fetv.co.kr/news/article.html?no=56065
3144,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.welfarenews.net/news/articleView.html?idxno=74015
3145,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.nbnnews.co.kr/news/articleView.html?idxno=396840
3146,2020-06-02,메디톡스품목취소영향美ITC대웅제약소송연기,http://www.newspim.com/news/view/20200602000656
3147,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://moneys.mt.co.kr/news/mwView.php?no=2020060211538070945
3148,2020-06-02,대웅제약발달장애인AAC그림카드기부대상기관모집,http://www.asiatoday.co.kr/view.php?key=20200602010001335
3149,2020-06-02,메디톡스대웅제약운명의날내달로연기7월6일결착,https://www.hankyung.com/it/article/2020060215026
3150,2020-06-02,메디톡스대웅제약ITC판결한달연기,http://www.edaily.co.kr/news/newspath.asp?newsid=03034006625797784
3151,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://sports.hankooki.com/lpage/economy/202006/sp20200602141558136980.htm?s_ref=nv
3152,2020-06-02,대웅제약메디톡스운명의날한달연기식약처결정주목,http://www.upinews.kr/newsView/upi202006020067
3153,2020-06-02,대웅제약사회공헌참지마요프로젝트진행,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=224428
3154,2020-06-02,대웅제약메디톡스ITC소송예비판결내달로연기,http://medipana.com/news/news_viewer.asp?NewsNum=257846&MainKind=A&NewsKind=5&vCount=12&vKind=1
3155,2020-06-02,대웅제약영업사원코로나19확진판정,http://www.seoulfn.com/news/articleView.html?idxno=384546
3156,2020-06-02,메디톡스대웅제약ITC판결한달연기,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020060214405937051
3157,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.updownnews.co.kr/news/articleView.html?idxno=219425
3158,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.dailysmart.co.kr/news/articleView.html?idxno=27551
3159,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,https://www.kpanews.co.kr/article/show.asp?idx=213659&category=D
3160,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.mediapen.com/news/view/529957
3161,2020-06-02,메디톡스대웅제약美ITC균주분쟁예비판결한달연기,http://it.chosun.com/site/data/html_dir/2020/06/02/2020060202736.html
3162,2020-06-02,메디톡스대웅제약美ITC예비판결다음달6일로연기,http://www.asiatoday.co.kr/view.php?key=20200602010001435
3163,2020-06-02,대웅제약AAC그림카드기부대상모집,http://www.seoulfn.com/news/articleView.html?idxno=384550
3164,2020-06-02,대웅제약메디톡스ITC판결1달연기,http://www.econovill.com/news/articleView.html?idxno=399197
3165,2020-06-02,제약사도뚫렸다”대웅제약영업사원2명코로나19확진,https://www.fetv.co.kr/news/article.html?no=56085
3166,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.newslock.co.kr/news/articleView.html?idxno=28419
3167,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.sportsseoul.com/news/read/922576?ref=naver
3168,2020-06-02,끝날듯말듯메디톡스대웅제약보톡스전쟁ITC예비판결한달연기,http://theviewers.co.kr/View.aspx?No=861227
3169,2020-06-02,대웅제약vs메디톡스ITC예비판결일7월6일로연기,http://news.mt.co.kr/mtview.php?no=2020060216292011444
3170,2020-06-02,대웅제약전승호vs메디톡스정현호ITC전쟁최후의승자는,https://www.fetv.co.kr/news/article.html?no=56092
3171,2020-06-02,ITC대웅제약메디톡스분쟁예비판결돌연한달연기,https://www.sedaily.com/NewsView/1Z3VE2MU4N
3172,2020-06-02,대웅제약메디톡스ITC예비판결일한달연기,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006020379&t=NN
3173,2020-06-02,메디톡스vs대웅제약보톡스분쟁한달연기,http://moneys.mt.co.kr/news/mwView.php?no=2020060217198067698
3174,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.thefirstmedia.net/news/articleView.html?idxno=58848
3175,2020-06-02,메디톡스대웅제약보툴리눔균주분쟁ITC예비판정한달연기,http://yna.kr/AKR20200602164500017?did=1195m
3176,2020-06-02,메디톡스대웅제약보툴리눔균주분쟁ITC예비판정연기,http://www.ekn.kr/news/article.html?no=503042
3177,2020-06-02,대웅제약치매치료제공백을편의성높인새치료제개발로만회힘써,http://www.businesspost.co.kr/BP?command=article_view&num=180999
3178,2020-06-02,부천지역대웅제약영업사원2명코로나19확진,http://inthenews.co.kr/article-51879/
3179,2020-06-02,보톡스균주공방메디톡스대웅제약美ITC예비판결한달연기,https://cnbc.sbs.co.kr/article_hub/10000985075?division=NAVER
3180,2020-06-02,ITC메디톡스대웅제약분쟁예비판정11월로연기,http://www.kukinews.com/news/article.html?no=794629
3181,2020-06-02,보툴리눔균주분쟁메디톡스대웅제약ITC예비판정한달연기,http://www.newsway.co.kr/news/view?tp=1&ud=2020060219222835725
3182,2020-06-02,글로벌Biz24美ITC메디톡스대웅제약보툴리눔균주분쟁예비판정연기,http://www.g-enews.com/ko-kr/news/article/news_all/202006021920346911e8b8a793f7_1/article.html
3183,2020-06-02,메디톡스대웅제약ITC예비판정한달연기,http://www.hankookilbo.com/news/npath/202006021918084781?did=NA
3184,2020-06-02,메디톡스대웅제약균주전쟁ITC예비판정한달연기,https://www.dailian.co.kr/news/view/894503?sc=Naver
3185,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.lawissue.co.kr/view.php?ud=202006021939122803204ead0791_12
3186,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=388717
3187,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.betanews.net:8080/article/1186348.html
3188,2020-06-02,대웅제약메디톡스균주분쟁의미국국제무역위예비판결7월로연기,http://www.businesspost.co.kr/BP?command=article_view&num=181015
3189,2020-06-02,메디톡스대웅제약ITC예비판정한달연기,http://www.cstimes.com/news/articleView.html?idxno=416373
3190,2020-06-02,데일리안오늘뉴스종합메디톡스대웅제약균주전쟁ITC예비판정한달연기수도권개척교회집단감염확산등,https://www.dailian.co.kr/news/view/894505?sc=Naver
3191,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.econovill.com/news/articleView.html?idxno=399263
3192,2020-06-02,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.thefirstmedia.net/news/articleView.html?idxno=58874
3193,2020-06-03,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.thefirstmedia.net/news/articleView.html?idxno=58893
3194,2020-06-03,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.ybsn.tv/news/articleView.html?idxno=15465
3195,2020-06-03,메디톡스대웅제약ITC예비판정한달연기,http://www.seoulfn.com/news/articleView.html?idxno=384599
3196,2020-06-03,메디톡스대웅제약美ITC판결한달연기,http://www.mdtoday.co.kr/mdtoday/index.html?no=388683
3197,2020-06-03,대웅제약영업사원2명코로나19확진영업소잠정폐쇄”,http://www.mdtoday.co.kr/mdtoday/index.html?no=388688
3198,2020-06-03,대웅제약ITC소송유리한입지가능성↑KTB투자증권,http://www.fnnews.com/news/202006030828115377
3199,2020-06-03,리포트브리핑대웅제약ITC소송이슈에연연할필요가없는주가목표가170000원KTB투자증권,http://www.newspim.com/news/view/20200603000118
3200,2020-06-03,메디톡스대웅제약보툴리눔균주분쟁ITC예비판정한달연기,http://www.fntoday.co.kr/news/articleView.html?idxno=219073
3201,2020-06-03,대웅제약ITC소송서유리한입지설가능성커KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=02010646625798112
3202,2020-06-03,메디톡스대웅제약ITC예비판결내달로연기,https://www.ebn.co.kr/news/view/1436591?sc=Naver
3203,2020-06-03,부천30대확진자대웅제약영업사원동선접촉자파악주력,https://www.seoul.co.kr/news/newsView.php?id=20200603500027&wlog_tag3=naver
3204,2020-06-03,부천시장대웅제약영업사원증상발현이후5곳다녔다”,http://www.kukinews.com/news/article.html?no=794790
3205,2020-06-03,대웅제약영업사원2명코로나19확진경인지점폐쇄,https://www.sisa-news.com/news/article.html?no=126808
3206,2020-06-03,비즈헬스대웅제약보툴리눔톡신균주전쟁굳히기들어가,http://www.bizwnews.com/news/articleView.html?idxno=13782
3207,2020-06-03,부천30대대웅제약영업사원코로나19확진병원약국비상,http://www.pinpointnews.co.kr/view.php?ud=2020060313294499822365609d9b_45
3208,2020-06-03,부천코로나19확진자누구대웅제약경인사무소30대남성,http://www.g-enews.com/ko-kr/news/article/news_all/202006031328532404e4869c120_1/article.html
3209,2020-06-03,대웅제약부천지역영업사원코로나19확진판정사내입단속논란,http://www.datasom.co.kr/news/articleView.html?idxno=106327
3210,2020-06-03,美ITC대웅제약메디톡스보톡스소송예비판결내달로연기,http://www.newsian.co.kr/news/articleView.html?idxno=41756
3211,2020-06-03,코로나19확진대웅제약부천담당영업사원병원약국5곳방문,https://www.news1.kr/articles/?3954468
3212,2020-06-03,대웅제약코로나19확진영업사원2명으로늘어,http://www.mediapen.com/news/view/530283
3213,2020-06-03,코로나19확진대웅제약부천담당영업사원5명접촉동선공개,https://www.news1.kr/articles/?3954704
3214,2020-06-04,메디톡스대웅제약ITC판결놓고동상이몽,https://www.ebn.co.kr/news/view/1436860?sc=Naver
3215,2020-06-04,이인애의뒷담화메디톡스대웅제약진흙탕균주싸움5년째2배비싼외국보톡스만맞아야하나,http://theviewers.co.kr/View.aspx?No=863843
3216,2020-06-05,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006054176L
3217,2020-06-05,시황분석대웅제약전일대비5상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006050955034006edd30cbc4a_45
3218,2020-06-05,대웅제약전일대비50상승중최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006050132&t=NN
3219,2020-06-05,특징주대웅제약117000원5일10시45분등락률636,http://www.getnews.co.kr/view.php?ud=202006051046551702c20b962611_16
3220,2020-06-05,대웅제약818상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501863.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3221,2020-06-05,대웅제약코로나19치료제동물효능시험효과확인,http://www.consumuch.com/news/articleView.html?idxno=49125
3222,2020-06-05,대웅제약1182VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501909.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3223,2020-06-05,특징주대웅제약동물효력시험서코로나19치료효과입증급등,https://view.asiae.co.kr/article/2020060512012536637
3224,2020-06-05,대웅제약니클로사마이드코로나19동물효력시험성공적,http://moneys.mt.co.kr/news/mwView.php?no=2020060511468016440
3225,2020-06-05,특징주대웅제약대웅니클로사마이드코로나19동물임상서완전사멸강세,https://www.etoday.co.kr/news/view/1902910
3226,2020-06-05,특징주대웅제약코로나19치료제바이러스완전제거확인급등,http://www.edaily.co.kr/news/newspath.asp?newsid=02394406625798768
3227,2020-06-05,대웅제약니클로사마이드코로나19치료효과입증,http://news.mk.co.kr/newsRead.php?no=577143&year=2020
3228,2020-06-05,코로나19제약주폭등일양약품SK바이오랜드아이센스진매트리스대웅제약동화약품종목이화제폭발,http://www.g-enews.com/ko-kr/news/article/news_all/20200605121900156451638db705_1/article.html
3229,2020-06-05,코로나19치료제효과대웅대웅제약주가급등,http://news.mt.co.kr/mtview.php?no=2020060512581253425
3230,2020-06-05,대웅제약대웅테라퓨틱스동물효능시험서코로나19치료제효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=389028
3231,2020-06-05,대웅제약코로나19치료제후보물질동물실험서효과,http://yna.kr/AKR20200605080700017?did=1195m
3232,2020-06-05,특징주대웅대웅제약동물시험서코로나19치료제효과입증에급등,http://moneys.mt.co.kr/news/mwView.php?no=2020060513108065494
3233,2020-06-05,대웅제약대웅대웅테라퓨틱스코로나치료제효과확인에급등,http://www.koreastocknews.com/news/articleView.html?idxno=54244
3234,2020-06-05,대웅제약보톡스보툴리눔톡신테마상승세에2273↑,https://view.asiae.co.kr/article/2020060513261976628
3235,2020-06-05,대웅제약일양약품제약주갑작스런급등대웅제약24급등이어일양약품17급등,http://www.econonews.co.kr/news/articleView.html?idxno=123300
3236,2020-06-05,대웅제약코로나19치료후보물질동물실험효과,https://www.sedaily.com/NewsView/1Z3WQMHKR0
3237,2020-06-05,대웅제약코로나19치료제후보물질동물시험서항바이러스효과확인,http://news.kbiz.or.kr/news/articleView.html?idxno=68258
3238,2020-06-05,조아제약이어대웅제약제약주낮부터갑작스런급등대웅제약25급등이어조아제약역시13급등,http://www.econonews.co.kr/news/articleView.html?idxno=123303
3239,2020-06-05,대웅제약코로나19치료제동물시험서효과확인,http://www.newspim.com/news/view/20200605000563
3240,2020-06-05,대웅제약니클로사마이드에코로나19치료효과동물시험통해효력입증,http://www.startuptoday.co.kr/news/articleView.html?idxno=43387
3241,2020-06-05,대웅제약니클로사마이드동물효능시험서코로나19바이러스감소,http://news.mk.co.kr/newsRead.php?no=577644&year=2020
3242,2020-06-05,코로나치료효능뚜렷확신대세상승파미셀씨젠에서대웅제약대웅으로옮겨붙나,http://www.thekpm.com/view.php?ud=202006051403008258861beb2d9d_17
3243,2020-06-05,대웅대웅제약주가장중급등코로나19치료제동물실험효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=181486
3244,2020-06-05,포털검색상위종목삼성전자대웅제약드림텍대웅조아제약투자자들관심증가,http://www.g-enews.com/ko-kr/news/article/news_all/202006051404044511edf69f862c_1/article.html
3245,2020-06-05,대웅제약코로나치료제동물시험진행,https://www.paxnetnews.com/articles/61353
3246,2020-06-05,강세토픽2020년임상예정제약바이오테마대웅제약2500앱클론718,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060502388.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3247,2020-06-05,머니e종목대웅제약대웅코로나19치료제효능입증성공에급등,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020060514220949722
3248,2020-06-05,대웅제약족제비대상임상서코로나바이러스감소확인,http://www.kpinews.co.kr/news/articleView.html?idxno=118283
3249,2020-06-05,시황네이버증권검색상위종목30위시황대웅대웅제약드림텍조아제약일양약품급등,http://www.topstarnews.net/news/articleView.html?idxno=798852
3250,2020-06-05,대웅제약코로나19치료제후보물질동물실험서효과보여,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003998446
3251,2020-06-05,대웅제약니클로사마이드동물실험서3일째부터코로나19바이러스완전제거확인”,https://jhealthmedia.joins.com/article/article_view.asp?pno=21915
3252,2020-06-05,대웅제약3000상한가,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060502537.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3253,2020-06-05,대웅제약상한가↑도달ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006055566L
3254,2020-06-05,이시각상한가대웅제약▲330005일오후14시46분,https://www.etoday.co.kr/news/view/1902997
3255,2020-06-05,구충제가옳았다”대웅제약동물시험통해니클로사마이드코로나19치료효과입증,https://www.donga.com/news/article/all/20200605/101380300/1
3256,2020-06-05,fnRASSI대웅제약상한가기록,http://www.fnnews.com/news/202006051513419589
3257,2020-06-05,대웅제약니클로사마이드코로나19치료효과입증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4174786
3258,2020-06-05,시황보톡스보툴리눔톡신테마주대웅제약급등제테마휴젤상승,http://www.topstarnews.net/news/articleView.html?idxno=798892
3259,2020-06-05,대웅제약코로나19치료제개발순항주가고공행진,http://sports.hankooki.com/lpage/economy/202006/sp20200605151546137020.htm?s_ref=nv
3260,2020-06-05,시황바이오시밀러복제바이오의약품테마주대웅제약상한가알테오젠급등한미약품LG화학셀트리온녹십자상승,http://www.topstarnews.net/news/articleView.html?idxno=798903
3261,2020-06-05,대웅제약니클로사마이드전임상서바이러스완전제거효과,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117941
3262,2020-06-05,시황제약업체테마주대웅제약상한가동화약품일양약품조아제약급등,http://www.topstarnews.net/news/articleView.html?idxno=798909
3263,2020-06-05,대웅제약코로나19치료제후보물질동물실험서효과,http://www.seoulfn.com/news/articleView.html?idxno=384967
3264,2020-06-05,fnRASSI오늘의상한가대웅제약300↑,http://www.fnnews.com/news/202006051537514570
3265,2020-06-05,fnRASSI장마감거래소상승종목대웅제약300↑,http://www.fnnews.com/news/202006051537575015
3266,2020-06-05,대웅제약코로나19치료제동물실험효과,http://www.thevaluenews.co.kr/news/view.php?idx=159669
3267,2020-06-05,특징주대웅제약코로나치료제동물실험효과에상한가,http://yna.kr/AKR20200605120300002?did=1195m
3268,2020-06-05,대웅제약코로나19치료제동물실험효과확인,http://www.dailysmart.co.kr/news/articleView.html?idxno=27803
3269,2020-06-05,대웅제약코로나19치료제동물실험효과에상한가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4174890
3270,2020-06-05,대웅제약코로나19치료용물질동물시험서효과입증,http://www.100ssd.co.kr/news/articleView.html?idxno=69206
3271,2020-06-05,대웅제약코로나치료제동물실험효과상한가,https://www.etoday.co.kr/news/view/1903056
3272,2020-06-05,급등락주짚어보기코로나19치료제개발기대감대웅제약동화약품일양약품급등,https://www.etoday.co.kr/news/view/1903058
3273,2020-06-05,대웅제약코로나19치료제동물효능시험성공,http://weekly.hankooki.com/lpage/economy/202006/wk20200605162413146380.htm?s_ref=nv
3274,2020-06-05,단독ITC재판부대웅제약추가자료연관성있다고판단,http://www.newsis.com/view/?id=NISX20200605_0001050009&cID=13001&pID=13000
3275,2020-06-05,특징주대웅제약코로나19치료제동물실험효과에상한가,http://www.kukinews.com/news/article.html?no=795873
3276,2020-06-05,특징주대웅제약코로나19치료제동물실험효과에상승,http://www.youthdaily.co.kr/news/article.html?no=39051
3277,2020-06-05,대웅제약지주회사대웅코로나치료제동물실험효과에상한가,http://www.newsfc.co.kr/news/articleView.html?idxno=41367
3278,2020-06-05,5일금요일특징주는삼성전자대웅제약셀트리온,http://www.leaders.kr/news/articleView.html?idxno=200825
3279,2020-06-05,팩트체크대웅제약코로나확진판정직원내부입단속의혹사측사실무근,http://www.startuptoday.co.kr/news/articleView.html?idxno=43235
3280,2020-06-05,주식대웅제약2409코로나19치료제소식에주가폭등관련내용은,http://www.ggilbo.com/news/articleView.html?idxno=774032
3281,2020-06-06,마감대웅제약코로나19치료제동물에효과상한가일양약품러시아임상기대급등,https://www.asiatime.co.kr/news/newsview.php?ncode=1065624948254534
3282,2020-06-06,메디톡스대웅제약보톡스전쟁에ITC예비판정한달연기,https://www.nocutnews.co.kr/news/5356524
3283,2020-06-06,대웅제약동화약품호재발표에상승장더해져상한가기록,http://medipana.com/news/news_viewer.asp?NewsNum=258049&MainKind=A&NewsKind=5&vCount=12&vKind=1
3284,2020-06-06,대웅제약니클로사마이드동물효력시험통해코로나19치료효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=28522
3285,2020-06-06,6일토요일10시현재특징주는대웅제약삼성전자셀트리온,http://www.leaders.kr/news/articleView.html?idxno=200852
3286,2020-06-06,시황6월5일네이버증권검색상위종목30위장마감시황삼성전자대웅제약SK텔레콤삼성전자우카카오등상황은,http://www.topstarnews.net/news/articleView.html?idxno=799330
3287,2020-06-06,기업분석코로나19치료제로상한가친대웅대웅제약어떤회사,http://www.g-enews.com/ko-kr/news/article/news_all/202006061357004712c5557f8da8_1/article.html
3288,2020-06-07,7일일요일10시현재특징주는삼성전자대웅제약셀트리온,http://www.leaders.kr/news/articleView.html?idxno=200890
3289,2020-06-07,시황6월5일바이오시밀러복제바이오의약품테마주장마감시황대웅제약알테오젠한미약품LG화학셀트리온등상황은,http://www.topstarnews.net/news/articleView.html?idxno=799811
3290,2020-06-07,시황6월5일제약업체테마주의장마감시황대웅제약동화약품일양약품조아제약KPX생명과학등상황은,http://www.topstarnews.net/news/articleView.html?idxno=799818
3291,2020-06-07,코로나치료제개발가속화상한가동화약품대웅제약급등일양약품부광약품,http://www.ggilbo.com/news/articleView.html?idxno=774346
3292,2020-06-07,이주의주식흐름은조선업철강업대박셀트리온급등일본불매관련주관심집중에대웅제약등제약주상한가,http://www.ggilbo.com/news/articleView.html?idxno=774373
3293,2020-06-08,자정택배뉴스한국인정서에딱맞는제약주정신없이뜀박질일양약품동화제약대웅제약JW중외제약조아제약셀트리온꼭짓점은,http://www.g-enews.com/ko-kr/news/article/news_all/20200607185735163951638db705_1/article.html
3294,2020-06-08,제약바이오주덜커덩수출424↓씨젠셀트리온대웅제약메디톡스파미셀SK케미칼바이오랜드2차폭발,http://www.g-enews.com/ko-kr/news/article/news_all/202006080448227634a01bf698f_1/article.html
3295,2020-06-08,6월바이오제약상승률상위종목은엘앤케이바이오셀트리온제약대웅제약동화약품순,http://www.g-enews.com/ko-kr/news/article/news_all/202006080608172947edf69f862c_1/article.html
3296,2020-06-08,대웅테라퓨틱스대웅제약마이크로니들활용한성장호르몬개발시작,http://www.ceoscoredaily.com/news/article.html?no=70217
3297,2020-06-08,메디톡스VS대웅제약ITC및국내민사소송균주분쟁의진실은일상톡톡플러스,http://www.segye.com/content/html/2020/06/07/20200607509270.html?OutUrl=naver
3298,2020-06-08,코로나관련주대웅제약동화약품일양약품호재코로나치료제이슈는계속씨젠등진단키트관련주는,http://www.ggilbo.com/news/articleView.html?idxno=774392
3299,2020-06-08,증시키워드대웅제약일양약품코로나19치료제개발기대감에급등조선주는숨고르기,https://www.etoday.co.kr/news/view/1903388
3300,2020-06-08,일양약품대웅제약제약주희비엇갈려대웅제약4하락반해일양약품19급등,http://www.econonews.co.kr/news/articleView.html?idxno=123532
3301,2020-06-08,주식일양약품대웅제약희비갈려일양약품은멈추지않는상승세대웅제약은3대하락,http://www.ggilbo.com/news/articleView.html?idxno=774413
3302,2020-06-08,재계톡톡대웅제약코로나19확진자입단속논란에진땀,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=583969
3303,2020-06-08,대웅제약ITC소송이슈에연연할필요가없는주가주가13만5500원524,https://view.asiae.co.kr/article/2020060810471872119
3304,2020-06-08,일양약품대웅제약엇갈리는주가여전일양약품25급등반해대웅제약4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=123626
3305,2020-06-08,대웅제약發코로나19후폭풍제약영업비대면강화되나,https://www.asiatime.co.kr/news/newsview.php?ncode=1065580046418005
3306,2020-06-08,대웅제약에거부당한중기부조사규정바꿨다,https://www.nocutnews.co.kr/news/5357445
3307,2020-06-09,병원가도되나요”대웅제약영업맨코로나19확진병의원대면영업기피심화,http://theviewers.co.kr/View.aspx?No=866576
3308,2020-06-09,일양약품대웅제약제약주희비엇갈려특히일양약품가파른하락세로5낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=123701
3309,2020-06-09,대웅제약상승출발후현재519최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006090231&t=NN
3310,2020-06-09,대웅제약630상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060901746.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3311,2020-06-09,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006096588L
3312,2020-06-09,시황분석대웅제약전일대비63상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006091132171579edd30bc0c0_45
3313,2020-06-09,특징주대웅제약144000원9일11시35분등락률667,http://www.getnews.co.kr/view.php?ud=202006091136491564c20b99e7dc_16
3314,2020-06-09,대웅제약1185VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060901826.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3315,2020-06-09,시황보톡스보툴리눔톡신테마주6월9일12시10분현재장중시황대웅제약디에스케이휴젤파마리서치프로덕트제테마등상황은,http://www.topstarnews.net/news/articleView.html?idxno=801475
3316,2020-06-09,시황코로나19진단치료제백신개발등테마주6월9일12시35분현재장중시황제일약품대웅대웅제약JW중외제약뉴지랩등상황은,http://www.topstarnews.net/news/articleView.html?idxno=801487
3317,2020-06-09,대웅대웅제약급등니클로사마이드동물임상긍정적,http://www.ggilbo.com/news/articleView.html?idxno=774851
3318,2020-06-09,대웅제약이어JW중외제약급등대웅제약15급등이어JW중외제약8급등,http://www.econonews.co.kr/news/articleView.html?idxno=123794
3319,2020-06-09,대웅제약부광약품모두급등대웅제약14급등이어부광약품23급등,http://www.econonews.co.kr/news/articleView.html?idxno=123798
3320,2020-06-09,이시각증시제약주강세제일약품상한가대웅대웅제약부광약품10이상급등,http://www.g-enews.com/ko-kr/news/article/news_all/202006091328105870edf69f862c_1/article.html
3321,2020-06-09,강세토픽2020년임상예정제약바이오테마대웅제약1333종근당876,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060902303.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3322,2020-06-09,강세토픽치매치료테마대웅제약1444종근당977,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060902446.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3323,2020-06-09,시황제약업체테마주6월9일15시2분현재장중시황제일약품신풍제약부광약품대웅제약테라젠이텍스등상황은,http://www.topstarnews.net/news/articleView.html?idxno=801639
3324,2020-06-09,대웅제약코로나19확진자발생에병의원대면영업손사래,http://www.seouleconews.com/news/articleView.html?idxno=55060
3325,2020-06-10,대웅제약일양약품제약주희비엇갈려대웅제약1상승반해일양약품2하락,http://www.econonews.co.kr/news/articleView.html?idxno=123908
3326,2020-06-10,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006100158L
3327,2020-06-10,특징주대웅제약158500원10일9시20분등락률673,http://www.getnews.co.kr/view.php?ud=202006100922053210c20b994deb_16
3328,2020-06-10,주식 에이비엘바이오 1141기대감상승‥ 한미약품앱클론대웅제약젬백스는,http://www.ggilbo.com/news/articleView.html?idxno=775185
3329,2020-06-10,부자들은경제신문을읽는다메디톡스결국메디톡신패배대웅대웅제약트레이딩대응유효,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020061013331139906
3330,2020-06-10,대웅제약일양약품부광약품신풍제약시총7조넘어중견제약코로나수혜로질풍노도,http://www.thevaluenews.co.kr/news/view.php?idx=159716
3331,2020-06-11,코로나19종목멈칫일양약품부광약품대웅제약셀트리온제약진원생명과학↓신풍제약씨젠파미셀엔지켐생명과학제넥신아이진↑,http://www.g-enews.com/ko-kr/news/article/news_all/20200611021926399851638db705_1/article.html
3332,2020-06-11,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006114872L
3333,2020-06-11,대웅제약일양약품제약주상승에급등까지특히대웅제약갑작스런6급등,http://www.econonews.co.kr/news/articleView.html?idxno=124078
3334,2020-06-11,시황분석대웅제약전일대비634상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006110928362081edd301a897_45
3335,2020-06-12,대웅제약의사몰래처방통계데이터빼돌렸다,https://www.paxnetnews.com/articles/61605
3336,2020-06-12,일양약품대웅제약제약주하락에급락까지일양약품8급락이어대웅제약5하락,http://www.econonews.co.kr/news/articleView.html?idxno=124198
3337,2020-06-12,이종욱전대웅제약부회장우정바이오회장으로자리옮겨,http://www.wikileaks-kr.org/news/articleView.html?idxno=88804
3338,2020-06-13,대웅제약병의원청구자료유출의혹제기,http://www.medigatenews.com/news/1811820519
3339,2020-06-13,메디톡스대웅제약신경전에결과관심집중메디톡신200단위출하승인에주가상승세이어질까,http://www.ggilbo.com/news/articleView.html?idxno=776072
3340,2020-06-15,대웅제약제약바이오액셀러레이터진출,http://www.press9.kr/news/articleView.html?idxno=44975
3341,2020-06-15,일양약품대웅제약제약주하락에급락까지특히일양약품가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=124452
3342,2020-06-15,대웅제약벤처투자강화,http://www.g-enews.com/ko-kr/news/article/news_all/20200615091207648751638db705_1/article.html
3343,2020-06-15,대웅제약제약바이오유망벤처기업육성,http://www.wikileaks-kr.org/news/articleView.html?idxno=88901
3344,2020-06-15,대웅제약액셀러레이터등록제약바이오유망기업키운다,http://news.mt.co.kr/mtview.php?no=2020061509145432214
3345,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.mediapen.com/news/view/532899
3346,2020-06-15,대웅제약액셀러레이터등록제약바이오벤처직접육성,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245550
3347,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://medipana.com/news/news_viewer.asp?NewsNum=258401&MainKind=A&NewsKind=5&vCount=12&vKind=1
3348,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://newsbrite.net/138157
3349,2020-06-15,대웅제약제약바이오전문엑셀러레이터로등록,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571480903141
3350,2020-06-15,대웅제약제약바이오전문엑셀러레이터로등록,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571480903141
3351,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.newsway.co.kr/news/view?tp=1&ud=2020061509105101678
3352,2020-06-15,대웅제약유망제약바이오벤처기업육성나서,https://www.fetv.co.kr/news/article.html?no=56936
3353,2020-06-15,대웅제약 유망제약바이오벤처직접키운다,http://www.businesskorea.co.kr/news/articleView.html?idxno=47521
3354,2020-06-15,대웅제약유망바이오벤처육성나선다,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006150093&t=NN
3355,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.dailypharm.com/Users/News/NewsView.html?ID=265569&REFERER=NP
3356,2020-06-15,대웅제약유망제약바이오벤처직접키운다,https://biz.chosun.com/site/data/html_dir/2020/06/15/2020061500999.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3357,2020-06-15,대웅제약제약바이오벤처육성위해액셀러레이터등록,http://news.mk.co.kr/newsRead.php?no=609626&year=2020
3358,2020-06-15,대웅제약엑셀러레이터등록제약바이오벤처육성나선다,http://www.asiatoday.co.kr/view.php?key=20200615010008842
3359,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.newsis.com/view/?id=NISX20200615_0001059445&cID=13001&pID=13000
3360,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.econovill.com/news/articleView.html?idxno=400882
3361,2020-06-15,대웅제약유망벤처전략지원연구에서사업화까지,http://moneys.mt.co.kr/news/mwView.php?no=2020061509068053384
3362,2020-06-15,대웅제약제약바이오전문엑셀러레이터등록,http://www.biospectator.com/view/news_view.php?varAtcId=10594
3363,2020-06-15,대웅제약유망벤처직접육성액셀러레이터등록,https://www.sedaily.com/NewsView/1Z41BFGVJA
3364,2020-06-15,대웅제약액셀러레이터등록스타트업키운다,http://www.mhj21.com/131453
3365,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.newspim.com/news/view/20200615000214
3366,2020-06-15,대웅제약제약바이오전문액셀러레이터로등록,http://www.lawissue.co.kr/view.php?ud=202006151001071709204ead0791_12
3367,2020-06-15,유망벤처직접키운다대웅제약제약바이오전문엑셀러레이터등록,http://theviewers.co.kr/View.aspx?No=872384
3368,2020-06-15,대웅제약국내유망제약바이오스타트업발굴해직접키운다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118207
3369,2020-06-15,대웅제약액셀러레이터등록제약바이오벤처육성,http://www.kpinews.co.kr/news/articleView.html?idxno=118961
3370,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.bokuennews.com/news/article.html?no=191271
3371,2020-06-15,대웅제약유망제약바이오벤처직접키운다스타트업과 에코시스템구축,http://www.sisaweek.com/news/articleView.html?idxno=134733
3372,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.m-i.kr/news/articleView.html?idxno=719811
3373,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.seoulwire.com/news/articleView.html?idxno=416127
3374,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.bosa.co.kr/news/articleView.html?idxno=2128689
3375,2020-06-15,대웅제약유망제약바이오벤처기업직접키운다,http://www.fnnews.com/news/202006151022521655
3376,2020-06-15,대웅제약유망제약바이오벤처엑셀러레이터등록,http://www.medigatenews.com/news/1657454732
3377,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.etnews.com/20200615000064
3378,2020-06-15,대웅제약바이오벤처직접육성,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93032
3379,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.thepublic.kr/news/newsview.php?ncode=1065575471210651
3380,2020-06-15,대웅제약 유망제약바이오육성나서중소기업벤처부액셀러레이터최종등록,http://www.newslock.co.kr/news/articleView.html?idxno=28701
3381,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.ybsn.tv/news/articleView.html?idxno=17428
3382,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.datasom.co.kr/news/articleView.html?idxno=106548
3383,2020-06-15,대웅제약유망한제약바이오벤처직접키운다,http://www.monews.co.kr/news/articleView.html?idxno=211419
3384,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.insightkorea.co.kr/news/articleView.html?idxno=80635
3385,2020-06-15,대웅제약유망제약바이오벤처육성나선다,http://www.dailysmart.co.kr/news/articleView.html?idxno=28286
3386,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://news.mk.co.kr/newsRead.php?no=610465&year=2020
3387,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.getnews.co.kr/view.php?ud=2020061511190734772fe691f917_16
3388,2020-06-15,대웅제약액셀러레이터로제약바이오벤처육성,http://www.economytalk.kr/news/articleView.html?idxno=206542
3389,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.segyebiz.com/newsView/20200615509199?OutUrl=naver
3390,2020-06-15,대웅제약제약바이오벤처기업육성위해투자교육박차,http://www.100ssd.co.kr/news/articleView.html?idxno=69392
3391,2020-06-15,대웅제약전문액셀러레이터등록유망제약바이오벤처육성,http://www.newsprime.co.kr/news/article.html?no=507821
3392,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://inthenews.co.kr/article-53848/
3393,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.mdtoday.co.kr/mdtoday/index.html?no=389907
3394,2020-06-15,대웅제약혁신제약바이오벤처키운다전문액셀러레이터등록,http://www.metroseoul.co.kr/article/20200615500260
3395,2020-06-15,대웅제약전문액셀러레이터등록유망제약바이오벤처직접육성,https://www.news1.kr/articles/?3965471
3396,2020-06-15,대웅제약엑셀러레이터등록제약바이오벤처육성,http://sports.hankooki.com/lpage/economy/202006/sp20200615140700136980.htm?s_ref=nv
3397,2020-06-15,대웅제약유망제약바이오벤처육성나선다,http://www.ekn.kr/news/article.html?no=505333
3398,2020-06-15,뉴스투데이L대웅제약유망제약바이오벤처육성나선다,https://www.news2day.co.kr/154606
3399,2020-06-15,대웅제약중기부액셀러레이터최종등록,https://www.ebn.co.kr/news/view/1438308?sc=Naver
3400,2020-06-15,대웅제약유망제약바이오벤처직접키운다,https://sports.donga.com/article/all/20200615/101515075/1
3401,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.nbnnews.co.kr/news/articleView.html?idxno=399827
3402,2020-06-15,대웅제약액셀러레이터로등록마쳐전승호유망벤처와함께성장,http://www.businesspost.co.kr/BP?command=article_view&num=182734
3403,2020-06-15,대웅제약병의원처방데이타불법수집폭로직원들에게도둑질을지시,http://hobbyen.co.kr/news/newsview.php?ncode=1065592563735408
3404,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61735
3405,2020-06-15,제약바이오벤처육성팔걷는대웅제약,http://www.fnnews.com/news/202006151651036696
3406,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.seoulfn.com/news/articleView.html?idxno=385857
3407,2020-06-15,대웅제약유망제약바이오벤처기업육성나서外,https://www.fetv.co.kr/news/article.html?no=57016
3408,2020-06-15,대웅제약제약바이오스타트업직접육성액셀러레이터등록完,https://www.donga.com/news/article/all/20200615/101518932/1
3409,2020-06-15,대웅제약제약바이오유망벤처육성앞장,http://www.shinailbo.co.kr/news/articleView.html?idxno=1289173
3410,2020-06-15,대웅제약유망제약바이오벤처직접키운다,https://www.dailian.co.kr/news/view/897807?sc=Naver
3411,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.thevaluenews.co.kr/news/view.php?idx=159765
3412,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://news.kbiz.or.kr/news/articleView.html?idxno=68690
3413,2020-06-15,대웅제약엑셀러레이터등록제약바이오벤처직접키운다,https://www.kpanews.co.kr/article/show.asp?idx=213959&category=D
3414,2020-06-16,대웅제약제약바이오전문액셀러레이터등록유망스타트업과에코시스템구축,http://www.thefirstmedia.net/news/articleView.html?idxno=59337
3415,2020-06-16,대웅제약유망제약바이오벤처직접키운다,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=224887
3416,2020-06-16,코로나재확산다시뜨는제약바이오주씨젠셀트리온일양약품파미셀SK케미칼대웅제약메디톡스,http://www.g-enews.com/ko-kr/news/article/news_all/2020061520281769834a01bf698f_1/article.html
3417,2020-06-16,대웅제약액셀러레이터등록유망제약바이오벤처지원프로그램운영,http://www.pressm.kr/news/articleView.html?idxno=30489
3418,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.fetv.co.kr/news/article.html?no=57051
3419,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://newsbrite.net/138199
3420,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://daily.hankooki.com/lpage/industry/202006/dh20200616092711148390.htm?s_ref=nv
3421,2020-06-16,대웅제약일양약품제약주상승에급등까지대웅제약4상승이어일양약품7급등,http://www.econonews.co.kr/news/articleView.html?idxno=124611
3422,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.mhj21.com/131485
3423,2020-06-16,대웅제약감염병예방쉬운글도서배포,http://www.whosaeng.com/118640
3424,2020-06-16,대웅제약감염병예방쉬운글도서배포,http://www.whosaeng.com/118640
3425,2020-06-16,대웅제약발달장애인을위한감염병예방도서무료배포​,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118258
3426,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,https://www.sedaily.com/NewsView/1Z41S3SPKP
3427,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://medipana.com/news/news_viewer.asp?NewsNum=258481&MainKind=A&NewsKind=5&vCount=12&vKind=1
3428,2020-06-16,대웅제약발달장애인용감염병예방도서배포,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574314070237
3429,2020-06-16,대웅제약발달장애인위한감염병예방도서배포,http://www.bosa.co.kr/news/articleView.html?idxno=2128774
3430,2020-06-16,대웅제약상승흐름전일대비511최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006160191&t=NN
3431,2020-06-16,대웅제약 발달장애인을위한 감염병예방 쉬운글도서배포,http://www.businesskorea.co.kr/news/articleView.html?idxno=47587
3432,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.m-i.kr/news/articleView.html?idxno=720217
3433,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245610
3434,2020-06-16,코로나19예방법쉬운책으로대웅제약발달장애인위한도서배포,http://theviewers.co.kr/View.aspx?No=873798
3435,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.ajunews.com/view/20200616102208430
3436,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.ekn.kr/news/article.html?no=505531
3437,2020-06-16,대웅제약발달장애인감염병예방쉬운글도서배포,http://www.newsis.com/view/?id=NISX20200616_0001061135&cID=13001&pID=13000
3438,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.youthdaily.co.kr/news/article.html?no=39688
3439,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.thepublic.kr/news/newsview.php?ncode=1065575528111062
3440,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61767
3441,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1394096
3442,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.getnews.co.kr/view.php?ud=2020061611165747502fe691f917_16
3443,2020-06-16,대웅제약발달장애인감염병예방도서배포,http://moneys.mt.co.kr/news/mwView.php?no=2020061610598057537
3444,2020-06-16,대웅제약참지마요프로젝트감염병예방쉬운글도서제작배포,http://www.kpinews.co.kr/news/articleView.html?idxno=119114
3445,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.press9.kr/news/articleView.html?idxno=44997
3446,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.koreaittimes.com/news/articleView.html?idxno=98263
3447,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.metroseoul.co.kr/article/20200616500193
3448,2020-06-16,대웅제약감염병예방관련발달장애인의이해돕는쉬운글도서제작,http://www.g-enews.com/ko-kr/news/article/news_all/20200616123842613851638db705_1/article.html
3449,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.dailysmart.co.kr/news/articleView.html?idxno=28350
3450,2020-06-16,대웅제약등니클로사마이드동물시험서코로나19치료효과입증,https://www.kpanews.co.kr/article/show.asp?idx=213758&category=D
3451,2020-06-16,대웅제약발달장애인이해돕는감염병예방쉬운글도서배포,http://www.pressm.kr/news/articleView.html?idxno=30525
3452,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.nbnnews.co.kr/news/articleView.html?idxno=400103
3453,2020-06-16,대웅제약발달장애인용감염병예방쉬운글도서배포,https://www.ebn.co.kr/news/view/1438524?sc=Naver
3454,2020-06-16,대웅제약발달장애인용감염병예방쉬운글도서배포,https://www.ebn.co.kr/news/view/1438524?sc=Naver
3455,2020-06-16,클로즈업무한협업앞세워공격경영속도내는대웅제약전승호,https://www.fetv.co.kr/news/article.html?no=57088
3456,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.newsway.co.kr/news/view?tp=1&ud=2020061614565477249
3457,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.greened.kr/news/articleView.html?idxno=256316
3458,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.ybsn.tv/news/articleView.html?idxno=17820
3459,2020-06-16,대웅제약발달장애인이읽기쉬운감염병예방도서제작배포,http://www.100ssd.co.kr/news/articleView.html?idxno=69420
3460,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://jhealthmedia.joins.com/article/article_view.asp?pno=21977
3461,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서제작배포,http://www.mdtoday.co.kr/mdtoday/index.html?no=390126
3462,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.lawissue.co.kr/view.php?ud=202006161928457699204ead0791_12
3463,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서500권배포,https://www.donga.com/news/article/all/20200616/101541436/1
3464,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.kpanews.co.kr/article/show.asp?idx=213993&category=D
3465,2020-06-16,대웅제약 발달장애인위한 감염병예방쉬운글도서배포,http://www.newslock.co.kr/news/articleView.html?idxno=28753
3466,2020-06-17,뉴스투데이L대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.news2day.co.kr/154759
3467,2020-06-17,단독직원에게처방내역빼내게한대웅제약,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202006170600015&code=940100
3468,2020-06-17,아침신문보기직원에게처방내역도둑질시킨대웅제약,https://imnews.imbc.com/replay/2020/nwtoday/article/5812723_32531.html
3469,2020-06-17,대웅제약일양약품제약주모두상승세로대웅제약소폭상승이어일양약품3상승,http://www.econonews.co.kr/news/articleView.html?idxno=124760
3470,2020-06-17,대웅제약유망제약바이오벤처직접키운다,http://www.wsobi.com/news/articleView.html?idxno=99495
3471,2020-06-17,대웅제약발달장애인위한감염병예방쉬운글도서500권배포,http://www.eroun.net/news/articleView.html?idxno=12310
3472,2020-06-17,영업사원이용해환자개인정보유출한대웅제약관련사항확인중,https://www.asiatime.co.kr/news/newsview.php?ncode=1065593192706448
3473,2020-06-17,대웅제약발달장애인 위한감염병예방 쉬운글제작배포,http://www.economytalk.kr/news/articleView.html?idxno=206604
3474,2020-06-17,대웅제약신종리베이트논란영업사원에처방내역입수지시,http://www.newsprime.co.kr/news/article.html?no=508195
3475,2020-06-17,대웅제약직원에병원약국처방데이터확보지시논란사측확인중,http://www.ftoday.co.kr/news/articleView.html?idxno=202959
3476,2020-06-17,전세계코로나19확진자급증에치료제개발부광약품신풍제약일양약품GC녹십자SK케미칼대웅제약시가총액껑충,http://www.thekpm.com/view.php?ud=202006171711261035861beb2d9d_17
3477,2020-06-17,전승호이끄는대웅제약에무슨일이,http://www.newsway.co.kr/news/view?tp=1&ud=2020061717435388332
3478,2020-06-17,대웅제약병의원처방데이터불법수집논란사실확인중,http://www.mediapen.com/news/view/533815
3479,2020-06-17,대웅제약영업사원에병원정보및환자개인정보불법수집지시논란,http://theviewers.co.kr/View.aspx?No=876438
3480,2020-06-18,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.thefirstmedia.net/news/articleView.html?idxno=59472
3481,2020-06-18,속보메디톡스보톡스끝내허가취소식약처메디톡신퇴출대웅제약ITC판결연기,http://www.g-enews.com/ko-kr/news/article/news_all/2020061807082786544a01bf698f_1/article.html
3482,2020-06-18,메디톡신취소확정대웅제약과ITC분쟁에악영향주나,https://www.sedaily.com/NewsView/1Z42OO9BHX
3483,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.getnews.co.kr/view.php?ud=2020061809041484112fe691f917_16
3484,2020-06-18,대웅제약보톡스보툴리눔톡신테마상승세에813↑,https://view.asiae.co.kr/article/2020061809070131755
3485,2020-06-18,대웅제약지노믹트리대장암체외진단검사얼리텍공동프로모션조인식,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020061809014059592
3486,2020-06-18,대웅제약10이상상승전일외국인대량순매수,https://www.hankyung.com/finance/article/202006180600L
3487,2020-06-18,대웅제약지노믹트리대장암진단검사얼리텍코프로모션,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245714
3488,2020-06-18,특징주식약처의메디톡신취소에대웅제약등후발보톡스주급등,http://news.mk.co.kr/newsRead.php?no=623947&year=2020
3489,2020-06-18,특징주메디톡스허가취소에급락대웅대웅제약급등,http://www.inews24.com/view/1274401
3490,2020-06-18,대웅제약지노믹트리얼리텍 공동프로모션조인식진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=47721
3491,2020-06-18,대웅제약얼리텍으로헬스케어진단시장진출,https://jhealthmedia.joins.com/article/article_view.asp?pno=21987
3492,2020-06-18,특징주대웅제약휴젤등식약처메디톡신취소에급등,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572195607635
3493,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61818
3494,2020-06-18,대웅제약헬스케어진단시장사업확대,http://www.dailypharm.com/Users/News/NewsView.html?ID=265699&REFERER=NP
3495,2020-06-18,국내1호보톡스메디톡신허가취소메디톡스대웅제약과소송전직격탄,http://www.dt.co.kr/contents.html?article_no=2020061802109931102001&ref=naver
3496,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동판매계약,http://www.press9.kr/news/articleView.html?idxno=45023
3497,2020-06-18,대웅제약지노믹트리대장암체외진단공동마케팅,http://www.biospectator.com/view/news_view.php?varAtcId=10632
3498,2020-06-18,메디톡신허가취소에대웅제약등급등반사이익기대,https://www.hankyung.com/finance/article/2020061808106
3499,2020-06-18,대웅제약지노믹트리대장암진단검사얼리텍공동프로모션,http://news.mt.co.kr/mtview.php?no=2020061809263417656
3500,2020-06-18,특징주메디톡스대웅제약식약처결정에주가희비,https://www.dailian.co.kr/news/view/898514?sc=Naver
3501,2020-06-18,대웅제약지노믹트리대장암검사시장확대나서,https://www.fetv.co.kr/news/article.html?no=57244
3502,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,https://www.youthdaily.co.kr/news/article.html?no=39907
3503,2020-06-18,시황분석대웅제약전일대비671상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006180940518210edd30037d8_45
3504,2020-06-18,게시판대웅제약지노믹트리대장암체외진단얼리텍공동판매,http://yna.kr/AKR20200618049600017?did=1195m
3505,2020-06-18,특징주메디톡스반사이익기대감대웅제약휴젤강세,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006180112&t=NN
3506,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션나선다,http://medipana.com/news/news_viewer.asp?NewsNum=258616&MainKind=A&NewsKind=5&vCount=12&vKind=1
3507,2020-06-18,대장암검사시장확대대웅제약지노믹트리얼리텍코프로모션계약,http://theviewers.co.kr/View.aspx?No=876836
3508,2020-06-18,대웅제약지노믹트리개발대장암체외진단기판매,https://www.news1.kr/articles/?3969040
3509,2020-06-18,메디톡신보톡스허가취소에대웅제약휴젤등급등,https://biz.chosun.com/site/data/html_dir/2020/06/18/2020061801337.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3510,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동판매헬스케어진단시장진출,http://www.ekn.kr/news/article.html?no=506011
3511,2020-06-18,메디톡스대웅제약급등에폭락으로희비엇갈려메디톡스17폭락반해대웅제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=124960
3512,2020-06-18,TF특징주대웅제약메디톡신허가취소반사이익6대상승,http://news.tf.co.kr/read/economy/1798109.htm
3513,2020-06-18,관심종목메디톡스경쟁업체들반사이익휴젤대웅제약주가상승,http://www.getnews.co.kr/view.php?ud=2020061809592633892aaae0046f_16
3514,2020-06-18,대웅제약전일대비565상승이시각거래량48만3614주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006180161&t=NN
3515,2020-06-18,메디톡스메디톡신허가취소에주가급락휴젤제테마휴온스글로벌대웅제약관련주주가는,http://www.topstarnews.net/news/articleView.html?idxno=807614
3516,2020-06-18,대웅제약지노믹트리와얼리텍대장암검사공동프로모션체결,http://www.kpinews.co.kr/news/articleView.html?idxno=119301
3517,2020-06-18,대웅제약지노믹트리와얼리텍공동프로모션조인식진행양사간시너지창출기대,http://www.updownnews.co.kr/news/articleView.html?idxno=219949
3518,2020-06-18,대웅제약지노믹트리와얼리텍공동프로모션조인식진행,http://www.m-i.kr/news/articleView.html?idxno=721125
3519,2020-06-18,대웅제약대장암체외진단얼리텍공동영업나선다,http://www.metroseoul.co.kr/article/20200618500085
3520,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.ybsn.tv/news/articleView.html?idxno=18206
3521,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션진행,http://www.econovill.com/news/articleView.html?idxno=401400
3522,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.segyebiz.com/newsView/20200618508433?OutUrl=naver
3523,2020-06-18,대웅제약지노믹트리대장암검사공동프로모션,http://www.newsis.com/view/?id=NISX20200618_0001064113&cID=13001&pID=13000
3524,2020-06-18,대웅제약지노믹트리와얼리텍시장확대협력,http://www.mhj21.com/131600
3525,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행헬스케어진단시장까지사업영역확대,http://newsbrite.net/138303
3526,2020-06-18,대웅제약지노믹트리대장암체외진단검사얼리텍공동프로모션진행,http://www.k-health.com/news/articleView.html?idxno=48945
3527,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행헬스케어시장사업확대,http://www.paxetv.com/news/articleView.html?idxno=94444
3528,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.thepublic.kr/news/newsview.php?ncode=1065574058623627
3529,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동마케팅,http://sports.hankooki.com/lpage/economy/202006/sp20200618104614137020.htm?s_ref=nv
3530,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식,http://www.bosa.co.kr/news/articleView.html?idxno=2128955
3531,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572963422788
3532,2020-06-18,대웅제약지노믹트리와대장암검사공동프로모션,http://www.choicenews.co.kr/news/articleView.html?idxno=71894
3533,2020-06-18,대웅제약체외진단시장에도손뻗친다,http://www.monews.co.kr/news/articleView.html?idxno=211529
3534,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.datasom.co.kr/news/articleView.html?idxno=106646
3535,2020-06-18,메디톡신취소ITC재판연기대웅제약신의한수되나,http://www.edaily.co.kr/news/newspath.asp?newsid=02532166625803032
3536,2020-06-18,대웅제약지노믹트리대장암체외진단얼리텍공동판매,http://yna.kr/PYH20200618049200017?did=1196m
3537,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동프로모션,http://www.mdtoday.co.kr/mdtoday/index.html?no=390331
3538,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1394669
3539,2020-06-18,뉴스투데이L대웅제약지노믹트리와얼리텍공동프로모션조인식진행,https://www.news2day.co.kr/154869
3540,2020-06-18,대웅제약지노믹트리대장암체외진단얼리텍공동판매,http://www.seoulfn.com/news/articleView.html?idxno=386247
3541,2020-06-18,메디톡신취소확정대웅제약ITC분쟁에도영향줄까,http://www.mediapen.com/news/view/533986
3542,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션계약,http://www.iminju.net/news/articleView.html?idxno=54524
3543,2020-06-18,대웅제약얼리텍도입헬스케어진단시장사업영역확대,http://www.newsprime.co.kr/news/article.html?no=508290
3544,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.pressm.kr/news/articleView.html?idxno=30603
3545,2020-06-18,대웅제약지노믹트리와손잡고대장암진단기공동판매,http://www.businesspost.co.kr/BP?command=article_view&num=183312
3546,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.nbnnews.co.kr/news/articleView.html?idxno=400730
3547,2020-06-18,대웅제약얼리텍대장암검사시장확대나서,http://www.dailysmart.co.kr/news/articleView.html?idxno=28466
3548,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션진단검사사업확대,http://kormedi.com/?p=1318856
3549,2020-06-18,대웅제약지노믹트리체외대장암검사얼리텍공동프로모션진행,https://www.donga.com/news/article/all/20200618/101573304/1
3550,2020-06-18,대웅제약지노믹트리대장암진단검사얼리텍코프로모션계약맺어,http://news.mk.co.kr/newsRead.php?no=627085&year=2020
3551,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.lawissue.co.kr/view.php?ud=202006181547584846204ead0791_12
3552,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션,http://www.bokuennews.com/news/article.html?no=191496
3553,2020-06-18,대웅제약얼리텍병․의원영업․마케팅진행,http://www.whosaeng.com/118758
3554,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션,http://www.medigatenews.com/news/3204965810
3555,2020-06-18,대웅제약지노믹트리와얼리텍공동프로모션계약진행,http://www.newspost.kr/news/articleView.html?idxno=79435
3556,2020-06-18,대웅제약지노믹트리대장암검사키트시장공략,http://www.sisaweek.com/news/articleView.html?idxno=134898
3557,2020-06-18,사설환자투약정보빼내고영업사원입막음까지한대웅제약,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202006182023025&code=990101
3558,2020-06-18,메디톡신허가취소휴젤대웅제약휴온스글로벌반사이익,http://www.medigatenews.com/news/2605795270
3559,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://news.kbiz.or.kr/news/articleView.html?idxno=68899
3560,2020-06-19,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.thefirstmedia.net/news/articleView.html?idxno=59530
3561,2020-06-19,단독작년에도처방통계불법수집”복지부대웅제약수사의뢰검토,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202006190600035&code=940202
3562,2020-06-19,메디톡신퇴출휴젤대웅제약반사이익주가기대감,http://moneys.mt.co.kr/news/mwView.php?no=2020061909088016353
3563,2020-06-19,대웅제약 우루사 담석예방효과 SCI급국제학술지에등재,http://www.businesskorea.co.kr/news/articleView.html?idxno=47798
3564,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.youthdaily.co.kr/news/article.html?no=39997
3565,2020-06-19,메디톡신품목허가취소대웅제약휴젤반사이익수혜,https://cnbc.sbs.co.kr/article_hub/10000987008?division=NAVER
3566,2020-06-19,대웅제약우루사담석예방효과학술지등재,http://www.mhj21.com/131659
3567,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.bosa.co.kr/news/articleView.html?idxno=2129030
3568,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지실려,https://www.etoday.co.kr/news/view/1908184
3569,2020-06-19,대웅제약우루사담석예방효과입증국제학술지등재,http://moneys.mt.co.kr/news/mwView.php?no=2020061909148050510
3570,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://medipana.com/news/news_viewer.asp?NewsNum=258679&MainKind=A&NewsKind=5&vCount=12&vKind=1
3571,2020-06-19,대웅제약우루사담석예방효과입증,http://www.koreastocknews.com/news/articleView.html?idxno=54636
3572,2020-06-19,대웅제약우루사의담석예방효과美의사협회학술지등재,http://www.kpinews.co.kr/news/articleView.html?idxno=119410
3573,2020-06-19,대웅제약우루사담석예방효과SCI급학술지등재,http://www.newsis.com/view/?id=NISX20200619_0001065588&cID=13001&pID=13000
3574,2020-06-19,대웅제약우루사수술받은위암환자의담석예방효능논문SCI급학술지등재,http://news.mk.co.kr/newsRead.php?no=629106&year=2020
3575,2020-06-19,대웅제약우루사임상결과JAMA장식,http://www.whosaeng.com/118779
3576,2020-06-19,대웅제약우루사담석예방효과SCI급학술지에등재,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572789932627
3577,2020-06-19,대웅제약우루사담석예방효과SCI급학술지등재,http://www.g-enews.com/ko-kr/news/article/news_all/202006190941473560a218188523_1/article.html
3578,2020-06-19,대웅제약우루사위암환자담석예방에효과있다,http://www.econovill.com/news/articleView.html?idxno=401543
3579,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지JAMASurgery등재,http://www.pressm.kr/news/articleView.html?idxno=30611
3580,2020-06-19,대웅제약우루사담석예방효과국제학술지등재,http://www.press9.kr/news/articleView.html?idxno=45039
3581,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61848
3582,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://news.mt.co.kr/mtview.php?no=2020061909250872974
3583,2020-06-19,대웅제약우루사위암환자담석예방효과입증,http://www.biospectator.com/view/news_view.php?varAtcId=10640
3584,2020-06-19,대웅제약 우루사 담석예방효과 SCI급국제학술지에등재,http://www.greened.kr/news/articleView.html?idxno=256807
3585,2020-06-19,대웅제약우루사담석예방효과입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118412
3586,2020-06-19,대웅제약우루사담석예방효과SCI급학술지등재,http://www.newspim.com/news/view/20200619000234
3587,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재담석예방효과입증한세계최초연구,http://newsbrite.net/138365
3588,2020-06-19,위암환자담석공포해소기대대웅제약국제학술지에우루사담석예방효과등재,http://theviewers.co.kr/View.aspx?No=878116
3589,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.ekn.kr/news/article.html?no=506243
3590,2020-06-19,대웅제약우루사담성예방효과국제학술지에등재,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020061910424853831
3591,2020-06-19,대웅제약우루사위암환자담석예방효과SCI급국제학술지등재,http://www.insightkorea.co.kr/news/articleView.html?idxno=80746
3592,2020-06-19,우루사대웅제약담석예방효과 SCI급국제학술지등재,http://www.economytalk.kr/news/articleView.html?idxno=206632
3593,2020-06-19,대웅제약우루사담석예방효과입증국제학술지에등재,http://www.koreaittimes.com/news/articleView.html?idxno=98375
3594,2020-06-19,메디톡스품목허가취소휴젤대웅제약반사이익얻나,https://www.ebn.co.kr/news/view/1438988?sc=Naver
3595,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.getnews.co.kr/view.php?ud=2020061911191240152fe691f917_16
3596,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.sisaweek.com/news/articleView.html?idxno=134918
3597,2020-06-19,대웅제약우루사담석예방효과국제학술지등재,http://www.dailysmart.co.kr/news/articleView.html?idxno=28537
3598,2020-06-19,대웅제약우루사위암환자담석예방효과입증,http://www.monews.co.kr/news/articleView.html?idxno=211550
3599,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.medigatenews.com/news/2035681504
3600,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.enewstoday.co.kr/news/articleView.html?idxno=1394957
3601,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.mdtoday.co.kr/mdtoday/index.html?no=390467
3602,2020-06-19,대웅제약우루사담석예방임상결과국제학술지등재,http://www.pharmnews.com/news/articleView.html?idxno=100717
3603,2020-06-19,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.newslock.co.kr/news/articleView.html?idxno=28839
3604,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.newsprime.co.kr/news/article.html?no=508436
3605,2020-06-19,대웅제약환자정보불법수집의혹영업사원에병의원처방통계데이터확보강요,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004014511
3606,2020-06-19,대웅제약검색상위랭킹주가478,https://view.asiae.co.kr/article/2020061914342758718
3607,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.mediapen.com/news/view/534362
3608,2020-06-19,대웅제약우루사임상연구국제적인정담석예방효과국제학술지에등재,http://kpenews.com/View.aspx?No=878683
3609,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.ybsn.tv/news/articleView.html?idxno=18531
3610,2020-06-19,대웅제약간기능개선우루사의담석예방효과를국제학술지에실어,http://www.businesspost.co.kr/BP?command=article_view&num=183532
3611,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.metroseoul.co.kr/article/20200619500156
3612,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.ebn.co.kr/news/view/1439045?sc=Naver
3613,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.lawissue.co.kr/view.php?ud=202006191518555362204ead0791_12
3614,2020-06-19,대웅제약우루사담석예방효과임상국제학술지게재,http://www.shinailbo.co.kr/news/articleView.html?idxno=1290712
3615,2020-06-19,뉴스투데이L대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.news2day.co.kr/154970
3616,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.donga.com/news/article/all/20200619/101589979/1
3617,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.nbnnews.co.kr/news/articleView.html?idxno=401085
3618,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.paxetv.com/news/articleView.html?idxno=94607
3619,2020-06-19,대웅제약우루사담석예방효과국제학술지에등재,http://www.100ssd.co.kr/news/articleView.html?idxno=69522
3620,2020-06-20,대웅제약지노믹트리대장암검사공동프로모션얼리텍도입헬스케어진단시장사업확대,http://www.econonews.co.kr/news/articleView.html?idxno=125212
3621,2020-06-20,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.wikileaks-kr.org/news/articleView.html?idxno=89312
3622,2020-06-20,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.thepublic.kr/news/newsview.php?ncode=1065598537502648
3623,2020-06-20,고지점한대웅제약ITC서도이길까,http://www.mediapen.com/news/view/534496
3624,2020-06-20,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.thefirstmedia.net/news/articleView.html?idxno=59583
3625,2020-06-22,코로나19펜데믹에공포한곳서만하루3500명감염모더나는3만명대상백신개발국내선셀트리온대웅제약부광약품신풍제약씨젠파미셀일양약품옵티팜동국제약주목,http://www.thekpm.com/view.php?ud=202006220505058592861beb2d9d_17
3626,2020-06-22,벼랑끝메디톡스대웅제약반사이익얻을까,http://it.chosun.com/site/data/html_dir/2020/06/20/2020062000757.html
3627,2020-06-22,대웅제약2년만에벨카이라특허분쟁첫승소,http://www.dailypharm.com/Users/News/NewsView.html?ID=265774&REFERER=NP
3628,2020-06-22,지이크대웅제약우루사와간肝x지콜라보컬렉션전개,http://www.fashionn.com/board/read_new.php?table=1006&number=33521
3629,2020-06-22,신원지이크대웅제약우루사와간肝x지콜라보제품출시,http://www.newsworks.co.kr/news/articleView.html?idxno=465509
3630,2020-06-22,대웅제약펜믹스엘러간벨카이라특허회피성공,http://medipana.com/news/news_viewer.asp?NewsNum=258786&MainKind=A&NewsKind=5&vCount=12&vKind=1
3631,2020-06-22,대웅제약윤재승의꼼수①묻지마코로나19치료제로상한가치고빠지기,http://www.globale.co.kr/news/articleView.html?idxno=10574
3632,2020-06-22,신원남성복지이크대웅제약우루사와이색협업,https://www.asiatime.co.kr/news/newsview.php?ncode=1065592217887350
3633,2020-06-22,신원지이크대웅제약우루사콜라보,https://www.ebn.co.kr/news/view/1439287?sc=Naver
3634,2020-06-22,남성복지이크x대웅제약우루사간肝x지컬래버레이션,http://www.busan.com/view/busan/view.php?code=2020062216112272713
3635,2020-06-22,지이크SIEG대웅제약우루사와손잡고간肝x지콜라보제품출시,http://www.apparelnews.co.kr/news/news_view/?idx=183448
3636,2020-06-22,신원지이크SIEG대웅제약우루사손잡고간肝x지콜라보머리부터간끝까지간지 ,http://www.kdfnews.com/news/articleView.html?idxno=49554
3637,2020-06-22,대웅제약수출길넓히고美희귀약지정도,https://www.sedaily.com/NewsView/1Z44KYXXA8
3638,2020-06-22,소간지말고곰간x지콜라보신원지이크대웅제약우루사와협업,http://www.megaeconomy.co.kr/news/articleView.html?idxno=94208
3639,2020-06-23,대웅제약엘러간벨카이라특허회피드디어성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=390724
3640,2020-06-23,대웅제약나보타대만품목허가중화권진출초읽기,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245872
3641,2020-06-23,중화권진출초읽기”대웅제약나보타대만품목허가,https://www.fetv.co.kr/news/article.html?no=57565
3642,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.getnews.co.kr/view.php?ud=2020062309075235222fe691f917_16
3643,2020-06-23,대웅제약나보타대만품목허가획득중화권진출초읽기,http://www.ekn.kr/news/article.html?no=506811
3644,2020-06-23,대웅제약보톡스나보타대만허가,http://www.dailypharm.com/Users/News/NewsView.html?ID=265833&REFERER=NP
3645,2020-06-23,대웅제약나보타대만서허가중화권진출초읽기,https://www.news1.kr/articles/?3973367
3646,2020-06-23,대웅제약나보타대만품목허가획득하반기출시,https://www.etoday.co.kr/news/view/1909367
3647,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://medipana.com/news/news_viewer.asp?NewsNum=258827&MainKind=A&NewsKind=5&vCount=12&vKind=1
3648,2020-06-23,대웅제약나보타대만품목허가중화권진출,http://www.press9.kr/news/articleView.html?idxno=45064
3649,2020-06-23,대웅제약나보타중화권진출초읽기,http://www.seoulwire.com/news/articleView.html?idxno=417265
3650,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가,http://yna.kr/AKR20200623039500017?did=1195m
3651,2020-06-23,대웅제약보톡스나보타대만품목허가중화권진출초읽기,http://www.m-i.kr/news/articleView.html?idxno=722416
3652,2020-06-23,대웅제약보톡스나보타중화권교두보확보,http://www.edaily.co.kr/news/newspath.asp?newsid=01922086625804672
3653,2020-06-23,대웅제약나보타대만품목허가획득중화권진출교두보,http://www.pressm.kr/news/articleView.html?idxno=30668
3654,2020-06-23,대웅제약나보타대만서품목허가中시장공략박차,http://news.mt.co.kr/mtview.php?no=2020062309165139558
3655,2020-06-23,대만땅밟는대웅제약나보타중화권진출초석,http://health.chosun.com/site/data/html_dir/2020/06/23/2020062301039.html
3656,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.dailysmart.co.kr/news/articleView.html?idxno=28685
3657,2020-06-23,대웅제약나보타대만허가52개국획득,http://www.newsis.com/view/?id=NISX20200623_0001069127&cID=13001&pID=13000
3658,2020-06-23,대웅제약미간주름개선나보타대만품목허가획득,http://www.economytalk.kr/news/articleView.html?idxno=206668
3659,2020-06-23,대웅제약나보타대만품목허가로아시아시장확대나서,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118517
3660,2020-06-23,대웅제약나보타대만서품목허가올하반기발매,http://www.mdtoday.co.kr/mdtoday/index.html?no=390749
3661,2020-06-23,나보타아시아시장영향력확대대웅제약하반기대만출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=89485
3662,2020-06-23,대웅제약대만서보툴리눔톡신나보타시판허가받아,http://news.mk.co.kr/newsRead.php?no=640721&year=2020
3663,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,https://www.dailian.co.kr/news/view/899653?sc=Naver
3664,2020-06-23,대웅제약대만서나보타품목허가획득으로아시아입지강화,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006230106&t=NN
3665,2020-06-23,대웅제약나보타대만서품목허가획득하반기발매,http://www.newspim.com/news/view/20200623000155
3666,2020-06-23,메트포르민관련주코로나여성당뇨병환자사망률↓대웅제약신풍제약등관심,http://www.ccreview.co.kr/news/articleView.html?idxno=267121
3667,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020062309425470304
3668,2020-06-23,대웅제약보톡스나보타대만품목허가,https://www.ebn.co.kr/news/view/1439412?sc=Naver
3669,2020-06-23,대웅제약나보타대만품목허가획득아시아시장영향력확대,http://www.newsprime.co.kr/news/article.html?no=508689
3670,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가획득중화권진출초읽기,http://www.startuptoday.co.kr/news/articleView.html?idxno=44801
3671,2020-06-23,대만품목허가대웅제약나보타중화권진출초읽기,http://www.koreaittimes.com/news/articleView.html?idxno=98445
3672,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://newsbrite.net/138510
3673,2020-06-23,대웅제약나보타대만품목허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2129202
3674,2020-06-23,대웅제약나보타대만서품목허가획득중화권진출초읽기,https://www.youthdaily.co.kr/news/article.html?no=40266
3675,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://inthenews.co.kr/article-55185/
3676,2020-06-23,대웅제약나보타대만품목허가획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61892
3677,2020-06-23,대웅제약나보타대만품목허가받으며중화권진출,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573048040111
3678,2020-06-23,대웅제약나보타대만서미간주름품목허가획득,https://www.hankyung.com/it/article/202006237311i
3679,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가,http://www.topstarnews.net/news/articleView.html?idxno=810774
3680,2020-06-23,대웅제약나보타대만서품목허가획득하반기발매,http://www.consumernews.co.kr/news/articleView.html?idxno=607325
3681,2020-06-23,대웅제약나보타대만서품목허가획득중화권진줄교두보확보,http://www.insightkorea.co.kr/news/articleView.html?idxno=80809
3682,2020-06-23,신원지이크대웅제약우루사간肝x지컬래버,http://www.fashionbiz.co.kr/TN/?cate=2&recom=2&idx=178822
3683,2020-06-23,대웅제약나보타대만시장품목허가중화권진출초읽기,http://theviewers.co.kr/View.aspx?No=880973
3684,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.thepublic.kr/news/newsview.php?ncode=1065575213298214
3685,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가획득,http://www.seoulfn.com/news/articleView.html?idxno=386706
3686,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.munhwa.com/news/view.html?no=20200623MW104202296861
3687,2020-06-23,대웅제약나보타대만서품목허가중화권진출초읽기,http://news.mk.co.kr/newsRead.php?no=641280&year=2020
3688,2020-06-23,대웅제약나보타대만식품약물관리서품목허가획득,http://www.kpinews.co.kr/news/articleView.html?idxno=119670
3689,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.newsway.co.kr/news/view?tp=1&ud=2020062311160741728
3690,2020-06-23,대웅제약나보타미간주름적응증대만품목허가,http://www.pharmnews.com/news/articleView.html?idxno=100735
3691,2020-06-23,대웅제약나보타대만TFDA품목허가획득,http://www.medigatenews.com/news/3990034547
3692,2020-06-23,대웅제약나보타대만품목허가획득,http://it.chosun.com/site/data/html_dir/2020/06/23/2020062302007.html
3693,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.segyebiz.com/newsView/20200623511273?OutUrl=naver
3694,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.fnnews.com/news/202006231149426528
3695,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.metroseoul.co.kr/article/20200623500239
3696,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가획득,https://www.asiatoday.co.kr/view.php?key=20200623010014214
3697,2020-06-23,대웅제약나보타대만품목허가획득중화권진출초읽기,https://www.donga.com/news/article/all/20200623/101646077/1
3698,2020-06-23,대웅제약나보타대만품목허가아시아시장영향력확대,http://www.thevaluenews.co.kr/news/view.php?idx=159847
3699,2020-06-23,대웅제약 나보타 대만품목허가로중화권진출초읽기,http://www.greened.kr/news/articleView.html?idxno=257325
3700,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.nbnnews.co.kr/news/articleView.html?idxno=401780
3701,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.ybsn.tv/news/articleView.html?idxno=19083
3702,2020-06-23,대웅제약중화권보툴리눔톡신시장진출대만서나보타품목허가획득,http://www.g-enews.com/ko-kr/news/article/news_all/20200623152756190269d76442fa_1/article.html
3703,2020-06-23,대웅제약보톡스나보타대만서품목허가,http://sports.khan.co.kr/news/sk_index.html?art_id=202006231559013&sec_id=561801&pt=nv
3704,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.businesskorea.co.kr/news/articleView.html?idxno=47953
3705,2020-06-23,대웅제약나보타대만품목허가획득중화권진출초읽기,http://sports.hankooki.com/lpage/economy/202006/sp20200623165521137020.htm?s_ref=nv
3706,2020-06-23,대웅제약 나보타대만품목허가중화권진출초읽기,http://www.newslock.co.kr/news/articleView.html?idxno=28947
3707,2020-06-23,대웅제약나보타하반기대만본격진출,http://www.koreastocknews.com/news/articleView.html?idxno=54750
3708,2020-06-23,대웅제약대만에서보툴리눔톡신제제품목허가받아,http://www.businesspost.co.kr/BP?command=article_view&num=184114
3709,2020-06-23,대웅제약보톡스나보타중화권간다,http://www.dt.co.kr/contents.html?article_no=2020062402101031820002&ref=naver
3710,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.lawissue.co.kr/view.php?ud=202006232032443650204ead0791_12
3711,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://news.kbiz.or.kr/news/articleView.html?idxno=69096
3712,2020-06-23,뉴스투데이L대웅제약나보타대만TFDA로부터품목허가,https://www.news2day.co.kr/155227
3713,2020-06-24,SK바이오팜청약30조제약바이오주2차폭발파미셀일양약품옵티팜바이오팜신풍대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/2020062405310745594a01bf698f_1/article.html
3714,2020-06-24,뿔난의료계대웅제약불매할까,https://www.paxnetnews.com/articles/61830
3715,2020-06-24,대웅제약보톡스나보타메디톡신주춤하는사이판로확대,http://www.sisaweek.com/news/articleView.html?idxno=135035
3716,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.lawissue.co.kr/view.php?ud=202006241350287152204ead0791_12
3717,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=48018
3718,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트간콜레스테롤케어동시에도와주는제품은,https://www.fetv.co.kr/news/article.html?no=57723
3719,2020-06-24,대웅제약간과콜레스테롤케어동시에도와주는제품은,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118592
3720,2020-06-24,대웅제약건기식홍보캐시워크돈버는퀴즈이벤트,http://news.mt.co.kr/mtview.php?no=2020062414122183646
3721,2020-06-24,대웅제약건기식알리기박차돈버는퀴즈이벤트진행,http://medipana.com/news/news_viewer.asp?NewsNum=258937&MainKind=A&NewsKind=5&vCount=12&vKind=1
3722,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행간과콜레스테롤케어를동시에도와주는제품은,http://www.nbnnews.co.kr/news/articleView.html?idxno=402065
3723,2020-06-24,대웅제약캐시워크돈버는퀴즈진행간과콜레스테롤케어를동시에도와주는제품은,http://theviewers.co.kr/View.aspx?No=882807
3724,2020-06-24,대웅제약건강기능식품캐시워크퀴즈이벤트문제등장,http://www.100ssd.co.kr/news/articleView.html?idxno=69601
3725,2020-06-24,대웅제약x캐시워크돈버는퀴즈이벤트,http://www.upinews.kr/newsView/upi202006240086
3726,2020-06-24,오늘의장바구니이마트GS홈쇼핑이베이코리아대웅제약외,http://www.newsprime.co.kr/news/article.html?no=508926
3727,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.bosa.co.kr/news/articleView.html?idxno=2129320
3728,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행간과콜레스테롤케어를동시에도와주는제품은,http://newsbrite.net/138606
3729,2020-06-24,대웅제약캐시위크앱서건강기능식품문제내는돈버는퀴즈이벤트나서,http://news.mk.co.kr/newsRead.php?no=648277&year=2020
3730,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61933
3731,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=390971
3732,2020-06-24,뉴스투데이L대웅제약캐시워크돈버는퀴즈이벤트로자사건기식알린다,https://www.news2day.co.kr/155293
3733,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.whosaeng.com/118900
3734,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.bokuennews.com/news/article.html?no=191704
3735,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,https://www.youthdaily.co.kr/news/article.html?no=40454
3736,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.thefirstmedia.net/news/articleView.html?idxno=59710
3737,2020-06-24,대웅제약건강기능식품퀴즈이벤트진행,http://www.dailymedi.com/detail.php?number=857501&thread=22r05
3738,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트열어,http://www.econovill.com/news/articleView.html?idxno=402214
3739,2020-06-25,대웅제약나보타대만품목허가받아,https://www.kpanews.co.kr/article/show.asp?idx=214182&category=D
3740,2020-06-25,대웅제약건기식소비자이벤트캐시워크돈버는퀴즈이벤트열어,https://www.kpanews.co.kr/article/show.asp?idx=214190&category=D
3741,2020-06-25,대웅제약나보타대만품목허가로중화권진출순항,http://www.thefirstmedia.net/news/articleView.html?idxno=59758
3742,2020-06-25,코로나192차대폭발다우지수와르르씨젠영업익급증삼성전자LG화학옵티팜대웅제약파미셀일양약품셀트리온제약주가출렁,http://www.thekpm.com/view.php?ud=202006250543468007861beb2d9d_17
3743,2020-06-25,하루확진자3만6000명LTE급속도씨젠수젠텍코젠바이오텍출혈경쟁괜찮나그리고부광약품신풍제약옵티팜신일제약중외제약대웅제약,http://www.thekpm.com/view.php?ud=202006250734314819861beb2d9d_17
3744,2020-06-25,통계불법수집대웅제약전사마케팅활용,https://www.paxnetnews.com/articles/62018
3745,2020-06-25,대웅제약보툴리눔톡신나보타글로벌브랜드화속도낸다,http://www.dt.co.kr/contents.html?article_no=2020062502109919607003&ref=naver
3746,2020-06-25,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.wsobi.com/news/articleView.html?idxno=99976
3747,2020-06-25,대웅제약 25일캐시워크돈버는퀴즈이벤트진행,http://www.greened.kr/news/articleView.html?idxno=257714
3748,2020-06-25,글로벌시장우리가간다”대웅제약나보타이을신약RD박차,http://www.kukinews.com/news/article.html?no=802980
3749,2020-06-25,에너씨슬콜레다운대웅제약캐시워크돈버는퀴즈2시정답실시간정답OPEN,https://nc.asiae.co.kr/view.htm?idxno=2020062513365186319
3750,2020-06-25,대웅제약캐시워크퀴즈이벤트진행,http://www.newsworks.co.kr/news/articleView.html?idxno=466877
3751,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://enter.etoday.co.kr/view/news_view.php?varAtcId=182666
3752,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.joygm.com/news/articleView.html?idxno=85492
3753,2020-06-25,이인애의뒷담화대웅제약하나제약영업수완뒤민낯,http://theviewers.co.kr/View.aspx?No=884120
3754,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,https://www.asiatime.co.kr/news/newsview.php?ncode=1065591466489256
3755,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.ccdn.co.kr/news/articleView.html?idxno=651265
3756,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈25일정답총정리,http://www.ajunews.com/view/20200625145648622
3757,2020-06-25,캐시워크대웅제약에너씨슬콜레다운돈버는퀴즈정답은무엇일까,http://www.newsfarm.co.kr/news/articleView.html?idxno=57036
3758,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈업데이트정답은,http://www.joygm.com/news/articleView.html?idxno=85494
3759,2020-06-25,매일반복되는야근대웅제약밀크씨슬주목도급상승피로한간을위한선택에너씨슬,http://www.thekpm.com/view.php?ud=202006251538125831861beb2d9d_17
3760,2020-06-25,자율성높이자업무효율상승대웅제약사내문화변화바람,http://www.meconomynews.com/news/articleView.html?idxno=42820
3761,2020-06-25,국내제약바이오10개사미국보스턴에둥지대웅제약동성제약동아에스티보령제약삼일제약아밀로이드솔루션일동제약종근당현대약품휴온스,http://www.topstarnews.net/news/articleView.html?idxno=812430
3762,2020-06-25,대웅제약동아에스티등10개제약사미국보스턴CIC입주완료,https://www.sedaily.com/NewsView/1Z45YKJNJF
3763,2020-06-25,대웅제약등10곳제약사최대의약품시장미국에새둥지틀어,http://www.wikileaks-kr.org/news/articleView.html?idxno=89730
3764,2020-06-25,종근당대웅제약등제약바이오10개사미국보스턴에둥지,http://www.dt.co.kr/contents.html?article_no=2020062502109931820010&ref=naver
3765,2020-06-26,SK바이오팜31조원오늘일제방출코로나관련주폭발대웅제약파미셀코미팜SK바이오팜일양,http://www.g-enews.com/ko-kr/news/article/news_all/2020062602425236264a01bf698f_1/article.html
3766,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246019
3767,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=48115
3768,2020-06-26,우루사를입자대웅제약지이크와우루사브랜드활용패션상품출시,https://www.fetv.co.kr/news/article.html?no=57887
3769,2020-06-26,우루사를입는다대웅제약지이크와손잡고패션상품출시,http://www.mediapen.com/news/view/536033
3770,2020-06-26,대웅제약정장브랜드지이크와협업젊은층에우루사공략,http://www.kpinews.co.kr/news/articleView.html?idxno=119953
3771,2020-06-26,대웅제약젊은감성더한우루사BI활용패션상품출시,http://www.ekn.kr/news/article.html?no=507615
3772,2020-06-26,대웅제약지이크와우루사브랜드활용패션상품선보여,http://www.pressm.kr/news/articleView.html?idxno=30788
3773,2020-06-26,대웅제약지이크우루사브랜드활용패션상품출시,http://medipana.com/news/news_viewer.asp?NewsNum=259040&MainKind=A&NewsKind=5&vCount=12&vKind=1
3774,2020-06-26,대웅제약지이크콜라보레이션이제입는우루사,http://moneys.mt.co.kr/news/mwView.php?no=2020062609238058968
3775,2020-06-26,대웅제약지이크와 우루사 콜라보패션상품출시우루사를입자,http://www.greened.kr/news/articleView.html?idxno=257855
3776,2020-06-26,대웅제약우루사티셔츠출시뉴트로열풍가세,https://www.dailian.co.kr/news/view/900593?sc=Naver
3777,2020-06-26,대웅제약젊은감성정장브랜드지이크와코라보우루사티셔츠슬리퍼양말출시,http://theviewers.co.kr/View.aspx?No=884829
3778,2020-06-26,대웅제약지이크와우루사브랜드활용패션출시이제는입는우루사,https://www.etoday.co.kr/news/view/1910994
3779,2020-06-26,대웅제약지이크협업우루사 브랜드활용패션상품출시,http://www.newslock.co.kr/news/articleView.html?idxno=29021
3780,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.m-i.kr/news/articleView.html?idxno=723762
3781,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시이제는입는우루사,http://www.dailysmart.co.kr/news/articleView.html?idxno=28881
3782,2020-06-26,대웅제약우루사정장브랜드지이크컬래버제약패션협업,http://www.consumuch.com/news/articleView.html?idxno=49525
3783,2020-06-26,대웅제약지이크와우루사패션상품출시,https://www.asiatoday.co.kr/view.php?key=20200626010016575
3784,2020-06-26,대웅제약뉴트로열풍에가세우루사를신는다,http://www.sisaweek.com/news/articleView.html?idxno=135131
3785,2020-06-26,뉴스투데이L대웅제약패션브랜드지이크와우루사패션상품3종출시,https://www.news2day.co.kr/155414
3786,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.fnnews.com/news/202006261043046090
3787,2020-06-26,대웅제약우루사x지이크패션상품출시 ,http://www.seoulfn.com/news/articleView.html?idxno=387150
3788,2020-06-26,이제는입는우루사대웅제약지이크와우루사브랜드활용한패션상품선보여,http://www.betanews.net:8080/article/1198141.html
3789,2020-06-26,대웅제약입는우루사출시패션브랜드지이크맞손,http://www.newstomato.com/ReadNews.aspx?no=980444
3790,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,https://jhealthmedia.joins.com/article/article_view.asp?pno=22033
3791,2020-06-26,대웅제약정장브랜드지이크와협업우루사곰담긴패션상품선봬,http://www.getnews.co.kr/view.php?ud=2020062611250972452fe691f917_16
3792,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020062611240540190
3793,2020-06-26,이제우루사를입는다대웅제약지이크패션상품출시,http://yna.kr/AKR20200626065500017?did=1195m
3794,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://newsbrite.net/138692
3795,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=391224
3796,2020-06-26,대웅제약이제는입는우루사,http://www.bosa.co.kr/news/articleView.html?idxno=2129453
3797,2020-06-26,이번엔우루사다대웅제약지이크와티셔츠슬리퍼등선보여,http://www.ajunews.com/view/20200626123843370
3798,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시이제는입는우루사,http://www.nbnnews.co.kr/news/articleView.html?idxno=402625
3799,2020-06-26,패션계진출한우루사대웅제약지이크협업패션상품3종출시,https://www.donga.com/news/article/all/20200626/101701889/1
3800,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시이제는입는우루사,http://www.ybsn.tv/news/articleView.html?idxno=19721
3801,2020-06-26,주간신상태크아모레퍼시픽LF세븐일레븐대웅제약신라호텔외,http://www.newsprime.co.kr/news/article.html?no=509200
3802,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.lawissue.co.kr/view.php?ud=202006261447559692204ead0791_12
3803,2020-06-26,대웅제약정장브랜드지이크와협업해우루사활용패션상품내놔,http://www.businesspost.co.kr/BP?command=article_view&num=184627
3804,2020-06-26,대웅제약지이크우루사활용한패션상품출시,http://www.finomy.com/news/articleView.html?idxno=79583
3805,2020-06-26,대웅제약우루사패션브랜드지이크와협업통한패션상품3종출시,http://news.mk.co.kr/newsRead.php?no=657232&year=2020
3806,2020-06-26,대웅제약지이크우루사브랜드활용한패션상품출시,https://www.ebn.co.kr/news/view/1440120?sc=Naver
3807,2020-06-26,우루사입으면피로가싹대웅제약지이크이색콜라보,https://www.sedaily.com/NewsView/1Z46F3JILF
3808,2020-06-26,대웅제약우루사×지이크이색콜라보여름패션3종출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200626018
3809,2020-06-26,종근당셀트리온GC녹십자대웅제약코로나19치료제개발선두주자는,http://www.insightkorea.co.kr/news/articleView.html?idxno=80895
3810,2020-06-26,우루사입으세요지이크대웅제약과머리부터간끝까지컬렉션,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006260336&t=NN
3811,2020-06-26,이제는입는우루사대웅제약패션상품출시,http://www.koreaittimes.com/news/articleView.html?idxno=98584
3812,2020-06-27,대웅제약x지이크우루사브랜드활용한패션상품출시,http://news.kbiz.or.kr/news/articleView.html?idxno=69277
3813,2020-06-27,대웅제약부광약품등정부코로나19치료제후보물질연구기업지정임박,http://www.thevaluenews.co.kr/news/view.php?idx=159913
3814,2020-06-28,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.thepublic.kr/news/newsview.php?ncode=1065595996098329
3815,2020-06-28,입는피로회복제대웅제약우루사티셔츠와양말로재탄생,http://www.metroseoul.co.kr/article/20200628500143
3816,2020-06-28,시경Today제약대웅제약지이크와우루사브랜드활용패션상품출시外,http://www.meconomynews.com/news/articleView.html?idxno=42854
3817,2020-06-28,대웅제약우루사지이크와콜라보상품출시,http://www.dailymedi.com/detail.php?number=857602&thread=22r05
3818,2020-06-29,우루사정장대웅제약의짜릿한외도,https://www.sedaily.com/NewsView/1Z47Q1OBSP
3819,2020-06-29,대웅제약참지마요사회공헌프로그램2기해단식성료,http://www.kpinews.co.kr/news/articleView.html?idxno=120050
3820,2020-06-29,대웅제약참지마요프로젝트2기봉사단비대면해단식,http://www.press9.kr/news/articleView.html?idxno=45129
3821,2020-06-29,대웅제약참지마요프로젝트제2기대학생80명봉사단비대면해단식실시,http://www.pressm.kr/news/articleView.html?idxno=30829
3822,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식,http://medipana.com/news/news_viewer.asp?NewsNum=259110&MainKind=A&NewsKind=5&vCount=12&vKind=1
3823,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=48193
3824,2020-06-29,대웅제약참지마요프로젝트대학생봉사단비대면해단식,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246084
3825,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.m-i.kr/news/articleView.html?idxno=724229
3826,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식성료,http://www.ekn.kr/news/article.html?no=507966
3827,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,https://www.fetv.co.kr/news/article.html?no=58030
3828,2020-06-29,대웅제약참지마요제2기봉사단비대면해단식진행,http://www.mediapen.com/news/view/536603
3829,2020-06-29,대웅제약참지마요프로젝트대학생봉사단비대면해단식진행,https://www.youthdaily.co.kr/news/article.html?no=40716
3830,2020-06-29,대웅제약참지마요프로젝트대학생봉사단2기의비대면해단식진행,http://news.mk.co.kr/newsRead.php?no=661965&year=2020
3831,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://newsbrite.net/138757
3832,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단비대면해단식실시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572814986722
3833,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식비대면진행발달장애인교육봉사,http://theviewers.co.kr/View.aspx?No=886331
3834,2020-06-29,대웅제약사회공헌참지마요프로젝트2기대학생봉사단해단식,http://news.mt.co.kr/mtview.php?no=2020062909595672754
3835,2020-06-29,대웅제약제2기대학생봉사단비대면해단식진행,http://www.bosa.co.kr/news/articleView.html?idxno=2129535
3836,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식,http://www.newsprime.co.kr/news/article.html?no=509312
3837,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.thepublic.kr/news/newsview.php?ncode=1065576460774530
3838,2020-06-29,대웅제약참지마요프로젝트봉사단비대면해단식진행,http://www.mhj21.com/132071
3839,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식,http://moneys.mt.co.kr/news/mwView.php?no=2020062910448011126
3840,2020-06-29,대웅제약화상프로그램으로참지마요프로젝트2기해단식진행,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=225513
3841,2020-06-29,대웅제약참지마요2기활동마무리 ,http://www.seoulfn.com/news/articleView.html?idxno=387361
3842,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.lawissue.co.kr/view.php?ud=202006291249178348204ead0791_12
3843,2020-06-29,대웅제약참지마요프로젝트2기비대면해단식진행,http://www.dailysmart.co.kr/news/articleView.html?idxno=28966
3844,2020-06-29,재계톡톡대웅제약영업직원환자정보불법수집폭로,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=663514
3845,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.nbnnews.co.kr/news/articleView.html?idxno=403058
3846,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=391423
3847,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.updownnews.co.kr/news/articleView.html?idxno=220312
3848,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.getnews.co.kr/view.php?ud=2020062914173892352fe691f917_16
3849,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단해단식진행,http://sports.hankooki.com/lpage/economy/202006/sp20200629144208136980.htm?s_ref=nv
3850,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.ybsn.tv/news/articleView.html?idxno=20124
3851,2020-06-29,대웅제약참지마요프로젝트2기봉사단화상해단식,http://www.consumuch.com/news/articleView.html?idxno=49552
3852,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식,http://www.ajunews.com/view/20200629170505216
3853,2020-06-29,대웅제약26일참지마요대학생봉사단해단식진행,http://www.finomy.com/news/articleView.html?idxno=79667
3854,2020-06-29,대웅제약참지마요2기대학생봉사단비대면해단식진행,http://www.100ssd.co.kr/news/articleView.html?idxno=69724
3855,2020-06-29,뉴스투데이L대웅제약참지마요프로젝트2기대학생봉사단비대면해단식진행,https://www.news2day.co.kr/155589
3856,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62000
3857,2020-06-30,대웅제약참지마요프로젝트대학생봉사단비대면해단식열어,https://www.kpanews.co.kr/article/show.asp?idx=214295&category=D
3858,2020-06-30,대웅제약비만예방포스터디자인공모전개최,https://www.fetv.co.kr/news/article.html?no=58134
3859,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://medipana.com/news/news_viewer.asp?NewsNum=259165&MainKind=A&NewsKind=5&vCount=12&vKind=1
3860,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246142
3861,2020-06-30,대웅제약비만예방포스터디자인공모전개최,https://www.ebn.co.kr/news/view/1440416/?sc=Naver
3862,2020-06-30,대웅제약비만예방포스터공모질병이라는인식강화해야”,http://theviewers.co.kr/View.aspx?No=887620
3863,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://news.mt.co.kr/mtview.php?no=2020063009245108537
3864,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.press9.kr/news/articleView.html?idxno=45146
3865,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.kpinews.co.kr/news/articleView.html?idxno=120173
3866,2020-06-30,대웅제약비만예방포스터디자인공모전개최심각성알리기위해기획,http://www.m-i.kr/news/articleView.html?idxno=724686
3867,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62006
3868,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118794
3869,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.koreaittimes.com/news/articleView.html?idxno=98640
3870,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://news.mk.co.kr/newsRead.php?no=666598&year=2020
3871,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.fnnews.com/news/202006300946414249
3872,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://newsbrite.net/138816
3873,2020-06-30,대웅제약비만예방포스터디자인공모연다,http://www.mhj21.com/132102
3874,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.newsis.com/view/?id=NISX20200630_0001077642&cID=13001&pID=13000
3875,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.youthdaily.co.kr/news/article.html?no=40847
3876,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=48266
3877,2020-06-30,대웅제약비만의심각성알리기위한포스터공모전개최,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573248208175
3878,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.newsway.co.kr/news/view?tp=1&ud=2020063010350981560
3879,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.getnews.co.kr/view.php?ud=2020063010425671412fe691f917_16
3880,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.ekn.kr/news/article.html?no=508308
3881,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://sports.hankooki.com/lpage/economy/202006/sp20200630104913136980.htm?s_ref=nv
3882,2020-06-30,대웅제약내달1일비만예방포스터디자인공모전개최,http://www.newslock.co.kr/news/articleView.html?idxno=29115
3883,2020-06-30,대웅제약비만경각심차원비만예방포스터디자인공모전개최,http://www.pressm.kr/news/articleView.html?idxno=30890
3884,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.ybsn.tv/news/articleView.html?idxno=20261
3885,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=29025
3886,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.bosa.co.kr/news/articleView.html?idxno=2129653
3887,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.whosaeng.com/119053
3888,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.ajunews.com/view/20200630135002876
3889,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.iminju.net/news/articleView.html?idxno=54781
3890,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=403423
3891,2020-06-30,대웅제약비만예방포스터디자인공모전개최사회적인식강화차원,http://www.paxetv.com/news/articleView.html?idxno=95209
3892,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.mediapen.com/news/view/537120
3893,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.lawissue.co.kr/view.php?ud=202006301514201563204ead0791_12
3894,2020-06-30,대웅제약비만심각성알린다포스터디자인공모전개최,http://www.econovill.com/news/articleView.html?idxno=402788
3895,2020-06-30,대웅제약비만예방포스터디자인공모전,http://www.fnnews.com/news/202006301716232497
3896,2020-06-30,대웅제약비만은질병알리는포스터공모전개최,http://www.100ssd.co.kr/news/articleView.html?idxno=69768
3897,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=391652
3898,2020-07-01,대웅제약비만예방포스터디자인공모전개최,http://www.thefirstmedia.net/news/articleView.html?idxno=59944
3899,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.getnews.co.kr/view.php?ud=2020070109072344662fe691f917_16
3900,2020-07-01,양치힘강조한특허칫솔대웅제약덴티가드랩그립핏칫솔출시,https://www.fetv.co.kr/news/article.html?no=58236
3901,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.mediapen.com/news/view/537294
3902,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.youthdaily.co.kr/news/article.html?no=40973
3903,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.kpinews.co.kr/news/articleView.html?idxno=120304
3904,2020-07-01,대웅제약양치힘좋은칫솔덴티가드랩그립핏정식출시,http://news.mt.co.kr/mtview.php?no=2020070109220277791
3905,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.m-i.kr/news/articleView.html?idxno=725170
3906,2020-07-01,대웅제약덴티가드랩그립핏칫솔출시프라그제거에필요한양치힘강조,http://theviewers.co.kr/View.aspx?No=888964
3907,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://medipana.com/news/news_viewer.asp?NewsNum=259276&MainKind=A&NewsKind=5&vCount=12&vKind=1
3908,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=29082
3909,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.press9.kr/news/articleView.html?idxno=45166
3910,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=58285
3911,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.newsis.com/view/?id=NISX20200701_0001079345&cID=13001&pID=13000
3912,2020-07-01,대웅제약항혈전제안플원출시5주년기념웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=120339
3913,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.youthdaily.co.kr/news/article.html?no=41001
3914,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246225
3915,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.bokuennews.com/news/article.html?no=191944
3916,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572520327885
3917,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,https://www.asiatoday.co.kr/view.php?key=20200701010000272
3918,2020-07-01,대웅제약안플원웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=45170
3919,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.wsobi.com/news/articleView.html?idxno=100357
3920,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://newsbrite.net/138874
3921,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://newsbrite.net/138884
3922,2020-07-01,대웅제약항혈전제안플원출시5주년웹심포지엄개최,http://www.consumuch.com/news/articleView.html?idxno=49573
3923,2020-07-01,대웅제약안플원 출시 5주년기념 2차심포지엄개최,http://www.economytalk.kr/news/articleView.html?idxno=206841
3924,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=259297&MainKind=A&NewsKind=5&vCount=12&vKind=1
3925,2020-07-01,대웅제약안플원두번째웹심포지엄진행,http://www.whosaeng.com/119084
3926,2020-07-01,대웅제약안플원 출시 5주년기념 2차웹심포지엄개최,http://www.greened.kr/news/articleView.html?idxno=258588
3927,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=391722
3928,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.koreaittimes.com/news/articleView.html?idxno=98679
3929,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=725265
3930,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62049
3931,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62060
3932,2020-07-01,대웅제약안플원출시5주년2차웹심포지엄개최,http://www.newslock.co.kr/news/articleView.html?idxno=29161
3933,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.bosa.co.kr/news/articleView.html?idxno=2129737
3934,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1397487
3935,2020-07-01,대웅제약자유로운사내문화조성힘써여름엔사무실에서반바지,http://www.thefirstmedia.net/news/articleView.html?idxno=59965
3936,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2129747
3937,2020-07-01,와디즈서목표의10배펀딩대웅제약덴티가드랩그립핏칫솔출시,http://news.mk.co.kr/newsRead.php?no=673218&year=2020
3938,2020-07-01,대웅제약2일항혈전제안플원출시5주년기념2차웹심포지엄개최,http://news.mk.co.kr/newsRead.php?no=673351&year=2020
3939,2020-07-01,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=211833
3940,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,https://www.ebn.co.kr/news/view/1440735/?sc=Naver
3941,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=403723
3942,2020-07-01,대웅제약안플원출시5주년기념닥터빌서2차웹심포지엄개최,http://www.pressm.kr/news/articleView.html?idxno=30969
3943,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.metroseoul.co.kr/article/20200701500437
3944,2020-07-01,대웅제약2일항혈전제안플원출시5주년2차웹심포지엄,http://news.mt.co.kr/mtview.php?no=2020070115305612640
3945,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최처방옵션및정보공유,http://www.paxetv.com/news/articleView.html?idxno=95317
3946,2020-07-01,대웅제약안플원출시5주년맞이2차웹심포지움열어,https://www.kpanews.co.kr/article/show.asp?idx=214369&category=D
3947,2020-07-01,대웅제약와디즈인기얻은덴티가드랩그립핏칫솔선봬,https://www.kpanews.co.kr/article/show.asp?idx=214371&category=D
3948,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1397632
3949,2020-07-01,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.mediapen.com/news/view/537566
3950,2020-07-01,대웅제약항혈전제안플원출시5주년기념2차심포지엄개최,https://www.donga.com/news/article/all/20200701/101777693/1
3951,2020-07-01,대웅제약안플원출시5주년웹심포지엄개최,http://www.100ssd.co.kr/news/articleView.html?idxno=69786
3952,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=2020070119553889204ead0791_12
3953,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.lawissue.co.kr/view.php?ud=202007012117322214204ead0791_12
3954,2020-07-01,뉴스투데이L대웅제약안플원출시5주년기념2차웹심포지엄개최,https://www.news2day.co.kr/155755
3955,2020-07-01,오늘의신상품대웅제약덴티가드랩그립핏칫솔출시,http://www.econovill.com/news/articleView.html?idxno=403132
3956,2020-07-02,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=60041
3957,2020-07-02,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.thefirstmedia.net/news/articleView.html?idxno=60047
3958,2020-07-02,대웅제약안플원2차웹심포지엄진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571277217065
3959,2020-07-02,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.thepublic.kr/news/newsview.php?ncode=1065575037493184
3960,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62100
3961,2020-07-02,대웅제약메티톡스로이직한前직원상대손배소허위사실유포,http://www.newspim.com/news/view/20200702000608
3962,2020-07-02,대웅제약메디톡스이직전직원소송허위사실유포,https://www.hankyung.com/finance/article/2020070248636
3963,2020-07-02,대웅제약메디톡스로이직한전직원상대허위사실유포혐의로소송,http://www.kukinews.com/news/article.html?no=805507
3964,2020-07-02,대웅제약메디톡스로이직한유모씨상대손해배상청구소송제기,http://www.wikileaks-kr.org/news/articleView.html?idxno=90177
3965,2020-07-02,대웅제약메디톡스로이직한전직원상대로소송허위사실유포혐의,http://www.ajunews.com/view/20200702113954874
3966,2020-07-02,대웅제약메디톡스이직한전직원허위사실유포로고소,https://www.news1.kr/articles/?3983868
3967,2020-07-02,대웅제약메디톡스로이직한전직원에소송ITC에허위자료제출”,http://daily.hankooki.com/lpage/industry/202007/dh20200702114714148390.htm?s_ref=nv
3968,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기∙∙허위사실유포혐의,http://www.businesskorea.co.kr/news/articleView.html?idxno=48408
3969,2020-07-02,대웅제약메디톡스이직직원에소송허위사실유포,http://news.mt.co.kr/mtview.php?no=2020070211470627783
3970,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기허위사실유포혐의,http://www.updownnews.co.kr/news/articleView.html?idxno=220459
3971,2020-07-02,대웅제약메디톡스로이직한전직원제소허위사실유포,http://www.newsis.com/view/?id=NISX20200702_0001081431&cID=13001&pID=13000
3972,2020-07-02,대웅제약메디톡스이직前직원허위사실유포로고소”,http://www.youthdaily.co.kr/news/article.html?no=41131
3973,2020-07-02,대웅제약메디톡스로이직한대웅제약前직원상대소송제기”,https://biz.chosun.com/site/data/html_dir/2020/07/02/2020070202065.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3974,2020-07-02,대웅제약메디톡스이직전직원상대소송제기허위사실유포혐의”,http://www.viva100.com/main/view.php?key=20200702010000433
3975,2020-07-02,대웅제약메디톡스로이직한전직원상대로소송제기,http://www.econovill.com/news/articleView.html?idxno=403191
3976,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기,http://www.medigatenews.com/news/1841067745
3977,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기”,http://www.newsway.co.kr/news/view?tp=1&ud=2020070211402196851
3978,2020-07-02,대웅제약메디톡스로이직한대웅제약전직원허위사실유포혐의로고소,http://www.sisafocus.co.kr/news/articleView.html?idxno=242611
3979,2020-07-02,대웅제약소송위해메디톡스로이직전직원상대소송제기,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246291
3980,2020-07-02,대웅제약소송위해메디톡스이직대웅제약전직원상대소송제기허위사실유포혐의”,http://newsclaim.co.kr/View.aspx?No=890942
3981,2020-07-02,대웅제약메디톡스이직전직원상대소송제기허위사실유포,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070212555998992
3982,2020-07-02,대웅제약메디톡스로이직한前직원상대소송제기,http://www.pharmnews.com/news/articleView.html?idxno=100812
3983,2020-07-02,대웅제약메디톡스이직전직원상대손해배상청구소송제기허위사실유포했다”,https://www.donga.com/news/article/all/20200702/101789997/1
3984,2020-07-02,대웅제약메디톡스로이직한前직원상대소송,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007020238&t=NN
3985,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기∙∙∙허위사실유포혐의,http://www.nbnnews.co.kr/news/articleView.html?idxno=404046
3986,2020-07-02,대웅제약메디톡스로이직한전직원에허위사실유포혐의로손배소,http://news.mk.co.kr/newsRead.php?no=678397&year=2020
3987,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기허위사실유포혐의,https://www.sedaily.com/NewsView/1Z55B5ZAQT
3988,2020-07-02,대웅제약메디톡스이직직원에게손배소허위사실유포,http://moneys.mt.co.kr/news/mwView.php?no=2020070213328092550
3989,2020-07-02,대웅제약메디톡스로이직한대웅前직원상대소송제기,http://www.edaily.co.kr/news/newspath.asp?newsid=02952006625830584
3990,2020-07-02,대웅제약메디톡스로이직한전직원소송허위사실유포,http://www.seoulwire.com/news/articleView.html?idxno=418614
3991,2020-07-02,대웅제약메디톡스로이직한前직원소송허위사실유포”,http://inthenews.co.kr/article-56725/
3992,2020-07-02,대웅제약허위사실유포한메디톡스이직前직원상대로소송제기,http://it.chosun.com/site/data/html_dir/2020/07/02/2020070202479.html
3993,2020-07-02,대웅제약메디톡스로이직한유모씨에손해배상청구,http://www.kpinews.co.kr/news/articleView.html?idxno=120522
3994,2020-07-02,대웅제약메디톡스로이직전직원에허위사실유포손배소,http://yna.kr/AKR20200702110200017?did=1195m
3995,2020-07-02,대웅제약메디톡스이직전직원소송허위사실유포,http://www.dailysmart.co.kr/news/articleView.html?idxno=29198
3996,2020-07-02,대웅제약메디톡스이직한前직원에소송허위사실유포했다”,https://www.etoday.co.kr/news/view/1913421
3997,2020-07-02,대웅제약메디톡스로이직대웅제약前직원상대소송제기”,https://www.fetv.co.kr/news/article.html?no=58439
3998,2020-07-02,대웅제약메디톡스로옮긴前직원에허위사실유포손배소,http://news.mk.co.kr/newsRead.php?no=678826&year=2020
3999,2020-07-02,美ITC예비판정D4대웅제약전면공세vs메디톡스담담왜,https://www.paxnetnews.com/articles/62518
4000,2020-07-02,대웅제약메디톡스이직한전직원상대소송제기,http://www.getnews.co.kr/view.php?ud=2020070214492848552fe691f917_16
4001,2020-07-02,대웅제약메디톡스로이직한전직원상대소송허위사실유포혐의,http://www.newsprime.co.kr/news/article.html?no=509804
4002,2020-07-02,대웅제약메디톡스이직전직원제소허위사실유포,https://view.asiae.co.kr/article/2020070215013197317
4003,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기허위사실유포혐의,http://www.m-i.kr/news/articleView.html?idxno=725926
4004,2020-07-02,대웅제약소송위해메디톡스이직한전직원소송제기,http://medipana.com/news/news_viewer.asp?NewsNum=259394&MainKind=A&NewsKind=5&vCount=12&vKind=1
4005,2020-07-02,대웅제약메디톡스이직한전직원소송허위사실유포,http://sports.hankooki.com/lpage/economy/202007/sp20200702151423137020.htm?s_ref=nv
4006,2020-07-02,대웅제약메디톡스로이직한전직원상대로손해배상청구소송,http://www.businesspost.co.kr/BP?command=article_view&num=185541
4007,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기∙∙∙허위사실유포혐의”,http://newsbrite.net/138956
4008,2020-07-02,대웅제약메디톡스이직전직원A씨소송허위사실유포했다,http://www.ftoday.co.kr/news/articleView.html?idxno=203494
4009,2020-07-02,대웅제약메디톡스로이직한전직원에허위사실유포소송,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4204063
4010,2020-07-02,대웅제약닥터빌에서안플원2차웨비나개최,http://www.medigatenews.com/news/2142416364
4011,2020-07-02,대웅제약메디톡스이직한전직원에허위사실유포손배청구,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004029060
4012,2020-07-02,대웅제약메디톡스로이직한대웅제약전직원에소송제기”,https://www.dailian.co.kr/news/view/902265?sc=Naver
4013,2020-07-02,대웅제약타사이직직원에소송허위사실유포혐의,http://www.finomy.com/news/articleView.html?idxno=79848
4014,2020-07-02,대웅제약메디톡스이직한전직원상대손배소제기,http://www.mediapen.com/news/view/537797
4015,2020-07-02,대웅제약메디톡스위기노려보톡스분쟁뒤집기시도,http://www.seouleconews.com/news/articleView.html?idxno=55418
4016,2020-07-02,대웅제약메디톡스이직전직원상대허위사실유포손배소,http://www.seoulfn.com/news/articleView.html?idxno=387890
4017,2020-07-02,대웅제약공익신고자대리인메디톡스흠집내기합세ITC예비판정앞두고불안감표출,http://theviewers.co.kr/View.aspx?No=902466
4018,2020-07-02,대웅제약메디톡스이직한前직원소송제기허위사실유포혐의,http://www.todaykorea.co.kr/news/articleView.html?idxno=273286
4019,2020-07-02,대웅제약메디톡스로이직대웅전직원에소송,https://www.kpanews.co.kr/article/show.asp?idx=214397&category=D
4020,2020-07-02,대웅제약메디톡스로이직한직원상대손배소,https://hankookilbo.com/News/Read/A2020070217030002353?did=NA
4021,2020-07-02,끝나지않은보톡스전쟁대웅제약메디톡스이직자상대허위사실유포소송,http://sports.chosun.com/news/ntype.htm?id=202007030100027240001479&servicedate=20200702
4022,2020-07-02,대웅제약메디톡스이직직원에허위사실유포손배소,http://news.kmib.co.kr/article/view.asp?arcid=0014759367&code=61141411&cp=nv
4023,2020-07-02,대웅제약비만예방포스터디자인공모전열어,https://www.kpanews.co.kr/article/show.asp?idx=214399&category=D
4024,2020-07-02,대웅제약ITC소송제출된모든자료공개해확인하면누가거짓말하는지알수있다,http://www.segye.com/content/html/2020/07/02/20200702520730.html?OutUrl=naver
4025,2020-07-02,김창수의e뉴스브리핑대웅제약메디톡스로이직대웅제약前직원상대소송제기”外,https://www.fetv.co.kr/news/article.html?no=58469
4026,2020-07-02,대웅제약메디톡스이직前직원상대소송∙∙∙허위사실유포그만해야,http://www.newslock.co.kr/news/articleView.html?idxno=29223
4027,2020-07-02,대웅제약메디톡스직원허위사실유포혐의고소,http://www.100ssd.co.kr/news/articleView.html?idxno=69810
4028,2020-07-02,대웅제약메디톡스이직한前직원상대로소송제기,http://www.cstimes.com/news/articleView.html?idxno=420721
4029,2020-07-02,대웅제약메디톡스로이직前직원에허위사실유포손배소,https://www.asiatoday.co.kr/view.php?key=20200702010001727
4030,2020-07-03,대웅제약메디톡스ITC소송다음주결판진실게임끝이보인다,https://www.dailian.co.kr/news/view/902281?sc=Naver
4031,2020-07-03,다우지수상승속SK바이오팜돌풍계속오스코텍종근당바이오삼성바이오로직스제일약품동국제약셀트리온부광약품신풍제약신일제약대웅제약위더스제약주가주목,http://www.thekpm.com/view.php?ud=202007030657185736861beb2d9d_17
4032,2020-07-03,대웅제약소송위해메디톡스로이직한전직원에소송제기,http://www.doctorstimes.com/news/articleView.html?idxno=211468
4033,2020-07-03,지속되는보툴리눔진실공방대웅제약전직원소송나선까닭,http://www.iminju.net/news/articleView.html?idxno=54915
4034,2020-07-03,사활건메디톡스와의5년전쟁대웅제약패소시2조원대美시장잃을수도,http://www.whitepaper.co.kr/news/articleView.html?idxno=195348
4035,2020-07-05,대웅제약메디톡스보톡스진실게임드디어끝난다,https://www.etoday.co.kr/news/view/1913891
4036,2020-07-05,보톡스원료분쟁대웅제약메디톡스간운명이번주갈린다,http://yna.kr/AKR20200704024400017?did=1195m
4037,2020-07-05,5년분쟁의끝대웅제약메디톡스다음주ITC소송결판,http://www.mediapen.com/news/view/538362
4038,2020-07-05,보톡스원료둘러싼대웅제약메디톡스진실게임5년전쟁누가승자될까,http://news.heraldcorp.com/view.php?ud=20200705000009
4039,2020-07-05,대웅제약vs메디톡스보툴리눔균주공방6일판가름,http://www.shinailbo.co.kr/news/articleView.html?idxno=1295746
4040,2020-07-05,대웅제약vs메디톡스보톡스균주진실게임승자는이번주결과앞둬,http://www.metroseoul.co.kr/article/20200705500197
4041,2020-07-05,대웅제약vs메디톡스균주분쟁사실상이번주판가름날듯,http://www.segye.com/content/html/2020/07/05/20200705509165.html?OutUrl=naver
4042,2020-07-05,대웅제약메디톡스간보톡스원료분쟁이번주일단락전망,http://news.mk.co.kr/newsRead.php?no=687389&year=2020
4043,2020-07-05,대웅제약메디톡스보톡스원료분쟁이주내판가름,http://www.sportsseoul.com/news/read/933739?ref=naver
4044,2020-07-05,한번내린결정번복않는美ITC어느손들어줄까대웅제약VS메디톡스보톡스원료분쟁판결임박,http://www.thevaluenews.co.kr/news/view.php?idx=159995
4045,2020-07-05,메디톡스대웅제약이번주균주논란결판,http://www.edaily.co.kr/news/newspath.asp?newsid=01758086625831568
4046,2020-07-05,보톡스분쟁메디톡스대웅제약ITC예비판결코앞,http://www.skyedaily.com/news/news_view.html?ID=107700
4047,2020-07-05,메디톡스대웅제약보톡스5년진실게임끝낼까,http://www.hani.co.kr/arti/economy/marketing/952342.html
4048,2020-07-06,전문기자칼럼대웅제약vs메디톡스타협이최선책,http://www.edaily.co.kr/news/newspath.asp?newsid=01220166625831896
4049,2020-07-06,보톡스분쟁메디톡스대웅제약오늘윤곽잡힌다ITC예비판결예정,http://moneys.mt.co.kr/news/mwView.php?no=2020070522388070467
4050,2020-07-06,대웅제약vs메디톡스ITC예비판정결과발표임박,http://www.dailypharm.com/Users/News/NewsView.html?ID=266256&REFERER=NP
4051,2020-07-06,초점대웅제약메디톡스균주분쟁승자는누구,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2000607
4052,2020-07-06,7일대웅제약vs메디톡스5년균주전쟁끝낸다최후승자는,http://news.mt.co.kr/mtview.php?no=2020070120321052884
4053,2020-07-06,대웅제약vs메디톡스이번주운명의날4년분쟁예비승자는,http://daily.hankooki.com/lpage/industry/202007/dh20200706070019148390.htm?s_ref=nv
4054,2020-07-06,대웅제약VS메디톡스보툴리눔톡신4년전쟁승자는,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246353
4055,2020-07-06,메디톡스대웅제약K보톡스승자는누구,http://www.econovill.com/news/articleView.html?idxno=403500
4056,2020-07-06,구충제다음은줄기세포”대웅제약줄기세포코로나19치료제임상1상개시,https://www.donga.com/news/article/all/20200706/101832533/1
4057,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제항바이러스효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246363
4058,2020-07-06,대웅제약줄기세포 코로나19 호흡기증상치료제로인도네시아임상 1상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=48528
4059,2020-07-06,대웅제약줄기세포코로나치료제인도네시아1상승인,http://www.newsis.com/view/?id=NISX20200706_0001084453&cID=13001&pID=13000
4060,2020-07-06,대웅제약줄기세포활용코로나19치료제인도네시아임상1상승인,http://www.sentv.co.kr/news/view/575728
4061,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.lawissue.co.kr/view.php?ud=202007060757189858204ead0791_12
4062,2020-07-06,대웅제약줄기세포로코로나19치료제도전인도네시아서임상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020070607408043095
4063,2020-07-06,대웅제약줄기세포코로나19치료제印尼서임상1상승인연내한국에서2상임상진행,http://www.pinpointnews.co.kr/view.php?ud=202007060758544792365609d9b_45
4064,2020-07-06,대웅제약줄기세포코로나치료제인도네시아1상승인,http://www.g-enews.com/ko-kr/news/article/news_all/202007060757393170a218188523_1/article.html
4065,2020-07-06,대웅제약코로나19호흡기증상줄기세포치료제인도네시아임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=726525
4066,2020-07-06,대웅제약줄기세포코로나치료제인도네시아서임상1상승인,http://www.ekn.kr/news/article.html?no=509420
4067,2020-07-06,대웅제약줄기세포코로나호흡기치료제인니1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2129947
4068,2020-07-06,대웅제약인니서줄기세포활용한코로나19증상치료후보임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=688679&year=2020
4069,2020-07-06,대웅제약코로나19치료제임상1상승인셀트리온부광약품신일제약신풍제약등주가상승불댕기나,http://www.thekpm.com/view.php?ud=202007060821395611861beb2d9d_17
4070,2020-07-06,대웅제약코로나줄기세포치료제인도네시아임상1상승인,https://view.asiae.co.kr/article/2020070608273305777
4071,2020-07-06,메디톡스대웅제약보톡스분쟁곧일단락,https://hankookilbo.com/News/Read/A2020070516590000574?did=NA
4072,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.newspim.com/news/view/20200706000036
4073,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인니임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=41338
4074,2020-07-06,대웅제약줄기세포로코로나치료제도전연내2상진입,http://news.mt.co.kr/mtview.php?no=2020070608262367875
4075,2020-07-06,대웅제약코로나19치료제인도네시아임상1상승인,http://www.newstomato.com/ReadNews.aspx?no=982207
4076,2020-07-06,대웅제약줄기세포활용코로나19치료제인니서임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070608294911858
4077,2020-07-06,대웅제약코로나19호흡기증상치료제인도네시아서임상1상승인,http://www.pressm.kr/news/articleView.html?idxno=31073
4078,2020-07-06,대웅제약코로나19줄기세포치료제인니임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=259494&MainKind=A&NewsKind=5&vCount=12&vKind=1
4079,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020070608514572237
4080,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.fnnews.com/news/202007060831210916
4081,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아1상승인,http://health.chosun.com/site/data/html_dir/2020/07/06/2020070600638.html
4082,2020-07-06,오늘의키워드보톡스전쟁일단락오늘대웅제약메디톡신예비판결,https://cnbc.sbs.co.kr/article_hub/10000988730?division=NAVER
4083,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인니임상1상승인,http://daily.hankooki.com/lpage/industry/202007/dh20200706090350148390.htm?s_ref=nv
4084,2020-07-06,대웅제약줄기세포인니서코로나치료제임상승인,https://www.ebn.co.kr/news/view/1441216/?sc=Naver
4085,2020-07-06,대웅제약줄기세포코로나치료제인도네시아에서임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4206944
4086,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.ajunews.com/view/20200706090222795
4087,2020-07-06,대웅제약DWP710인니서코로나임상1상진행,http://www.whosaeng.com/119183
4088,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.newsprime.co.kr/news/article.html?no=510010
4089,2020-07-06,대웅제약메디톡스5년보톡스진실공방ITC판결로분수령,http://www.inews24.com/view/1279164
4090,2020-07-06,대웅제약메디톡스보톡스원료분쟁내일분수령승자는누구,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4206965
4091,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://newsbrite.net/139082
4092,2020-07-06,대웅제약코로나19치료제인도네시아임상1상승인,http://isplus.live.joins.com/news/article/article.asp?total_id=23817897
4093,2020-07-06,대웅제약줄기세포이용코로나19치료제인도네시아임상1상승인,https://www.etoday.co.kr/news/view/1914268
4094,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아서임상1상승인,http://it.chosun.com/site/data/html_dir/2020/07/06/2020070600824.html
4095,2020-07-06,대웅제약줄기세포코로나19치료제로인도네시아1상승인,http://www.press9.kr/news/articleView.html?idxno=45206
4096,2020-07-06,대웅제약인니서줄기세포코로나19치료제임상1상승인,http://inthenews.co.kr/article-57105/
4097,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아1상승인,http://www.mediapen.com/news/view/538590
4098,2020-07-06,대웅제약vs메디톡스보톡스원료분쟁끝이보인다최후승자는,http://www.wolyo.co.kr/news/articleView.html?idxno=106642
4099,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=392132
4100,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,https://www.fetv.co.kr/news/article.html?no=58616
4101,2020-07-06,대웅제약코로나19줄기세포치료제인도네시아임상승인,http://www.medigatenews.com/news/2525966519
4102,2020-07-06,전승호대웅제약사장코로나19대체의약품개발속도,http://www.wikileaks-kr.org/news/articleView.html?idxno=90347
4103,2020-07-06,대웅제약인니서줄기세포코로나19치료제임상돌입,http://www.viva100.com/main/view.php?key=20200706010000971
4104,2020-07-06,대웅제약보툴리눔분쟁판결앞두고하락세,http://www.whitepaper.co.kr/news/articleView.html?idxno=195368
4105,2020-07-06,대웅제약줄기세포코로나치료제인도네시아임상1상승인,https://www.sedaily.com/NewsView/1Z574NY3JN
4106,2020-07-06,대웅제약인도네시아서코로나19치료제임상돌입,http://www.finomy.com/news/articleView.html?idxno=79934
4107,2020-07-06,메디톡스대웅제약보톡스전쟁오늘밤예비판정나온다,http://moneys.mt.co.kr/news/mwView.php?no=2020070608228066626
4108,2020-07-06,대웅제약인니서중간엽줄기세포이용코로나치료제임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=120687
4109,2020-07-06,대웅제약줄기세포 코로나19 호흡기증상치료제임상 印尼1상승인,http://www.economytalk.kr/news/articleView.html?idxno=206918
4110,2020-07-06,대웅제약코로나19치료제인도네시아임상1상승인,http://www.seoulfn.com/news/articleView.html?idxno=388124
4111,2020-07-06,대웅제약코로나19 호흡기증상치료제인도네시아서임상 1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119015
4112,2020-07-06,대웅제약코로나19호흡기증상치료제개발가속화,http://www.sisaweek.com/news/articleView.html?idxno=135411
4113,2020-07-06,대웅제약DWP710인도네시아임상1상승인,http://www.bokuennews.com/news/article.html?no=192123
4114,2020-07-06,대웅제약줄기세포코로나19치료제임상1상승인,http://sports.hankooki.com/lpage/economy/202007/sp20200706100853137020.htm?s_ref=nv
4115,2020-07-06,대웅제약줄기세포코로나19치료제인니서임상1상승인,http://yna.kr/AKR20200706045500017?did=1195m
4116,2020-07-06,대웅제약인도네시아서코로나치료제임상1상승인,http://www.upinews.kr/newsView/upi202007060025
4117,2020-07-06,보톡스전쟁대웅제약메디톡스ITC예비판결임박누가울고웃을까,http://www.ajunews.com/view/20200706101539934
4118,2020-07-06,대웅제약줄기세포 코로나19 호흡기증상치료제로인도네시아임상 1상승인,http://www.greened.kr/news/articleView.html?idxno=259219
4119,2020-07-06,대웅제약줄기세포이용코로나19치료제인도네시아서1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=70980
4120,2020-07-06,대웅제약인니서줄기세포코로나19치료제임상1상진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571003647008
4121,2020-07-06,대웅제약코로나19증상치료제인도네시아서임상1상승인,http://www.econovill.com/news/articleView.html?idxno=403546
4122,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인도네시아임상1상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1398501
4123,2020-07-06,대웅제약줄기세포코로나19치료제인니서임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=29395
4124,2020-07-06,대웅제약vs메디톡스보톡스분쟁7일분수령ICT예비판결예정,http://www.newsworks.co.kr/news/articleView.html?idxno=469945
4125,2020-07-06,대웅제약메디톡스5년균주분쟁최후승자주목,http://www.dailysmart.co.kr/news/articleView.html?idxno=29408
4126,2020-07-06,대웅제약줄기세포코로나19치료제인니임상돌입연내2상임상목표,http://www.getnews.co.kr/view.php?ud=2020070611175283442fe691f917_16
4127,2020-07-06,균주전쟁판결앞둔대웅제약전승호사장코로나19도메디톡스와맞불,http://www.babytimes.co.kr/news/articleView.html?idxno=37576
4128,2020-07-06,대웅제약인도네시아서줄기세포이용코로나19치료제임상1상승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=81097
4129,2020-07-06,메디톡스vs대웅제약ITC예비판정Dday보톡스안을승자는,http://www.newspim.com/news/view/20200706000386
4130,2020-07-06,대웅제약줄기세포코로나19치료제인니임상1상승인,https://www.hankyung.com/finance/article/2020070665936
4131,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.metroseoul.co.kr/article/20200706500143
4132,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.press9.kr/news/articleView.html?idxno=45210
4133,2020-07-06,대웅제약혈행혈압건강에좋은건기식세노메가큐텐출시,http://www.ekn.kr/news/article.html?no=509529
4134,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://medipana.com/news/news_viewer.asp?NewsNum=259536&MainKind=A&NewsKind=5&vCount=12&vKind=1
4135,2020-07-06,대웅제약줄기세포코로나19치료제인니임상1상승인호흡기증상치료효과확인할것,http://theviewers.co.kr/View.aspx?No=904863
4136,2020-07-06,대웅제약혈압혈행건강돕는건기식세노메가큐텐출시,http://www.medisobizanews.com/news/articleView.html?idxno=70984
4137,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아1상승인,http://www.wolyo.co.kr/news/articleView.html?idxno=106658
4138,2020-07-06,대웅제약혈압혈행개선신제품세노메가큐텐출시,http://news.mt.co.kr/mtview.php?no=2020070611430898809
4139,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.updownnews.co.kr/news/articleView.html?idxno=220557
4140,2020-07-06,대웅제약메디톡스균주출처공방첫결론임박,http://medipana.com/news/news_viewer.asp?NewsNum=259530&MainKind=A&NewsKind=5&vCount=12&vKind=1
4141,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인니임상1상승인,http://www.pharmnews.com/news/articleView.html?idxno=100826
4142,2020-07-06,혈행개선혈압건강한알로”대웅제약세노메가큐텐출시,https://www.fetv.co.kr/news/article.html?no=58665
4143,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.getnews.co.kr/view.php?ud=2020070612261036282fe691f917_16
4144,2020-07-06,대웅제약코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62133
4145,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62144
4146,2020-07-06,대웅제약건기식세노메가큐텐출시혈압과혈행을한알로,http://www.metroseoul.co.kr/article/20200706500174
4147,2020-07-06,부자들은경제신문을읽는다대웅제약VS메디톡스최후승자는,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070612555171577
4148,2020-07-06,메디톡스대웅제약5년균주전쟁7일판가름,http://www.viva100.com/main/view.php?key=20200706010001077
4149,2020-07-06,시황분석대웅제약전일대비956상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202007061316093973edd30f5664_45
4150,2020-07-06,대웅제약438상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/07/06/2020070601771.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4151,2020-07-06,대웅제약상승출발후현재956최근단기조정후반등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007060241&t=NN
4152,2020-07-06,대웅제약757VI발동,https://biz.chosun.com/site/data/html_dir/2020/07/06/2020070601773.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4153,2020-07-06,대웅제약중간엽줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.paxetv.com/news/articleView.html?idxno=95542
4154,2020-07-06,신풍제약대웅제약제약주가파른상승신풍제약5급등이어대웅제약3상승,http://www.econonews.co.kr/news/articleView.html?idxno=127603
4155,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.m-i.kr/news/articleView.html?idxno=726714
4156,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.etnews.com/20200706000220
4157,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=392170
4158,2020-07-06,대웅제약코로나19치료제임상승인319상승,http://www.ccreview.co.kr/news/articleView.html?idxno=269794
4159,2020-07-06,대웅제약복합제올로스타올로맥스차별화된경쟁력주목,http://www.bosa.co.kr/news/articleView.html?idxno=2130008
4160,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=404801
4161,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시혈행개선과혈압건강을한알로,http://www.nbnnews.co.kr/news/articleView.html?idxno=404795
4162,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.cstimes.com/news/articleView.html?idxno=421119
4163,2020-07-06,대웅제약코로나19줄기세포치료제로인도네시아임상1상진행,http://www.businesspost.co.kr/BP?command=article_view&num=185983
4164,2020-07-06,글로벌의약품시장메카美보스턴에둥지튼종근당대웅제약보령제약등10개제약사제약바이오협회주도로공유오피스입주해美시장공략강화,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004032623
4165,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.lawissue.co.kr/view.php?ud=202007061427489269204ead0791_12
4166,2020-07-06,대웅제약줄기세포 코로나19 호흡기치료제인도네시아임상 1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=29305
4167,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시혈행개선과혈압건강을한알로,http://www.ybsn.tv/news/articleView.html?idxno=21219
4168,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시혈행개선과혈압건강을한알로,http://newsbrite.net/139130
4169,2020-07-06,대웅제약건기식세노메가큐텐출시,http://www.bokuennews.com/news/article.html?no=192154
4170,2020-07-06,대웅제약혈행혈압까지한알로케어하는세노메가큐텐출시,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119048
4171,2020-07-06,대웅제약혈압혈행동시케어건강기능식품세노메가큐텐출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200706011
4172,2020-07-06,메디톡스대웅제약의보톡스이전투구어떻게시작됐나,https://www.asiatime.co.kr/news/newsview.php?ncode=1065586427633025
4173,2020-07-06,오늘의신상품대웅제약혈행혈압건강챙기는세노메가큐텐출시,http://www.econovill.com/news/articleView.html?idxno=403600
4174,2020-07-06,대웅제약세노메가큐텐출시혈압혈행건강케어,http://www.kpinews.co.kr/news/articleView.html?idxno=120755
4175,2020-07-06,대웅제약VS메디톡스오늘보톡스분쟁ITC예비판결결과나온다보톡스보툴리눔톡신테마주7월6일14시55분현재장중시황,http://www.topstarnews.net/news/articleView.html?idxno=817815
4176,2020-07-06,대웅제약줄기세포코로나19치료제로인니서임상1상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=03194726625831896
4177,2020-07-06,대웅제약줄기세포코로나19치료제로인도네시아임상1상승인,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=225872
4178,2020-07-06,대웅제약혈행개선과혈압건강건강기능식품세노메가큐텐출시,http://www.k-health.com/news/articleView.html?idxno=49175
4179,2020-07-06,대웅제약건기식신제품세노메가큐텐출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=29415
4180,2020-07-06,뉴스투데이L대웅제약혈압혈행건강동시케어가능한세노메가큐텐출시,https://www.news2day.co.kr/156038
4181,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.edaily.co.kr/news/newspath.asp?newsid=03411206625831896
4182,2020-07-06,대웅제약카모스타트제제코로나19임상2상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=266282&REFERER=NP
4183,2020-07-06,대웅제약혈행혈압관리건강기능식품세노메가큐텐출시,http://news.mk.co.kr/newsRead.php?no=691593&year=2020
4184,2020-07-06,대웅제약세노메가큐텐플러스출시,https://www.ebn.co.kr/news/view/1441359/?sc=Naver
4185,2020-07-06,대웅제약vs메디톡스5년보톡스전쟁이르면오늘결론,http://www.newsway.co.kr/news/view?tp=1&ud=2020070614395653549
4186,2020-07-06,대웅제약코로나19호흡기치료제인도네시아임상1상,http://www.mhj21.com/132396
4187,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=100641
4188,2020-07-06,대웅제약코로나19치료제인도네시아서임상1상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=69870
4189,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인올해안2상진입,http://www.startuptoday.co.kr/news/articleView.html?idxno=46192
4190,2020-07-06,대웅제약인도네시아서코로나치료제임상1상승인,http://www.koreastocknews.com/news/articleView.html?idxno=55097
4191,2020-07-06,대웅제약코로나19치료제개발임상2상승인,http://www.bokuennews.com/news/article.html?no=192160
4192,2020-07-06,대웅제약vs메디톡스기술탈취논란판결앞두고주가는엇갈려,http://www.whitepaper.co.kr/news/articleView.html?idxno=195387
4193,2020-07-06,김창수의e뉴스브리핑대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인外,https://www.fetv.co.kr/news/article.html?no=58699
4194,2020-07-06,줄기세포치료제가코로나에효과대웅제약印尼서코로나임상,http://news.mk.co.kr/newsRead.php?no=692144&year=2020
4195,2020-07-06,대웅제약지이크×우루사브랜드이색컬래버,https://www.jungle.co.kr/magazine/201806
4196,2020-07-06,대웅제약세노메가큐텐출시한알로혈행및혈압건강,http://theviewers.co.kr/View.aspx?No=905304
4197,2020-07-06,메디톡스vs대웅제약5년간의균주전쟁분수령ITC예비판결임박,http://www.youthdaily.co.kr/news/article.html?no=41434
4198,2020-07-06,메디톡스vs대웅제약5년보톡스균분쟁결과임박,https://cnbc.sbs.co.kr/article_hub/10000988806?division=NAVER
4199,2020-07-06,대웅제약줄기세포코로나19치료제인니서임상1상승인안정성확인,http://www.dt.co.kr/contents.html?article_no=2020070702101831102002&ref=naver
4200,2020-07-06,관점뉴스대웅제약과메디톡스의안타까운보톡스전쟁1라운드결과는,https://www.news2day.co.kr/156069
4201,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인도네시아임상1상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=69732
4202,2020-07-07,임상의맥①대웅제약급등날고민김씨어떻게,http://www.edaily.co.kr/news/newspath.asp?newsid=01272646625832224
4203,2020-07-07,메디톡스대웅제약보톡스원료분쟁미ITC영업상비밀침해혐의예비판결임박,http://www.seoulwire.com/news/articleView.html?idxno=419061
4204,2020-07-07,다우지수또환호SK바이오팜상장이후메디톡스대웅제약이연제약부광약품주목도상승,http://www.thekpm.com/view.php?ud=202007070701111922861beb2d9d_17
4205,2020-07-07,로스탁대웅제약호이스타정코로나19치료제임상2상승인,http://www.lawissue.co.kr/view.php?ud=20200707073850815204ead0791_12
4206,2020-07-07,대웅제약美협력사에볼루스시간외서21급락,https://www.hankyung.com/finance/article/2020070796097
4207,2020-07-07,메디톡스대웅제약균주분쟁분위기악화메디톡스로이직한전직원제소,http://www.ccreview.co.kr/news/articleView.html?idxno=270017
4208,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://medipana.com/news/news_viewer.asp?NewsNum=259568&MainKind=A&NewsKind=5&vCount=12&vKind=1
4209,2020-07-07,1보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/AKR20200707021300017?did=1195m
4210,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해10년수입금지,http://news.mt.co.kr/mtview.php?no=2020070707500210060
4211,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,https://news.sbs.co.kr/news/endPage.do?news_id=N1005871156&plink=ORI&cooper=NAVER
4212,2020-07-07,美ITC메디톡스에손대웅제약보톡스수입금지10년,https://news.chosun.com/site/data/html_dir/2020/07/07/2020070700469.html?utm_source=naver&utm_medium=original&utm_campaign=news
4213,2020-07-07,속보메디톡스손들어준美ITC대웅제약영업비밀침해,https://view.asiae.co.kr/article/2020070707544039214
4214,2020-07-07,대웅제약480억규모美에볼루스사모전환사채취득,https://view.asiae.co.kr/article/2020070707554147127
4215,2020-07-07,메디톡스손들어준ITC대웅제약예비결정명백한오판이의절차착수,http://www.sentv.co.kr/news/view/575794
4216,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://news.mk.co.kr/newsRead.php?no=692888&year=2020
4217,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,https://www.hankyung.com/economy/article/2020070796467
4218,2020-07-07,1보美ITC대웅제약메디톡스영업비밀침해,http://www.newspim.com/news/view/20200707000052
4219,2020-07-07,속보美ITC대웅제약이메디톡스영업비밀침해,http://www.ajunews.com/view/20200707070059585
4220,2020-07-07,속보美ITC대웅제약메디톡스의영업비밀침해10년수입금지,http://www.newsis.com/view/?id=NISX20200706_0001085781&cID=13001&pID=13000
4221,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고이의제기,http://yna.kr/AKR20200707021900017?did=1195m
4222,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00008&news_seq_no=4208118
4223,2020-07-07,속보美ITC메디톡스손들어줘대웅제약영업비밀침해10년수입금지,http://www.fnnews.com/news/202007070755437297
4224,2020-07-07,속보미국ITC대웅제약보톡스균주메디톡스와동일,http://www.edaily.co.kr/news/newspath.asp?newsid=01479286625832224
4225,2020-07-07,속보美ITC메디톡스승소판결대웅제약메디톡스영업비밀침해”,http://www.viva100.com/main/view.php?key=20200707010001189
4226,2020-07-07,2보ITC대웅제약나보타10년수입금지명령,http://www.newspim.com/news/view/20200707000055
4227,2020-07-07,공시대웅제약480억규모美에볼루스사모전환사채취득,http://www.fnnews.com/news/202007070758010786
4228,2020-07-07,미국ITC대웅제약이메디톡스영업비밀침해”,https://www.sedaily.com/NewsView/1Z57KBLZUW
4229,2020-07-07,속보美ITC대웅제약나보타10년수입금지권고,https://view.asiae.co.kr/article/2020070708005680696
4230,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고이의제기,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4208121
4231,2020-07-07,ITC메디톡스손들어줘대웅제약보톡스수입금지10년,http://www.ekn.kr/news/article.html?no=509623
4232,2020-07-07,ITC예비결정서메디톡스웃었다대웅제약이의절차착수,https://www.kpanews.co.kr/article/show.asp?idx=214479&category=D
4233,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고,https://www.hankyung.com/economy/article/2020070796557
4234,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고이의제기,http://www.newsway.co.kr/news/view?tp=1&ud=2020070707582049342
4235,2020-07-07,속보대웅제약美ITC예비결정명백한오판이의절차착수,http://www.fnnews.com/news/202007070759438945
4236,2020-07-07,속보미국ITC메디톡스손들어줬다대웅제약명백한오판,http://www.ccreview.co.kr/news/articleView.html?idxno=270018
4237,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://biz.newdaily.co.kr/site/data/html/2020/07/07/2020070700012.html
4238,2020-07-07,ITC예비판결서대웅제약나보타10년수입금지결정,http://medipana.com/news/news_viewer.asp?NewsNum=259569&MainKind=A&NewsKind=5&vCount=12&vKind=1
4239,2020-07-07,속보美ITC메디톡스손들어줘대웅제약보톡스10년간수입금지권고,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070700501.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4240,2020-07-07,공시대웅제약480억규모美에볼루스사모전환사채취득,http://www.newsway.co.kr/news/view?tp=1&ud=2020070708030174880
4241,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해1보,https://www.asiatoday.co.kr/view.php?key=20200707010003564
4242,2020-07-07,속보미ITC대웅제약보톡스10년간수입금지메디톡스손들어줘,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070047&t=NN
4243,2020-07-07,美ITC메디톡스손들어줘대웅제약10년수입금지철퇴,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070048&t=NN
4244,2020-07-07,美ITC메디톡스손대웅제약영업비밀침해1보,http://www.seoulfn.com/news/articleView.html?idxno=388233
4245,2020-07-07,메디톡스승기잡아대웅제약영업비밀침해,http://www.edaily.co.kr/news/newspath.asp?newsid=01521926625832224
4246,2020-07-07,속보美ITC메디톡스손들었다대웅제약영업비밀침해,https://www.etoday.co.kr/news/view/1914694
4247,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해,https://www.etoday.co.kr/news/view/1914697
4248,2020-07-07,메디톡스주가변동오르락내리락대웅제약보톡스영업비밀침해소송웃었다,http://kpenews.com/View.aspx?No=905457
4249,2020-07-07,메디톡스손들어준ITC 대웅제약나보타10년수입금지권고,https://hankookilbo.com/News/Read/A2020070708030000306?did=NA
4250,2020-07-07,속보대웅제약ITC예비결정명백한오판이의절차착수,https://www.hankyung.com/finance/article/2020070796907
4251,2020-07-07,대웅제약호이스타정코로나19치료제로2상승인하반기중3상,http://www.medisobizanews.com/news/articleView.html?idxno=71001
4252,2020-07-07,속보美ITC대웅제약나보타10년수입금지명령권고,https://www.etoday.co.kr/news/view/1914699
4253,2020-07-07,대웅제약이메디톡스영업비밀침해,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93450
4254,2020-07-07,상보美ITC대웅제약이메디톡스영업비밀침해10년간나보타수입금지예비판결,http://news.mk.co.kr/newsRead.php?no=692929&year=2020
4255,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해”,http://www.youthdaily.co.kr/news/article.html?no=41444
4256,2020-07-07,메디톡스완승메디톡스승기잡아대웅제약영업비밀침해,http://www.edaily.co.kr/news/newspath.asp?newsid=01554726625832224
4257,2020-07-07,메디톡스손들어준美ITC대웅제약명백한오판이의절차착수”,http://www.ajunews.com/view/20200707080826653
4258,2020-07-07,속보ITC대웅제약나보타美10년수입금지권고,http://moneys.mt.co.kr/news/mwView.php?no=2020070708128089822
4259,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해나보타10년수입금지,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070708094180052
4260,2020-07-07,ITC예비결정은명백한오판”대웅제약이의절차착수,http://www.newsway.co.kr/news/view?tp=1&ud=2020070708082900642
4261,2020-07-07,메디톡스대웅제약과균주전쟁서승리9부능선넘어,http://www.newstomato.com/ReadNews.aspx?no=982458
4262,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고,http://www.kukinews.com/newsView/kuk202007070015
4263,2020-07-07,메디톡스손들어준美ITC대웅제약나보타10년수입금지권고,http://news.mt.co.kr/mtview.php?no=2020070708040436188
4264,2020-07-07,2보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/AKR20200707024400017?did=1195m
4265,2020-07-07,대웅제약ITC예비결정은명백한오판”이의절차착수,http://www.viva100.com/main/view.php?key=20200707010001195
4266,2020-07-07,美ITC메디톡스손들어줘대웅제약보톡스10년간수입금지,https://www.asiatoday.co.kr/view.php?key=20200707010003570
4267,2020-07-07,美ITC메디톡스손들어줘대웅제약나보타10년수입금지,http://www.econovill.com/news/articleView.html?idxno=403658
4268,2020-07-07,속보대웅제약영업비밀침해”미국ITC메디톡스손들어줘,http://www.kukinews.com/newsView/kuk202007070016
4269,2020-07-07,5년보톡스전쟁메디톡스손들어준美ITC대웅제약영업비밀침해상보,https://view.asiae.co.kr/article/2020070708230701298
4270,2020-07-07,대웅제약美ITC나보타10년수입금지명령에명백한오판,http://www.newspim.com/news/view/20200707000065
4271,2020-07-07,대웅제약ITC예비결정은명백한오판”이의절차착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246420
4272,2020-07-07,美ITC대웅제약메디톡스영업비밀침해판정,http://www.dailypharm.com/Users/News/NewsView.html?ID=266297&REFERER=NP
4273,2020-07-07,속보미국ITC대웅제약10년간수입금지예비결정”,http://www.mediapen.com/news/view/538839
4274,2020-07-07,종합美ITC대웅제약이메디톡스영업비밀침해대웅이의절차진행할것,http://news.mk.co.kr/newsRead.php?no=692957&year=2020
4275,2020-07-07,미국ITC메디톡스손들어줘대웅제약수입금지10년,https://www.dailian.co.kr/news/view/903025?sc=Naver
4276,2020-07-07,대웅제약vs메디톡스ITC예비판결나보타수입금지10년,https://www.news1.kr/articles/?3987905
4277,2020-07-07,美ITC대웅제약메디톡스영업비밀침해”10년수입금지,https://www.donga.com/news/article/all/20200707/101849738/2
4278,2020-07-07,대웅제약ITC예비결정은명백한오판”이의절차착수,http://www.kukinews.com/newsView/kuk202007070019
4279,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해했다,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00008&news_seq_no=4208148
4280,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해,http://www.kukinews.com/newsView/kuk202007070018
4281,2020-07-07,미국ITC대웅제약에10년간수입금지권고,http://www.g-enews.com/ko-kr/news/article/news_all/202007070827376802a218188523_1/article.html
4282,2020-07-07,서울와이어7일모닝브리핑ITC메디톡스손들어줘대웅제약나보타10년간수입금지권고파장일파만파,http://www.seoulwire.com/news/articleView.html?idxno=419071
4283,2020-07-07,대웅제약호이스타정코로나19치료제2상승인,http://www.biospectator.com/view/news_view.php?varAtcId=10779
4284,2020-07-07,대웅제약ITC판결은단순권고이의제기,https://www.paxnetnews.com/articles/62649
4285,2020-07-07,대웅제약미국파트너에볼루스에480억규모CB투자,https://www.etoday.co.kr/news/view/1914722
4286,2020-07-07,대웅제약VS메디톡스보톡스전쟁예비결정ITC는,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246421
4287,2020-07-07,ITC예비판결敗대웅제약명백한오판이의절차착수할것”,http://www.youthdaily.co.kr/news/article.html?no=41447
4288,2020-07-07,균주전쟁종지부ITC대웅제약수입금지10년결정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134586&REFERER=NP
4289,2020-07-07,미ITC메디톡스손들어줘대웅제약영업비밀침해대웅제약10년간수입금지권고,http://news.heraldcorp.com/view.php?ud=20200707000039
4290,2020-07-07,보톡스전쟁메디톡스승리美ITC대웅제약영업비밀침해”,http://news.kmib.co.kr/article/view.asp?arcid=0014773109&code=61141111&cp=nv
4291,2020-07-07,美ITC메디톡스손들어줬다대웅제약메디톡스영업비밀침해1보,http://www.fnnews.com/news/202007070832402719
4292,2020-07-07,美ITC대웅제약이메디톡스비밀침해”대웅제약이의절차착수”,http://daily.hankooki.com/lpage/industry/202007/dh20200707083303148390.htm?s_ref=nv
4293,2020-07-07,해설제약바이오보톡스전쟁메디톡스압승미국ITC예비판정대웅제약나보타운명은,http://www.g-enews.com/ko-kr/news/article/news_all/2020070708340498234a01bf698f_1/article.html
4294,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해,http://www.shinailbo.co.kr/news/articleView.html?idxno=1296431
4295,2020-07-07,대웅제약美ITC결정납득불가이의절차착수,https://www.etoday.co.kr/news/view/1914726
4296,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246422
4297,2020-07-07,2보미국ITC대웅제약메디톡스영업비밀침해10년수입금지권고,http://www.seoulwire.com/news/articleView.html?idxno=419074
4298,2020-07-07,증시키워드미ITC보톡스판결에메디톡스대웅제약주가는SK바이오팜상한가언제까지,https://www.etoday.co.kr/news/view/1914730
4299,2020-07-07,메디톡스완승기사회생메디톡스vs최대위기대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=01708886625832224
4300,2020-07-07,대웅제약췌장염식도염치료제코로나19치료제로2상승인,http://news.mt.co.kr/mtview.php?no=2020070708413645311
4301,2020-07-07,ITC예비결정은명백한오판대웅제약이의절차착수,http://www.m-i.kr/news/articleView.html?idxno=726928
4302,2020-07-07,대웅제약ITC예비결정은명백한오판11월최종결정서승소할것,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070066&t=NN
4303,2020-07-07,보톡스전쟁메디톡스승기잡아美대웅제약나보타수입금지,http://biz.newdaily.co.kr/site/data/html/2020/07/07/2020070700023.html
4304,2020-07-07,대웅제약ITC예비결정은명백한오판,http://www.bosa.co.kr/news/articleView.html?idxno=2130047
4305,2020-07-07,美ITC메디톡스손들어줬다대웅제약영업비밀침해,http://www.sisajournal-e.com/news/articleView.html?idxno=220827
4306,2020-07-07,대웅제약역류성식도염치료제코로나19치료제임상2상승인,http://www.newspim.com/news/view/20200707000085
4307,2020-07-07,보톡스5년전쟁종지부찍나美ITC대웅제약제품10년수입금지,http://www.enewstoday.co.kr/news/articleView.html?idxno=1398768
4308,2020-07-07,ITC예비판결勝메디톡스대웅제약거짓주장입증국내서민형사소송진행”,http://www.youthdaily.co.kr/news/article.html?no=41454
4309,2020-07-07,종합美ITC대웅제약메디톡스영업비밀침해,http://www.fnnews.com/news/202007070851372508
4310,2020-07-07,미국ITC대웅제약이메디톡스영업비밀침해대웅제약명백한오판종합,http://www.seoulwire.com/news/articleView.html?idxno=419075
4311,2020-07-07,美ITC예비판결메디톡스손들어줘대웅제약영업비밀침해”,https://www.fetv.co.kr/news/article.html?no=58719
4312,2020-07-07,美ITC대웅제약이메디톡스영업비밀침해나보타10년간수입금지”종합,http://www.ajunews.com/view/20200707085111709
4313,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해10년수입금지,https://www.ytn.co.kr/_ln/0103_202007070857278957
4314,2020-07-07,ITC대웅제약메디톡스영업비밀침해10년수입금지권고,http://news.tf.co.kr/read/economy/1800778.htm
4315,2020-07-07,美보톡스전쟁서대웅제약일단패,https://www.nocutnews.co.kr/news/5373655
4316,2020-07-07,아침지금미대웅제약메디톡스영업비밀침해,http://news.jtbc.joins.com/article/article.aspx?news_id=NB11958387
4317,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.seoulwire.com/news/articleView.html?idxno=419078
4318,2020-07-07,美ITC메디톡스손대웅제약10년간수입금지권고종합,http://www.seoulfn.com/news/articleView.html?idxno=388245
4319,2020-07-07,대웅제약000VI발동,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070700738.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4320,2020-07-07,ITC승기잡은메디톡스대웅제약균주도용명백히밝혀져”,http://www.viva100.com/main/view.php?key=20200707010001214
4321,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스승기종합,http://yna.kr/AKR20200707024451017?did=1195m
4322,2020-07-07,대웅제약ITC예비결정은명백한오판이의절차착수,http://www.medisobizanews.com/news/articleView.html?idxno=71007
4323,2020-07-07,5년보톡스전쟁메디톡스승기ITC대웅제약영업비밀침해”종합,http://www.newsway.co.kr/news/view?tp=1&ud=2020070709023968259
4324,2020-07-07,균주전쟁메디톡스완승ITC대웅제약보톡스10년간수입금지,https://www.hankyung.com/it/article/202007079862i
4325,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.press9.kr/news/articleView.html?idxno=45219
4326,2020-07-07,미ITC대웅제약메디톡스영업비밀침해”10년수입금지권고,https://www.seoul.co.kr/news/newsView.php?id=20200707500011&wlog_tag3=naver
4327,2020-07-07,특징주대웅대웅제약메디톡스영업비밀침해소식에동반급락,https://www.etoday.co.kr/news/view/1914753
4328,2020-07-07,대웅제약메디톡스ITC결정에폭락에상한가로엇갈리는주가대웅제약21폭락반해메디톡스상한가,http://www.econonews.co.kr/news/articleView.html?idxno=127662
4329,2020-07-07,메디톡스上대웅제약20균주논란판정에희비,https://www.hankyung.com/finance/article/2020070798526
4330,2020-07-07,대웅제약메디톡스손들어준미국ITC예비결정에명백한오판이의절차착수,http://www.consumernews.co.kr/news/articleView.html?idxno=608149
4331,2020-07-07,美ITC대웅제약보톡스10년간수입금지희비엇갈린메디톡스대웅,http://www.sisafocus.co.kr/news/articleView.html?idxno=242875
4332,2020-07-07,특징주메디톡스대웅제약美ITC예비판결에희비교차메디톡스上직행,http://news.mk.co.kr/newsRead.php?no=693172&year=2020
4333,2020-07-07,메디톡스美ITC대웅제약나보타10년간수입금지균주도용밝혀져,http://www.newspim.com/news/view/20200707000118
4334,2020-07-07,특징주메디톡스대웅제약균주도용확인에상한가직행,https://www.etoday.co.kr/news/view/1914759
4335,2020-07-07,시황분석대웅제약전일대비1948하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=20200707091239820edd30c1ef1_45
4336,2020-07-07,대웅제약주보FDA허가1년4개월만에철수위기종합,https://www.sedaily.com/NewsView/1Z57LYXTN6
4337,2020-07-07,특징주美ITC판정에표정엇갈린메디톡스대웅제약,https://www.sedaily.com/NewsView/1Z57LSDENO
4338,2020-07-07,승기잡은메디톡스ITC대웅제약나보타10년수입금지권고,http://www.mediapen.com/news/view/538870
4339,2020-07-07,메디톡스ITC예비판결서대웅제약이메디톡스균주도용,http://www.medisobizanews.com/news/articleView.html?idxno=71009
4340,2020-07-07,美ITC메디톡스손들어줘대웅제약10년간수입금지”권고긴장,http://www.sporbiz.co.kr/news/articleView.html?idxno=452694
4341,2020-07-07,특징주메디톡스美ITC승소에상한가대웅제약은급락,http://www.inews24.com/view/1279629
4342,2020-07-07,대웅제약식도염치료제호이스타정코로나19치료제임상2상승인,https://www.sedaily.com/NewsView/1Z57KNRAMN
4343,2020-07-07,대웅대웅제약모두갑작스런폭락에투자자들당황대웅12폭락이어대웅제약17폭락,http://www.econonews.co.kr/news/articleView.html?idxno=127670
4344,2020-07-07,ITC대웅메디톡스기술탈취맞다대웅제약주가급락,http://www.whitepaper.co.kr/news/articleView.html?idxno=195404
4345,2020-07-07,속보7일오전9시증시메디톡스30급등대웅제약20급락,https://news.joins.com/article/olink/23413509
4346,2020-07-07,특징주메디톡스대웅제약보톡스원료판결에주가희비극명,https://www.dailian.co.kr/news/view/903068?sc=Naver
4347,2020-07-07,특징주메디톡스대웅제약美소송예비판결에엇갈린희비,http://www.edaily.co.kr/news/newspath.asp?newsid=01925366625832224
4348,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.koreaittimes.com/news/articleView.html?idxno=98815
4349,2020-07-07,미ITC보톡스분쟁서메디톡스손들어줘대웅제약최종판결서승소할것,http://kormedi.com/?p=1320017
4350,2020-07-07,특징주균주분쟁판결에메디톡스웃고대웅제약울고,http://inthenews.co.kr/article-57364/
4351,2020-07-07,특징주대웅제약메디톡스영업비밀침해예비판결하락,http://moneys.mt.co.kr/news/mwView.php?no=2020070709198016350
4352,2020-07-07,메디톡스美ITC판결로결정적승기잡아대웅제약보톡스사업치명타,http://www.greened.kr/news/articleView.html?idxno=259456
4353,2020-07-07,대웅제약메디톡스균주도용했다美ITC행정판사결론,http://www.wikileaks-kr.org/news/articleView.html?idxno=90428
4354,2020-07-07,특징주美ITC판결에메디톡스상한가대웅제약과희비,http://www.newspim.com/news/view/20200707000188
4355,2020-07-07,보톡스소송전메디톡스활짝대웅제약미국시장타격불가피,http://isplus.live.joins.com/news/article/article.asp?total_id=23818948
4356,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인빠른치료제개발예상,http://www.paxetv.com/news/articleView.html?idxno=95631
4357,2020-07-07,특징주대웅ITC예비판정에급락대웅제약메디톡스영업비밀침해,http://moneys.mt.co.kr/news/mwView.php?no=2020070709268036892
4358,2020-07-07,메디톡스美ITC대웅제약나보타10년간수입금지균주도용밝혀져”,http://www.newsway.co.kr/news/view?tp=1&ud=2020070709253090156
4359,2020-07-07,대웅제약췌장염식도염치료제코로나19치료임상2상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020070708548038090
4360,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스승기,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4208261
4361,2020-07-07,메디톡스vs대웅제약미국ITC메디톡스손들어줘,https://www.news2day.co.kr/156093
4362,2020-07-07,특징주메디톡스상한가ITC대웅제약영업비밀침해예비판결,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573033954965
4363,2020-07-07,대웅제약vs메디톡스보툴리늄균주전쟁메디톡스승기잡았다,http://www.pinpointnews.co.kr/view.php?ud=202007070929499714f090c8dbcb_45
4364,2020-07-07,ITC승소메디톡스대웅제약거짓주장들통,https://www.paxnetnews.com/articles/62653
4365,2020-07-07,특징주메디톡스대웅제약과보톡스분쟁승기에상한가,https://www.asiatoday.co.kr/view.php?key=20200707010003681
4366,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.ybsn.tv/news/articleView.html?idxno=21316
4367,2020-07-07,균주분쟁美ITC대웅제약영업비밀침해”예비판결메디톡스승기잡았다,https://www.fetv.co.kr/news/article.html?no=58736
4368,2020-07-07,대웅제약480억규모美에볼루스사모전환사채취득,http://www.edaily.co.kr/news/newspath.asp?newsid=02013926625832224
4369,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스손들어줘,http://sports.chosun.com/news/ntype.htm?id=202007080100064320004220&servicedate=20200707
4370,2020-07-07,대웅제약호이스타정;코로나19치료제임상2상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=120812
4371,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.metroseoul.co.kr/article/20200707500050
4372,2020-07-07,보톡스진실공방5년메디톡스가대웅제약이겼다,http://www.bizhankook.com/article/20252
4373,2020-07-07,포털검색상위종목SK바이오팜강세메디톡스와대웅제약주가희비교차,http://www.g-enews.com/ko-kr/news/article/news_all/202007070920074571edf69f862c_1/article.html
4374,2020-07-07,대웅제약호이스타정코로나치료제개발임상2상승인,http://isplus.live.joins.com/news/article/article.asp?total_id=23818961
4375,2020-07-07,대웅제약카모스타트성분호이스타정의코로나19임상2상승인받아,http://news.mk.co.kr/newsRead.php?no=693417&year=2020
4376,2020-07-07,ITC예비결정은명백한오판대웅제약이의절차착수,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62153
4377,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62152
4378,2020-07-07,美ITC메디톡스손들어줬다대웅제약보톡스10년간수입금지,http://www.ezyeconomy.com/news/articleView.html?idxno=102761
4379,2020-07-07,美첫진출국산보톡스10년간수입금지대웅제약미국사업차질,http://yna.kr/AKR20200707045600017?did=1195m
4380,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.etnews.com/20200707000039
4381,2020-07-07,TF특징주보톡스전쟁승기잡은메디톡스상한가대웅제약급락,http://news.tf.co.kr/read/economy/1800799.htm
4382,2020-07-07,보툴리눔논란메디톡스미ITC예비판결승리대웅제약최종판결서승소확신,http://www.kpinews.co.kr/news/articleView.html?idxno=120815
4383,2020-07-07,美ITC예비판정이슈메디톡스장중급등vs대웅제약장중추락,http://www.choicenews.co.kr/news/articleView.html?idxno=72453
4384,2020-07-07,특징주메디톡스대웅제약美ITC판결에희비,http://www.cstimes.com/news/articleView.html?idxno=421252
4385,2020-07-07,메디톡스완승사활건메디톡스대웅제약왜이지경까지,http://www.edaily.co.kr/news/newspath.asp?newsid=02050006625832224
4386,2020-07-07,대웅제약메디톡스균주도용했다”미국ITC판결,http://www.joseilbo.com/news/news_read.php?uid=401565&class=27&grp=
4387,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://yna.kr/AKR20200707051500017?did=1195m
4388,2020-07-07,특징주대웅제약메디톡스영업비밀침해”美ITC예비판결에급락,http://www.kukinews.com/newsView/kuk202007070076
4389,2020-07-07,메디톡스대웅제약미국ITC예비판결에주가희비교차,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4208319
4390,2020-07-07,대웅제약호이스타정코로나19치료제로식약처임상2상승인받아,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572441830135
4391,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://daily.hankooki.com/lpage/industry/202007/dh20200707095025148390.htm?s_ref=nv
4392,2020-07-07,대웅제약ITC예비판결납득할수없어이의절차할것,https://www.hankyung.com/it/article/202007070331i
4393,2020-07-07,메디톡스대웅제약보톡스분쟁미국ITC대웅제약에영업비밀침해예비판결,http://news.kbs.co.kr/news/view.do?ncd=4488311&ref=A
4394,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,https://www.fetv.co.kr/news/article.html?no=58745
4395,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://it.chosun.com/site/data/html_dir/2020/07/07/2020070701185.html
4396,2020-07-07,美ITC대웅제약10년간수입금지보톡스戰승기잡은메디톡스종합,http://www.newspim.com/news/view/20200707000269
4397,2020-07-07,보톡스전쟁승기잡은메디톡스ITC대웅제약영업비밀침해,http://www.cstimes.com/news/articleView.html?idxno=421253
4398,2020-07-07,대웅제약전일대비1498하락이시각거래량97만8184주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070141&t=NN
4399,2020-07-07,특징주미국ITC영업비밀침해예비판결에대웅제약하락,https://www.ebn.co.kr/news/view/1441444/?sc=Naver
4400,2020-07-07,그래픽메디톡스대웅제약보톡스원료분쟁주요일지,http://yna.kr/GYH20200707000800044?did=1363m
4401,2020-07-07,대웅제약코로나19치료제임상2상승인주목,https://news.imaeil.com/Economy/2020070710000596387
4402,2020-07-07,대웅제약호이스타코로나19치료제임상2상승인,http://www.econovill.com/news/articleView.html?idxno=403690
4403,2020-07-07,대웅제약ITC예비판결은오판”이의절차착수,http://www.kukinews.com/newsView/kuk202007070069
4404,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,https://www.etoday.co.kr/news/view/1914811
4405,2020-07-07,ITC대웅제약이메디톡스영업비밀침해나보타수입금지권고,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119074
4406,2020-07-07,메디톡스5년분쟁승기ITC대웅제약이영업비밀침해,https://www.ebn.co.kr/news/view/1441443/?sc=Naver
4407,2020-07-07,특징주메디톡스상한가대웅제약15↓영업비밀침해소송희비,http://www.viva100.com/main/view.php?key=20200707010001242
4408,2020-07-07,대웅제약메디톡스보톡스분쟁양사공멸로마무리되나,http://www.upinews.kr/newsView/upi202007070016
4409,2020-07-07,메디톡스주가초반급등대웅제약급락균주소송예비판결영향,http://www.businesspost.co.kr/BP?command=article_view&num=186143
4410,2020-07-07,대웅제약ITC예비결정은명백한오판입장이의절차착수,http://www.pressm.kr/news/articleView.html?idxno=31118
4411,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.segyebiz.com/newsView/20200707508408?OutUrl=naver
4412,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,https://www.dailian.co.kr/news/view/903084?sc=Naver
4413,2020-07-07,대웅제약식도염치료제호이스타정코로나19치료제임상2상직행,http://kbench.com/?q=node/212135
4414,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인췌장염식도염약,http://theviewers.co.kr/View.aspx?No=905740
4415,2020-07-07,미국ITC대웅제약영업비밀침해나보타10년수입금지메디톡스손들어줘,http://www.queen.co.kr/news/articleView.html?idxno=337965
4416,2020-07-07,이데일리N美ITC메디톡스손들어줘대웅제약이의절차착수外,http://www.edaily.co.kr/news/newspath.asp?newsid=02259926625832224
4417,2020-07-07,ICT판정에엇갈린주가메디톡스활짝대웅제약침울,http://moneys.mt.co.kr/news/mwView.php?no=2020070710078027508
4418,2020-07-07,메디톡스美ITC승소주가폭등대웅제약명백한오판이의절차착수,http://www.babytimes.co.kr/news/articleView.html?idxno=37627
4419,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.dt.co.kr/contents.html?article_no=2020070702109931102002&ref=naver
4420,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.sisaweek.com/news/articleView.html?idxno=135457
4421,2020-07-07,메디톡스미국ITC소송서승기대웅제약명백한오판,http://sports.hankooki.com/lpage/economy/202007/sp20200707101933137020.htm?s_ref=nv
4422,2020-07-07,보톡스전쟁승기잡은메디톡스ITC대웅제약영업비밀침해,http://www.newsprime.co.kr/news/article.html?no=510184
4423,2020-07-07,대웅제약美ITC판결예비결정자체효력없다,http://www.wikileaks-kr.org/news/articleView.html?idxno=90437
4424,2020-07-07,ITC대웅제약메디톡스영업비밀침해나보타수입금지10년예비판결,http://www.newsworks.co.kr/news/articleView.html?idxno=470285
4425,2020-07-07,메디톡스보톡스전쟁승리대웅제약은수출금지손배소이어질듯,http://www.koreastocknews.com/news/articleView.html?idxno=55114
4426,2020-07-07,5년보톡스전쟁메디톡스가이겼다美ITC대웅제약영업비밀침해종합,https://view.asiae.co.kr/article/2020070710284058769
4427,2020-07-07,대웅제약역류성식도염치료제호이스타정코로나19치료제임상2상승인,http://www.newsprime.co.kr/news/article.html?no=510188
4428,2020-07-07,특징주＂대웅제약메디톡스영업비밀침해했다美판결이후주가폭락,http://www.nspna.com/news/?mode=view&newsid=439496
4429,2020-07-07,미국ITC행정판사대웅제약메디톡스균주도용했다”나보타10년간수입금지,http://medicalworldnews.co.kr/news/view.php?idx=1510936456
4430,2020-07-07,메디톡스균주분쟁서승기美ITC대웅제약메디톡스영업비밀침해,http://www.wolyo.co.kr/news/articleView.html?idxno=106680
4431,2020-07-07,메디톡스웃고대웅제약울고창사75주년최대위기직면,http://www.startuptoday.co.kr/news/articleView.html?idxno=46281
4432,2020-07-07,메디톡스손들어준美ITC대웅제약메디톡스영업비밀침해”,http://inthenews.co.kr/article-57387/
4433,2020-07-07,미국ITC대웅제약나보타10년수입금지권고영업비밀침해,http://www.womaneconomy.kr/news/articleView.html?idxno=91980
4434,2020-07-07,오늘의제약대웅제약종근당광동제약,http://www.babytimes.co.kr/news/articleView.html?idxno=37630
4435,2020-07-07,메디톡스美ITC소송서대웅제약상대로승기,http://it.chosun.com/site/data/html_dir/2020/07/07/2020070701487.html
4436,2020-07-07,미국첫진출국산보톡스10년간수입금지미국ITC예비판결에대웅제약메디톡스운명엇갈려,http://www.topstarnews.net/news/articleView.html?idxno=818111
4437,2020-07-07,미ITC대웅제약메디톡스영업비밀침해예비판결,http://www.rapportian.com/news/articleView.html?idxno=126418
4438,2020-07-07,대웅제약호이스타정 코로나19 치료제임상 2상승인,http://www.economytalk.kr/news/articleView.html?idxno=206940
4439,2020-07-07,美ITC예비판결균주분쟁서메디톡스손들어줘대웅제약명백한오판이의절차착수,http://www.updownnews.co.kr/news/articleView.html?idxno=220603
4440,2020-07-07,3번째코로나19치료제후보”대웅제약안전성입증한카모스타트임상2상진행,https://www.donga.com/news/article/all/20200707/101852467/1
4441,2020-07-07,대웅제약췌장염치료제호이스타정코로나19치료제임상2상시험승인,http://news.mk.co.kr/newsRead.php?no=694085&year=2020
4442,2020-07-07,대웅제약명백한오판”이의절차착수,http://www.whosaeng.com/119229
4443,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://newsbrite.net/139173
4444,2020-07-07,ITC예비결정은명백한오판”대웅제약이의절차착수,http://newsbrite.net/139174
4445,2020-07-07,메디톡스사실상승리대웅제약남은기회3번,https://www.hankyung.com/finance/article/2020070708546
4446,2020-07-07,美ITC대웅제약메디톡스보톡스기술도용,http://www.finomy.com/news/articleView.html?idxno=80012
4447,2020-07-07,대웅제약나보타美에서10년간수입금지ITC메디톡스손들어줘,http://www.whitepaper.co.kr/news/articleView.html?idxno=195411
4448,2020-07-07,대웅제약호이스타정코로나19치료제식약처임상2상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4208465
4449,2020-07-07,美ICT대웅제약나보타수입금지권고,https://www.news1.kr/photos/view/?4275716
4450,2020-07-07,대웅제약美ITC나보타수입금지권고자국산업보호위한오판,https://www.news1.kr/photos/view/?4275718
4451,2020-07-07,美ICT대웅제약나보타수입금지권고,https://www.news1.kr/photos/view/?4275719
4452,2020-07-07,美ITC대웅제약영업비밀침해예비판결메디톡스보톡스전쟁승기,http://www.etnews.com/20200707000119
4453,2020-07-07,대웅제약美ITC권고납득할수없는결정,https://www.news1.kr/photos/view/?4275717
4454,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스승기,http://www.topstarnews.net/news/articleView.html?idxno=818117
4455,2020-07-07,대웅제약ITC예비결정이의제기메디톡스손들어준ITC명백한오판주장,http://theviewers.co.kr/View.aspx?No=905894
4456,2020-07-07,대웅제약나보타美ICT수입금지권고,https://www.news1.kr/photos/view/?4275720
4457,2020-07-07,대웅제약美ICT나보타수입금지권고명백한오판,https://www.news1.kr/photos/view/?4275727
4458,2020-07-07,더벨메디톡스대웅제약에판정승국내소송영향은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202007071026037800107180
4459,2020-07-07,5년동안무슨일이메디톡스대웅제약보톡스전쟁1라운드종료,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070710094336159
4460,2020-07-07,메디톡스손들어준美ITC대웅제약영업비밀침해맞다,http://www.sisajournal.com/news/articleView.html?idxno=202214
4461,2020-07-07,메디톡스대웅제약과균주분쟁서승기잡나,https://www.news1.kr/photos/view/?4275752
4462,2020-07-07,대웅제약과균주분쟁서승기잡은메디톡스,https://www.news1.kr/photos/view/?4275750
4463,2020-07-07,보톡스전쟁에서대웅제약패배종합,https://www.nocutnews.co.kr/news/5373796
4464,2020-07-07,美진출국산보톡스10년간수입금지돼대웅제약사업차질종합,http://yna.kr/AKR20200707045651017?did=1195m
4465,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=392281
4466,2020-07-07,대웅제약480억규모美에볼루스사모전환사채취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=392283
4467,2020-07-07,메디톡스균주분쟁서승기美ICT대웅제약나보타수입금지권고,https://www.news1.kr/photos/view/?4275771
4468,2020-07-07,메디톡스보톡스전쟁승기美ITC대웅제약영업비밀침해,http://www.newsquest.co.kr/news/articleView.html?idxno=77612
4469,2020-07-07,보톡스전쟁美ITC메디톡스에손대웅제약명백한오판,http://www.dailysmart.co.kr/news/articleView.html?idxno=29474
4470,2020-07-07,보톡스분쟁이긴메디톡스상한가대웅제약은하락세,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070701747.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4471,2020-07-07,종합美ITC10년간대웅제약나보타수입금지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1296560
4472,2020-07-07,대웅제약미국ITC예비판결에명백한오판,http://www.insightkorea.co.kr/news/articleView.html?idxno=81129
4473,2020-07-07,5년보톡스전쟁메디톡스승기대웅제약납득할수없다,http://4th.kr/View.aspx?No=905946
4474,2020-07-07,美ITC대웅제약메디톡스균주도용판결나보타10년간수입금지,http://www.mdtoday.co.kr/mdtoday/index.html?no=392263
4475,2020-07-07,메디톡스대웅제약상대균주도용소송서승기나보타10년간수입금지,http://www.kdpress.co.kr/news/articleView.html?idxno=96199
4476,2020-07-07,美ITC대웅제약이메디톡스영업비밀도용”판결,https://cnbc.sbs.co.kr/article_hub/10000988877?division=NAVER
4477,2020-07-07,ITC대웅제약메디톡스영업비밀침해”,http://www.munhwa.com/news/view.html?no=2020070701072127097001
4478,2020-07-07,대웅제약미국의예비판결은오판메디톡스국내소송에적극활용,http://www.businesspost.co.kr/BP?command=article_view&num=186163
4479,2020-07-07,보톡스5년전쟁승자는메디톡스美ITC대웅제약메디톡스영업비밀침해판정,http://www.sportsseoul.com/news/read/934390?ref=naver
4480,2020-07-07,보톡스전쟁승소의지대웅제약480억원규모美파트너에볼루스사모전환사채취득,https://www.donga.com/news/article/all/20200707/101854196/1
4481,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=225921
4482,2020-07-07,미국ITC대웅제약영업비밀침해예비판결미국나보타사업위기,http://www.newsfc.co.kr/news/articleView.html?idxno=41751
4483,2020-07-07,보톡스전쟁서대웅제약고개푹美ITC메디톡스손들어줘,http://www.seouleconews.com/news/articleView.html?idxno=55484
4484,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707106200013?did=1196m
4485,2020-07-07,미국ITC대웅제약영업비밀침해,http://yna.kr/PYH20200707106500013?did=1196m
4486,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707105900013?did=1196m
4487,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707106700013?did=1196m
4488,2020-07-07,미국ITC대웅제약영업비밀침해,http://yna.kr/PYH20200707106400013?did=1196m
4489,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707106100013?did=1196m
4490,2020-07-07,미국ITC대웅제약영업비밀침해,http://yna.kr/PYH20200707106600013?did=1196m
4491,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707106800013?did=1196m
4492,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707106000013?did=1196m
4493,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707106100013?did=1196m
4494,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707107000013?did=1196m
4495,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707106900013?did=1196m
4496,2020-07-07,대웅제약ITC예비결정은명백한오판이의절차착수,http://www.businesskorea.co.kr/news/articleView.html?idxno=48637
4497,2020-07-07,ITC메디톡스분쟁대웅제약에영업비밀침해예비판결,http://news.kbs.co.kr/news/view.do?ncd=4488488&ref=A
4498,2020-07-07,메디톡스대웅제약에천문학적손해배상청구할까,http://www.newsis.com/view/?id=NISX20200707_0001086556&cID=13001&pID=13000
4499,2020-07-07,대웅제약ITC예비결정은명백한오판법적구속력없어,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200707012
4500,2020-07-07,재기메디톡스vs위기대웅제약희비엇갈린국산보톡스전쟁,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4208591
4501,2020-07-07,미국ITC메디톡스손들어줘메디톡스민형사진행대웅제약이의절차착수,http://www.efnews.co.kr/news/articleView.html?idxno=85564
4502,2020-07-07,4년균주전쟁총정리메디톡스승기잡았다벼랑끝대웅제약명백한오판”,http://www.thepublic.kr/news/newsview.php?ncode=1065578001061466
4503,2020-07-07,뉴스투데이L대웅제약호이스타정코로나19치료제임상2상승인,https://www.news2day.co.kr/156114
4504,2020-07-07,신풍제약대웅제약급등에폭락으로희비엇갈려대웅제약16폭락반해신풍제약22급등,http://www.econonews.co.kr/news/articleView.html?idxno=127758
4505,2020-07-07,대웅제약호이스타정코로나19임상2상승인,https://www.hankyung.com/it/article/202007070850i
4506,2020-07-07,대웅제약나보타예비판결메디톡스에패소주가급락,http://www.ccreview.co.kr/news/articleView.html?idxno=270053
4507,2020-07-07,미국첫진출대웅제약보톡스수출길막히나,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202007071348001&code=920501
4508,2020-07-07,메디톡스완승대웅제약vs메디톡스타협가능성은,http://www.edaily.co.kr/news/newspath.asp?newsid=02870006625832224
4509,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2130083
4510,2020-07-07,메디톡스대웅제약보톡스논란업계진입장벽높일것,https://www.hankyung.com/finance/article/2020070717526
4511,2020-07-07,ITC예판서승기잡은메디톡스당연한결과대웅제약이의절차착수,https://www.asiatime.co.kr/news/newsview.php?ncode=1065586884024044
4512,2020-07-07,전화연결삼성전자2분기영업익8조1천억어닝서프라이즈비건코로나뚫고방한북미와마주앉을생각없어미ITC대웅제약메디톡스영업비밀침해,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004033801
4513,2020-07-07,ITC예비결정은명백한오판대웅제약이의절차착수,http://www.nbnnews.co.kr/news/articleView.html?idxno=405130
4514,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.newstomato.com/ReadNews.aspx?no=982584
4515,2020-07-07,메디톡스대웅제약과ITC분쟁서승기국내서도주름펼까,http://www.mediapen.com/news/view/538985
4516,2020-07-07,대웅제약호이스타정코로나19치료제2상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=214495&category=D
4517,2020-07-07,승기잡은메디톡스총공세수세몰린대웅제약이의절차착수”,http://www.pinpointnews.co.kr/view.php?ud=202007071437295475f090c8dbcb_45
4518,2020-07-07,美첫진출국산보톡스10년간수입금지대웅제약미국사업차질,http://www.fntoday.co.kr/news/articleView.html?idxno=223316
4519,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=29499
4520,2020-07-07,美ITC메디톡스손들어줘대웅제약도용인정,http://www.todaykorea.co.kr/news/articleView.html?idxno=273492
4521,2020-07-07,식약처대웅제약호이스타정코로나19치료임상2상승인,http://www.todaykorea.co.kr/news/articleView.html?idxno=273484
4522,2020-07-07,흔들리는K보톡스선두주자들대웅제약⋅메디톡스분쟁의승리자는,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070702444.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4523,2020-07-07,메디톡스대웅제약보톡스싸움일단락남은건상처뿐,https://www.hankyung.com/it/article/2020070719606
4524,2020-07-07,대웅제약ITC균주소송판정패신뢰도하락불가피,http://www.shinailbo.co.kr/news/articleView.html?idxno=1296691
4525,2020-07-07,美ITC대웅제약메디톡스균주도용맞다”나보타수입금지까지,http://theviewers.co.kr/View.aspx?No=906255
4526,2020-07-07,美ITC대웅제약보톡스10년간수입금지메디톡스승기,http://www.newspost.kr/news/articleView.html?idxno=79685
4527,2020-07-07,대웅제약췌장염치료제호이스타정코로나19치료제로임상2상승인,https://www.news1.kr/articles/?3988595
4528,2020-07-07,대웅제약코로나19치료제임상2상식약처승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=186216
4529,2020-07-07,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=60224
4530,2020-07-07,ITC나보타미국수입배제권고궁지몰린대웅제약,https://hankookilbo.com/News/Read/A2020070709400001854?did=NA
4531,2020-07-07,대웅제약ITC예비결정서10년수입금지명령,https://view.asiae.co.kr/article/2020070715264114453
4532,2020-07-07,대웅제약호이스타정코로나치료제임상2상승인,http://www.getnews.co.kr/view.php?ud=2020070715271228382fe691f917_16
4533,2020-07-07,메디톡스4년보톡스균주전쟁판정승대웅제약10년수입금지,http://www.metroseoul.co.kr/article/20200707500410
4534,2020-07-07,fnRASSI장마감거래소하락종목대웅제약172↓,http://www.fnnews.com/news/202007071536437323
4535,2020-07-07,승기잡은메디톡스대웅제약은나보타판매등해외사업난항예상,http://www.sisajournal-e.com/news/articleView.html?idxno=220853
4536,2020-07-07,美ITC예비판결서메디톡스손들어줘대웅제약이의절차나설것,http://news.mk.co.kr/newsRead.php?no=695812&year=2020
4537,2020-07-07,대웅제약호이스타코로나19치료제임상2상승인,http://www.monews.co.kr/news/articleView.html?idxno=211942
4538,2020-07-07,메디톡스보톡스전쟁승리조짐에상한가마감대웅제약17↓,http://news.mt.co.kr/mtview.php?no=2020070715502739794
4539,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.m-i.kr/news/articleView.html?idxno=727258
4540,2020-07-07,메디톡스완승기사회생메디톡스대웅제약균주훔친게사실로,http://www.edaily.co.kr/news/newspath.asp?newsid=03499766625832224
4541,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해”,http://www.sentv.co.kr/news/view/575849
4542,2020-07-07,대웅제약ITC영업비밀침해로10년수입금지명령예비결정”,http://www.edaily.co.kr/news/newspath.asp?newsid=03614566625832224
4543,2020-07-07,대웅제약ITC영업비밀침해로10년수입금지명령예비결정,https://view.asiae.co.kr/article/2020070716151983016
4544,2020-07-07,대웅제약ITC판결이후병의원달래기중,https://www.ebn.co.kr/news/view/1441539/?sc=Naver
4545,2020-07-07,2조원의꿈은어디로대웅제약보툴리눔톡신사업비상,http://www.whitepaper.co.kr/news/articleView.html?idxno=195425
4546,2020-07-07,대웅제약이끄는전승호ITC판결로보톡스사업주름,http://www.newsway.co.kr/news/view?tp=1&ud=2020070715083294946
4547,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.bokuennews.com/news/article.html?no=192208
4548,2020-07-07,대웅제약나보타10년간美수입금지,http://www.lawissue.co.kr/view.php?ud=202007071641413516f4ab64559d_12
4549,2020-07-07,미국ITC대웅제약나보타수입10년금지예비판결내려,http://ilyo.co.kr/?ac=article_view&entry_id=374136
4550,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=03739206625832224
4551,2020-07-07,대웅제약메디톡스균주갈등ITC판결로다시주목받는폴카임보고서,http://www.ajunews.com/view/20200707164650381
4552,2020-07-07,메디톡스완승기사회생한메디톡스대웅제약상대민형사소송우위,http://www.edaily.co.kr/news/newspath.asp?newsid=03765446625832224
4553,2020-07-07,美ITC대웅제약메디톡스영업비밀침해대웅제약이의절차착수,http://www.fnnews.com/news/202007071528597480
4554,2020-07-07,대웅제약보톡스균주는어디서왔을까수백억원대소송승자는,http://news.kbs.co.kr/news/view.do?ncd=4488628&ref=A
4555,2020-07-07,대웅제약보톡스균주도용했다나보타美서퇴출위기,http://news.mk.co.kr/newsRead.php?no=696484&year=2020
4556,2020-07-07,대웅제약美ITC예비결정에최종판결서적극소명할것”,http://www.mdtoday.co.kr/mdtoday/index.html?no=392346
4557,2020-07-07,메디톡스손들어준美ITC대웅제약나보타10년간수입금지,https://www.asiatoday.co.kr/view.php?key=20200707010004225
4558,2020-07-07,보톡스전쟁5년미국은메디톡스선택남은불씨움켜쥔대웅제약,http://www.ajunews.com/view/20200707163817366
4559,2020-07-07,대웅제약에승소한메디톡스다른국내보톡스제품들도조사해야”,http://www.segye.com/content/html/2020/07/07/20200707520784.html?OutUrl=naver
4560,2020-07-07,ITC예비판결로기선제압한메디톡스대웅제약의새전략은,http://daily.hankooki.com/lpage/industry/202007/dh20200707174217148390.htm?s_ref=nv
4561,2020-07-07,보톡스전쟁승기잡은메디톡스美ITC대웅제약영업비밀침해,http://www.fnnews.com/news/202007071801509407
4562,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=69899
4563,2020-07-07,메디톡스보톡스분쟁美ITC소송서승기대웅제약명백한오판,http://www.ntoday.co.kr/news/articleView.html?idxno=73549
4564,2020-07-07,메디톡스손들어준美ITC대웅제약10년간수입금지,http://www.dt.co.kr/contents.html?article_no=2020070802100151102001&ref=naver
4565,2020-07-07,기사회생메디톡스국내소송도청신호대웅제약美시장퇴출위기,http://www.dt.co.kr/contents.html?article_no=2020070802100451102001&ref=naver
4566,2020-07-07,메디톡스균주전에승기대웅제약손실눈덩이,https://cnbc.sbs.co.kr/article_hub/10000988919?division=NAVER
4567,2020-07-07,메디톡스기사회생美ITC대웅제약메디톡스영업비밀침해,http://www.opinionnews.co.kr/news/articleView.html?idxno=36252
4568,2020-07-07,美ITC메디톡스대웅제약균주전쟁예비판결미국내나보타수입금지,http://www.wsobi.com/news/articleView.html?idxno=100708
4569,2020-07-07,주름살펴진메디톡스벼랑끝몰린대웅제약,https://www.seoul.co.kr/news/newsView.php?id=20200708020021&wlog_tag3=naver
4570,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=69786
4571,2020-07-08,ITC대웅제약보톡스10년간수입금지”,https://news.joins.com/article/olink/23414169
4572,2020-07-08,코로나19공기감염가능성씨젠수출급증셀트리온부광약품메디톡스대웅제약주목,http://www.thekpm.com/view.php?ud=20200708040619782861beb2d9d_17
4573,2020-07-08,ITC가던진주사위대웅제약메디톡스운명가를까,https://www.dailian.co.kr/news/view/903257?sc=Naver
4574,2020-07-08,ITC대웅제약도용명시국내민사에영향미칠까,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134601&REFERER=NP
4575,2020-07-08,파국향하는보톡스전쟁대웅제약메디톡스상처만남았다,http://www.econovill.com/news/articleView.html?idxno=403813
4576,2020-07-08,출근길대웅제약예비판결이대로갈까삼성전자아무도예상못한깜짝실적外경제,https://www.etoday.co.kr/news/view/1915059
4577,2020-07-08,대웅제약보톡스분쟁현장조사이어과태료도거부,http://yna.kr/AKR20200707156900030?did=1195m
4578,2020-07-08,메디톡스vs대웅제약보톡스균주소송이제시작,http://www.medigatenews.com/news/1134607154
4579,2020-07-08,병원진화나선대웅제약ITC판결국내판매와무관,http://www.press9.kr/news/articleView.html?idxno=45227
4580,2020-07-08,김대성의종목분석메디톡스상한가vs대웅제약주가곤두박질,http://www.joseilbo.com/news/news_read.php?uid=401632&class=53&grp=
4581,2020-07-08,보톡스분쟁관련현장조사과태료거부한대웅제약,https://www.hankyung.com/economy/article/2020070841067
4582,2020-07-08,현장조사거부대웅제약과태료부과도이의제기,http://news.kmib.co.kr/article/view.asp?arcid=0014777466&code=61141111&cp=nv
4583,2020-07-08,대웅제약메디톡스와의보톡스분쟁현장조사이어과태료도거부,http://www.topstarnews.net/news/articleView.html?idxno=818324
4584,2020-07-08,대웅대웅제약소송장기화가능성부담투자의견↓KTB증권,https://www.etoday.co.kr/news/view/1915162
4585,2020-07-08,대웅제약보톡스전쟁에목표가↓KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01472726625832552
4586,2020-07-08,대웅제약ITC예비판결로소송장기화가능성부담KTB,http://news.mt.co.kr/mtview.php?no=2020070808241119828
4587,2020-07-08,대웅제약보톡스분쟁현장조사과태료거부,http://www.getnews.co.kr/view.php?ud=2020070808235686992fe691f917_16
4588,2020-07-08,SK證대웅제약ITC소송에서패소투자의견목표가↓,http://www.newsis.com/view/?id=NISX20200708_0001087498&cID=10401&pID=10400
4589,2020-07-08,대웅제약ITC예비판정부정적투자의견목표가↓,http://www.inews24.com/view/1279924
4590,2020-07-08,전일주요공시대한항공알테오젠대웅제약외,https://www.etoday.co.kr/news/view/1915178
4591,2020-07-08,리포트브리핑대웅제약끝이보이지않는소송의결과불확실성잔재목표가120000원KTB투자증권,http://www.newspim.com/news/view/20200708000102
4592,2020-07-08,리포트브리핑대웅대웅제약소송장기화가능성이부담목표가25000원KTB투자증권,http://www.newspim.com/news/view/20200708000108
4593,2020-07-08,메디톡스대웅제약균주전쟁의역사,https://www.paxnetnews.com/articles/62669
4594,2020-07-08,대웅제약보톡스분쟁현장조사이어과태료부과거부,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007080074&t=NN
4595,2020-07-08,리포트브리핑대웅제약ITC소송에서패소목표가100000원SK증권,http://www.newspim.com/news/view/20200708000140
4596,2020-07-08,오늘기업오늘사람LG전자대웅제약틱톡SK바이오팜,https://cnbc.sbs.co.kr/article_hub/10000988957?division=NAVER
4597,2020-07-08,대웅제약보툴리눔톡신분쟁관련중기부현장조사이어과태료도거부,http://www.youthdaily.co.kr/news/article.html?no=41553
4598,2020-07-08,대웅제약보톡스분쟁관련중기부현장조사이어과태료도거부,http://www.seoulwire.com/news/articleView.html?idxno=419258
4599,2020-07-08,대웅제약소송장기화우려목표가↓KTB증권,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007080071&t=NN
4600,2020-07-08,대웅제약호이스타정코로나19치료제임상2상승인,http://www.doctorstimes.com/news/articleView.html?idxno=211511
4601,2020-07-08,ITC판결승기에메디톡스이틀째급등대웅제약약세,https://www.hankyung.com/finance/article/2020070846656
4602,2020-07-08,대웅제약ITC패소로수출빨간불주가는↓,http://www.whitepaper.co.kr/news/articleView.html?idxno=195448
4603,2020-07-08,대웅제약보톡스분쟁현장조사과태료거부법원간다,http://moneys.mt.co.kr/news/mwView.php?no=2020070808218099573
4604,2020-07-08,대웅제약최근5일개인19만7630주순매수주가10만8500원181,https://view.asiae.co.kr/article/2020070809320461896
4605,2020-07-08,주름깊어진韓보톡스대웅제약美수입금지메디톡스식약처허가취소,http://www.inews24.com/view/1279943
4606,2020-07-08,대웅제약보톡스기술침해행정조사거부로부과받은과태료에이의제기,http://news.mk.co.kr/newsRead.php?no=697806&year=2020
4607,2020-07-08,특징주휴젤대웅제약나보타수입금지반사이익에상승세,http://moneys.mt.co.kr/news/mwView.php?no=2020070809408096681
4608,2020-07-08,대웅제약보톡스분쟁현장조사이어과태료도거부,http://www.ekn.kr/news/article.html?no=509951
4609,2020-07-08,SK증권대웅제약美ITC패소목표주가투자의견↓,http://www.ezyeconomy.com/news/articleView.html?idxno=102819
4610,2020-07-08,이데일리N대웅제약보톡스분쟁현장조사이어과태료도거부外,http://www.edaily.co.kr/news/newspath.asp?newsid=02187766625832552
4611,2020-07-08,대웅제약주가하락나보타미국시장에서쫓겨나나,http://www.mediasr.co.kr/news/articleView.html?idxno=60743
4612,2020-07-08,대웅제약호이스타정코로나19치료제임상시작,http://www.finomy.com/news/articleView.html?idxno=80014
4613,2020-07-08,메디톡스대웅제약보톡스전쟁에주가도희비,http://sports.hankooki.com/lpage/economy/202007/sp20200708102630137020.htm?s_ref=nv
4614,2020-07-08,증권가대웅제약균주전쟁패배목표가줄하향,http://www.sentv.co.kr/news/view/575881
4615,2020-07-08,대웅제약보톡스분쟁현장조사거부과태료에이의제기,http://www.cstimes.com/news/articleView.html?idxno=421422
4616,2020-07-08,메디톡스대웅제약싸움에속으로웃는美엘러간,https://view.asiae.co.kr/article/2020070810013143904
4617,2020-07-08,ITC예비판결대웅제약나보타균주출처조사로번지나,https://www.ebn.co.kr/news/view/1441667/?sc=Naver
4618,2020-07-08,대웅제약혈행개선과혈압건강위한건기식세노메가큐텐출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200708091903819369d76442fa_1/article.html
4619,2020-07-08,보톡스분쟁현장조사거부한대웅제약과태료도거부,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4209685
4620,2020-07-08,지분가치하락대웅제약주가비틀메디톡스신풍제약상승셀트리온제약녹십자하락,http://www.thekpm.com/view.php?ud=20200708111015742861beb2d9d_17
4621,2020-07-08,보톡스분쟁관련중기부현장조사거부한대웅제약,https://biz.chosun.com/site/data/html_dir/2020/07/08/2020070801913.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4622,2020-07-08,영업비밀도용”대가대웅제약수백억원손실위기,https://cnbc.sbs.co.kr/article_hub/10000989002?division=NAVER
4623,2020-07-08,중기부행정조사거부한대웅제약과태료도부당법정으로,http://www.whitepaper.co.kr/news/articleView.html?idxno=195454
4624,2020-07-08,대웅제약보톡스현장조사거부과태료에이의제기,http://daily.hankooki.com/lpage/industry/202007/dh20200708131716148390.htm?s_ref=nv
4625,2020-07-08,메디톡스대웅제약실적전망도희비,https://www.paxnetnews.com/articles/62721
4626,2020-07-08,대웅제약구충제니클로사마이드코로나19치료제임상가속화,https://www.fetv.co.kr/news/article.html?no=58866
4627,2020-07-08,대웅제약 코로나19치료제후보물질니클로사마이드DWRX2003 글로벌임상가속화,http://www.greened.kr/news/articleView.html?idxno=259732
4628,2020-07-08,美수출위기닥친대웅제약ITC판결뒤집힌사례는,http://www.viva100.com/main/view.php?key=20200708010001556
4629,2020-07-08,대웅제약필리핀서코로나19치료제임상승인신청,http://www.kpinews.co.kr/news/articleView.html?idxno=120944
4630,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.wsobi.com/news/articleView.html?idxno=100790
4631,2020-07-08,대웅제약코로나19치료제니클로사마이드글로벌임상가속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246494
4632,2020-07-08,메디톡스대웅제약희비엇갈려메디톡스18급등반해대웅제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=127888
4633,2020-07-08,7월8일뉴스락주식네비대웅제약소송장기화로목표주가하향조정,http://www.newslock.co.kr/news/articleView.html?idxno=29370
4634,2020-07-08,대웅제약코로나19치료물질글로벌임상가속화,http://www.medisobizanews.com/news/articleView.html?idxno=71068
4635,2020-07-08,대웅제약구충제니클로사마이드코로나19글로벌임상가속화,http://www.econovill.com/news/articleView.html?idxno=403902
4636,2020-07-08,로스탁대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.lawissue.co.kr/view.php?ud=202007081342147837204ead0791_12
4637,2020-07-08,대웅제약니클로사마이드필리핀인도현지임상1상IND신청,http://www.newsprime.co.kr/news/article.html?no=510358
4638,2020-07-08,대웅제약구충제필리핀서코로나19임상준비동남아겨냥,http://moneys.mt.co.kr/news/mwView.php?no=2020070813238057718
4639,2020-07-08,대웅제약니클로사마이드글로벌임상가속화코로나19치료제로개발위해역량집중,http://www.newslock.co.kr/news/articleView.html?idxno=29376
4640,2020-07-08,대웅제약코로나19치료제개발위한니클로사마이드글로벌임상가속화,http://www.youthdaily.co.kr/news/article.html?no=41608
4641,2020-07-08,대웅제약에등돌리는증권街한올바이오파마가희망,https://www.hankyung.com/finance/article/2020070862326
4642,2020-07-08,대웅제약코로나19치료제필리핀임상시험계획서제출,http://yna.kr/AKR20200708102600017?did=1195m
4643,2020-07-08,대웅제약니클로사마이드필리핀인도현지임상1상IND신청완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=392458
4644,2020-07-08,대웅제약니클로사마이드코로나글로벌임상확대,http://www.newsis.com/view/?id=NISX20200708_0001088185&cID=13001&pID=13000
4645,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.bosa.co.kr/news/articleView.html?idxno=2130156
4646,2020-07-08,대웅제약필리핀서구충제니클로사마이드코로나19임상신청,http://www.newspim.com/news/view/20200708000739
4647,2020-07-08,대웅제약코로나19치료제글로벌임상가속화,https://www.hankyung.com/it/article/202007086231i
4648,2020-07-08,대웅제약니클로사마이드코로나글로벌임상확대,http://www.newsway.co.kr/news/view?tp=1&ud=2020070814220611101
4649,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.dailypharm.com/Users/News/NewsView.html?ID=266348&REFERER=NP
4650,2020-07-08,대웅제약필리핀서코로나치료제임상계획제출,https://view.asiae.co.kr/article/2020070814280810994
4651,2020-07-08,대웅제약코로나치료효과구충제필리핀서임상,http://news.mt.co.kr/mtview.php?no=2020070814234213034
4652,2020-07-08,대웅제약중기부현장조사불응이어과태료도거부,http://www.mediapen.com/news/view/539290
4653,2020-07-08,대웅제약니클로사마이드필리핀인도임상1상IND신청완료,http://inthenews.co.kr/article-57665/
4654,2020-07-08,대웅제약니클로사마이드DWRX2003필리핀인도임상가속화,http://www.pressm.kr/news/articleView.html?idxno=31185
4655,2020-07-08,보톡스분쟁관련중기부현장조사거부한대웅제약과태료도거부,http://www.startuptoday.co.kr/news/articleView.html?idxno=46556
4656,2020-07-08,대웅제약코로나19치료제필리핀임상시험계획서제출,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4210020
4657,2020-07-08,세계에서유일한제형으로개발추진”대웅제약구충제코로나19치료제임상확대,https://www.donga.com/news/article/all/20200708/101875331/1
4658,2020-07-08,대웅제약필리핀에코로나19치료제임상시험계획서제출,http://www.ekn.kr/news/article.html?no=510052
4659,2020-07-08,대웅제약니클로사마이드코로나19글로벌임상가속화,http://medipana.com/news/news_viewer.asp?NewsNum=259671&MainKind=A&NewsKind=5&vCount=12&vKind=1
4660,2020-07-08,대웅제약니클로사마이드성분코로나치료제글로벌임상가속화,http://www.getnews.co.kr/view.php?ud=2020070814460091152fe691f917_16
4661,2020-07-08,대웅제약코로나19치료제개발위해니클로사마이드글로벌임상가속,http://www.metroseoul.co.kr/article/20200708500354
4662,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.press9.kr/news/articleView.html?idxno=45237
4663,2020-07-08,대웅제약니클로사마이드코로나19글로벌임상가속화,http://www.dailysmart.co.kr/news/articleView.html?idxno=29559
4664,2020-07-08,대웅제약DWRX2003글로벌임상가속화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065591363602129
4665,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.nbnnews.co.kr/news/articleView.html?idxno=405487
4666,2020-07-08,대웅제약인도서니클로사마이드임상진입신청,http://news.mk.co.kr/newsRead.php?no=700186&year=2020
4667,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.m-i.kr/news/articleView.html?idxno=727622
4668,2020-07-08,대웅제약필리핀에코로나19치료제임상계획신청,http://www.koreastocknews.com/news/articleView.html?idxno=55171
4669,2020-07-08,대웅제약필리핀에코로나19치료제임상계획서제출,http://www.seoulfn.com/news/articleView.html?idxno=388457
4670,2020-07-08,대웅제약필리핀인도서니클로사마이드코로나19치료제임상착수,http://www.viva100.com/main/view.php?key=20200708010001686
4671,2020-07-08,대웅제약코로나19치료제후보물질니클로사마이드글로벌임상가속화,http://www.ceoscoredaily.com/news/article.html?no=71291
4672,2020-07-08,대웅제약코로나19치료제후보물질니클로사마이드글로벌임상가속화,http://www.paxetv.com/news/articleView.html?idxno=95757
4673,2020-07-08,대웅제약니클로사마이드필리핀임상신청글로벌개발가속,https://www.etoday.co.kr/news/view/1915466
4674,2020-07-08,대웅제약니클로사마이드글로벌임상가속도,http://www.monews.co.kr/news/articleView.html?idxno=211973
4675,2020-07-08,대웅제약코로나치료제개발위해필리핀에임상시험계획신청,https://www.asiatoday.co.kr/view.php?key=20200708010004969
4676,2020-07-08,대웅제약필리핀에코로나치료제임상시험계획서제출,http://www.dt.co.kr/contents.html?article_no=2020070902101031102001&ref=naver
4677,2020-07-08,보톡스5년전쟁승리한메디톡스대웅제약글로벌진출빨간불,http://www.enewstoday.co.kr/news/articleView.html?idxno=1399293
4678,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.whosaeng.com/119287
4679,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화필리핀인도등으로해외임상확대,http://newsbrite.net/139254
4680,2020-07-08,대웅제약니클로사마이드글로벌임상가속화필리핀인도등으로확대,http://www.koreaittimes.com/news/articleView.html?idxno=98879
4681,2020-07-08,대웅제약보톡스분쟁현장조사과태료거부,http://www.seoulfn.com/news/articleView.html?idxno=388461
4682,2020-07-08,오늘Who전승호대웅제약의앨러간도전야심찬꿈물거품위기,http://www.businesspost.co.kr/BP?command=article_view&num=186432
4683,2020-07-08,팜스원주대웅제약코로나19극복면역력증강비타민제기탁,http://www.nbnnews.co.kr/news/articleView.html?idxno=405549
4684,2020-07-08,팜스원대웅제약코로나19극복면역력증강비타민제및성금기탁,http://daily.hankooki.com/lpage/society/202007/dh20200708164034148510.htm?s_ref=nv
4685,2020-07-08,대웅제약니클로사마이드필리핀인도에임상1상신청,http://www.medigatenews.com/news/2182621479
4686,2020-07-08,대웅제약니클로사마이드코로나19글로벌임상가속화,https://www.dailian.co.kr/news/view/903638?sc=Naver
4687,2020-07-08,메디톡스대웅제약보톡스싸움진짜승자는엘러간,http://www.opinionnews.co.kr/news/articleView.html?idxno=36321
4688,2020-07-08,대웅제약코로나19치료제니클로사마이드DWRX2003글로벌임상가속화,http://www.thepublic.kr/news/newsview.php?ncode=1065600658576811
4689,2020-07-08,구례군에팜스원주대웅제약코로나19극복비타민제기탁,http://www.enewstoday.co.kr/news/articleView.html?idxno=1399326
4690,2020-07-08,김창수의e뉴스브리핑대웅제약니클로사마이드글로벌임상가속화外,https://www.fetv.co.kr/news/article.html?no=58888
4691,2020-07-08,sk바이오팜매수열풍비트코인연상부광약품셀트리온녹십자수젠텍씨젠메디톡스대웅제약출렁,http://www.thekpm.com/view.php?ud=202007081722324681861beb2d9d_17
4692,2020-07-08,대웅제약구충제필리핀서코로나19임상준비,http://it.chosun.com/site/data/html_dir/2020/07/08/2020070803592.html
4693,2020-07-08,팜스원㈜대웅제약코로나19극복면역력증강비타민제기탁,https://view.asiae.co.kr/article/2020070817562278528
4694,2020-07-08,대웅제약코로나치료제임상계획서필리핀식약처에제출,http://www.edaily.co.kr/news/newspath.asp?newsid=04122966625832552
4695,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62196
4696,2020-07-08,팜스원대웅제약구례군에코로나19극복비타민제기탁,http://www.ccreview.co.kr/news/articleView.html?idxno=270522
4697,2020-07-08,구례팜스원대웅제약코로나19극복면역력증강비타민제기탁,http://www.nspna.com/news/?mode=view&newsid=439969
4698,2020-07-08,대웅제약코로나치료물질필리핀서도임상시험추진,https://www.hankyung.com/it/article/2020070881631
4699,2020-07-08,美ITC메디톡스균주도용대웅제약나보타수입금지10년”,http://www.betanews.net:8080/article/1203583.html
4700,2020-07-08,팜스원주대웅제약코로나19극복면역력증강비타민제기탁,http://www.newsworker.co.kr/news/articleView.html?idxno=77499
4701,2020-07-08,뉴스투데이L대웅제약코로나19치료제후보물질니클로사마이드임상에속도,https://www.news2day.co.kr/156257
4702,2020-07-08,대웅제약코로나19치료제니클로사마이드글로벌임상가속화,http://news.kbiz.or.kr/news/articleView.html?idxno=69842
4703,2020-07-09,SK증권}대웅제약ITC소송에서패소기나긴균주싸움에서일단락,http://www.g-enews.com/ko-kr/news/article/news_all/202007090617032611442088f476_1/article.html
4704,2020-07-09,대웅제약파트너에볼루스ITC결정동의못해이의제기할것,http://www.press9.kr/news/articleView.html?idxno=45239
4705,2020-07-09,기사회생메디톡스美ITC10년간대웅제약나보타수입금지”,http://www.mdtoday.co.kr/mdtoday/index.html?no=392487
4706,2020-07-09,대웅제약보툴리눔톡신분쟁현장조사거부과태료에이의제기,http://www.mdtoday.co.kr/mdtoday/index.html?no=392510
4707,2020-07-09,영업비밀침해체면구긴대웅제약나보타美시장진출1년여만에퇴출위기,http://www.youthdaily.co.kr/news/article.html?no=41647
4708,2020-07-09,뉴스브리핑7월9일대웅제약임상아반떼N라인정보보호의날,http://it.chosun.com/site/data/html_dir/2020/07/08/2020070804033.html
4709,2020-07-09,더벨코너몰린대웅제약파트너사에볼루스CB투자승부수,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202007081647052320109349
4710,2020-07-09,팜스원주대웅제약코로나19극복면역력증강비타민제기탁,http://www.breaknews.com/741280
4711,2020-07-09,메디톡스보톡스분쟁서승기잡아대웅제약美ITC오판이의신청할것,http://www.dailypop.kr/news/articleView.html?idxno=45793
4712,2020-07-09,좋은약돋보기대웅제약자체개발복합제올로스타올로맥스,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62201
4713,2020-07-09,대웅제약니클로사마이드글로벌임상진행코로나19치료제개발가속화,http://theviewers.co.kr/View.aspx?No=908202
4714,2020-07-09,대웅제약오픈콜라보레이션을통해혁신신약개발가속화,http://www.lawissue.co.kr/view.php?ud=202007091117545958204ead0791_12
4715,2020-07-09,메디톡스대웅제약보톡스전쟁최종승자는엘러간,http://www.newsprime.co.kr/news/article.html?no=510511
4716,2020-07-09,여름엔반바지대웅제약자율적사내문화강화,http://www.meconomynews.com/news/articleView.html?idxno=43305
4717,2020-07-09,여름엔사무실에서반바지대웅제약사내문화눈길,http://www.newstomato.com/ReadNews.aspx?no=983155
4718,2020-07-09,ITC소송의끝메디톡스대웅제약모두새드엔딩,http://ilyo.co.kr/?ac=article_view&entry_id=374243
4719,2020-07-09,대웅제약혁신신약개발가속화,http://www.mhj21.com/132590
4720,2020-07-09,대웅제약제약업계반항아이번엔중기부과태료부과이의제기,http://theviewers.co.kr/View.aspx?No=909078
4721,2020-07-09,나이스신용평가ITC예비판정대웅제약수익성악화,http://news.mt.co.kr/mtview.php?no=2020070917125458917
4722,2020-07-09,오늘의토막뉴스영업비밀침해체면구긴대웅제약나보타美시장진출1년여만에퇴출위기外,http://www.youthdaily.co.kr/news/article.html?no=41742
4723,2020-07-09,대웅제약나보타美퇴출위기에수익성회복어려워져,https://www.ajunews.com/view/20200709165727164
4724,2020-07-09,대웅제약美파트너사주주집단소송가능성↑,https://www.ajunews.com/view/20200709185657269
4725,2020-07-10,오늘의제약대웅제약한미약품동국제약,http://www.babytimes.co.kr/news/articleView.html?idxno=37781
4726,2020-07-10,대웅제약올로스타올로맥스고혈압복합제시장서두각,http://www.biospectator.com/view/news_view.php?varAtcId=10812
4727,2020-07-10,대웅제약덴티가드랩치약그립핏칫솔출시,http://www.iminju.net/news/articleView.html?idxno=55111
4728,2020-07-10,시경Today제약대웅제약생리통발생원인다스리는진통제신중히골라야,http://www.meconomynews.com/news/articleView.html?idxno=43346
4729,2020-07-10,대웅제약임직원자율성높이고효율은올리는사내문화눈길,http://www.viva100.com/main/view.php?key=20200710010002068
4730,2020-07-10,RD경쟁력인정대웅제약아태지역혁신제약사12위에선정,http://kpenews.com/View.aspx?No=909971
4731,2020-07-10,대웅제약에볼루스500억투자美판매자신감vs무리수,http://www.koreastocknews.com/news/articleView.html?idxno=55255
4732,2020-07-10,여름엔반바지입고출근”대웅제약자율성효율성UP,http://daily.hankooki.com/lpage/industry/202007/dh20200710152128148390.htm?s_ref=nv
4733,2020-07-10,대웅제약오픈콜라보레이션통해혁신신약개발가속화,http://www.kukinews.com/newsView/kuk202007100257
4734,2020-07-10,대웅제약이긴메디톡스메디톡신판매재개할수있을까,http://www.sisajournal-e.com/news/articleView.html?idxno=221029
4735,2020-07-10,대웅제약美ITC예비판결서메디톡스에패소,http://hobbyen.co.kr/news/newsview.php?ncode=1065596618895103
4736,2020-07-10,나이스신평ITC판정대웅제약신용도에부정적,http://www.finomy.com/news/articleView.html?idxno=80209
4737,2020-07-11,주간산업동향메디톡스대웅제약과보톡스전쟁서승기잡았다,http://www.cstimes.com/news/articleView.html?idxno=421825
4738,2020-07-11,식품의약품안전처코로나19치료제백신임상12건승인부광약품엔지켐생명과학신풍제약종근당크리스탈지노믹스대웅제약국제백신연구소제넥신등렘데시비르및클로로퀸등5건임상종료,http://www.econonews.co.kr/news/articleView.html?idxno=128339
4739,2020-07-11,이주의CEODOWN전승호대웅제약대표이사나보타미국발충격,http://www.econovill.com/news/articleView.html?idxno=404061
4740,2020-07-12,한국코로나19치료제백신12건임상시험진행중크리스탈지노믹스대웅제약추가승인,http://www.ccreview.co.kr/news/articleView.html?idxno=271226
4741,2020-07-12,보툴리눔톡신균주도용의혹대웅제약11월최종패소땐최대위기,https://www.hankyung.com/it/article/2020071200331
4742,2020-07-13,우리도있어요대웅제약vs메디톡스닮은제2균주전쟁,http://www.edaily.co.kr/news/newspath.asp?newsid=01341526625834192
4743,2020-07-13,베스트워스트피라맥스기대에신풍제약64급등미국ITC판정에대웅제약13급락,https://www.etoday.co.kr/news/view/1916727
4744,2020-07-13,메디톡스대웅제약보톡스전쟁끝나지않는총성,https://www.donga.com/news/article/all/20200710/101917870/1
4745,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.press9.kr/news/articleView.html?idxno=45265
4746,2020-07-13,대웅제약웨어러블심전도기모비케어출시,https://www.fetv.co.kr/news/article.html?no=59157
4747,2020-07-13,대웅제약사용편의성높인웨어러블심전도기모비케어출시,http://www.ekn.kr/news/article.html?no=510763
4748,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200713093218867651638db705_1/article.html
4749,2020-07-13,대웅제약웨어러블심전도기기모비케어출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572957011842
4750,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.youthdaily.co.kr/news/article.html?no=41907
4751,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어판매,http://www.kpinews.co.kr/news/articleView.html?idxno=121217
4752,2020-07-13,대웅제약모비케어출시부정맥조기진단기대,http://www.mhj21.com/132675
4753,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://medipana.com/news/news_viewer.asp?NewsNum=259833&MainKind=A&NewsKind=5&vCount=12&vKind=1
4754,2020-07-13,메디톡스대웅제약손배청구10억α,https://view.asiae.co.kr/article/2020071309534866706
4755,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.econovill.com/news/articleView.html?idxno=404371
4756,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62257
4757,2020-07-13,대웅제약부정맥검출용웨어러블심전도기모비케어출시,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119278
4758,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=266470&REFERER=NP
4759,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어출시,http://www.pressm.kr/news/articleView.html?idxno=31277
4760,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=29807
4761,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어출시,http://www.medisobizanews.com/news/articleView.html?idxno=71152
4762,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://news.mt.co.kr/mtview.php?no=2020071309332774674
4763,2020-07-13,대웅제약가슴에붙이는심전도기모비케어출시,http://health.chosun.com/site/data/html_dir/2020/07/13/2020071301192.html
4764,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.bokuennews.com/news/article.html?no=192410
4765,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02122166625834192
4766,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.newspim.com/news/view/20200713000179
4767,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.getnews.co.kr/view.php?ud=2020071310125164632fe691f917_16
4768,2020-07-13,대웅제약패치형심전도기모비케어판매연속72시간심전도검사가능,http://theviewers.co.kr/View.aspx?No=911054
4769,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://moneys.mt.co.kr/news/mwView.php?no=2020071310008059207
4770,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.newsis.com/view/?id=NISX20200713_0001092687&cID=13001&pID=13000
4771,2020-07-13,대웅제약패치형심전도기모비케어판매시작,https://www.sedaily.com/NewsView/1Z5ACOZNO0
4772,2020-07-13,대웅제약코로나19치료제개발위해니클로사마이드글로벌임상연구가속화,http://www.g-enews.com/ko-kr/news/article/news_all/2020071310023451669d76442fa_1/article.html
4773,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.mediapen.com/news/view/540327
4774,2020-07-13,뉴스투데이L대웅제약패치형심전도기모비케어출시,https://www.news2day.co.kr/156432
4775,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://newsbrite.net/139421
4776,2020-07-13,대웅제약 웨어러블심전도기 모비케어 출시,http://www.greened.kr/news/articleView.html?idxno=260375
4777,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://news.mk.co.kr/newsRead.php?no=715068&year=2020
4778,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246642
4779,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.medigatenews.com/news/1339702705
4780,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://www.lawissue.co.kr/view.php?ud=202007131109485833204ead0791_12
4781,2020-07-13,대웅제약웨어러블심전도기모비케어출시,https://biz.chosun.com/site/data/html_dir/2020/07/13/2020071301569.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4782,2020-07-13,대웅제약ITC예비결정전례없는중대오류최종승소자신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246646
4783,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://www.seoulwire.com/news/articleView.html?idxno=419971
4784,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62264
4785,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.metroseoul.co.kr/article/20200713500196
4786,2020-07-13,대웅제약ITC예비결정은중대한오류최종승소자신,http://www.medisobizanews.com/news/articleView.html?idxno=71162
4787,2020-07-13,대웅제약ITC예비결정에중대한오류발견최종승소자신”,http://daily.hankooki.com/lpage/industry/202007/dh20200713112603148390.htm?s_ref=nv
4788,2020-07-13,대웅제약ITC예비결정전례없는중대오류최종승소자신”,http://www.econovill.com/news/articleView.html?idxno=404401
4789,2020-07-13,대웅제약ITC예비결정전례없는중대한오류,http://medipana.com/news/news_viewer.asp?NewsNum=259841&MainKind=A&NewsKind=5&vCount=12&vKind=1
4790,2020-07-13,대웅제약ITC예비판결중대한오류최종승소할것”,http://www.viva100.com/main/view.php?key=20200713010002484
4791,2020-07-13,대웅제약ITC예비결정전례없는오류승소자신,http://www.press9.kr/news/articleView.html?idxno=45270
4792,2020-07-13,대웅제약ITC예비결정중대한오류있어11월승소자신,http://moneys.mt.co.kr/news/mwView.php?no=2020071311358037281
4793,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://newsclaim.co.kr/View.aspx?No=911385
4794,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.lawissue.co.kr/view.php?ud=202007131154119481204ead0791_12
4795,2020-07-13,대웅제약패치형심전도기모비케어출시,http://yna.kr/AKR20200713067000017?did=1195m
4796,2020-07-13,씨어스테크놀로지개발첨단심전도기대웅제약판매개시,http://www.joseilbo.com/news/news_read.php?uid=401929&class=27&grp=
4797,2020-07-13,대웅제약나보타균주도용예비판결에멘붕,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=715592
4798,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신,http://www.newsis.com/view/?id=NISX20200713_0001093023&cID=13001&pID=13000
4799,2020-07-13,대웅제약반격ITC추론기반균주절취결론,http://www.bosa.co.kr/news/articleView.html?idxno=2130414
4800,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.koreaittimes.com/news/articleView.html?idxno=98983
4801,2020-07-13,대웅제약ITC예비결정자국엘러간만보호중대한오류범해,https://www.news1.kr/articles/?3994020
4802,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.monews.co.kr/news/articleView.html?idxno=212076
4803,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://newsbrite.net/139428
4804,2020-07-13,대웅제약씨어스웨어러블심전도기모비케어출시,http://www.biospectator.com/view/news_view.php?varAtcId=10828
4805,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신”,http://www.newsway.co.kr/news/view?tp=1&ud=2020071312525605244
4806,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.ybsn.tv/news/articleView.html?idxno=22281
4807,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=392903
4808,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.updownnews.co.kr/news/articleView.html?idxno=220849
4809,2020-07-13,대웅제약웨어러블심전도기모비케어판매,http://www.consumuch.com/news/articleView.html?idxno=49723
4810,2020-07-13,대웅제약패치형심전도기모비케어출시,http://yna.kr/PYH20200713089300017?did=1196m
4811,2020-07-13,대웅제약ITC예비결정은전례없는중대오류,http://www.m-i.kr/news/articleView.html?idxno=728827
4812,2020-07-13,대웅제약미국ITC예비판결중대오류최종승소자신,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020071313311033865
4813,2020-07-13,대웅제약ITC예비결정전례없는중대오류최종승소할것,http://www.dailysmart.co.kr/news/articleView.html?idxno=29835
4814,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신,http://www.wolyo.co.kr/news/articleView.html?idxno=106858
4815,2020-07-13,대웅제약패치형웨어러블심전도기모비케어출시,http://news.kbiz.or.kr/news/articleView.html?idxno=70070
4816,2020-07-13,보툴리눔소송대웅제약과매디톡스안개속의앞날,http://www.g-enews.com/ko-kr/news/article/news_all/2020071313433770251638db705_1/article.html
4817,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://www.paxetv.com/news/articleView.html?idxno=95985
4818,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.nbnnews.co.kr/news/articleView.html?idxno=406541
4819,2020-07-13,대웅제약ITC전례없는오류최종결정뒤집을것,http://www.dailypharm.com/Users/News/NewsView.html?ID=266483&REFERER=NP
4820,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신,https://www.hankyung.com/finance/article/2020071326496
4821,2020-07-13,대웅제약ITC판결은오류에기반한것최종승소자신,https://www.hankyung.com/it/article/202007132096i
4822,2020-07-13,대웅제약ITC예비결정중대한오류최종승소자신,http://www.newsprime.co.kr/news/article.html?no=510875
4823,2020-07-13,대웅제약간편한웨어러블심전도기모비케어출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200713005
4824,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://sports.hankooki.com/lpage/economy/202007/sp20200713141108136980.htm?s_ref=nv
4825,2020-07-13,대웅제약ITC예비판결은중대오류메디톡스도결국빈손,http://www.ajunews.com/view/20200713140035072
4826,2020-07-13,대웅제약ITC예비결정중대오류메디톡스는외국기업엘러간만도와주고있다,http://www.topstarnews.net/news/articleView.html?idxno=819625
4827,2020-07-13,대웅제약美ITC예비판결오류있다최종판결승소할것”,https://www.etoday.co.kr/news/view/1917089
4828,2020-07-13,대웅제약ITC예비결정전례없는중대한오류저질러”,http://www.mdtoday.co.kr/mdtoday/index.html?no=392912
4829,2020-07-13,대웅제약ITC예비판결은중대한오류최종승소자신,http://yna.kr/AKR20200713094500017?did=1195m
4830,2020-07-13,대웅제약ITC판결중대한오류최종승소자신있다,http://www.newspim.com/news/view/20200713000723
4831,2020-07-13,대웅제약ITC예비결정중대오류자국엘러간만보호,http://www.thevaluenews.co.kr/news/view.php?idx=160091
4832,2020-07-13,대웅제약패치형심전도기모비케어출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4214710
4833,2020-07-13,대웅제약ITC예비결정은중대한오류최종승소자신,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4214715
4834,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,https://www.asiatoday.co.kr/view.php?key=20200713010007684
4835,2020-07-13,대웅제약ITC예비결정중대한오류범해최종승소자신,http://www.mediapen.com/news/view/540425
4836,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어출시,http://www.todaykorea.co.kr/news/articleView.html?idxno=273815
4837,2020-07-13,대웅제약ITC예비결정전례없는중대한오류승소자신,http://www.ceoscoredaily.com/news/article.html?no=71424
4838,2020-07-13,대웅제약ITC예비결정전례없는중대한오류”주장최종승소자신,http://www.thepublic.kr/news/newsview.php?ncode=1065587527990644
4839,2020-07-13,메디톡스vs대웅제약균주전쟁다시과열상처뿐인싸움될것,http://www.metroseoul.co.kr/article/20200713500367
4840,2020-07-13,대웅제약패치형심전도기모비케어출시,http://www.seoulfn.com/news/articleView.html?idxno=388897
4841,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://news.mt.co.kr/mtview.php?no=2020071314474111458
4842,2020-07-13,대웅제약웨어러블심전도기모비케어출시,https://www.ebn.co.kr/news/view/1442282/?sc=Naver
4843,2020-07-13,대웅제약ITC예비판결중대한오류최종승소자신,https://www.fetv.co.kr/news/article.html?no=59223
4844,2020-07-13,대웅제약ITC예비결정중대한오류11월승소자신,http://www.getnews.co.kr/view.php?ud=2020071315232642762fe691f917_16
4845,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1400279
4846,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.etnews.com/20200713000281
4847,2020-07-13,대웅제약ITC예비판결은엘러간의승리,https://hankookilbo.com/News/Read/A2020071315430001404?did=NA
4848,2020-07-13,대웅제약ITC예비결정중대한오류최종결정은11월,http://weekly.hankooki.com/lpage/economy/202007/wk20200713160025146380.htm?s_ref=nv
4849,2020-07-13,대웅제약美ITC예비판결중대한오류범해11월최종결정서승소의지다져,http://hobbyen.co.kr/news/newsview.php?ncode=1065596352486957
4850,2020-07-13,대웅제약장시간심전도검사가능한모비케어판매나서,http://news.mk.co.kr/newsRead.php?no=717103&year=2020
4851,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=48881
4852,2020-07-13,대웅제약ITC가메디톡스일방적인주장을받아들여최종승소자신있어”,http://inthenews.co.kr/article-58370/
4853,2020-07-13,대웅제약ITC예비결정중대한오류최종승소자신한다,https://www.news2day.co.kr/156471
4854,2020-07-13,대웅제약ITC예비판결중대한오류실체적진실과거리멀다,http://www.newsworks.co.kr/news/articleView.html?idxno=471927
4855,2020-07-13,대웅제약메디톡스가스스로발등찍어ITC최종승소자신,https://www.dailian.co.kr/news/view/904754?sc=Naver
4856,2020-07-13,대웅제약보톡스패배ITC결정전례없는중대오류,https://www.nocutnews.co.kr/news/5377461
4857,2020-07-13,대웅제약ITC예비결정전례없는중대한오류”최종승소자신,http://www.pinpointnews.co.kr/view.php?ud=20200713165007227f090c8dbcb_45
4858,2020-07-13,대웅제약ITC예비결정전례없는중대한오류,http://www.monews.co.kr/news/articleView.html?idxno=212082
4859,2020-07-13,대웅제약ITC예비결정美앨러간만보호중대한오류범했다,https://biz.chosun.com/site/data/html_dir/2020/07/13/2020071303118.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4860,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.fnnews.com/news/202007131652112910
4861,2020-07-13,대웅제약vs메디톡스보톡스전쟁11월ITC최종결론은,http://www.wikileaks-kr.org/news/articleView.html?idxno=90848
4862,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신주장,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007130321&t=NN
4863,2020-07-13,대웅제약ITC예비결정은오류최종승소자신있어”,http://theviewers.co.kr/View.aspx?No=911888
4864,2020-07-13,대웅제약ITC예비판결중대한오류범해최종승리할것,http://www.whitepaper.co.kr/news/articleView.html?idxno=195603
4865,2020-07-13,대웅제약메디톡스난타전지속대웅ITC예비결정전례없는중대한오류최종승소자신,http://www.kdpress.co.kr/news/articleView.html?idxno=96307
4866,2020-07-13,대웅제약ITC예비판결오류최종승소자신,http://www.seoulfn.com/news/articleView.html?idxno=388928
4867,2020-07-13,대웅제약씨어스테크놀로지가개발한패치형부정맥진단기기판매,http://www.businesspost.co.kr/BP?command=article_view&num=187129
4868,2020-07-13,대웅제약균주소송의미국국제무역위예비판결에중대한오류있어,http://www.businesspost.co.kr/BP?command=article_view&num=187133
4869,2020-07-13,대웅제약보톡스관련ITC예비결정은추론불과한전례없는오판”,https://www.donga.com/news/article/all/20200713/101950699/1
4870,2020-07-13,대웅제약붙이는웨어러블심전도기모비케어선봬,https://www.kpanews.co.kr/article/show.asp?idx=214639&category=D
4871,2020-07-13,대웅제약ITC예비결정중대한오류최종승소할것,https://www.kpanews.co.kr/article/show.asp?idx=214638&category=D
4872,2020-07-14,종목PICK대웅제약ITC중대한오류범했다주장투자에는유의해야,https://www.asiatoday.co.kr/view.php?key=20200713010007813
4873,2020-07-14,대웅제약ITC예비판정중대오류메디톡스반박예고,http://www.medigatenews.com/news/4132123391
4874,2020-07-14,대웅제약92g초소형웨어러블심전도기출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2000853
4875,2020-07-14,진실공방밀린대웅제약신용등급도내려갈까,https://www.paxnetnews.com/articles/62886
4876,2020-07-14,갱년기증상완화도움”대웅제약마그네슘비타민B복합제마그온맥스출시,https://www.fetv.co.kr/news/article.html?no=59244
4877,2020-07-14,대웅제약마그온맥스출시갱년기증상완화도움,http://www.kpinews.co.kr/news/articleView.html?idxno=121321
4878,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.youthdaily.co.kr/news/article.html?no=42005
4879,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://medipana.com/news/news_viewer.asp?NewsNum=259889&MainKind=A&NewsKind=5&vCount=12&vKind=1
4880,2020-07-14,대웅제약마그온맥스출시갱년기증상완화도움,http://www.mediapen.com/news/view/540551
4881,2020-07-14,대웅제약마그온신규라인업구축마그네슘강화한마그온맥스출시,http://kpenews.com/View.aspx?No=912225
4882,2020-07-14,대웅제약갱년기증상완화마그온맥스출시,http://www.press9.kr/news/articleView.html?idxno=45274
4883,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://www.ybsn.tv/news/articleView.html?idxno=22432
4884,2020-07-14,대웅제약갱년기완화마그온맥스출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=90882
4885,2020-07-14,대웅제약ITC예비결정전례없는중대한오류,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200713012
4886,2020-07-14,대웅제약비타민B마그네슘보강한근육경련개선제출시,http://moneys.mt.co.kr/news/mwView.php?no=2020071409048027112
4887,2020-07-14,대웅제약갱년기증상개선마그온맥스출시,http://news.mt.co.kr/mtview.php?no=2020071409231292388
4888,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62286
4889,2020-07-14,대웅제약갱년기증상완화도움마그온맥스출시,https://www.etoday.co.kr/news/view/1917402
4890,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화도움,http://www.m-i.kr/news/articleView.html?idxno=729050
4891,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020071409340189459
4892,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,https://www.sedaily.com/NewsView/1Z5ASWUC6I
4893,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.bosa.co.kr/news/articleView.html?idxno=2130455
4894,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246683
4895,2020-07-14,대웅제약갱년기증상개선복합제마그온맥스출시,http://www.medisobizanews.com/news/articleView.html?idxno=71185
4896,2020-07-14,SR유통대웅제약ITC예비판결중대한오류승소자신,http://www.srtimes.kr/news/articleView.html?idxno=67116
4897,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.bokuennews.com/news/article.html?no=192475
4898,2020-07-14,대웅제약갱년기증상완화제마그온맥스출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02204166625834520
4899,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.newspim.com/news/view/20200714000226
4900,2020-07-14,대웅제약마그네슘비타민B 복합제 마그온맥스 출시갱년기증상에도움,http://www.greened.kr/news/articleView.html?idxno=260542
4901,2020-07-14,오늘의신상품대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.econovill.com/news/articleView.html?idxno=404528
4902,2020-07-14,대웅제약김성중팀장홍보실실장발령,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246687
4903,2020-07-14,대웅제약갱년기증상완화마그온맥스출시,http://www.pharmnews.com/news/articleView.html?idxno=100889
4904,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020071410082638484
4905,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.newsis.com/view/?id=NISX20200714_0001094075&cID=13001&pID=13000
4906,2020-07-14,대웅제약갱년기증상완화일반의약품마그온맥스출시,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007140118&t=NN
4907,2020-07-14,대웅제약갱년기증상완화마그온맥스출시,http://sports.hankooki.com/lpage/economy/202007/sp20200714102109136980.htm?s_ref=nv
4908,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.metroseoul.co.kr/article/20200714500070
4909,2020-07-14,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.healthinnews.co.kr/news/articleView.html?idxno=13694
4910,2020-07-14,대웅제약갱년기증상도움주는마그네슘비타민B복합제출시,http://daily.hankooki.com/lpage/industry/202007/dh20200714103538148390.htm?s_ref=nv
4911,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://newsbrite.net/139459
4912,2020-07-14,뉴스투데이L대웅제약마그네숨비타민B보강된마그온맥스출시,https://www.news2day.co.kr/156511
4913,2020-07-14,대웅제약마그온맥스출시갱년기증상완화도움,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119322
4914,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.viva100.com/main/view.php?key=20200714010002730
4915,2020-07-14,대웅제약웨어러블심전도기모비케어출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=13692
4916,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화도움 ,http://www.updownnews.co.kr/news/articleView.html?idxno=220900
4917,2020-07-14,대웅제약마그온맥스출시,https://www.ebn.co.kr/news/view/1442399/?sc=Naver
4918,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.thepublic.kr/news/newsview.php?ncode=1065576354491252
4919,2020-07-14,시경Today건강대웅제약마그네슘비타민B복합제마그온맥스출시外,http://www.meconomynews.com/news/articleView.html?idxno=43446
4920,2020-07-14,대웅제약갱년기증상개선마그온맥스출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=393018
4921,2020-07-14,과기정통부상반기우수기업연구소에대웅제약등19곳지정,http://yna.kr/AKR20200714066400017?did=1195m
4922,2020-07-14,과기정통부대웅제약등19개우수기업연구소선정,https://www.asiatoday.co.kr/view.php?key=20200714010008183
4923,2020-07-14,대웅제약한국야쿠르트우수기업연구소지정,http://news.mt.co.kr/mtview.php?no=2020071409543761311
4924,2020-07-14,정부대웅제약의약연구소등19개우수기업연구소선정,http://www.newsis.com/view/?id=NISX20200714_0001094126&cID=13001&pID=13000
4925,2020-07-14,대웅제약한국야쿠르트등19곳우수기업연구소지정,http://www.dongascience.com/news/view/38167
4926,2020-07-14,과기부대웅제약한국야쿠르트등우수기업연구소지정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1400484
4927,2020-07-14,과기정통부대웅제약등19곳우수기업연구소지정,https://biz.chosun.com/site/data/html_dir/2020/07/14/2020071401148.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4928,2020-07-14,대웅제약등19개연구소한국형K연구개발우수연구소선정,https://www.etoday.co.kr/news/view/1917517
4929,2020-07-14,과기정통부대웅제약등우수기업연구소19곳지정,http://biz.newdaily.co.kr/site/data/html/2020/07/14/2020071400022.html
4930,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.wsobi.com/news/articleView.html?idxno=101082
4931,2020-07-14,대웅제약마그온맥스출시갱년기증상완화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065570891042888
4932,2020-07-14,대웅제약웨어러블심전도기모비케어판매,http://www.whosaeng.com/119436
4933,2020-07-14,대웅제약갱년기증상완화위한마그온맥스출시,http://news.mk.co.kr/newsRead.php?no=720174&year=2020
4934,2020-07-14,인사대웅제약,http://www.mediapen.com/news/view/540705
4935,2020-07-14,과기정통부대웅제약등19개우수기업연구소지정,http://news.heraldcorp.com/view.php?ud=20200714000690
4936,2020-07-14,대웅제약의약연구소등19개우수기업연구소지정,http://www.etnews.com/20200714000196
4937,2020-07-14,대웅제약한국야쿠르트등19개우수기업연구소선정,http://www.fnnews.com/news/202007141405346506
4938,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://www.nbnnews.co.kr/news/articleView.html?idxno=406876
4939,2020-07-14,대웅제약근육경련갱녕기증상완화제마그온맥스선봬,http://www.100ssd.co.kr/news/articleView.html?idxno=70036
4940,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.pressm.kr/news/articleView.html?idxno=31335
4941,2020-07-14,메디톡스대웅제약주장ITC가받아들이지않은내용예비판결로진실밝혀져”,https://www.fetv.co.kr/news/article.html?no=59294
4942,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://www.healthinnews.co.kr/news/articleView.html?idxno=13695
4943,2020-07-14,메디톡스ITC예비판결문은비공개대웅제약주장은거짓또는위반,http://www.seoulwire.com/news/articleView.html?idxno=420198
4944,2020-07-14,보톡스위기대웅제약당뇨병치료제로돌파할까,http://www.bizhankook.com/article/20288
4945,2020-07-14,정부대웅제약등19개우수기업연구소지정,http://www.newsprime.co.kr/news/article.html?no=511045
4946,2020-07-14,메디톡스대웅제약예비판결전문공개되면더이상변명못해”,http://www.pinpointnews.co.kr/view.php?ud=202007141454135700f090c8dbcb_45
4947,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1400618
4948,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.getnews.co.kr/view.php?ud=2020071414574175722fe691f917_16
4949,2020-07-14,메디톡스ITC예비판결문은비공개대웅제약주장은거짓,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007140261&t=NN
4950,2020-07-14,메디톡스대웅제약주장거짓예비판결로진실밝혀진것”,http://www.viva100.com/main/view.php?key=20200714010002840
4951,2020-07-14,과기정통부대웅제약한국야쿠르트등19개우수기업연구소지정,http://www.marketnews.co.kr/news/articleView.html?idxno=48487
4952,2020-07-14,대웅제약메디톡스ITC결과두고또해석차오류vs규정위반,http://biz.newdaily.co.kr/site/data/html/2020/07/14/2020071400138.html
4953,2020-07-14,메디톡스대웅제약주장ITC가받아들이지않은내용,http://medipana.com/news/news_viewer.asp?NewsNum=259944&MainKind=A&NewsKind=5&vCount=12&vKind=1
4954,2020-07-14,과기정통부대웅제약야쿠르트등19곳상반기우수기업연구소지정,http://www.ajunews.com/view/20200714151613166
4955,2020-07-14,대웅제약마그온맥스출시,http://www.finomy.com/news/articleView.html?idxno=80309
4956,2020-07-14,인사대웅제약홍보실장상무김성중,http://kpenews.com/View.aspx?No=913017
4957,2020-07-14,대웅제약한국야쿠르트등19개우수기업연구소지정,http://www.dt.co.kr/contents.html?article_no=2020071402109931731004&ref=naver
4958,2020-07-14,대웅제약갱년기증상완화마그온맥스출시,http://www.fnnews.com/news/202007141530430215
4959,2020-07-14,대웅제약마그온맥스출시마그네슘비타민B,http://www.consumuch.com/news/articleView.html?idxno=49762
4960,2020-07-14,제약오늘JW중외제약치주질환보조치료제덴드리스캡슐출시대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.sisaon.co.kr/news/articleView.html?idxno=115521
4961,2020-07-14,메디톡스vs대웅제약이제는장외전치열한언론공방,http://www.babytimes.co.kr/news/articleView.html?idxno=37886
4962,2020-07-14,메디톡스미국예비판결전문공개되면대웅제약은변명못한다,http://www.businesspost.co.kr/BP?command=article_view&num=187238
4963,2020-07-14,메디톡스대웅제약의반박거짓주장혹은규정위반,https://view.asiae.co.kr/article/2020071415433517253
4964,2020-07-14,메디톡스대웅제약ITC규정위반”,http://theviewers.co.kr/View.aspx?No=913042
4965,2020-07-14,ITC나보타판결에흔들리는대웅제약2분기실적흐림,http://www.wikileaks-kr.org/news/articleView.html?idxno=90914
4966,2020-07-14,메디톡스ITC예비판결로이미진실드러나오류라는대웅제약에반박,https://www.dailian.co.kr/news/view/905013?sc=Naver
4967,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200714155920825951638db705_1/article.html
4968,2020-07-14,넥스틴대웅제약등우수기업연구소19곳지정,http://www.edaily.co.kr/news/newspath.asp?newsid=03844166625834520
4969,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.todaykorea.co.kr/news/articleView.html?idxno=273885
4970,2020-07-14,정부상반기우수기업연구소대웅제약한국야쿠르트19개지정,http://www.viva100.com/main/view.php?key=20200714010002894
4971,2020-07-14,메디톡스ITC예비판결문은비공개대웅제약에반박,http://www.newspim.com/news/view/20200714001034
4972,2020-07-14,메디톡스대웅제약ITC규정어겼거나거짓주장중,http://www.medigatenews.com/news/1318477568
4973,2020-07-14,대웅제약갱년기증상완화마그온맥스출시마그네슘비타민B복합제,http://theviewers.co.kr/View.aspx?No=913155
4974,2020-07-14,메디톡스대웅제약측모든주장은ITC가인정하지않은내용,http://www.newsworks.co.kr/news/articleView.html?idxno=472415
4975,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.lawissue.co.kr/view.php?ud=2020071419230193204ead0791_12
4976,2020-07-14,과기정통부대웅제약등19사우수기업연구소지정,http://www.segye.com/content/html/2020/07/14/20200714523323.html?OutUrl=naver
4977,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스선봬,https://www.kpanews.co.kr/article/show.asp?idx=214681&category=D
4978,2020-07-14,ITC예비결정두고대웅제약vs메디톡스11월최종결정관심UP,http://medicalworldnews.co.kr/news/view.php?idx=1510936584
4979,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.thefirstmedia.net/news/articleView.html?idxno=60515
4980,2020-07-15,KBIO5년균주전쟁메디톡스웃고대웅제약울고,http://moneys.mt.co.kr/news/mwView.php?no=2020071010178061657
4981,2020-07-15,美ITC예비판결불구대웅제약vs메디톡스대립격화,http://www.dailymedi.com/detail.php?number=858194&thread=22r05
4982,2020-07-15,대웅제약자회사힐리언스국내여행증가로매출부진만회할까,http://www.ceoscoredaily.com/news/article.html?no=71464
4983,2020-07-15,대웅제약vs메디톡스보톡스논쟁여전히진흙탕,http://www.cstimes.com/news/articleView.html?idxno=422205
4984,2020-07-15,대웅제약에볼루스CB취득속내는,https://www.paxnetnews.com/articles/62903
4985,2020-07-15,상반기우수기업연구소에대웅제약등19개사,https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&s_hcd=&key=202007141654327952
4986,2020-07-15,대웅제약과메디톡스평행선달려ITC판결두고샅바싸움치열,https://www.fetv.co.kr/news/article.html?no=59366
4987,2020-07-15,메디톡스에카운터펀치맞은대웅제약美법원소송카드만지작,http://www.newsway.co.kr/news/view?tp=1&ud=2020071419120260249
4988,2020-07-15,위키시선독한전쟁대웅제약메디톡스승자가있을까,http://www.wikileaks-kr.org/news/articleView.html?idxno=91000
4989,2020-07-15,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.mhj21.com/132798
4990,2020-07-15,종목이슈메디톡스vs대웅제약끝나지않은ITC논쟁불확실성지속,http://www.newspim.com/news/view/20200715001114
4991,2020-07-16,대웅제약메디톡스美ITC예비판결놓고또논쟁,http://www.youthdaily.co.kr/news/article.html?no=42256
4992,2020-07-17,대웅제약주식중립으로낮아져미국균주소송불확실성지속,http://www.businesspost.co.kr/BP?command=article_view&num=187730
4993,2020-07-17,오늘의제약동국제약한미약품메디톡스대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=37971
4994,2020-07-17,메디톡스대웅제약이균주훔쳐갔다ITC예비판결국내소송영향미칠까,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200717011
4995,2020-07-18,ITC예비결정승자메디톡스도대웅제약도아닌슬픈현실,http://newsclaim.co.kr/View.aspx?No=917064
4996,2020-07-18,이기자의메디컬나우김성중대웅제약팀장상무승진배경보니,http://www.sisajournal-e.com/news/articleView.html?idxno=221333
4997,2020-07-20,대웅제약보툴리눔소송불확실성지속에주가↓,http://www.whitepaper.co.kr/news/articleView.html?idxno=195785
4998,2020-07-20,메디톡스대웅제약ITC제출자료국내민사재판부에제출,https://www.hankyung.com/finance/article/2020072070986
4999,2020-07-20,기자수첩6년혈투메디톡스대웅제약상처만남았다,http://news.bizwatch.co.kr/article/consumer/2020/07/20/0017/naver
5000,2020-07-20,증권가전문가들이대웅제약투자의견을중립으로낮춘까닭은,http://www.wikileaks-kr.org/news/articleView.html?idxno=91260
5001,2020-07-20,대웅제약웨어러블심전도기모비케어출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200720161937579869d76442fa_1/article.html
5002,2020-07-21,기자수첩대웅제약메디톡스소모전끝내야,http://www.shinailbo.co.kr/news/articleView.html?idxno=1301450
5003,2020-07-22,대웅제약한미약품동병상련실적악화에숨고르기,http://www.ajunews.com/view/20200721161055238
5004,2020-07-22,대웅제약우루사중국의약품재임상착수,http://www.press9.kr/news/articleView.html?idxno=45353
5005,2020-07-22,대웅제약500억규모단기차입금증가,https://www.etoday.co.kr/news/view/1920907
5006,2020-07-22,공시대웅제약500억원단기차입결정,http://www.fnnews.com/news/202007221717351936
5007,2020-07-22,대웅제약500억원단기차입결정,http://www.edaily.co.kr/news/newspath.asp?newsid=04027846625837144
5008,2020-07-22,대웅제약500억원단기차입결정,http://www.newsprime.co.kr/news/article.html?no=511946
5009,2020-07-22,공시대웅제약500억규모단기차입금증가결정,http://www.newsway.co.kr/news/view?tp=1&ud=2020072217360448796
5010,2020-07-22,대웅제약500억원단기차입결정,https://www.asiatoday.co.kr/view.php?key=20200722010013775
5011,2020-07-23,기업공시7월22일대웅제약운영자금용단기차입금500억증가등,https://www.sedaily.com/NewsView/1Z5EY18RNF
5012,2020-07-23,전일주요공시대웅제약게임빌LG이노텍등,https://www.etoday.co.kr/news/view/1920942
5013,2020-07-23,대웅제약500억원단기차입,http://www.bokuennews.com/news/article.html?no=192796
5014,2020-07-23,장마감후공시대웅제약500억규모단기차입금결정外,http://www.ezyeconomy.com/news/articleView.html?idxno=103335
5015,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.press9.kr/news/articleView.html?idxno=45370
5016,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247044
5017,2020-07-23,대웅제약뉴트로우루사리미티드에디션발매,http://www.kpinews.co.kr/news/articleView.html?idxno=122063
5018,2020-07-23,대웅제약우루사뉴트로패키지한정출시,http://www.mediapen.com/news/view/542966
5019,2020-07-23,오늘의제약종근당건강광동제약대웅제약아스트라제네카,http://www.babytimes.co.kr/news/articleView.html?idxno=38108
5020,2020-07-23,대웅제약우루사 뉴트로한정판출시,http://www.greened.kr/news/articleView.html?idxno=261983
5021,2020-07-23,대웅제약뉴트로트렌드맞춘우루사리미티드에디션출시,http://www.youthdaily.co.kr/news/article.html?no=42767
5022,2020-07-23,대웅제약우루사뉴트로한정판출시​중년층향수자극,https://www.dailian.co.kr/news/view/907145?sc=Naver
5023,2020-07-23,대웅제약2020우루사리미티드에디션뉴트로한정판출시,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119660
5024,2020-07-23,대웅제약뉴트로감성더한우루사한정판발매,http://moneys.mt.co.kr/news/mwView.php?no=2020072309218021518
5025,2020-07-23,대웅제약뉴트로디자인우루사리미티드에디션한정판출시,http://www.medisobizanews.com/news/articleView.html?idxno=71417
5026,2020-07-23,대웅제약우루사뉴트로한정판에디션출시,http://www.ekn.kr/news/article.html?no=512956
5027,2020-07-23,대웅제약500억원단기차입결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=393968
5028,2020-07-23,대웅제약우루사뉴트로한정판출시,http://newsbrite.net/139776
5029,2020-07-23,대웅제약우루사뉴트로한정판출시복고감성담았다,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020072309462030942
5030,2020-07-23,콜라보로젊어진우루사대웅제약리미티드에디션출시,http://www.viva100.com/main/view.php?key=20200723010004598
5031,2020-07-23,우루사의끝없는변신대웅제약우루사뉴트로한정판출시,http://daily.hankooki.com/lpage/industry/202007/dh20200723095727148390.htm?s_ref=nv
5032,2020-07-23,대웅제약뉴트로감성맞춘우루사한정판출시,http://news.mt.co.kr/mtview.php?no=2020072309500549127
5033,2020-07-23,대웅제약우루사뉴트로한정판선봬,http://www.insightkorea.co.kr/news/articleView.html?idxno=81471
5034,2020-07-23,대웅제약우루사뉴트로패키지디자인한정판매,http://sports.chosun.com/news/ntype.htm?id=202007240100219950014942&servicedate=20200723
5035,2020-07-23,대웅제약우루사리미티드에디션출시,http://www.ybsn.tv/news/articleView.html?idxno=23844
5036,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=13767
5037,2020-07-23,대웅제약우루사뉴트로한정판출시,http://yna.kr/AKR20200723060300017?did=1195m
5038,2020-07-23,대웅제약우루사뉴트로Newtro한정판출시​,http://www.pharmnews.com/news/articleView.html?idxno=100969
5039,2020-07-23,대웅제약뉴트로한정판우루사출시향수와신선한재미동시에,http://theviewers.co.kr/View.aspx?No=921720
5040,2020-07-23,대웅제약80년대느낌담아우루사뉴트로한정판출시,http://www.newsis.com/view/?id=NISX20200723_0001105121&cID=13001&pID=13000
5041,2020-07-23,대웅제약우루사뉴트로특별한정판발매,http://www.smartfn.co.kr/view.php?ud=202007231025028423d5d29c6899_46
5042,2020-07-23,우루사의변신은계속대웅제약우루사뉴트로한정판출시​,http://www.upinews.kr/newsView/upi202007230029
5043,2020-07-23,대웅제약우루사뉴트로한정판출시중년층향수자극,https://www.asiatime.co.kr/news/newsview.php?ncode=1065576632388001
5044,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=30314
5045,2020-07-23,대웅제약우루사리미티드에디션발매,http://www.bosa.co.kr/news/articleView.html?idxno=2131076
5046,2020-07-23,대웅제약우루사뉴트로입는다한정판패키지출시,http://www.consumuch.com/news/articleView.html?idxno=49901
5047,2020-07-23,대웅제약우루사뉴트로한정판우루사리미티드에디션출시​,http://www.pressm.kr/news/articleView.html?idxno=31603
5048,2020-07-23,우루사의변신은계속된다”대웅제약우루사뉴트로한정판출시​,https://www.fetv.co.kr/news/article.html?no=59872
5049,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.newstomato.com/ReadNews.aspx?no=985831
5050,2020-07-23,대웅제약우루사뉴트로한정판출시,https://biz.chosun.com/site/data/html_dir/2020/07/23/2020072301796.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5051,2020-07-23,우루사변신”대웅제약우루사뉴트로한정판우루사리미티드에디션출시,http://www.betanews.net:8080/article/1211303.html
5052,2020-07-23,우루사의변신은계속된다대웅제약우루사뉴트로한정판출시,http://www.metroseoul.co.kr/article/20200723500129
5053,2020-07-23,대웅제약간기능개선제우루사뉴트로한정판출시,http://www.getnews.co.kr/view.php?ud=2020072311250239172fe691f917_16
5054,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.bokuennews.com/news/article.html?no=192811
5055,2020-07-23,대웅제약뉴트로트렌드맞춰우루사한정판출시​,http://www.newslock.co.kr/news/articleView.html?idxno=29721
5056,2020-07-23,대웅제약우루사뉴트로한정판출시변신은계속된다,http://www.m-i.kr/news/articleView.html?idxno=731933
5057,2020-07-23,대웅제약우루사뉴트로한정판출시,https://www.asiatoday.co.kr/view.php?key=20200723010014189
5058,2020-07-23,대웅제약MZ세대맞춤우루사뉴트로한정판출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001115
5059,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62452
5060,2020-07-23,대웅제약우루사뉴트로한정판선봬,https://www.kpanews.co.kr/article/show.asp?idx=214905&category=D
5061,2020-07-23,대웅제약우루사뉴트로한정판출시우루사의변신은계속된다”,http://www.thepublic.kr/news/newsview.php?ncode=1065579090031228
5062,2020-07-23,대웅제약우루사뉴트로한정판출시​,https://www.ebn.co.kr/news/view/1443787/?sc=Naver
5063,2020-07-23,이인애의뒷담화갑질피해자외면하는대웅제약윤재승마케팅사임한전회장이름왜자꾸꺼내나,http://theviewers.co.kr/View.aspx?No=922251
5064,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=394020
5065,2020-07-23,우루사의변신은계속된다대웅제약우루사뉴트로한정판출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=409377
5066,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.edaily.co.kr/news/newspath.asp?newsid=03148806625837472
5067,2020-07-23,대웅제약우루사리미티드에디션출시,http://www.finomy.com/news/articleView.html?idxno=80736
5068,2020-07-23,대웅제약간기능개선제우루사뉴트로디자인포장의한정판내놔,http://www.businesspost.co.kr/BP?command=article_view&num=188622
5069,2020-07-23,대웅제약뉴트로감성입힌우루사리미티드에디션출시,http://news.mk.co.kr/newsRead.php?no=755916&year=2020
5070,2020-07-23,대웅제약등161개기업근무혁신우수기업선정,https://www.asiatoday.co.kr/view.php?key=20200723010014544
5071,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.dailymedi.com/detail.php?number=858518&thread=22r05
5072,2020-07-23,대웅제약뉴트로버전우루사리미티드에디션출시,http://www.updownnews.co.kr/news/articleView.html?idxno=221270
5073,2020-07-23,오늘의신상품대웅제약우루사뉴트로한정판출시,http://www.econovill.com/news/articleView.html?idxno=405745
5074,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.thefirstmedia.net/news/articleView.html?idxno=60908
5075,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.lawissue.co.kr/view.php?ud=202007231816082892204ead0791_12
5076,2020-07-23,젊어지는우루사대웅제약우루사리미티드에디션출시,https://www.donga.com/news/article/all/20200723/102132333/1
5077,2020-07-23,대웅제약겹악재에실적방어안간힘지금믿을건우루사뿐,http://www.businesspost.co.kr/BP?command=article_view&num=188733
5078,2020-07-23,뉴스투데이L대웅제약우루사뉴트로한정판출시,https://www.news2day.co.kr/157194
5079,2020-07-23,대웅제약우루사뉴트로한정판출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4226216
5080,2020-07-24,신상품대웅제약우루사뉴트로한정판 ,http://www.seoulfn.com/news/articleView.html?idxno=389980
5081,2020-07-24,대웅제약단기차입금500억증가배경은,https://www.paxnetnews.com/articles/63313
5082,2020-07-24,대웅제약의한올바이오파마인수5년성과합격점,http://news.mk.co.kr/newsRead.php?no=757617&year=2020
5083,2020-07-24,대웅제약단기차입자금에볼루스로해결하나,https://www.ebn.co.kr/news/view/1444000/?sc=Naver
5084,2020-07-24,끝나지않은대웅제약과메디톡스의보톡스전쟁,https://news.chosun.com/site/data/html_dir/2020/07/24/2020072402708.html?utm_source=naver&utm_medium=original&utm_campaign=news
5085,2020-07-24,대웅제약우루사뉴트로한정판출시​,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200724016
5086,2020-07-24,주간신상태그아모레퍼시픽애경산업버커루대웅제약롯데호텔외,http://www.newsprime.co.kr/news/article.html?no=512230
5087,2020-07-24,대웅제약윤재승마케팅원고의뢰받은사람있는데준사람은없어귀신이곡할노릇”,http://theviewers.co.kr/View.aspx?No=923669
5088,2020-07-25,연재기획①대웅제약vs메디톡스보툴리눔톡신전쟁톺아보기균주도용의진실은,http://newsclaim.co.kr/View.aspx?No=923971
5089,2020-07-27,대웅제약우루사뉴트로한정판출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200726182712389669d76442fa_1/article.html
5090,2020-07-27,더벨대웅제약500억단기차입이갖는세가지의미,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202007231517055240108534
5091,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=260491&MainKind=A&NewsKind=5&vCount=12&vKind=1
5092,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.ekn.kr/news/article.html?no=513590
5093,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.youthdaily.co.kr/news/article.html?no=42990
5094,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://daily.hankooki.com/lpage/industry/202007/dh20200727090516148390.htm?s_ref=nv
5095,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://www.fetv.co.kr/news/article.html?no=60052
5096,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247148
5097,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.sentv.co.kr/news/view/576769
5098,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://newsbrite.net/139866
5099,2020-07-27,로스탁대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.lawissue.co.kr/view.php?ud=202007270912302205204ead0791_12
5100,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.newsis.com/view/?id=NISX20200727_0001108404&cID=13001&pID=13000
5101,2020-07-27,대웅제약지노믹트리코로나19진단키트공급계약체결,http://www.press9.kr/news/articleView.html?idxno=45388
5102,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020072709062962690
5103,2020-07-27,대웅제약지노믹트리와고감도코로나19진단키트글로벌공급계약,http://www.medisobizanews.com/news/articleView.html?idxno=71478
5104,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급공동협력시너지창출기대,http://theviewers.co.kr/View.aspx?No=924480
5105,2020-07-27,대웅제약지노믹트리의코로나19진단키트글로벌공급맡기로,http://news.mk.co.kr/newsRead.php?no=764582&year=2020
5106,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외판매계약,http://news.mt.co.kr/mtview.php?no=2020072709140137520
5107,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=01912246625838784
5108,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.bosa.co.kr/news/articleView.html?idxno=2131244
5109,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=394270
5110,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급협력,https://www.etoday.co.kr/news/view/1922229
5111,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=30440
5112,2020-07-27,대웅제약지노믹트리코로나19진단키트글로벌공급계약체결,http://moneys.mt.co.kr/news/mwView.php?no=2020072709038090188
5113,2020-07-27,대웅제약지노믹트리코로나19진단키트수출계약,http://health.chosun.com/site/data/html_dir/2020/07/27/2020072701131.html
5114,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://inthenews.co.kr/article-60991/
5115,2020-07-27,대웅제약코로나19진단키트해외공급계약체결,http://www.seoulwire.com/news/articleView.html?idxno=421754
5116,2020-07-27,대웅제약지노믹트리코로나진단키트해외공급계약체결,http://www.newspim.com/news/view/20200727000117
5117,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://sports.chosun.com/news/ntype.htm?id=202007280100249020017052&servicedate=20200727
5118,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://biz.chosun.com/site/data/html_dir/2020/07/27/2020072701170.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5119,2020-07-27,지노믹트리대웅제약과코로나19진단키트해외공급계약체결,http://www.paxetv.com/news/articleView.html?idxno=96830
5120,2020-07-27,검체채취4시간이내결과확인대웅제약코로나진단키트공급,http://www.wikileaks-kr.org/news/articleView.html?idxno=91693
5121,2020-07-27,대웅제약지노믹트리와코로나19분자진단키트해외공급,http://www.kpinews.co.kr/news/articleView.html?idxno=122293
5122,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급,http://www.viva100.com/main/view.php?key=20200727010005242
5123,2020-07-27,대웅제약지노믹트리와손잡고코로나19진단키트수출한다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119740
5124,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573301559852
5125,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.getnews.co.kr/view.php?ud=2020072709501738582fe691f917_16
5126,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.biospectator.com/view/news_view.php?varAtcId=10920
5127,2020-07-27,대웅제약지노믹트리와코로나19진단키트공급계약,http://www.mhj21.com/133202
5128,2020-07-27,대웅제약4시간내확인지노믹트리코로나19진단키트해외공급,http://yna.kr/AKR20200727039600017?did=1195m
5129,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.sisafocus.co.kr/news/articleView.html?idxno=244219
5130,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.fnnews.com/news/202007270958592717
5131,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93858
5132,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=13789
5133,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.m-i.kr/news/articleView.html?idxno=732591
5134,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급,http://www.newstomato.com/ReadNews.aspx?no=986392
5135,2020-07-27,대웅제약지노믹트리개발진단키트해외공급계약4시간내코로나19확인,http://www.startuptoday.co.kr/news/articleView.html?idxno=48754
5136,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://www.dailian.co.kr/news/view/907979/?sc=Naver
5137,2020-07-27,대웅제약지노믹트리코로나19키트글로벌판매공급계약,http://www.newsprime.co.kr/news/article.html?no=512281
5138,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급,http://www.seoulfn.com/news/articleView.html?idxno=390196
5139,2020-07-27,대웅제약코로나19진단키트해외공급,http://www.whosaeng.com/119736
5140,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.medigatenews.com/news/1848578930
5141,2020-07-27,대웅제약지노믹트리 코로나19 진단키트해외공급계약체결,http://www.economytalk.kr/news/articleView.html?idxno=207247
5142,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.upinews.kr/newsView/upi202007270030
5143,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007270208&t=NN
5144,2020-07-27,대웅제약지노믹트리코로나19진단키트해외판매,https://view.asiae.co.kr/article/2020072710483307076
5145,2020-07-27,대웅제약지노믹트리코로나진단키트해외공급,http://www.dailypharm.com/Users/News/NewsView.html?ID=266945&REFERER=NP
5146,2020-07-27,대웅제약지노믹트리코로나19진단키트글로벌판매계약,http://www.pressm.kr/news/articleView.html?idxno=31690
5147,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.metroseoul.co.kr/article/20200727500159
5148,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.thepublic.kr/news/newsview.php?ncode=1065575761474492
5149,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=49555
5150,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://sports.hankooki.com/lpage/economy/202007/sp20200727112710137020.htm?s_ref=nv
5151,2020-07-27,대웅제약지노믹트리 코로나19 분자진단키트해외공급체결,http://www.newslock.co.kr/news/articleView.html?idxno=29818
5152,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1403398
5153,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134960&REFERER=NP
5154,2020-07-27,대웅제약4시간내확인지노믹트리코로나19진단키트해외공급,http://www.topstarnews.net/news/articleView.html?idxno=822932
5155,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62501
5156,2020-07-27,대웅제약지노믹트리코로나19키트해외공급계약,https://www.hankyung.com/it/article/202007271270i
5157,2020-07-27,대웅제약지노믹트리와코로나키트해외공급계약체결,http://www.koreastocknews.com/news/articleView.html?idxno=55727
5158,2020-07-27,대웅제약지노믹트리진단키트아큐라디텍글로벌공급,http://www.todaykorea.co.kr/news/articleView.html?idxno=274549
5159,2020-07-27,대웅제약지노믹트리와코로나19 진단키트해외공급계약,http://www.greened.kr/news/articleView.html?idxno=262510
5160,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결外,http://www.newswatch.kr/news/articleView.html?idxno=50182
5161,2020-07-27,오늘의제약대웅제약한미헬스케어GC녹십자의료재단,http://www.babytimes.co.kr/news/articleView.html?idxno=38213
5162,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.econovill.com/news/articleView.html?idxno=406078
5163,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=410200
5164,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.ftoday.co.kr/news/articleView.html?idxno=204316
5165,2020-07-27,명인제약대웅제약등부패방지경영시스템인증제약사불법리베이트多실효성의문,http://theviewers.co.kr/View.aspx?No=925231
5166,2020-07-27,흔들리는대웅제약1년만에매출1조클럽탈락위기,http://www.wikileaks-kr.org/news/articleView.html?idxno=91729
5167,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.bokuennews.com/news/article.html?no=192954
5168,2020-07-27,대웅제약지노믹트리의코로나19진단키트를해외공급하는계약,http://www.businesspost.co.kr/BP?command=article_view&num=189136
5169,2020-07-27,대웅제약지노믹트리손잡고코로나19진단키트해외공급,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001218
5170,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200727009
5171,2020-07-27,대웅제약과지노믹트리코로나19진단키트해외공급계약체결,http://www.wsobi.com/news/articleView.html?idxno=101801
5172,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.dailymedi.com/detail.php?number=858635&thread=22r05
5173,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급협력,https://www.news2day.co.kr/157377
5174,2020-07-27,김창수의e뉴스브리핑대웅제약지노믹트리코로나19진단키트해외공급계약체결外,https://www.fetv.co.kr/news/article.html?no=60122
5175,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.mediapen.com/news/view/544110
5176,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=60988
5177,2020-07-27,대웅제약지노믹트리와코로나19진단키트파트너십,http://www.shinailbo.co.kr/news/articleView.html?idxno=1303679
5178,2020-07-27,대웅제약코로나19진단키트아큐라디텍지노믹트리와글로벌공급나서,http://www.kdpress.co.kr/news/articleView.html?idxno=96568
5179,2020-07-28,한미3277억1위종근당대웅제약HK이노엔유한順,http://www.dailymedi.com/detail.php?number=858648&thread=22r05
5180,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=260555&MainKind=A&NewsKind=5&vCount=12&vKind=1
5181,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=122366
5182,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.youthdaily.co.kr/news/article.html?no=43103
5183,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.mediapen.com/news/view/544147
5184,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄,http://www.medisobizanews.com/news/articleView.html?idxno=71512
5185,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최웨어러블심전도기,http://theviewers.co.kr/View.aspx?No=925836
5186,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념웹심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247208
5187,2020-07-28,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://kormedi.com/?p=1321205
5188,2020-07-28,게시판대웅제약모비케어출시기념웹심포지엄개최,http://yna.kr/AKR20200728038900017?did=1195m
5189,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572295329340
5190,2020-07-28,대웅제약웨어러블심전도기런칭웨비나개최,http://moneys.mt.co.kr/news/mwView.php?no=2020072809148029908
5191,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.metroseoul.co.kr/article/20200728500050
5192,2020-07-28,대웅제약모비케어런칭기념웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2131326
5193,2020-07-28,대웅제약오는30일모비케어론칭웹심포지엄개최,http://www.viva100.com/main/view.php?key=20200728010005475
5194,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄개최,http://news.mt.co.kr/mtview.php?no=2020072809283085562
5195,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119784
5196,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=60165
5197,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=45401
5198,2020-07-28,대웅제약웨어러블심전도측정기모비케어출시기념웹심포지엄개최,http://news.mk.co.kr/newsRead.php?no=769335&year=2020
5199,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=733016
5200,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.healthinnews.co.kr/news/articleView.html?idxno=13800
5201,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://newsbrite.net/139937
5202,2020-07-28,대웅제약웨어러블심전도기런칭기념웹심포지엄개최,http://www.ekn.kr/news/article.html?no=513921
5203,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최,http://www.mhj21.com/133300
5204,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념웹심포지엄개최,http://www.getnews.co.kr/view.php?ud=2020072810443648142fe691f917_16
5205,2020-07-28,대웅제약웨어러블심전도기모비케어심포지엄개최,http://www.econovill.com/news/articleView.html?idxno=406189
5206,2020-07-28,대웅제약모비케어출시기념웹심포지엄개최,http://www.consumuch.com/news/articleView.html?idxno=49952
5207,2020-07-28,대웅제약 웨어러블심전도기 모비케어 런칭기념웹심포지엄개최,http://www.greened.kr/news/articleView.html?idxno=262667
5208,2020-07-28,오늘의제약동화약품CG녹십자랩셀대웅제약셀트리온,http://www.babytimes.co.kr/news/articleView.html?idxno=38247
5209,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62513
5210,2020-07-28,대웅제약 웨어러블심전도기모비케어 런칭기념웹심포지엄진행,http://www.newslock.co.kr/news/articleView.html?idxno=29856
5211,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.iminju.net/news/articleView.html?idxno=55680
5212,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=20200728131325630204ead0791_12
5213,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.updownnews.co.kr/news/articleView.html?idxno=221384
5214,2020-07-28,벤처투자돈몰리는바이오의료대웅제약보령제약발빠른행보,http://www.viva100.com/main/view.php?key=20200728010005505
5215,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=394457
5216,2020-07-28,뉴스투데이L대웅제약모비케어런칭기념웹심포지엄개최,https://www.news2day.co.kr/157438
5217,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=410589
5218,2020-07-28,대웅제약웨어러블심전도기런칭기념웹심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=30545
5219,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1403827
5220,2020-07-28,대웅제약모비케어론칭기념웹심포지엄개최,https://www.ebn.co.kr/news/view/1444440/?sc=Naver
5221,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄,http://daily.hankooki.com/lpage/industry/202007/dh20200728175722148390.htm?s_ref=nv
5222,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=61048
5223,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념온라인심포지엄개최,https://www.donga.com/news/article/all/20200728/102198960/1
5224,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄개최,http://www.medigatenews.com/news/2769713394
5225,2020-07-29,대웅제약심전도기모비케어런칭웹심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001260
5226,2020-07-29,대웅제약발달장애인을위한의사소통그림책배포,http://www.press9.kr/news/articleView.html?idxno=45411
5227,2020-07-29,발달장애인질병표현돕는다대웅제약질병표현을돕는의사소통그림책배포,http://www.youthdaily.co.kr/news/article.html?no=43203
5228,2020-07-29,대웅제약발달장애인질병표현돕는그림책배포,http://www.medisobizanews.com/news/articleView.html?idxno=71544
5229,2020-07-29,대웅제약질병표현을돕는의사소통그림책배포,http://www.kpinews.co.kr/news/articleView.html?idxno=122478
5230,2020-07-29,대웅제약질병표현을돕는의사소통그림책AAC그림책배포발달장애인위한제작,http://www.pressm.kr/news/articleView.html?idxno=31755
5231,2020-07-29,대웅제약발달장애인돕는의사소통그림책배포,https://www.fetv.co.kr/news/article.html?no=60260
5232,2020-07-29,대웅제약질병표현을돕는의사소통그림책제작배포,http://medipana.com/news/news_viewer.asp?NewsNum=260611&MainKind=A&NewsKind=5&vCount=12&vKind=1
5233,2020-07-29,대웅제약발달장애인위한AAC그림책배포,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572549905450
5234,2020-07-29,대웅제약발달장애인의사소통돕는그림책무료배포,http://www.econovill.com/news/articleView.html?idxno=406295
5235,2020-07-29,대웅제약질병표현의사소통그림책배포,https://www.ebn.co.kr/news/view/1444526/?sc=Naver
5236,2020-07-29,사회공헌특집62대웅제약 발달장애인 위한의사소통그림책 배포,http://www.economytalk.kr/news/articleView.html?idxno=207291
5237,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.m-i.kr/news/articleView.html?idxno=733340
5238,2020-07-29,대웅제약질병표현돕는AAC그림책배포발달장애인의사소통위해,http://theviewers.co.kr/View.aspx?No=927204
5239,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.paxetv.com/news/articleView.html?idxno=97037
5240,2020-07-29,대웅제약발달장애인위해의사소통그림책배포,http://www.mhj21.com/133339
5241,2020-07-29,대웅제약발달장애인질병표현돕는그림책제작,http://www.bosa.co.kr/news/articleView.html?idxno=2131400
5242,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.healthinnews.co.kr/news/articleView.html?idxno=13821
5243,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://sports.hankooki.com/lpage/economy/202007/sp20200729102149136980.htm?s_ref=nv
5244,2020-07-29,대웅제약 발달장애인을위한 질병표현을돕는의사소통그림책 배포,http://www.greened.kr/news/articleView.html?idxno=262838
5245,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.newsfc.co.kr/news/articleView.html?idxno=42040
5246,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://newsbrite.net/139988
5247,2020-07-29,대웅제약발달장애인위한의사소통그림책배포,http://www.dailysmart.co.kr/news/articleView.html?idxno=30584
5248,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.getnews.co.kr/view.php?ud=2020072910585175862fe691f917_16
5249,2020-07-29,대웅제약발달장애인을위한질병표현의사소통그림책배포,http://www.medigatenews.com/news/2753086442
5250,2020-07-29,대웅제약발달장애인의사소통그림책배포,http://www.consumuch.com/news/articleView.html?idxno=49986
5251,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.mdtoday.co.kr/mdtoday/index.html?no=394579
5252,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62541
5253,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.thepublic.kr/news/newsview.php?ncode=1065577450634082
5254,2020-07-29,대웅제약발달장애인위한AAC그림책제작배포,http://www.whosaeng.com/119813
5255,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.metroseoul.co.kr/article/20200729500261
5256,2020-07-29,치료기회놓치지마요대웅제약발달장애인들의질병표현돕는다,https://www.kpanews.co.kr/article/show.asp?idx=215061&category=D
5257,2020-07-29,대웅제약발달장애인위한질병표현돕는의사소통그림책제작배포,http://www.newslock.co.kr/news/articleView.html?idxno=29905
5258,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.datasom.co.kr/news/articleView.html?idxno=107441
5259,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.nbnnews.co.kr/news/articleView.html?idxno=410952
5260,2020-07-29,대웅제약발달장애인의사소통용그림책배포,http://www.seoulfn.com/news/articleView.html?idxno=390487
5261,2020-07-29,단독대웅제약나보타중국임상3상속도다음달인체투약돌입,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020072915335362792
5262,2020-07-29,대웅제약발달장애인위한의사소통그림책배포,http://www.wsobi.com/news/articleView.html?idxno=102015
5263,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책제작배포,http://news.mk.co.kr/newsRead.php?no=777263&year=2020
5264,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.lawissue.co.kr/view.php?ud=202007291814509545204ead0791_12
5265,2020-07-29,마지막동아줄마저대웅제약아직도맞을매남았다,http://ilyo.co.kr/?ac=article_view&entry_id=376052
5266,2020-07-29,대웅제약보톡스나보타다음달中서인체투약시작,https://www.asiatoday.co.kr/view.php?key=20200729010018141
5267,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.thefirstmedia.net/news/articleView.html?idxno=61136
5268,2020-07-30,뉴스투데이L대웅제약발달장애인위한질병표현돕는의사소통그림책배포,https://www.news2day.co.kr/157604
5269,2020-07-30,대웅제약발달장애인위한의사소통그림책배포,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001307
5270,2020-07-30,대웅제약아박타줄기세포치료제개발등제휴확대,http://www.medisobizanews.com/news/articleView.html?idxno=71572
5271,2020-07-30,대웅제약발달장애인위한질병표현돕는의사소통그림책배포,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247311
5272,2020-07-30,대웅제약신풍제약제약주갑작스런급등대웅제약7급등이어신풍제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=130497
5273,2020-07-30,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1404212
5274,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.lawissue.co.kr/view.php?ud=202007301001325816204ead0791_12
5275,2020-07-30,대웅제약나보타수면중이갈이완화효과입증,https://www.ebn.co.kr/news/view/1444747/?sc=Naver
5276,2020-07-30,대웅제약 나보타 연구자임상통해수면중이갈이증상완화효과입증,http://www.greened.kr/news/articleView.html?idxno=263056
5277,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020073009595529380
5278,2020-07-30,대웅제약나보타이갈이증상완화에도효과연구자임상결과발표,https://www.sedaily.com/NewsView/1Z5I690S04
5279,2020-07-30,대웅제약나보타수면중이갈이증상완화입증연구자임상결과발표,http://www.pressm.kr/news/articleView.html?idxno=31806
5280,2020-07-30,대웅제약나보타연구자임상서수면이갈이완화확인,http://www.newsis.com/view/?id=NISX20200730_0001112848&cID=13001&pID=13000
5281,2020-07-30,대웅제약나보타수면중이갈이완화효과입증,http://www.medisobizanews.com/news/articleView.html?idxno=71588
5282,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.getnews.co.kr/view.php?ud=2020073010172824332fe691f917_16
5283,2020-07-30,대웅제약나보타수면중이갈이증상완화에효과,http://daily.hankooki.com/lpage/industry/202007/dh20200730101936148390.htm?s_ref=nv
5284,2020-07-30,대웅제약보툴리눔톡신나보타수면이갈이증상완화,http://yna.kr/AKR20200730062200017?did=1195m
5285,2020-07-30,대웅제약보톡스나보타수면중이갈이증상완화효과확인,http://www.metroseoul.co.kr/article/20200730500075
5286,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,https://www.fetv.co.kr/news/article.html?no=60352
5287,2020-07-30,특징주대웅제약나보타수면중이갈이완화효과입증소식에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020073010278055944
5288,2020-07-30,대웅제약나보타임상결과수면중이갈이증상해소입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=49753
5289,2020-07-30,보톡스약으로이갈이치료효과확인한대웅제약,http://news.mt.co.kr/mtview.php?no=2020073010304943645
5290,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://www.newsprime.co.kr/news/article.html?no=512775
5291,2020-07-30,대웅제약나보타수면중이갈이증상완화효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=13845
5292,2020-07-30,대웅제약나보타수면중이갈이에도효과,https://view.asiae.co.kr/article/2020073010353014033
5293,2020-07-30,대웅제약나보타수면중이갈이증상완화연구논문나와,http://www.kpinews.co.kr/news/articleView.html?idxno=122621
5294,2020-07-30,대웅제약나보타수면중이갈이완화효과입증,https://www.asiatime.co.kr/news/newsview.php?ncode=1065575464856794
5295,2020-07-30,대웅제약미용치료제나보타수면중이갈이증상완화확인,http://www.dt.co.kr/contents.html?article_no=2020073002109931102001&ref=naver
5296,2020-07-30,오늘의제약한미약품동아STGC녹십자녹십자홀딩스동아제약광동제약대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=38296
5297,2020-07-30,대웅제약임상통해나보타수면중이갈이완화효과입증,http://www.m-i.kr/news/articleView.html?idxno=733760
5298,2020-07-30,특징주대웅제약나보타수면중이갈이완화효과입증에강세,https://www.asiatoday.co.kr/view.php?key=20200730010018418
5299,2020-07-30,대웅제약보툴리눔톡신나보타의수면중이갈이연구결과SCI급학술지게재,http://news.mk.co.kr/newsRead.php?no=779374&year=2020
5300,2020-07-30,대웅제약나보타수면중이갈이증상완화효과,http://www.bosa.co.kr/news/articleView.html?idxno=2131492
5301,2020-07-30,이갈이완화효과입증소식에대웅제약강세,https://biz.chosun.com/site/data/html_dir/2020/07/30/2020073001543.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5302,2020-07-30,대웅제약보톡스나보타수면중이갈이개선입증,http://health.chosun.com/site/data/html_dir/2020/07/30/2020073001561.html
5303,2020-07-30,대웅제약나보타이갈이증상완화효과입증,http://www.viva100.com/main/view.php?key=20200730010006043
5304,2020-07-30,대웅제약나보타수면중이갈이증상완화효과확인,https://www.etoday.co.kr/news/view/1923891
5305,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020073010462406480
5306,2020-07-30,대웅제약나보타수면중이갈이증상완화에효과,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4232862
5307,2020-07-30,대웅제약나보타연구자임상서수면이갈이완화확인,http://inthenews.co.kr/article-61616/
5308,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증치료시장확대잠재력,http://www.thepublic.kr/news/newsview.php?ncode=1065575463801488
5309,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증”,http://www.youthdaily.co.kr/news/article.html?no=43330
5310,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247336
5311,2020-07-30,대웅제약나보타수면이갈이증상완화효과입증,http://www.press9.kr/news/articleView.html?idxno=45426
5312,2020-07-30,대웅제약보툴리눔톡신나보타수면중이갈이증상완화,http://www.econovill.com/news/articleView.html?idxno=406501
5313,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://newsbrite.net/140027
5314,2020-07-30,대웅제약보툴리눔나보타수면중이갈이증상완화효과입증,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007300195&t=NN
5315,2020-07-30,대웅제약보툴리눔톡신나보타수면이갈이증상완화,http://www.topstarnews.net/news/articleView.html?idxno=823686
5316,2020-07-30,대웅제약英아박타와코로나치료제개발추진,https://www.theguru.co.kr/news/article.html?no=12858
5317,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=394724
5318,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62568
5319,2020-07-30,대웅제약보톨리늄톡신나보타투여하면이갈이증상줄어든다,https://www.news1.kr/articles/?4011555
5320,2020-07-30,중국서활로찾는국산보톡스휴젤대웅제약꽃길걸을까,http://www.viva100.com/main/view.php?key=20200730010006038
5321,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.sisaweek.com/news/articleView.html?idxno=136237
5322,2020-07-30,대웅제약나보타수면이갈이증상완화확인,http://www.seoulfn.com/news/articleView.html?idxno=390581
5323,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=30673
5324,2020-07-30,잠잘때이갈이줄어요대웅제약나보타이갈이감소효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020073010408020325
5325,2020-07-30,추가적인치료제개발가능성확인”대웅제약나보타수면중이갈이완화효과입증,https://www.donga.com/news/article/all/20200730/102229956/1
5326,2020-07-30,대웅제약나보타연구자임상서수면중이갈이완화효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=29942
5327,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=411298
5328,2020-07-30,대웅제약나보타수면중이갈이증상완화에도효과적,https://www.asiatoday.co.kr/view.php?key=20200730010018757
5329,2020-07-30,대웅제약나보타수면중이갈이감소효과입증,http://www.koreastocknews.com/news/articleView.html?idxno=55864
5330,2020-07-30,대웅제약나보타수면중이갈이환자에효과입증,http://www.mediapen.com/news/view/544850
5331,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://kormedi.com/?p=1321409
5332,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,https://www.dailian.co.kr/news/view/909107/?sc=Naver
5333,2020-07-30,대웅제약나보타수면중이갈이완화효과,http://www.dailymedi.com/detail.php?number=858767&thread=22r05
5334,2020-07-30,대웅제약나보타수면중이갈이증상완화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001329
5335,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1404429
5336,2020-07-30,대웅제약2분기매출2259억영업손실47억,http://www.edaily.co.kr/news/newspath.asp?newsid=04188566625839768
5337,2020-07-30,대웅제약2Q영업손실47억원적자전환,http://www.ftoday.co.kr/news/articleView.html?idxno=204495
5338,2020-07-30,대웅제약2Q영업손실47억원적자전환,http://www.ftoday.co.kr/news/articleView.html?idxno=204495
5339,2020-07-30,대웅제약2분기영업손실47억적자전환,http://www.dailypharm.com/Users/News/NewsView.html?ID=267084&REFERER=NP
5340,2020-07-30,대웅제약2분기영업손실47억원적자전환,https://biz.chosun.com/site/data/html_dir/2020/07/30/2020073003723.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5341,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://www.seoulwire.com/news/articleView.html?idxno=422328
5342,2020-07-30,대웅제약2분기매출액2260억원전년대비142감소,http://medipana.com/news/news_viewer.asp?NewsNum=260751&MainKind=A&NewsKind=5&vCount=12&vKind=1
5343,2020-07-30,공시대웅제약2분기영업손실47억적자전환,http://www.newsway.co.kr/news/view?tp=1&ud=2020073017532362615
5344,2020-07-30,대웅제약실적타격에도RD투자확대,http://www.press9.kr/news/articleView.html?idxno=45431
5345,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://www.econovill.com/news/articleView.html?idxno=406573
5346,2020-07-30,대웅제약2분기실적발표적극적인RD투자로성장동력육성,http://www.lawissue.co.kr/view.php?ud=202007301754573843204ead0791_12
5347,2020-07-30,대웅제약2분기47억원영업손실라니티딘성분약판매중지소송비용등영향,https://www.sedaily.com/NewsView/1Z5I71S5NA
5348,2020-07-30,대웅제약2분기매출2260억원전년대비142감소,http://www.medisobizanews.com/news/articleView.html?idxno=71615
5349,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=04208246625839768
5350,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://news.mk.co.kr/newsRead.php?no=782347&year=2020
5351,2020-07-30,대웅제약2Q실적영업손실47억원RD비용296억원,http://www.mediapen.com/news/view/545093
5352,2020-07-30,코로나19소송비용에대웅제약2분기영업손실47억원적자전환,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020073017535153899
5353,2020-07-30,대웅제약2Q영업손실47억위장약판매중지조치연구개발비증가,http://www.newspim.com/news/view/20200730001216
5354,2020-07-30,대웅제약2분기영업손실47억원소송비영향적자전환,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007300394&t=NN
5355,2020-07-30,대웅제약2분기영업손실47억불순물악재등여파,http://www.dailypharm.com/Users/News/NewsView.html?ID=267087&REFERER=NP
5356,2020-07-30,대웅제약2Q영업익적자전환매출액도142감소,https://www.news1.kr/articles/?4012165
5357,2020-07-30,대웅제약2Q영업손실47억RD투자확대,http://www.newsis.com/view/?id=NISX20200730_0001113803&cID=13001&pID=13000
5358,2020-07-30,대웅제약2분기매출액2260억원전년比142감소,http://health.chosun.com/site/data/html_dir/2020/07/30/2020073003809.html
5359,2020-07-30,대웅제약2분기매출2260억전년比142감소영업이익적자전환,http://www.joseilbo.com/news/news_read.php?uid=403165&class=27&grp=
5360,2020-07-30,적자전환대웅제약2Q순손실눈에띄네,https://www.paxnetnews.com/articles/63662
5361,2020-07-30,나보타소송영향대웅제약2분기영업익매출모두감소,http://www.wikileaks-kr.org/news/articleView.html?idxno=92066
5362,2020-07-30,대웅제약2Q영업손실47억원적자전환,http://inthenews.co.kr/article-61705/
5363,2020-07-30,대웅제약2분기매출2259억영업손실47억적자전환,https://www.dailian.co.kr/news/view/909154/?sc=Naver
5364,2020-07-30,대웅제약2분기영업손실47억원으로적자전환,https://www.hankyung.com/finance/article/202007307219i
5365,2020-07-30,대웅제약소송후유증2분기실적적자전환,http://www.upinews.kr/newsView/upi202007300091
5366,2020-07-30,대웅제약2분기영업손실47억원RD투자비용증가,http://www.viva100.com/main/view.php?key=20200730010006204
5367,2020-07-30,대웅제약2분기적자전환에도RD투자22늘려,http://news.mt.co.kr/mtview.php?no=2020073018032765296
5368,2020-07-30,대웅제약2분기영업손실47억적자전환,http://www.newsprime.co.kr/news/article.html?no=512893
5369,2020-07-30,대웅제약2분기영업손실47억전년동기대비적자전환,http://yna.kr/AKR20200730172600017?did=1195m
5370,2020-07-30,대웅제약2분기영업손실47억원알비스판매중지나보타소송비용영향,https://www.news2day.co.kr/157671
5371,2020-07-30,대웅제약2Q영업손실47억기록RD증가와코로나영향,http://www.m-i.kr/news/articleView.html?idxno=734097
5372,2020-07-30,대웅제약2분기영업손실47억코로나19소송비용등영향”,http://www.newsway.co.kr/news/view?tp=1&ud=2020073018140479535
5373,2020-07-30,대웅제약2분기영업손실47억적자전환,https://view.asiae.co.kr/article/2020073018353620941
5374,2020-07-30,대웅제약2Q영업손실47억원적자전환,http://it.chosun.com/site/data/html_dir/2020/07/30/2020073003923.html
5375,2020-07-30,대웅제약2분기영업손실47억적자전환,http://www.mdtoday.co.kr/mdtoday/index.html?no=394812
5376,2020-07-30,대웅제약2분기영업손실47억적자전환,https://www.ebn.co.kr/news/view/1444901/?sc=Naver
5377,2020-07-30,대웅제약2Q영업손실47억원RD투자비용증가”,http://www.youthdaily.co.kr/news/article.html?no=43387
5378,2020-07-30,나보타소송비용에대웅제약2분기영업익적자전환,http://news.mk.co.kr/newsRead.php?no=782476&year=2020
5379,2020-07-30,대웅제약2분기적자불구RD투자221↑,https://www.donga.com/news/article/all/20200730/102236657/1
5380,2020-07-30,대웅제약2Q영업손실47억,http://www.seoulfn.com/news/articleView.html?idxno=390667
5381,2020-07-30,뉴스투데이L대웅제약나보타수면중이갈이증상완화효과입증,https://www.news2day.co.kr/157674
5382,2020-07-30,대웅제약2분기매출액은2260억원영업손실47억원,http://newsbrite.net/140046
5383,2020-07-30,대웅제약2Q전년비매출14감소영업익적전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247363
5384,2020-07-30,대웅제약2분기영업손실47억원나보타소송비용등영향,http://www.cstimes.com/news/articleView.html?idxno=424491
5385,2020-07-30,대웅제약2분기영업손실47억적자전환,https://cnbc.sbs.co.kr/article_hub/10000991398?division=NAVER
5386,2020-07-30,대웅제약2분기매출2260억전년比142↓,https://www.fetv.co.kr/news/article.html?no=60423
5387,2020-07-30,대웅제약자체보툴리눔톡의수면이갈이완화효과인정받아,http://www.businesspost.co.kr/BP?command=article_view&num=189786
5388,2020-07-30,대웅제약의약품판매중지와소송비용영향으로2분기적자전환,http://www.businesspost.co.kr/BP?command=article_view&num=189819
5389,2020-07-30,대웅제약보툴리눔톡신나보타연구자임상서수면이갈이완화확인연세대치과대학구강내과김성택교수팀연구진행,http://www.econonews.co.kr/news/articleView.html?idxno=130587
5390,2020-07-30,대웅제약 2Q영업익47억원적자전환RD296억원전년比221↑,http://www.greened.kr/news/articleView.html?idxno=263220
5391,2020-07-30,대웅제약2분기적자전환에도RD투자증가,http://www.medigatenews.com/news/3124293216
5392,2020-07-30,대웅제약2분기적자전환에도RD투자증가,http://www.medigatenews.com/news/1033552913
5393,2020-07-30,대웅제약2분기영업손실48억적자전환,http://www.biospectator.com/view/news_view.php?varAtcId=10962
5394,2020-07-30,대웅제약2분기매출액2260억원지난해보다142감소,http://daily.hankooki.com/lpage/industry/202007/dh20200730233719148390.htm?s_ref=nv
5395,2020-07-31,대웅제약적극적인RD투자로성장동력육성,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62586
5396,2020-07-31,KBiz리뷰대웅제약줄기세포활용코로나19치료제개발추진7월31일,https://www.theguru.co.kr/news/article.html?no=12876
5397,2020-07-31,대웅제약2020년2분기실적보다는소송관련불확실성,http://www.g-enews.com/ko-kr/news/article/news_all/20200731070105926442088f476_1/article.html
5398,2020-07-31,대웅제약나보타미용성형넘어치료시장진출타진,http://www.edaily.co.kr/news/newspath.asp?newsid=01715446625840096
5399,2020-07-31,특징주대웅제약2분기적자전환에약세,http://www.seoulfn.com/news/articleView.html?idxno=390691
5400,2020-07-31,특징주대웅제약2분기적자전환에약세,http://www.inews24.com/view/1286669
5401,2020-07-31,대웅제약2Q영업손실47억원전년比적자전환,http://www.getnews.co.kr/view.php?ud=2020073109350560422fe691f917_16
5402,2020-07-31,대웅제약2분기매출액2260억원전년비142↓,http://www.bokuennews.com/news/article.html?no=193143
5403,2020-07-31,대웅제약2분기영업손실47억원적자전환,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572355111440
5404,2020-07-31,오늘의제약2분기실적발표​GC녹십자대웅제약유비케어제이브이엠,http://www.babytimes.co.kr/news/articleView.html?idxno=38332
5405,2020-07-31,오늘의제약2분기실적발표​GC녹십자대웅제약유비케어제이브이엠,http://www.babytimes.co.kr/news/articleView.html?idxno=38332
5406,2020-07-31,대웅제약적극적인RD투자성장동력육성노력,http://www.pressm.kr/news/articleView.html?idxno=31861
5407,2020-07-31,대웅제약우루사뉴트로마케팅으로MZ세대공략,http://www.ajunews.com/view/20200731094649483
5408,2020-07-31,대웅제약미래신약개발핵심오픈콜라보레이션확대나서,http://www.newslock.co.kr/news/articleView.html?idxno=29951
5409,2020-07-31,대웅제약2분기적자전환영업손실47억,http://www.koreastocknews.com/news/articleView.html?idxno=55885
5410,2020-07-31,대웅제약2분기실적발표영업손실47억원적자전환,http://www.updownnews.co.kr/news/articleView.html?idxno=221542
5411,2020-07-31,대웅제약2분기RD에만300억투자,http://www.whosaeng.com/119873
5412,2020-07-31,대웅제약2분기매출액2260억원전년동기대비142감소,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119924
5413,2020-07-31,대웅제약2분기실적발표적극적인RD투자로성장동력육성,http://www.nbnnews.co.kr/news/articleView.html?idxno=411615
5414,2020-07-31,적극적RD투자성장동력육성에대웅제약2분기전년동기比적자전환,http://www.betanews.net:8080/article/1215556.html
5415,2020-07-31,대웅제약소송코로나19전방위직격탄2Q영업익적자전환,http://moneys.mt.co.kr/news/mwView.php?no=2020073018298055965
5416,2020-07-31,대웅제약이제약바이오엑셀러레이터사업진출한까닭은,http://www.insightkorea.co.kr/news/articleView.html?idxno=81689
5417,2020-07-31,대웅제약2분기영업손실47억원적자전환,http://www.wolyo.co.kr/news/articleView.html?idxno=107630
5418,2020-08-01,연재기획②대웅제약vs메디톡스보툴리눔균주출처톺아보기,http://newsclaim.co.kr/View.aspx?No=930494
5419,2020-08-01,대웅제약질병표현을돕는의사소통그림책배포,http://weekly.cnbnews.com/news/article.html?no=135210
5420,2020-08-01,대웅제약나보타수면중이갈이치료효과입증,http://weekly.cnbnews.com/news/article.html?no=135216
5421,2020-08-02,KBiz리뷰LG화학LG전자美전기차부품공장인수대웅제약英아박타와코로나치료제개발7월4주차,https://www.theguru.co.kr/news/article.html?no=12934
5422,2020-08-02,K진단키트금주의진단키트소식은대웅제약엑세스바이오앤디포스,http://www.seoulwire.com/news/articleView.html?idxno=422453
5423,2020-08-02,정부치매극복기술지원한다면SK케미칼신신제약이연제약대웅제약환인제약에시선,http://www.pinpointnews.co.kr/view.php?ud=202008021431148687861beb2d9d_45
5424,2020-08-03,대웅제약펙수프라잔적응증확대매출효자되나,http://www.press9.kr/news/articleView.html?idxno=45433
5425,2020-08-03,의약품생산5년간연평균71성장제조업의3배생산실적TOP5는한미약품종근당대웅제약녹십자셀트리온,http://www.topstarnews.net/news/articleView.html?idxno=824388
5426,2020-08-03,대웅제약연이은악재에올해1조클럽유지불투명,http://www.sisajournal-e.com/news/articleView.html?idxno=221959
5427,2020-08-03,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=61261
5428,2020-08-03,대웅제약2분기실적발표적극적인RD투자로성장동력육성,http://www.thefirstmedia.net/news/articleView.html?idxno=61256
5429,2020-08-04,펄펄끓는코로나주왜종근당유한양행웃고한미약품대웅제약울고씨젠신풍제약은,http://www.pinpointnews.co.kr/view.php?ud=202008041547205017861beb2d9d_45
5430,2020-08-05,악재겹친대웅제약하반기에는회복될까,https://www.asiatime.co.kr/news/newsview.php?ncode=1065592063611426
5431,2020-08-05,특징주종근당유한양행웃고한미약품대웅제약울고제약바이오株주가희비갈렸다,http://www.ccreview.co.kr/news/articleView.html?idxno=276117
5432,2020-08-05,더벨대웅제약적자전환감내하고RD비용늘린까닭,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202008031514056240106863
5433,2020-08-05,단독공정위대웅제약심판대올린다부당특허소송남발,http://www.etnews.com/20200805000229
5434,2020-08-06,대웅대웅제약오후갑자기가파른상승대웅제약2상승이어대웅5상승,http://www.econonews.co.kr/news/articleView.html?idxno=131412
5435,2020-08-06,대웅제약종근당상한가에급락으로희비엇갈려대웅제약상한가반해종근당6급락,http://www.econonews.co.kr/news/articleView.html?idxno=131418
5436,2020-08-06,대웅제약국내외제약바이오기업과개방형협력신약개발박차,http://www.100ssd.co.kr/news/articleView.html?idxno=70519
5437,2020-08-06,주식대웅대웅제약오후갑작스런급등상한가달성 그이유는,http://www.ggilbo.com/news/articleView.html?idxno=788048
5438,2020-08-06,니클로사마이드관련주대웅제약대웅과동반급등,http://www.ccreview.co.kr/news/articleView.html?idxno=276416
5439,2020-08-06,6일오늘의상한가종목총정리대웅대웅제약등코로나19제약바이오주급등,http://www.ccreview.co.kr/news/articleView.html?idxno=276419
5440,2020-08-06,보톡스에라니티딘사태까지실적뚝대웅제약1조클럽위태,http://www.enewstoday.co.kr/news/articleView.html?idxno=1405923
5441,2020-08-06,대웅제약우루사뉴트로마케팅으로MZ세대공략,http://www.econovill.com/news/articleView.html?idxno=407401
5442,2020-08-07,니클라소마이드관련주대웅대웅제약장초반하락세코로나효과매우우수,http://www.ccreview.co.kr/news/articleView.html?idxno=276661
5443,2020-08-07,대웅제약ITC예비결정문분석조목조목반박이의신청서제출,http://www.pressm.kr/news/articleView.html?idxno=32096
5444,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류조목조목반박,http://newsbrite.net/140247
5445,2020-08-07,대웅대웅제약급등하루만에하락에급락까지특히대웅제약갑작스런7급락,http://www.econonews.co.kr/news/articleView.html?idxno=131454
5446,2020-08-07,대웅제약ITC에이의신청예비결정문편향왜곡의극치”,http://daily.hankooki.com/lpage/industry/202008/dh20200807090921148390.htm?s_ref=nv
5447,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡극치”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247642
5448,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류반박,https://biz.chosun.com/site/data/html_dir/2020/08/07/2020080700969.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5449,2020-08-07,대웅제약ITC예비판결문편향과왜곡의극치,http://medipana.com/news/news_viewer.asp?NewsNum=261055&MainKind=A&NewsKind=5&vCount=12&vKind=1
5450,2020-08-07,ITC예비판결문전문공개에대웅제약영업비밀침해했다는구체적근거없어,https://www.sedaily.com/NewsView/1Z6HJNKYWQ
5451,2020-08-07,대웅제약ITC예비결정은편향왜곡의극치,http://www.medisobizanews.com/news/articleView.html?idxno=71791
5452,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치,https://www.hankyung.com/it/article/202008072906i
5453,2020-08-07,대웅제약美ITC에예비결정문이의신청서제출,https://www.paxnetnews.com/articles/63958
5454,2020-08-07,대웅제약ITC예비결정문편향왜곡됐다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94088
5455,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62684
5456,2020-08-07,대웅제약ITC에이의신청서제출예비결정편향과왜곡의극치”,http://www.viva100.com/main/view.php?key=20200807010001283
5457,2020-08-07,대웅제약ITC에이의신청서제출예비결정에중대한오류반박,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020080709540165768
5458,2020-08-07,대웅제약ITC에이의신청예비결정오류반박,http://www.mediapen.com/news/view/546940
5459,2020-08-07,대웅제약ITC에이의신청제출구체증거없는명백한오판,http://www.newsis.com/view/?id=NISX20200807_0001121835&cID=13001&pID=13000
5460,2020-08-07,대웅제약美ITC에이의신청서제출,http://www.medigatenews.com/news/2097723041
5461,2020-08-07,대웅제약ITC명백한오판11월반드시승소할것,http://www.koreastocknews.com/news/articleView.html?idxno=56071
5462,2020-08-07,대웅제약ITC예비결정문분석증거없이추론에기반한결론,http://www.press9.kr/news/articleView.html?idxno=45477
5463,2020-08-07,대웅제약美ITC에이의신청서제출예비판결문오류반박,http://it.chosun.com/site/data/html_dir/2020/08/07/2020080701307.html
5464,2020-08-07,메디톡스대웅제약2차전예고ICT에공식이의신청,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135134&REFERER=NP
5465,2020-08-07,대웅제약ITC에이의신청예비결정문편향과왜곡의극치,http://www.seoulwire.com/news/articleView.html?idxno=423237
5466,2020-08-07,대웅제약ITC에이의신청예비판결문편향왜곡극치,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008070154&t=NN
5467,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치,http://www.dailysmart.co.kr/news/articleView.html?idxno=31069
5468,2020-08-07,ITC예비판결명백한오판대웅제약ITC에이의신청서제출,http://moneys.mt.co.kr/news/mwView.php?no=2020080709598052183
5469,2020-08-07,대웅제약ITC예비결정편향과왜곡의극치진실가려질것,http://www.newspim.com/news/view/20200807000228
5470,2020-08-07,대웅제약ITC에이의신청서제출예비결정문편향과왜곡의극치”,https://www.dailian.co.kr/news/view/910899/?sc=Naver
5471,2020-08-07,편향과왜곡의극치대웅제약ITC에이의신청서제출,http://www.newsprime.co.kr/news/article.html?no=513739
5472,2020-08-07,대웅제약미ITC예비판결문편향과왜곡뒤집힐가능성있어,http://yna.kr/AKR20200807056800017?did=1195m
5473,2020-08-07,대웅제약美ITC에이의신청명백한오판이다,https://www.asiatoday.co.kr/view.php?key=20200807010003738
5474,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류반박,http://www.youthdaily.co.kr/news/article.html?no=44026
5475,2020-08-07,대웅제약미ITC예비판결문편향왜곡됐다,http://www.ekn.kr/news/article.html?no=515940
5476,2020-08-07,대웅제약미ITC자국산업보호위해무리수남발,http://www.bosa.co.kr/news/articleView.html?idxno=2131971
5477,2020-08-07,대웅제약메디톡스영업비밀침해소송관련 미ITC예비판결문편향과왜곡”,https://www.seoul.co.kr/news/newsView.php?id=20200807500071&wlog_tag3=naver
5478,2020-08-07,대웅제약ITC에이의신청서제출예비결정문편향적,http://www.newstomato.com/ReadNews.aspx?no=988836
5479,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치추론기반한부당판결,http://www.startuptoday.co.kr/news/articleView.html?idxno=50084
5480,2020-08-07,대웅제약ITC예비결정문분석증거없이추론에기반한결론,http://www.insightkorea.co.kr/news/articleView.html?idxno=81888
5481,2020-08-07,美ITC대웅제약균주메디톡스서왔다”,https://www.hankyung.com/it/article/202008073447i
5482,2020-08-07,대웅제약대웅장중주가급락무슨일,http://www.choicenews.co.kr/news/articleView.html?idxno=73440
5483,2020-08-07,대웅제약메디톡스손들어준美ITC예비판결문에편향과왜곡의극치,http://news.mk.co.kr/newsRead.php?no=810586&year=2020
5484,2020-08-07,대웅제약ITC예비결정문편향왜곡극치이의신청서제출,http://www.sisafocus.co.kr/news/articleView.html?idxno=245099
5485,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치,http://www.pharmnews.com/news/articleView.html?idxno=101068
5486,2020-08-07,대웅제약ITC예비결정구체적인증거없어추론에기반한결론에불과,http://www.ceoscoredaily.com/news/article.html?no=72204
5487,2020-08-07,대웅제약ITC보툴리눔톡신예비판결왜곡됐다,https://hankookilbo.com/News/Read/A2020080709240005986?did=NA
5488,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치”,http://www.econovill.com/news/articleView.html?idxno=407473
5489,2020-08-07,대웅제약미국ITC보톡스예비판결문편향과왜곡뒤집힐가능성있어,http://www.topstarnews.net/news/articleView.html?idxno=825348
5490,2020-08-07,특징주대웅제약메디톡스美ITC예비판결문공개로또희비교차,http://news.mk.co.kr/newsRead.php?no=810738&year=2020
5491,2020-08-07,대웅제약ITC에이의신청서제출편향과왜곡의극치,http://www.ezyeconomy.com/news/articleView.html?idxno=103931
5492,2020-08-07,대웅제약美ITC예비결정오판이의신청제출,http://www.dailypharm.com/Users/News/NewsView.html?ID=267263&REFERER=NP
5493,2020-08-07,ITC예비결정문조목조목반박한대웅제약편향왜곡의극치”,http://www.segye.com/content/html/2020/08/07/20200807508489.html?OutUrl=naver
5494,2020-08-07,대웅제약편향과왜곡극치ITC예비결정문맹비난,http://www.wikileaks-kr.org/news/articleView.html?idxno=92527
5495,2020-08-07,대웅대웅제약하락에폭락으로무너지는주가대웅5하락이어대웅제약10폭락,http://www.econonews.co.kr/news/articleView.html?idxno=131555
5496,2020-08-07,ITC메디톡스대웅제약보톡스분쟁예비판결문공개,http://news.mk.co.kr/newsRead.php?no=811020&year=2020
5497,2020-08-07,대웅제약ITC예비결정반박편향과왜곡의극치,http://www.monews.co.kr/news/articleView.html?idxno=212588
5498,2020-08-07,대웅제약ITC예비결정문편향적이고왜곡많아이의신청서제출,http://www.newslock.co.kr/news/articleView.html?idxno=30149
5499,2020-08-07,대웅제약美ITC에이의신청서제출예비판결문편향과왜곡의극치”,http://inthenews.co.kr/article-62945/
5500,2020-08-07,대웅제약미ITC예비판결오판이의신청제출”,http://www.newsway.co.kr/news/view?tp=1&ud=2020080714200695096
5501,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치”,http://www.pinpointnews.co.kr/view.php?ud=202008071420498070f090c8dbcb_45
5502,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치주장,http://www.newsfc.co.kr/news/articleView.html?idxno=42196
5503,2020-08-07,대웅제약ITC예비결정편향왜곡의극치이의신청,http://news.mt.co.kr/mtview.php?no=2020080714312145796
5504,2020-08-07,대웅제약ITC결정문중대한오류발견이의신청,http://www.upinews.kr/newsView/upi202008070032
5505,2020-08-07,대웅제약ITC에이의신청서제출예비결정문분석결과편향과왜곡의극치”,http://www.mdtoday.co.kr/mdtoday/index.html?no=395522
5506,2020-08-07,대웅제약미국국제무역위예비결정문에중대오류이의신청서제출,http://www.businesspost.co.kr/BP?command=article_view&num=190910
5507,2020-08-07,대웅제약ITC예비결정은사실을편향왜곡해11월최종결정에서승소할것”,https://jhealthmedia.joins.com/article/article_view.asp?pno=22217
5508,2020-08-07,美ITC대웅제약균주메디톡스서왔다”대웅이의신청서제출,http://www.edaily.co.kr/news/newspath.asp?newsid=02847046625865024
5509,2020-08-07,美ITC대웅제약메디톡스보톡스균주유전적으로유사,https://www.hankyung.com/it/article/202008074390i
5510,2020-08-07,美ITC대웅제약균주메디톡스에서왔다,http://www.whitepaper.co.kr/news/articleView.html?idxno=196307
5511,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치,http://www.nbnnews.co.kr/news/articleView.html?idxno=413624
5512,2020-08-07,대웅제약ITC예비판결탄핵추진ITC행정판사미국기업엘러간편들어,https://www.news2day.co.kr/158210
5513,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치”,http://www.getnews.co.kr/view.php?ud=2020080715512514962fe691f917_16
5514,2020-08-07,美ITC대웅제약메디톡스균주6개돌연변이일치,https://www.hankyung.com/finance/article/202008074806i
5515,2020-08-07,대웅제약ITC예비결정문은편향과왜곡의극치,http://www.m-i.kr/news/articleView.html?idxno=736150
5516,2020-08-07,美ITC대웅제약균주메디톡스서왔다대웅이의신청종합,https://www.hankyung.com/finance/article/202008075062i
5517,2020-08-07,대웅제약美ITC예비판결문편향왜곡뒤집힐수도,http://www.seoulfn.com/news/articleView.html?idxno=391454
5518,2020-08-07,편향과왜곡의극치주장ITC에먹힐까대웅제약메디톡스에반전승리노려,http://www.thevaluenews.co.kr/news/view.php?idx=160426
5519,2020-08-07,美ITC대웅제약보톡스균주메디톡스와동일,https://www.hankyung.com/it/article/2020080751371
5520,2020-08-07,대웅제약ITC나보타수입금지예비결정편향극치vs메디톡스증거기반과학적결론,http://www.ltn.kr/news/articleView.html?idxno=29249
5521,2020-08-07,미국ITC대웅제약나보타10년수입금지예비결정대웅제약메디톡스에미칠영향은,http://www.ltn.kr/news/articleView.html?idxno=29248
5522,2020-08-07,메디톡스대웅제약수년째보톡스전쟁두회사간무슨일이,http://www.ltn.kr/news/articleView.html?idxno=29247
5523,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류조목조목반박,http://www.thefirstmedia.net/news/articleView.html?idxno=61425
5524,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡극치,https://www.kpanews.co.kr/article/show.asp?idx=215236&category=D
5525,2020-08-08,대웅제약ITC에예비판정오류조목조목반박이의신청서제출편향왜곡의극치,http://www.updownnews.co.kr/news/articleView.html?idxno=221828
5526,2020-08-08,연재기획③대웅제약vs메디톡스톺아보기ITC소송이노톡스상관관계,http://newsclaim.co.kr/View.aspx?No=1043249
5527,2020-08-08,ITC예비결정문공개에다시불붙는대웅제약메디톡스진실공방,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001591
5528,2020-08-08,대웅제약ITC예비결정문은편향과왜곡의극치,http://www.datasom.co.kr/news/articleView.html?idxno=107661
5529,2020-08-08,대웅제약美ITC예비판결불복편향과왜곡의극치”이의신청서제출,http://www.thepublic.kr/news/newsview.php?ncode=1065597850491339
5530,2020-08-08,지난주제약업계주요이슈대웅제약보툴리눔톡신관련ITC예비결정오류발견반박外,http://www.youthdaily.co.kr/news/article.html?no=44087
5531,2020-08-09,대웅제약미ITC예비결정은편향과왜곡의극치,http://www.legaltimes.co.kr/news/articleView.html?idxno=54815
5532,2020-08-10,대웅대웅제약지지부진한주가대웅제약2하락이어대웅소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=131768
5533,2020-08-10,메디톡스美ITC증거사실로대웅제약균주도용혐의입증,http://www.medisobizanews.com/news/articleView.html?idxno=71828
5534,2020-08-10,메디톡스美ITC과학적증거로대웅제약도용혐의입증,https://www.hankyung.com/it/article/202008100032i
5535,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약의도용혐의명백히입증”,http://www.pinpointnews.co.kr/view.php?ud=202008100913435161f090c8dbcb_45
5536,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의입증,http://biz.newdaily.co.kr/site/data/html/2020/08/10/2020081000023.html
5537,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의명백히입증”,https://www.fetv.co.kr/news/article.html?no=61035
5538,2020-08-10,메디톡스미국ITC대웅제약의균주제조공정도용혐의입증”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247697
5539,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약의균주도용혐의명백히입증,http://www.seoulwire.com/news/articleView.html?idxno=423439
5540,2020-08-10,메디톡스ITC대웅제약균주제조공정도용입증,https://www.ebn.co.kr/news/view/1446020/?sc=Naver
5541,2020-08-10,메디톡스ITC과학적증거와사실로대웅제약균주도용혐의입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020081009213771458
5542,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의입증”,http://www.viva100.com/main/view.php?key=20200810010001666
5543,2020-08-10,메디톡스美ITC대웅제약이자사균주및제조공정도용혐의입증,https://www.asiatoday.co.kr/view.php?key=20200810010004737
5544,2020-08-10,특징주대웅제약급락할까메디톡스대웅제약자체개발모두거짓,http://www.ccreview.co.kr/news/articleView.html?idxno=277080
5545,2020-08-10,메디톡스ITC대웅제약보툴리눔균주도용혐의명백히입증”,http://www.getnews.co.kr/view.php?ud=2020081009363053082fe691f917_16
5546,2020-08-10,메디톡스ITC대웅제약의균주제조공정도용혐의입증,http://medipana.com/news/news_viewer.asp?NewsNum=261113&MainKind=A&NewsKind=5&vCount=12&vKind=1
5547,2020-08-10,메디톡스美ITC대웅제약의도용혐의명백히입증대웅주장은거짓”,http://daily.hankooki.com/lpage/industry/202008/dh20200810094527148390.htm?s_ref=nv
5548,2020-08-10,메디톡스미국ITC과학적증거로대웅제약균주도용입증,http://yna.kr/AKR20200810041500017?did=1195m
5549,2020-08-10,메디톡스미국ITC과학적증거로대웅제약도용혐의명백히입증,http://www.ekn.kr/news/article.html?no=516292
5550,2020-08-10,메디톡스美ITC대웅제약균주도용혐의입증,http://www.newspim.com/news/view/20200810000219
5551,2020-08-10,메디톡스美ITC대웅제약균주도용혐의명백히입증이유살펴보니,https://www.etoday.co.kr/news/view/1927522
5552,2020-08-10,메디톡스美ITC과학적증거로대웅제약균주도용입증,https://view.asiae.co.kr/article/2020081010070726156
5553,2020-08-10,메디톡스美ITC과학적증거통해대웅제약도용혐의입증”,http://www.youthdaily.co.kr/news/article.html?no=44184
5554,2020-08-10,메디톡스ITC과학적증거와사실로대웅제약의메디톡스균주및제조공정도용혐의입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62703
5555,2020-08-10,메디톡스ITC예비판결문에대해대웅제약거짓드러나,http://www.wikileaks-kr.org/news/articleView.html?idxno=92632
5556,2020-08-10,美ITC예비판결문공개메디톡스균주도용명백입증vs대웅제약편향과왜곡의극치,http://www.babytimes.co.kr/news/articleView.html?idxno=38523
5557,2020-08-10,메디톡스美ITC예비판결문공개대웅제약균주도용사실입증,http://www.econovill.com/news/articleView.html?idxno=407674
5558,2020-08-10,메디톡스대웅제약주장은거짓美ITC가도용혐의명백히입증,http://www.sisafocus.co.kr/news/articleView.html?idxno=245279
5559,2020-08-10,메디톡스美ITC과학적증거로대웅제약균주도용혐의명백히입증,http://www.newsprime.co.kr/news/article.html?no=513925
5560,2020-08-10,메디톡스美ITC대웅제약메디톡스균주도용혐의명백히입증,http://www.medigatenews.com/news/2372213087
5561,2020-08-10,메디톡스ITC대웅제약균주제조공정도용혐의입증,http://news.tf.co.kr/read/economy/1806156.htm
5562,2020-08-10,메디톡스대웅제약ITC예비판결문두고설전,http://www.upinews.kr/newsView/upi202008100025
5563,2020-08-10,메디톡스ITC예비판결문공개대웅제약균주도용혐의명백히입증”,http://theviewers.co.kr/View.aspx?No=1044124
5564,2020-08-10,메디톡스미ITC과학적증거로대웅제약의균주도용혐의입증,http://www.cstimes.com/news/articleView.html?idxno=425711
5565,2020-08-10,메디톡스ITC대웅제약의도용과학적으로입증했다,https://hankookilbo.com/News/Read/A2020081009290000259?did=NA
5566,2020-08-10,메디톡스ITC예비판결문대웅제약균주도용과학적증거입증,http://isplus.live.joins.com/news/article/article.asp?total_id=23844902
5567,2020-08-10,메디톡스미국ITC과학적증거로대웅제약균주도용입증,http://www.seoulfn.com/news/articleView.html?idxno=391572
5568,2020-08-10,메디톡스미국ITC과학적증거로대웅제약균주도용입증,http://www.fntoday.co.kr/news/articleView.html?idxno=227616
5569,2020-08-10,대웅대웅제약상승에급등까지특히대웅갑작스런14급등에투자자들놀라,http://www.econonews.co.kr/news/articleView.html?idxno=131850
5570,2020-08-10,메디톡스과학적증거사실로대웅제약혐의입증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1307679
5571,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약도용혐의명백히입증,http://www.wolyo.co.kr/news/articleView.html?idxno=107940
5572,2020-08-10,메디톡스美ITC대웅제약의균주제조공정도용혐의입증”,http://www.mdtoday.co.kr/mdtoday/index.html?no=395618
5573,2020-08-10,메디톡스과학적증거로대웅제약균주도용혐의입증VS대웅제약추론기반한결론,http://www.segye.com/content/html/2020/08/10/20200810513421.html?OutUrl=naver
5574,2020-08-10,대웅제약균주와제조공정도용없어메디톡스보도자료조목조목반박,http://www.pressm.kr/news/articleView.html?idxno=32165
5575,2020-08-10,끝없는대웅제약메디톡스보톡스전쟁최종승자는,http://www.mediapen.com/news/view/547431
5576,2020-08-10,주식대웅대웅제약상승에급등까지훨훨특히대웅갑작스런22급등투자자들어머나,http://www.ggilbo.com/news/articleView.html?idxno=788614
5577,2020-08-10,대웅제약균주제조공정도용없어ITC편향왜곡결정,http://www.medisobizanews.com/news/articleView.html?idxno=71843
5578,2020-08-10,대웅제약균주제조공정도용없었다반박,https://www.ebn.co.kr/news/view/1446106/?sc=Naver
5579,2020-08-10,대웅제약메디톡스주장에반박균주와제조공정도용없어”,https://www.fetv.co.kr/news/article.html?no=61107
5580,2020-08-10,재반박나선대웅제약메디톡스ITC오판번역한억지주장”,http://daily.hankooki.com/lpage/industry/202008/dh20200810144119148390.htm?s_ref=nv
5581,2020-08-10,대웅제약균주및제조공정도용없어”메디톡스에자료공개촉구,http://www.viva100.com/main/view.php?key=20200810010001822
5582,2020-08-10,대웅제약균주와제조공정도용없어”,http://www.econovill.com/news/articleView.html?idxno=407724
5583,2020-08-10,대웅제약균주와제조공정도용없어재차반박하고나서,http://medipana.com/news/news_viewer.asp?NewsNum=261146&MainKind=A&NewsKind=5&vCount=12&vKind=1
5584,2020-08-10,대웅제약균주도용여부유전자분석으로는불가능,https://www.news1.kr/articles/?4021893
5585,2020-08-10,미국ITC판결문에메디톡스균주도용입증vs대웅제약편향과왜곡,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4243610
5586,2020-08-10,균주와제조공정도용없어대웅제약메디톡스보도자료반박,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62722
5587,2020-08-10,대웅제약균주제조공정도용없어메디톡스보도자료반박,https://www.hankyung.com/it/article/202008102008i
5588,2020-08-10,균주와제조공정도용없어대웅제약메디톡스보도자료반박,http://www.nbnnews.co.kr/news/articleView.html?idxno=414147
5589,2020-08-10,메디톡스ITC판결문대웅제약보톡스균주도용입증,http://www.seouleconews.com/news/articleView.html?idxno=56034
5590,2020-08-10,ITC예비결정문두고대립에재반박대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510937040
5591,2020-08-10,메디톡스vs대웅제약ITC예비결정문놓고또공방,http://news.mt.co.kr/mtview.php?no=2020081015173146434
5592,2020-08-10,메디톡스대웅제약ITC예비판결문놓고난타전,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008100334&t=NN
5593,2020-08-10,대웅제약균주제조공정도용없다”메디톡스에ITC제출자료공개촉구,http://www.youthdaily.co.kr/news/article.html?no=44239
5594,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의입증,http://www.todaykorea.co.kr/news/articleView.html?idxno=275151
5595,2020-08-10,대웅제약균주제조공정도용안했다메디톡스보도자료반박,http://www.mediapen.com/news/view/547576
5596,2020-08-10,대웅제약K바이오미국시장저지가이번소송본질,http://www.bosa.co.kr/news/articleView.html?idxno=2132097
5597,2020-08-10,메디톡스ITC예비판결문공개대웅제약도용혐의입증돼,http://www.pharmnews.com/news/articleView.html?idxno=101077
5598,2020-08-10,메디톡스균주도용과학적으로입증VS대웅제약편향왜곡된예비판결의진실곧가려질것,http://www.sportsseoul.com/news/read/944563?ref=naver
5599,2020-08-10,메디톡스대웅제약반박에ITC가확실한증거없이결정했다는주장터무니없다”,https://www.news2day.co.kr/158341
5600,2020-08-10,대웅제약메디톡스억지주장불과균주제조공정도용없어,http://www.newsprime.co.kr/news/article.html?no=513991
5601,2020-08-10,균주와제조공정도용없어”대웅제약메디톡스보도자료반박,http://newsbrite.net/140334
5602,2020-08-10,대웅제약균주제조공정도용없다메디톡스에반박,http://www.newspim.com/news/view/20200810000931
5603,2020-08-10,대웅제약메디톡스균주의혹투성이제조공정도용없다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247730
5604,2020-08-10,ITC판결문공개에도승복않는메디톡스와대웅제약,http://www.opinionnews.co.kr/news/articleView.html?idxno=37968
5605,2020-08-10,메디톡스ITC서도용판결vs대웅제약편향적결론반박,http://www.wolyo.co.kr/news/articleView.html?idxno=107954
5606,2020-08-10,메디톡스대웅제약美ITC예비판결문놓고또진실공방,http://news.mk.co.kr/newsRead.php?no=820769&year=2020
5607,2020-08-10,대웅제약균주와제조공정도용없어유전자분석의한계”반박,http://www.mdtoday.co.kr/mdtoday/index.html?no=395686
5608,2020-08-10,메디톡스대웅제약ITC판결문두고날선공방,https://www.sedaily.com/NewsView/1Z6IYOU6C5
5609,2020-08-10,메디톡스ITC예비판결문에서대웅제약도용사실명백하게밝혀져,http://www.kdpress.co.kr/news/articleView.html?idxno=96858
5610,2020-08-10,대웅제약메디톡스주장은억지;균주와제조공정도용없었다반박,http://www.kdpress.co.kr/news/articleView.html?idxno=96862
5611,2020-08-10,상반기상위제약사실적보니종근당웃음대웅제약눈물,http://www.wikileaks-kr.org/news/articleView.html?idxno=92672
5612,2020-08-10,보톡스전쟁ITC예비판결진실공방전대웅제약→메디톡스→대웅제약반박재반박,http://www.thepublic.kr/news/newsview.php?ncode=1065597158375514
5613,2020-08-10,대웅제약균주와제조공정도용없다메디톡스주장반박,http://www.thefirstmedia.net/news/articleView.html?idxno=61467
5614,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약의메디톡스균주및제조공정도용혐의명백히입증,http://www.thefirstmedia.net/news/articleView.html?idxno=61491
5615,2020-08-10,메디톡스ITC예비판결대웅제약균주도용입증,http://www.finomy.com/news/articleView.html?idxno=81519
5616,2020-08-10,대웅제약메디톡스보도자료반박균주와제조공정도용없어,http://www.newslock.co.kr/news/articleView.html?idxno=30204
5617,2020-08-10,대웅제약균주도용여부유전자분석으로는불가능메디톡스주장반박,http://www.updownnews.co.kr/news/articleView.html?idxno=221882
5618,2020-08-10,대웅제약ITC오판균주와제조공정도용없어,https://www.asiatoday.co.kr/view.php?key=20200810010005152
5619,2020-08-10,균주제조공정도용필요도없고동기도없다”대웅제약메디톡스주장정면반박,https://www.donga.com/news/article/all/20200810/102391541/1
5620,2020-08-10,대웅제약美ITC예비결정문메디톡스해석에재반격나서,http://www.medigatenews.com/news/1286432430
5621,2020-08-10,메디톡스대웅제약보톡스진실공방가속화메디톡스ITC예비판결승리로절대우세,http://www.greened.kr/news/articleView.html?idxno=264623
5622,2020-08-11,대웅제약재반박ITC에제출모든자료제한없이공개하면진실가려질것최종승리자신,http://www.segye.com/content/html/2020/08/10/20200810513724.html?OutUrl=naver
5623,2020-08-11,대웅제약실적보다소송관련불확실성이문제,http://www.g-enews.com/ko-kr/news/article/news_all/202008110637008510442088f476_1/article.html
5624,2020-08-11,메디톡스대웅제약ITC예비판결문놓고격돌소모전심화,https://www.dailian.co.kr/news/view/911455/?sc=Naver
5625,2020-08-11,메디톡스대웅제약균주전쟁갑론을박ITC예비판결문둘러싼갈등,http://www.ntoday.co.kr/news/articleView.html?idxno=74058
5626,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247739
5627,2020-08-11,대웅제약코로나치료제인도임상1상승인,https://www.ebn.co.kr/news/view/1446189/?sc=Naver
5628,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/08/11/2020081101000.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5629,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.getnews.co.kr/view.php?ud=2020081109145347792fe691f917_16
5630,2020-08-11,대웅제약코로나19치료제인도1상승인,http://www.press9.kr/news/articleView.html?idxno=45497
5631,2020-08-11,대웅대웅제약모두상승세로특히대웅가파른상승세로5상승,http://www.econonews.co.kr/news/articleView.html?idxno=131924
5632,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.dailian.co.kr/news/view/911584/?sc=Naver
5633,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=123357
5634,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.fetv.co.kr/news/article.html?no=61144
5635,2020-08-11,대웅제약니클로사마이드임상1상인도서승인코로나19치료제후보물질,http://theviewers.co.kr/View.aspx?No=1044944
5636,2020-08-11,대웅제약니클로사마이드 코로나19 치료제인도임상 1상승인,http://www.economytalk.kr/news/articleView.html?idxno=207490
5637,2020-08-11,대웅제약니클로사마이드코로나19치료제로인도1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=71853
5638,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020081109291754287
5639,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.seoulwire.com/news/articleView.html?idxno=423599
5640,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.lawissue.co.kr/view.php?ud=202008110931106338204ead0791_12
5641,2020-08-11,대웅제약코로나19치료제인도서1상진행,http://www.bosa.co.kr/news/articleView.html?idxno=2132124
5642,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,https://www.hankyung.com/it/article/202008114444i
5643,2020-08-11,대웅제약인도서코로나19치료임상1상승인올해완료목표,http://moneys.mt.co.kr/news/mwView.php?no=2020081109178090159
5644,2020-08-11,대웅제약코로나19치료제인도임상1상승인,http://www.bokuennews.com/news/article.html?no=193414
5645,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.medigatenews.com/news/3051808455
5646,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.fnnews.com/news/202008110950510176
5647,2020-08-11,대웅제약인도서니클로사마이드코로나19치료제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008110115&t=NN
5648,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=72267
5649,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=44297
5650,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=50248
5651,2020-08-11,대웅제약니클로사마이드코로나19치료제인도서임상1상승인,https://www.etoday.co.kr/news/view/1928045
5652,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.pharmnews.com/news/articleView.html?idxno=101082
5653,2020-08-11,대웅제약니클로사마이드코로나19치료제임상1상승인,http://www.mhj21.com/133861
5654,2020-08-11,대웅제약코로나치료제19니클로사마이드인도임상1상승인,http://www.newsprime.co.kr/news/article.html?no=514051
5655,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인쾌거,http://www.pressm.kr/news/articleView.html?idxno=32179
5656,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=120265
5657,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020081110203285863
5658,2020-08-11,대웅제약코로나19치료제개발속도인도서임상1상승인,http://www.sisaweek.com/news/articleView.html?idxno=136553
5659,2020-08-11,대웅제약코로나19치료제니클로사마이드인도1상승인,http://www.monews.co.kr/news/articleView.html?idxno=212656
5660,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=13945
5661,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인주요선진국임상신속진행,http://www.paxetv.com/news/articleView.html?idxno=97858
5662,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상승인,http://medipana.com/news/news_viewer.asp?NewsNum=261176&MainKind=A&NewsKind=5&vCount=12&vKind=1
5663,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://newsbrite.net/140356
5664,2020-08-11,대웅제약구충제성분코로나19치료후보물질인도서임상,http://yna.kr/AKR20200811062800017?did=1195m
5665,2020-08-11,대웅제약인도에서코로나19치료제임상1상승인,http://news.mt.co.kr/mtview.php?no=2020081110335441985
5666,2020-08-11,대웅제약니클로사마이드코로나치료제인도1상승인,http://www.newsis.com/view/?id=NISX20200811_0001125394&cID=13001&pID=13000
5667,2020-08-11,대웅제약인도서니클로사마이드코로나19치료제임상1상승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=81966
5668,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.sedaily.com/NewsView/1Z6JDWL4B1
5669,2020-08-11,대웅제약코로나19치료제인도1상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001648
5670,2020-08-11,대웅제약구충제성분코로나19치료제인도임상1상승인,http://it.chosun.com/site/data/html_dir/2020/08/11/2020081101579.html
5671,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=102631
5672,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://daily.hankooki.com/lpage/industry/202008/dh20200811104532148390.htm?s_ref=nv
5673,2020-08-11,대웅제약니클로사마이드코로나치료제인도서임상승인,http://news.mk.co.kr/newsRead.php?no=822856&year=2020
5674,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.segyebiz.com/newsView/20200811509768?OutUrl=naver
5675,2020-08-11,대웅제약코로나치료제인도임상1상승인,http://www.upinews.kr/newsView/upi202008110027
5676,2020-08-11,대웅제약코로나19치료제DWRX2003인도서임상1상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065577798981961
5677,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=736909
5678,2020-08-11,대웅제약코로나19치료제인도임상1상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135188&REFERER=NP
5679,2020-08-11,대웅제약태국학회참가보툴리눔톡신나보타강의진행,http://www.consumuch.com/news/articleView.html?idxno=50169
5680,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.lawissue.co.kr/view.php?ud=202008111112378510204ead0791_12
5681,2020-08-11,대웅제약나보타태국미용성형학회서소개,http://www.medisobizanews.com/news/articleView.html?idxno=71863
5682,2020-08-11,대웅제약코로나치료제인도서임상1상승인,https://www.nocutnews.co.kr/news/5392899
5683,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=30215
5684,2020-08-11,대웅제약구충제성분코로나19치료후보물질인도서임상,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4244446
5685,2020-08-11,대웅제약나보타글로벌공략계속태국컨퍼런스강연개최,http://www.press9.kr/news/articleView.html?idxno=45501
5686,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=50260
5687,2020-08-11,대웅제약태국미용피부성형학회버추얼콘퍼런스서나보타강의진행,http://www.youthdaily.co.kr/news/article.html?no=44310
5688,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=395751
5689,2020-08-11,대웅제약태국미용학회서나보타강의진행,http://moneys.mt.co.kr/news/mwView.php?no=2020081111188081018
5690,2020-08-11,대웅제약인도서코로나19치료제임상시작,http://www.whosaeng.com/120008
5691,2020-08-11,대웅제약태국미용피부성형학회서나보타강의,http://www.bosa.co.kr/news/articleView.html?idxno=2132152
5692,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.econovill.com/news/articleView.html?idxno=407841
5693,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.healthinnews.co.kr/news/articleView.html?idxno=13953
5694,2020-08-11,대웅제약태국서나보타강의진행미국대신태국경쟁력강화하나,http://theviewers.co.kr/View.aspx?No=1045385
5695,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.getnews.co.kr/view.php?ud=2020081111460438952fe691f917_16
5696,2020-08-11,대웅제약나보타태국미용피부성형학회서경쟁력알린다,http://medipana.com/news/news_viewer.asp?NewsNum=261192&MainKind=A&NewsKind=5&vCount=12&vKind=1
5697,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.iminju.net/news/articleView.html?idxno=56132
5698,2020-08-11,대웅제약코로나19치료제임상1상인도승인받아전승호신속개발,http://www.businesspost.co.kr/BP?command=article_view&num=191312
5699,2020-08-11,대웅제약태국미용성형학회서나보타경쟁력알려,http://www.newsis.com/view/?id=NISX20200811_0001125592&cID=13001&pID=13000
5700,2020-08-11,대웅제약태국미용피부성형학회서나보타강연개최,https://www.fetv.co.kr/news/article.html?no=61179
5701,2020-08-11,대웅제약코로나19치료제인도임상1상승인,http://www.koreaittimes.com/news/articleView.html?idxno=99560
5702,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,https://www.news2day.co.kr/158406
5703,2020-08-11,대웅제약니클로사마이드코로나19치료제로인도1상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=215294&category=D
5704,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=31217
5705,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=31222
5706,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.metroseoul.co.kr/article/20200811500203
5707,2020-08-11,대웅대웅제약오후갑작스런상승에급등특히대웅깜짝10급등에투자자들놀라,http://www.econonews.co.kr/news/articleView.html?idxno=132026
5708,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,http://www.wikileaks-kr.org/news/articleView.html?idxno=92710
5709,2020-08-11,뉴스투데이L대웅제약태국미용피부성형학회버추얼콘퍼런스서강연개최,https://www.news2day.co.kr/158410
5710,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.asiatoday.co.kr/view.php?key=20200811010005700
5711,2020-08-11,대웅제약코로나치료제임상1상승인,http://www.skyedaily.com/news/news_view.html?ID=109951
5712,2020-08-11,대웅제약태국미용피부성형학회서나보타강연,http://www.fnnews.com/news/202008111340183301
5713,2020-08-11,대웅제약태국미용성형학회서나보타경쟁력알려,http://www.econovill.com/news/articleView.html?idxno=407856
5714,2020-08-11,대웅제약태국미용피부성형학회서나보타강연,http://www.mdtoday.co.kr/mdtoday/index.html?no=395792
5715,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,http://kormedi.com/?p=1322061
5716,2020-08-11,대웅제약니클로사마이드해외임상확대추진,http://www.koreastocknews.com/news/articleView.html?idxno=56163
5717,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://newsbrite.net/140372
5718,2020-08-11,대웅제약니클로사마이드코로나19치료제인도서임상1상승인,https://news.joins.com/article/olink/23440512
5719,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62737
5720,2020-08-11,대웅제약태국미용피부성형학회서강연개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62741
5721,2020-08-11,대웅제약니클로사마이드인도서코로나19치료제임상1상승인,http://kbench.com/?q=node/213134
5722,2020-08-11,대웅제약코로나치료제니클로사마이드인도임상1상승인,http://www.mediapen.com/news/view/547835
5723,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065591016791800
5724,2020-08-11,대웅제약인도서니클로사마이드의코로나19대상임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=824288&year=2020
5725,2020-08-11,ITC예판전문공개되자또다시맞붙은메디톡스와대웅제약,http://www.m-i.kr/news/articleView.html?idxno=737014
5726,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,https://view.asiae.co.kr/article/2020081114591359620
5727,2020-08-11,대웅제약태국미용피부성형학회버추얼컨버런스서나보타소개,http://www.kpinews.co.kr/news/articleView.html?idxno=123419
5728,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://inthenews.co.kr/article-63465/
5729,2020-08-11,글로벌무대에나보타경쟁력알린다대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=414524
5730,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=414515
5731,2020-08-11,대웅제약인도서니클로사마이드코로나19임상,http://www.seoulfn.com/news/articleView.html?idxno=391714
5732,2020-08-11,구충제성분코로나19치료제임상돌입대웅제약인도서니클로사마이드임상1상승인,https://www.donga.com/news/article/all/20200811/102403197/1
5733,2020-08-11,대웅제약태국미용피부성형학회서나보타강연개최,http://www.mediapen.com/news/view/547889
5734,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.kdpress.co.kr/news/articleView.html?idxno=96874
5735,2020-08-11,대웅제약태국미용피부성형학회서2ndVirtualConference강연,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247768
5736,2020-08-11,대웅제약인니합작사에포디온원액역수출1450억루피아돌파,https://www.theguru.co.kr/news/article.html?no=13192
5737,2020-08-11,대웅제약인도서코로나19치료제니클로사마이드임상1상시험승인,http://www.whitepaper.co.kr/news/articleView.html?idxno=196399
5738,2020-08-11,대웅제약니클로사마이드 코로나19 치료제인도임상 1상승인,http://www.doctorstimes.com/news/articleView.html?idxno=211903
5739,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.newsian.co.kr/news/articleView.html?idxno=42664
5740,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://sports.chosun.com/news/ntype.htm?id=202008120100098240006347&servicedate=20200811
5741,2020-08-11,대웅제약인도서구충제성분코로나19치료후보물질임상승인,http://www.dt.co.kr/contents.html?article_no=2020081102109931102003&ref=naver
5742,2020-08-11,대웅제약인도서코로나19치료제임상1상승인받아,http://www.finomy.com/news/articleView.html?idxno=81578
5743,2020-08-11,대웅제약코로나치료제인도임상승인획득,https://www.hankyung.com/it/article/2020081172851
5744,2020-08-11,대웅제약vs메디톡스보톡스전쟁4년마지막퍼즐은,http://www.insightkorea.co.kr/news/articleView.html?idxno=81987
5745,2020-08-11,대웅제약나보타웨비나로태국미용피부성형학회강연,http://www.medigatenews.com/news/1118183009
5746,2020-08-11,대웅제약 코로나19 치료제니클로사마이드 인도임상 1상승인,http://www.greened.kr/news/articleView.html?idxno=264793
5747,2020-08-12,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=61578
5748,2020-08-12,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.thefirstmedia.net/news/articleView.html?idxno=61572
5749,2020-08-12,끝나지않는균주전쟁대웅제약메디톡스ITC예비판결문놓고또정면충돌,http://www.youthdaily.co.kr/news/article.html?no=44368
5750,2020-08-12,대웅제약코로나19치료제인도임상1상시험승인,http://weekly.cnbnews.com/news/article.html?no=135405
5751,2020-08-12,대웅대웅제약모두하락부진대웅제약1하락이어대웅소폭하락,http://www.econonews.co.kr/news/articleView.html?idxno=132119
5752,2020-08-12,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.startuptoday.co.kr/news/articleView.html?idxno=50501
5753,2020-08-12,메디톡스대웅제약보톡스전쟁에조용히웃은휴젤,http://biz.newdaily.co.kr/site/data/html/2020/08/12/2020081200051.html
5754,2020-08-12,대웅제약균주도용ITC소송본질은美국익위해K바이오죽이기,http://www.meconomynews.com/news/articleView.html?idxno=44346
5755,2020-08-12,대웅제약코로나19치료제글로벌임상박차,http://newsbrite.net/sub_read.html?uid=140415§ion=sc15
5756,2020-08-12,위키시선공세메디톡스수세대웅제약ITC최종판결은,http://www.wikileaks-kr.org/news/articleView.html?idxno=92799
5757,2020-08-12,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.insight.co.kr/news/298611
5758,2020-08-12,오늘의토막뉴스끝나지않는균주전쟁대웅제약메디톡스ITC예비판결문놓고또정면충돌外,http://www.youthdaily.co.kr/news/article.html?no=44486
5759,2020-08-12,대웅제약vs메디톡스ITC예비판결문놓고또다시격돌,http://www.newsway.co.kr/news/view?tp=1&ud=2020081214454824240
5760,2020-08-13,배보다배꼽더큰보톡스소송대웅제약美진출에사활,https://www.asiatoday.co.kr/view.php?key=20200812010006510
5761,2020-08-13,대웅제약은보톡스판정에서왜대패했을까,https://www.nocutnews.co.kr/news/5394146
5762,2020-08-13,대웅제약니클로사마이드인도임상에NYT아사히도관심왜,http://news.mt.co.kr/mtview.php?no=2020081218243533352
5763,2020-08-13,대웅대웅제약희비엇갈려대웅제약보합반해대웅1상승,http://www.econonews.co.kr/news/articleView.html?idxno=132255
5764,2020-08-14,대웅자회사대웅제약859억규모수출공급계약체결,https://view.asiae.co.kr/article/2020081413592159602
5765,2020-08-14,비즈헬스대웅제약VS메디톡스끝나지않는보툴리눔톡신균주전쟁ITC예비판결문놓고강하게맞붙어,http://www.bizwnews.com/news/articleView.html?idxno=20643
5766,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약,https://www.fetv.co.kr/news/article.html?no=61519
5767,2020-08-14,대웅제약브라질에펙수프라잔860억수출계약,http://www.press9.kr/news/articleView.html?idxno=45548
5768,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.lawissue.co.kr/view.php?ud=202008141402198092204ead0791_12
5769,2020-08-14,대웅제약브라질에859억펙수프라잔수출계약,http://www.edaily.co.kr/news/newspath.asp?newsid=02584646625867320
5770,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약체결,http://www.ekn.kr/news/article.html?no=517335
5771,2020-08-14,대웅제약펙수프라잔브라질과860억규모수출계약,http://www.fnnews.com/news/202008141404184373
5772,2020-08-14,대웅제약브라질제약사에860억원규모펙수프라잔수출,http://www.newspim.com/news/view/20200814000696
5773,2020-08-14,대웅제약브라질1위제약사와860억원규모펙수프라잔수출계약,http://www.viva100.com/main/view.php?key=20200814010002708
5774,2020-08-14,대웅제약859억원규모펙수프라잔수출계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=267477&REFERER=NP
5775,2020-08-14,대웅제약위식도역류질환신약브라질수출860억원규모,http://yna.kr/AKR20200814101300017?did=1195m
5776,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.metroseoul.co.kr/article/20200814500098
5777,2020-08-14,대웅제약위식도역류치료제펙수프라잔브라질수출,http://www.medisobizanews.com/news/articleView.html?idxno=71962
5778,2020-08-14,대웅제약위식도역류질환藥브라질에860억원수출,https://www.hankyung.com/it/article/202008149172i
5779,2020-08-14,대웅제약위식도역류질환약브라질에860억규모수출,http://www.newsis.com/view/?id=NISX20200814_0001130103&cID=13001&pID=13000
5780,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.mediapen.com/news/view/548886
5781,2020-08-14,대웅제약브라질에860억원규모펙수프라잔수출,http://news.mt.co.kr/mtview.php?no=2020081414270647316
5782,2020-08-14,대웅제약위식도역류질환치료제브라질수출860억원규모계약,http://www.startuptoday.co.kr/news/articleView.html?idxno=50861
5783,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약체결,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004075556
5784,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결로중남미서입지굳힌다,http://newsbrite.net/140513
5785,2020-08-14,대웅제약위식도역류질환치료제브라질에860억원어치수출계약,http://news.mk.co.kr/newsRead.php?no=839360&year=2020
5786,2020-08-14,대웅제약위식도역류질환치료제멕시코이어브라질수출길열어,http://www.econovill.com/news/articleView.html?idxno=408324
5787,2020-08-14,대웅제약펙수프라잔브라질에860억규모수출,http://www.bosa.co.kr/news/articleView.html?idxno=2132417
5788,2020-08-14,대웅제약펙수프라잔브라질과860억규모수출계약,http://www.newsway.co.kr/news/view?tp=1&ud=2020081414374214373
5789,2020-08-14,대웅제약펙수프라잔860억규모브라질수출계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247920
5790,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질진출,http://www.pinpointnews.co.kr/view.php?ud=2020081414541758382365609d9b_45
5791,2020-08-14,대웅제약위식도역류질환치료제브라질수출,http://www.dailysmart.co.kr/news/articleView.html?idxno=31401
5792,2020-08-14,공시대웅제약859억규모펙수프라잔브라질수출계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2020081415063006724
5793,2020-08-14,대웅제약펙수프라잔860억규모브라질수출계약,http://www.newsprime.co.kr/news/article.html?no=514544
5794,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.seoulfn.com/news/articleView.html?idxno=392174
5795,2020-08-14,대웅제약펙수프라잔브라질수출계약체결,https://www.ebn.co.kr/news/view/1446836/?sc=Naver
5796,2020-08-14,대웅제약펙수프라잔브라질제약사와수출계약체결,http://www.kpinews.co.kr/news/articleView.html?idxno=123704
5797,2020-08-14,대웅제약펙수프라잔중남미시장또뚤었다브라질에860억원규모수출,http://moneys.mt.co.kr/news/mwView.php?no=2020081415238067145
5798,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결로중남미서입지굳힌다,http://www.nbnnews.co.kr/news/articleView.html?idxno=415632
5799,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질로중남미입지굳혀,http://www.pressm.kr/news/articleView.html?idxno=32374
5800,2020-08-14,대웅제약브라질에펙수프라잔7300만수출계약,https://www.sedaily.com/NewsView/1Z6KRT57ZE
5801,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약약860억원규모,https://www.donga.com/news/article/all/20200814/102454750/1
5802,2020-08-14,대웅제약펙수프라잔브라질진출7300만달러수출계약,https://www.etoday.co.kr/news/view/1929721
5803,2020-08-14,대웅제약브라질에860억규모수출계약체결,http://www.koreastocknews.com/news/articleView.html?idxno=56306
5804,2020-08-14,대웅제약펙수프라잔브라질에950억규모수출계약,http://www.koreaittimes.com/news/articleView.html?idxno=99691
5805,2020-08-14,대웅제약860억원규모펙수프라잔브라질수출계약체결,http://www.youthdaily.co.kr/news/article.html?no=44728
5806,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔수출860억원규모,http://www.smartfn.co.kr/view.php?ud=20200814145552367d5d29c6899_46
5807,2020-08-14,대웅제약브라질제약사와위식도역류질환치료제수출계약체결,http://www.businesspost.co.kr/BP?command=article_view&num=191924
5808,2020-08-14,대웅제약펙수프라잔브라질수출계약체결로중남미서입지굳힌다,http://www.healthinnews.co.kr/news/articleView.html?idxno=14010
5809,2020-08-14,대웅제약펙수프라잔860억규모브라질수출계약체결,http://www.newstomato.com/ReadNews.aspx?no=990333
5810,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.getnews.co.kr/view.php?ud=2020081415594713752fe691f917_16
5811,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=61714
5812,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,https://www.asiatoday.co.kr/view.php?key=20200814010007866
5813,2020-08-14,대웅제약브라질제약사와펙수프라잔수출계약860억원규모,http://www.sisafocus.co.kr/news/articleView.html?idxno=245642
5814,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62827
5815,2020-08-14,대웅제약펙수프라잔브라질EMS와860억규모수출계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=396203
5816,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.finomy.com/news/articleView.html?idxno=81740
5817,2020-08-14,대웅제약브라질에860억규모신약수출,https://news.chosun.com/site/data/html_dir/2020/08/14/2020081403253.html?utm_source=naver&utm_medium=original&utm_campaign=news
5818,2020-08-14,대웅제약위식도역류질환신약펙수프라잔브라질수출,http://it.chosun.com/site/data/html_dir/2020/08/14/2020081403255.html
5819,2020-08-14,대웅제약펙수프라잔브라질진출위식도역류질환치료제PPI약물,http://theviewers.co.kr/View.aspx?No=1051435
5820,2020-08-14,대웅제약위식도역류질환치료제브라질진출,http://www.100ssd.co.kr/news/articleView.html?idxno=70768
5821,2020-08-14,대웅제약펙수프라잔브라질수출계약체결,http://www.wsobi.com/news/articleView.html?idxno=102876
5822,2020-08-14,대웅제약펙수프라잔브라질7300만弗수출계약,http://www.biospectator.com/view/news_view.php?varAtcId=11087
5823,2020-08-15,기업공시8월14일대웅제약펙수프라잔브라질과860억규모수출계약등,https://www.sedaily.com/NewsView/1Z6L6WOEXO
5824,2020-08-15,연재기획④대웅제약vs메디톡스톺아보기공정기술력차이로희비교차,http://newsclaim.co.kr/View.aspx?No=1051542
5825,2020-08-15,뉴스브리핑8월15일의협2차파업예고대웅제약위식도역류질환신약펙수프라잔브라질수출,http://it.chosun.com/site/data/html_dir/2020/08/14/2020081403390.html
5826,2020-08-15,대웅제약브라질에펙수프라잔860억원수출계약체결,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001797
5827,2020-08-15,대웅제약펙수프라잔중남미최대시장브라질간다860억원규모계약달성,http://www.thepublic.kr/news/newsview.php?ncode=1065596770938898
5828,2020-08-16,대웅제약위식도역류질환치료제펙수프라잔브라질에860억규모수출멕시코이은두번째중남미진출,http://www.econonews.co.kr/news/articleView.html?idxno=132637
5829,2020-08-16,대웅제약신약수출진단키트코로나임상으로돌파구찾나,http://www.mediapen.com/news/view/549209
5830,2020-08-17,대웅제약의중남미드림위식도역류질환약펙수프라잔멕시코이어브라질에860억수출,http://www.globale.co.kr/news/articleView.html?idxno=10859
5831,2020-08-17,균주전쟁美ITC예비판결문공개에대웅제약발끈,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=844540
5832,2020-08-17,대웅제약상반기매출5113억81영업익93감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247957
5833,2020-08-17,전승호대웅제약위기를위식도역류질환치료제로활로만들기온힘,http://www.businesspost.co.kr/BP?command=article_view&num=192137
5834,2020-08-18,대웅제약브라질에860억규모펙수프라잔수출중남미입지굳히기,http://www.newsian.co.kr/news/articleView.html?idxno=42763
5835,2020-08-18,뉴욕증시제약바이오옥석가리기메디톡스SK케미칼대웅제약엇갈리는운명,http://www.g-enews.com/ko-kr/news/article/news_all/202008172018575004a01bf698f_1/article.html
5836,2020-08-18,오늘의제약한미약품GC녹십자셀트리온제약대웅제약광동제약,http://www.babytimes.co.kr/news/articleView.html?idxno=38688
5837,2020-08-18,대웅제약마구간서균주발견전혀확인안된잘못된사실,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247981
5838,2020-08-18,대웅제약균주출처논란에또다시반박사실왜곡지적,http://medipana.com/news/news_viewer.asp?NewsNum=261483&MainKind=A&NewsKind=5&vCount=12&vKind=1
5839,2020-08-18,대웅제약닭똥같은이야기기사는보툴리눔균주악의적보도,http://www.medisobizanews.com/news/articleView.html?idxno=72014
5840,2020-08-18,대웅제약대웅주장닭똥같은이야기보도악의적인왜곡해석,http://www.newslock.co.kr/news/articleView.html?idxno=30347
5841,2020-08-18,대웅제약균주와제조공정도용없어메디톡스보도자료반박,http://www.nbnnews.co.kr/news/articleView.html?idxno=416317
5842,2020-08-18,대웅제약균주관련닭똥보도반박기존입장인데새로운내용처럼오인”,https://www.donga.com/news/article/all/20200818/102538588/1
5843,2020-08-18,대웅제약균주출처논란에재반박사실왜곡했다,https://www.dailian.co.kr/news/view/913233/?sc=Naver
5844,2020-08-18,대웅제약균주출처논란에악의적으로왜곡”반박,http://www.mdtoday.co.kr/mdtoday/index.html?no=396445
5845,2020-08-19,CEO리뷰1조클럽마술사대웅제약전승호신약개발가속패달밟는다,https://www.fetv.co.kr/news/article.html?no=61588
5846,2020-08-20,대웅제약파스퇴르硏원자력의학원코로나19치료제해외임상계약,http://daily.hankooki.com/lpage/industry/202008/dh20200820092801148390.htm?s_ref=nv
5847,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248087
5848,2020-08-20,카모스타트개발잰걸음대웅제약한국파스퇴르원자력의학원과맞손,https://www.fetv.co.kr/news/article.html?no=61806
5849,2020-08-20,대웅제약카모스타트코로나19치료제글로벌개발속도,http://www.viva100.com/main/view.php?key=20200820010003553
5850,2020-08-20,오늘의제약대웅제약셀트리온광동제약19일동화약품19일,http://www.babytimes.co.kr/news/articleView.html?idxno=38746
5851,2020-08-20,대웅제약∙파스퇴르연구소∙원자력의학원코로나19치료제해외연구자임상계약,https://biz.chosun.com/site/data/html_dir/2020/08/20/2020082000979.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5852,2020-08-20,대웅제약코로나19치료물질카모스타트글로벌개발,http://www.medisobizanews.com/news/articleView.html?idxno=72074
5853,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.press9.kr/news/articleView.html?idxno=45597
5854,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속화,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008200101&t=NN
5855,2020-08-20,단독인터뷰전승호대웅제약대표ITC예비판결뒤죽박죽최종서뒤집힐것,https://view.asiae.co.kr/article/2020082009463912999
5856,2020-08-20,코로나19치료제백신생산장비지원기관지정소식유나이티드제약GC녹십자대웅제약등,http://www.ccreview.co.kr/news/articleView.html?idxno=279301
5857,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573505571742
5858,2020-08-20,대웅제약카모스타트성분코로나19치료제개발속도낸다,http://www.getnews.co.kr/view.php?ud=2020082009513519692fe691f917_16
5859,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://inthenews.co.kr/article-64865/
5860,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속화,http://www.newsprime.co.kr/news/article.html?no=514937
5861,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속화,http://medipana.com/news/news_viewer.asp?NewsNum=261607&MainKind=A&NewsKind=5&vCount=12&vKind=1
5862,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.lawissue.co.kr/view.php?ud=202008200955544418204ead0791_12
5863,2020-08-20,대웅제약코로나19치료제카모스타트글로벌연구박차,http://www.sisafocus.co.kr/news/articleView.html?idxno=245949
5864,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진,http://yna.kr/AKR20200820051900017?did=1195m
5865,2020-08-20,대웅제약코로나19치료제카모스타트해외연구자임상계약체결,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=120617
5866,2020-08-20,대웅제약카모스타트코로나19치료제글로벌개발박차,http://www.newstomato.com/ReadNews.aspx?no=991173
5867,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,https://www.dailian.co.kr/news/view/913591/?sc=Naver
5868,2020-08-20,대웅제약카모스타트글로벌개발가속화나선다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62894
5869,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발속도,https://www.etoday.co.kr/news/view/1931339
5870,2020-08-20,대웅제약호이스타정해외연구자임상계약체결임상2상시험착수,http://www.healthinnews.co.kr/news/articleView.html?idxno=14061
5871,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진,http://yna.kr/PYH20200820038400017?did=1196m
5872,2020-08-20,대웅제약코로나19치료제해외연구자임상협약체결,http://www.kpinews.co.kr/news/articleView.html?idxno=123996
5873,2020-08-20,대웅제약카모스타트코로나19치료제글로벌개발속도,http://news.mt.co.kr/mtview.php?no=2020082009591142161
5874,2020-08-20,대웅제약코로나19치료제공동연구계약협약식체결,http://www.pharmnews.com/news/articleView.html?idxno=101146
5875,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://newsbrite.net/140660
5876,2020-08-20,대웅제약카모스타트코로나19치료제로글로벌임상가속화,http://moneys.mt.co.kr/news/mwView.php?no=2020082009438065849
5877,2020-08-20,대웅제약코로나19치료제호이스타정해외연구자임상계약,http://it.chosun.com/site/data/html_dir/2020/08/20/2020082001234.html
5878,2020-08-20,대웅제약파스퇴르연구소원자력의학원코로나19대상카모스타트해외임상맞손,http://news.mk.co.kr/newsRead.php?no=856335&year=2020
5879,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.economytalk.kr/news/articleView.html?idxno=207639
5880,2020-08-20,대웅제약카모스타트글로벌임상가속화,http://www.mhj21.com/134187
5881,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,https://www.hankyung.com/finance/article/202008206341i
5882,2020-08-20,대웅제약카모스타트코로나치료글로벌개발박차,http://www.newsis.com/view/?id=NISX20200820_0001135667&cID=13001&pID=13000
5883,2020-08-20,대웅제약카모스타트코로나19치료제개발가속화공동연구협력관계구축”,http://www.youthdaily.co.kr/news/article.html?no=45154
5884,2020-08-20,대웅제약카모스타트글로벌개발가속화,http://news.mk.co.kr/newsRead.php?no=856532&year=2020
5885,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=31575
5886,2020-08-20,대웅제약코로나19치료제호이스타정해외임상추진,http://www.pinpointnews.co.kr/view.php?ud=202008201057225020266f8e1a9f_45
5887,2020-08-20,대웅제약한국파스퇴르연구소한국원자력의학원과카모스타트개발협력코로나19치료효과도기대,http://theviewers.co.kr/View.aspx?No=1055216
5888,2020-08-20,대웅제약호이스타정임상2상시험착수하반기3상시험진입목표,http://www.leaders.kr/news/articleView.html?idxno=209557
5889,2020-08-20,대웅제약코로나치료제해외연구자임상계약체결,https://www.ebn.co.kr/news/view/1447436/?sc=Naver
5890,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://kormedi.com/?p=1322613
5891,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=61910
5892,2020-08-20,대웅제약카모스타트글로벌개발가속화나선다,http://www.bosa.co.kr/news/articleView.html?idxno=2132709
5893,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진협약,http://www.smartfn.co.kr/view.php?ud=202008201357458531d5d29c6899_46
5894,2020-08-20,대웅제약카모스타트코로나19치료제개발가속화,http://www.newsway.co.kr/news/view?tp=1&ud=2020082014092300222
5895,2020-08-20,대웅제약코로나19치료제카모스타트글로벌공동연구관련협력관계구축,http://www.updownnews.co.kr/news/articleView.html?idxno=222215
5896,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=417083
5897,2020-08-20,대웅제약코로나19치료제카모스타트글로벌연구협력나서,http://www.monews.co.kr/news/articleView.html?idxno=212842
5898,2020-08-20,대웅제약코로나치료제카모스타트개발잰걸음,http://www.whosaeng.com/120219
5899,2020-08-20,대웅제약파스퇴르연구소코로나19치료제해외연구자임상계약체결,http://www.koreaittimes.com/news/articleView.html?idxno=99798
5900,2020-08-20,대웅제약코로나19치료제카모스타트개발박차,http://www.mediapen.com/news/view/550375
5901,2020-08-20,구충제다음은식도염치료제”대웅제약카모스타트코로나19치료제글로벌임상박차,https://www.donga.com/news/article/all/20200820/102575420/1
5902,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.shinailbo.co.kr/news/articleView.html?idxno=1311447
5903,2020-08-20,뉴스투데이L대웅제약한국파스퇴르연구소한국원자력의학원과코로나19치료제공동연구계약체결,https://www.news2day.co.kr/158991
5904,2020-08-20,대웅제약코로나19치료제호이스타정해외연구자임상개발위한공동연구계약협약,http://www.paxetv.com/news/articleView.html?idxno=98508
5905,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진,http://sports.chosun.com/news/ntype.htm?id=202008210100179660011905&servicedate=20200820
5906,2020-08-20,대웅제약코로나치료제해외임상추진,http://www.dt.co.kr/contents.html?article_no=2020082102101031102001&ref=naver
5907,2020-08-20,대웅제약파스퇴르연원자력의학원호이스타코로나19치료제공동연구,https://www.kpanews.co.kr/article/show.asp?idx=215518&category=D
5908,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.bokuennews.com/news/article.html?no=193740
5909,2020-08-20,대웅제약코로나치료제카모스타트상용화박차,http://www.meconomynews.com/news/articleView.html?idxno=44664
5910,2020-08-20,대웅제약코로나19치료제호이스타정해외연구자임상협약체결,http://www.newslock.co.kr/news/articleView.html?idxno=30427
5911,2020-08-21,대웅제약이온채널플랫폼키운다아이엔테라퓨틱스설립,http://www.ceoscoredaily.com/news/article.html?no=72503
5912,2020-08-21,대웅제약코로나19치료제호이스타정개발박차,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001974
5913,2020-08-21,기자수첩대웅제약은정말보톡스균주를훔치지않았나,http://moneys.mt.co.kr/news/mwView.php?no=2020082018198037701
5914,2020-08-21,속보정부녹십자대웅제약등코로나19임상비지원결정,https://www.hankyung.com/it/article/202008210503i
5915,2020-08-21,대웅제약한국파스퇴르연구소한국원자력의학원코로나19치료제해외연구자공동연구계약협약,http://www.wsobi.com/news/articleView.html?idxno=103152
5916,2020-08-21,제넥신대웅제약진원생명과학주가오후급반등↑정부코로나백신개발지원,http://kpenews.com/View.aspx?No=1056700
5917,2020-08-23,대웅제약매출1조올해는흔들전승호건강기능식품에서만회노려,http://www.businesspost.co.kr/BP?command=article_view&num=192896
5918,2020-08-24,대웅제약등주요제약사영업직재택근무전환의약품유통업체는꿈도못꿔,http://theviewers.co.kr/View.aspx?No=1058331
5919,2020-08-25,누드비치서코로나집단감염도진원생명과학녹십자대웅제약신풍제약제넥신주가폭발,http://www.pinpointnews.co.kr/view.php?ud=202008250509171665861beb2d9d_45
5920,2020-08-25,특징주제넥신SK바이오사이언스진원생명과학코로나19백신개발정부지원소식에급등셀트리온녹십자대웅제약치료제부문도,http://www.ccreview.co.kr/news/articleView.html?idxno=280411
5921,2020-08-25,더벨대웅제약JV스핀오프신약개발통로다변화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202008241452599160103477
5922,2020-08-25,단독메디톡스vs대웅제약보톡스전쟁전체업계후폭풍,http://www.edaily.co.kr/news/newspath.asp?newsid=02312406625870928
5923,2020-08-25,대웅대웅제약같은상승세지만흐름달라특히대웅오후갑작스런11급등,http://www.econonews.co.kr/news/articleView.html?idxno=133839
5924,2020-08-26,연이은악재대웅제약이번엔LG로부터당뇨약계약해지통보,http://www.sisajournal-e.com/news/articleView.html?idxno=222749
5925,2020-08-26,대웅제약개방형협력확대로스타트업액셀러레이팅육성,http://www.economytalk.kr/news/articleView.html?idxno=207747
5926,2020-08-26,대웅제약흔들리는1조클럽위상만회전략은,http://www.mediapen.com/news/view/551768
5927,2020-08-26,대웅제약엑셀러레이터사업으로오픈콜라보레이션확대,http://www.metroseoul.co.kr/article/20200826500374
5928,2020-08-26,대웅제약엑셀러레이터사업으로오픈콜라보레이션확대,http://www.metroseoul.co.kr/article/20200826500388
5929,2020-08-26,발달장애인위한코로나정보책나왔다대웅제약알기쉽게제작,http://www.meconomynews.com/news/articleView.html?idxno=44809
5930,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614309
5931,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614308
5932,2020-08-26,대웅제약국회산업통상자원중소벤처기업위원회위원장상수상,http://www.newsis.com/view/?id=NISI20200826_0016614346
5933,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614349
5934,2020-08-26,국회산업통상자원중소벤처기업위원장상수상한대웅제약,http://www.newsis.com/view/?id=NISI20200826_0016614368
5935,2020-08-26,뉴시스2020한류엑스포나보타로미국진출대웅제약K바이오미래위해노력하겠다,http://www.newsis.com/view/?id=NISX20200826_0001143703&cID=13001&pID=13000
5936,2020-08-26,뉴시스2020한류엑스포기업대상에LG생건농심CJ제일제당대웅제약하이트진로,http://www.newsis.com/view/?id=NISX20200826_0001143722&cID=13001&pID=13000
5937,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614385
5938,2020-08-27,대웅제약해외법인흑자전환성장세뚜렷,http://www.press9.kr/news/articleView.html?idxno=45653
5939,2020-08-27,LG화학대웅제약에당뇨치료제제미글로공동마케팅계약해지통보,http://www.mdtoday.co.kr/mdtoday/index.html?no=397163
5940,2020-08-27,대웅제약품질고도화도입지원기업선정,http://www.press9.kr/news/articleView.html?idxno=45655
5941,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248357
5942,2020-08-27,대웅제약식약처로부터품질고도화QbD도입지원기업선정,https://biz.chosun.com/site/data/html_dir/2020/08/27/2020082700943.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5943,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020082709055540106
5944,2020-08-27,대웅제약 식약처품질고도화QbD 도입지원기업선정,http://www.greened.kr/news/articleView.html?idxno=266834
5945,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업에선정,http://www.koreaittimes.com/news/articleView.html?idxno=99945
5946,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.mediapen.com/news/view/552024
5947,2020-08-27,대웅제약식약처품질고도화도입지원기업에선정,http://yna.kr/AKR20200827042800017?did=1195m
5948,2020-08-27,대웅제약식약처품질고도화시스템지원기업선정,https://www.hankyung.com/it/article/202008271447i
5949,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,https://www.fetv.co.kr/news/article.html?no=62277
5950,2020-08-27,대웅제약식약처의약품설계기반품질고도화시스템도입지원기업으로선정,http://newsbrite.net/140922
5951,2020-08-27,대웅제약의약품품질고도화식약처QbD지원기업으로선정,https://www.etoday.co.kr/news/view/1933947
5952,2020-08-27,대웅제약의약품품질경쟁력강화QbD도입지원기업선정,http://www.viva100.com/main/view.php?key=20200827010004914
5953,2020-08-27,식약처대웅제약에전문컨설팅사업지원의약품품질강화한다,http://moneys.mt.co.kr/news/mwView.php?no=2020082709038077650
5954,2020-08-27,대웅제약식약처맞춤형QbD전문컨설팅지원기업선정,http://www.medisobizanews.com/news/articleView.html?idxno=72251
5955,2020-08-27,대웅제약QbD기반으로최고품질의약품개발나선다”,http://www.youthdaily.co.kr/news/article.html?no=45826
5956,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.bokuennews.com/news/article.html?no=193944
5957,2020-08-27,대웅제약식약처의맞춤형QbD전문컨설팅지원대상으로선정돼,http://news.mk.co.kr/newsRead.php?no=881480&year=2020
5958,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://news.mk.co.kr/newsRead.php?no=881494&year=2020
5959,2020-08-27,대웅제약QbD기반최고품질의약품개발나서,http://medipana.com/news/news_viewer.asp?NewsNum=261912&MainKind=A&NewsKind=5&vCount=12&vKind=1
5960,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020082709210148524
5961,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.ekn.kr/news/article.html?no=519548
5962,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=31863
5963,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.m-i.kr/news/articleView.html?idxno=741061
5964,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.biospectator.com/view/news_view.php?varAtcId=11168
5965,2020-08-27,대웅제약식약처품질고도화시스템지원기업으로선정,http://it.chosun.com/site/data/html_dir/2020/08/27/2020082701208.html
5966,2020-08-27,대웅제약QbD기반최고품질의의약품개발,http://www.newsprime.co.kr/news/article.html?no=515713
5967,2020-08-27,대웅제약식약처QbD도입지원기업선정,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572536477688
5968,2020-08-27,대웅제약식약처부터품질고도화도입지원기업선정,http://www.beyondpost.co.kr/view.php?ud=20200827094430595fb6e4c4ee4_30
5969,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.dailymedi.com/detail.php?number=859766&thread=22r05
5970,2020-08-27,대웅제약식약처품질고도화지원기업선정,http://www.seoulfn.com/news/articleView.html?idxno=393259
5971,2020-08-27,대웅제약식약처품질고도화도입지원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94518
5972,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.marketnews.co.kr/news/articleView.html?idxno=50796
5973,2020-08-27,대웅제약식약처품질고도화도입지원기업선정의약품불량률감소,http://theviewers.co.kr/View.aspx?No=1064030
5974,2020-08-27,대웅제약의약품품질고도화컨설팅업체선정,http://www.dt.co.kr/contents.html?article_no=2020082702109931102001&ref=naver
5975,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업에선정,http://www.datasom.co.kr/news/articleView.html?idxno=108066
5976,2020-08-27,전승호사장대웅제약QbD전문기업선정글로벌품질강화,http://www.wikileaks-kr.org/news/articleView.html?idxno=93679
5977,2020-08-27,대웅제약식약처품질고도화시스템지원기업으로선정,http://inthenews.co.kr/article-66126/
5978,2020-08-27,대웅제약의약품품질고도화도입지원기업선정,http://www.econovill.com/news/articleView.html?idxno=409642
5979,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.pressm.kr/news/articleView.html?idxno=32677
5980,2020-08-27,대웅제약식약처QbD지원기업선정고품질의약품개발,http://www.medigatenews.com/news/2434910577
5981,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업에선정,http://news.mt.co.kr/mtview.php?no=2020082710311143760
5982,2020-08-27,대웅제약식약처QbD도입지원기업선정최고품질의약품개발할것,http://www.sisaweek.com/news/articleView.html?idxno=137031
5983,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1410463
5984,2020-08-27,대웅제약맞춤형QbD전문컨설팅사업지원기업선정,http://www.kpinews.co.kr/news/articleView.html?idxno=124508
5985,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=14166
5986,2020-08-27,뉴스투데이L대웅제약식약처맞춤형QbD전문컨설팅사업지원기업선정,https://www.news2day.co.kr/159419
5987,2020-08-27,대웅제약최고품질의약품개발에한발더,http://www.bosa.co.kr/news/articleView.html?idxno=2133129
5988,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.metroseoul.co.kr/article/20200827500091
5989,2020-08-27,대웅제약QbD기반최고품질의약품개발가속,http://www.dailypharm.com/Users/News/NewsView.html?ID=267846&REFERER=NP
5990,2020-08-27,대웅제약QbD기반최고품질의의약품개발나선다,http://www.insightkorea.co.kr/news/articleView.html?idxno=82357
5991,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=397270
5992,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,https://www.ebn.co.kr/news/view/1448318/?sc=Naver
5993,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,https://jhealthmedia.joins.com/article/article_view.asp?pno=22289
5994,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=50954
5995,2020-08-27,대웅제약식약처QbD도입지원기업으로선정,http://weekly.cnbnews.com/news/article.html?no=135656
5996,2020-08-27,대웅제약식약처QbD도입지원기업선정,http://www.whosaeng.com/120382
5997,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.mhj21.com/134316
5998,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63010
5999,2020-08-27,의약품도품질시대대웅제약글로벌수준으로강화,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135512&REFERER=NP
6000,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.paxetv.com/news/articleView.html?idxno=98884
6001,2020-08-27,제약오늘일동히알테크히알루론산제조법특허취득대웅제약식약처품질고도화QbD도입지원기업선정,http://www.sisaon.co.kr/news/articleView.html?idxno=117302
6002,2020-08-27,대웅제약품질고도화QbD도입지원기업선정,http://www.pinpointnews.co.kr/view.php?ud=2020082712335321642365609d9b_45
6003,2020-08-27,대웅제약식약처품질고도화도입지원기업에선정,https://www.dailian.co.kr/news/view/915287/?sc=Naver
6004,2020-08-27,대웅제약식약처의약품설계기반품질고도화도입지원기업선정,http://www.newslock.co.kr/news/articleView.html?idxno=30581
6005,2020-08-27,대웅제약식약처의의약품설계기반품질고도화지원받아,http://www.businesspost.co.kr/BP?command=article_view&num=193503
6006,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=419238
6007,2020-08-27,오늘의제약에스티팜광동제약대웅제약한미약품26일,http://www.babytimes.co.kr/news/articleView.html?idxno=38922
6008,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://sports.hankooki.com/lpage/economy/202008/sp20200827142843137020.htm?s_ref=nv
6009,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.thefirstmedia.net/news/articleView.html?idxno=62277
6010,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.koreastocknews.com/news/articleView.html?idxno=56640
6011,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://daily.hankooki.com/lpage/industry/202008/dh20200827145910148390.htm?s_ref=nv
6012,2020-08-27,대웅제약식약처QbD통해의약품경쟁력강화,http://www.skyedaily.com/news/news_view.html?ID=110917
6013,2020-08-27,대웅제약의약품품질고도화컨설팅지원기업선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1314058
6014,2020-08-27,대웅제약식약처로부터품질고도화QbD도입지원기업선정,http://www.newstomato.com/ReadNews.aspx?no=992682
6015,2020-08-27,김창수의e뉴스브리핑대웅제약식약처품질고도화도입지원기업선정外,https://www.fetv.co.kr/news/article.html?no=62355
6016,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.lawissue.co.kr/view.php?ud=202008271752002979204ead0791_12
6017,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.worktoday.co.kr/news/articleView.html?idxno=9701
6018,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정최고품질의약품개발박차”,https://www.donga.com/news/article/all/20200827/102680920/1
6019,2020-08-27,대웅제약맞춤형QbD전문컨설팅사업최종선정경쟁력↑불량률↓,http://www.100ssd.co.kr/news/articleView.html?idxno=70994
6020,2020-08-28,대웅제약ITC소송패소시에볼루스CB날릴판,https://www.paxnetnews.com/articles/64625
6021,2020-08-28,대웅제약품질고도화도입지원기업선정,http://www.monews.co.kr/news/articleView.html?idxno=213041
6022,2020-08-28,SK케미칼대웅제약스카이조스터공동판매종료,http://www.dailypharm.com/Users/News/NewsView.html?ID=267908&REFERER=NP
6023,2020-08-28,전승호대웅제약반전의발판으로코로나19치료제개발희망품어,http://www.businesspost.co.kr/BP?command=article_view&num=193721
6024,2020-08-29,연재기획⑤대웅제약vs메디톡스톺아보기ITC소송의향방은,http://newsclaim.co.kr/View.aspx?No=1066025
6025,2020-08-31,인터뷰대웅제약대표보톡스균주ITC분쟁美엘러간의반독점행위에서시작,https://biz.chosun.com/site/data/html_dir/2020/08/30/2020083001895.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6026,2020-08-31,대웅제약펙수프라잔자신있다지만적자늪탈출할까,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020082816264755027
6027,2020-08-31,대웅제약니클로사마이드신종코로나치료제개발에주목,http://newsbrite.net/sub_read.html?uid=141066§ion=sc74
6028,2020-09-01,삼성바이오로직스첫1조클럽입성유력대웅제약은글쎄,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090111362414390
6029,2020-09-01,대웅제약안풀리네하반기먹구름잔뜩,http://www.sporbiz.co.kr/news/articleView.html?idxno=466801
6030,2020-09-01,대웅제약보톡스소송대형품목판권등악재돌파할까,http://news.mk.co.kr/newsRead.php?no=901672&year=2020
6031,2020-09-01,JW신약대웅제약담당의료기관에스카이조스터판매한다,http://www.mdtoday.co.kr/mdtoday/index.html?no=397835
6032,2020-09-02,대웅제약발달장애인위한참지마요프로젝트로사회공헌활동전개,http://www.businesskorea.co.kr/news/articleView.html?idxno=51192
6033,2020-09-02,대웅제약개방형협력으로경쟁력강화박차,https://www.ebn.co.kr/news/view/1449175/?sc=Naver
6034,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.sentv.co.kr/news/view/578699
6035,2020-09-03,대웅제약파트너사이온바이오파마보툴리눔톡신美FDA임상2상승인,http://daily.hankooki.com/lpage/industry/202009/dh20200903090717148390.htm?s_ref=nv
6036,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,https://www.fetv.co.kr/news/article.html?no=62767
6037,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248595
6038,2020-09-03,대웅제약미국보툴리눔톡신치료시장진출내년임상2상시작,https://www.etoday.co.kr/news/view/1936674
6039,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.youthdaily.co.kr/news/article.html?no=46507
6040,2020-09-03,대웅제약美보톡스치료시장목표임상2상내년시작,http://moneys.mt.co.kr/news/mwView.php?no=2020090309068081830
6041,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://medipana.com/news/news_viewer.asp?NewsNum=262250&MainKind=A&NewsKind=5&vCount=12&vKind=1
6042,2020-09-03,대웅제약미국보툴리눔톡신치료시장진출,http://www.press9.kr/news/articleView.html?idxno=45715
6043,2020-09-03,대웅제약美보툴리눔톡신치료시장진출가속페달,http://www.newsis.com/view/?id=NISX20200903_0001152913&cID=13001&pID=13000
6044,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://news.mt.co.kr/mtview.php?no=2020090309161331634
6045,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.fnnews.com/news/202009030924521425
6046,2020-09-03,대웅제약美FDA서경부근긴장이상적응증임상2상승인선진국보툴리눔톡신치료시장공략,https://biz.chosun.com/site/data/html_dir/2020/09/03/2020090300881.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6047,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.koreaittimes.com/news/articleView.html?idxno=100120
6048,2020-09-03,대웅제약美보툴리눔톡신시장본격진출,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572440791186
6049,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.medisobizanews.com/news/articleView.html?idxno=72423
6050,2020-09-03,대웅제약美보톡스치료시장진출임상2상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090309281376469
6051,2020-09-03,대웅제약파트너사통해미국보툴리눔톡신시장본격진출,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121077
6052,2020-09-03,대웅제약美FDA나보타의경부근긴장이상적응증임상2상승인,http://news.mk.co.kr/newsRead.php?no=908892&year=2020
6053,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://sports.hankooki.com/lpage/economy/202009/sp20200903093910137020.htm?s_ref=nv
6054,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.pharmnews.com/news/articleView.html?idxno=101226
6055,2020-09-03,대웅제약美치료용보톡스시장진출,http://health.chosun.com/site/data/html_dir/2020/09/03/2020090300999.html
6056,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.bosa.co.kr/news/articleView.html?idxno=2133623
6057,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://inthenews.co.kr/article-67451/
6058,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.seoulwire.com/news/articleView.html?idxno=425796
6059,2020-09-03,대웅제약美FDA경부근긴장이상적응증임상2상승인받아,http://www.economytalk.kr/news/articleView.html?idxno=207932
6060,2020-09-03,대웅제약나보타미FDA경부근긴장이상임상2상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009030470&t=NN
6061,2020-09-03,대웅제약미국보툴리눔톡신치료시장진출나선다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1412178
6062,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63150
6063,2020-09-03,대웅제약美보툴리눔톡신치료시장진출,http://www.healthinnews.co.kr/news/articleView.html?idxno=14271
6064,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=398000
6065,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출미래먹거리사업기대,http://www.newsprime.co.kr/news/article.html?no=516590
6066,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.onews.tv/news/articleView.html?idxno=29979
6067,2020-09-03,대웅제약美FDA나보타경부근긴장이상임상2상승인,http://it.chosun.com/site/data/html_dir/2020/09/03/2020090301099.html
6068,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상허가획득,http://yna.kr/AKR20200903063500017?did=1195m
6069,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.newstomato.com/ReadNews.aspx?no=993946
6070,2020-09-03,대웅제약美파트너사보툴리눔톡신경부근긴장이상2상임상승인,http://weekly.cnbnews.com/news/article.html?no=135807
6071,2020-09-03,대웅제약美보툴리눔톡신치료시장진출속도,https://view.asiae.co.kr/article/2020090310174623601
6072,2020-09-03,대웅제약나보타美톡신치료시장진출FDA임상2상승인,http://www.viva100.com/main/view.php?key=20200903010000620
6073,2020-09-03,대웅제약보툴리눔톡신제제미국서치료용임상2상승인,https://www.sedaily.com/NewsView/1Z7PMW7ALJ
6074,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상2상허가,http://www.metroseoul.co.kr/article/20200903500078
6075,2020-09-03,대웅제약나보타美FDA경부근긴장이상적응증임상2상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020090310161933023
6076,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://newsbrite.net/141169
6077,2020-09-03,전승호대웅제약사장나보타美시장성공위해끝까지최선,http://www.wikileaks-kr.org/news/articleView.html?idxno=94154
6078,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.pinpointnews.co.kr/view.php?ud=2020090310201479022365609d9b_45
6079,2020-09-03,대웅제약파트너사임상2상승인보톡스시장진출,http://www.mhj21.com/134457
6080,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.m-i.kr/news/articleView.html?idxno=743095
6081,2020-09-03,대웅제약미국FDA나보타경부근긴장이상임상2상승인,http://www.mediapen.com/news/view/554380
6082,2020-09-03,종근당지난해임상시험계획승인1위대웅제약에드파마HK이노엔한미약품도선방,https://biz.chosun.com/site/data/html_dir/2020/09/03/2020090301317.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6083,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.bokuennews.com/news/article.html?no=194208
6084,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.todaykorea.co.kr/news/articleView.html?idxno=276107
6085,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상2상허가,https://www.dailian.co.kr/news/view/917075/?sc=Naver
6086,2020-09-03,대웅제약파트너사이온바이오파마美FDA서임상2상승인,https://www.asiatoday.co.kr/view.php?key=20200903010002071
6087,2020-09-03,대웅제약美보툴리눔톡신치료시장초읽기내년상반기임상2상돌입,http://www.newspim.com/news/view/20200903000483
6088,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.dailysmart.co.kr/news/articleView.html?idxno=32218
6089,2020-09-03,대웅제약나보타미국서경부근긴장이상임상2상승인,http://www.upinews.kr/newsView/upi202009030039
6090,2020-09-03,대웅제약미국보툴리눔톡신시장진출속도,http://www.monews.co.kr/news/articleView.html?idxno=213251
6091,2020-09-03,대웅제약美보툴리눔톡신치료시장진출본격화FDA임상2상승인,http://www.newslock.co.kr/news/articleView.html?idxno=30768
6092,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.segyebiz.com/newsView/20200903511854?OutUrl=naver
6093,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.thepublic.kr/news/newsview.php?ncode=1065575735827748
6094,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.ceoscoredaily.com/news/article.html?no=72862
6095,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.kpinews.co.kr/news/articleView.html?idxno=125044
6096,2020-09-03,오늘의제약메디톡스대웅제약광동제약동화약품유한건강생활,http://www.babytimes.co.kr/news/articleView.html?idxno=39110
6097,2020-09-03,대웅제약美보툴리눔톡신치료시장진출,http://news.mk.co.kr/newsRead.php?no=910162&year=2020
6098,2020-09-03,대웅제약나보타FDA서치료목적임상2상승인획득,http://www.insightkorea.co.kr/news/articleView.html?idxno=82553
6099,2020-09-03,대웅제약치료용보툴리눔톡신미국임상허가획득,http://www.seoulfn.com/news/articleView.html?idxno=394095
6100,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출美임상2상승인,http://www.pressm.kr/news/articleView.html?idxno=32887
6101,2020-09-03,대웅제약미국보툴리눔톡신시장본격진출,https://www.news2day.co.kr/159882
6102,2020-09-03,美FDA대웅제약치료용보툴리놈톡신2상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002478
6103,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.econovill.com/news/articleView.html?idxno=410580
6104,2020-09-03,대웅제약나보타미국치료시장임상내년시작,https://hankookilbo.com/News/Read/A2020090309520004121?did=NA
6105,2020-09-03,대웅제약보툴리눔톡신치료제로미국에서임상2상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=194505
6106,2020-09-03,대웅제약美FDA서보툴리늄톡신임상2상승인받아,http://www.opinionnews.co.kr/news/articleView.html?idxno=39226
6107,2020-09-03,대웅제약美ITC소송승소자신감승천,http://www.whosaeng.com/120592
6108,2020-09-03,대웅제약FDA나보타경부근긴장이상임상2상승인,http://www.dailymedi.com/detail.php?number=860059&thread=22r05
6109,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.medigatenews.com/news/1709155065
6110,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.businesskorea.co.kr/news/articleView.html?idxno=51283
6111,2020-09-03,대웅제약美보톡스치료시장진출,http://www.finomy.com/news/articleView.html?idxno=82532
6112,2020-09-03,대웅제약보툴리눔톡신FDA서치료용임상2상승인美시장본격진출,http://www.thevaluenews.co.kr/news/view.php?idx=160699
6113,2020-09-03,대웅제약美치료용보톡스시장진출본격화,http://www.koreastocknews.com/news/articleView.html?idxno=56824
6114,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://news.kbiz.or.kr/news/articleView.html?idxno=72053
6115,2020-09-03,대웅제약美FDA로부터나보타치료제임상2상승인미용이어치료시장진출박차,https://www.donga.com/news/article/all/20200903/102777447/1
6116,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.worktoday.co.kr/news/articleView.html?idxno=9849
6117,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.lawissue.co.kr/view.php?ud=202009031438273735204ead0791_12
6118,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.nbnnews.co.kr/news/articleView.html?idxno=421288
6119,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.shinailbo.co.kr/news/articleView.html?idxno=1316899
6120,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,https://jhealthmedia.joins.com/article/article_view.asp?pno=22343
6121,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상허가받아,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4269103
6122,2020-09-03,김해시대웅제약자회사김해강소특구에유치,http://www.gimhaenews.co.kr/news/articleView.html?idxno=33698
6123,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.updownnews.co.kr/news/articleView.html?idxno=222765
6124,2020-09-03,특구재단대웅제약바이오분야기술창업기업인큐베이팅협력MOU,http://news.mt.co.kr/mtview.php?no=2020090315234515919
6125,2020-09-03,김해강소특구대웅제약자회사유치,http://www.kndaily.co.kr/news/articleView.html?idxno=166896
6126,2020-09-03,대웅제약협력사이온보툴리눔톡신치료2상美승인,https://www.hankyung.com/it/article/202009031069i
6127,2020-09-03,대웅제약나보타경부근긴장이상치료임상2상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=215826&category=D
6128,2020-09-03,특구진흥재단대웅제약과바이오분야스타트업발굴협약,http://www.ccnnews.co.kr/news/articleView.html?idxno=191468
6129,2020-09-03,특구재단대웅제약특구내히든스타트업발굴협약,http://yna.kr/AKR20200903152300063?did=1195m
6130,2020-09-03,김해강소특구대웅제약자회사유치,http://www.newsis.com/view/?id=NISX20200903_0001153863&cID=10812&pID=10800
6131,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.thefirstmedia.net/news/articleView.html?idxno=62658
6132,2020-09-03,대웅제약선진국보툴리눔톡신치료시장진출잰걸음,http://www.100ssd.co.kr/news/articleView.html?idxno=71131
6133,2020-09-03,대웅제약장애인고용안정릴레이캠페인동참,http://www.ablenews.co.kr/News/NewsContent.aspx?CategoryCode=0036&NewsCode=003620200903164814218555
6134,2020-09-03,특구재단대웅제약특구를바이오기술창업요람으로,http://www.newsis.com/view/?id=NISX20200903_0001153961&cID=10807&pID=10800
6135,2020-09-03,김창수의e뉴스브리핑대웅제약美보툴리눔톡신치료시장본격진출外,https://www.fetv.co.kr/news/article.html?no=62858
6136,2020-09-03,시경Today제약대웅제약미국보툴리눔톡신치료시장본격진출外,http://www.meconomynews.com/news/articleView.html?idxno=45060
6137,2020-09-03,특구재단대웅제약히든스타트업육성에맞손,http://www.dt.co.kr/contents.html?article_no=2020090302109931731006&ref=naver
6138,2020-09-03,특구재단대웅제약오픈콜라보플랫폼구축,http://www.ggilbo.com/news/articleView.html?idxno=793482
6139,2020-09-03,김해의생명강소특구대웅제약자회사유치,http://www.knnews.co.kr/news/articleView.php?idxno=1333203
6140,2020-09-03,특구재단대웅제약글로벌스타벤처육성을위한오픈콜라보플랫폼구축,http://www.cctoday.co.kr/news/articleView.html?idxno=2091935
6141,2020-09-03,김해시，강소특구에대웅제약자회사유치,http://www.gnmaeil.com/news/articleView.html?idxno=456902
6142,2020-09-03,특구재단대웅제약특구내히든스타트업발굴협약,http://www.fntoday.co.kr/news/articleView.html?idxno=230844
6143,2020-09-04,김해시김해강소특구에대웅제약자회사유치,http://moneys.mt.co.kr/news/mwView.php?no=2020090406408065657
6144,2020-09-04,장애인고용공단경기맞춤훈련센터㈜대웅제약과장애인고용안정캠페인,http://www.greened.kr/news/articleView.html?idxno=267957
6145,2020-09-04,제약街23세가뛴다갑질회장윤재승대웅제약경영복귀시동걸까,http://www.inews24.com/view/1296385
6146,2020-09-04,대웅제약나보타웹세미나개최효과적통증감소시술노하우공유,https://www.fetv.co.kr/news/article.html?no=62887
6147,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.youthdaily.co.kr/news/article.html?no=46639
6148,2020-09-04,대웅제약나보타웹세미나개최,http://www.bosa.co.kr/news/articleView.html?idxno=2133703
6149,2020-09-04,통증감소시술노하우공유대웅제약나보타웹세미나개최,http://www.koreaittimes.com/news/articleView.html?idxno=100155
6150,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571884179922
6151,2020-09-04,대웅제약나보타웹세미나개최,https://www.ebn.co.kr/news/view/1449494/?sc=Naver
6152,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.ekn.kr/news/article.html?no=521199
6153,2020-09-04,대웅제약통증감소시술노하우공개나보타웹세미나개최,http://www.pressm.kr/news/articleView.html?idxno=32927
6154,2020-09-04,대웅제약나보타웹세미나개최,http://www.press9.kr/news/articleView.html?idxno=45726
6155,2020-09-04,대웅제약나보타효과적통증감소시술노하우공유,http://www.econovill.com/news/articleView.html?idxno=410694
6156,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://newsbrite.net/141205
6157,2020-09-04,대웅제약보툴리눔톡신나보타웹세미나개최,http://www.mediapen.com/news/view/554757
6158,2020-09-04,대웅제약나보타웹세미나통증감소시술노하우공유,http://medipana.com/news/news_viewer.asp?NewsNum=262313&MainKind=A&NewsKind=5&vCount=12&vKind=1
6159,2020-09-04,대웅제약나보타웹세미나개최통증완화시술노하우공유,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090409415915600
6160,2020-09-04,대웅제약나보타웹세미나개최비대면마케팅강화,http://www.newsis.com/view/?id=NISX20200904_0001154454&cID=13001&pID=13000
6161,2020-09-04,대웅제약나보타웹세미나개최마케팅강화,http://theviewers.co.kr/View.aspx?No=1071584
6162,2020-09-04,대웅제약나보타웹세미나통증감소시술노하우공유,http://www.medisobizanews.com/news/articleView.html?idxno=72456
6163,2020-09-04,대웅제약나보타웹세미나개최,http://www.monews.co.kr/news/articleView.html?idxno=213275
6164,2020-09-04,대웅제약나보타웹세미나개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63169
6165,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121125
6166,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.healthinnews.co.kr/news/articleView.html?idxno=14283
6167,2020-09-04,대웅제약보툴리눔톡신시술통증완화결과공유,http://www.meconomynews.com/news/articleView.html?idxno=45080
6168,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.metroseoul.co.kr/article/20200904500029
6169,2020-09-04,대웅제약나보타통증감소시술노하우공유웹세미나개최,http://www.whosaeng.com/120625
6170,2020-09-04,대웅제약나보타웨비나개최통증감소시술법공유,http://health.chosun.com/site/data/html_dir/2020/09/04/2020090401376.html
6171,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,https://jhealthmedia.joins.com/article/article_view.asp?pno=22351
6172,2020-09-04,대웅제약나보타라이브세미타성료,http://www.kpinews.co.kr/news/articleView.html?idxno=125150
6173,2020-09-04,대웅제약나보타비대면웹세미나개최효과적인통증감소시술노하우공유,http://www.pinpointnews.co.kr/view.php?ud=2020090410441916652365609d9b_45
6174,2020-09-04,뉴스투데이L대웅제약나보타웹세미나개최,https://www.news2day.co.kr/159961
6175,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.datasom.co.kr/news/articleView.html?idxno=108239
6176,2020-09-04,대웅제약미용성형의료진대상나보타웹세미나진행,http://www.newslock.co.kr/news/articleView.html?idxno=30815
6177,2020-09-04,대웅제약나보타웹세미나개최,http://www.marketnews.co.kr/news/articleView.html?idxno=51253
6178,2020-09-04,대웅제약나보타웹세미나에1200명미용성형의료진참여,http://www.medigatenews.com/news/2724523573
6179,2020-09-04,대웅제약건강기능식품쿠팡서추석특가전진행,http://news.tf.co.kr/read/economy/1810934.htm
6180,2020-09-04,오늘의제약화이자동국생명과학유비케어대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39145
6181,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.lawissue.co.kr/view.php?ud=202009041214118473204ead0791_12
6182,2020-09-04,김해시강소특구에대웅제약자회사유치,http://www.cnbnews.com/news/article.html?no=459420
6183,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.mdtoday.co.kr/mdtoday/index.html?no=398154
6184,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.m-i.kr/news/articleView.html?idxno=743584
6185,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.worktoday.co.kr/news/articleView.html?idxno=9880
6186,2020-09-04,대웅제약나보타라이브세미나개최,http://news.mk.co.kr/newsRead.php?no=915011&year=2020
6187,2020-09-04,대웅제약나보타웹세미나개최시술노하우공유,http://news.mt.co.kr/mtview.php?no=2020090411401773859
6188,2020-09-04,대웅제약나보타통증완화시술법공유온라인세미나개최,https://www.donga.com/news/article/all/20200904/102793201/1
6189,2020-09-04,대웅제약나보타라이브세미나개최,http://www.consumuch.com/news/articleView.html?idxno=50479
6190,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.nbnnews.co.kr/news/articleView.html?idxno=421640
6191,2020-09-04,대웅제약건강기능식품단하루할인판매진행,http://www.newstomato.com/ReadNews.aspx?no=994308
6192,2020-09-04,단독대웅제약대상포진백신스카이조스터공동판매때도계약사항어겨,http://news.mk.co.kr/newsRead.php?no=915523&year=2020
6193,2020-09-04,대웅제약나보타웹세미나개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1412563
6194,2020-09-04,대웅제약발달장애인건강한삶위해따듯한동행,http://www.g-enews.com/ko-kr/news/article/news_all/20200904151727484369d76442fa_1/article.html
6195,2020-09-04,대웅제약나보타디지털마케팅강화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1317391
6196,2020-09-04,김창수의e뉴스브리핑대웅제약나보타웹세미나개최효과적통증감소시술노하우공유外,https://www.fetv.co.kr/news/article.html?no=62944
6197,2020-09-04,대웅제약나보타통증감소시술웹세미나열어,https://www.kpanews.co.kr/article/show.asp?idx=215862&category=D
6198,2020-09-04,대웅제약과ITC승소굳치기메디톡스1800억유상증자승부수,http://www.wikileaks-kr.org/news/articleView.html?idxno=94269
6199,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.paxetv.com/news/articleView.html?idxno=99603
6200,2020-09-05,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.updownnews.co.kr/news/articleView.html?idxno=222837
6201,2020-09-05,대웅제약미용성형분야의료진대상나보타웹세미나개최비대면마케팅강화,http://www.econonews.co.kr/news/articleView.html?idxno=135379
6202,2020-09-06,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.thefirstmedia.net/news/articleView.html?idxno=62746
6203,2020-09-07,대웅제약코로나치료제필리핀환자대상1상승인,https://www.ebn.co.kr/news/view/1449674/?sc=Naver
6204,2020-09-07,대웅제약니클로사마이드코로나19필리핀1상승인,http://www.press9.kr/news/articleView.html?idxno=45735
6205,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020090709061892175
6206,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상돌입,http://www.ekn.kr/news/article.html?no=521566
6207,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.viva100.com/main/view.php?key=20200907010001190
6208,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.sentv.co.kr/news/view/578885
6209,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=743944
6210,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀임상1상승인,https://www.fetv.co.kr/news/article.html?no=62986
6211,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀서임상1상승인,http://www.fnnews.com/news/202009070914189239
6212,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://news.mt.co.kr/mtview.php?no=2020090709110525397
6213,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=46795
6214,2020-09-07,대웅제약니클로사마이드코로나19필리핀임상1상승인,https://www.dailian.co.kr/news/view/917791/?sc=Naver
6215,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.lawissue.co.kr/view.php?ud=20200907091758351204ead0791_12
6216,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=32346
6217,2020-09-07,대웅제약코로나19치료제필리핀임상1상승인,http://health.chosun.com/site/data/html_dir/2020/09/07/2020090700823.html
6218,2020-09-07,대웅제약코로나19치료제필리핀서임상1상승인받아,https://www.etoday.co.kr/news/view/1937696
6219,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248692
6220,2020-09-07,대웅제약니클로사마이드코로나19필리핀1상승인,http://www.mediapen.com/news/view/555334
6221,2020-09-07,대웅제약코로나19치료제필리핀서임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090709160278749
6222,2020-09-07,대웅제약코로나19치료제필리핀임상1상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=02004086625897824
6223,2020-09-07,ITC나보타최종판결2달앞으로대웅제약코로나개발집중,http://www.wikileaks-kr.org/news/articleView.html?idxno=94329
6224,2020-09-07,대웅제약코로나19치료제니클로사마이드임상1상승인글로벌임상및개발본격화,http://www.paxetv.com/news/articleView.html?idxno=99638
6225,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.medigatenews.com/news/2983209973
6226,2020-09-07,대웅제약필리핀서도코로나19대상니클로사마이드임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=920885&year=2020
6227,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀서임상1상승인,http://www.econovill.com/news/articleView.html?idxno=410943
6228,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀1상승인,http://www.newsis.com/view/?id=NISX20200907_0001156566&cID=13001&pID=13000
6229,2020-09-07,대웅제약코로나치료제필리핀서임상1상승인,http://www.newspim.com/news/view/20200907000124
6230,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제로임상1상승인,http://yna.kr/AKR20200907040300017?did=1195m
6231,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://news.heraldcorp.com/view.php?ud=20200907000163
6232,2020-09-07,대웅제약필리핀서코로나19치료제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009070086&t=NN
6233,2020-09-07,대웅제약니클로사마이드필리핀임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=262389&MainKind=A&NewsKind=5&vCount=12&vKind=1
6234,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀환자대상임상1상승인,https://www.sedaily.com/NewsView/1Z7RHBTG1A
6235,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://newsbrite.net/141273
6236,2020-09-07,대웅제약필리핀에서코로나19치료제임상1상시험승인,http://www.busan.com/view/busan/view.php?code=2020090709390625584
6237,2020-09-07,대웅제약필리핀서코로나치료제로임상1상승인,https://www.hankyung.com/society/article/2020090706427
6238,2020-09-07,대웅제약코로나19藥니클로사마이드필리핀1상승인,https://www.hankyung.com/it/article/202009070649i
6239,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=398281
6240,2020-09-07,대웅제약필리핀FDA서코로나19치료제임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=125219
6241,2020-09-07,대웅제약니클로사마이드코로나19치료제로필리핀1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=72494
6242,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.newstomato.com/ReadNews.aspx?no=994553
6243,2020-09-07,대웅제약니클로사마이드코로나19치료제PFDA임상1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121194
6244,2020-09-07,대웅제약니클로사마이드코로나19치료제개발본격화기대감조성,http://theviewers.co.kr/View.aspx?No=1072953
6245,2020-09-07,대웅제약필리핀서코로나19치료제임상1상승인,http://www.marketnews.co.kr/news/articleView.html?idxno=51319
6246,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제임상1상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004100565
6247,2020-09-07,대웅제약구충제성분필리핀서코로나치료제로임상1상승인,https://news.joins.com/article/olink/23460492
6248,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://news.mk.co.kr/newsRead.php?no=921126&year=2020
6249,2020-09-07,대웅제약인도이어필리핀서도코로나19임상1상진행,https://jhealthmedia.joins.com/article/article_view.asp?pno=22357
6250,2020-09-07,대웅제약필리핀환자대상니클로사마이드임상1상승인,http://www.newsprime.co.kr/news/article.html?no=516953
6251,2020-09-07,대웅제약니클로사마이드코로나치료제필리핀서1상,http://www.bosa.co.kr/news/articleView.html?idxno=2133811
6252,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상승인,http://www.bokuennews.com/news/article.html?no=194316
6253,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14304
6254,2020-09-07,대웅제약코로나치료제필리핀서임상시험승인,https://www.chosun.com/economy/science/2020/09/07/YBUEVWE3CJCQTOGKDIB725KFFI/?utm_source=naver&utm_medium=original&utm_campaign=news
6255,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009070068&t=NN
6256,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63196
6257,2020-09-07,대웅제약글로벌코로나19치료제개발본격화필리핀임상1상승인,http://kbench.com/?q=node/213880
6258,2020-09-07,대웅제약코로나19치료제필리핀서임상1상승인,http://www.koreaittimes.com/news/articleView.html?idxno=100199
6259,2020-09-07,대웅제약추석앞두고쿠팡서건강기능식품할인기획전진행,http://www.newspost.kr/news/articleView.html?idxno=90072
6260,2020-09-07,오늘의제약메디톡스GC녹십자웰빙대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39180
6261,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=72931
6262,2020-09-07,대웅제약코로나19치료제필리핀임상1상승인,http://www.mhj21.com/134515
6263,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상승인,http://www.pinpointnews.co.kr/view.php?ud=2020090710222124022365609d9b_45
6264,2020-09-07,대웅제약구충제성분코로나19치료제필리핀임상돌입우수한효능에심사2개월단축,https://www.donga.com/news/article/all/20200907/102819362/1
6265,2020-09-07,대웅제약필리핀에서니클로사마이드코로나19치료제임상1상종합,https://biz.chosun.com/site/data/html_dir/2020/09/07/2020090701261.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6266,2020-09-07,대웅제약구충제필리핀서코로나19임상이번달첫투여,http://moneys.mt.co.kr/news/mwView.php?no=2020090709408056651
6267,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://sports.hankooki.com/lpage/economy/202009/sp20200907103104136980.htm?s_ref=nv
6268,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀환자대상임상 1상승인,http://www.greened.kr/news/articleView.html?idxno=268171
6269,2020-09-07,대웅제약DWRX2003필리핀서코로나19치료제로임상1상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065575356642865
6270,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://www.etnews.com/20200907000054
6271,2020-09-07,대웅제약필리핀서니클로사마이드코로나19임상진행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002573
6272,2020-09-07,제약워치대웅제약니클로사마이드코로나19치료제글로벌임상개발확대外,http://www.newswatch.kr/news/articleView.html?idxno=50865
6273,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인받아,http://www.datasom.co.kr/news/articleView.html?idxno=108284
6274,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀임상1상,http://www.upinews.kr/newsView/upi202009070034
6275,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065575049080571
6276,2020-09-07,인도이어필리핀대웅제약코로나치료제임상승인,http://www.whosaeng.com/120672
6277,2020-09-07,대웅제약구충제성분필리핀서코로나치료제임상계획승인,https://view.asiae.co.kr/article/2020090711331105776
6278,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.pharmnews.com/news/articleView.html?idxno=101244
6279,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상승인,http://www.metroseoul.co.kr/article/20200907500171
6280,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀환자대상임상1상승인,http://www.ezyeconomy.com/news/articleView.html?idxno=104992
6281,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제임상승인,http://www.newsquest.co.kr/news/articleView.html?idxno=78498
6282,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=30860
6283,2020-09-07,대웅제약니클로사마이드필리핀서코로나19치료제임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4272493
6284,2020-09-07,대웅제약주가니클로사마이드필리핀1상승인소식에소폭상승세,http://www.ccreview.co.kr/news/articleView.html?idxno=283423
6285,2020-09-07,대웅제약필리핀에서코로나19치료제임상1상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=194933
6286,2020-09-07,대웅제약구충제니클로사마이드필리핀서코로나19치료제로임상1상승인,http://news.tf.co.kr/read/economy/1811366.htm
6287,2020-09-07,대웅제약니클로사마이드코로나19치료제임상1상승인쾌거,http://www.pressm.kr/news/articleView.html?idxno=33004
6288,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상,https://www.news1.kr/articles/?4050744
6289,2020-09-07,대웅제약해외서코로나19치료제임상에속도낸다,http://www.seoulwire.com/news/articleView.html?idxno=426051
6290,2020-09-07,대웅제약코로나치료제나올까필리핀서임상1상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=71200
6291,2020-09-07,대웅제약니클로사마이드코로나치료제로필리핀서임상1상승인,http://inthenews.co.kr/article-67927/
6292,2020-09-07,특징주대웅제약코로나19치료제해외임상소식에216↑,http://moneys.mt.co.kr/news/mwView.php?no=2020090714178068368
6293,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.getnews.co.kr/view.php?ud=2020090714204295402fe691f917_16
6294,2020-09-07,대웅제약 코로나19 치료제 필리핀서 임상 1상 승인,http://kormedi.com/?p=1323838
6295,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제로임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4272659
6296,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=422270
6297,2020-09-07,대웅제약코로나19치료제개발탄력붙나,http://www.segye.com/content/html/2020/09/07/20200907515624.html?OutUrl=naver
6298,2020-09-07,LG화학대웅제약제미글로공동판매재협상에관심집중,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002594
6299,2020-09-07,대웅제약코로나19치료제필리핀PFDA로부터임상1상승인,https://www.news2day.co.kr/160091
6300,2020-09-07,대웅제약 니클로사마이드 코로나19 치료제필리핀환자대상임상 1상승인,http://www.economytalk.kr/news/articleView.html?idxno=208006
6301,2020-09-07,대웅제약구충제성분니클로사마이드필리핀서코로나19치료제로임상1상승인,http://www.topstarnews.net/news/articleView.html?idxno=832047
6302,2020-09-07,위드코로나시대명절선물키워드는건강대웅제약건기식라인업확대,http://www.sportsseoul.com/news/read/955866?ref=naver
6303,2020-09-07,대웅제약필리핀서니클로사마이드코로나19임상,http://www.seoulfn.com/news/articleView.html?idxno=394435
6304,2020-09-07,시경Today제약대웅제약니클로사마이드코로나치료제필리핀환자임상1상승인外,http://www.meconomynews.com/news/articleView.html?idxno=45135
6305,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.opinionnews.co.kr/news/articleView.html?idxno=39419
6306,2020-09-07,대웅제약코로나치료제필리핀임상1상승인,http://www.skyedaily.com/news/news_view.html?ID=111527
6307,2020-09-07,대웅제약코로나19치료제필리핀에서임상1상승인,http://daily.hankooki.com/lpage/industry/202009/dh20200907155834148390.htm?s_ref=nv
6308,2020-09-07,부침겪은대웅제약1조클럽재입성가능할까,http://www.wolyo.co.kr/news/articleView.html?idxno=109189
6309,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=9932
6310,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=104232
6311,2020-09-07,대웅제약필리핀서코로나19치료제임상승인받아,http://www.finomy.com/news/articleView.html?idxno=82693
6312,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상승인,http://weekly.hankooki.com/lpage/economy/202009/wk20200907170813146380.htm?s_ref=nv
6313,2020-09-07,대웅제약코로나19치료제니클로사마이드인도이어필리핀임상1상승인,http://hobbyen.co.kr/news/newsview.php?ncode=1065600893395394
6314,2020-09-07,김창수의e뉴스브리핑대웅제약코로나치료제니클로사마이드필리핀임상1상승인外,https://www.fetv.co.kr/news/article.html?no=63064
6315,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀임상1상승인,https://www.asiatoday.co.kr/view.php?key=20200907010003655
6316,2020-09-07,대웅제약필리핀서코로나19치료제임상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1318208
6317,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=486267
6318,2020-09-07,대웅제약니클로사마이드임상1상승인필리핀서코로나환자40명대상첫투여,http://www.dt.co.kr/contents.html?article_no=2020090802101831102002&ref=naver
6319,2020-09-07,대웅제약코로나19치료제로개발중인니클로사마이드필리핀1상승인,http://www.econonews.co.kr/news/articleView.html?idxno=135602
6320,2020-09-07,대웅제약필리핀서니클로사마이드코로나191상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=215924&category=D
6321,2020-09-08,단독대웅제약인니서코로나줄기세포치료제임상착수내년2상추진,https://www.theguru.co.kr/news/article.html?no=13937
6322,2020-09-08,ITC최종판결D60메디톡스대웅제약치열한생존전략,https://www.dailian.co.kr/news/view/917983/?sc=Naver
6323,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.fnnews.com/news/202009080835427327
6324,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.press9.kr/news/articleView.html?idxno=45748
6325,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://medipana.com/news/news_viewer.asp?NewsNum=262460&MainKind=A&NewsKind=5&vCount=12&vKind=1
6326,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.m-i.kr/news/articleView.html?idxno=744344
6327,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종신규출시,http://www.youthdaily.co.kr/news/article.html?no=46907
6328,2020-09-08,어린이양치습관안심”대웅제약덴티가드랩그립핏칫솔어린이용2종출시,https://www.fetv.co.kr/news/article.html?no=63081
6329,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.whosaeng.com/120695
6330,2020-09-08,대웅제약KC인증받은어린이용덴티가드랩그립핏칫솔출시,http://moneys.mt.co.kr/news/mwView.php?no=2020090809088096578
6331,2020-09-08,오늘의신상품대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.econovill.com/news/articleView.html?idxno=411109
6332,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.mediapen.com/news/view/555801
6333,2020-09-08,대웅제약어린이용덴티가드랩그립핏칫솔2종출시,http://news.mk.co.kr/newsRead.php?no=925663&year=2020
6334,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63226
6335,2020-09-08,칫솔물고씹어도OK대웅제약어린이안심칫솔출시,http://www.newsis.com/view/?id=NISX20200908_0001158007&cID=13001&pID=13000
6336,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://newsbrite.net/141304
6337,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,https://www.ebn.co.kr/news/view/1449882/?sc=Naver
6338,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://news.mk.co.kr/newsRead.php?no=925721&year=2020
6339,2020-09-08,대웅제약어린이용덴티가드랩그린핏칫솔2종출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065570505447456
6340,2020-09-08,대웅제약어린이용덴티가드랩그립핏칫솔2종출시,http://www.medisobizanews.com/news/articleView.html?idxno=72525
6341,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020090809371410651
6342,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.metroseoul.co.kr/article/20200908500056
6343,2020-09-08,대웅제약안심하고사용할수있는덴티가드랩어린이용칫솔2종출시,https://www.donga.com/news/article/all/20200908/102835572/1
6344,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://news.mt.co.kr/mtview.php?no=2020090808404450507
6345,2020-09-08,대웅제약어린이용덴티가드랩그립핏칫솔출시양치습관케어,http://theviewers.co.kr/View.aspx?No=1074035
6346,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종선보여,http://www.pressm.kr/news/articleView.html?idxno=33017
6347,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=14321
6348,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.bosa.co.kr/news/articleView.html?idxno=2133922
6349,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용출시,http://www.koreaittimes.com/news/articleView.html?idxno=100235
6350,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.kpinews.co.kr/news/articleView.html?idxno=125362
6351,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248765
6352,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.segyebiz.com/newsView/20200908510690?OutUrl=naver
6353,2020-09-08,뉴스투데이L대웅제약덴티가드랩그립핏칫솔어린이용2종출시,https://www.news2day.co.kr/160166
6354,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=32445
6355,2020-09-08,오늘의제약GC녹십자대웅제약KIMCo네이버신테카바이오AI센터제약바이오협회,http://www.babytimes.co.kr/news/articleView.html?idxno=39223
6356,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=422592
6357,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.worktoday.co.kr/news/articleView.html?idxno=9950
6358,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=398455
6359,2020-09-08,대웅제약덴티가드랩어린이용칫솔2종출시,http://www.finomy.com/news/articleView.html?idxno=82739
6360,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.updownnews.co.kr/news/articleView.html?idxno=222945
6361,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.thepublic.kr/news/newsview.php?ncode=1065592793947570
6362,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.lawissue.co.kr/view.php?ud=202009081641378856204ead0791_12
6363,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://weekly.hankooki.com/lpage/life/202009/wk20200908171904147650.htm?s_ref=nv
6364,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.thefirstmedia.net/news/articleView.html?idxno=62881
6365,2020-09-08,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=62898
6366,2020-09-09,이번에는대웅제약코로나19치료제글로벌임상순항,http://www.bosa.co.kr/news/articleView.html?idxno=2134008
6367,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제현지건강인대상투약시작,http://www.lawissue.co.kr/view.php?ud=202009090736487445204ead0791_12
6368,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.m-i.kr/news/articleView.html?idxno=744742
6369,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.sentv.co.kr/news/view/579059
6370,2020-09-09,대웅제약코로나19치료제니클로사마이드인도1상투약시작,https://www.hankyung.com/it/article/202009099047i
6371,2020-09-09,대웅제약코로나19치료제글로벌임상순항중,http://www.medisobizanews.com/news/articleView.html?idxno=72550
6372,2020-09-09,대웅제약인도서니클로사마이드코로나임상1상환자첫투약,http://www.viva100.com/main/view.php?key=20200909010001793
6373,2020-09-09,대웅제약인도서코로나19대상니클로사마이드임상1상투약개시,http://news.mk.co.kr/newsRead.php?no=929777&year=2020
6374,2020-09-09,대웅제약코로나치료제임상순항인도이어필리핀서환자투약,http://news.mt.co.kr/mtview.php?no=2020090908181712425
6375,2020-09-09,대웅제약코로나19치료제니클로사마이드인도1상투약,https://view.asiae.co.kr/article/2020090908292366634
6376,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.getnews.co.kr/view.php?ud=2020090908283818412fe691f917_16
6377,2020-09-09,대웅제약코로나치료제글로벌임상순항,https://www.ebn.co.kr/news/view/1450049/?sc=Naver
6378,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248795
6379,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제안전성확인,http://www.press9.kr/news/articleView.html?idxno=45762
6380,2020-09-09,대웅제약코로나치료제임상순항중인도첫환자투약,http://www.newspim.com/news/view/20200909000098
6381,2020-09-09,대웅제약구충제인도서코로나임상1상환자첫투약,http://moneys.mt.co.kr/news/mwView.php?no=2020090908348093477
6382,2020-09-09,대웅제약코로나19치료제글로벌임상순항인체투약돌입,http://www.ekn.kr/news/article.html?no=522076
6383,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,https://www.fetv.co.kr/news/article.html?no=63174
6384,2020-09-09,대웅제약코로나19치료제인도에서피험자대상투약시작,https://www.etoday.co.kr/news/view/1938636
6385,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항중,https://www.dailian.co.kr/news/view/918334/?sc=Naver
6386,2020-09-09,대웅제약니클로사마이드글로벌임상순항,http://medipana.com/news/news_viewer.asp?NewsNum=262531&MainKind=A&NewsKind=5&vCount=12&vKind=1
6387,2020-09-09,대웅제약인도서니클로사마이드코로나임상1상투약개시”,http://www.newsway.co.kr/news/view?tp=1&ud=2020090909011764969
6388,2020-09-09,대웅제약코로나19치료제글로벌임상순항중,http://www.businesskorea.co.kr/news/articleView.html?idxno=51477
6389,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.fnnews.com/news/202009090905503569
6390,2020-09-09,대웅제약코로나19치료제니클로사마이드인도임상1상투약개시,http://www.newstomato.com/ReadNews.aspx?no=995028
6391,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://newsbrite.net/141346
6392,2020-09-09,대웅제약니클로사마이드코로나19치료제개발글로벌임상순항”,http://www.youthdaily.co.kr/news/article.html?no=47026
6393,2020-09-09,대웅제약코로나19치료제니클로사마이드글로벌임상순항,http://health.chosun.com/site/data/html_dir/2020/09/09/2020090900896.html
6394,2020-09-09,대웅제약코로나19치료제개발인도서순항,http://www.wikileaks-kr.org/news/articleView.html?idxno=94491
6395,2020-09-09,대웅제약니클로사마이드코로나1상환자투약시작,http://www.newsis.com/view/?id=NISX20200909_0001159490&cID=13001&pID=13000
6396,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제니클로사마이드임상순항 ,http://www.pressm.kr/news/articleView.html?idxno=33065
6397,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제글로벌임상순항,http://www.koreaittimes.com/news/articleView.html?idxno=100268
6398,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.pharmnews.com/news/articleView.html?idxno=101255
6399,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63249
6400,2020-09-09,대웅제약코로나19대상니클로사마이드임상1상투약시작,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4274696
6401,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제후보니클로사마이드환자투약시작,http://theviewers.co.kr/View.aspx?No=1076205
6402,2020-09-09,대웅제약DWRX2003코로나19치료제인도임상순항중,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571108079927
6403,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.fnnews.com/news/202009090949214597
6404,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248815
6405,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63258
6406,2020-09-09,대웅제약LG화학제미글로 공동프로모션지속합의,http://www.economytalk.kr/news/articleView.html?idxno=208040
6407,2020-09-09,대웅제약코로나19치료제인도서임상투약시작,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009090110&t=NN
6408,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.ekn.kr/news/article.html?no=522130
6409,2020-09-09,대웅제약1000억규모당뇨약지켰다LG화학공동프로모션2030년까지유지,http://moneys.mt.co.kr/news/mwView.php?no=2020090909488045490
6410,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.medisobizanews.com/news/articleView.html?idxno=72562
6411,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.koreaittimes.com/news/articleView.html?idxno=100275
6412,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항중,http://www.healthinnews.co.kr/news/articleView.html?idxno=14344
6413,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.youthdaily.co.kr/news/article.html?no=47041
6414,2020-09-09,대웅제약LG화학제미글로계속판매한다,http://www.press9.kr/news/articleView.html?idxno=45767
6415,2020-09-09,대웅제약LG화학2030년까지제미글로공동프로모션지속,http://daily.hankooki.com/lpage/industry/202009/dh20200909095817148390.htm?s_ref=nv
6416,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1413444
6417,2020-09-09,대웅제약LG화학 제미글로 공동프로모션지속합의,http://www.greened.kr/news/articleView.html?idxno=268525
6418,2020-09-09,대웅제약인도에서코로나19치료제임상1상투약시작,https://biz.chosun.com/site/data/html_dir/2020/09/09/2020090901176.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6419,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,https://www.kpanews.co.kr/article/show.asp?idx=215958&category=D
6420,2020-09-09,대웅제약LG화학제미글로공동프로모션합의,http://www.sentv.co.kr/news/view/579081
6421,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.ceoscoredaily.com/news/article.html?no=73021
6422,2020-09-09,대웅제약LG화학과제미글로공동프로모션지속,http://www.newstomato.com/ReadNews.aspx?no=995057
6423,2020-09-09,대웅제약LG화학제미글로공동프로모션지속하기로,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090910035613348
6424,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.lawissue.co.kr/view.php?ud=20200909100645379907f28b58b8_12
6425,2020-09-09,대웅제약제미글로판매2030년까지계속LG화학發불확실성제거,http://www.viva100.com/main/view.php?key=20200909010001860
6426,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://newsbrite.net/141355
6427,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.pharmnews.com/news/articleView.html?idxno=101257
6428,2020-09-09,대웅제약코로나19치료제니클로사마이드인도서임상1상투약,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090910061911440
6429,2020-09-09,대웅제약LG화학당뇨병치료신약제미글로공동프로모션이어간다,https://www.etoday.co.kr/news/view/1938725
6430,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항,http://www.dailysmart.co.kr/news/articleView.html?idxno=32496
6431,2020-09-09,대웅제약코로나19치료제글로벌임상순항중,http://www.kpinews.co.kr/news/articleView.html?idxno=125469
6432,2020-09-09,대웅제약xLG화학제미글로공동프로모션10년더간다,http://www.upinews.kr/newsView/upi202009090030
6433,2020-09-09,대웅제약LG화학제미글로공동판매지속,http://www.dailypharm.com/Users/News/NewsView.html?ID=268304&REFERER=NP
6434,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.getnews.co.kr/view.php?ud=2020090910260139632fe691f917_16
6435,2020-09-09,대웅제약LG화학당뇨약제미글로공동프로모션지속키로,http://news.mk.co.kr/newsRead.php?no=930606&year=2020
6436,2020-09-09,대웅제약LG화학제미글로공동프로모션10년더,http://www.newsis.com/view/?id=NISX20200909_0001159742&cID=13001&pID=13000
6437,2020-09-09,대웅제약코로나19치로졔인도서임상1상돌입,https://www.sedaily.com/NewsView/1Z7SDFZP54
6438,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,https://www.fetv.co.kr/news/article.html?no=63207
6439,2020-09-09,대웅제약LG화학제미글로공동프로모션2030년까지,http://www.medigatenews.com/news/2845976347
6440,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.newsway.co.kr/news/view?tp=1&ud=2020090910300193194
6441,2020-09-09,대웅제약LG화학과1000억대매출제미글로공동판매10년더,https://www.news1.kr/articles/?4053027
6442,2020-09-09,대웅제약LG화학당뇨신약제미글로공동판매지속합의,http://www.econovill.com/news/articleView.html?idxno=411329
6443,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.bosa.co.kr/news/articleView.html?idxno=2134036
6444,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.metroseoul.co.kr/article/20200909500146
6445,2020-09-09,대웅제약니클로사마이드코로나19치료제임상순항중,http://www.upinews.kr/newsView/upi202009090033
6446,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의양사개발신약상호협력도추진,http://www.segye.com/content/html/2020/09/09/20200909509997.html?OutUrl=naver
6447,2020-09-09,대웅제약코로나치료제글로벌임상순항중,http://www.koreastocknews.com/news/articleView.html?idxno=56965
6448,2020-09-09,대웅제약니클로사마이드글로벌임상시험개시치료제개발본격화,http://www.newsprime.co.kr/news/article.html?no=517289
6449,2020-09-09,대웅제약해지통보LG화학과재계약제미글로10년간판매,http://news.mt.co.kr/mtview.php?no=2020090910505373895
6450,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상투약개시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002677
6451,2020-09-09,대웅제약LG화학과당뇨병치료신약제미글로공동프로모션지속최종합의,http://www.kdpress.co.kr/news/articleView.html?idxno=97285
6452,2020-09-09,오늘의제약대웅제약LG화학아스트라제네카GC녹십자사노피한미약품,http://www.babytimes.co.kr/news/articleView.html?idxno=39267
6453,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://medipana.com/news/news_viewer.asp?NewsNum=262553&MainKind=A&NewsKind=5&vCount=12&vKind=1
6454,2020-09-09,2030년까지함께한다”대웅제약LG화학당뇨병신약제미글로협력최종합의,https://www.donga.com/news/article/all/20200909/102855294/1
6455,2020-09-09,대웅제약LG화학과제미글로공동프로모션지속합의,http://www.mediapen.com/news/view/556253
6456,2020-09-09,대웅제약코로나19치료제인도에서투약안전성확인,http://www.metroseoul.co.kr/article/20200909500164
6457,2020-09-09,대웅제약LG화학과제미글로공동프로모션지속합의,http://news.mk.co.kr/newsRead.php?no=930980&year=2020
6458,2020-09-09,대웅제약LG화학제미글로공동프로모션지속,http://www.choicenews.co.kr/news/articleView.html?idxno=74368
6459,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.healthinnews.co.kr/news/articleView.html?idxno=14355
6460,2020-09-09,대웅제약LG화학제미글로공동프로모션30년까지지속,http://www.consumuch.com/news/articleView.html?idxno=50520
6461,2020-09-09,대웅제약니클로사마이드코로나19치료제인도임상1상투약개시,http://www.mdtoday.co.kr/mdtoday/index.html?no=398565
6462,2020-09-09,대웅제약LG화학제미글로공동프로모션2030년까지지속합의,http://www.mdtoday.co.kr/mdtoday/index.html?no=398564
6463,2020-09-09,대웅제약잇따른계약사항위반으로계약종료구설수논란들여다보니,http://www.startuptoday.co.kr/news/articleView.html?idxno=53725
6464,2020-09-09,대웅제약LG화학당뇨병치료제제미글로공동프로모션지속키로,http://www.pinpointnews.co.kr/view.php?ud=2020090911380219092365609d9b_45
6465,2020-09-09,LG화학대웅제약매출1000억제미글로신화이어간다,http://www.dailymedi.com/detail.php?number=860276&thread=22r05
6466,2020-09-09,대웅제약LG화학과공동프로모션지속합의,http://www.businesskorea.co.kr/news/articleView.html?idxno=51502
6467,2020-09-09,대웅제약구충제성분코로나19치료제인체투약개시서방형주사제로효능차별화”,https://www.donga.com/news/article/all/20200909/102857105/1
6468,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.wsobi.com/news/articleView.html?idxno=104411
6469,2020-09-09,대웅제약LG화학제미글로공동프로모션지속,http://www.monews.co.kr/news/articleView.html?idxno=213387
6470,2020-09-09,대웅제약LG화학제미글로공동판매지속키로계약해지논란종식,http://www.todaykorea.co.kr/news/articleView.html?idxno=276354
6471,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.m-i.kr/news/articleView.html?idxno=744896
6472,2020-09-09,대웅제약XLG화학당뇨병치료제제미글로공동프로모션합의,http://weekly.hankooki.com/lpage/economy/202009/wk20200909131641146380.htm?s_ref=nv
6473,2020-09-09,대웅제약LG화학제미글로공동판매10년더,http://www.newspim.com/news/view/20200909000614
6474,2020-09-09,대웅제약코로나19치료제인도임상1상시작전승호속도내겠다,http://www.businesspost.co.kr/BP?command=article_view&num=195325
6475,2020-09-09,대웅제약LG화학당뇨신약제미글로공동프로모션2030년까지지속한다,http://www.betanews.net:8080/article/1231976.html
6476,2020-09-09,대웅제약LG화학당뇨병신약제미글로공동판매2030년까지연장,http://www.businesspost.co.kr/BP?command=article_view&num=195334
6477,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,https://jhealthmedia.joins.com/article/article_view.asp?pno=22373
6478,2020-09-09,대웅제약LG화학제미글로공동프로모션지속한다,https://www.dailian.co.kr/news/view/918477/?sc=Naver
6479,2020-09-09,대웅제약코로나19치료제니클로사마이드글로벌임상순항중,http://news.kbiz.or.kr/news/articleView.html?idxno=72290
6480,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.nbnnews.co.kr/news/articleView.html?idxno=423000
6481,2020-09-09,대웅제약2030년까지LG화학과제미글로 공동프로모션지속한다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121341
6482,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제니클로사마이드현지인대상임상시작,http://www.newslock.co.kr/news/articleView.html?idxno=30922
6483,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.nbnnews.co.kr/news/articleView.html?idxno=423037
6484,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.worktoday.co.kr/news/articleView.html?idxno=9987
6485,2020-09-09,대웅제약LG화학당뇨병신약제미글로공동프로모션지속합의,http://www.newsprime.co.kr/news/article.html?no=517363
6486,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.worktoday.co.kr/news/articleView.html?idxno=9991
6487,2020-09-09,대웅제약LG화학제미글로2030년까지공동프로모션최종합의,http://www.k-health.com/news/articleView.html?idxno=50136
6488,2020-09-09,뉴스투데이L대웅제약LG화학과제미글로공동프로모션지속합의,https://www.news2day.co.kr/160290
6489,2020-09-09,대웅제약덴티가드랩그립핏칫솔어린이용2종선봬,https://www.kpanews.co.kr/article/show.asp?idx=215972&category=D
6490,2020-09-09,대웅제약LG화학당뇨병치료신약제미글로2030년까지공동프로모션,http://www.g-enews.com/ko-kr/news/article/news_all/2020090915513158042500a1b5d6_1/article.html
6491,2020-09-09,대웅제약인도서코로나치료제임상1상투약시작,http://www.skyedaily.com/news/news_view.html?ID=111681
6492,2020-09-09,대웅제약LG화학제미글로공동프로모션,http://www.mhj21.com/134571
6493,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.updownnews.co.kr/news/articleView.html?idxno=223022
6494,2020-09-09,대웅제약코로나19치료제니클로사마이드인도서건강인대상투약시작,http://kbench.com/?q=node/213981
6495,2020-09-09,대웅제약LG화학제미글로공동프로모션계약해지없다최종합의,http://theviewers.co.kr/View.aspx?No=1078281
6496,2020-09-09,대웅제약코로나19치료제임상순항,http://www.finomy.com/news/articleView.html?idxno=82820
6497,2020-09-09,대웅제약코로나19치료제니클로사마이드인도서임상1상투약,http://inthenews.co.kr/article-68363/
6498,2020-09-09,대웅제약LG화학당뇨병치료제제미글로공동프로모션지속합의,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004104074
6499,2020-09-09,대웅제약LG화학제미글로공동프로모션이어간다,http://www.finomy.com/news/articleView.html?idxno=82825
6500,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.thefirstmedia.net/news/articleView.html?idxno=62934
6501,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항중,https://www.asiatoday.co.kr/view.php?key=20200909010005736
6502,2020-09-09,대웅제약LG화학제미글로공동프로모션지속,http://www.shinailbo.co.kr/news/articleView.html?idxno=1319187
6503,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.thefirstmedia.net/news/articleView.html?idxno=62969
6504,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제글로벌임상순항중,http://www.doctorstimes.com/news/articleView.html?idxno=212348
6505,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.iminju.net/news/articleView.html?idxno=57219
6506,2020-09-09,뉴스투데이L대웅제약코로나19치료제글로벌임상순항중,https://www.news2day.co.kr/160304
6507,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.thepublic.kr/news/newsview.php?ncode=1065603752208236
6508,2020-09-09,금일제약업계주요이슈대웅제약니클로사마이드코로나19치료제개발글로벌임상순항”外,http://www.youthdaily.co.kr/news/article.html?no=47112
6509,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료인도임상투약시작,https://www.kpanews.co.kr/article/show.asp?idx=215981&category=D
6510,2020-09-10,대웅제약코로나19치료제니클로사마이드개발본격화,http://www.g-enews.com/ko-kr/news/article/news_all/20200909155716189369d76442fa_1/article.html
6511,2020-09-10,종근당셀트리온대웅제약코로나19치료제해외임상활발,http://daily.hankooki.com/lpage/industry/202009/dh20200910070004148390.htm?s_ref=nv
6512,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.lawissue.co.kr/view.php?ud=202009100905051021204ead0791_12
6513,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,https://www.ebn.co.kr/news/view/1450292/?sc=Naver
6514,2020-09-10,대웅제약2020일자리박람회서인턴십경력직채용,http://www.wikileaks-kr.org/news/articleView.html?idxno=94570
6515,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248858
6516,2020-09-10,대웅제약바이오헬스일자리박람회서채용방향등소개,http://medipana.com/news/news_viewer.asp?NewsNum=262602&MainKind=A&NewsKind=5&vCount=12&vKind=1
6517,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,https://www.fetv.co.kr/news/article.html?no=63288
6518,2020-09-10,대웅제약바이오헬스일자리박람회참가기업문화혁신에집중,http://www.medisobizanews.com/news/articleView.html?idxno=72585
6519,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://www.youthdaily.co.kr/news/article.html?no=47162
6520,2020-09-10,대웅제약2020바이오헬스일자리박람회서채용계획발표,http://sports.hankooki.com/lpage/economy/202009/sp20200910094330136980.htm?s_ref=nv
6521,2020-09-10,대웅제약2020바이오헬스일자리박람회참가채용계획공개,http://www.ekn.kr/news/article.html?no=522373
6522,2020-09-10,대웅제약2020바이오헬스일자리박람회서채용계획발표,http://www.koreaittimes.com/news/articleView.html?idxno=100309
6523,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2020091009434162557
6524,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,https://www.dailian.co.kr/news/view/918666/?sc=Naver
6525,2020-09-10,대웅제약2020바이오헬스일자리박람회참가유튜브생중계로소통,http://theviewers.co.kr/View.aspx?No=1079435
6526,2020-09-10,대웅제약2020바이오헬스일자리박람회서채용계획발표채용박람회도비대면,http://hobbyen.co.kr/news/newsview.php?ncode=1065574767676024
6527,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63280
6528,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.econovill.com/news/articleView.html?idxno=411464
6529,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.healthinnews.co.kr/news/articleView.html?idxno=14367
6530,2020-09-10,대웅제약2020바이오헬스일자리박람회참가코로나사태반영해비대면진행,http://newsbrite.net/141395
6531,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.press9.kr/news/articleView.html?idxno=45777
6532,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://news.mk.co.kr/newsRead.php?no=935234&year=2020
6533,2020-09-10,대웅제약2020바이오헬스일자리박람회참가상시채용계획공개,http://www.pressm.kr/news/articleView.html?idxno=33098
6534,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1413753
6535,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://www.businesskorea.co.kr/news/articleView.html?idxno=51562
6536,2020-09-10,대웅제약2020바이오헬스일자리박람회참가채용계획밝혀,http://www.pinpointnews.co.kr/view.php?ud=2020091010361245662365609d9b_45
6537,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.m-i.kr/news/articleView.html?idxno=745163
6538,2020-09-10,대웅제약비대면바이오헬스일자리박람회참가,http://www.dailysmart.co.kr/news/articleView.html?idxno=32553
6539,2020-09-10,대웅제약LG화학제미글로공동프로모션지속 ,http://www.mkhealth.co.kr/news/articleView.html?idxno=50425
6540,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.metroseoul.co.kr/article/20200910500173
6541,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://www.kpinews.co.kr/news/articleView.html?idxno=125603
6542,2020-09-10,대웅제약유튜브생중계로구직자와소통,http://www.medigatenews.com/news/2633705491
6543,2020-09-10,오늘의제약한미약품대웅제약식약처SK바이오사이언스파우치박사SK케미칼동국제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39304
6544,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.monews.co.kr/news/articleView.html?idxno=213416
6545,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.nbnnews.co.kr/news/articleView.html?idxno=423389
6546,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.mdtoday.co.kr/mdtoday/index.html?no=398745
6547,2020-09-10,대웅제약LG화학제미글로공동프로모션지속합의,http://www.bokuennews.com/news/article.html?no=194492
6548,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.segyebiz.com/newsView/20200910518564?OutUrl=naver
6549,2020-09-10,이인애의뒷담화당뇨약에대웅제약웃고한미약품울고,http://theviewers.co.kr/View.aspx?No=1080242
6550,2020-09-10,대웅제약인턴십과경력직채용으로투트랙상시채용계획공개,http://www.worktoday.co.kr/news/articleView.html?idxno=10030
6551,2020-09-10,뉴스투데이L대웅제약2020바이오헬스일자리박람회참가,https://www.news2day.co.kr/160381
6552,2020-09-10,대웅제약PCAB주사제개발나선다임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=398803
6553,2020-09-10,김창수의e뉴스브리핑대웅제약2020바이오헬스일자리박람회참가外,https://www.fetv.co.kr/news/article.html?no=63369
6554,2020-09-11,대웅제약2020바이오헬스일자리박람회참가,http://www.thefirstmedia.net/news/articleView.html?idxno=63042
6555,2020-09-11,대웅제약LG화학제미글로2030년까지판다,http://weekly.cnbnews.com/news/article.html?no=135946
6556,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.getnews.co.kr/view.php?ud=2020091409040257042fe691f917_16
6557,2020-09-14,대웅제약카모스타트코로나치료제글로벌임상돌입,https://www.ebn.co.kr/news/view/1450703/?sc=Naver
6558,2020-09-14,대웅제약카모스타트글로벌임상속도멕시코연구자임상개시,http://www.sentv.co.kr/news/view/579307
6559,2020-09-14,대웅제약멕시코서카모스타트코로나19임상2상돌입,http://www.viva100.com/main/view.php?key=20200914010002765
6560,2020-09-14,대웅제약카모스타트코로나19치료제글로벌임상돌입,http://medipana.com/news/news_viewer.asp?NewsNum=262751&MainKind=A&NewsKind=5&vCount=12&vKind=1
6561,2020-09-14,대웅제약멕시코에서코로나19치료제카모스타트임상개시,http://daily.hankooki.com/lpage/industry/202009/dh20200914091019148390.htm?s_ref=nv
6562,2020-09-14,대웅제약한국파스퇴르원자력의학원과코로나치료제멕시코임상개시,https://www.fetv.co.kr/news/article.html?no=63496
6563,2020-09-14,대웅제약카모스타트글로벌임상속도낸다,http://www.press9.kr/news/articleView.html?idxno=45795
6564,2020-09-14,대웅제약한국파스퇴르연구소코로나19치료제멕시코연구자임상개시,http://www.koreaittimes.com/news/articleView.html?idxno=100369
6565,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상속도,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248952
6566,2020-09-14,대웅제약멕시코서코로나치료제연구자임상개시,http://www.newspim.com/news/view/20200914000159
6567,2020-09-14,대웅제약코로나19치료제카모스타트멕시코서2상임상,https://www.etoday.co.kr/news/view/1940215
6568,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자임상개시,http://www.youthdaily.co.kr/news/article.html?no=47447
6569,2020-09-14,대웅제약멕시코서카모스타트코로나19연구자임상,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009140072&t=NN
6570,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상최초돌입,http://www.paxetv.com/news/articleView.html?idxno=100135
6571,2020-09-14,대웅제약호이스타정멕시코서코로나19효과검증임상2상개시,http://yna.kr/AKR20200914037200017?did=1195m
6572,2020-09-14,대웅제약 카모스타트 코로나19 치료제개발글로벌임상최초돌입,http://www.economytalk.kr/news/articleView.html?idxno=208106
6573,2020-09-14,대웅제약멕시코에서코로나19치료제임상2상진행,https://biz.chosun.com/site/data/html_dir/2020/09/14/2020091400974.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6574,2020-09-14,대웅제약한국파스퇴르연구소한국원자력의학원과멕시코연구자2상임상개시,http://www.m-i.kr/news/articleView.html?idxno=746025
6575,2020-09-14,대웅제약코로나19치료제멕시코연구자임상개시,http://www.fnnews.com/news/202009140942183036
6576,2020-09-14,대웅제약경구용코로나치료제카모스타트멕시코임상돌입,http://www.ekn.kr/news/article.html?no=522969
6577,2020-09-14,대웅제약카모스타트멕시코서코로나19치료제임상2상,http://kbench.com/?q=node/214076
6578,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.lawissue.co.kr/view.php?ud=202009140944118248204ead0791_12
6579,2020-09-14,대웅제약호이스타정멕시코서코로나19치료임상2상,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009140114&t=NN
6580,2020-09-14,대웅제약코로나19치료제로호이스타정멕시코2상돌입,http://www.medisobizanews.com/news/articleView.html?idxno=72645
6581,2020-09-14,대웅제약코로나19치료제호이스타정멕시코2상돌입,http://health.chosun.com/site/data/html_dir/2020/09/14/2020091401025.html
6582,2020-09-14,대웅제약호이스타정멕시코서코로나19임상2상,https://view.asiae.co.kr/article/2020091409554738577
6583,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자임상개시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020091409444849527
6584,2020-09-14,대웅제약카모스타트멕시코임상2상돌입임상확대해코로나19치료제개발가속화”,https://www.donga.com/news/article/all/20200914/102919022/1
6585,2020-09-14,대웅제약호이스타정코로나19치료제로멕시코연구자임상개시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572241284379
6586,2020-09-14,대웅제약카모스타트멕시코해외연구자2상임상돌입,http://www.newsprime.co.kr/news/article.html?no=517736
6587,2020-09-14,대웅제약식도염치료제코로나用개발멕시코연구자임상2상,http://news.mt.co.kr/mtview.php?no=2020091409553377616
6588,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63329
6589,2020-09-14,대웅제약멕시코서코로나19치료제임상2상진행,http://inthenews.co.kr/article-68981/
6590,2020-09-14,대웅제약멕시코서코로나19치료제카모스타트2상임상돌입,http://it.chosun.com/site/data/html_dir/2020/09/14/2020091401129.html
6591,2020-09-14,대웅제약파스퇴르연구소원자력의학원멕시코코로나19치료제임상시작,http://www.medigatenews.com/news/1735133745
6592,2020-09-14,대웅제약호이스타정멕시코서코로나19치료제로임상2상돌입,http://www.opinionnews.co.kr/news/articleView.html?idxno=39836
6593,2020-09-14,대웅제약카모스타트코로나19치료제글로벌임상돌입,http://sports.hankooki.com/lpage/economy/202009/sp20200914100854137020.htm?s_ref=nv
6594,2020-09-14,대웅제약∙한국파스퇴르연구소∙한국원자력의학원멕시코연구자임상개시,http://www.healthinnews.co.kr/news/articleView.html?idxno=14412
6595,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://newsbrite.net/141476
6596,2020-09-14,대웅제약코로나19치료제카모스타트해외임상돌입,http://www.businesskorea.co.kr/news/articleView.html?idxno=51729
6597,2020-09-14,대웅제약멕시코서코로나19치료제임상2상시작,http://moneys.mt.co.kr/news/mwView.php?no=2020091410008091681
6598,2020-09-14,대웅제약해외임상통해코로나19치료제연구개발가속화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121476
6599,2020-09-14,대웅제약멕시코서카모스타트코로나19치료제임상2상돌입최초글로벌임상,http://theviewers.co.kr/View.aspx?No=1083335
6600,2020-09-14,대웅제약코로나9치료제카모스타트글로벌임상가속화,http://www.pinpointnews.co.kr/view.php?ud=2020091410235517462365609d9b_45
6601,2020-09-14,대웅제약코로나19치료제멕시코연구자임상개시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1414392
6602,2020-09-14,대웅제약카모스타트코로나19치료제멕시코연구자임상돌입,https://www.dailian.co.kr/news/view/919483/?sc=Naver
6603,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상가속화멕시코연구자임상최초,http://www.newslock.co.kr/news/articleView.html?idxno=31014
6604,2020-09-14,대웅제약멕시코서코로나19연구자임상2상진행,https://jhealthmedia.joins.com/article/article_view.asp?pno=22398
6605,2020-09-14,대웅제약코로나치료제개발중인호이스타정멕시코서2상임상돌입,https://www.asiatoday.co.kr/view.php?key=20200914010007825
6606,2020-09-14,대웅제약코로나치료제카모스타트멕시코임상2상착수,http://www.upinews.kr/newsView/upi202009140024
6607,2020-09-14,대웅제약카모스타트글로벌임상속도낸다멕시코연구자임상개시,http://www.thepublic.kr/news/newsview.php?ncode=1065576242159129
6608,2020-09-14,코로나19치료제개발속도내는대웅제약,http://www.sisaweek.com/news/articleView.html?idxno=137506
6609,2020-09-14,대웅제약카모스타트글로벌임상속도낸다,http://www.pharmnews.com/news/articleView.html?idxno=101287
6610,2020-09-14,대웅제약멕시코서코로나19치료제연구자임상개시,http://www.mediapen.com/news/view/557507
6611,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상개시,http://www.dailysmart.co.kr/news/articleView.html?idxno=32694
6612,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자2상개시,https://www.hankyung.com/it/article/202009146553i
6613,2020-09-14,대웅제약코로나치료제멕시코서2상임상개시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135893&REFERER=NP
6614,2020-09-14,대웅제약펙수프라잔주사제개발나서임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020091411213945123
6615,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009140208&t=NN
6616,2020-09-14,대웅제약위식도역류질환치료제국내최초PCAB주사제임상1상승인,http://www.sentv.co.kr/news/view/579346
6617,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.lawissue.co.kr/view.php?ud=202009141124184569204ead0791_12
6618,2020-09-14,대웅제약펙수프라잔주사제개발국내임상1상승인경구제이어제형다양화,https://www.etoday.co.kr/news/view/1940350
6619,2020-09-14,대웅제약펙수프라잔주사제임상1상승인경구제이어제형다양화선도,http://www.healthinnews.co.kr/news/articleView.html?idxno=14426
6620,2020-09-14,대웅제약멕시코서코로나19치료제연구자임상개시,http://www.kpinews.co.kr/news/articleView.html?idxno=125805
6621,2020-09-14,대웅제약PCAB제제펙수프라잔주사제로개발,http://www.dailypharm.com/Users/News/NewsView.html?ID=268454&REFERER=NP
6622,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.econovill.com/news/articleView.html?idxno=411807
6623,2020-09-14,대웅제약카모스타트코로나치료제멕시코2상임상,http://www.bosa.co.kr/news/articleView.html?idxno=2134328
6624,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,https://www.ebn.co.kr/news/view/1450792/?sc=Naver
6625,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63339
6626,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2134333
6627,2020-09-14,대웅제약국내최초PCAB계열주사제임상1상승인,http://daily.hankooki.com/lpage/industry/202009/dh20200914114725148390.htm?s_ref=nv
6628,2020-09-14,대웅제약신약펙수프라잔주사제1상승인정제이어제형개발다양화,http://www.medisobizanews.com/news/articleView.html?idxno=72659
6629,2020-09-14,대웅제약카모스타트글로벌임상속도,http://www.monews.co.kr/news/articleView.html?idxno=213489
6630,2020-09-14,대웅제약PCAB펙수프라잔주사제변신도전,http://www.monews.co.kr/news/articleView.html?idxno=213493
6631,2020-09-14,대웅제약국내최초PCAB주사제임상1상승인,https://www.hankyung.com/it/article/202009146950i
6632,2020-09-14,대웅제약펙수프라잔제형다양화국내최초PCAB주사제1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=47488
6633,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020091412443216519
6634,2020-09-14,대웅제약위식도역류질환치료제펙수프라잔주사제임상승인,https://www.fetv.co.kr/news/article.html?no=63549
6635,2020-09-14,대웅제약위식도역류치료제펙수프라잔주사제임상1상승인,http://news.mt.co.kr/mtview.php?no=2020091413083337637
6636,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.newsprime.co.kr/news/article.html?no=517781
6637,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=73171
6638,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.metroseoul.co.kr/article/20200914500248
6639,2020-09-14,대웅제약펙수프라잔경구제이어주사제까지제형다양화,http://moneys.mt.co.kr/news/mwView.php?no=2020091413258043789
6640,2020-09-14,대웅제약펙수프라잔임상1상승인해외시장공략박차,http://weekly.hankooki.com/lpage/economy/202009/wk20200914134447146380.htm?s_ref=nv
6641,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=746197
6642,2020-09-14,대웅제약호이스타정멕시코서코로나19치료제임상,http://www.seoulfn.com/news/articleView.html?idxno=395180
6643,2020-09-14,대웅제약펙수프라잔주사제개발착수임상1상승인,http://www.viva100.com/main/view.php?key=20200914010002913
6644,2020-09-14,대웅제약카모스타트글로벌임상속도,http://www.newstomato.com/ReadNews.aspx?no=995837
6645,2020-09-14,국내최초대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.koreaittimes.com/news/articleView.html?idxno=100387
6646,2020-09-14,대웅제약펙수프라잔주사제개발임상1상승인받아,http://www.kpinews.co.kr/news/articleView.html?idxno=125827
6647,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=104663
6648,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.mhj21.com/134637
6649,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,https://view.asiae.co.kr/article/2020091414241721077
6650,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://www.nbnnews.co.kr/news/articleView.html?idxno=424288
6651,2020-09-14,카모스타트글로벌임상속도낸다대웅제약∙한국파스퇴르연구소∙한국원자력의학원멕시코연구자임상개시,http://www.nbnnews.co.kr/news/articleView.html?idxno=424291
6652,2020-09-14,대웅제약펙수프라잔주사제식약처임상1상승인,https://www.news2day.co.kr/160552
6653,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.newsis.com/view/?id=NISX20200914_0001165255&cID=13001&pID=13000
6654,2020-09-14,대웅제약카모스타트코로나19치료제로글로벌임상첫돌입,http://news.mk.co.kr/newsRead.php?no=948137&year=2020
6655,2020-09-14,대웅제약카모스타트글로벌임상속도,http://www.mdtoday.co.kr/mdtoday/index.html?no=399042
6656,2020-09-14,대웅제약개발중인코로나19치료제2종글로벌임상순항,http://www.metroseoul.co.kr/article/20200914500367
6657,2020-09-14,대웅제약펙수프라잔주사제개발임상1상승인제형다양화,https://www.sedaily.com/NewsView/1Z7UPIV48Y
6658,2020-09-14,대웅제약펙수프라잔주사제개발식약처서임상1상승인,https://www.asiatoday.co.kr/view.php?key=20200914010008134
6659,2020-09-14,대웅제약코로나19치료제연구자임상2상을멕시코에서시작,http://www.businesspost.co.kr/BP?command=article_view&num=195999
6660,2020-09-14,대웅제약펙수프라잔주사제개발임상1상승인,http://www.mediapen.com/news/view/557640
6661,2020-09-14,대웅제약코로나19치료제개발중인호이스타정멕시코연구자임상개시,https://www.news2day.co.kr/160556
6662,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://sports.hankooki.com/lpage/economy/202009/sp20200914153934137020.htm?s_ref=nv
6663,2020-09-14,대웅제약위식도역류질환치료제펙수프라잔주사제임상1상승인제형다양화선도,http://www.paxetv.com/news/articleView.html?idxno=100205
6664,2020-09-14,대웅제약펙수프라잔주사제임상1상승인적응증추가임상병행,https://www.donga.com/news/article/all/20200914/102927202/1
6665,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://www.worktoday.co.kr/news/articleView.html?idxno=10091
6666,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=399075
6667,2020-09-14,대웅제약연이은해외임상소식코로나19치료제개발속도,http://www.sporbiz.co.kr/news/articleView.html?idxno=468757
6668,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자임상개시,http://www.newsway.co.kr/news/view?tp=1&ud=2020091415534436345
6669,2020-09-14,대웅제약호이스타정멕시코에서임상2상시작,http://sports.khan.co.kr/news/sk_index.html?art_id=202009141622003&sec_id=561801&pt=nv
6670,2020-09-14,대웅제약국내최초펙수프라잔주사제임상1상승인,http://www.finomy.com/news/articleView.html?idxno=82962
6671,2020-09-14,대웅제약위식도역류치료제펙수프라잔PCAB주사제임상1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121508
6672,2020-09-14,대웅제약멕시코서코로나19치료제임상2상돌입,http://www.skyedaily.com/news/news_view.html?ID=111993
6673,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,https://www.dailian.co.kr/news/view/919696/?sc=Naver
6674,2020-09-14,대웅제약위식도역류질환약펙수프라잔먹는약이어주사제개발임상1상승인,http://theviewers.co.kr/View.aspx?No=1084128
6675,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://newsbrite.net/141510
6676,2020-09-14,대웅제약코로나19치료제카모스타트임상속도”,http://www.econovill.com/news/articleView.html?idxno=411867
6677,2020-09-14,대웅제약카모스타트코로나19치료멕시코연구자임상2상개시,https://www.kpanews.co.kr/article/show.asp?idx=216092&category=D
6678,2020-09-14,대웅제약펙수프라잔임상1상승인경구제이어제형다양화,https://www.news1.kr/articles/?4058296
6679,2020-09-14,대웅제약멕시코서코로나19대상카모스타트의연구자임상2상돌입,http://news.mk.co.kr/newsRead.php?no=949352&year=2020
6680,2020-09-14,대웅제약펙수프라잔주사제1상승인,http://www.press9.kr/news/articleView.html?idxno=45802
6681,2020-09-14,김창수의e뉴스브리핑대웅제약한국파스퇴르원자력의학원과코로나치료제멕시코임상개시外,https://www.fetv.co.kr/news/article.html?no=63584
6682,2020-09-14,대웅제약위식도역류질환신약후보펙수프라잔주사제로도개발한다,http://news.mk.co.kr/newsRead.php?no=949419&year=2020
6683,2020-09-14,대웅제약카모스타트코로나19글로벌임상속도,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002822
6684,2020-09-14,대웅제약췌장염역류성식도염치료제코로나19해외임상2상진행,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004109022
6685,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1320881
6686,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://it.chosun.com/site/data/html_dir/2020/09/14/2020091402851.html
6687,2020-09-14,대웅제약펙수프라잔주사제식약처임상1상승인,http://www.iminju.net/news/articleView.html?idxno=57493
6688,2020-09-14,금일의제약업계주요기사대웅제약PCAB주사제1상승인국내최초길리어드이뮤노메딕스전격인수外,http://www.youthdaily.co.kr/news/article.html?no=47526
6689,2020-09-14,대웅제약호이스타정코로나효과입증멕시코서임상2상돌입,http://www.dt.co.kr/contents.html?article_no=2020091502101831102002&ref=naver
6690,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.medigatenews.com/news/64540601
6691,2020-09-14,대웅제약멕시코서코로나19치료제2상임상돌입,http://www.100ssd.co.kr/news/articleView.html?idxno=71356
6692,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상최초돌입,http://news.kbiz.or.kr/news/articleView.html?idxno=72479
6693,2020-09-15,블루오션PCAB이노엔대웅제약글로벌시장선도,http://www.dailypharm.com/Users/News/NewsView.html?ID=268473&REFERER=NP
6694,2020-09-15,대웅제약펙수프라잔국내첫PCAB주사제1상승인,http://www.biospectator.com/view/news_view.php?varAtcId=11316
6695,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립글로벌신약개발가속화,http://www.m-i.kr/news/articleView.html?idxno=746444
6696,2020-09-15,대웅제약신약개발전문사아이엔테라퓨틱스신규설립,http://www.sentv.co.kr/news/view/579434
6697,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.lawissue.co.kr/view.php?ud=202009150909172150204ead0791_12
6698,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립글로벌신약개발가속화,http://www.ekn.kr/news/article.html?no=523196
6699,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.youthdaily.co.kr/news/article.html?no=47558
6700,2020-09-15,바이오텍설립으로신약개발에나선대웅제약,http://www.wikileaks-kr.org/news/articleView.html?idxno=94837
6701,2020-09-15,대웅제약첫스핀아웃바이오텍아이엔테라퓨틱스설립,http://news.mt.co.kr/mtview.php?no=2020091509014374388
6702,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://www.getnews.co.kr/view.php?ud=20200915091221152fe691f917_16
6703,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249018
6704,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://yna.kr/AKR20200915037900017?did=1195m
6705,2020-09-15,대웅제약이온채널신약개발전문신규바이오텍설립,http://www.medisobizanews.com/news/articleView.html?idxno=72682
6706,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,https://www.fetv.co.kr/news/article.html?no=63620
6707,2020-09-15,대웅제약 신규바이오텍설립으로글로벌신약개발가속화,http://www.greened.kr/news/articleView.html?idxno=269212
6708,2020-09-15,대웅제약신약개발기업아이엔테라퓨틱스설립,https://www.ebn.co.kr/news/view/1450929/?sc=Naver
6709,2020-09-15,대웅제약신규바이오텍설립2025년IPO목표,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009150070&t=NN
6710,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://www.press9.kr/news/articleView.html?idxno=45812
6711,2020-09-15,대웅제약아이엔테라퓨틱스설립글로벌신약개발가속화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571347157453
6712,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발에속도,https://www.etoday.co.kr/news/view/1940737
6713,2020-09-15,대웅제약아이엔테라퓨틱스설립글로벌신약개발가속화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571347157453
6714,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.mediapen.com/news/view/557850
6715,2020-09-15,대웅제약新바이오텍세워글로벌신약개발가속화,http://news.mk.co.kr/newsRead.php?no=950586&year=2020
6716,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://yna.kr/PYH20200915019600017?did=1196m
6717,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://medipana.com/news/news_viewer.asp?NewsNum=262828&MainKind=A&NewsKind=5&vCount=12&vKind=1
6718,2020-09-15,대웅제약비마약성진통제파이프라인중심신규법인설립,https://jhealthmedia.joins.com/article/article_view.asp?pno=22400
6719,2020-09-15,대웅제약신규바이오텍설립신약개발가속화,https://www.paxnetnews.com/articles/65257
6720,2020-09-15,대웅제약아이엔테라퓨틱스설립혁신신약개발가속화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121526
6721,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63364
6722,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020091509334457010
6723,2020-09-15,대웅제약유망신약파이프라인법인화신약개발가속화,http://www.newsprime.co.kr/news/article.html?no=517892
6724,2020-09-15,대웅제약글로벌신약개발가속화신규바이오텍설립,http://www.seoulwire.com/news/articleView.html?idxno=426545
6725,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://www.enewstoday.co.kr/news/articleView.html?idxno=1414664
6726,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.kpinews.co.kr/news/articleView.html?idxno=125896
6727,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스신설,http://www.newspim.com/news/view/20200915000199
6728,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://it.chosun.com/site/data/html_dir/2020/09/15/2020091501060.html
6729,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.mdtoday.co.kr/mdtoday/index.html?no=399148
6730,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스신규설립신약개발가속화,http://newsbrite.net/141525
6731,2020-09-15,대웅제약신약개발전문기업설립2025년IPO목표,http://www.upinews.kr/newsView/upi202009150016
6732,2020-09-15,대웅제약아이엔테라퓨틱스설립으로글로벌신약개발가속화,http://inthenews.co.kr/article-69152/
6733,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,https://www.dailian.co.kr/news/view/919836/?sc=Naver
6734,2020-09-15,대웅제약아이엔테라퓨틱스설립2025년IPO목표,https://www.asiatoday.co.kr/view.php?key=20200915010008531
6735,2020-09-15,대웅제약아이엔테라퓨틱스신규설립,http://www.businesskorea.co.kr/news/articleView.html?idxno=51812
6736,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.segye.com/content/html/2020/09/15/20200915508614.html?OutUrl=naver
6737,2020-09-15,대웅제약RD전문바이오텍설립신약개발가속화,http://www.econovill.com/news/articleView.html?idxno=411944
6738,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스신규설립,http://www.dailysmart.co.kr/news/articleView.html?idxno=32750
6739,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://sports.hankooki.com/lpage/economy/202009/sp20200915101556137020.htm?s_ref=nv
6740,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://health.chosun.com/site/data/html_dir/2020/09/15/2020091501253.html
6741,2020-09-15,대웅제약글로벌신약개발위해신규바이오텍설립아이엔테라퓨틱스,http://theviewers.co.kr/View.aspx?No=1236432
6742,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립혁신신약연구개발박차,http://www.pressm.kr/news/articleView.html?idxno=33219
6743,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발속도낸다,http://www.pinpointnews.co.kr/view.php?ud=2020091510352861052365609d9b_45
6744,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://www.healthinnews.co.kr/news/articleView.html?idxno=14446
6745,2020-09-15,대웅제약아이엔테라퓨틱스설립글로벌신약개발가속,http://daily.hankooki.com/lpage/industry/202009/dh20200915103918148390.htm?s_ref=nv
6746,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://www.mhj21.com/134658
6747,2020-09-15,대웅제약바이오텍설립글로벌신약개발가속화,http://www.koreaittimes.com/news/articleView.html?idxno=100417
6748,2020-09-15,대웅제약신약개발기업아이엔테라퓨틱스설립,http://www.fnnews.com/news/202009151045517095
6749,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://news.kbiz.or.kr/news/articleView.html?idxno=72512
6750,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://www.newsway.co.kr/news/view?tp=1&ud=2020091510581673747
6751,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://kormedi.com/?p=1324299
6752,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://www.newstomato.com/ReadNews.aspx?no=996074
6753,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.metroseoul.co.kr/article/20200915500170
6754,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,https://view.asiae.co.kr/article/2020091511225991157
6755,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립신약개발가속화,http://www.newslock.co.kr/news/articleView.html?idxno=31062
6756,2020-09-15,대웅제약아이엔테라퓨틱스설립2025년IPO목표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002841
6757,2020-09-15,대웅제약신규바이오텍설립해글로벌신약개발가속화,http://www.medigatenews.com/news/607260617
6758,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.bosa.co.kr/news/articleView.html?idxno=2134412
6759,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스스핀아웃,https://www.kpanews.co.kr/article/show.asp?idx=216125&category=D
6760,2020-09-15,대웅제약신약개발기업아이엔테라퓨틱스설립,http://www.smartfn.co.kr/view.php?ud=202009151145118270df6c52f68c_46
6761,2020-09-15,대웅제약아이엔테라퓨틱스설립,http://www.monews.co.kr/news/articleView.html?idxno=213548
6762,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립2025년IPO추진”,http://www.viva100.com/main/view.php?key=20200915010003156
6763,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립코오롱제약출신박종덕대표선임,https://www.donga.com/news/article/all/20200915/102941733/1
6764,2020-09-15,대웅제약신약개발전문기업아이엔타라퓨틱스설립,https://www.hankyung.com/it/article/202009151634i
6765,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스분사,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95011
6766,2020-09-15,대웅제약신약개발가속화위해바이오텍설립,http://www.whosaeng.com/120891
6767,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.nbnnews.co.kr/news/articleView.html?idxno=424705
6768,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립글로벌진출가속화,http://www.sportsseoul.com/news/read/958331?ref=naver
6769,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://news.bizwatch.co.kr/article/consumer/2020/09/15/0012/naver
6770,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스신규설립,https://www.news2day.co.kr/160660
6771,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4281392
6772,2020-09-15,대웅제약신약개발분사하여바이오텍신규설립,http://www.joseilbo.com/news/news_read.php?uid=406272&class=27&grp=
6773,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://www.worktoday.co.kr/news/articleView.html?idxno=10121
6774,2020-09-15,대웅제약신규바이오텍설립신약개발가속화,http://www.edaily.co.kr/news/newspath.asp?newsid=03693286625900448
6775,2020-09-15,대웅제약신약개발담당아이엔테라퓨틱스설립,http://www.skyedaily.com/news/news_view.html?ID=112061
6776,2020-09-15,기업대웅제약신약개발전문기업아이엔테라퓨틱스설립,https://www.ytn.co.kr/_ln/0102_202009151627251605
6777,2020-09-15,대웅제약스핀오프바이오벤처아이엔테라퓨틱스출범,http://www.dailypharm.com/Users/News/NewsView.html?ID=268518&REFERER=NP
6778,2020-09-15,대웅제약지사제스멕타11월부터잠정생산중단,http://www.dailypharm.com/Users/News/NewsView.html?ID=268519&REFERER=NP
6779,2020-09-15,오픈이노베이션강화나선대웅제약신약개발속도,http://www.sporbiz.co.kr/news/articleView.html?idxno=468934
6780,2020-09-15,대웅제약아이엔테라퓨틱스세워신약개발 ,http://www.seoulfn.com/news/articleView.html?idxno=395370
6781,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://www.finomy.com/news/articleView.html?idxno=83018
6782,2020-09-15,대웅제약신약개발전문자회사설립,http://news.mk.co.kr/newsRead.php?no=953843&year=2020
6783,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.updownnews.co.kr/news/articleView.html?idxno=223273
6784,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.thefirstmedia.net/news/articleView.html?idxno=63227
6785,2020-09-15,대웅제약신약개발자회사아이엔테라퓨틱스대표에박종덕,http://www.businesspost.co.kr/BP?command=article_view&num=196242
6786,2020-09-15,금일제약업계주요기사삼성바이오에피스에이빈시오오리지널과동등성입증”대웅제약신규바이오텍설립外,http://www.youthdaily.co.kr/news/article.html?no=47636
6787,2020-09-15,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://www.thefirstmedia.net/news/articleView.html?idxno=63244
6788,2020-09-15,바이오텍아이엔테라퓨틱스설립대웅제약글로벌신약개발가속도,http://www.dt.co.kr/contents.html?article_no=2020091602101031102001&ref=naver
6789,2020-09-15,일동이어대웅제약도신약개발전문회사설립,http://www.dailymedi.com/detail.php?number=860512&thread=22r05
6790,2020-09-16,매출1조빨간불위태로운대웅제약돌파구는,http://moneys.mt.co.kr/news/mwView.php?no=2020091116058083725
6791,2020-09-16,메디톡스vs대웅제약보툴리눔톡신논쟁미국서가열,http://www.bosa.co.kr/news/articleView.html?idxno=2134449
6792,2020-09-16,K팜강자나야나”전승호의대웅제약신약개발속도낸다,https://www.fetv.co.kr/news/article.html?no=63766
6793,2020-09-16,우리아기배탈나면어쩌나대웅제약스멕타생산중단경쟁제품에밀려매출감소우려도,http://theviewers.co.kr/View.aspx?No=1238511
6794,2020-09-16,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=63327
6795,2020-09-16,오늘Who전승호대웅제약위식도역류질환주사제효능입증할까,http://www.businesspost.co.kr/BP?command=article_view&num=196413
6796,2020-09-17,대성에너지대웅제약등45곳인적자원개발우수기관인증총82개사로늘어,http://www.newspim.com/news/view/20200917000432
6797,2020-09-17,대웅제약등82개기업인적자원관리우수기업에선정,https://www.etoday.co.kr/news/view/1941924
6798,2020-09-18,대웅제약불확실성장기화우려하이투자증권,https://www.ebn.co.kr/news/view/1451470/?sc=Naver
6799,2020-09-18,대웅제약소송불확실성장기화우려하이투자증권목표가하향,http://kpenews.com/View.aspx?No=1240550
6800,2020-09-18,미국ITC대웅제약이의제기수용여부21일결정,https://www.dailian.co.kr/news/view/920833/?sc=Naver
6801,2020-09-18,하이투자증권대웅제약소송불확실성장기화우려,http://www.econovill.com/news/articleView.html?idxno=412412
6802,2020-09-19,대웅제약ITC소송불확실성장기화우려목표가↓,https://view.asiae.co.kr/article/2020091916132849148
6803,2020-09-20,대웅제약이온채널신약개발전문기업설립,http://weekly.cnbnews.com/news/article.html?no=136059
6804,2020-09-20,집단소송당한美에볼루스대웅제약영향촉각,https://www.hankyung.com/it/article/2020092098531
6805,2020-09-21,나보타美판매사에볼루스상대주주집단소송모집봇물대웅제약도연대책임,http://news.mk.co.kr/newsRead.php?no=970812&year=2020
6806,2020-09-21,대웅제약당뇨신약임상2상서효능안전성입증,http://www.econovill.com/news/articleView.html?idxno=412564
6807,2020-09-21,대웅제약이나보글리플로진당뇨환자혈당강하입증,http://www.press9.kr/news/articleView.html?idxno=45861
6808,2020-09-21,대웅제약당뇨병신약이나보글리플로진혈당강하안전성입증,http://health.chosun.com/site/data/html_dir/2020/09/21/2020092100663.html
6809,2020-09-21,대웅제약당뇨신약임상2상결과최초공개혈당강하및안전성입증,http://www.ekn.kr/news/article.html?no=524368
6810,2020-09-21,대웅제약ICDM서이나보글리플로진2상결과발표,https://www.ebn.co.kr/news/view/1451674/?sc=Naver
6811,2020-09-21,대웅제약당뇨신약임상2상서혈당강하안전성입증,http://www.newsis.com/view/?id=NISX20200921_0001172848&cID=13001&pID=13000
6812,2020-09-21,대웅제약이나보글리플로진당뇨환자혈당강하안전성입증”,http://www.sentv.co.kr/news/view/579747
6813,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하안전성입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249254
6814,2020-09-21,대웅제약이나보글리플로진임상2상서혈당강하입증,http://news.mt.co.kr/mtview.php?no=2020092109062450691
6815,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하와안전성입증,http://www.ceoscoredaily.com/news/article.html?no=73365
6816,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://newsbrite.net/141712
6817,2020-09-21,대웅제약SGLT2억제제당뇨병신약임상2상서안전성입증,http://www.newspim.com/news/view/20200921000190
6818,2020-09-21,대웅제약당뇨병신약임상2상에서당뇨환자혈당강하및안전성입증,https://www.fetv.co.kr/news/article.html?no=64075
6819,2020-09-21,대웅제약이나보글리플로진임상2상혈당강하안전성입증,http://medipana.com/news/news_viewer.asp?NewsNum=263102&MainKind=A&NewsKind=5&vCount=12&vKind=1
6820,2020-09-21,대웅제약SGLT2억제제당뇨병신약혈당강하안전성입증”,https://www.etoday.co.kr/news/view/1942858
6821,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://www.lawissue.co.kr/view.php?ud=20200921093929230107f28b58b8_12
6822,2020-09-21,대웅제약2020ICDM서SGLT2억제제당뇨병신약임상2상구연발표,http://www.medigatenews.com/news/2395043730
6823,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상서효과안전성확인,http://yna.kr/AKR20200921044000017?did=1195m
6824,2020-09-21,대웅제약당뇨신약이나보글리플로진2상서혈당강하안전성입증,http://www.medisobizanews.com/news/articleView.html?idxno=72830
6825,2020-09-21,당뇨환자희소식대웅제약이나보글리플로진임상2상서혈당강하및안정성입증,http://kpenews.com/View.aspx?No=1247663
6826,2020-09-21,대웅제약당뇨신약임상2상서효과안전성확인,https://view.asiae.co.kr/article/2020092110011899721
6827,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상2상서혈당강하및안전성입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121729
6828,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하및안전성입증,http://www.m-i.kr/news/articleView.html?idxno=748227
6829,2020-09-21,대웅제약SGLT2억제당뇨신약임상2상서효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2134778
6830,2020-09-21,대웅제약당뇨치료제임상2상서혈당강하안전성입증,http://sports.hankooki.com/lpage/economy/202009/sp20200921100125137020.htm?s_ref=nv
6831,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자의혈당강하및안전성입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092110024251672
6832,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨병환자혈당강하및안전성입증,http://www.fnnews.com/news/202009211006124366
6833,2020-09-21,대웅제약이나보글리플로진임상2상서혈당강하효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020092109338080659
6834,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자 혈당강하안전성확인,http://www.economytalk.kr/news/articleView.html?idxno=208227
6835,2020-09-21,대웅제약SGLT2당뇨병신약이나보글리플로진임상2상환자혈당강하,http://www.kpinews.co.kr/news/articleView.html?idxno=126408
6836,2020-09-21,대웅제약이나보글리플로진임상2상결과발표혈당강하및안전성입증”,http://www.mdtoday.co.kr/mdtoday/index.html?no=399736
6837,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상2상결과발표혈당강하안전성입증”,https://www.donga.com/news/article/all/20200921/103027221/1
6838,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자의혈당강하및안전성입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63505
6839,2020-09-21,대웅제약SGLT2억제제당뇨병신약임상2상서안전성입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020092110270906541
6840,2020-09-21,대웅제약이나보글리플로진당뇨환자혈당강하안전성입증,http://www.newsprime.co.kr/news/article.html?no=518559
6841,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상서효과안전성확인,http://inthenews.co.kr/article-70043/
6842,2020-09-21,대웅제약ICDM서SGLT2억제제후보의임상2상결과발표,http://news.mk.co.kr/newsRead.php?no=971943&year=2020
6843,2020-09-21,대웅제약당뇨병신약혈당강하및안전성입증,http://www.monews.co.kr/news/articleView.html?idxno=213692
6844,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상서당화혈색소눈에띄게감소,https://www.sedaily.com/NewsView/1Z7XWWJT83
6845,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상효과확인,http://www.pinpointnews.co.kr/view.php?ud=2020092110455896542365609d9b_45
6846,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자혈당강하및안전성확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14557
6847,2020-09-21,대웅제약이나보글리플로진임상2상당뇨환자혈당강하안전성입증,http://www.segye.com/content/html/2020/09/21/20200921510069.html?OutUrl=naver
6848,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상2상서안전성입증,http://www.koreaittimes.com/news/articleView.html?idxno=100546
6849,2020-09-21,대웅제약이나보글리플로진임상2상결과공개,http://www.mhj21.com/134750
6850,2020-09-21,대웅제약이나보글리플로진안전성입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=52122
6851,2020-09-21,곤란해진대웅제약美에볼루스대상집단소송확산,http://www.segyebiz.com/newsView/20200921510980?OutUrl=naver
6852,2020-09-21,대웅제약당뇨신약이나보글리플로진2상서효능안전성입증,https://www.hankyung.com/it/article/202009211593i
6853,2020-09-21,대웅제약국내최초SGLT2신약임상2상혈당강하및안전성입증,http://www.pharmnews.com/news/articleView.html?idxno=101327
6854,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하입증”,http://www.youthdaily.co.kr/news/article.html?no=48139
6855,2020-09-21,대웅제약당뇨신약이나보글리플로진혈당강하및안전성입증,http://www.metroseoul.co.kr/article/20200921500266
6856,2020-09-21,대웅제약이나보글리플로진임상2상당뇨환자혈당강하및안전성입증,http://www.newslock.co.kr/news/articleView.html?idxno=31214
6857,2020-09-21,오늘의제약GC녹십자코로나19혈장치료제첫투여한미약품대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39555
6858,2020-09-21,대웅제약당뇨병약이나보글리플로진효과안전성입증,http://www.seoulfn.com/news/articleView.html?idxno=395884
6859,2020-09-21,대웅제약보툴리눔톡신소송의불확실성을단기간에해소는어려워,http://www.businesspost.co.kr/BP?command=article_view&num=197016
6860,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=426445
6861,2020-09-21,대웅제약이나보글리플로진임상2상서혈당강하및안전성입증국내최초SGLT2억제제당뇨병신약,http://www.thepublic.kr/news/newsview.php?ncode=1065591521705868
6862,2020-09-21,대웅제약미국에천문학적손해배상금지불위기균주도용여부관건,http://theviewers.co.kr/View.aspx?No=1248474
6863,2020-09-21,대웅제약개발중인당뇨병신약임상2상서혈당강하및안전성입증,http://www.mkhealth.co.kr/news/articleView.html?idxno=50568
6864,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상효과안전성확인,https://www.dailian.co.kr/news/view/921517/?sc=Naver
6865,2020-09-21,대웅제약2형당뇨병SGLT2저해제2상긍정적,http://www.biospectator.com/view/news_view.php?varAtcId=11361
6866,2020-09-21,대웅제약당뇨치료제임상2상서효과안전성확인,http://www.dt.co.kr/contents.html?article_no=2020092102109931102001&ref=naver
6867,2020-09-21,대웅제약당뇨약이나보글리플로진임상2상결과발표혈당강하및안전성입증,http://theviewers.co.kr/View.aspx?No=1248648
6868,2020-09-21,대웅제약당뇨신약이나보글리플로진임상2상서효과안전성확인,http://hobbyen.co.kr/news/newsview.php?ncode=1065601486107589
6869,2020-09-21,한미약품대웅제약신약임상3상보인다,https://www.sedaily.com/NewsView/1Z7XXGG6MN
6870,2020-09-21,뉴스투데이L대웅제약당뇨병치료제이나보글리플로진임상2상결과최초발표,https://www.news2day.co.kr/161008
6871,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자의혈당강하및안전성입증,http://www.wsobi.com/news/articleView.html?idxno=105164
6872,2020-09-21,대웅제약당뇨병치료제임상2상서효과안전성확인,https://biz.chosun.com/site/data/html_dir/2020/09/21/2020092102657.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6873,2020-09-22,대웅제약당뇨병신약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://www.thefirstmedia.net/news/articleView.html?idxno=63537
6874,2020-09-22,대웅제약이나보글리플로진2상서혈당강하안전성입증,https://www.kpanews.co.kr/article/show.asp?idx=216265&category=D
6875,2020-09-22,제약업계소식보령제약투베로멕시코발매대웅제약아이엔테라퓨틱스설립태반주사제라이넥러시아서코로나19치료효과확인종근당바이오시밀러네스벨동남아3개국수출한미헬스케어,http://www.newsian.co.kr/news/articleView.html?idxno=43424
6876,2020-09-22,2020추석선물대웅제약임팩타민코로나19에지친우리가족피로회복,http://www.m-i.kr/news/articleView.html?idxno=748253
6877,2020-09-22,대웅제약당뇨병신약이나보글리플로진혈당강하안전입증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003072
6878,2020-09-22,단독전승호대웅제약대표ITC이의제기수용최선의결과,https://view.asiae.co.kr/article/2020092208260976972
6879,2020-09-22,대웅제약보톡스美판매금지10년ITC재검토결정에메디톡스문제없다,http://moneys.mt.co.kr/news/mwView.php?no=2020092208228030233
6880,2020-09-22,美ITC위원회대웅제약의이의제기일부재검토결정,http://news.mt.co.kr/mtview.php?no=2020092208111871321
6881,2020-09-22,대웅제약메디톡스보톡스분쟁2차전美ITC예비판결재검토,https://news.joins.com/article/olink/23472270
6882,2020-09-22,보톡스분쟁美ITC위원회대웅제약이의제기중일부재검토,http://www.ekn.kr/news/article.html?no=524615
6883,2020-09-22,대웅제약ITC전면재검토결정보톡스분쟁다시원점,http://www.medisobizanews.com/news/articleView.html?idxno=72863
6884,2020-09-22,메디톡스대웅제약이의제기중일부재검토는통상적절차”,http://www.newsway.co.kr/news/view?tp=1&ud=2020092208522424398
6885,2020-09-22,대웅제약메디톡스보톡스분쟁다시원점,http://www.bosa.co.kr/news/articleView.html?idxno=2134851
6886,2020-09-22,美ITC대웅제약이의제기일부재검토,http://www.newspim.com/news/view/20200922000124
6887,2020-09-22,대웅제약美ITC예비결정오판ITC이의제기수용,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092208255320841
6888,2020-09-22,대웅제약당뇨신약이나보글리플로진효과안전성입증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1323556
6889,2020-09-22,美ITC대웅제약메디톡스균주분쟁예비판결일부재검토결정,http://www.youthdaily.co.kr/news/article.html?no=48207
6890,2020-09-22,대웅제약ITC예비판결재검토보톡스분쟁원점”,http://www.sentv.co.kr/news/view/579828
6891,2020-09-22,대웅제약ITC보톡스도용인정하는예비결정재검토결정”,https://www.etoday.co.kr/news/view/1943288
6892,2020-09-22,대웅제약메디톡스보톡스분쟁2차전美ITC예비판결재검토,http://www.startuptoday.co.kr/news/articleView.html?idxno=54953
6893,2020-09-22,대웅제약메디톡스보톡스분쟁원점되나美ITC예비판결재검토결정,https://biz.chosun.com/site/data/html_dir/2020/09/22/2020092200795.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6894,2020-09-22,대웅제약ITC전면재검토결정보톡스분쟁다시원점”,http://www.viva100.com/main/view.php?key=20200922010004563
6895,2020-09-22,미국ITC대웅제약이의제기일부재검토결정,http://inthenews.co.kr/article-70208/
6896,2020-09-22,대웅제약美ITC예비판결재검토결정보톡스분쟁다시원점,http://news.mk.co.kr/newsRead.php?no=975871&year=2020
6897,2020-09-22,대웅제약vs메디톡스보톡스전쟁원점으로ITC전면재검토결정”,https://www.fetv.co.kr/news/article.html?no=64182
6898,2020-09-22,美ITC예비판결일부재검토대웅제약다시원점,http://www.newspim.com/news/view/20200922000159
6899,2020-09-22,美ITC대웅제약이의제기중일부재검토결정”메디톡스통상적일반적절차일뿐”,https://www.fetv.co.kr/news/article.html?no=64186
6900,2020-09-22,미국ITC대웅제약메디톡스예비판결일부재검토결정,http://news.tf.co.kr/read/economy/1814241.htm
6901,2020-09-22,대웅제약메디톡스분쟁새국면맞나ITC예비판결재검토종합,http://yna.kr/AKR20200922029551017?did=1195m
6902,2020-09-22,대웅제약ITC재검토결정보톡스분쟁다시원점,http://www.press9.kr/news/articleView.html?idxno=45871
6903,2020-09-22,美ITC대웅제약메디톡스예비결정재검토 ,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95155
6904,2020-09-22,대웅제약美ITC톡신분쟁이의제기에재검토결정,http://www.dailypharm.com/Users/News/NewsView.html?ID=268716&REFERER=NP
6905,2020-09-22,대웅제약ITC이의제기수용보톡스분쟁원점으로,https://view.asiae.co.kr/article/2020092209433957790
6906,2020-09-22,메디톡스통상적절차일뿐vs대웅제약원점재검토,http://www.wikileaks-kr.org/news/articleView.html?idxno=95316
6907,2020-09-22,美ITC재검토결정대웅제약메디톡스보톡스분쟁11월최종결정,http://news.mt.co.kr/mtview.php?no=2020092209280706122
6908,2020-09-22,미국ITC예비판결뒤집을까대웅제약이의제기수용재검토,https://www.news1.kr/articles/?4066009
6909,2020-09-22,오늘의제약메디톡스vs대웅제약아스트라제네카삼성바이오로직스종근당홀딩스동화약품,http://www.babytimes.co.kr/news/articleView.html?idxno=39588
6910,2020-09-22,ITC예비결정재검토대웅제약원점재검토vs메디톡스통상적절차,http://www.seoulwire.com/news/articleView.html?idxno=426871
6911,2020-09-22,대웅제약메디톡스보톡스분쟁다시원점,http://www.businesskorea.co.kr/news/articleView.html?idxno=52176
6912,2020-09-22,미국ITC메디톡스대웅제약보톡스분쟁재검토,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004117623
6913,2020-09-22,美ITC대웅제약의의제기수용보툴리눔균주논란2R,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136065&REFERER=NP
6914,2020-09-22,대웅제약美ITC예비판결재검토메디톡스통상적인절차반박,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009220095&t=NN
6915,2020-09-22,대웅제약메디톡스ITC검토결정두고재충돌,http://www.newstomato.com/ReadNews.aspx?no=997391
6916,2020-09-22,美ITC대웅제약메디톡스균주분쟁예비판결재검토결정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092210140183018
6917,2020-09-22,대웅제약메디톡스보톡스분쟁2차전ITC예비판결재검토,http://www.newsworks.co.kr/news/articleView.html?idxno=489885
6918,2020-09-22,美ITC예비판결재검토보톡스大戰반격나선대웅제약,http://www.dt.co.kr/contents.html?article_no=2020092202109931102002&ref=naver
6919,2020-09-22,ITC보툴리눔균예비판결재검토대웅제약이의수용,https://hankookilbo.com/News/Read/A2020092210210005456?did=NA
6920,2020-09-22,대웅제약美ITC예비판결재검토결정보톡스분쟁다시원점,http://www.dailysmart.co.kr/news/articleView.html?idxno=33100
6921,2020-09-22,대웅제약메디톡스보톡스분쟁ITC전면재검토결정,http://www.healthinnews.co.kr/news/articleView.html?idxno=14595
6922,2020-09-22,대웅제약vs메디톡스새국면美ITC대웅이의신청수용,http://www.dailymedi.com/detail.php?number=860740&thread=22r05
6923,2020-09-22,보톡스분쟁새국면대웅제약美ITC재검토vs메디톡스통상절차불과,http://www.upinews.kr/newsView/upi202009220018
6924,2020-09-22,대웅제약메디톡스분쟁원점美ITC예비판결재검토,http://it.chosun.com/site/data/html_dir/2020/09/22/2020092201277.html
6925,2020-09-22,대웅제약메디톡스미국소송새국면,http://www.whosaeng.com/121069
6926,2020-09-22,ITC이의제기수용메디톡스통상적절차vs대웅제약다시원점,http://www.mediapen.com/news/view/559932
6927,2020-09-22,관심종목메디톡스대웅제약ITC재검토에동시약세,http://www.getnews.co.kr/view.php?ud=2020092210485240872aaae0046f_16
6928,2020-09-22,ITC예비판결재검토대웅제약vs메디톡스새국면,https://ilyo.co.kr/?ac=article_view&entry_id=380566
6929,2020-09-22,대웅제약섭취편의성높인비타민2종출시,http://www.press9.kr/news/articleView.html?idxno=45882
6930,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.lawissue.co.kr/view.php?ud=202009221111066710204ead0791_12
6931,2020-09-22,대웅제약ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://www.ceoscoredaily.com/news/article.html?no=73421
6932,2020-09-22,대웅제약ITC전면재검토결정보톡스분쟁원점”,http://www.econovill.com/news/articleView.html?idxno=412787
6933,2020-09-22,대웅제약섭취편리한비타민건기식대웅비타C등2종출시,http://www.medisobizanews.com/news/articleView.html?idxno=72888
6934,2020-09-22,대웅제약비타민건강기능식품2종출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=52197
6935,2020-09-22,대웅제약섭취편의성높인비타민건기식2종출시,http://medipana.com/news/news_viewer.asp?NewsNum=263201&MainKind=A&NewsKind=5&vCount=12&vKind=1
6936,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.metroseoul.co.kr/article/20200922500226
6937,2020-09-22,대웅제약비타민건강기능식품2종출시,http://news.mk.co.kr/newsRead.php?no=977352&year=2020
6938,2020-09-22,오늘의제약GC녹십자웰빙동아ST슈가논광동제약대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39596
6939,2020-09-22,대웅제약섭취편의성높인비타민건기식2종출시,https://www.fetv.co.kr/news/article.html?no=64239
6940,2020-09-22,대웅제약비타민건강기능식품2종출시섭취편의성개선,http://theviewers.co.kr/View.aspx?No=1249559
6941,2020-09-22,메디톡스손들어줬던ITC예비판결재검토대웅제약승기잡나,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4288467
6942,2020-09-22,대웅제약비타민건강기능식품2종출시,http://news.mt.co.kr/mtview.php?no=2020092213073864271
6943,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://newsbrite.net/141777
6944,2020-09-22,대웅제약섭취편의성높인비타민2종출시,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009221358133510029
6945,2020-09-22,ITC재검토결정에대웅제약메디톡스보톡스분쟁새국면맞나,https://www.fetv.co.kr/news/article.html?no=64255
6946,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=426843
6947,2020-09-22,미국국제무역위대웅제약과메디톡스균주다툼의예비판결재검토,http://www.businesspost.co.kr/BP?command=article_view&num=197226
6948,2020-09-22,대웅제약섭취편의성높인비타민건기식2종출시,http://www.econovill.com/news/articleView.html?idxno=412829
6949,2020-09-22,ITC전면재검토결정대웅제약의미있다vs메디톡스통상적절차,http://www.opinionnews.co.kr/news/articleView.html?idxno=40392
6950,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.thefirstmedia.net/news/articleView.html?idxno=63552
6951,2020-09-22,대웅제약美ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://www.kpinews.co.kr/news/articleView.html?idxno=126596
6952,2020-09-22,대웅메디톡스보톡스전쟁다시원점美ITC대웅제약이의제기받아들여재검토,http://www.todaykorea.co.kr/news/articleView.html?idxno=276947
6953,2020-09-22,대웅메디톡스보톡스전쟁다시원점美ITC대웅제약이의제기받아들여재검토,http://www.todaykorea.co.kr/news/articleView.html?idxno=276947
6954,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.kpinews.co.kr/news/articleView.html?idxno=126597
6955,2020-09-22,ITC재검토에대웅제약예비판결뒤집고승소VS메디톡스일반절차일상톡톡플러스,http://www.segye.com/content/html/2020/09/22/20200922511406.html?OutUrl=naver
6956,2020-09-22,ITC보톡스전쟁예비판결재검토대웅제약메디톡스반응엇갈려,http://www.sportsseoul.com/news/read/960865?ref=naver
6957,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시비타민제제라인업구축,http://www.updownnews.co.kr/news/articleView.html?idxno=223561
6958,2020-09-22,대웅제약메디톡스보톡스분쟁ITC재검토결정,http://www.koreaittimes.com/news/articleView.html?idxno=100591
6959,2020-09-22,이데일리N미국ITC대웅제약메디톡스예비판결일부재검토결정外,http://www.edaily.co.kr/news/newspath.asp?newsid=03585046625902744
6960,2020-09-22,대웅제약메디톡스분쟁새국면맞나ITC예비판결재검토,http://www.seouleconews.com/news/articleView.html?idxno=56804
6961,2020-09-22,대웅제약메디톡스ITC재판새국면분쟁원점”VS절차일뿐”,http://daily.hankooki.com/lpage/industry/202009/dh20200922160530148390.htm?s_ref=nv
6962,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63558
6963,2020-09-22,대웅제약메디톡스보톡스분쟁새국면ITC예비판결재검토,http://www.etnews.com/20200922000230
6964,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.youthdaily.co.kr/news/article.html?no=48276
6965,2020-09-22,대웅제약美ITC예비결정뒤엎나이의제기받아들여져,http://hobbyen.co.kr/news/newsview.php?ncode=1065597228304291
6966,2020-09-22,보톡스일부재검토대웅제약분쟁원점vs메디톡스통상적절차,http://news.mk.co.kr/newsRead.php?no=978898&year=2020
6967,2020-09-22,대웅제약건강기능식품시장강화,http://www.g-enews.com/ko-kr/news/article/news_all/20200922160004160869d76442fa_1/article.html
6968,2020-09-22,미국ITC예비판결재검토대웅제약메디톡스엇갈린반응,http://sports.hankooki.com/lpage/economy/202009/sp20200922162153137020.htm?s_ref=nv
6969,2020-09-22,보툴리눔균주戰ITC예비판결재검토”장외신경전ING대웅제약이례적”vs메디톡스일반적”,http://www.thepublic.kr/news/newsview.php?ncode=1065591591868682
6970,2020-09-22,ITC예비판결전면재검토결정대웅제약vs메디톡스보톡스분쟁새국면맞나,http://www.updownnews.co.kr/news/articleView.html?idxno=223565
6971,2020-09-22,대웅제약메디톡스發보톡스전쟁ITC재검토결정환영오류잡아승소할것,http://www.newslock.co.kr/news/articleView.html?idxno=31239
6972,2020-09-22,美ITC재검토에대웅제약최종결정승소확신메디톡스통상적인절차일뿐,http://www.mdtoday.co.kr/mdtoday/index.html?no=399982
6973,2020-09-22,대웅제약메디톡스美보톡스분쟁원점으로ITC예비판정재검토,http://www.finomy.com/news/articleView.html?idxno=83309
6974,2020-09-22,대웅제약비타민시장확대대웅비타C대웅비타D2800IU출시,http://kpenews.com/View.aspx?No=1250269
6975,2020-09-22,대웅제약이의제기에따라ICT전면재검토결정,http://www.medigatenews.com/news/1070289645
6976,2020-09-22,뉴스투데이L대웅제약비타민건강기능식품2종출시,https://www.news2day.co.kr/161093
6977,2020-09-22,김창수의e뉴스브리핑ITC재검토결정에대웅제약메디톡스보톡스분쟁새국면맞나外,https://www.fetv.co.kr/news/article.html?no=64266
6978,2020-09-22,ITC대웅제약손들어줘메디톡스와소송전새국면,http://www.doctorstimes.com/news/articleView.html?idxno=212502
6979,2020-09-22,금일제약업계주요기사하루만에뒤바뀐합격자제일약품취준생분통美ITC대웅제약메디톡스균주분쟁예비판결일부재검토外,http://www.youthdaily.co.kr/news/article.html?no=48295
6980,2020-09-22,ITC전면재검토결정대웅제약VS메디톡스대립11월6일최종결정,http://medicalworldnews.co.kr/news/view.php?idx=1510937750
6981,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=400053
6982,2020-09-23,대웅제약섭취편의높인비타민건강기능식품2종선봬,https://www.kpanews.co.kr/article/show.asp?idx=216300&category=D
6983,2020-09-23,균주전쟁5년대웅제약메디톡스11월6일최종결판,http://www.g-enews.com/ko-kr/news/article/news_all/20200922114339528469d76442fa_1/article.html
6984,2020-09-23,대웅제약불확실성장기화에대한우려,http://www.g-enews.com/ko-kr/news/article/news_all/202009230720003623442088f476_1/article.html
6985,2020-09-23,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249389
6986,2020-09-23,WhoIs윤재춘대웅제약대표이사사장,http://www.businesspost.co.kr/BP?command=article_view&num=197361
6987,2020-09-23,ITC예비판결재검토로새국면반격나선대웅제약,https://www.dailian.co.kr/news/view/922127/?sc=Naver
6988,2020-09-24,식품대웅제약임팩타민비타민B8종에생체이용률8배쑥항산화면역력유지에방점,http://news.mk.co.kr/newsRead.php?no=985452&year=2020
6989,2020-09-24,대웅제약상반기구긴자존심하반기회복잰걸음,http://www.sporbiz.co.kr/news/articleView.html?idxno=470119
6990,2020-09-24,대웅제약글로벌제약사장악당뇨병치료제도전전승호국산화의지,http://www.businesspost.co.kr/BP?command=article_view&num=197662
6991,2020-09-25,엎치락뒤치락메디톡스vs대웅제약→앨러간어부지리,http://www.dailymedi.com/detail.php?number=860878&thread=22r12
6992,2020-09-25,티앤엘11월초코스닥상장추진중외제약대웅제약독일로만라우셔등에제품공급,http://www.econonews.co.kr/news/articleView.html?idxno=138162
6993,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63643
6994,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박나서,http://medipana.com/news/news_viewer.asp?NewsNum=263423&MainKind=A&NewsKind=5&vCount=12&vKind=1
6995,2020-09-25,대웅제약신규보툴리눔균주구매예비결정반박증거제출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249541
6996,2020-09-25,대웅제약신규보툴리눔균주구매통해ITC예비결정반박증거제출,http://www.ceoscoredaily.com/news/article.html?no=73566
6997,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092510263566818
6998,2020-09-25,대웅제약미국서보툴리눔톡신구매과거에도쉽게구할수있었다,https://www.dailian.co.kr/news/view/922676/?sc=Naver
6999,2020-09-25,대웅제약보툴리눔균주쉽게구매가능메디톡스반박,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009250129&t=NN
7000,2020-09-25,대웅제약보툴리눔균주구매예비결정반박증거제출,http://www.businesskorea.co.kr/news/articleView.html?idxno=52407
7001,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://newsbrite.net/141926
7002,2020-09-25,대웅제약신규보툴리눔균주구매ITC예비결정반박증거제출,http://www.medisobizanews.com/news/articleView.html?idxno=72990
7003,2020-09-25,대웅제약보툴리눔균주어디서나쉽게구할수있어ITC에추가자료제출,https://www.sedaily.com/NewsView/1Z7ZQCSXC3
7004,2020-09-25,대웅제약美ITC에신규보툴리눔균주구매통해예비결정반박증거제출,http://www.kpinews.co.kr/news/articleView.html?idxno=126932
7005,2020-09-25,대웅제약신규보툴리눔균주구매ITC예비결정반박증거제출,https://www.asiatoday.co.kr/view.php?key=20200925010015911
7006,2020-09-25,보툴리눔균주못산다고대웅제약ITC에반박자료제출,http://www.newsis.com/view/?id=NISX20200925_0001179488&cID=13001&pID=13000
7007,2020-09-25,대웅제약보툴리눔균주구매예비결정반박증거제출,http://www.press9.kr/news/articleView.html?idxno=45916
7008,2020-09-25,대웅제약보툴리눔균주구매가능해”ITC에반박증거자료제출,http://www.viva100.com/main/view.php?key=20200925010005488
7009,2020-09-25,대웅제약신규보툴리눔균주구매예비결정반박증거제출,http://www.newsprime.co.kr/news/article.html?no=519230
7010,2020-09-25,대웅제약ITC에추가자료제출⋯보툴리눔균주어디서나구할수있다,https://biz.chosun.com/site/data/html_dir/2020/09/25/2020092501585.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7011,2020-09-25,대웅제약보툴리눔균주구매가능해ITC예비결정반박증거제출,http://www.newspim.com/news/view/20200925000508
7012,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.medigatenews.com/news/1854856702
7013,2020-09-25,보란듯이새보툴리눔산대웅제약영업비밀아니다,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136167&REFERER=NP
7014,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.pharmnews.com/news/articleView.html?idxno=101361
7015,2020-09-25,대웅제약비타민건강기능식품2종출시,http://www.wsobi.com/news/articleView.html?idxno=105412
7016,2020-09-25,대웅제약신규보툴리눔균주구매ITC예비결정반박증거제출,https://www.fetv.co.kr/news/article.html?no=64592
7017,2020-09-25,대웅제약신규보툴리늄균주구매ITC예비결정반박증거제출”,https://www.hankyung.com/it/article/202009250808i
7018,2020-09-25,대웅제약보툴리눔균주신규구매메디톡스영업비밀침해판결반박,https://www.etoday.co.kr/news/view/1944883
7019,2020-09-25,대웅제약보툴리눔균주쉽게구매”예비결정반박증거제출,http://www.mdtoday.co.kr/mdtoday/index.html?no=400433
7020,2020-09-25,대웅제약미국에서새보툴리눔균주구매쉽게구할수있음입증,http://www.businesspost.co.kr/BP?command=article_view&num=197816
7021,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.metroseoul.co.kr/article/20200925500127
7022,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.thefirstmedia.net/news/articleView.html?idxno=63811
7023,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.nbnnews.co.kr/news/articleView.html?idxno=428088
7024,2020-09-25,대웅대웅제약같은상승세지만흐름달라특히대웅오후갑작스런7급등,http://www.econonews.co.kr/news/articleView.html?idxno=138284
7025,2020-09-25,대웅제약신규홀A하이퍼보툴리눔균주구매,http://news.mk.co.kr/newsRead.php?no=993620&year=2020
7026,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://newsclaim.co.kr/View.aspx?No=1265543
7027,2020-09-25,대웅제약보톡스균주구매예비판결오판,https://www.ebn.co.kr/news/view/1452610/?sc=Naver
7028,2020-09-25,보툴리눔균주쉽게구할수있다”대웅제약신규보툴리눔균주구매,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009251451271500761
7029,2020-09-25,보툴리눔균주구매가능해”대웅제약美ITC에반박자료제출,http://www.youthdaily.co.kr/news/article.html?no=48650
7030,2020-09-25,대웅제약ITC예비판결반박주가5거래일만에반등,http://sports.hankooki.com/lpage/economy/202009/sp20200925155459137020.htm?s_ref=nv
7031,2020-09-25,메디톡스대웅제약균주구매가능놓고재격돌,http://www.newstomato.com/ReadNews.aspx?no=998346
7032,2020-09-25,이데일리N대웅제약보툴리눔균주쉽게구매가능”메디톡스반박外,http://www.edaily.co.kr/news/newspath.asp?newsid=03155366625903728
7033,2020-09-25,대웅제약신규보툴리눔균주구매했다”,http://www.whosaeng.com/121201
7034,2020-09-25,대웅제약보톡스균주구매ITC에반박자료제출,http://daily.hankooki.com/lpage/industry/202009/dh20200925155930148390.htm?s_ref=nv
7035,2020-09-25,대웅제약보툴리눔균주쉽게구매가능메디톡스주장전격반박,http://moneys.mt.co.kr/news/mwView.php?no=2020092514558022443
7036,2020-09-25,대웅제약보툴리눔톡신균주돈으로살수있다”메디톡스생채기내기혈안,http://theviewers.co.kr/View.aspx?No=1265747
7037,2020-09-25,세계심장의날전세계심장질환우려↑대웅제약모비케어로잡아내세요,http://www.newspim.com/news/view/20200925000906
7038,2020-09-25,대웅제약보툴리눔균주쉽게구한다ITC예비결정반박,http://www.mediapen.com/news/view/561333
7039,2020-09-25,대웅제약웨어러블심전도기기로심장질환조기진단활성화기대,http://www.sisafocus.co.kr/news/articleView.html?idxno=248278
7040,2020-09-25,금일제약업계주요기사셀트리온그룹내년말까지지주사체제확립”대웅제약美ITC에반박자료제출外,http://www.youthdaily.co.kr/news/article.html?no=48656
7041,2020-09-26,대웅제약신규보툴리눔균주구매예비결정반박증거제출,https://www.kpanews.co.kr/article/show.asp?idx=216425&category=D
7042,2020-09-26,미국vs중국코로나백신최종승자는국내는신풍제약대웅제약진원생명과학등주목,http://www.g-enews.com/ko-kr/news/article/news_all/2020092606465826414e4869c120_1/article.html
7043,2020-09-26,오늘의제약셀트리온3총사합병동화약품동아쏘시오홀딩스대웅제약광동제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39703
7044,2020-09-26,미ITC대웅제약메디톡스보톡스분쟁예비판결재검토外,http://www.cstimes.com/news/articleView.html?idxno=431917
7045,2020-09-26,글로벌Biz24대웅제약건강분야지식공유위한글로벌플랫폼쉐어독출시,http://www.g-enews.com/ko-kr/news/article/news_all/202009261825182720e0eaf3841f_1/article.html
7046,2020-09-28,인벤티지랩대웅제약과남성형탈모치료제공동개발계약체결,https://www.news1.kr/articles/?4072145
7047,2020-09-28,대웅제약인벤티지랩과장기지속형남성형탈모치료제개발,http://it.chosun.com/site/data/html_dir/2020/09/28/2020092800480.html
7048,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.sentv.co.kr/news/view/580154
7049,2020-09-28,대웅제약인벤티지랩과주사형남성형탈모치료제공동개발추진,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092809135896817
7050,2020-09-28,대웅제약주사형남성형탈모치료제개발나선다,http://www.ekn.kr/news/article.html?no=525780
7051,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.lawissue.co.kr/view.php?ud=202009280918018088204ead0791_12
7052,2020-09-28,대웅제약주사형탈모치료제공동개발추진,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571815071680
7053,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.press9.kr/news/articleView.html?idxno=45925
7054,2020-09-28,인벤티지랩대웅제약과남성형탈모치료제공동개발계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=400511
7055,2020-09-28,월1회주사로탈모치료를대웅제약주사형남성형탈모치료제개발추진,http://kpenews.com/View.aspx?No=1266795
7056,2020-09-28,월1회주사로탈모치료를대웅제약주사형남성형탈모치료제개발추진,http://kpenews.com/View.aspx?No=1266795
7057,2020-09-28,대웅제약탈모주사제공동개발,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95275
7058,2020-09-28,먹는약대신주사”대웅제약주사형남성탈모치료제공동개발추진,https://www.fetv.co.kr/news/article.html?no=64686
7059,2020-09-28,대웅제약남성형탈모치료월1회주사제공동개발,http://www.medisobizanews.com/news/articleView.html?idxno=73018
7060,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249596
7061,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.newstomato.com/ReadNews.aspx?no=998519
7062,2020-09-28,대웅제약월1회투여남성형탈모치료제공동개발추진,http://medipana.com/news/news_viewer.asp?NewsNum=263503&MainKind=A&NewsKind=5&vCount=12&vKind=1
7063,2020-09-28,대웅제약인벤티지랩주사형탈모치료제공동개발매일먹는약대신월1회주사,http://theviewers.co.kr/View.aspx?No=1266854
7064,2020-09-28,대웅제약탈모치료제한달에한번맞는주사제로개발,http://moneys.mt.co.kr/news/mwView.php?no=2020092809228049695
7065,2020-09-28,대웅제약인벤티지랩과남성형탈모주사제공동개발,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009280075&t=NN
7066,2020-09-28,대웅제약주사형탈모치료제개발13개월에1회투여,http://www.koreastocknews.com/news/articleView.html?idxno=57519
7067,2020-09-28,대웅제약인벤티지랩과남성형탈모주사제공동개발,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009280075&t=NN
7068,2020-09-28,대웅제약월1회주사치료남성형탈모치료제공동개발,https://www.etoday.co.kr/news/view/1945447
7069,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,https://www.ebn.co.kr/news/view/1452771/?sc=Naver
7070,2020-09-28,대웅제약인벤티지랩과주사형남성형탈모치료제개발나서,http://sports.hankooki.com/lpage/economy/202009/sp20200928094135137020.htm?s_ref=nv
7071,2020-09-28,게시판대웅제약인벤티지랩남성형탈모치료제개발협약,http://yna.kr/AKR20200928044500017?did=1195m
7072,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.newsway.co.kr/news/view?tp=1&ud=2020092809465868879
7073,2020-09-28,상처뿐인보톡스전쟁대웅제약메디톡스나란히적자,http://news.mt.co.kr/mtview.php?no=2020092417451374982
7074,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.mediapen.com/news/view/561741
7075,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://newsbrite.net/141979
7076,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.kpinews.co.kr/news/articleView.html?idxno=127032
7077,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.bosa.co.kr/news/articleView.html?idxno=2135245
7078,2020-09-28,대웅제약월1회주사탈모치료제개발추진,http://www.newsis.com/view/?id=NISX20200928_0001181518&cID=13001&pID=13000
7079,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.m-i.kr/news/articleView.html?idxno=750464
7080,2020-09-28,대웅제약13개월1회주사형남성형탈모치료제공동개발추진,http://www.econovill.com/news/articleView.html?idxno=413531
7081,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63674
7082,2020-09-28,대웅제약월1회주사형탈모치료제공동개발추진,http://www.medigatenews.com/news/1834060944
7083,2020-09-28,대웅제약월1회주사탈모치료제개발나선다,http://inthenews.co.kr/article-71151/
7084,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.businesskorea.co.kr/news/articleView.html?idxno=52524
7085,2020-09-28,대웅제약월1회주사형탈모치료제공동개발,http://health.chosun.com/site/data/html_dir/2020/09/28/2020092801282.html
7086,2020-09-28,월1회주사로탈모방지대웅제약남성형탈모치료제개발,http://www.metroseoul.co.kr/article/20200928500151
7087,2020-09-28,뉴스투데이L대웅제약장기지속형남성형탈모치료제개발본격화,https://www.news2day.co.kr/161408
7088,2020-09-28,대웅제약인벤티지랩주사형남성형탈모치료제공동개발추진,http://www.ceoscoredaily.com/news/article.html?no=73610
7089,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009281039434900924
7090,2020-09-28,대웅제약인벤티지랩과월1회주사남성형탈모치료제개발,https://www.hankyung.com/it/article/202009288176i
7091,2020-09-28,대웅제약월1회주사로탈모치료치료제개발,http://www.mhj21.com/134936
7092,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://news.mk.co.kr/newsRead.php?no=999904&year=2020
7093,2020-09-28,대웅제약월1회주사형남성형탈모치료제공동개발추진,http://www.healthinnews.co.kr/news/articleView.html?idxno=14694
7094,2020-09-28,먹는약대신월1회주사로”대웅제약주사형탈모치료제개발본격화,http://www.viva100.com/main/view.php?key=20200928010005947
7095,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.dailysmart.co.kr/news/articleView.html?idxno=33442
7096,2020-09-28,대웅제약주사형남성형탈모치료제개발나서,http://www.bokuennews.com/news/article.html?no=195249
7097,2020-09-28,대웅제약인벤티지랩과장기지속형남성탈모치료제공동개발추진,http://www.businesspost.co.kr/BP?command=article_view&num=198059
7098,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=400611
7099,2020-09-28,대웅제약글로벌지식공유플랫폼출시언택트마케팅강화,https://www.theguru.co.kr/news/article.html?no=14603
7100,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진월1회주사로탈모치료,http://www.paxetv.com/news/articleView.html?idxno=101275
7101,2020-09-28,대웅제약월1회주사로탈모치료가능한치료제본격개발,http://www.koreaittimes.com/news/articleView.html?idxno=100736
7102,2020-09-28,대웅제약인벤티지랩의장기지속형탈모치료후보물질공동개발키로,http://news.mk.co.kr/newsRead.php?no=1000862&year=2020
7103,2020-09-28,월1회탈모주사제개발대웅제약RD착수,http://www.wikileaks-kr.org/news/articleView.html?idxno=95776
7104,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.nbnnews.co.kr/news/articleView.html?idxno=428679
7105,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.enewstoday.co.kr/news/articleView.html?idxno=1417769
7106,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://www.newsworks.co.kr/news/articleView.html?idxno=491585
7107,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://enter.etoday.co.kr/view/news_view.php?varAtcId=188337
7108,2020-09-28,종합대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.getnews.co.kr/view.php?ud=20200928150516431fab1982f6a_16
7109,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://www.ccdn.co.kr/news/articleView.html?idxno=666451
7110,2020-09-28,대웅제약인벤티지랩남성형탈모치료제개발협약,http://www.seoulfn.com/news/articleView.html?idxno=396679
7111,2020-09-28,대웅제약에너씨슬콜레다운관련캐시워크돈버는퀴즈정답 ,http://www.joygm.com/news/articleView.html?idxno=88073
7112,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.fnnews.com/news/202009281553093014
7113,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답이목집중,http://www.newsfarm.co.kr/news/articleView.html?idxno=59521
7114,2020-09-28,종합두번째대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.getnews.co.kr/view.php?ud=202009281622472250fab1982f6a_16
7115,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답업데이트,http://www.ccdn.co.kr/news/articleView.html?idxno=666524
7116,2020-09-28,대웅제약인벤티지랩남성탈모치료주사제공동개발,http://www.finomy.com/news/articleView.html?idxno=83600
7117,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답힌트는,http://www.rapportian.com/news/articleView.html?idxno=128100
7118,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈추가정답은,http://www.joygm.com/news/articleView.html?idxno=88078
7119,2020-09-28,종합캐시워크정답을한번에28일오후5시10분현재대웅제약에너씨슬성분에디터튼살크림커넬오일성분에디터등4건퀴즈의정답은 ,http://www.bizwnews.com/news/articleView.html?idxno=21197
7120,2020-09-28,대웅제약에너씨슬콜레다운관련캐시워크추가된돈버는퀴즈정답 ,http://www.newsfarm.co.kr/news/articleView.html?idxno=59523
7121,2020-09-28,대웅제약월1회주사남성형탈모치료제공동개발,http://www.shinailbo.co.kr/news/articleView.html?idxno=1326415
7122,2020-09-28,대웅제약벤처월1회주사탈모치료제공동개발본격화,http://www.100ssd.co.kr/news/articleView.html?idxno=71667
7123,2020-09-28,김창수의e뉴스브리핑먹는약대신주사”대웅제약주사형남성탈모치료제공동개발추진外,https://www.fetv.co.kr/news/article.html?no=64780
7124,2020-09-28,매일먹는약대신월1회주사로탈모치료대웅제약공동개발추진,http://daily.hankooki.com/lpage/industry/202009/dh20200928173749148390.htm?s_ref=nv
7125,2020-09-28,금일제약업계주요기사LG화학비만신약美FDA희귀의약품지정대웅제약주사형남성형탈모치료제공동개발外,http://www.youthdaily.co.kr/news/article.html?no=48860
7126,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.thefirstmedia.net/news/articleView.html?idxno=63959
7127,2020-09-28,대웅제약월1회탈모치료주사개발나서,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003310
7128,2020-09-28,매일먹는대신월1회주사”대웅제약13개월지속형탈모치료제공동개발,https://www.donga.com/news/article/all/20200928/103183741/1
7129,2020-09-28,대웅제약에너씨슬콜레다운관련캐시워크돈버는퀴즈정답추가 ,http://www.ccdn.co.kr/news/articleView.html?idxno=666673
7130,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답업데이트,http://www.joygm.com/news/articleView.html?idxno=88083
7131,2020-09-29,대웅제약인벤티지랩과주사형남성형탈모치료제공동개발추진,http://www.g-enews.com/ko-kr/news/article/news_all/2020092817271281762500a1b5d6_1/article.html
7132,2020-09-29,캐시워크돈버는퀴즈오늘29일정답성분에디터튼살크림대웅제약에너씨슬콜레다운,http://daily.hankooki.com/lpage/economy/202009/dh20200929102820138060.htm?s_ref=nv
7133,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답 ,http://www.newsfarm.co.kr/news/articleView.html?idxno=59533
7134,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249691
7135,2020-09-29,대웅제약니클로사마이드인플루엔자치료효과도확인,http://health.chosun.com/site/data/html_dir/2020/09/29/2020092901385.html
7136,2020-09-29,종합29일대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.getnews.co.kr/view.php?ud=202009291113568641fab1982f6a_16
7137,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://newsclaim.co.kr/View.aspx?No=1268896
7138,2020-09-29,대웅제약니클로사마이드인플루엔자서도효과확인,https://www.sedaily.com/NewsView/1Z81LDE7D4
7139,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63718
7140,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자효과확인,http://www.press9.kr/news/articleView.html?idxno=45938
7141,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자에도효과,http://www.seoulwire.com/news/articleView.html?idxno=427275
7142,2020-09-29,대웅제약개발코로나19치료약물인플루엔자도효과,http://www.medisobizanews.com/news/articleView.html?idxno=73069
7143,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.pharmnews.com/news/articleView.html?idxno=101379
7144,2020-09-29,대웅제약니클로사마이드인플루엔자효과확인,http://www.wsobi.com/news/articleView.html?idxno=105607
7145,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.newsway.co.kr/news/view?tp=1&ud=2020092911253394792
7146,2020-09-29,대웅제약니클로사마이드인플루엔자사망률감소확인,https://www.ebn.co.kr/news/view/1453004/?sc=Naver
7147,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=400818
7148,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://newsbrite.net/142056
7149,2020-09-29,특징주대웅제약코로나19치료제인플루엔자동물효과확인소식에상승,http://www.newsprime.co.kr/news/article.html?no=519576
7150,2020-09-29,대웅제약니클로사마이드독감치료가능성확인,http://www.newsis.com/view/?id=NISX20200929_0001183421&cID=13001&pID=13000
7151,2020-09-29,대웅제약니클로사마이드코로나이어인플루엔자도효과확인,http://www.ekn.kr/news/article.html?no=526102
7152,2020-09-29,대웅제약코로나치료제니클로사마이드인플루엔자효과확인,http://www.consumernews.co.kr/news/articleView.html?idxno=613230
7153,2020-09-29,특징주대웅제약니클로사마이드코로나19독감동물실험서사망100억제확인강세,https://www.etoday.co.kr/news/view/1946078
7154,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092911390544326
7155,2020-09-29,대웅제약니클로사마이드코로나19인플루엔자사망률감소효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020092911198060778
7156,2020-09-29,대웅제약대웅모두상승흐름특히대웅제약오전가파른상승세로3상승,http://www.econonews.co.kr/news/articleView.html?idxno=138671
7157,2020-09-29,종합캐시워크정답을한번에29일오전11시45분현재대웅제약에너씨슬성분에디터튼살크림커넬오일성분에디터등4건퀴즈의정답은 ,http://www.bizwnews.com/news/articleView.html?idxno=21208
7158,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자도효과,http://www.econovill.com/news/articleView.html?idxno=413761
7159,2020-09-29,대웅제약니클로사마이드인플루엔자효과확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=52625
7160,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.lawissue.co.kr/view.php?ud=202009291148524469204ead0791_12
7161,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자효과확인,http://www.viva100.com/main/view.php?key=20200929010006190
7162,2020-09-29,대웅제약니클로사마이드인플루엔자서도효과확인,http://www.techholic.co.kr/news/articleView.html?idxno=193890
7163,2020-09-29,대웅제약니클로사마이드독감인플루엔자에도효과,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122032
7164,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://weekly.cnbnews.com/news/article.html?no=136221
7165,2020-09-29,코로나19에효과대웅제약니클로사마이드인플루엔자에도효과확인,http://www.koreaittimes.com/news/articleView.html?idxno=100770
7166,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14738
7167,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.newstomato.com/ReadNews.aspx?no=998844
7168,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자에도효과”,https://www.etoday.co.kr/news/view/1946070
7169,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자효과확인,http://www.onews.tv/news/articleView.html?idxno=33947
7170,2020-09-29,대웅제약니클로사마이드코로나인플루엔자효과확인,http://sports.hankooki.com/lpage/economy/202009/sp20200929130722137020.htm?s_ref=nv
7171,2020-09-29,대웅제약에너씨슬콜레다운성분에디터시카튼살크림캐시워크돈버는퀴즈정답공개,http://www.ccdn.co.kr/news/articleView.html?idxno=666680
7172,2020-09-29,대웅제약코로나치료제독감에도효과확인,http://news.mk.co.kr/newsRead.php?no=1005402&year=2020
7173,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.paxetv.com/news/articleView.html?idxno=101382
7174,2020-09-29,구충제코로나19인플루엔자둘다잡는다대웅제약효력시험통해사망률제로확인,https://www.donga.com/news/article/all/20200929/103193331/1
7175,2020-09-29,대웅제약니클로사마이드코로나19에이어독감치료가능성확인,http://inthenews.co.kr/article-71540/
7176,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.fnnews.com/news/202009291352143296
7177,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자도효과확인,https://www.news1.kr/articles/?4074161
7178,2020-09-29,대웅제약코로나19치료제후보물질인플루엔자에도효과보여,http://www.businesspost.co.kr/BP?command=article_view&num=198327
7179,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.dailysmart.co.kr/news/articleView.html?idxno=33538
7180,2020-09-29,대웅제약니클로사마이드코로나19와독감모두효과,http://www.medigatenews.com/news/1261173960
7181,2020-09-29,대웅제약니클로사마이드인플루엔자효과확인,http://www.kpinews.co.kr/news/articleView.html?idxno=127250
7182,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.ceoscoredaily.com/news/article.html?no=73689
7183,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.getnews.co.kr/view.php?ud=2020092914064646672fe691f917_16
7184,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=429085
7185,2020-09-29,대웅제약니클로사마이드코로나19뿐아니라인플루엔자에도효과확인,https://www.fetv.co.kr/news/article.html?no=64870
7186,2020-09-29,대웅제약코로나19치료제후보니클로사마이드독감에도효과,https://www.hankyung.com/it/article/202009293667i
7187,2020-09-29,뉴스투데이L대웅제약니클로사마이드인플루엔자감염사망률감소효과확인,https://www.news2day.co.kr/161533
7188,2020-09-29,대웅제약니클로사마이드인플루엔자에효과,http://www.seoulfn.com/news/articleView.html?idxno=396827
7189,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.worktoday.co.kr/news/articleView.html?idxno=10498
7190,2020-09-29,대웅제약니클로사마이드독감치료효과도확인,http://it.chosun.com/site/data/html_dir/2020/09/29/2020092901907.html
7191,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009291422250970139
7192,2020-09-29,대웅제약니클로사마이드동물실험서독감에효과,http://www.finomy.com/news/articleView.html?idxno=83659
7193,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.thefirstmedia.net/news/articleView.html?idxno=63990
7194,2020-09-29,대웅제약개발중인코로나치료제독감치료효과확인,https://biz.chosun.com/site/data/html_dir/2020/09/29/2020092902185.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7195,2020-09-29,대웅제약코로나19치료제후보물질DWRX2003독감에도효과확인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065595547200573
7196,2020-09-29,김창수의e뉴스브리핑대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인外,https://www.fetv.co.kr/news/article.html?no=64898
7197,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.mediapen.com/news/view/562455
7198,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답업데이트,http://www.joygm.com/news/articleView.html?idxno=88104
7199,2020-09-29,대웅제약니클로사마이드코로나19에이어독감에도효과,http://www.metroseoul.co.kr/article/20200929500226
7200,2020-09-29,대웅제약니클로사마이드코로나19도인플루엔자에도효과,https://www.kpanews.co.kr/article/show.asp?idx=216507&category=D
7201,2020-09-30,대웅제약주사형남성형탈모치료제공동개발추진,https://www.kpanews.co.kr/article/show.asp?idx=216522&category=D
7202,2020-09-30,대웅제약에너씨슬콜레다운성분에디터시카튼살크림마미레시피골든아르간커넬오일캐시워크돈버는퀴즈정답업데이트,http://www.ccdn.co.kr/news/articleView.html?idxno=666703
7203,2020-09-30,대웅제약니클로사마이드코로나19에이어인플루엔자서효과확인,http://www.m-i.kr/news/articleView.html?idxno=751047
7204,2020-09-30,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.thepublic.kr/news/newsview.php?ncode=1065579802518781
7205,2020-10-01,대웅제약니클로사마이드독감치료가능성확인코로나19치료제로개발중,http://www.econonews.co.kr/news/articleView.html?idxno=138847
7206,2020-10-01,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://www.newsfarm.co.kr/news/articleView.html?idxno=59546
7207,2020-10-01,대웅제약니클로사마이드코로나19이어인플루엔자75개선확인,http://www.newslock.co.kr/news/articleView.html?idxno=31419
7208,2020-10-02,대웅제약에너씨슬콜레다운성분에디터시카튼살크림캐시워크돈버는퀴즈정답은,http://www.joygm.com/news/articleView.html?idxno=88120
7209,2020-10-02,글로벌Biz24대웅제약빠르면내년중인니에코로나19치료제공급,http://www.g-enews.com/ko-kr/news/article/news_all/20201002151013563469d76442fa_1/article.html
7210,2020-10-02,대웅제약신약코로나19인플루엔자트윈데믹사망감소효과동물시험입증,http://weekly.cnbnews.com/news/article.html?no=136238
7211,2020-10-02,종합캐시워크정답정리2일오후7시10분현재대웅제약에너씨슬성분에디터튼살크림등2건퀴즈의정답은 ,http://www.bizwnews.com/news/articleView.html?idxno=21234
7212,2020-10-04,종합캐시워크정답정리4일오전11시현재대웅제약에너씨슬성분에디터튼살크림등2건퀴즈의정답은,http://www.bizwnews.com/news/articleView.html?idxno=21242
7213,2020-10-04,캐시워크대웅제약에너씨슬콜레다운성분에디터시카튼살크림돈버는퀴즈정답은,http://www.ccdn.co.kr/news/articleView.html?idxno=666740
7214,2020-10-04,대웅제약떠난막말논란윤재승회장헬스케어기업미래는,http://www.skyedaily.com/news/news_view.html?ID=113134
7215,2020-10-05,대웅제약개발SGLT2당뇨신약국내임상3상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=269033&REFERER=NP
7216,2020-10-05,대웅제약의정면돌파,https://www.dailian.co.kr/news/view/923879/?sc=Naver
7217,2020-10-05,한경팩트체크균주전쟁에보톡스美수출90급감한대웅제약,https://www.hankyung.com/it/article/202010054698i
7218,2020-10-05,대웅제약주사형남성탈모치료제개발추진,http://www.monews.co.kr/news/articleView.html?idxno=213969
7219,2020-10-05,대웅제약당뇨병치료제DWP16001국내임상3상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=401116
7220,2020-10-05,대웅제약당뇨약이나보글리플로진임상2건승인개발순항,http://daily.hankooki.com/lpage/industry/202010/dh20201005173126148390.htm?s_ref=nv
7221,2020-10-05,대웅제약주사형남성형탈모치료제공동개발추진,http://www.wsobi.com/news/articleView.html?idxno=105824
7222,2020-10-06,대웅제약국내최초SGLT2억제제당뇨병신약국내임상3상동시승인,http://www.fnnews.com/news/202010061403550066
7223,2020-10-06,대웅제약당뇨신약단독병용요법국내임상3상동시승인,http://www.metroseoul.co.kr/article/20201006500303
7224,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://www.lawissue.co.kr/view.php?ud=202010061410277128204ead0791_12
7225,2020-10-06,대웅제약이나보글리플로진단독요법메트포르민병용요법국내임상3상동시승인,http://www.segye.com/content/html/2020/10/06/20201006514993.html?OutUrl=naver
7226,2020-10-06,대웅제약당뇨신약이나보글리플로진식약처임상3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020100614151145046
7227,2020-10-06,대웅제약당뇨병신약단독병용요법임상3상동시승인,http://www.medisobizanews.com/news/articleView.html?idxno=73165
7228,2020-10-06,대웅제약이나보글리플로진단독및메트포르민병용국내임상3상동시승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63786
7229,2020-10-06,대웅제약이나보글리플로진메트포르민국내임상3상동시승인,https://www.fetv.co.kr/news/article.html?no=65114
7230,2020-10-06,대웅제약SGLT2당뇨신약단독병용3상동시승인,http://www.newsis.com/view/?id=NISX20201006_0001188190&cID=13001&pID=13000
7231,2020-10-06,대웅제약이나보글리플로진국내임상3상승인,http://medipana.com/news/news_viewer.asp?NewsNum=263783&MainKind=A&NewsKind=5&vCount=12&vKind=1
7232,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상동시승인,http://www.g-enews.com/ko-kr/news/article/news_all/2020100614190075512500a1b5d6_1/article.html
7233,2020-10-06,대웅제약당뇨신약이나보글리플로진단독병용국내임상3상승인획득”,http://www.youthdaily.co.kr/news/article.html?no=49287
7234,2020-10-06,대웅제약당뇨신약단독요법및메트포르민병용요법국내임상3상승인,http://www.ekn.kr/news/article.html?no=526892
7235,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아,http://yna.kr/AKR20201006112600017?did=1195m
7236,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://www.m-i.kr/news/articleView.html?idxno=751906
7237,2020-10-06,대웅제약당뇨약이나보글리플로진국내임상3상승인획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065591308175045
7238,2020-10-06,대웅제약당뇨병신약이나보글리플로진임상3상승인,http://www.upinews.kr/newsView/upi202010060057
7239,2020-10-06,대웅제약이나보글리플로진개발가속단독병용임상3상동시승인,https://www.etoday.co.kr/news/view/1947508
7240,2020-10-06,대웅제약제2형당뇨병신약임상3상계획동시승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010060258&t=NN
7241,2020-10-06,대웅제약당뇨신약단독병용임상3상승인개발박차,http://moneys.mt.co.kr/news/mwView.php?no=2020100614238099527
7242,2020-10-06,대웅제약당뇨신약단독병용임상3상승인개발박차,http://moneys.mt.co.kr/news/mwView.php?no=2020100614238099527
7243,2020-10-06,대웅제약당뇨신약단독병용사용국내임상3상동시승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=33700
7244,2020-10-06,대웅제약당뇨병신약단독및병용국내임상3상승인,https://www.hankyung.com/it/article/202010069765i
7245,2020-10-06,대웅제약당뇨병신약단독병용요법임상3상동시승인,http://sports.hankooki.com/lpage/economy/202010/sp20201006150205137020.htm?s_ref=nv
7246,2020-10-06,대웅제약개발당뇨신약단독병용국내임상3상동시승인,https://biz.chosun.com/site/data/html_dir/2020/10/06/2020100602017.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7247,2020-10-06,대웅제약이나보글리플로진단독요법메트포르민병용요법국내임상3상동시승인,http://www.economytalk.kr/news/articleView.html?idxno=208482
7248,2020-10-06,대웅제약국내첫SGLT2i신약메트포르민병용3상착수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136324&REFERER=NP
7249,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아개발총력전,http://www.startuptoday.co.kr/news/articleView.html?idxno=56439
7250,2020-10-06,대웅제약당뇨신약단독병용3상동시승인,https://view.asiae.co.kr/article/2020100615162792532
7251,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://www.kpinews.co.kr/news/articleView.html?idxno=127540
7252,2020-10-06,대웅제약당뇨신약이나보글리플로진단독병용국내임상3상승인획득”,http://www.newsway.co.kr/news/view?tp=1&ud=2020100615184939976
7253,2020-10-06,대웅제약이나보글리플로진국내임상3상승인,http://www.fnnews.com/news/202010061521026625
7254,2020-10-06,대웅제약당뇨병신약이나보글리플로진임상3상계획승인받아,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004131525
7255,2020-10-06,대웅제약당뇨신약단독병용임상3상동시승인오는2023년발매목표,http://www.viva100.com/main/view.php?key=20201006010000771
7256,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상동시승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14787
7257,2020-10-06,뉴스투데이L대웅제약이나보글리플로진단독요법메트포르민병용요법국내임상3상동시승인,https://www.news2day.co.kr/161754
7258,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4301174
7259,2020-10-06,대웅제약이나보글리플로진단독병용요법3상승인,http://www.press9.kr/news/articleView.html?idxno=45962
7260,2020-10-06,대웅제약국내최초SGLT2억제제당뇨신약3상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2135595
7261,2020-10-06,대웅제약이나보글리플로진단독병용국내임상3상동시승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=401319
7262,2020-10-06,대웅제약당뇨병신약단독병용요법국내임상3상동시승인,http://health.chosun.com/site/data/html_dir/2020/10/06/2020100602251.html
7263,2020-10-06,대웅제약주사형탈모치료제개발나서,http://www.munhwa.com/news/view.html?no=20201006MW161215523417
7264,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아”,http://www.smartfn.co.kr/view.php?ud=202010061602372255379cda9ab3_46
7265,2020-10-06,대웅제약당뇨병신약단독병용국내임상3상승인,http://www.mhj21.com/135076
7266,2020-10-06,대웅제약당뇨신약이나보글리플로진국내임상3상승인단독요법및메트포르민병용요법동시,http://theviewers.co.kr/View.aspx?No=1272698
7267,2020-10-06,대웅제약이나보글리플로진단독메트포르민병용요법임상3상승인,http://www.newsprime.co.kr/news/article.html?no=519951
7268,2020-10-06,대웅제약당뇨병신약단독병용요법국내임상3상동시승인,https://www.asiatoday.co.kr/view.php?key=20201006010002047
7269,2020-10-06,식약처대웅제약당뇨병신약이나보글리플로진임상3상승인,http://www.finomy.com/news/articleView.html?idxno=83789
7270,2020-10-06,대웅제약이나보글리플로진 단독병용사용임상3상동시승인,http://www.koreastocknews.com/news/articleView.html?idxno=57675
7271,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아,http://www.mediapen.com/news/view/563630
7272,2020-10-06,대웅제약국내최초SGLT2억제제당뇨병신약국내임상3상동시승인,http://www.koreaittimes.com/news/articleView.html?idxno=100846
7273,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://www.thepublic.kr/news/newsview.php?ncode=1065599484114575
7274,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://newsbrite.net/142152
7275,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202010061726033150643
7276,2020-10-06,대웅제약당뇨병치료제혁신신약임상3상본격화단독병용시험동시승인,https://www.donga.com/news/article/all/20201006/103270779/1
7277,2020-10-06,대웅제약당뇨병신약이나보글리플로진임상3상착수,http://www.seoulfn.com/news/articleView.html?idxno=397182
7278,2020-10-06,금일제약업계주요기사대웅제약당뇨신약단독병용국내임상3상승인획득”GC북미법인매각대금46억달러수취外,http://www.youthdaily.co.kr/news/article.html?no=49315
7279,2020-10-06,대웅제약이나보글리플로진단독요법메트포르민병용요법임상3상승인,http://www.newslock.co.kr/news/articleView.html?idxno=31513
7280,2020-10-06,대웅제약당뇨병신약단독병용임상3상동시승인,http://news.mt.co.kr/mtview.php?no=2020100614042344962
7281,2020-10-06,대웅제약SGLT2억제제당뇨병신약이나보글리플로진국내임상3상동시승인,http://www.thefirstmedia.net/news/articleView.html?idxno=64152
7282,2020-10-06,대웅제약국내임상3상동시승인받아,http://www.businesskorea.co.kr/news/articleView.html?idxno=52783
7283,2020-10-06,대웅제약당뇨병치료제임상3상승인받아전승호최고신약개발,http://www.businesspost.co.kr/BP?command=article_view&num=198861
7284,2020-10-06,대웅제약당뇨신약단독요법병용요법임상3상동시승인”,http://www.econovill.com/news/articleView.html?idxno=414350
7285,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1418897
7286,2020-10-07,글로벌K바이오⑦대웅제약100개국수출네트워크로글로벌헬스케어그룹목표,http://www.g-enews.com/ko-kr/news/article/news_all/20201006135525706569d76442fa_1/article.html
7287,2020-10-07,대웅제약SGLT2당뇨병치료제국내3상진행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003500
7288,2020-10-07,대웅제약나보타양성교근비대임상3상돌입,http://www.ceoscoredaily.com/news/article.html?no=73769
7289,2020-10-07,대웅제약당뇨병신약단독병용요법국내3상동시승인,http://www.consumernews.co.kr/news/articleView.html?idxno=613460
7290,2020-10-07,대웅제약당뇨신약단독병용국내임상3상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1328371
7291,2020-10-07,오늘의제약한미약품그룹JVM대웅제약6일GC녹십자엠에스6일,http://www.babytimes.co.kr/news/articleView.html?idxno=39897
7292,2020-10-07,대웅제약SGLT2저해제단독병용3상식약처승인,http://www.biospectator.com/view/news_view.php?varAtcId=11490
7293,2020-10-07,대웅제약이나보글리플로진단독병용요법임상3상승인,https://www.kpanews.co.kr/article/show.asp?idx=216646&category=D
7294,2020-10-07,대웅제약SGLT2억제제당뇨병신약단독병용임상3상승인,http://www.medigatenews.com/news/1976589027
7295,2020-10-08,식약처대웅제약구충제코로나치료제임상1상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=04086886625930952
7296,2020-10-08,식약처코로나19치료제대웅제약1상임상승인,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=249967
7297,2020-10-08,대웅제약구충제성분코로나19치료제임상1상승인받아,https://cnbc.sbs.co.kr/article_hub/10000998752?division=NAVER
7298,2020-10-08,식약처대웅제약개발코로나19치료제임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=263979&MainKind=A&NewsKind=5&vCount=12&vKind=1
7299,2020-10-08,대웅제약구충제성분코로나19치료제임상1상승인,https://www.sedaily.com/NewsView/1Z91WGEHQB
7300,2020-10-08,대웅제약DWRX2003코로나19치료제로국내임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63847
7301,2020-10-08,식약처국내개발코로나19치료제대웅제약제품1상임상승인,http://www.ecomedia.co.kr/news/newsview.php?ncode=1065604178494113
7302,2020-10-08,대웅제약DWRX2003코로나치료제임상1상승인,https://www.ebn.co.kr/news/view/1453924/?sc=Naver
7303,2020-10-08,식약처대웅제약DWRX2003코로나치료제임상1상승인,https://www.asiatoday.co.kr/view.php?key=20201008010003786
7304,2020-10-08,식약처대웅제약코로나19치료제임상1상시험계획승인,http://yna.kr/AKR20201008183900017?did=1195m
7305,2020-10-08,식약처코로나19치료제대웅제약DWRX20031상임상승인,http://www.fnnews.com/news/202010081820561243
7306,2020-10-08,대웅제약구충제성분니클로사미드로코로나19치료제임상1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=73231
7307,2020-10-08,식약처대웅제약코로나19치료제1상승인,http://www.newsis.com/view/?id=NISX20201008_0001191873&cID=13001&pID=13000
7308,2020-10-08,대웅제약코로나19치료제식약처임상1상승인,https://www.hankyung.com/it/article/202010080198i
7309,2020-10-08,식약처대웅제약코로나19치료제DWRX2003임상1상승인,http://www.getnews.co.kr/view.php?ud=2020100818222530342fe691f917_16
7310,2020-10-08,대웅제약구충제성분코로나19치료제로임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020100818200966077
7311,2020-10-08,식약처대웅제약코로나19치료제임상1상승인,http://www.medigatenews.com/news/475731186
7312,2020-10-08,대웅제약니클로사미드주사제코로나19에1상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=269262&REFERER=NP
7313,2020-10-08,식약처대웅제약코로나19치료제임상1상승인,http://news.mt.co.kr/mtview.php?no=2020100818381343276
7314,2020-10-08,식약처대웅제약개발코로나19치료제1상승인,http://www.wikileaks-kr.org/news/articleView.html?idxno=96354
7315,2020-10-08,식약처대웅제약구충제코로나치료제임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/10/08/2020100802884.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7316,2020-10-08,식약처대웅제약코로나19치료제1상승인,http://news.mk.co.kr/newsRead.php?no=1033679&year=2020
7317,2020-10-08,대웅제약니클로사마이드코로나19치료제식약처임상1상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020100818498082378
7318,2020-10-08,대웅제약코로나19치료제DWRX2003임상1상본격화,https://www.etoday.co.kr/news/view/1948673
7319,2020-10-08,대웅제약코로나19치료물질DWRX2003국내임상1상승인,https://www.news1.kr/articles/?4081823
7320,2020-10-08,식약처대웅제약코로나19치료제1상임상승인,http://www.m-i.kr/news/articleView.html?idxno=752784
7321,2020-10-08,식약처대웅제약코로나19치료제DWRX2003임상1상승인,http://www.newspim.com/news/view/20201008001400
7322,2020-10-08,식약처대웅제약코로나19치료제DWRX2003임상1상승인,https://www.youthdaily.co.kr/news/article.html?no=49573
7323,2020-10-08,대웅제약코로나19치료제임상1상승인,http://www.cstimes.com/news/articleView.html?idxno=433706
7324,2020-10-09,대웅제약전승호號신약개발잰걸음,https://www.fetv.co.kr/news/article.html?no=65179
7325,2020-10-09,대웅제약코로나19치료제1상임상시험승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95494
7326,2020-10-09,식약처대웅제약코로나19치료제임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=401773
7327,2020-10-09,식약처대웅제약개발코로나19치료제임상1상승인,http://www.seoulfn.com/news/articleView.html?idxno=397511
7328,2020-10-10,식약처대웅제약코로나19치료제DWRX2003임상시험승인,http://www.gukjenews.com/news/articleView.html?idxno=2087065
7329,2020-10-10,코로나19치료제DWRX2003대웅제약1상임상시험승인국내총20건진행중,http://medicalworldnews.co.kr/news/view.php?idx=1510938072
7330,2020-10-10,대웅제약개발코로나19치료제1상임상승인,http://www.bokuennews.com/news/article.html?no=195625
7331,2020-10-10,식약처대웅제약코로나19치료제임상1상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1419585
7332,2020-10-11,지난주제약업계주요이슈셀트리온코로나19치료제CTP593상승인대웅제약DWRX20031상승인外,http://www.youthdaily.co.kr/news/article.html?no=49610
7333,2020-10-11,대웅제약SGLT2당뇨치료신약임상3상승인받아,http://weekly.cnbnews.com/news/article.html?no=136342
7334,2020-10-11,대웅제약구충제로코로나치료제임상,https://www.hankyung.com/it/article/2020101157671
7335,2020-10-11,대웅제약구충제성분코로나19치료제임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020101118210578589
7336,2020-10-12,대웅제약DWRX2003코로나19치료제임상1상승인,http://www.monews.co.kr/news/articleView.html?idxno=214169
7337,2020-10-12,구충제주사한방에코로나19치료”대웅제약부작용해소한니클로사마이드치료제국내임상돌입,https://www.donga.com/news/article/all/20201012/103356598/1
7338,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.fnnews.com/news/202010120923484158
7339,2020-10-12,대웅제약코로나19치료제한국임상승인으로개발가속화,http://medipana.com/news/news_viewer.asp?NewsNum=264021&MainKind=A&NewsKind=5&vCount=12&vKind=1
7340,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.sentv.co.kr/news/view/580645
7341,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://www.ekn.kr/news/article.html?no=527752
7342,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.press9.kr/news/articleView.html?idxno=45987
7343,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=127834
7344,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상승인,http://www.viva100.com/main/view.php?key=20201012010001606
7345,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://weekly.hankooki.com/lpage/life/202010/wk20201012093057147650.htm?s_ref=nv
7346,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상시작,https://www.etoday.co.kr/news/view/1949130
7347,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=49685
7348,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.mediapen.com/news/view/564854
7349,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020101209302076568
7350,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상한국승인,http://www.lcnews.co.kr/news/articleView.html?idxno=8889
7351,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상,http://www.medisobizanews.com/news/articleView.html?idxno=73252
7352,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상승인,http://www.upinews.kr/newsView/upi202010120010
7353,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.getnews.co.kr/view.php?ud=2020101209395091042fe691f917_16
7354,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250011
7355,2020-10-12,대웅제약대웅테라퓨틱스코로나치료제한국임상1상승인,http://www.koreastocknews.com/news/articleView.html?idxno=57782
7356,2020-10-12,대웅제약대웅테라퓨틱스코로나치료제한국임상1상승인,http://www.koreastocknews.com/news/articleView.html?idxno=57782
7357,2020-10-12,대웅제약니콜로사마이드코로나치료제임상승인,https://www.ebn.co.kr/news/view/1454050/?sc=Naver
7358,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573550930541
7359,2020-10-12,대웅제약니클로사마이드성분코로나치료제韓임상승인,http://it.chosun.com/site/data/html_dir/2020/10/12/2020101200864.html
7360,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,https://biz.chosun.com/site/data/html_dir/2020/10/12/2020101200876.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7361,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://newsbrite.net/142281
7362,2020-10-12,대웅제약니클로사마이드의코로나19대상한국임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=1040768&year=2020
7363,2020-10-12,대웅제약코로나치료제니클로사마이드임상1상승인,http://news.mt.co.kr/mtview.php?no=2020101209185151263
7364,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.mhj21.com/135265
7365,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://news.heraldcorp.com/view.php?ud=20201012000245
7366,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://news.heraldcorp.com/view.php?ud=20201012000245
7367,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://www.fnnews.com/news/202010120949008857
7368,2020-10-12,대웅제약코로나19치료제니클로사마이드식약처임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101209451942151
7369,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,https://www.hankyung.com/it/article/202010127276i
7370,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,https://www.fetv.co.kr/news/article.html?no=65438
7371,2020-10-12,대웅제약코로나19치료제韓임상승인10월시작,http://www.newsis.com/view/?id=NISX20201012_0001193511&cID=13001&pID=13000
7372,2020-10-12,대웅제약코로나19치료제국내임상승인,https://view.asiae.co.kr/article/2020101209591453329
7373,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.lawissue.co.kr/view.php?ud=202010120954467152204ead0791_12
7374,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.m-i.kr/news/articleView.html?idxno=753071
7375,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=33895
7376,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.etnews.com/20201012000022
7377,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,https://www.asiatoday.co.kr/view.php?key=20201012010004573
7378,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://daily.hankooki.com/lpage/industry/202010/dh20201012095526148390.htm?s_ref=nv
7379,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상승인글로벌개발가속화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122273
7380,2020-10-12,대웅제약니클로사마이드글로벌이어한국서도임상승인,http://www.seoulwire.com/news/articleView.html?idxno=427775
7381,2020-10-12,대웅제약코로나치료제니클로사마이드국내임상1상승인,http://inthenews.co.kr/article-72870/
7382,2020-10-12,대웅제약니클로사마이드코로나19치료제국내임상승인,http://www.newstomato.com/ReadNews.aspx?no=1000221
7383,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010120137&t=NN
7384,2020-10-12,대웅제약니클로사마이드코로나임상1상시작이번달환자투여,http://moneys.mt.co.kr/news/mwView.php?no=2020101209288097497
7385,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상승인인도필리핀에서도임상,http://www.g-enews.com/ko-kr/news/article/news_all/2020101210113573512500a1b5d6_1/article.html
7386,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://www.newspim.com/news/view/20201012000316
7387,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.pinpointnews.co.kr/view.php?ud=2020101210272984662365609d9b_45
7388,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14850
7389,2020-10-12,식약처대웅제약코로나19치료제임상1상시험계획승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010120805457780151
7390,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.koreaittimes.com/news/articleView.html?idxno=100944
7391,2020-10-12,대웅제약니클로사마이드코로나19국내1상승인,http://www.biospectator.com/view/news_view.php?varAtcId=11519
7392,2020-10-12,대웅제약구충제성분코로나19치료제임상1상승인,http://www.econovill.com/news/articleView.html?idxno=414879
7393,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://health.chosun.com/site/data/html_dir/2020/10/12/2020101201125.html
7394,2020-10-12,대웅제약서방형니클로사마이드트윈데믹에도효과적,https://jhealthmedia.joins.com/article/article_view.asp?pno=22522
7395,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,https://www.dailian.co.kr/news/view/926368/?sc=Naver
7396,2020-10-12,셀트리온대웅제약코로나19치료제나란히임상승인,http://www.mkhealth.co.kr/news/articleView.html?idxno=50776
7397,2020-10-12,대웅제약코로나19치료제식약처임상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=52981
7398,2020-10-12,대웅제약코로나19치료제니클로사마이드1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2135884
7399,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.metroseoul.co.kr/article/20201012500157
7400,2020-10-12,대웅제약의약품박람회CPhIFestivalofPharma참가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250032
7401,2020-10-12,대웅제약 의약품박람회CPhIFestivalofPharma 참가,http://www.economytalk.kr/news/articleView.html?idxno=208572
7402,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.metroseoul.co.kr/article/20201012500171
7403,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.pharmnews.com/news/articleView.html?idxno=101442
7404,2020-10-12,대웅제약코로나19치료제국내임상1상승인,https://www.nocutnews.co.kr/news/5426361
7405,2020-10-12,주력파이프라인홍보집중대웅제약PhIFestivalofPharma참가,http://kpenews.com/View.aspx?No=1276666
7406,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.ceoscoredaily.com/news/article.html?no=73924
7407,2020-10-12,대웅제약코로나치료제니클로사마이드임상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136424&REFERER=NP
7408,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.finomy.com/news/articleView.html?idxno=83940
7409,2020-10-12,해외매출이국내매출넘는다대웅제약글로벌2025비전,http://www.wikileaks-kr.org/news/articleView.html?idxno=96459
7410,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가주력파이프라인홍보집중,http://newsbrite.net/142305
7411,2020-10-12,대웅제약CPhIFestivalofPharma참가글로벌파트너십강화모색”,http://www.youthdaily.co.kr/news/article.html?no=49717
7412,2020-10-12,대웅제약CPhI참가로글로벌파트너십강화방안모색,http://medipana.com/news/news_viewer.asp?NewsNum=264048&MainKind=A&NewsKind=5&vCount=12&vKind=1
7413,2020-10-12,대웅제약글로벌의약품박람회CPhI에참가,http://www.medisobizanews.com/news/articleView.html?idxno=73270
7414,2020-10-12,대웅제약세계적의약품박람회참가,http://www.businesskorea.co.kr/news/articleView.html?idxno=52994
7415,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.healthinnews.co.kr/news/articleView.html?idxno=14864
7416,2020-10-12,대웅제약글로벌의약품박람회CPhIFestivalofPharma참가,http://www.newsworks.co.kr/news/articleView.html?idxno=493957
7417,2020-10-12,대웅제약CPhIFestivalofPharma참가,http://www.bosa.co.kr/news/articleView.html?idxno=2135901
7418,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,https://www.fetv.co.kr/news/article.html?no=65477
7419,2020-10-12,코로나19셀트리온대웅제약치료제개발한발앞으로,http://www.ajunews.com/view/20201012123039701
7420,2020-10-12,대웅제약글로벌의약품박람회CPhl참가,http://www.monews.co.kr/news/articleView.html?idxno=214202
7421,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.joseilbo.com/news/news_read.php?uid=408000&class=27&grp=
7422,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4306658
7423,2020-10-12,대웅제약의약품박람회서글로벌파트너십강화,http://www.econovill.com/news/articleView.html?idxno=414924
7424,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63856
7425,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63864
7426,2020-10-12,대웅제약 코로나19 치료제니클로사마이드한국임상승인,http://www.greened.kr/news/articleView.html?idxno=272020
7427,2020-10-12,대웅제약코로나치료제니클로사마이드한국임상승인10월투여개시,http://www.newslock.co.kr/news/articleView.html?idxno=31629
7428,2020-10-12,대웅제약글로벌의약품박람회CPhI참가,http://www.mdtoday.co.kr/mdtoday/index.html?no=401923
7429,2020-10-12,대웅제약나보타수면중이갈이증상완화효과입증,http://www.insightkorea.co.kr/news/articleView.html?idxno=83492
7430,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.paxetv.com/news/articleView.html?idxno=101927
7431,2020-10-12,한국유니온제약대웅제약상승에급등까지대웅제약소폭상승이어한국유니온제약12급등,http://www.econonews.co.kr/news/articleView.html?idxno=139975
7432,2020-10-12,대웅제약코로나19치료제국내임상1상시작전승호역량집중,http://www.businesspost.co.kr/BP?command=article_view&num=199478
7433,2020-10-12,식약처대웅제약코로나19치료제임상1상시험계획승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010121410294890277
7434,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=431423
7435,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.sportsseoul.com/news/read/968563?ref=naver
7436,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.thefirstmedia.net/news/articleView.html?idxno=64336
7437,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상시험승인,http://www.thefirstmedia.net/news/articleView.html?idxno=64338
7438,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.nbnnews.co.kr/news/articleView.html?idxno=431428
7439,2020-10-12,대웅제약코로나19치료제니클로사마이드이달중국내임상시험개시,http://kbench.com/?q=node/214812
7440,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상시험승인,http://www.kdpress.co.kr/news/articleView.html?idxno=97742
7441,2020-10-12,대웅제약코로나19치료제국내임상1상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=494032
7442,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,http://www.segye.com/content/html/2020/10/12/20201012514508.html?OutUrl=naver
7443,2020-10-12,대웅제약CPhIFestivalofPharma참가해코로나19치료후보홍보,http://news.mk.co.kr/newsRead.php?no=1043051&year=2020
7444,2020-10-12,대웅제약CPhIFestivalofPharma참가,http://www.lawissue.co.kr/view.php?ud=202010121502248679204ead0791_12
7445,2020-10-12,니클로사마이드관련주대웅제약주가상승기미임상1상시험승인,http://www.ccreview.co.kr/news/articleView.html?idxno=289815
7446,2020-10-12,대웅제약메디톡스어느쪽이신뢰추락할까독한전쟁내달마침표,http://www.wikileaks-kr.org/news/articleView.html?idxno=96478
7447,2020-10-12,대웅제약코로나19치료제韓임상승인˝10월시작˝,http://www.kbsm.net/default/index_view_page.php?idx=289729&part_idx=320
7448,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.ekn.kr/news/article.html?no=527865
7449,2020-10-12,대웅제약코로나19치료제국내임상1상승인,http://news.tf.co.kr/read/economy/1817743.htm
7450,2020-10-12,뉴스투데이L대웅제약코로나19치료제니클로사마이드한국임상1상승인,https://www.news2day.co.kr/162027
7451,2020-10-12,대웅제약세계의약품박람회서코로나19치료제등파이프라인소개,http://www.medigatenews.com/news/2504357643
7452,2020-10-12,대웅제약글로벌의약품박람회CPhIFestivalofPharma참가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003666
7453,2020-10-12,12일특징주총정리대웅제약모르텍스컴투스오성첨단소재초관심코로나치료제원격수업등부각,http://www.ccreview.co.kr/news/articleView.html?idxno=289816
7454,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065593349901584
7455,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.segyebiz.com/newsView/20201012518115?OutUrl=naver
7456,2020-10-12,제약업계소식종근당고촌재단대웅제약한미약품동국제약,http://www.newsian.co.kr/news/articleView.html?idxno=43755
7457,2020-10-12,대웅제약나보타글로벌보툴리눔톡신치료시장진출가속화,http://www.ceoscoredaily.com/news/article.html?no=73951
7458,2020-10-12,대웅제약코로나19치료제니클로사마이드해외이어국내임상승인,http://www.sporbiz.co.kr/news/articleView.html?idxno=471940
7459,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=10662
7460,2020-10-12,뉴스투데이L대웅제약글로벌의약품박람회CPhIFestivalofPharma참가,https://www.news2day.co.kr/162037
7461,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.newsworker.co.kr/news/articleView.html?idxno=87872
7462,2020-10-12,대웅제약코로나19치료제임상1상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1330103
7463,2020-10-12,대웅제약세계최대박람회서혁신신약홍보파트너십모색,http://www.100ssd.co.kr/news/articleView.html?idxno=71831
7464,2020-10-12,금일제약업계주요기사셀트리온코로나19항체치료제예방임상개시대웅제약니클로사마이드韓임상1상승인획득外,http://www.youthdaily.co.kr/news/article.html?no=49786
7465,2020-10-12,대웅제약코로나치료제니클로사마이드한국임상1상,http://www.dt.co.kr/contents.html?article_no=2020101302101831102001&ref=naver
7466,2020-10-12,대웅제약글로벌파트너십강화방안모색,http://www.bokuennews.com/news/article.html?no=195701
7467,2020-10-12,대웅제약글로벌의약품박람회참가코로나19치료제개발중제품등홍보,http://www.g-enews.com/ko-kr/news/article/news_all/2020101220275192502500a1b5d6_1/article.html
7468,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=73460
7469,2020-10-13,단신대웅제약코로나19치료제임상1상승인이달중투여,https://www.donga.com/news/article/all/20201012/103374560/1
7470,2020-10-13,대웅제약나보타글로벌보툴리눔톡신치료사업본격화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1419982
7471,2020-10-13,대웅제약코로나치료제국내임상승인,http://www.whosaeng.com/121528
7472,2020-10-13,대웅제약글로벌의약품박람회서코로나19치료제니클로사마이드와카모스타트등홍보,http://theviewers.co.kr/View.aspx?No=1278048
7473,2020-10-13,대웅제약니클로사마이드코로나19치료제개발순항국내임상1상승인,http://www.sisaweek.com/news/articleView.html?idxno=138230
7474,2020-10-13,윤재승전대웅제약회장인성정보지분180억원매각왜,http://www.sisajournal-e.com/news/articleView.html?idxno=224445
7475,2020-10-14,대웅제약흑자전환에도미국ITC소송은리스크투자의견중립,https://www.asiatoday.co.kr/view.php?key=20201014010006496
7476,2020-10-14,대웅제약나보타글로벌보툴리눔톡신치료시장진출가속화,http://www.lawissue.co.kr/view.php?ud=202010131040468860204ead0791_12
7477,2020-10-14,대웅제약내달ITC결과주목투자의견하향NH투자,https://www.etoday.co.kr/news/view/1950161
7478,2020-10-14,하이로우대웅제약단기실적보다다음달ITC최종판결주목해야NH투자증권,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101409055999098
7479,2020-10-14,대웅제약언택트마케팅으로고객접점확장,http://www.seoulwire.com/news/articleView.html?idxno=427913
7480,2020-10-14,시경Today제약코로나시대대웅제약나보타언택트마케팅실시外,http://www.meconomynews.com/news/articleView.html?idxno=46220
7481,2020-10-14,대웅제약코로나19치료신약국내임상1상개시,http://weekly.cnbnews.com/news/article.html?no=136390
7482,2020-10-15,대웅제약子아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.sentv.co.kr/news/view/580906
7483,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250155
7484,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.lawissue.co.kr/view.php?ud=20201015091744865204ead0791_12
7485,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=402447
7486,2020-10-15,대웅제약나보타라이브세미나언택트마케팅활발,http://www.consumuch.com/news/articleView.html?idxno=50890
7487,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.upinews.kr/newsView/upi202010150009
7488,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.pharmnews.com/news/articleView.html?idxno=101477
7489,2020-10-15,대웅제약아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.newspim.com/news/view/20201015000244
7490,2020-10-15,대웅제약비마약성진통제신약호주임상1상착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=269453&REFERER=NP
7491,2020-10-15,대웅제약자회사비마약성진통제호주임상1상계획승인,http://yna.kr/AKR20201015049800017?did=1195m
7492,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제임상1상시작,http://health.chosun.com/site/data/html_dir/2020/10/15/2020101500951.html
7493,2020-10-15,대웅제약자회사아이엔테라퓨틱스진통제호주서임상,http://www.medisobizanews.com/news/articleView.html?idxno=73378
7494,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.ceoscoredaily.com/news/article.html?no=74056
7495,2020-10-15,대웅제약자회사비마약성진통제임상1상계획호주승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010150125&t=NN
7496,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제1상돌입,http://www.newsis.com/view/?id=NISX20201015_0001198200&cID=13001&pID=13000
7497,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://newsbrite.net/142418
7498,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,https://www.dailian.co.kr/news/view/927422/?sc=Naver
7499,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2020101510314278999
7500,2020-10-15,대웅제약자회사비마약성진통제호주임상1상계획승인,http://news.mk.co.kr/newsRead.php?no=1055683&year=2020
7501,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상,http://www.medigatenews.com/news/2691758826
7502,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상안전한진통제,http://theviewers.co.kr/View.aspx?No=1290345
7503,2020-10-15,대웅제약70조진통제시장도전아이엔테라퓨틱스호주임상1상승인”,http://www.viva100.com/main/view.php?key=20201015010002584
7504,2020-10-15,대웅제약자회사아이엔테라퓨틱스호주서비마약성진통제임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/10/15/2020101501305.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7505,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.healthinnews.co.kr/news/articleView.html?idxno=14940
7506,2020-10-15,대웅제약자회사비마약성진통제호주임상1상계획승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010151107320310992
7507,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101511163757564
7508,2020-10-15,대웅제약나보타라이브세미나서탈모치료정보공유,http://www.sisaon.co.kr/news/articleView.html?idxno=119041
7509,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제호주임상1상돌입,http://www.newstomato.com/ReadNews.aspx?no=1000993
7510,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63932
7511,2020-10-15,대웅제약자회사개발비마약성진통제호주임상1상계획승인,http://www.seoulfn.com/news/articleView.html?idxno=398015
7512,2020-10-15,대웅제약자회사비마약성진통제호주서1상돌입,http://www.whosaeng.com/121656
7513,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상승인,https://www.asiatoday.co.kr/view.php?key=20201015010007824
7514,2020-10-15,코로나19와제약업계6대웅제약오너갑질논란에코로나로실적악화까지오너경영인체제로다시전환하나윤재승전회장경영장악력더욱강력해져,http://www.newsworker.co.kr/news/articleView.html?idxno=88108
7515,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.updownnews.co.kr/news/articleView.html?idxno=224228
7516,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=432483
7517,2020-10-15,대웅제약자회사호주에서비마약성진통제글로벌임상1상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=200041
7518,2020-10-15,뉴스투데이L대웅제약아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,https://www.news2day.co.kr/162257
7519,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.worktoday.co.kr/news/articleView.html?idxno=10750
7520,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상,http://daily.hankooki.com/lpage/industry/202010/dh20201015175941148390.htm?s_ref=nv
7521,2020-10-15,나보타美수출급감에수백억소송비엎친데덮친대웅제약,http://www.dt.co.kr/contents.html?article_no=2020101602101031102001&ref=naver
7522,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=64525
7523,2020-10-16,대웅제약자회사아이엔테라퓨틱스70조원글로벌진통제시장도전첫발,http://www.g-enews.com/ko-kr/news/article/news_all/2020101517040214002500a1b5d6_1/article.html
7524,2020-10-16,더벨대웅제약900억만기채금융권차입으로대응,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202010141602075760104268
7525,2020-10-16,오늘의제약동아제약박카스한미약품동국제약대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=40132
7526,2020-10-19,대웅제약상반기재고자산회전율전년비04회감소한31회,http://www.ceoscoredaily.com/news/article.html?no=73976
7527,2020-10-19,대웅제약나보타IMCASAsiaClass서우수성알려,http://medipana.com/news/news_viewer.asp?NewsNum=264426&MainKind=A&NewsKind=5&vCount=12&vKind=1
7528,2020-10-19,대웅제약국제미용성형학회참가나보타효능알려,http://www.press9.kr/news/articleView.html?idxno=46042
7529,2020-10-19,대웅제약국제미용성형학회서나보타활용최신시술법공유,http://www.m-i.kr/news/articleView.html?idxno=755297
7530,2020-10-19,대웅제약나보타IMCASAsiaClass2020서우수성알려,http://www.medisobizanews.com/news/articleView.html?idxno=73446
7531,2020-10-19,대웅제약나보타국제미용성형학회서전세계의료진대상우수성알려,https://www.fetv.co.kr/news/article.html?no=66030
7532,2020-10-19,대웅제약 나보타 국제미용성형학회에서전세계의료진대상우수성알려,http://www.lcnews.co.kr/news/articleView.html?idxno=9054
7533,2020-10-19,대웅제약국제미용성형학회서보툴리눔톡신나보타우수성알려,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122525
7534,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,http://www.newsis.com/view/?id=NISX20201019_0001201838&cID=13001&pID=13000
7535,2020-10-19,대웅제약나보타국제미용성형학회에서최신시술법공개,http://www.econovill.com/news/articleView.html?idxno=415773
7536,2020-10-19,대웅제약IMCAS아시아클래스서나보타우수성알려,http://www.kpinews.co.kr/news/articleView.html?idxno=128481
7537,2020-10-19,대웅제약나보타국제미용성형학회심포지엄서효능시술법소개,http://moneys.mt.co.kr/news/mwView.php?no=2020101909218041617
7538,2020-10-19,대웅제약국제미용성형학회서나보타우수성홍보,http://www.ekn.kr/news/article.html?no=529070
7539,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,https://www.hankyung.com/it/article/202010192446i
7540,2020-10-19,대웅제약나보타국제학회서의료진대상우수성알려,http://news.mt.co.kr/mtview.php?no=2020101909280325544
7541,2020-10-19,대웅제약나보타IMCASAsiaClass2020서전세계의료진대상우수성알려,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63973
7542,2020-10-19,대웅제약나보타국제미용성형학회전세계의료진대상우수성알려,http://www.pharmnews.com/news/articleView.html?idxno=101494
7543,2020-10-19,대웅제약전세계의료진대상나보타우수성알려,http://www.newsprime.co.kr/news/article.html?no=521253
7544,2020-10-19,대웅제약국제미용성형학회서나보타우수성알려,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101909411149151
7545,2020-10-19,대웅제약국제미용성형학회서전세계의료진에게나보타우수성알려,http://www.pinpointnews.co.kr/view.php?ud=2020101909590777062365609d9b_45
7546,2020-10-19,대웅제약나보타IMCASAsia서우수성알려,http://www.bosa.co.kr/news/articleView.html?idxno=2136307
7547,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,https://www.dailian.co.kr/news/view/928340/?sc=Naver
7548,2020-10-19,대웅제약국제미용성형학회서전세계의료진에나보타우수성알려,http://www.youthdaily.co.kr/news/article.html?no=50423
7549,2020-10-19,대웅제약나보타IMCASAsiaClass2020서우수성홍보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250270
7550,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020에서전세계의료진대상우수성알려,http://newsbrite.net/142538
7551,2020-10-19,뉴스투데이L대웅제약국제미용성형학회IMCASAsiaClass2020서나보타우수성알려,https://www.news2day.co.kr/162392
7552,2020-10-19,대웅제약나보타국제미용성형학회에서전세계의료진대상,http://www.businesskorea.co.kr/news/articleView.html?idxno=53378
7553,2020-10-19,대웅제약나보타세계의료진에우수성입증,http://health.chosun.com/site/data/html_dir/2020/10/19/2020101901002.html
7554,2020-10-19,대웅제약국제미용성형학회IMCASAsia참여나보타우수성전해,http://www.newslock.co.kr/news/articleView.html?idxno=31833
7555,2020-10-19,균주도용분쟁중이지만우수한보톡스대웅제약국제미용성형학회참가해나보타홍보,http://theviewers.co.kr/View.aspx?No=1293825
7556,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020에서전세계의료진대상우수성알려,http://www.segye.com/content/html/2020/10/19/20201019508993.html?OutUrl=naver
7557,2020-10-19,대웅제약나보타국제미용성형학회서최신시술법공유,http://www.dailysmart.co.kr/news/articleView.html?idxno=34280
7558,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.metroseoul.co.kr/article/20201019500176
7559,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://newsbrite.net/142554
7560,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250283
7561,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,http://www.pressm.kr/news/articleView.html?idxno=33777
7562,2020-10-19,대웅제약호주서코로나19대상니클로사마이드임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=1068377&year=2020
7563,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,https://www.etoday.co.kr/news/view/1951862
7564,2020-10-19,대웅제약니클로사마이드코로나치료호주1상승인,http://www.newsis.com/view/?id=NISX20201019_0001202173&cID=13001&pID=13000
7565,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020101911192470954
7566,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.medigatenews.com/news/838683540
7567,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.ekn.kr/news/article.html?no=529127
7568,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.fnnews.com/news/202010191121390203
7569,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101911091185602
7570,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상승인,https://www.fetv.co.kr/news/article.html?no=66079
7571,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.lawissue.co.kr/view.php?ud=202010191128451905204ead0791_12
7572,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://it.chosun.com/site/data/html_dir/2020/10/19/2020101901176.html
7573,2020-10-19,대웅제약니클로사마이드코로나치료제호주임상1상승인,http://www.lcnews.co.kr/news/articleView.html?idxno=9064
7574,2020-10-19,대웅제약코로나19치료제호주1상임상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136589&REFERER=NP
7575,2020-10-19,대웅제약호주서코로나19치료제니클로사마이드임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=128532
7576,2020-10-19,대웅제약호주서코로나19치료제니클로사마이드임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=128532
7577,2020-10-19,대웅제약니클로사마이드코로나19치료제호주1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=73464
7578,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=50448
7579,2020-10-19,대웅제약코로나19치료니클로사마이드호주임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=264469&MainKind=A&NewsKind=5&vCount=12&vKind=1
7580,2020-10-19,대웅제약코로나9치료제니클로사마이드호주식약청임상1상승인,http://www.newsprime.co.kr/news/article.html?no=521304
7581,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=495909
7582,2020-10-19,대웅제약니클로사마이드코로나19호주1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2136339
7583,2020-10-19,대웅제약호주식품의약청으로부터코로나19치료제임상1상시험승인,https://www.asiatoday.co.kr/view.php?key=20201019010009829
7584,2020-10-19,대웅제약코로나치료제호주임상1상승인,https://www.ebn.co.kr/news/view/1455055/?sc=Naver
7585,2020-10-19,대웅제약국제미용성형학회에서자체보툴리눔톡신강점알려,http://www.businesspost.co.kr/BP?command=article_view&num=200433
7586,2020-10-19,대웅제약호주서코로나19치료제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010190178&t=NN
7587,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,https://www.news2day.co.kr/162403
7588,2020-10-19,대웅제약코로나19치료제호주임상1상승인11월니클로사마이드임상돌입”,http://www.viva100.com/main/view.php?key=20201019010003324
7589,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=53405
7590,2020-10-19,대웅제약국제미용성형학회서나보타우수성알려,http://www.shinailbo.co.kr/news/articleView.html?idxno=1332453
7591,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.economytalk.kr/news/articleView.html?idxno=208694
7592,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.press9.kr/news/articleView.html?idxno=46048
7593,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=402812
7594,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,http://www.mdtoday.co.kr/mdtoday/index.html?no=402811
7595,2020-10-19,대웅제약코로나19치료제놓고호주에서임상1상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=200469
7596,2020-10-19,대웅제약코로나19치료제호주임상1상승인글로벌임상박차,http://health.chosun.com/site/data/html_dir/2020/10/19/2020101901442.html
7597,2020-10-19,대웅제약IMCASAsiaClass에서나보타우수성알려,http://www.monews.co.kr/news/articleView.html?idxno=214437
7598,2020-10-19,대웅제약니클로사마이드코로나치료제호주임상1상,http://www.monews.co.kr/news/articleView.html?idxno=214438
7599,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://news.mt.co.kr/mtview.php?no=2020101911365911929
7600,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.sentv.co.kr/news/view/581109
7601,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020참여,http://www.healthinnews.co.kr/news/articleView.html?idxno=14983
7602,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.newstomato.com/ReadNews.aspx?no=1001574
7603,2020-10-19,대웅제약니클로사마이드코로나19호주임상1상승인,https://www.hankyung.com/it/article/202010193809i
7604,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,https://www.dailian.co.kr/news/view/928401/?sc=Naver
7605,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.etnews.com/20201019000166
7606,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020서전세계의료진대상우수성알려,http://www.thebigdata.co.kr/view.php?ud=202010191342017899d0a8833aad_23
7607,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=433336
7608,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.whosaeng.com/121742
7609,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상,http://yna.kr/AKR20201019095700017?did=1195m
7610,2020-10-19,대웅제약호주서코로나19치료제니클로사마이드임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=755505
7611,2020-10-19,대웅제약니클로사마이드호주서코로나19치료제임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4313823
7612,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010190271&t=NN
7613,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.dailymedi.com/detail.php?number=861698&thread=22r05
7614,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=74165
7615,2020-10-19,대웅제약니클로사마이드호주서코로나19치료제임상1상승인,https://news.joins.com/article/olink/23492328
7616,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://inthenews.co.kr/article-74042/
7617,2020-10-19,대웅제약니클로사마이드호주서코로나19치료제임상1상승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010191416300690648
7618,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상”,http://www.smartfn.co.kr/view.php?ud=202010191419502953379cda9ab3_46
7619,2020-10-19,대웅제약코로나19치료제호주임상1상진입,http://moneys.mt.co.kr/news/mwView.php?no=2020101914038014285
7620,2020-10-19,대웅제약코로나19치료제호주임상1상승인,https://view.asiae.co.kr/article/2020101914285528935
7621,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://daily.hankooki.com/lpage/industry/202010/dh20201019143808148390.htm?s_ref=nv
7622,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=34307
7623,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.thebigdata.co.kr/view.php?ud=202010191426418935d0a8833aad_23
7624,2020-10-19,대웅제약호주서코로나19치료제임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/10/19/2020101901964.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7625,2020-10-19,대웅제약니클로사마이드호주서임상1상승인받아,http://www.mediapen.com/news/view/567005
7626,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14996
7627,2020-10-19,대웅제약코로나치료제후보물질니클로사마이드호주임상1상승인,http://www.newspim.com/news/view/20201019000913
7628,2020-10-19,대웅제약코로나치료제호주임상1상승인,http://www.koreastocknews.com/news/articleView.html?idxno=58013
7629,2020-10-19,대웅제약구충제성분니클로사마이드호주서코로나19치료제임상1상,http://www.topstarnews.net/news/articleView.html?idxno=840289
7630,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=83731
7631,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.ftoday.co.kr/news/articleView.html?idxno=207248
7632,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.betanews.net:8080/article/1236849.html
7633,2020-10-19,대웅제약호주서코로나19치료제임상승인구충제성분니클로사마이드활용,http://www.joseilbo.com/news/news_read.php?uid=408531&class=33&grp=
7634,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.seoulwire.com/news/articleView.html?idxno=428201
7635,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010191558458420693
7636,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,https://www.asiatime.co.kr/news/newsview.php?ncode=1065596712039056
7637,2020-10-19,대웅제약코로나19치료후보니클로사마이드호주임상1상승인,https://www.news1.kr/articles/?4091625
7638,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상승인,https://www.hankyung.com/life/article/2020101947277
7639,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://sports.hankooki.com/lpage/economy/202010/sp20201019161903137020.htm?s_ref=nv
7640,2020-10-19,대웅제약메디톡스균주전쟁최종결론연기가능성↑,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010191324398120626
7641,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=31848
7642,2020-10-19,대웅제약구충제성분코로나19치료제호주서임상1상승인,https://www.sedaily.com/NewsView/1Z96YY8HXT
7643,2020-10-19,대웅제약국제미용성형학회서나보타효능알려,http://www.enewstoday.co.kr/news/articleView.html?idxno=1421476
7644,2020-10-19,대웅제약니클로사마이드호주임상1상승인코로나19치료제개발본격화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122570
7645,2020-10-19,대웅제약코로나19치료제니클로사마이드호주서임상1상승인,http://www.thedailypost.kr/news/articleView.html?idxno=76827
7646,2020-10-19,대웅제약호주서니클로사마이드코로나19치료제임상1상승인,http://news.tf.co.kr/read/economy/1819238.htm
7647,2020-10-19,대웅제약주가내일상승할까니클로사마이드호주식품의약청임상1상시험승인,http://www.ggilbo.com/news/articleView.html?idxno=803075
7648,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=64655
7649,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인11월본격임상돌입,http://www.paxetv.com/news/articleView.html?idxno=102505
7650,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.seoulfn.com/news/articleView.html?idxno=398334
7651,2020-10-19,대웅제약니클로사마이드코로나19치료제임상시험승인,http://www.slist.kr/news/articleView.html?idxno=193448
7652,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020에서전세계의료진대상우수성알려,http://www.thefirstmedia.net/news/articleView.html?idxno=64705
7653,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63997
7654,2020-10-19,김창수의e뉴스브리핑대웅제약코로나19치료제니클로사마이드호주임상승인外,https://www.fetv.co.kr/news/article.html?no=66121
7655,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004145906
7656,2020-10-19,대웅제약호주서코로나19치료제임상시작,http://www.finomy.com/news/articleView.html?idxno=84249
7657,2020-10-19,대웅제약나보타국제미용성형학회서전세계의료진대상홍보,http://www.worktoday.co.kr/news/articleView.html?idxno=10843
7658,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004145976
7659,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.econovill.com/news/articleView.html?idxno=500005
7660,2020-10-19,대웅제약코로나19치료제후보니클로사마이드호주임상1상승인,http://www.ajunews.com/view/20201019174205663
7661,2020-10-19,대웅제약국제미용성형학회참가나보타최신시술법공유,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003912
7662,2020-10-19,금일제약업계주요기사대웅제약니클로사마이드코로나19치료제호주임상1상승인바이오일레븐삼바로직스와면역항암제위탁개발생산계약外,http://www.youthdaily.co.kr/news/article.html?no=50488
7663,2020-10-19,대웅제약코로나19치료후보물질호주임상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1332848
7664,2020-10-19,대웅제약코로나19치료제니클로사마이드로호주임상1상승인획득,http://www.iminju.net/news/articleView.html?idxno=58654
7665,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상”,http://www.kukinews.com/newsView/kuk202010190463
7666,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.fnnews.com/news/202010191812345025
7667,2020-10-19,대웅제약코로나19치료제호주임상1상시험승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1421526
7668,2020-10-19,대웅제약보툴리눔톡신나보타국제미용성형학회서우수성공유,http://www.dt.co.kr/contents.html?article_no=2020102002101831102002&ref=naver
7669,2020-10-19,시간외거래특징주신테카바이오한솔홈데코급등현대차기아차하락세대웅제약상승,http://www.ggilbo.com/news/articleView.html?idxno=803184
7670,2020-10-19,대웅제약코로나19치료제DWRX2003호주임상1상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=73706
7671,2020-10-20,대웅제약코로나19치료제호주서1상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003920
7672,2020-10-20,대웅제약코로나19치료후보물질호주임상1상승인,https://www.nocutnews.co.kr/news/5431455
7673,2020-10-20,특징주대웅제약코로나19치료제호주서인정받고미국가나4상승,http://moneys.mt.co.kr/news/mwView.php?no=2020102009218025989
7674,2020-10-20,특징주대웅제약주가코로나19치료제니클로사마이드1상시험승인소식에상승세기록,http://www.ccreview.co.kr/news/articleView.html?idxno=291461
7675,2020-10-20,단독대웅제약코로나19치료제3호에100억쏜다,https://www.sedaily.com/NewsView/1Z97FFL37B
7676,2020-10-21,대웅제약신약연구개발강화로글로벌시장공략,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202010211404001&code=920100
7677,2020-10-21,주식고민해결스탁솔루션대웅제약현대그린푸드전화문자노란톡상담外,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102113462156029
7678,2020-10-21,보톡스균주도용의혹대웅제약美파트너사에볼루스9개로펌에집단소송당해,http://www.getnews.co.kr/view.php?ud=2020102115283441342fe691f917_16
7679,2020-10-21,대웅대웅제약900억차입회사채차환용”,http://www.edaily.co.kr/news/newspath.asp?newsid=03680166625935216
7680,2020-10-21,대웅제약900억원차입결정회사채차환위해,https://www.asiatoday.co.kr/view.php?key=20201021010012288
7681,2020-10-22,대웅제약간의날기념해우루사캡슐맨야구시구나섰다,https://www.dailian.co.kr/news/view/929542/?sc=Naver
7682,2020-10-22,대웅제약RD결실의해내년글로벌임상만5건,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102210532182539
7683,2020-10-22,우루사가야구장에서시구를대웅제약우루사와함께하는브랜드데이진행,http://www.insightkorea.co.kr/news/articleView.html?idxno=83840
7684,2020-10-22,시경Today제약대웅제약우루사캡슐맨야구시구이벤트外,http://www.meconomynews.com/news/articleView.html?idxno=46543
7685,2020-10-22,메디톡스대웅제약美ITC소송판결임박,http://www.finomy.com/news/articleView.html?idxno=84414
7686,2020-10-22,대웅제약나보타라이브세미나개최피부미용최신지견공유,http://www.viva100.com/main/view.php?key=20201022010004456
7687,2020-10-22,대웅제약나보타라이브세미나서피부미용최신지견공유,http://www.newscj.com/news/articleView.html?idxno=791810
7688,2020-10-23,단독대웅제약인니서코로나19진단키트판매허가획득,https://www.theguru.co.kr/news/article.html?no=15402
7689,2020-10-23,식약처대웅제약한국아스트라제네카의약품신속한제품화지원,https://www.etoday.co.kr/news/view/1953842
7690,2020-10-23,단독메디톡스대웅제약美ITC소송최종판결2주연기,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010230851031180562
7691,2020-10-23,대웅제약당뇨병치료제최초로신속심사대상지정,http://news.mt.co.kr/mtview.php?no=2020102309212582753
7692,2020-10-23,대웅제약제2형당뇨병치료제식약처신속심사대상의약품지정획득,http://www.youthdaily.co.kr/news/article.html?no=50956
7693,2020-10-23,대웅제약한국아스트라제네카의약품신속심사대상지정,http://www.edaily.co.kr/news/newspath.asp?newsid=01902406625935872
7694,2020-10-23,대웅제약나보타온라인세미나통해모공축소시술법공유,http://www.upinews.kr/newsView/upi202010230010
7695,2020-10-23,대웅제약DWP16001AZ셀루메티닙신속심사의약품첫지정,http://www.medisobizanews.com/news/articleView.html?idxno=73588
7696,2020-10-23,대웅제약AZ신약최초신속심사의약품지정,http://www.newsis.com/view/?id=NISX20201023_0001208080&cID=13001&pID=13000
7697,2020-10-23,식약처대웅제약DWP16001아스트라제네카셀루메티닙신속심사의약품지정,http://www.kpinews.co.kr/news/articleView.html?idxno=128982
7698,2020-10-23,美ITC메디톡스대웅제약보톡스분쟁최종판결2주연기,https://www.hankyung.com/it/article/202010230782i
7699,2020-10-23,美ITC대웅제약메디톡스소송최종결론일2주연기,http://news.mt.co.kr/mtview.php?no=2020102310413618667
7700,2020-10-23,식약처대웅제약당뇨병치료제등신속심사대상지정,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010230141&t=NN
7701,2020-10-23,美ITC대웅제약메디톡스분쟁최종판결2주연기,http://www.newsis.com/view/?id=NISX20201023_0001208267&cID=13001&pID=13000
7702,2020-10-23,식약처대웅제약당뇨병치료제등2개의약품신속심사대상지정,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004150929
7703,2020-10-23,종합ITC대웅제약메디톡스보톨리늄톡신균주분쟁2주간연기,http://www.ccreview.co.kr/news/articleView.html?idxno=292325
7704,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64096
7705,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.ekn.kr/news/article.html?no=530128
7706,2020-10-23,대웅제약당뇨병신약이나보글리플로진개발가속화기대,http://medipana.com/news/news_viewer.asp?NewsNum=264814&MainKind=A&NewsKind=5&vCount=12&vKind=1
7707,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://news.kbiz.or.kr/news/articleView.html?idxno=73857
7708,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://news.kbiz.or.kr/news/articleView.html?idxno=73857
7709,2020-10-23,대웅제약당뇨병치료제이나보글리플로진신속심사대상의약품지정,http://www.healthinnews.co.kr/news/articleView.html?idxno=15103
7710,2020-10-23,대웅제약이나보글리플로진국내최초신속심사대상지정,http://www.press9.kr/news/articleView.html?idxno=46101
7711,2020-10-23,대웅제약당뇨병신약국내최초신속심사지정,http://www.medisobizanews.com/news/articleView.html?idxno=73602
7712,2020-10-23,대웅제약당뇨병신약이나보글리플로진패스트트랙지정,https://www.sedaily.com/NewsView/1Z98QZK0B9
7713,2020-10-23,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250534
7714,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상지정,https://www.fetv.co.kr/news/article.html?no=66575
7715,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://newsbrite.net/142724
7716,2020-10-23,신속심사의약품첫지정대웅제약아스트라제네카수혜,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136721&REFERER=NP
7717,2020-10-23,대웅제약과메디톡스미국균주소송최종판결11월19일로연기돼,http://www.businesspost.co.kr/BP?command=article_view&num=201232
7718,2020-10-23,대웅제약당뇨신약DWP16001신속심사대상지정,https://www.kpanews.co.kr/article/show.asp?idx=217099&category=D
7719,2020-10-23,첫신속심사제수혜자는대웅제약아스트라제네카,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2004096
7720,2020-10-23,대웅제약당뇨병신약국내첫신속심사대상의약품지정,http://www.metroseoul.co.kr/article/20201023500109
7721,2020-10-23,대웅제약제2형당뇨병치료제식약처신속심사대상의약품지정획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020102311554812533
7722,2020-10-23,대웅제약당뇨병신약이나보글리프로진국내최초신속심사대상의약품지정,https://www.news2day.co.kr/162733
7723,2020-10-23,국내첫식약처패스트트랙의약품대웅제약당뇨병신약신속심사대상지정,https://www.donga.com/news/article/all/20201023/103593590/1
7724,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.pinpointnews.co.kr/view.php?ud=2020102312405588032365609d9b_45
7725,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.m-i.kr/news/articleView.html?idxno=757280
7726,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.ceoscoredaily.com/news/article.html?no=74351
7727,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://moneys.mt.co.kr/news/mwView.php?no=2020102311398048504
7728,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내첫신속심사대상의약품지정,http://www.ajunews.com/view/20201023130741029
7729,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.thebigdata.co.kr/view.php?ud=202010231130043342d0a8833aad_23
7730,2020-10-23,대웅제약당뇨병치료제이나보글리플로진패스트트랙지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=403552
7731,2020-10-23,메디톡스대웅제약보톡스전쟁최종결론내달19일,http://www.koreastocknews.com/news/articleView.html?idxno=58172
7732,2020-10-23,대웅제약당뇨병신약이나보글리플로진식약처신속심사대상지정,https://www.etoday.co.kr/news/view/1953956
7733,2020-10-23,대웅제약이나보글리플로진신속심사대상의약품지정,http://www.businesskorea.co.kr/news/articleView.html?idxno=53737
7734,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.viva100.com/main/view.php?key=20201023010004609
7735,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.lawissue.co.kr/view.php?ud=202010231337422114204ead0791_12
7736,2020-10-23,대웅제약당뇨병신약 이나보글리플로진 국내최초신속심사대상의약품지정,http://www.greened.kr/news/articleView.html?idxno=273469
7737,2020-10-23,대웅제약당뇨병신약후보국내첫신속심사의약품지정,https://www.hankyung.com/it/article/202010231903i
7738,2020-10-23,대웅제약이나보글리플로진우선순위심사권확보,http://www.mhj21.com/135692
7739,2020-10-23,대웅제약식약처SGLT2억제신약후보신속심사대상지정,http://news.mk.co.kr/newsRead.php?no=1088790&year=2020
7740,2020-10-23,대웅제약라이브세미나열어나보타최신지견공유,http://www.seoulfn.com/news/articleView.html?idxno=398800
7741,2020-10-23,제약워치대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정外,http://www.newswatch.kr/news/articleView.html?idxno=51550
7742,2020-10-23,대웅제약당뇨병치료물질식약처신속심사대상의약품에지정돼,http://www.businesspost.co.kr/BP?command=article_view&num=201257
7743,2020-10-23,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,https://www.asiatoday.co.kr/view.php?key=20201023010013652
7744,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.nbnnews.co.kr/news/articleView.html?idxno=434752
7745,2020-10-23,대웅제약당뇨병치료제이나보글리플로진신속심사대상지정,http://health.chosun.com/site/data/html_dir/2020/10/23/2020102301762.html
7746,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102314352626351
7747,2020-10-23,식약처대웅제약당뇨병 치료제등신속심사대상의약품지정,http://www.rapportian.com/news/articleView.html?idxno=128609
7748,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,https://www.dailian.co.kr/news/view/930139/?sc=Naver
7749,2020-10-23,메디톡스대웅제약보톡스분쟁ITC최종판결2주연기,http://yna.kr/AKR20201023104200017?did=1195m
7750,2020-10-23,대웅제약당뇨병신약신속심사대상의약품으로지정,http://www.thedailypost.kr/news/articleView.html?idxno=76941
7751,2020-10-23,미국ITC대웅제약메디톡스분쟁최종판결2주연기,http://www.econovill.com/news/articleView.html?idxno=501360
7752,2020-10-23,메디톡스대웅제약보톡스분쟁11월중순께최종판결,http://www.smartfn.co.kr/view.php?ud=202010231459402353379cda9ab3_46
7753,2020-10-23,대웅제약 당뇨병신약 이나보글리플로진국내최초 신속심사대상의약품지정,http://www.lcnews.co.kr/news/articleView.html?idxno=9171
7754,2020-10-23,식약처대웅제약당뇨병신약이나보글리플로진신속심사대상지정,http://www.seoulfn.com/news/articleView.html?idxno=398829
7755,2020-10-23,우수한혈당강하효과대웅제약당뇨병신약이나보글리플로진신속심사대상지정,http://theviewers.co.kr/View.aspx?No=1300921
7756,2020-10-23,美ITC메디톡스대웅제약보톡스판결2주연기,https://www.asiatoday.co.kr/view.php?key=20201023010013734
7757,2020-10-23,미국ITC서벌이는메디톡스대웅제약보톡스분쟁최종판결2주연기,http://www.idsn.co.kr/news/articleView.html?idxno=35398
7758,2020-10-23,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,http://www.medigatenews.com/news/3222436576
7759,2020-10-23,메디톡스대웅제약美ITC소송최종판결2주연기,https://www.paxnetnews.com/articles/66390
7760,2020-10-23,대웅제약당뇨병신약이나보글리플로진패스트트랙지정,http://sports.hankooki.com/lpage/economy/202010/sp20201023154847137020.htm?s_ref=nv
7761,2020-10-23,대웅제약당뇨병신약신속심사대상의약품지정,http://www.dailysmart.co.kr/news/articleView.html?idxno=34602
7762,2020-10-23,글로벌Biz24대웅제약인도네시아서코로나19분자진단키트아큐라디텍허가,http://www.g-enews.com/ko-kr/news/article/news_all/20201023154215241269d76442fa_1/article.html
7763,2020-10-23,대웅제약당뇨병신약신속심사대상의약품지정,https://www.ebn.co.kr/news/view/1455864/?sc=Naver
7764,2020-10-23,메디톡스대웅제약美ITC최종판결2주연기내달19일결과,http://www.newspim.com/news/view/20201023001011
7765,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.koreaittimes.com/news/articleView.html?idxno=101253
7766,2020-10-23,美ITC대웅제약메디톡스균주소송전최종판결11월19일로연기,https://www.fetv.co.kr/news/article.html?no=66620
7767,2020-10-23,시그널보톡스분쟁대웅제약메디톡스현금확보비상,https://www.sedaily.com/NewsView/1Z98SHJEBW
7768,2020-10-23,美ITC메디톡스대웅제약최종판결2주연기,http://daily.hankooki.com/lpage/industry/202010/dh20201023162546148390.htm?s_ref=nv
7769,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내첫신속심사대상의약품지정,http://www.sportsseoul.com/news/read/972619?ref=naver
7770,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.mediapen.com/news/view/568422
7771,2020-10-23,메디톡스대웅제약보톡스최종판정연기,https://www.nocutnews.co.kr/news/5434588
7772,2020-10-23,메디톡스대웅제약균주전쟁ITC최종판결2주연기,http://www.newstomato.com/ReadNews.aspx?no=1002738
7773,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.sisafocus.co.kr/news/articleView.html?idxno=249485
7774,2020-10-23,美ITC메디톡스대웅제약보톡스분쟁최종판결2주연기,http://www.newsway.co.kr/news/view?tp=1&ud=2020102316522575260
7775,2020-10-23,미국ITC대웅제약메디톡스판결2주연기,https://www.sedaily.com/NewsView/1Z98RX5DSM
7776,2020-10-23,대웅제약당뇨병신약국내최초패스트트랙지정,http://www.pressm.kr/news/articleView.html?idxno=33928
7777,2020-10-23,메디톡스대웅제약보톡스분쟁ITC최종판결2주연기,http://www.mediapen.com/news/view/568433
7778,2020-10-23,메디톡스대웅제약보톡스균주분쟁ITC최종판결2주연기,http://it.chosun.com/site/data/html_dir/2020/10/23/2020102302445.html
7779,2020-10-23,메디톡스대웅제약보톡스분쟁美ITC최종판결2주연기,http://www.edaily.co.kr/news/newspath.asp?newsid=03401366625935872
7780,2020-10-23,식약처대웅제약당뇨신약신속심사대상으로지정,http://www.finomy.com/news/articleView.html?idxno=84468
7781,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.thefirstmedia.net/news/articleView.html?idxno=64966
7782,2020-10-23,대웅제약당뇨신약이나보글리플로진신속심사의약품지정,http://www.econovill.com/news/articleView.html?idxno=501444
7783,2020-10-24,한국아스트라제네카셀루메티닙대웅제약DWP16001식약처최초신속심사대상의약품지정,http://medicalworldnews.co.kr/news/view.php?idx=1510938305
7784,2020-10-24,대웅제약당뇨병신약이나보글리플로진국내최초패스트트랙의약품지정,http://www.updownnews.co.kr/news/articleView.html?idxno=224580
7785,2020-10-25,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010250809244030721
7786,2020-10-25,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.thepublic.kr/news/newsview.php?ncode=1065599229814641
7787,2020-10-25,기업자금조달보톡스전쟁대웅제약공모채포기후대출단기차입선회,https://view.asiae.co.kr/article/2020102511070717259
7788,2020-10-26,美ITC조사국대웅제약나보타영구수입금지해야,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010260013&t=NN
7789,2020-10-26,대웅제약나보타영구수입금지해야ITC조사국의견서제출,http://www.getnews.co.kr/view.php?ud=2020102606553194732aaae0046f_16
7790,2020-10-26,미국ITC보톡스분쟁에대웅제약나보타수입무기한금지해야,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00008&news_seq_no=4320577
7791,2020-10-26,미무역위대웅제약나보타수입금지무기한으로늘려야”,https://www.chosun.com/economy/science/2020/10/26/AMFLAA35ONECPIAPEJ54KXI6QQ/?utm_source=naver&utm_medium=original&utm_campaign=news
7792,2020-10-26,美ITC조사국예비판결지지대웅제약나보타영구수입금지해야”,http://www.youthdaily.co.kr/news/article.html?no=51124
7793,2020-10-26,美ITC불공정수입조사국대웅제약이의신청반대나보타수입영구금지해야,http://news.mk.co.kr/newsRead.php?no=1094292&year=2020
7794,2020-10-26,특징주대웅제약과보톡스전쟁메디톡스4↑,http://moneys.mt.co.kr/news/mwView.php?no=2020102609078082836
7795,2020-10-26,대웅제약당뇨병신약신속심사대상의약품지정,http://weekly.cnbnews.com/news/article.html?no=136564
7796,2020-10-26,헬스특집대웅제약임팩타민비타민B로피로회복면역력관리,http://www.newscj.com/news/articleView.html?idxno=792693
7797,2020-10-26,오늘의제약동아제약한국아스트라제네카휴젤23일대웅제약23일,http://www.babytimes.co.kr/news/articleView.html?idxno=40368
7798,2020-10-26,美ITC조사국대웅제약나보타무기한수입금지해야,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010260100&t=NN
7799,2020-10-26,대웅제약ITCOUII의견서는기존주장반복일뿐정정보도요청”,http://daily.hankooki.com/lpage/industry/202010/dh20201026093741148390.htm?s_ref=nv
7800,2020-10-26,대웅제약OUII는美ITC스탭어토니기존주장반복한것,http://www.medisobizanews.com/news/articleView.html?idxno=73627
7801,2020-10-26,대웅제약나보타라이브세미나에서피부미용최신지견공유,http://inthenews.co.kr/article-74954/
7802,2020-10-26,마켓인사이트A대웅제약3년만기로900억대출,https://www.hankyung.com/finance/article/202010268813u
7803,2020-10-26,ITC조사국나보타수입금지계속돼야대웅제약이의반박하는의견제출,https://hankookilbo.com/News/Read/A2020102609470002632?did=NA
7804,2020-10-26,美OUII대웅제약나보타수입금지해야”,https://www.seoul.co.kr/news/newsView.php?id=20201027021038&wlog_tag3=naver
7805,2020-10-26,대웅제약신약연구개발강화로글로벌공략나선다,http://www.betanews.net:8080/article/1237803.html
7806,2020-10-26,대웅제약대웅장중주가급락무슨일,http://www.choicenews.co.kr/news/articleView.html?idxno=75670
7807,2020-10-26,보툴리눔톡신소송전메디톡스승대웅제약패로결론나나,http://www.newsquest.co.kr/news/articleView.html?idxno=79219
7808,2020-10-26,대웅제약OUII주장예비판결부터반복한편향적의견ITC도인지,https://www.ajunews.com/view/20201026122638094
7809,2020-10-26,대웅제약vs메디톡스보톡스전쟁내달19일美서최종결론,http://4th.kr/View.aspx?No=1303089
7810,2020-10-26,대웅제약신약RD강화로글로벌공략나서나보타성공신화이어간다,http://www.sisaweek.com/news/articleView.html?idxno=138608
7811,2020-10-26,美ITC조사국대웅제약나보타무기한수입금지필요,http://www.metroseoul.co.kr/article/20201026500479
7812,2020-10-26,美ITC조사국대웅제약영업비밀침해시나보타무기한수입금지해야,https://www.etoday.co.kr/news/view/1954730
7813,2020-10-26,메디톡스주가급등대웅제약급락미국보툴리눔균주소송영향,http://www.businesspost.co.kr/BP?command=article_view&num=201536
7814,2020-10-26,미국ITC조사국대웅제약보톡스제품영구수입금지를”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202010261611001&code=920501
7815,2020-10-26,美ITC조사국나보타수입무기한금지해야”대웅제약기존주장의반복”반박,http://www.thepublic.kr/news/newsview.php?ncode=1065596265520734
7816,2020-10-26,미ITC조사국예비판결지지대웅제약편향된의견,http://www.mediapen.com/news/view/569248
7817,2020-10-26,ITC조사국대웅제약보톡스미국내수입영구금지해야,https://www.nocutnews.co.kr/news/5435907
7818,2020-10-26,美ITC조사국대웅제약이의제기반박대웅나보타영구수입금지해야,http://www.betanews.net:8080/article/1237920.html
7819,2020-10-27,美ITC조사국메디톡스손들어줬다대웅제약나보타수입무기한금지해야”,https://www.chosun.com/economy/science/2020/10/27/LQVIBLDCERATXF5CKVT4266FMI/?utm_source=naver&utm_medium=original&utm_campaign=news
7820,2020-10-27,美ITC산하조직나보타수입무기한금지해야”대웅제약기존주장번복”,http://www.mdtoday.co.kr/mdtoday/index.html?no=403795
7821,2020-10-27,대웅제약美ITC최종판결앞두고900억원대출,http://www.mdtoday.co.kr/mdtoday/index.html?no=403833
7822,2020-10-27,美ITC조사국메디톡스손들어줘대웅제약편향된의견,http://weekly.hankooki.com/lpage/economy/202010/wk20201027113314146380.htm?s_ref=nv
7823,2020-10-27,대웅제약패배로기우는보톡스전쟁,http://www.seouleconews.com/news/articleView.html?idxno=57365
7824,2020-10-27,대웅제약나보타치료시장선점속도연말치료용美임상2상돌입,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102710510178210
7825,2020-10-27,대웅제약당뇨병신약이나보글리플로진첫패스트트랙지정,http://www.doctorsnews.co.kr/news/articleView.html?idxno=136752
7826,2020-10-27,윤재승대웅제약50억원손배청구소송피소백왕기사기로77억원손해,http://www.sisajournal-e.com/news/articleView.html?idxno=224979
7827,2020-10-27,마켓줌인美ITC판결앞둔대웅제약향배는,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102714510144147
7828,2020-10-28,굿닥터대웅제약이나보글리플로진이기대되는이유,http://www.g-enews.com/ko-kr/news/article/news_all/20201028110551120469d76442fa_1/article.html
7829,2020-10-28,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,http://www.kukinews.com/newsView/kuk202010280192
7830,2020-10-28,대웅제약미국균주소송판결뒤대비하나전승호유동성확보나서,http://www.businesspost.co.kr/BP?command=article_view&num=201914
7831,2020-10-29,더벨대웅제약테라퓨틱스인적교류통해RD강화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202010271549108200104294
7832,2020-10-29,대웅제약美터프츠메디컬센터와공동연구협약체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=54061
7833,2020-10-29,대웅제약미국대학병원과니클로사마이드미국임상2상협약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250758
7834,2020-10-29,대웅제약코로나19치료제美터프츠메디컬센터와공동연구,http://medipana.com/news/news_viewer.asp?NewsNum=265081&MainKind=A&NewsKind=5&vCount=12&vKind=1
7835,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.lawissue.co.kr/view.php?ud=202010291102052827204ead0791_12
7836,2020-10-29,대웅제약코로나19치료제美터프츠메디컬센터와공동연구협약,https://www.asiatoday.co.kr/view.php?key=20201029010017880
7837,2020-10-29,대웅제약코로나치료제글로벌임상위해美메디컬센터와연구협약체결,http://www.ekn.kr/news/article.html?no=531283
7838,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제글로벌임상연구협약,http://it.chosun.com/site/data/html_dir/2020/10/29/2020102901250.html
7839,2020-10-29,대웅제약니클로사마이드코로나美임상2상에터프츠병원과맞손,http://moneys.mt.co.kr/news/mwView.php?no=2020102910548094633
7840,2020-10-29,대웅제약美터프츠메디컬센터와협약니클로사마이드글로벌임상,http://www.mhj21.com/136041
7841,2020-10-29,대웅제약美터프츠메디컬센터와니클로사마이드글로벌임상공동연구협약체결,http://www.m-i.kr/news/articleView.html?idxno=759309
7842,2020-10-29,대웅제약美메디컬센터와코로나19치료제공동연구,http://www.newsis.com/view/?id=NISX20201029_0001215157&cID=13001&pID=13000
7843,2020-10-29,대웅제약코로나19치료제美임상2상공동임상협약체결,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010290163&t=NN
7844,2020-10-29,대웅제약美터프츠메디컬센터와니클로사마이드美임상2상진행,http://www.viva100.com/main/view.php?key=20201029010006191
7845,2020-10-29,대웅제약니클로사마이드글로벌임상박차美터프츠메디컬센터공동연구협약,http://www.newslock.co.kr/news/articleView.html?idxno=32223
7846,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64237
7847,2020-10-29,대웅제약美터프츠메디컬센터와코로나치료제 공동개발,http://www.upinews.kr/newsView/upi202010290042
7848,2020-10-29,대웅제약니클로사마이드임상美터프츠메디컬센터와공동연구손잡아,http://www.lcnews.co.kr/news/articleView.html?idxno=9290
7849,2020-10-29,대웅제약美터프츠메디컬센터니클로사마이드글로벌임상맞손,http://www.newsprime.co.kr/news/article.html?no=522521
7850,2020-10-29,대웅제약美터프츠메디컬센터와글로벌임상공동연구협약,http://www.dailysmart.co.kr/news/articleView.html?idxno=34863
7851,2020-10-29,대웅제약터프츠와코로나19美2상추진,http://www.press9.kr/news/articleView.html?idxno=46153
7852,2020-10-29,대웅제약美대학병원과코로나치료제임상2상협약,http://news.mt.co.kr/mtview.php?no=2020102911235723999
7853,2020-10-29,대웅제약美터프츠메디컬센터와니클로사마이드글로벌임상협업,http://www.medisobizanews.com/news/articleView.html?idxno=73747
7854,2020-10-29,대웅제약니클로사마이드글로벌임상美터프츠메디컬센터와공동연구협약,http://www.sentv.co.kr/news/view/581843
7855,2020-10-29,대웅제약美터프츠메디컬센터와공동연구협약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=15236
7856,2020-10-29,대웅제약니클로사마이드글로벌임상美터프츠메디컬센터와협약체결,http://www.opinionnews.co.kr/news/articleView.html?idxno=42347
7857,2020-10-29,대웅제약코로나치료제글로벌2상진입에총력전,http://www.bosa.co.kr/news/articleView.html?idxno=2137056
7858,2020-10-29,대웅제약美터프츠메디컬센터와연구협약체결,https://www.ebn.co.kr/news/view/1456755/?sc=Naver
7859,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제공동연구,http://www.youthdaily.co.kr/news/article.html?no=51524
7860,2020-10-29,대웅제약코로나19치료제미국임상가속도,http://www.dailymedi.com/detail.php?number=862134&thread=22r05
7861,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://newsbrite.net/142923
7862,2020-10-29,대웅제약구충제성분코로나19치료제미국임상박차니클로사마이드임상병원과협력,https://www.donga.com/news/article/all/20201029/103695885/1
7863,2020-10-29,대웅제약니클로사마이드공동연구협약체결,http://www.pharmnews.com/news/articleView.html?idxno=101554
7864,2020-10-29,대웅제약니클로사마이드글로벌임상위해美기관과연구협약체결,https://www.fetv.co.kr/news/article.html?no=67057
7865,2020-10-29,대웅제약美터프츠메디컬센터와공동연구계약코로나치료제임상위해,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102913020390515
7866,2020-10-29,구충제로코로나19치료대웅제약美대학병원과니클로사마이드글로벌임상,http://theviewers.co.kr/View.aspx?No=1313358
7867,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제임상협약,https://www.hankyung.com/it/article/202010292919i
7868,2020-10-29,메디톡스대웅제약소송에휴젤단독질주,http://www.seoulwire.com/news/articleView.html?idxno=428808
7869,2020-10-29,대웅제약코로나19치료제美터프츠메디컬센터와공동연구추진,http://www.kpinews.co.kr/news/articleView.html?idxno=129525
7870,2020-10-29,대웅제약美터프츠메디컬센터와공동연구협약체결,http://www.leaders.kr/news/articleView.html?idxno=218076
7871,2020-10-29,대웅제약코로나19치료제글로벌임상속도,http://sports.hankooki.com/lpage/economy/202010/sp20201029135224137020.htm?s_ref=nv
7872,2020-10-29,대웅제약코로나19치료제후보물질글로벌임상위해美터프츠메디컬센터와협약체결,http://www.ceoscoredaily.com/news/article.html?no=74609
7873,2020-10-29,코로나치료제미국임상에박차대웅제약美대학병원과맞손,http://inthenews.co.kr/article-75555/
7874,2020-10-29,대웅제약코로나19치료제글로벌임상위해美대학병원과연구협약,https://www.etoday.co.kr/news/view/1956342
7875,2020-10-29,구충제성분국산코로나치료제개발박차대웅제약美연구센터와임상협약,http://news.mk.co.kr/newsRead.php?no=1111203&year=2020
7876,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=436527
7877,2020-10-29,대웅제약미국터프츠메디컬센터와니클로사마이드공동연구협약,http://www.newstomato.com/ReadNews.aspx?no=1003830
7878,2020-10-29,대웅제약미국메디컬센터와코로나19치료제공동연구,http://www.mediapen.com/news/view/570259
7879,2020-10-29,대웅제약미국터프츠메디컬센터와공동연구협약체결,https://www.dailian.co.kr/news/view/931996/?sc=Naver
7880,2020-10-29,대웅제약美터프츠메디컬센터와협약체결코로나19치료제개발더순조로울것,http://www.paxetv.com/news/articleView.html?idxno=103254
7881,2020-10-29,뉴스투데이L대웅제약코로나19치료제니클로사마이드美임상2상공동연구협약체결,https://www.news2day.co.kr/163129
7882,2020-10-29,대웅제약美터프츠메디컬센터코로나19치료제연구협업,http://kormedi.com/?p=1326493
7883,2020-10-29,김해시대웅제약과세포유전자치료제산업육성한다,http://www.busan.com/view/busan/view.php?code=2020102916124081079
7884,2020-10-29,김해시대웅제약과세포유전자치료제산업육성,http://www.newspim.com/news/view/20201029001050
7885,2020-10-29,대웅제약미터프츠메디컬센터코로나19치료제글로벌임상공동연구협약,https://www.kpanews.co.kr/article/show.asp?idx=217277&category=D
7886,2020-10-29,대웅제약美대학병원과코로나19치료제임상협력,http://www.finomy.com/news/articleView.html?idxno=84723
7887,2020-10-29,김해시대웅제약과세포유전자치료제산업육성한다,http://www.kndaily.co.kr/news/articleView.html?idxno=173824
7888,2020-10-29,대웅제약미국터프츠와니클로사마이드코로나19임상,http://www.seoulfn.com/news/articleView.html?idxno=399443
7889,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.medigatenews.com/news/584913801
7890,2020-10-29,대웅제약미터프츠메디컬센터와코로나19치료제공동연구,http://www.fnnews.com/news/202010291658498632
7891,2020-10-29,경남김해시대웅제약과세포유전자치료제산업육성추진,http://daily.hankooki.com/lpage/society/202010/dh20201029170153148520.htm?s_ref=nv
7892,2020-10-29,대웅제약美터프츠메디컬센터 니클로사마이드글로벌공동연구협약,http://www.economytalk.kr/news/articleView.html?idxno=208952
7893,2020-10-29,대웅제약DWRX2003글로벌임상준비착착,http://www.monews.co.kr/news/articleView.html?idxno=214910
7894,2020-10-29,대웅제약미국터프츠메디컬센터와코로나19치료제임상협력,http://www.businesspost.co.kr/BP?command=article_view&num=202189
7895,2020-10-29,대웅제약개발중인코로나19치료제임상위해美메디컬센터와협력,http://daily.hankooki.com/lpage/industry/202010/dh20201029175414148390.htm?s_ref=nv
7896,2020-10-29,김해시대웅제약과세포유전자치료제산업육성,https://www.news1.kr/articles/?4103166
7897,2020-10-29,보톡스균주도용의혹대웅제약미국최종판결앞두고전전긍긍,https://ilyo.co.kr/?ac=article_view&entry_id=383344
7898,2020-10-29,대웅제약美대학병원코로나19치료제임상시험협업,http://www.100ssd.co.kr/news/articleView.html?idxno=72265
7899,2020-10-29,대웅제약코로나19치료후보물질美임상순항,http://www.shinailbo.co.kr/news/articleView.html?idxno=1337246
7900,2020-10-29,대웅제약코로나19치료제약물임상위해美터프츠메디컬센터와공동연구협약체결,http://www.worktoday.co.kr/news/articleView.html?idxno=11093
7901,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제공동연구협약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=404261
7902,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.thepublic.kr/news/newsview.php?ncode=1065602875525714
7903,2020-10-29,대웅제약니클로사마이드美터프츠메디컬과공동연구협약,http://www.thedailypost.kr/news/articleView.html?idxno=77090
7904,2020-10-29,김해시대웅제약과세포유전자치료제산업육성한다,https://www.wikitree.co.kr/articles/586143
7905,2020-10-30,대웅제약ITC최종결정승소확신,http://www.medisobizanews.com/news/articleView.html?idxno=73760
7906,2020-10-30,대웅제약의반격ITC최종결정승소확신,http://www.bosa.co.kr/news/articleView.html?idxno=2137093
7907,2020-10-30,대웅제약ITC위원회에오류지적의견서제출최종결정승소확신,http://www.m-i.kr/news/articleView.html?idxno=759695
7908,2020-10-30,대웅제약美ITC에예비결정반박추가의견서제출,https://www.hankyung.com/finance/article/202010305689i
7909,2020-10-30,김해시대웅제약과세포유전자치료제산업육성,http://www.queen.co.kr/news/articleView.html?idxno=345295
7910,2020-10-30,대웅제약ITC에반박의견서추가제출최종결정승소확신”,http://www.viva100.com/main/view.php?key=20201030010006453
7911,2020-10-30,미국반독점연구소대웅제약ITC예비결정뒤집어야공익의견서제출,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020103008111128039
7912,2020-10-30,대웅제약ITC위원회에의견서제출예비결정오류,http://www.press9.kr/news/articleView.html?idxno=46159
7913,2020-10-30,대웅제약ITC에추가의견서제출최종결정승소확신,http://www.newsis.com/view/?id=NISX20201030_0001216297&cID=13001&pID=13000
7914,2020-10-30,대웅제약ITC에의견서제출후최종결정승소확신주장,http://www.lcnews.co.kr/news/articleView.html?idxno=9303
7915,2020-10-30,대웅제약메디톡스대상ITC최종결정승소확신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250791
7916,2020-10-30,대웅제약ITC에추가의견서제출균주는어디서든구할수있어”,https://www.sedaily.com/NewsView/1Z9BZ06GQH
7917,2020-10-30,김해시대웅제약과세포유전자치료제산업육성지원,http://www.viva100.com/main/view.php?key=20201030010006448
7918,2020-10-30,막바지이른보톡스균주전쟁대웅제약ITC최종결정승소확신,http://www.consumernews.co.kr/news/articleView.html?idxno=614798
7919,2020-10-30,대웅제약ITC최종결정승소확신의견서추가제출,http://www.businesskorea.co.kr/news/articleView.html?idxno=54108
7920,2020-10-30,대웅제약美ITC에추가의견서제출최종결정승소확신”,http://www.youthdaily.co.kr/news/article.html?no=51627
7921,2020-10-30,보톡스분쟁속대웅제약美ITC예비결정에반박의견서제출,http://yna.kr/AKR20201030033700017?did=1195m
7922,2020-10-30,대웅제약美ITC에추가의견서제출최종결정승소확신”,http://inthenews.co.kr/article-75694/
7923,2020-10-30,내달6일ITC최종판결대웅제약최종결정승소확신,http://www.wikileaks-kr.org/news/articleView.html?idxno=97641
7924,2020-10-30,대웅제약ITC에추가의견서제출반드시승소할것,http://moneys.mt.co.kr/news/mwView.php?no=2020103009328032024
7925,2020-10-30,대웅제약ITC최종결정승소확신ITC위원회에오류지적의견서추가제출,http://www.updownnews.co.kr/news/articleView.html?idxno=224782
7926,2020-10-30,대웅제약美ITC에추가의견서제출최종결정승소확신”,http://www.newsway.co.kr/news/view?tp=1&ud=2020103009325346046
7927,2020-10-30,대웅제약경상남도김해시인제대학교와MOU체결,http://www.lawissue.co.kr/view.php?ud=202010300938156849204ead0791_12
7928,2020-10-30,대웅제약김해시인제대학교MOU체결세포유전자치료산업육성,http://www.thebigdata.co.kr/view.php?ud=202010300938377531d0a8833aad_23
7929,2020-10-30,대웅제약ITC최종결정승소확신한다,http://www.mdtoday.co.kr/mdtoday/index.html?no=404299
7930,2020-10-30,대웅제약경남도김해시와세포유전자치료제산업공동육성,http://www.kpinews.co.kr/news/articleView.html?idxno=129592
7931,2020-10-30,보톡스분쟁속대웅제약美ITC예비결정에반박의견서제출,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010300948105100105
7932,2020-10-30,대웅제약지역사회와MOU세포유전자치료제산업육성,http://www.medisobizanews.com/news/articleView.html?idxno=73770
7933,2020-10-30,대웅제약세포유전자치료제육성위해지역사회와MOU,http://www.newstomato.com/ReadNews.aspx?no=1004045
7934,2020-10-30,대웅제약美ITC예비결정에반박의견서제출,http://it.chosun.com/site/data/html_dir/2020/10/30/2020103000908.html
7935,2020-10-30,대웅제약내달ITC최종결정서승소확신,http://www.whosaeng.com/122099
7936,2020-10-30,대웅제약ITC최종결정승소확신,http://www.wsobi.com/news/articleView.html?idxno=107392
7937,2020-10-30,대웅제약ITC에추가의견서균주기술영업비밀아냐,http://news.mt.co.kr/mtview.php?no=2020103009533698375
7938,2020-10-30,대웅제약지역사회와MOU세포유전자산업육성,http://www.press9.kr/news/articleView.html?idxno=46161
7939,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.ceoscoredaily.com/news/article.html?no=74660
7940,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010300954027600109
7941,2020-10-30,대웅제약세포유전자치료제산업키운다,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020103009490247066
7942,2020-10-30,대웅제약세포유전자치료제산업키운다,http://www.bosa.co.kr/news/articleView.html?idxno=2137115
7943,2020-10-30,대웅제약ITC위원회에예비결정오류지적의견서추가제출승소확신,http://www.healthinnews.co.kr/news/articleView.html?idxno=15254
7944,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,https://www.etoday.co.kr/news/view/1956753
7945,2020-10-30,대웅제약세포유전자치료제산업육성위해지역사회와MOU체결,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123008
7946,2020-10-30,대웅제약지역사회와세포유전자치료제산업육성,http://www.newsis.com/view/?id=NISX20201030_0001216502&cID=13001&pID=13000
7947,2020-10-30,대웅제약지역사회와세포유전자치료제산업육성MOU,https://www.hankyung.com/it/article/202010306280i
7948,2020-10-30,김해시대웅제약과세포유전자치료제산업육성한다外,https://ilyo.co.kr/?ac=article_view&entry_id=383352
7949,2020-10-30,대웅제약타사영업비밀도용한적없다,http://www.segye.com/content/html/2020/10/30/20201030508768.html?OutUrl=naver
7950,2020-10-30,메디톡스대웅제약11월보톡스분쟁최종판결앞두고서로승소자신,https://biz.chosun.com/site/data/html_dir/2020/10/30/2020103001025.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7951,2020-10-30,대웅제약美ITC에예비결정반박추가의견서제출승소확신,http://www.newslock.co.kr/news/articleView.html?idxno=32275
7952,2020-10-30,보톡스분쟁대웅제약ITC최종결정승소확신,http://www.dailysmart.co.kr/news/articleView.html?idxno=34930
7953,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.newsworker.co.kr/news/articleView.html?idxno=90067
7954,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.healthinnews.co.kr/news/articleView.html?idxno=15261
7955,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.pharmnews.com/news/articleView.html?idxno=101560
7956,2020-10-30,대웅제약경남도김해시인제대와함께세포유전자치료제산업육성,http://daily.hankooki.com/lpage/industry/202010/dh20201030103010148390.htm?s_ref=nv
7957,2020-10-30,대웅제약민관학협력해세포유전자치료제산업키운다,http://www.bokuennews.com/news/article.html?no=196561
7958,2020-10-30,대웅제약ITC최종결정승소확신예비결정오류지적의견서추가제출,http://www.newsprime.co.kr/news/article.html?no=522661
7959,2020-10-30,대웅제약美ITC예비결정추가반박서제출,https://view.asiae.co.kr/article/2020103010474189199
7960,2020-10-30,대웅제약경남서세포유전자치료제산업육성,http://www.dailypharm.com/Users/News/NewsView.html?ID=270067&REFERER=NP
7961,2020-10-30,대웅제약美터프츠메디컬센터와코로나치료제공동연구협약체결,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010291534556310015
7962,2020-10-30,대웅제약세포유전자치료제육성위해지역사회와MOU,http://www.newsway.co.kr/news/view?tp=1&ud=2020103010454516097
7963,2020-10-30,대웅제약지역사회와세포유전자치료제산업육성,https://view.asiae.co.kr/article/2020103010542051207
7964,2020-10-30,대웅제약美ITC예비결정에추가반박의견서제출,https://www.etoday.co.kr/news/view/1956782
7965,2020-10-30,대웅제약경남지역과MOU세포유전자치료제산업육성,http://www.lcnews.co.kr/news/articleView.html?idxno=9317
7966,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,http://www.youthdaily.co.kr/news/article.html?no=51655
7967,2020-10-30,대웅제약지역스타트업인재발굴및지원나서,http://www.segyebiz.com/newsView/20201030509882?OutUrl=naver
7968,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://newsbrite.net/142981
7969,2020-10-30,대웅제약ITC위원회에예비결정오류지적하는의견서추가제출,http://newsbrite.net/142976
7970,2020-10-30,대웅제약ITC에예비결정반박의견서제출,http://www.dailypharm.com/Users/News/NewsView.html?ID=270068&REFERER=NP
7971,2020-10-30,대웅제약ITC최종결정승소확신,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64259
7972,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64268
7973,2020-10-30,대웅제약메디톡스영업비밀사용하지않았다주가는반등다운반등없이하락세,http://www.pinpointnews.co.kr/view.php?ud=202010301115241120861beb2d9d_45
7974,2020-10-30,대웅제약지자체와세포유전자치료제산업육성나선다,http://www.medigatenews.com/news/2672693600
7975,2020-10-30,대웅제약민관학손잡고세포유전자치료제육성한다,http://www.g-enews.com/ko-kr/news/article/news_all/2020103011192698032500a1b5d6_1/article.html
7976,2020-10-30,대웅제약ITC최종결정승소확신예비결정오류지적의견서공개,http://www.consumuch.com/news/articleView.html?idxno=51084
7977,2020-10-30,대웅제약ITC예비판결반박의견서제출,https://hankookilbo.com/News/Read/A2020103009370000243?did=NA
7978,2020-10-30,대웅제약ITC최종결정승소확신,http://www.shinailbo.co.kr/news/articleView.html?idxno=1337389
7979,2020-10-30,대웅제약ITC에예비결정오류지적의견서추가제출최종결정승소확신,https://www.asiatoday.co.kr/view.php?key=20201030010018575
7980,2020-10-30,보톡스분쟁대웅제약美ITC예비결정에반박의견서제출,https://www.nocutnews.co.kr/news/5438671
7981,2020-10-30,보톡스분쟁대웅제약ITC에예비결정오류지적의견서제출승소확신,http://www.sisaweek.com/news/articleView.html?idxno=138771
7982,2020-10-30,대웅제약보톡스분쟁관련美ITC예비결정반박메디톡스기존판결대로될것,http://www.ajunews.com/view/20201030104857754
7983,2020-10-30,대웅제약ITC위원회에의견서추가제출,http://www.dailymedi.com/detail.php?number=862185&thread=22r05
7984,2020-10-30,대웅제약경상남도김해시인제대와세포및유전자치료제산업육성,http://www.businesspost.co.kr/BP?command=article_view&num=202312
7985,2020-10-30,대웅제약세포유전자치료제산업민관학협력체계구축,http://medipana.com/news/news_viewer.asp?NewsNum=265170&MainKind=A&NewsKind=5&vCount=12&vKind=1
7986,2020-10-30,대웅제약경남지역서세포유전자치료제산업육성지원,http://news.mt.co.kr/mtview.php?no=2020103011430859510
7987,2020-10-30,지역인재발굴지원대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://theviewers.co.kr/View.aspx?No=1315193
7988,2020-10-30,대웅제약미국ITC예비결정에대한반박의견서제출,https://www.dailian.co.kr/news/view/932173/?sc=Naver
7989,2020-10-30,대웅제약ITC최종결정승소확신,http://www.thebigdata.co.kr/view.php?ud=202010301335075371d0a8833aad_23
7990,2020-10-30,대웅제약미국ITC예비결정에반박의견서추가제출,http://www.seoulfn.com/news/articleView.html?idxno=399537
7991,2020-10-30,대웅제약ITC위원회에예비결정오류지적하는의견서추가제출,http://www.paxetv.com/news/articleView.html?idxno=103352
7992,2020-10-30,대웅제약지역사회와세포유전자치료제산업키운다,http://www.mediapen.com/news/view/570578
7993,2020-10-30,대웅제약메디톡스와균주소송관련미국국제무역위에의견서더내,http://www.businesspost.co.kr/BP?command=article_view&num=202324
7994,2020-10-30,대웅제약ITC최종결정승소확신”,https://www.fetv.co.kr/news/article.html?no=67172
7995,2020-10-30,대웅제약경남권세포유전자치료제산업육성나서,https://www.fetv.co.kr/news/article.html?no=67175
7996,2020-10-30,대웅제약지역사회와MOU세포유전자치료제산업키운다,http://www.datasom.co.kr/news/articleView.html?idxno=109595
7997,2020-10-30,대웅제약ITC위원회에의견서추가제출승소확신,http://www.thedailypost.kr/news/articleView.html?idxno=77104
7998,2020-10-30,대웅제약세포유전자치료제산업키운다민관학협력체계구축,http://www.thedailypost.kr/news/articleView.html?idxno=77102
7999,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.nbnnews.co.kr/news/articleView.html?idxno=436935
8000,2020-10-30,대웅제약경상남도김해시인제대학교와MOU세포유전자치료제산업육성,http://www.wsobi.com/news/articleView.html?idxno=107457
8001,2020-10-30,대웅제약미국ITC예비결정에반박의견서제출,http://sports.hankooki.com/lpage/economy/202010/sp20201030145549137020.htm?s_ref=nv
8002,2020-10-30,대웅제약ITC최종결정승소확신,http://www.nbnnews.co.kr/news/articleView.html?idxno=436919
8003,2020-10-30,대웅제약ITC에추가의견서제출최종결정승소확신,http://www.ekn.kr/web/view.php?key=20201030010006010
8004,2020-10-30,대웅제약경남시와손잡고세포유전자치료제산업키운다,http://www.ekn.kr/web/view.php?key=20201030010006026
8005,2020-10-30,대웅제약미국ITC제출의견서홈페이지공개,http://www.mediapen.com/news/view/570620
8006,2020-10-30,보톡스분쟁대웅제약美ITC예비결정에반박의견서제출,https://www.asiatime.co.kr/news/newsview.php?ncode=1065594606605917
8007,2020-10-30,대웅제약지역사회와MOU세포유전자치료제산업키울것,http://www.sportsseoul.com/news/read/974993?ref=naver
8008,2020-10-30,대웅제약美ITC에의견서제출보톡스균주영업비밀아니다,http://news.mk.co.kr/newsRead.php?no=1116097&year=2020
8009,2020-10-30,대웅제약메디톡스보톡스판결앞두고의견서제출공방종합,http://yna.kr/AKR20201030033751017?did=1195m
8010,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.thefirstmedia.net/news/articleView.html?idxno=65346
8011,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업육성,http://www.dailysmart.co.kr/news/articleView.html?idxno=34956
8012,2020-10-30,보툴리눔톡신균주분쟁메디톡스대웅제약최종판결앞두고ITC에의견서제출,http://www.getnews.co.kr/view.php?ud=2020103016154246012fe691f917_16
8013,2020-10-30,대웅제약경남김해서세포유전자치료제산업키운다,http://www.finomy.com/news/articleView.html?idxno=84771
8014,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.worktoday.co.kr/news/articleView.html?idxno=11127
8015,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,https://www.dailian.co.kr/news/view/932476/?sc=Naver
8016,2020-10-30,김창수의e뉴스브리핑대웅제약ITC최종결정승소확신”外,https://www.fetv.co.kr/news/article.html?no=67212
8017,2020-10-30,대웅제약경남도와세포유전자치료제개발맞손,http://www.100ssd.co.kr/news/articleView.html?idxno=72353
8018,2020-10-30,오늘의제약GC녹십자엠에스29일대웅제약동국제약제이브이엠동아ST,http://www.babytimes.co.kr/news/articleView.html?idxno=40523
8019,2020-10-30,대웅제약세포유전자치료제육성위한MOU,http://www.koreastocknews.com/news/articleView.html?idxno=58427
8020,2020-10-30,보톡스판결앞두고대웅제약메디톡스의견서제출공방,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004159172
8021,2020-10-30,뉴스투데이L대웅제약지역사회와함께세포유전자치료제산업키운다,https://www.news2day.co.kr/163238
8022,2020-10-30,보톡스분쟁서승리할것”대웅제약ITC예비결정반박의견추가제출,https://www.donga.com/news/article/all/20201030/103721706/1
8023,2020-10-30,김해시대웅제약과세포유전자치료제산업육성,http://www.cnbnews.com/news/article.html?no=466284
8024,2020-10-31,대웅제약경상남도등세포유전자치료제산업육성협약,https://www.kpanews.co.kr/article/show.asp?idx=217318&category=D
8025,2020-10-31,바이오세미나박준석대웅제약신약센터장차세대먹거리는희귀질환줄기세포치료제”,http://www.viva100.com/main/view.php?key=20201031010006636
8026,2020-11-01,대웅제약경상남도김해시인제대등지역사회와세포유전자치료제산업육성협력,http://www.econonews.co.kr/news/articleView.html?idxno=142516
8027,2020-11-02,ITC소송최종판결임박전운감도는메디톡스대웅제약,https://www.dailian.co.kr/news/view/932417/?sc=Naver
8028,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.getnews.co.kr/view.php?ud=2020110209045011842fe691f917_16
8029,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참가,http://medipana.com/news/news_viewer.asp?NewsNum=265226&MainKind=A&NewsKind=5&vCount=12&vKind=1
8030,2020-11-02,대웅제약신약개발위한글로벌학술네트워킹강화,http://www.medisobizanews.com/news/articleView.html?idxno=73812
8031,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.sentv.co.kr/news/view/582011
8032,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.press9.kr/news/articleView.html?idxno=46179
8033,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110209094134493
8034,2020-11-02,대웅제약KASBP추계심포지엄참석글로벌학술네트워킹강화,http://www.youthdaily.co.kr/news/article.html?no=51789
8035,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석글로벌네트워킹강화,http://www.ekn.kr/web/view.php?key=20201102010000177
8036,2020-11-02,대웅제약코로나19치료제美임상2상준비중,http://www.wikileaks-kr.org/news/articleView.html?idxno=97764
8037,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,https://www.fetv.co.kr/news/article.html?no=67260
8038,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://newsbrite.net/143057
8039,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석신약개발글로벌네트워킹강화,http://www.lcnews.co.kr/news/articleView.html?idxno=9363
8040,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004160716
8041,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.mediapen.com/news/view/571153
8042,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.monews.co.kr/news/articleView.html?idxno=214969
8043,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.businesskorea.co.kr/news/articleView.html?idxno=54227
8044,2020-11-02,대웅제약신약개발위한글로벌학술네트워킹강화,http://www.bosa.co.kr/news/articleView.html?idxno=2137213
8045,2020-11-02,대웅제약KASBP심포지엄참석학술교류강화,http://www.econovill.com/news/articleView.html?idxno=503023
8046,2020-11-02,대웅제약2020년재미한인제약인협회추계심포지엄참석,http://www.newslock.co.kr/news/articleView.html?idxno=32352
8047,2020-11-02,대웅제약재미한인제약인과코로나19등신약개발논의,http://www.medigatenews.com/news/2791358867
8048,2020-11-02,대웅제약신약개발위한글로벌학술네트워킹강화나서,http://www.betanews.net:8080/article/1238787.html
8049,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석글로벌학술네트워킹강화,http://www.m-i.kr/news/articleView.html?idxno=760296
8050,2020-11-02,대웅제약신약개발위한네트워킹강화,http://www.mhj21.com/136256
8051,2020-11-02,대웅제약 재미한인제약인협회 추계심포지엄참석,http://www.economytalk.kr/news/articleView.html?idxno=209006
8052,2020-11-02,대웅제약재미한인제약인협회KASBP심포지엄참석글로벌학술네트워킹강화”,http://www.viva100.com/main/view.php?key=20201102010000325
8053,2020-11-02,대웅제약지역사회와손잡고유전자치료제산업육성앞장,http://www.monews.co.kr/news/articleView.html?idxno=214978
8054,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.pressm.kr/news/articleView.html?idxno=34116
8055,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64300
8056,2020-11-02,대웅제약메디톡스ITC최종판결임박에여론전점입가경,https://www.fetv.co.kr/news/article.html?no=67303
8057,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.healthinnews.co.kr/news/articleView.html?idxno=15298
8058,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.lawissue.co.kr/view.php?ud=202011021154252607204ead0791_12
8059,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.newsway.co.kr/news/view?tp=1&ud=2020110212331821369
8060,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.dailysmart.co.kr/news/articleView.html?idxno=35047
8061,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.nbnnews.co.kr/news/articleView.html?idxno=437435
8062,2020-11-02,오늘의제약셀트리온GC녹십자엠에스동화약품에스티팜유비케어대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=40575
8063,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.thebigdata.co.kr/view.php?ud=202011021521264894d0a8833aad_23
8064,2020-11-02,한미약품메디톡스대웅제약5년속앓이같은날끝19일최종판결,http://theviewers.co.kr/View.aspx?No=1317640
8065,2020-11-02,대웅제약2020재미한인제약인협회추계심포지엄참석,http://www.enewstoday.co.kr/news/articleView.html?idxno=1424865
8066,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.dt.co.kr/contents.html?article_no=2020110202109931820010&ref=naver
8067,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.mdtoday.co.kr/mdtoday/index.html?no=404580
8068,2020-11-02,메디톡스대웅제약균주소송5년만에마무리승자는,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123104
8069,2020-11-02,대웅제약재미한인제약인협회온라인심포지엄참석,http://www.100ssd.co.kr/news/articleView.html?idxno=72392
8070,2020-11-02,뉴스투데이L대웅제약재미한인제약인협회추계심포지엄참석,https://www.news2day.co.kr/163353
8071,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,https://www.kpanews.co.kr/article/show.asp?idx=217363&category=D
8072,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석신약개발위한글로벌학술네트워킹강화,http://www.thefirstmedia.net/news/articleView.html?idxno=65436
8073,2020-11-03,대웅제약인니서코로나진단키트판매추진,https://www.theguru.co.kr/news/article.html?no=15772
8074,2020-11-03,대웅제약DWP160013상임상3건승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=404665
8075,2020-11-03,대웅제약전승호대표KASBP추계심포지엄참석,http://www.thedailypost.kr/news/articleView.html?idxno=77189
8076,2020-11-04,대웅제약이나보글리플로진신규적응증3상승인,https://www.ebn.co.kr/news/view/1457544/?sc=Naver
8077,2020-11-04,대웅제약이나보글리플로진3제병용요법임상3상승인,http://medipana.com/news/news_viewer.asp?NewsNum=265367&MainKind=A&NewsKind=5&vCount=12&vKind=1
8078,2020-11-04,대웅제약당뇨신약이나보글리플로진3제병용3상승인,http://www.newsis.com/view/?id=NISX20201104_0001221544&cID=13001&pID=13000
8079,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.lawissue.co.kr/view.php?ud=202011040914196588204ead0791_12
8080,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진신규적응증으로임상3상승인,https://www.etoday.co.kr/news/view/1958415
8081,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.newsprime.co.kr/news/article.html?no=523145
8082,2020-11-04,대웅제약당뇨병치료제이나보글리플로진임상3상승인,https://www.fetv.co.kr/news/article.html?no=67514
8083,2020-11-04,대웅제약당뇨병신약이나보글리플로진 국내임상3상승인,http://www.koreastocknews.com/news/articleView.html?idxno=58528
8084,2020-11-04,대웅제약당뇨병신약세번째적응증국내임상3상승인,https://www.hankyung.com/it/article/202011041733i
8085,2020-11-04,대웅제약이나보글리플로진세번째신규적응증으로임상3상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=129925
8086,2020-11-04,대웅제약당뇨병치료신약신규적응증임상3상승인,https://biz.chosun.com/site/data/html_dir/2020/11/04/2020110400679.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8087,2020-11-04,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020110409188050067
8088,2020-11-04,대웅제약당뇨병신약이나보글리플로진3상승인,http://www.medisobizanews.com/news/articleView.html?idxno=73901
8089,2020-11-04,대웅제약이나보글리플로진3제병용요법임상3상승인,http://news.mt.co.kr/mtview.php?no=2020110409125689637
8090,2020-11-04,대웅제약당뇨신약신규적응증국내임상3상승인획득,http://www.youthdaily.co.kr/news/article.html?no=52053
8091,2020-11-04,전승호대웅제약사장당뇨병신약2023년발매목표,http://www.wikileaks-kr.org/news/articleView.html?idxno=97899
8092,2020-11-04,대웅제약당뇨병신약세번째신규적응증임상3상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250971
8093,2020-11-04,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://www.lcnews.co.kr/news/articleView.html?idxno=9444
8094,2020-11-04,대웅제약당뇨신약이나보글리플로진3제병용임상3상승인,http://www.viva100.com/main/view.php?key=20201104010000976
8095,2020-11-04,대웅제약당뇨병신약이나보글리플로진세번째신규적응증으로임상3상,https://www.sedaily.com/NewsView/1ZA9YFU03D
8096,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진3제병용요법3상임상승인,http://weekly.hankooki.com/lpage/life/202011/wk20201104093903147650.htm?s_ref=nv
8097,2020-11-04,대웅제약이나보글리플로진세번째적응증국내임상3상승인,http://www.newspim.com/news/view/20201104000236
8098,2020-11-04,대웅제약당뇨신약이나보글리플로진국내임상3상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020110409412138531
8099,2020-11-04,대웅제약당뇨병치료신약국내임상3상승인적응증확대,http://www.ekn.kr/web/view.php?key=20201104010000888
8100,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=404776
8101,2020-11-04,대웅제약이나보글리플로진적응증확대,http://www.press9.kr/news/articleView.html?idxno=46197
8102,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진임상3상승인,https://www.dailian.co.kr/news/view/933484/?sc=Naver
8103,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=35155
8104,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인받아,http://yna.kr/AKR20201104050200017?did=1195m
8105,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.pharmnews.com/news/articleView.html?idxno=101588
8106,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.pharmnews.com/news/articleView.html?idxno=101588
8107,2020-11-04,대웅제약당뇨병신약이나보글리플로진임상3상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572515048973
8108,2020-11-04,대웅제약당뇨병신약이나보글리플로진적응증확대,http://www.mhj21.com/136315
8109,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.fnnews.com/news/202011040955532855
8110,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=54387
8111,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.m-i.kr/news/articleView.html?idxno=761348
8112,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인받아,http://www.fntoday.co.kr/news/articleView.html?idxno=238630
8113,2020-11-04,대웅제약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=15361
8114,2020-11-04,세가지약물병용투여대웅제약당뇨약이나보글리플로진국내임상3상승인,http://theviewers.co.kr/View.aspx?No=1320080
8115,2020-11-04,대웅제약SGLT2당뇨신약신규적응증3상돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=270206&REFERER=NP
8116,2020-11-04,대웅제약SGLT2당뇨신약신규적응증3상돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=270206&REFERER=NP
8117,2020-11-04,대웅제약당뇨병치료신약세번째신규적응증으로국내임상3상승인,http://www.sisaweek.com/news/articleView.html?idxno=138894
8118,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진3제병용임상3상승인,https://www.asiatoday.co.kr/view.php?key=20201104010002437
8119,2020-11-04,대웅제약당뇨병신약이나보글리플로진3제병용3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110410195979056
8120,2020-11-04,대웅제약SGLT2저해제삼중요법도국내3상승인,http://www.biospectator.com/view/news_view.php?varAtcId=11707
8121,2020-11-04,대웅제약이나보글리플로진3제병용임상3상승인,https://view.asiae.co.kr/article/2020110410321948312
8122,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인받아,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011041024438230065
8123,2020-11-04,대웅제약당뇨병치료신약 국내임상3상승인,http://www.upinews.kr/newsView/upi202011040021
8124,2020-11-04,대웅제약당뇨병신약이나보글리플로진3번째적응증3상임상승인,http://www.medigatenews.com/news/994957536
8125,2020-11-04,대웅제약당뇨병치료제이나보글리플로진임상3상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004163301
8126,2020-11-04,대웅제약당뇨치료신약이나보글리플로진신규적응증임상3상승인,http://www.newslock.co.kr/news/articleView.html?idxno=32445
8127,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://newsbrite.net/143132
8128,2020-11-04,대웅제약이나보글리플로진세번째적응증국내3상승인,http://www.newstomato.com/ReadNews.aspx?no=1004939
8129,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.pinpointnews.co.kr/view.php?ud=2020110410533643592365609d9b_45
8130,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진3제병용요법임상3상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=500478
8131,2020-11-04,대웅제약당뇨병신약이나보글리플로진임상3상승인,http://sports.hankooki.com/lpage/economy/202011/sp20201104110152137020.htm?s_ref=nv
8132,2020-11-04,대웅제약이나보글리플로진3번째적응증국내3상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2137407
8133,2020-11-04,대웅제약이나보글리플로진경쟁력강화박차,http://www.whosaeng.com/122223
8134,2020-11-04,대웅제약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64367
8135,2020-11-04,대웅제약당뇨병치료신약임상3상승인,https://www.nocutnews.co.kr/news/5441190
8136,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.bokuennews.com/news/article.html?no=196764
8137,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065577331848791
8138,2020-11-04,대웅제약당뇨병신약신규적응증으로국내3상추진,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136934&REFERER=NP
8139,2020-11-04,대웅제약당뇨병치료제병용요법임상3상진행전승호적응증확대,http://www.businesspost.co.kr/BP?command=article_view&num=202963
8140,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.leaders.kr/news/articleView.html?idxno=218868
8141,2020-11-04,대웅제약당뇨병신약세번째적응증임상3상승인,http://www.mediapen.com/news/view/571997
8142,2020-11-04,대웅제약당뇨병치료신약세번째적응증으로임상3상승인,http://www.metroseoul.co.kr/article/20201104500240
8143,2020-11-04,대웅제약당뇨병치료신약세번째신규적응증으로국내임상3상승인,http://www.ceoscoredaily.com/news/article.html?no=74790
8144,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.thebigdata.co.kr/view.php?ud=202011041105133362d0a8833aad_23
8145,2020-11-04,대웅제약이나보글리플로진국내임상3상승인제2형당뇨병신약,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4330187
8146,2020-11-04,대웅제약이나보글리플로진국산신약31호개발하기위해도전,http://www.slist.kr/news/articleView.html?idxno=198200
8147,2020-11-04,대웅제약이나보글리플로진3제병용임상3상승인,http://www.cstimes.com/news/articleView.html?idxno=437320
8148,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=438140
8149,2020-11-04,당뇨신약대웅제약이나보글리플로진국내임상3상승인,https://www.yeongnam.com/web/view.php?key=20201104001455178
8150,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=65541
8151,2020-11-04,대웅제약당뇨병신약이나보글리플로진3제병용3상승인,http://www.sporbiz.co.kr/news/articleView.html?idxno=500496
8152,2020-11-04,대웅제약당뇨신약3번째적응증임상3상승인,https://www.econovill.com/news/articleView.html?idxno=503527
8153,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인획득,http://www.dt.co.kr/contents.html?article_no=2020110402109931102001&ref=naver
8154,2020-11-04,식약처대웅제약당뇨병신약국내임상3상승인,http://it.chosun.com/site/data/html_dir/2020/11/04/2020110402084.html
8155,2020-11-04,대웅제약당뇨병치료신약국내임상3상승인,http://www.skyedaily.com/news/news_view.html?ID=115180
8156,2020-11-04,대웅제약당뇨병치료신약임상3상시험계획식약처로부터승인받았다,http://www.segye.com/content/html/2020/11/04/20201104519081.html?OutUrl=naver
8157,2020-11-04,대웅제약이나보글리플로진병용요법임상3상승인,http://www.doctorstimes.com/news/articleView.html?idxno=212957
8158,2020-11-04,대웅제약메디톡스운명의달ITC승자주목,https://www.econovill.com/news/articleView.html?idxno=503543
8159,2020-11-04,뉴스투데이L대웅제약이나보글리플로진신규적응증으로국내임상3상승인,https://www.news2day.co.kr/163547
8160,2020-11-04,대웅제약당뇨병치료신약임상3상승인2023년발매목표,https://www.vop.co.kr/A00001523887.html
8161,2020-11-04,대웅제약 당뇨병신약 이나보글리플로진국내임상 3상승인,http://www.economytalk.kr/news/articleView.html?idxno=209074
8162,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=11254
8163,2020-11-04,김창수의e뉴스브리핑대웅제약당뇨병치료제이나보글리플로진임상3상승인外,https://www.fetv.co.kr/news/article.html?no=67601
8164,2020-11-04,대웅제약이나보글리플로진3제병용임상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1339469
8165,2020-11-04,대웅제약3Q영업익70억전년비151↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=270239&REFERER=NP
8166,2020-11-04,대웅제약당뇨신약이나보글리플로진3제병용3상승인,http://daily.hankooki.com/lpage/industry/202011/dh20201104175042148390.htm?s_ref=nv
8167,2020-11-04,대웅제약3분기영업익70억원전년比1508↑,http://www.viva100.com/main/view.php?key=20201104010001286
8168,2020-11-04,금일제약업계주요기사대웅제약당뇨신약신규적응증국내3상승인획득식약처뉴젠테라퓨틱스코로나19치료제1상승인外,http://www.youthdaily.co.kr/news/article.html?no=52133
8169,2020-11-04,대웅제약3분기영업이익70억원흑자전환,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110418014122233
8170,2020-11-04,대웅제약3분기매출2489억원영업익70억원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=96077
8171,2020-11-04,공시대웅제약3분기영업익70억전년比1508↑,http://www.newsway.co.kr/news/view?tp=1&ud=2020110418044193193
8172,2020-11-04,대웅제약3분기영업이익70억전년比151↑,http://www.koreastocknews.com/news/articleView.html?idxno=58568
8173,2020-11-04,대웅제약3분기영업이익70억원전년比151↑,https://www.asiatoday.co.kr/view.php?key=20201104010003097
8174,2020-11-04,대웅제약3분기영업익70억원전년比151↑,http://www.newsprime.co.kr/news/article.html?no=523265
8175,2020-11-04,대웅제약3분기매출2489억역대최고전문의약품덕,https://hankookilbo.com/News/Read/A2020110418010001537?did=NA
8176,2020-11-04,대웅제약3분기매출2489억원영업이익70억원,http://newsclaim.co.kr/View.aspx?No=1321370
8177,2020-11-04,대웅제약3분기영업이익70억원전년대비1508↑,http://moneys.mt.co.kr/news/mwView.php?no=2020110418018071427
8178,2020-11-04,대웅제약3분기영업이익70억원전년비151↑,http://www.mediapen.com/news/view/572133
8179,2020-11-04,대웅제약3분기영업이익70억원151증가,http://yna.kr/AKR20201104172100017?did=1195m
8180,2020-11-04,대웅제약3분기실적매출액2489억원영업이익70억원달성,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64382
8181,2020-11-04,대웅제약3분기영업이익70억원전년대비151증가,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011040402&t=NN
8182,2020-11-04,대웅제약3분기순항매출액2489억원영업이익70억원,http://medipana.com/news/news_viewer.asp?NewsNum=265410&MainKind=A&NewsKind=5&vCount=12&vKind=1
8183,2020-11-04,대웅제약3분기매출액2489억원영업이익70억원,http://www.businesskorea.co.kr/news/articleView.html?idxno=54433
8184,2020-11-04,대웅제약3Q매출2489억영업익전년비151증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251017
8185,2020-11-04,대웅제약1분기만에적자탈출전문약사업호조,http://www.dailypharm.com/Users/News/NewsView.html?ID=270241&REFERER=NP
8186,2020-11-04,대웅제약3분기매출역대최고2489억,https://cnbc.sbs.co.kr/article_hub/10001001511?division=NAVER
8187,2020-11-04,대웅제약3분기영업익70억전년比151↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=404871
8188,2020-11-04,대웅제약3분기매출액2489억원영업이익70억원분기매출역대최대,http://www.worktoday.co.kr/news/articleView.html?idxno=11257
8189,2020-11-04,대웅제약3분기순항영업이익70억원흑자전환,http://news.mt.co.kr/mtview.php?no=2020110418554030065
8190,2020-11-04,대웅제약전문의약품실적호조로3분기매출과영업이익모두늘어,http://www.businesspost.co.kr/BP?command=article_view&num=203088
8191,2020-11-04,대웅제약3분기영업익70억전년비151↑,http://www.edaily.co.kr/news/newspath.asp?newsid=04159046625962440
8192,2020-11-04,대웅제약3분기실적맑음전문의약품역대최고,http://www.newsis.com/view/?id=NISX20201104_0001222793&cID=13001&pID=13000
8193,2020-11-04,대웅제약3분기매출2489억원ITC소송등악재뚫고선방,http://www.medisobizanews.com/news/articleView.html?idxno=73925
8194,2020-11-04,대웅제약3분기매출2489억영업이익70억기록,http://www.medigatenews.com/news/1992928868
8195,2020-11-04,대웅제약3분기매출2489억원크레젯등고성장으로전문의약품역대최고경신,http://www.segye.com/content/html/2020/11/04/20201104525058.html?OutUrl=naver
8196,2020-11-04,대웅제약3분기영업익70억원전년비151↑,http://www.ajunews.com/view/20201104195211612
8197,2020-11-04,대웅제약당뇨병신약이나보글리플로진3번째적응증임상3상돌입,https://www.donga.com/news/article/all/20201104/103803775/1
8198,2020-11-04,대웅제약3분기매출2489억원영업이익70억원기록,http://www.wsobi.com/news/articleView.html?idxno=107746
8199,2020-11-04,대웅제약3분기영업익70억전년비1508증가,http://www.newstomato.com/ReadNews.aspx?no=1005128
8200,2020-11-04,대웅제약3분기매출2489억전문의약품역대최고,https://www.etoday.co.kr/news/view/1958867
8201,2020-11-04,대웅제약3분기영업익70억원전년比151↑,https://www.fetv.co.kr/news/article.html?no=67611
8202,2020-11-04,대웅제약3분기영업이익70억원당기순이익262증가,http://www.slist.kr/news/articleView.html?idxno=198307
8203,2020-11-04,대웅제약3분기영업이익70억원전년비151증가,https://www.dailian.co.kr/news/view/933812/?sc=Naver
8204,2020-11-04,대웅제약3분기영업이익70억원전년비151늘었다,http://news.tf.co.kr/read/economy/1822680.htm
8205,2020-11-04,대웅제약당뇨병치료제이나보글리플로진임상3상승인,http://www.thedailypost.kr/news/articleView.html?idxno=77228
8206,2020-11-05,대웅제약3분기매출2489억전년비27늘어,https://www.kpanews.co.kr/article/show.asp?idx=217436&category=D
8207,2020-11-05,대웅제약이나보글리플로진3번째적응증3상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=217438&category=D
8208,2020-11-05,대웅제약 3분기 매출 2489억원영업이익 70억원분기매출역대최고,http://www.greened.kr/news/articleView.html?idxno=274991
8209,2020-11-05,대웅제약최악이미반영했다투자의견목표가↑KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01459606625962768
8210,2020-11-05,클릭e종목대웅제약소송결과반영된주가호실적주목,https://view.asiae.co.kr/article/2020110507534375673
8211,2020-11-05,대웅제약악재반영후정상화중목표가투자의견↑KTB투자증권,https://www.etoday.co.kr/news/view/1958923
8212,2020-11-05,iTN대웅제약현주가는최악의소송결과반영한것목표가↑KTB증권,http://inthenews.co.kr/article-76530/
8213,2020-11-05,대웅제약소송비용축소실적정상화목표가상향,https://www.asiatoday.co.kr/view.php?key=20201105010003166
8214,2020-11-05,대웅제약모두투어코웨이3분기서프라이즈3분기실적브리핑,http://www.pinpointnews.co.kr/view.php?ud=202011050812464838cd1e7f0bdf_45
8215,2020-11-05,대웅제약나보타소송여파로3분기에도실적부진지속,http://www.consumernews.co.kr/news/articleView.html?idxno=615101
8216,2020-11-05,대웅제약소송악재에도실적정상화성공목표가↑KTB투자증권,https://www.dailian.co.kr/news/view/933845/?sc=Naver
8217,2020-11-05,오늘의목표주가녹십자대웅제약↑오이솔루션코웨이↓,https://www.sedaily.com/NewsView/1ZAAFY01EV
8218,2020-11-05,대웅제약소송불안고려해도주가너무낮아목표가↑,https://www.sedaily.com/NewsView/1ZAAEYN6RX
8219,2020-11-05,대웅제약3Q영업이익70억원전년동기比151↑,http://www.youthdaily.co.kr/news/article.html?no=52158
8220,2020-11-05,대웅제약3분기영업이익70억151성장,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011050849036860309
8221,2020-11-05,대웅제약3Q전문의약품매출최고치경신,http://www.press9.kr/news/articleView.html?idxno=46211
8222,2020-11-05,대웅제약ITC소송주가에이미반영목표가8↑KTB,http://www.inews24.com/view/1313910
8223,2020-11-05,대웅제약3분기영업이익전년比151증가전문의약품성장주효”,http://health.chosun.com/site/data/html_dir/2020/11/05/2020110500680.html
8224,2020-11-05,대웅제약3분기영업이익70억원151증가,http://news.mk.co.kr/newsRead.php?no=1134889&year=2020
8225,2020-11-05,대웅제약나보타3분기매출113억기록전년比37↑,http://www.wikileaks-kr.org/news/articleView.html?idxno=97980
8226,2020-11-05,KTB證대웅제약투자의견매수상향주가최악소송결과반영,https://www.hankyung.com/it/article/202011056340i
8227,2020-11-05,대웅제약3Q매출2489억영업익순익전기比흑자전환,http://www.kukinews.com/newsView/kuk202011050039
8228,2020-11-05,미국10년수입금지에도실적선방대웅제약3분기매출액27↑동남아매출성장덕,http://theviewers.co.kr/View.aspx?No=1321809
8229,2020-11-05,대웅제약3분기영업이익151증가전문의약품분기매출최고치경신,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123209
8230,2020-11-05,대웅제약3분기실적발표영업이익70억원151증가,http://www.healthinnews.co.kr/news/articleView.html?idxno=15389
8231,2020-11-05,대웅제약전문의약품호조에3분기영업익전년비151증가,http://sports.hankooki.com/lpage/economy/202011/sp20201105102813137020.htm?s_ref=nv
8232,2020-11-05,대웅제약3분기실적발표매출액2489억원영업이익70억원,http://newsbrite.net/143181
8233,2020-11-05,대웅제약3분기매출액2489억원영업이익70억원알비스판매중단불구역대최고매출경신,http://www.kdpress.co.kr/news/articleView.html?idxno=98299
8234,2020-11-05,대웅제약이나보글리플로진3상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2004470
8235,2020-11-05,대웅제약악재불구3분기날다,http://www.whosaeng.com/122264
8236,2020-11-05,1조클럽제약사실적희비교차유한양행녹십자종근당웃고한미약품대웅제약울고,http://www.consumernews.co.kr/news/articleView.html?idxno=615114
8237,2020-11-05,대웅제약3분기매출액2489억원전문의약품분기매출역대최고경신,http://www.updownnews.co.kr/news/articleView.html?idxno=224990
8238,2020-11-05,대웅제약3분기매출액2489억원영업이익70억원,http://www.bokuennews.com/news/article.html?no=196817
8239,2020-11-05,대웅제약3분기매출2489억전문의약품매출최고치,http://www.meconomynews.com/news/articleView.html?idxno=47071
8240,2020-11-05,대웅제약3Q영업익70억달성전년比151↑,http://www.m-i.kr/news/articleView.html?idxno=762090
8241,2020-11-05,대웅제약3분기실적발표매출액2489억원영업이익70억원,http://www.nbnnews.co.kr/news/articleView.html?idxno=438528
8242,2020-11-05,이인애의뒷담화바이든시대메디톡스대웅제약ITC소송영향은,http://theviewers.co.kr/View.aspx?No=1322857
8243,2020-11-05,대웅제약3분기실적발표매출액2489억원영업이익70억원전년동기대비151증가,http://www.thefirstmedia.net/news/articleView.html?idxno=65657
8244,2020-11-05,금일제약업계주요기사엔케이맥스알츠하이머임상1상순항”대웅제약3Q영업이익70억원外,http://www.youthdaily.co.kr/news/article.html?no=52231
8245,2020-11-05,대웅제약3분기매출액2489억원영업이익70억원보툴리눔톡신나보타국내매출지속성장,http://www.econonews.co.kr/news/articleView.html?idxno=143211
8246,2020-11-06,ETC3분기역대최고매출에도우울한대웅제약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2004494
8247,2020-11-06,더벨CompanyWatch대웅제약알비스빈자리나보타로채웠다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202011041817075720106557
8248,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,http://daily.hankooki.com/lpage/industry/202011/dh20201106090344148390.htm?s_ref=nv
8249,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.kpinews.co.kr/news/articleView.html?idxno=130136
8250,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://www.fetv.co.kr/news/article.html?no=67765
8251,2020-11-06,대웅제약안전보건경영시스템인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020110609098087117
8252,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.press9.kr/news/articleView.html?idxno=46230
8253,2020-11-06,대웅제약오송공장안전보건경영시스템인증안전우수성재입증,http://www.newsprime.co.kr/news/article.html?no=523434
8254,2020-11-06,대웅제약안전보건경영시스템KOSHAMS인증획득,http://medipana.com/news/news_viewer.asp?NewsNum=265493&MainKind=A&NewsKind=5&vCount=12&vKind=1
8255,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://view.asiae.co.kr/article/2020110609243242543
8256,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://view.asiae.co.kr/article/2020110609243242543
8257,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.m-i.kr/news/articleView.html?idxno=762244
8258,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572088112845
8259,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004166180
8260,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.ajunews.com/view/20201106091948474
8261,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=98060
8262,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110609261545230
8263,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251078
8264,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020110609165347601
8265,2020-11-06,대웅제약오송공장안전보건경영시스템KOSHAMS인증획득,http://www.medisobizanews.com/news/articleView.html?idxno=73965
8266,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득 ,http://www.lcnews.co.kr/news/articleView.html?idxno=9510
8267,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2137589
8268,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.newspim.com/news/view/20201106000234
8269,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=54536
8270,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,https://www.etoday.co.kr/news/view/1959501
8271,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.bokuennews.com/news/article.html?no=196880
8272,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://news.mt.co.kr/mtview.php?no=2020110609511395612
8273,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://www.dailian.co.kr/news/view/934292/?sc=Naver
8274,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.newsworks.co.kr/news/articleView.html?idxno=501137
8275,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=35343
8276,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.newsis.com/view/?id=NISX20201106_0001224707&cID=13001&pID=13000
8277,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.mediapen.com/news/view/572624
8278,2020-11-06,제약오늘동아제약해독제타치온정출시대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.sisaon.co.kr/news/articleView.html?idxno=120053
8279,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.youthdaily.co.kr/news/article.html?no=52298
8280,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.ekn.kr/web/view.php?key=20201106010001537
8281,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득 ,http://www.pressm.kr/news/articleView.html?idxno=34248
8282,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.healthinnews.co.kr/news/articleView.html?idxno=15423
8283,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,http://www.consumuch.com/news/articleView.html?idxno=51176
8284,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011061049396900627
8285,2020-11-06,대웅제약메디톡스美ITC보톡스소송위원회만장일치로재검토승인,https://www.donga.com/news/article/all/20201106/103831632/1
8286,2020-11-06,대웅제약안전성입증안전보건경영시스템KOSHAMS취득,http://www.newsian.co.kr/news/articleView.html?idxno=44453
8287,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.upinews.kr/newsView/upi202011060030
8288,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.thebigdata.co.kr/view.php?ud=202011061040523011d0a8833aad_23
8289,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=405048
8290,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://newsbrite.net/143214
8291,2020-11-06,대웅제약안전보건경영시스템KOSHAMS인증획득,http://www.pinpointnews.co.kr/view.php?ud=202011061125521582365609d9b_45
8292,2020-11-06,대웅제약3분기방긋매출영업익전년比상승,http://www.thedailypost.kr/news/articleView.html?idxno=77256
8293,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득체계적이고효과적인시스템운영할것,http://www.segye.com/content/html/2020/11/06/20201106510610.html?OutUrl=naver
8294,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64411
8295,2020-11-06,대웅제약안전보건경영시스템KOSHAMS획득,http://www.monews.co.kr/news/articleView.html?idxno=215135
8296,2020-11-06,대웅제약산업안전보건공단안전보건경영시스템인증획득,http://www.iminju.net/news/articleView.html?idxno=59226
8297,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://weekly.hankooki.com/lpage/life/202011/wk20201106123641147650.htm?s_ref=nv
8298,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.updownnews.co.kr/news/articleView.html?idxno=225035
8299,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.newstomato.com/ReadNews.aspx?no=1005437
8300,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=438813
8301,2020-11-06,대웅제약오송공장산업안전보건공단안전보건경영시스템인증받아,http://www.businesspost.co.kr/BP?command=article_view&num=203396
8302,2020-11-06,대웅제약오송공장KOSHAMS인증취득업계최상위안전보건경영시스템구축,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123290
8303,2020-11-06,대웅제약안전보건경영시스템인증획득,https://www.econovill.com/news/articleView.html?idxno=503912
8304,2020-11-06,대웅제약안전보건경영시스템인증획득,https://www.ebn.co.kr/news/view/1458057/?sc=Naver
8305,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.thefirstmedia.net/news/articleView.html?idxno=65689
8306,2020-11-06,대웅제약메디톡스보톡스전쟁종지부코앞승기누가잡나,http://www.mediapen.com/news/view/572747
8307,2020-11-06,대웅제약3분기실적발표,http://www.thebigdata.co.kr/view.php?ud=202011061602596122d0a8833aad_23
8308,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,http://www.paxetv.com/news/articleView.html?idxno=103869
8309,2020-11-06,뉴스투데이L대웅제약안전보건경영시스템인증획득,https://www.news2day.co.kr/163769
8310,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.lawissue.co.kr/view.php?ud=202011061733125454204ead0791_12
8311,2020-11-06,대웅제약오송공장ISO45001획득이어KOSHAMS취득,http://www.thedailypost.kr/news/articleView.html?idxno=77283
8312,2020-11-06,대웅제약안전보건경영시스템인증취득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1340331
8313,2020-11-07,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.sportsseoul.com/news/read/978301?ref=naver
8314,2020-11-08,메디톡스대웅제약보톡스5년분쟁마침표찍나,https://biz.chosun.com/site/data/html_dir/2020/11/07/2020110701166.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8315,2020-11-08,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.thepublic.kr/news/newsview.php?ncode=1065601662978806
8316,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.lcnews.co.kr/news/articleView.html?idxno=9563
8317,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://medipana.com/news/news_viewer.asp?NewsNum=265558&MainKind=A&NewsKind=5&vCount=12&vKind=1
8318,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.press9.kr/news/articleView.html?idxno=46244
8319,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.ekn.kr/web/view.php?key=20201109010001959
8320,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.youthdaily.co.kr/news/article.html?no=52445
8321,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,https://www.fetv.co.kr/news/article.html?no=67901
8322,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251122
8323,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004168214
8324,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.newsis.com/view/?id=NISX20201109_0001226766&cID=13001&pID=13000
8325,2020-11-09,대웅제약인적자원개발우수기관인증획득,https://www.ebn.co.kr/news/view/1458196/?sc=Naver
8326,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=35437
8327,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.k-health.com/news/articleView.html?idxno=50858
8328,2020-11-09,직원성장이곧회사성장대웅제약2020인적자원개발우수기관인증,http://theviewers.co.kr/View.aspx?No=1325238
8329,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.whosaeng.com/122329
8330,2020-11-09,대웅제약인적자원개발우수기관정부인증획득,http://www.medisobizanews.com/news/articleView.html?idxno=74007
8331,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020110909441393196
8332,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.mediapen.com/news/view/573167
8333,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=54620
8334,2020-11-09,대웅제약2020인적자원개발우수기관선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1426421
8335,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.m-i.kr/news/articleView.html?idxno=762734
8336,2020-11-09,대웅제약인적자원개발우수기관인증획득,https://www.econovill.com/news/articleView.html?idxno=504118
8337,2020-11-09,대웅제약2020인적자원개발우수기관인증,https://www.asiatoday.co.kr/view.php?key=20201109010005158
8338,2020-11-09,대웅제약2020인적자원개발우수기관선정,http://www.newspim.com/news/view/20201109000193
8339,2020-11-09,대웅제약2020BestHRD인증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2137671
8340,2020-11-09,대웅제약인적자원개발우수기관인증,http://news.mt.co.kr/mtview.php?no=2020110909593862424
8341,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://newsbrite.net/143278
8342,2020-11-09,대웅제약인적자원개발우수기관인증획득,https://view.asiae.co.kr/article/2020110910133358171
8343,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.healthinnews.co.kr/news/articleView.html?idxno=15449
8344,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.lawissue.co.kr/view.php?ud=202011091014415588204ead0791_12
8345,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=405174
8346,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.viva100.com/main/view.php?key=20201109010002213
8347,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020110909548071699
8348,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.pharmnews.com/news/articleView.html?idxno=101623
8349,2020-11-09,대웅제약인적자원개발우수기관BestHRD인증획득,http://www.upinews.kr/newsView/upi202011090023
8350,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64444
8351,2020-11-09,대웅제약인적자원개발우수기관으로인정받아,http://www.monews.co.kr/news/articleView.html?idxno=215192
8352,2020-11-09,대웅제약민간대기업부문2020인적자원개발우수기관선정,http://www.kpinews.co.kr/news/articleView.html?idxno=130284
8353,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.pinpointnews.co.kr/view.php?ud=2020110911054273952365609d9b_45
8354,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011091117127350999
8355,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.newslock.co.kr/news/articleView.html?idxno=32597
8356,2020-11-09,대웅제약인적자원개발우수기관인증,http://www.dailymedi.com/detail.php?number=862530&thread=22r05
8357,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.pressm.kr/news/articleView.html?idxno=34299
8358,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.newsworker.co.kr/news/articleView.html?idxno=91144
8359,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573979597454
8360,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.seoulwire.com/news/articleView.html?idxno=429384
8361,2020-11-09,대웅제약2020인적자원개발우수기관인증,http://www.seoulfn.com/news/articleView.html?idxno=400426
8362,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.newstomato.com/ReadNews.aspx?no=1005761
8363,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.thebigdata.co.kr/view.php?ud=202011091400407523d0a8833aad_23
8364,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=439308
8365,2020-11-09,美ITC보툴리늄균주판결후윤재승전대웅제약회장복귀설솔솔,http://www.sisajournal-e.com/news/articleView.html?idxno=225519
8366,2020-11-09,뉴스투데이L대웅제약인적자원개발우수기관선정,https://www.news2day.co.kr/163862
8367,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.worktoday.co.kr/news/articleView.html?idxno=11340
8368,2020-11-09,대웅제약민간대기업인적자원개발우수기관선정,http://www.skyedaily.com/news/news_view.html?ID=115524
8369,2020-11-09,위기의대웅제약전승호대표다시신뢰할까,http://www.sporbiz.co.kr/news/articleView.html?idxno=501012
8370,2020-11-09,대웅제약인적자원개발우수기관선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1341084
8371,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.thedailypost.kr/news/articleView.html?idxno=77315
8372,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.leaders.kr/news/articleView.html?idxno=219539
8373,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.medigatenews.com/news/2683729196
8374,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://daily.hankooki.com/lpage/industry/202011/dh20201109170201148390.htm?s_ref=nv
8375,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=65812
8376,2020-11-09,직원성장이곧회사의성장”대웅제약인적자원개발우수기관인증획득,https://www.donga.com/news/article/all/20201109/103876251/1
8377,2020-11-10,보톡스4사실적희비엇갈려휴온스휴젤웃고메디톡스대웅제약울상,http://www.consumernews.co.kr/news/articleView.html?idxno=615260
8378,2020-11-10,대웅제약내년나보타소송비용축소긍정적,https://www.asiatoday.co.kr/view.php?key=20201110010005916
8379,2020-11-10,대웅제약소송관련불확실성여전중립SK,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011100835214940176
8380,2020-11-10,대웅제약vs메디톡스9일후나보타명운갈린다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1341444
8381,2020-11-11,대웅제약올로스타혈압강하효과SCI급국제학술지등재,http://medipana.com/news/news_viewer.asp?NewsNum=265673&MainKind=A&NewsKind=5&vCount=12&vKind=1
8382,2020-11-11,대웅제약올로스타우수한혈압강하효과입증국제학술지등재,http://www.press9.kr/news/articleView.html?idxno=46258
8383,2020-11-11,대웅제약 올로스타 혈압강하효과美저널등재,http://www.economytalk.kr/news/articleView.html?idxno=209187
8384,2020-11-11,대웅제약올로스타국제학술지등재우수한혈압강하효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=130466
8385,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://www.ftoday.co.kr/news/articleView.html?idxno=208066
8386,2020-11-11,대웅제약올로스타혈압강하입증SCI급학술지등재,http://www.medisobizanews.com/news/articleView.html?idxno=74078
8387,2020-11-11,대웅제약올로스타우수한혈압강하효과입증국제학술지등재,https://www.fetv.co.kr/news/article.html?no=68170
8388,2020-11-11,대웅제약올로스타우수한혈압강하효과국제학술지등재,http://www.newsis.com/view/?id=NISX20201111_0001229658&cID=13001&pID=13000
8389,2020-11-11,대웅제약올로스타임상결과SCI급국제학술지등재,http://www.mhj21.com/136574
8390,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.newsprime.co.kr/news/article.html?no=523793
8391,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011110919405930503
8392,2020-11-11,대웅제약올로스타혈압강하효과연구국제학술지등재,https://www.hankyung.com/it/article/202011116960i
8393,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.pharmnews.com/news/articleView.html?idxno=101648
8394,2020-11-11,대웅제약올로스타우수혈압강하효과입증국제학술지등재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251218
8395,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2137867
8396,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.businesskorea.co.kr/news/articleView.html?idxno=54789
8397,2020-11-11,대웅제약올로스타혈압강하효과입증국제학술지등재,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571487720412
8398,2020-11-11,대웅제약올로스타임상결과SCI급국제학술지에등재,http://www.mediapen.com/news/view/573787
8399,2020-11-11,국제적인정받은대웅제약올로스타美치료약저널등재,http://weekly.hankooki.com/lpage/life/202011/wk20201111100250147610.htm?s_ref=nv
8400,2020-11-11,대웅제약올로스타임상연구미국치료학저널등재,https://biz.chosun.com/site/data/html_dir/2020/11/11/2020111100963.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8401,2020-11-11,대웅제약고혈압이상지질혈증치료제임상연구SCI급등재,http://news.mt.co.kr/mtview.php?no=2020111110052554371
8402,2020-11-11,대웅제약올로스타혈압강하및지질농도개선효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020111110028041306
8403,2020-11-11,혈압콜레스테롤강하효과대웅제약올로스타연구SCI급국제학술지에등재,http://theviewers.co.kr/View.aspx?No=1329119
8404,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.healthinnews.co.kr/news/articleView.html?idxno=15514
8405,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://newsbrite.net/143345
8406,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://www.m-i.kr/news/articleView.html?idxno=763664
8407,2020-11-11,대웅제약고정용량복합제올로스타혈압콜레스테롤조절효과입증,https://jhealthmedia.joins.com/article/article_view.asp?pno=22670
8408,2020-11-11,대웅제약올로스타혈압강하및지질농도개선효과,http://www.bokuennews.com/news/article.html?no=197086
8409,2020-11-11,대웅제약올로스타혈압강하효과우수입증,http://www.dailymedi.com/detail.php?number=862632&thread=22r05
8410,2020-11-11,대웅제약복합제올로스타혈압↓복약순응도↑,http://www.biospectator.com/view/news_view.php?varAtcId=11766
8411,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.newslock.co.kr/news/articleView.html?idxno=32683
8412,2020-11-11,뉴스투데이L대웅제약올로스타혈압강하효과SCI급국제학술지등재,https://www.news2day.co.kr/164026
8413,2020-11-11,대웅제약올로스타혈압강하효과입증,http://www.lawissue.co.kr/view.php?ud=202011111243538644204ead0791_12
8414,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,http://www.newstomato.com/ReadNews.aspx?no=1006280
8415,2020-11-11,제약워치대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지등재外,http://www.newswatch.kr/news/articleView.html?idxno=51912
8416,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.newsworker.co.kr/news/articleView.html?idxno=91516
8417,2020-11-11,대웅제약고혈압치료제올로스타SCI급국제학술지에등재,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020111113180019392
8418,2020-11-11,대웅제약올로스타SCI급국제학술지등재,https://www.dailian.co.kr/news/view/935769/?sc=Naver
8419,2020-11-11,대웅제약올로스타혈압강하효과연구국제학술지등재,http://www.monews.co.kr/news/articleView.html?idxno=215294
8420,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.newsworks.co.kr/news/articleView.html?idxno=502466
8421,2020-11-11,대웅제약올로스타혈압강하효과SCI급국제학술지등재,http://www.thebigdata.co.kr/view.php?ud=202011111259447206d0a8833aad_23
8422,2020-11-11,대웅제약올로스타혈압강하효과국제학술지게재,https://www.ebn.co.kr/news/view/1458645/?sc=Naver
8423,2020-11-11,대웅제약올로스타혈압강하효과국제학술지등재,http://sports.hankooki.com/lpage/economy/202011/sp20201111141025137020.htm?s_ref=nv
8424,2020-11-11,대웅제약올로스타임상연구결과국제학술지등재,https://www.econovill.com/news/articleView.html?idxno=504562
8425,2020-11-11,대웅제약올로스타혈압강하효과국제유명학술지등재,http://www.segye.com/content/html/2020/11/11/20201111515387.html?OutUrl=naver
8426,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지등재,http://www.mdtoday.co.kr/mdtoday/index.html?no=405485
8427,2020-11-11,대웅제약올로스타SCI급국제학술지에등재우수한혈압강하효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=65897
8428,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://www.nbnnews.co.kr/news/articleView.html?idxno=440103
8429,2020-11-11,술잘마시는남성우대대웅제약성차별채용논란,http://www.newspim.com/news/view/20201111000749
8430,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.updownnews.co.kr/news/articleView.html?idxno=225186
8431,2020-11-11,대웅제약올로스타혈압강하효과입증국제학술지등재,http://www.thedailypost.kr/news/articleView.html?idxno=77363
8432,2020-11-11,대웅제약올로스타혈압감소효과입증국제학술지에등재,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004171686
8433,2020-11-11,대웅제약올로스타특별한점살펴보니,http://www.slist.kr/news/articleView.html?idxno=200368
8434,2020-11-11,대웅제약올로스타임상연구美치료학저널등재,http://www.dailysmart.co.kr/news/articleView.html?idxno=35612
8435,2020-11-11,대웅제약올로스타ARB스타틴약물대비우수한효과입증,http://daily.hankooki.com/lpage/industry/202011/dh20201111155357148390.htm?s_ref=nv
8436,2020-11-11,대웅제약혈압및이상지질혈증치료제올로스타SCI급국제학술지에등재,http://www.lcnews.co.kr/news/articleView.html?idxno=9667
8437,2020-11-11,대웅제약고혈압치료제우수한혈압강화효과입증연구결과국제학술지등재,https://www.donga.com/news/article/all/20201111/103912238/1
8438,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64515
8439,2020-11-11,대웅제약올로스타혈압강하효과SCI급국제학술지에등재,http://www.medigatenews.com/news/2941556333
8440,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.consumuch.com/news/articleView.html?idxno=51240
8441,2020-11-12,대웅제약올로스타SCI급국제학술지등재,http://www.enewstoday.co.kr/news/articleView.html?idxno=1427446
8442,2020-11-12,대웅제약올로스타혈압강하효과연구국제학술지등재,http://www.shinailbo.co.kr/news/articleView.html?idxno=1342291
8443,2020-11-13,보톡스3사실적희비메디톡스대웅제약박터지는동안휴젤홀로웃었다,http://www.getnews.co.kr/view.php?ud=2020111316092789582fe691f917_16
8444,2020-11-13,위투게더대웅제약코로나19에도참지마요,http://www.seoulfn.com/news/articleView.html?idxno=401021
8445,2020-11-15,D7대웅제약메디톡스보툴리눔톡신균주전쟁승자는,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011150929127220236
8446,2020-11-16,대웅제약vs메디톡스보톡스균주5년전쟁최종판결카운트다운,https://www.fetv.co.kr/news/article.html?no=68604
8447,2020-11-16,인니연구기술부대웅제약등민간제약사와코로나백신개발협업작성와뇰,https://www.theguru.co.kr/news/article.html?no=16203
8448,2020-11-16,보톡스전쟁마침표찍지만내상커진대웅제약메디톡스,https://www.sedaily.com/NewsView/1ZAFIZC2ME
8449,2020-11-17,메디톡스대웅제약보톡스5년분쟁이번주마침표,https://www.dailian.co.kr/news/view/937185/?sc=Naver
8450,2020-11-17,크리스탈지노믹스헬릭스미스일동홀딩스부광약품대웅제약등잇따른바이오신약개발자회사설립,http://www.topstarnews.net/news/articleView.html?idxno=845847
8451,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://medipana.com/news/news_viewer.asp?NewsNum=265940&MainKind=A&NewsKind=5&vCount=12&vKind=1
8452,2020-11-17,대웅제약子아이엔테라퓨틱스AI신약개발기업디어젠과난청치료제개발,http://www.sentv.co.kr/news/view/582933
8453,2020-11-17,대웅제약자회사AI전문기업과난청치료제개발돌입,http://news.mt.co.kr/mtview.php?no=2020111709240534309
8454,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료신약개발,http://www.medisobizanews.com/news/articleView.html?idxno=74229
8455,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발나서,http://www.bosa.co.kr/news/articleView.html?idxno=2138217
8456,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://www.pharmnews.com/news/articleView.html?idxno=101680
8457,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과손잡고난청치료제개발,https://www.fetv.co.kr/news/article.html?no=68679
8458,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발나서,http://daily.hankooki.com/lpage/industry/202011/dh20201117094732148390.htm?s_ref=nv
8459,2020-11-17,대웅제약아이엔테라퓨틱스AI개발디어젠과난청치료제개발,http://www.press9.kr/news/articleView.html?idxno=46306
8460,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제신약물질발굴돌입,http://www.lawissue.co.kr/view.php?ud=202011170950342505204ead0791_12
8461,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,http://newsbrite.net/143574
8462,2020-11-17,난청치료제개발협력대웅제약자회사아이엔테라퓨틱스AI신약개발기업디어젠과맞손,http://theviewers.co.kr/View.aspx?No=1337401
8463,2020-11-17,대웅제약자회사디어젠과난청치료제개발한다,http://www.dailysmart.co.kr/news/articleView.html?idxno=35869
8464,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI로난청치료제개발,http://www.newsis.com/view/?id=NISX20201117_0001236365&cID=13001&pID=13000
8465,2020-11-17,대웅제약아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020111710170926847
8466,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571676055464
8467,2020-11-17,대웅제약자회사AI신약개발전문기업과난청치료제개발맞손,http://yna.kr/AKR20201117062600017?did=1195m
8468,2020-11-17,대웅제약아이엔테라퓨틱스 난청치료제개발,http://www.businesskorea.co.kr/news/articleView.html?idxno=55175
8469,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발나서,http://www.monews.co.kr/news/articleView.html?idxno=215478
8470,2020-11-17,대웅제약자회사AI신약개발전문기업과난청치료제개발,https://www.asiatoday.co.kr/view.php?key=20201117010010892
8471,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://www.newsworker.co.kr/news/articleView.html?idxno=92140
8472,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발돌입,http://www.thebigdata.co.kr/view.php?ud=202011171056421170d0a8833aad_23
8473,2020-11-17,대웅제약자회사AI업체와난청치료제개발,http://www.whosaeng.com/122526
8474,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64629
8475,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제공동개발,http://www.newstomato.com/ReadNews.aspx?no=1007333
8476,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발 추진,http://www.seoulfn.com/news/articleView.html?idxno=401306
8477,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발도전,http://www.updownnews.co.kr/news/articleView.html?idxno=225362
8478,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠AI로난청치료제개발,https://www.econovill.com/news/articleView.html?idxno=505530
8479,2020-11-17,대웅제약인공지능신약개발플랫폼기업과난청치료제개발추진,http://www.businesspost.co.kr/BP?command=article_view&num=204817
8480,2020-11-17,대웅제약아이엔테라퓨틱스AI전문기업디어젠과난청치료제개발돌입,http://www.newslock.co.kr/news/articleView.html?idxno=32900
8481,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,http://www.nbnnews.co.kr/news/articleView.html?idxno=441763
8482,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발협업,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004178084
8483,2020-11-17,보톡스전쟁운명의날대웅제약vs메디톡스승자는누구,https://www.etoday.co.kr/news/view/1962979
8484,2020-11-17,대웅제약3Q누적매출7882억영업익80감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251489
8485,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과AI플랫폼활용난청치료제개발,http://www.mdtoday.co.kr/mdtoday/index.html?no=406120
8486,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발착수,http://www.thefirstmedia.net/news/articleView.html?idxno=66221
8487,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://www.thedailypost.kr/news/articleView.html?idxno=77500
8488,2020-11-17,대웅제약vs메디톡스보톡스전쟁마침표보인다,http://www.edaily.co.kr/news/newspath.asp?newsid=03837606625966704
8489,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발나서,https://health.chosun.com/site/data/html_dir/2020/11/17/2020111702113.html
8490,2020-11-17,코스피2530선약보합마감대웅제약↓메디톡스↑,http://www.opinionnews.co.kr/news/articleView.html?idxno=43097
8491,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI기업손잡고난청치료제개발돌입,http://www.ajunews.com/view/20201117160932343
8492,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,http://www.worktoday.co.kr/news/articleView.html?idxno=11550
8493,2020-11-17,대웅제약임팩타민필수비타민B8종함유구내염등개선환절기건강관리,https://www.sedaily.com/NewsView/1ZAFZI264F
8494,2020-11-17,뉴스투데이L대웅제약아이엔티라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,https://www.news2day.co.kr/164470
8495,2020-11-18,대웅제약신풍제약희비엇갈려특히대웅제약낮에급등했다가4상승,http://www.econonews.co.kr/news/articleView.html?idxno=144978
8496,2020-11-18,대웅제약궤양성대장염치료제아사콜디알정1600mg품목허가승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=406259
8497,2020-11-18,대웅제약파트너에볼루스美서보톡스분쟁여론전,https://www.theguru.co.kr/news/article.html?no=16306
8498,2020-11-18,오늘Who대웅제약보툴리눔톡신운명19일결정전승호긴하루,http://www.businesspost.co.kr/BP?command=article_view&num=204989
8499,2020-11-19,ITC19일최종판결대웅제약vs메디톡스5년전쟁일단락,http://www.newsis.com/view/?id=NISX20201118_0001239013&cID=13001&pID=13000
8500,2020-11-19,건강관리잇템대웅제약임팩타민겨울철면역관리위해비타민B가필요할때,http://www.m-i.kr/news/articleView.html?idxno=766248
8501,2020-11-19,대웅제약나보타글로벌톡신시장서잘나가네,http://news.mk.co.kr/newsRead.php?no=1190014&year=2020
8502,2020-11-19,운명의날앞둔대웅제약메디톡스美ITC최종판결임박,http://www.youthdaily.co.kr/news/article.html?no=53519
8503,2020-11-19,대웅제약vs메디톡스보톡스전쟁ITC최종판결임박,http://www.seoulwire.com/news/articleView.html?idxno=430085
8504,2020-11-19,대웅제약vs메디톡스5년균주소송ITC판결D1최후의승자는,https://www.fetv.co.kr/news/article.html?no=68997
8505,2020-11-19,메디톡스대웅제약보톡스분쟁미국ITC최종판결임박,http://yna.kr/AKR20201119153600017?did=1195m
8506,2020-11-19,메디톡스VS대웅제약5년보톡스전쟁美ITC최종판결임박,http://www.newsway.co.kr/news/view?tp=1&ud=2020111917060818895
8507,2020-11-19,김창수의e뉴스브리핑대웅제약vs메디톡스5년균주소송ITC최종판결임박마지막승자는外,https://www.fetv.co.kr/news/article.html?no=69008
8508,2020-11-19,대웅제약vs메디톡스균주전쟁5년ITC최종판결결전의날밝았다,http://www.medigatenews.com/news/983629463
8509,2020-11-19,메디톡스대웅제약보톡스분쟁미국ITC최종판결이르면20일새벽,https://www.news2day.co.kr/article/20201119164727
8510,2020-11-20,메디톡스VS대웅제약5년균주분쟁끝날까종합,http://www.ccreview.co.kr/news/articleView.html?idxno=295568
8511,2020-11-20,속보메디톡스대웅제약美ITC최종판결12월16일로연기,https://view.asiae.co.kr/article/2020112007164485509
8512,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로연기속보,http://www.edaily.co.kr/news/newspath.asp?newsid=01436646625967688
8513,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로연기상보,https://view.asiae.co.kr/article/2020112007265519913
8514,2020-11-20,속보대웅제약메디톡스美ITC소송최종판결12월16일로연기,https://www.fetv.co.kr/news/article.html?no=69032
8515,2020-11-20,속보美ITC메디톡스대웅제약최종판결다음달16일로연기,http://www.newspim.com/news/view/20201120000037
8516,2020-11-20,대웅제약메디톡스균주분쟁ITC최종판결12월16일로재연기,https://www.fetv.co.kr/news/article.html?no=69034
8517,2020-11-20,속보美ITC메디톡스대웅제약최종판결12월16일로재연기,https://www.etoday.co.kr/news/view/1964793
8518,2020-11-20,메디톡스대웅제약美ITC최종판결또연기상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01453046625967688
8519,2020-11-20,속보대웅제약메디톡스균주분쟁ITC최종판결재연기,http://www.ccreview.co.kr/news/articleView.html?idxno=295576
8520,2020-11-20,대웅제약메디톡스美ITC최종판결내달16일로재연기,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011200741197960443
8521,2020-11-20,美ITC메디톡스대웅제약보툴리눔톡신최종판결내달16일로연기,http://www.newspim.com/news/view/20201120000052
8522,2020-11-20,美ITC메디톡스대웅제약최종판결12월16일로재연기,https://www.etoday.co.kr/news/view/1964797
8523,2020-11-20,대웅제약vs메디톡스보툴리눔톡신균주전쟁종착역오리무중,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251620
8524,2020-11-20,메디톡스VS대웅제약보톡스분쟁ITC최종판결12월16일로재연기,http://www.newsway.co.kr/news/view?tp=1&ud=2020112007564711334
8525,2020-11-20,메디톡스대웅제약균주분쟁ITC최종판결또연기,http://www.newsis.com/view/?id=NISX20201120_0001240841&cID=13001&pID=13000
8526,2020-11-20,美ITC메디톡스대웅제약보톡스분쟁최종판결또연기,http://www.slist.kr/news/articleView.html?idxno=202823
8527,2020-11-20,또최종판결미룬ICT장기화하는메디톡스대웅제약보톡스전쟁,https://www.sedaily.com/NewsView/1ZAHBIY1K2
8528,2020-11-20,메디톡스대웅제약미국ITC최종판결또연기,https://www.dailian.co.kr/news/view/938523/?sc=Naver
8529,2020-11-20,메디톡스대웅제약美ITC최종판결12월로또연기종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01538326625967688
8530,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로연기속보,https://www.asiatoday.co.kr/view.php?key=20201120010013313
8531,2020-11-20,ITC메디톡스대웅제약최종판결또연기,https://www.econovill.com/news/articleView.html?idxno=506059
8532,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로또연기,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011200042&t=NN
8533,2020-11-20,ITC대웅제약vs메디톡스최종판결일12월16일로또다시연기,http://www.medigatenews.com/news/3153238346
8534,2020-11-20,종합美ITC최종판결재연기메디톡스승리확신VS대웅제약뒤집기가능,https://www.etoday.co.kr/news/view/1964812
8535,2020-11-20,메디톡스대웅제약ITC최종결론내달16일로재연기,https://www.ebn.co.kr/news/view/1460065/?sc=Naver
8536,2020-11-20,메디톡스대웅제약보톡스균주분쟁美ITC판결12월16일로미뤄져,http://www.getnews.co.kr/news/articleView.html?idxno=500677
8537,2020-11-20,대웅제약vs메디톡스ITC소송최종결정12월16일,http://www.shinailbo.co.kr/news/articleView.html?idxno=1345243
8538,2020-11-20,美ITC대웅제약보톡스분쟁최종판결연기바이든이결정종합,https://www.hankyung.com/finance/article/202011200245i
8539,2020-11-20,종합메디톡스대웅제약ITC판결재연기양사해석제각각,http://www.newspim.com/news/view/20201120000090
8540,2020-11-20,메디톡스대웅제약균주분쟁ITC최종판결또연기종합,http://www.newsis.com/view/?id=NISX20201120_0001240884&cID=13001&pID=13000
8541,2020-11-20,대웅제약메디톡스균주분쟁美ITC최종판결내달16일로재연기,http://www.youthdaily.co.kr/news/article.html?no=53600
8542,2020-11-20,그래픽메디톡스대웅제약보톡스원료분쟁주요일지,http://yna.kr/GYH20201120000400044?did=1363m
8543,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로또연기종합,https://www.asiatoday.co.kr/view.php?key=20201120010013339
8544,2020-11-20,대웅제약메디톡스美ITC최종판결12월로또연기,http://www.dailypharm.com/Users/News/NewsView.html?ID=270746&REFERER=NP
8545,2020-11-20,ITC메디톡스대웅제약보툴리눔균주판결12월로연기,http://4th.kr/View.aspx?No=1342912
8546,2020-11-20,미ITC메디톡스대웅제약보톡스분쟁최종판결재연기,http://www.cstimes.com/news/articleView.html?idxno=439537
8547,2020-11-20,대웅제약미국판매사트럼프행정부상대로로비블룸버그폭로,http://www.getnews.co.kr/news/articleView.html?idxno=500688
8548,2020-11-20,대웅제약메디톡스보톡스분쟁ITC최종판결또연기,http://www.seoulwire.com/news/articleView.html?idxno=430147
8549,2020-11-20,메디톡스대웅제약보톡스분쟁최종판결또연기,http://moneys.mt.co.kr/news/mwView.php?no=2020112009018015022
8550,2020-11-20,비즈헬스보툴리눔톡신균주전쟁최종승자는ITC다음달16일로대웅제약메디톡스최종판결재연기,http://www.bizwnews.com/news/articleView.html?idxno=21910
8551,2020-11-20,메디톡스대웅제약보톡스분쟁ITC최종판결또연기,http://www.mediapen.com/news/view/576307
8552,2020-11-20,보톡스분쟁판결또연기대웅제약메디톡스희비엇갈려,http://www.sentv.co.kr/news/view/583211
8553,2020-11-20,美ITC메디톡스대웅제약최종판결내달16일로연기,http://news.mk.co.kr/newsRead.php?no=1194542&year=2020
8554,2020-11-20,메디톡스vs대웅제약보톡스분쟁ITC최종판결12월로재연기,http://daily.hankooki.com/lpage/industry/202011/dh20201120092024148000.htm?s_ref=nv
8555,2020-11-20,보톡스분쟁판결연기메디톡스급락대웅제약상승,https://www.hankyung.com/finance/article/2020112005826
8556,2020-11-20,대웅제약美ITC최종판결연기대웅에게유리할것,http://news.mk.co.kr/newsRead.php?no=1194647&year=2020
8557,2020-11-20,美ITC대웅제약메디톡스보톡스분쟁또연기,http://it.chosun.com/site/data/html_dir/2020/11/20/2020112000794.html
8558,2020-11-20,ITC대웅제약․메디톡스판결내달16일로또연기,http://www.whosaeng.com/122629
8559,2020-11-20,메디톡스대웅제약과보톡스소송최종판결연기에급락,http://news.mt.co.kr/mtview.php?no=2020112009425538811
8560,2020-11-20,메디톡스대웅제약美ITC판결또연기의견분분,http://www.edaily.co.kr/news/newspath.asp?newsid=01925366625967688
8561,2020-11-20,美ITC판결또연기대웅제약메디톡스누가더유리할까,http://www.wikileaks-kr.org/news/articleView.html?idxno=98881
8562,2020-11-20,특징주메디톡스美ITC최종판결연기에급락대웅제약은강세,http://www.ajunews.com/view/20201120094640986
8563,2020-11-20,TF특징주보톡스분쟁ITC최종판결연기에대웅제약↑메디톡스↓,http://news.tf.co.kr/read/economy/1826002.htm
8564,2020-11-20,메디톡스와대웅제약의보톡스분쟁결론미뤄져,http://www.busan.com/view/busan/view.php?code=2020112009550896286
8565,2020-11-20,메디톡스대웅제약 보톡스전쟁최종판결내달16일로연기,http://www.sporbiz.co.kr/news/articleView.html?idxno=502215
8566,2020-11-20,美ITC최종판결연기메디톡스대웅제약입장은,https://www.paxnetnews.com/articles/67562
8567,2020-11-20,美ITC메디톡스대웅제약판결또연기바이든에공넘기나,http://www.upinews.kr/newsView/upi202011200010
8568,2020-11-20,미ITC메디톡스대웅제약보툴리눔제제최종판결내달16일로연기,http://www.kpinews.co.kr/news/articleView.html?idxno=131210
8569,2020-11-20,대웅제약메디톡스ITC판결또다시연기다음달16일최종판결,http://www.g-enews.com/ko-kr/news/article/news_all/20201120085314562469d76442fa_1/article.html
8570,2020-11-20,美ITC메디톡스대웅제약보톡스분쟁최종판결12월로재연기,http://www.ezyeconomy.com/news/articleView.html?idxno=107248
8571,2020-11-20,보톡스전쟁한달더메디톡스대웅제약주가안갯속,http://news.heraldcorp.com/view.php?ud=20201120000251
8572,2020-11-20,메디톡스대웅제약보톡스분쟁ITC최종판결재연기,http://sports.hankooki.com/lpage/economy/202011/sp20201120102211137020.htm?s_ref=nv
8573,2020-11-20,전화연결옵티머스사태에개미만운다개인판매분모두만기에전액상환연기회수가능10밑돌듯끝나지않는보톡스분쟁美ITC메디톡스대웅제약최종판결내달16일로재연기,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004181972
8574,2020-11-20,ITC판결연기메디톡스장중급락vs대웅제약장중강세,http://www.choicenews.co.kr/news/articleView.html?idxno=76549
8575,2020-11-20,메디톡스대웅제약ITC최종판결한달재연기,http://www.seoulfn.com/news/articleView.html?idxno=401709
8576,2020-11-20,메디톡스대웅제약ITC최종판결코로나19사태로연기됐다고요,http://www.segye.com/content/html/2020/11/20/20201120505799.html?OutUrl=naver
8577,2020-11-20,대웅제약vs메디톡스지루한균주소송최종판결또연기왜양사해석극과극,http://www.startuptoday.co.kr/news/articleView.html?idxno=61593
8578,2020-11-20,대웅제약메디톡스美ITC최종판결재연기12월16일,http://www.dailymedi.com/detail.php?number=862987&thread=22r05
8579,2020-11-20,대웅제약측美트럼프행정부에로비설나보타수입금지관련,http://news.mk.co.kr/newsRead.php?no=1195560&year=2020
8580,2020-11-20,메디톡스와대웅제약미국균주소송최종판결12월16일로또미뤄져,http://www.businesspost.co.kr/BP?command=article_view&num=205294
8581,2020-11-20,메디톡스대웅제약보톡스분쟁ITC최종판결재연기,http://www.newsfc.co.kr/news/articleView.html?idxno=43631
8582,2020-11-20,한달뒤로또미뤄진보톡스전쟁메디톡스대웅제약주가안갯속,http://news.heraldcorp.com/view.php?ud=20201120000444
8583,2020-11-20,대웅제약메디톡스보톡스분쟁ITC최종판결또연기12월6일로,http://www.newsworks.co.kr/news/articleView.html?idxno=505000
8584,2020-11-20,메디톡스대웅제약보톡스최종판정또연기,https://www.nocutnews.co.kr/news/5450687
8585,2020-11-20,메디톡스대웅제약보톡스분쟁살얼음판한달더ITC최종판결12월16일로또연기,http://theviewers.co.kr/View.aspx?No=1343432
8586,2020-11-20,대웅제약메디톡스보톡스전쟁美ITC최종판결12월로연기,http://www.newslock.co.kr/news/articleView.html?idxno=33055
8587,2020-11-20,보톡스판결연기대웅제약웃고메디톡스울고,http://www.smartfn.co.kr/view.php?ud=202011201247028607d3eee0def8_46
8588,2020-11-20,미국블룸버그메디톡스대웅제약의ITC연기결정은매우흔히있는일”,http://www.kukinews.com/newsView/kuk202011200222
8589,2020-11-20,메디톡스대웅제약보톡스소송최종판결또연기,http://www.munhwa.com/news/view.html?no=2020112001072039342001
8590,2020-11-20,ITC메디톡스대웅제약보톡스전쟁최종판정또연기,http://www.seouleconews.com/news/articleView.html?idxno=57772
8591,2020-11-20,대웅제약메디톡스보톡스분쟁주요쟁점은,http://www.mediapen.com/news/view/576391
8592,2020-11-20,전화연결코로나193차대유행가능성에기업들확산방지에선제대응회식금지재택근무다시시행끝나지않는보톡스분쟁美ITC메디톡스대웅제약최종판결내달16일로재연기,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004182422
8593,2020-11-20,오후포털사이트상위검색순위메디톡스대웅제약영업비밀침해소송연기,http://www.slist.kr/news/articleView.html?idxno=203084
8594,2020-11-20,메디톡스대웅제약분쟁美ITC판결내달연기어느업체가유리,http://www.sisajournal-e.com/news/articleView.html?idxno=226020
8595,2020-11-20,메디톡스대웅제약美ITC최종판결재연기놓고극명한입장차,https://www.asiatime.co.kr/news/newsview.php?ncode=1065577752039610
8596,2020-11-20,美블룸버그메디톡스대웅제약 ITC 연기결정매우흔한일,http://www.thefirstmedia.net/news/articleView.html?idxno=66400
8597,2020-11-20,메디톡스대웅제약균주전쟁ITC최종판결재연기,http://www.newstomato.com/ReadNews.aspx?no=1008205
8598,2020-11-20,미국에서균주소송최종판결또연기대웅제약전세역전희망품어,http://www.businesspost.co.kr/BP?command=article_view&num=205351
8599,2020-11-20,메디톡스대웅제약보톡스분쟁또연기ITC판결달라지나,https://www.asiatoday.co.kr/view.php?key=20201120010013728
8600,2020-11-20,김창수의e뉴스브리핑대웅제약메디톡스균주분쟁ITC최종판결12월16일로재연기外,https://www.fetv.co.kr/news/article.html?no=69164
8601,2020-11-20,금일제약업계주요기사대웅제약메디톡스美ITC최종판결재연기한미약품4제복합제품목허가획득外,http://www.youthdaily.co.kr/news/article.html?no=53699
8602,2020-11-20,대웅제약메디톡스보톡스분쟁최종판결연기,http://weekly.hankooki.com/lpage/economy/202011/wk20201120213800146380.htm?s_ref=nv
8603,2020-11-21,메디톡스vs대웅제약균주전쟁연기된ITC최종판결누구에게유리할까,http://www.thepublic.kr/news/newsview.php?ncode=1065599253375342
8604,2020-11-22,메디톡스대웅제약균주분쟁ITC최종판결또연기12월16일로재연기,http://www.econonews.co.kr/news/articleView.html?idxno=145535
8605,2020-11-22,메디톡스VS대웅제약美ITC최종판결연기에아전인수해석,https://www.ekn.kr/web/view.php?key=20201122010005140
8606,2020-11-22,메디톡스대웅제약보톡스분쟁또다시재연기”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011221107045140653
8607,2020-11-22,메디톡스vs대웅제약보톡스전쟁판결또연기美ITC최종판결내달16일로,http://www.smartfn.co.kr/view.php?ud=20201122154411177999c6307fbc_46
8608,2020-11-22,ITC대웅제약메디톡스최종판결재연기내달16일승패갈린다,http://www.mdtoday.co.kr/mdtoday/index.html?no=406544
8609,2020-11-23,초고함량비타민시장도선점대웅제약임팩타민케어플러스정허가,http://www.medisobizanews.com/news/articleView.html?idxno=74364
8610,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁생산업무협약,https://biz.chosun.com/site/data/html_dir/2020/11/23/2020112300856.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8611,2020-11-23,시지바이오대웅제약자가줄기세포치료제CDMO업무협약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251680
8612,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO협약,http://medipana.com/news/news_viewer.asp?NewsNum=266240&MainKind=A&NewsKind=5&vCount=12&vKind=1
8613,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁개발생산업무협약,http://it.chosun.com/site/data/html_dir/2020/11/23/2020112300927.html
8614,2020-11-23,대웅제약시지바이오자가줄기세포치료제위탁개발생산MOU,http://www.medisobizanews.com/news/articleView.html?idxno=74372
8615,2020-11-23,시지바이오대웅제약과줄기세포치료제위탁개발생산MOU,http://www.press9.kr/news/articleView.html?idxno=46361
8616,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁생산업무협약,http://inthenews.co.kr/article-78645/
8617,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.newstomato.com/ReadNews.aspx?no=1008393
8618,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁개발생산협약,http://www.metroseoul.co.kr/article/20201123500118
8619,2020-11-23,시지바이오자가줄기세포치료제대웅제약에위탁개발생산맡긴다,https://www.etoday.co.kr/news/view/1965600
8620,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64734
8621,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO협약,https://www.hankyung.com/it/article/202011230402i
8622,2020-11-23,대웅제약펜믹스벨카이라특허두번째허들넘었다,http://medipana.com/news/news_viewer.asp?NewsNum=266257&MainKind=A&NewsKind=5&vCount=12&vKind=1
8623,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=20240
8624,2020-11-23,시지바이오대웅제약자가줄기세포치료제CDMO업무협약체결,http://www.youthdaily.co.kr/news/article.html?no=53837
8625,2020-11-23,대웅제약시지바이오자가줄기세포치료제위탁개발생산업무협약체결,https://www.fetv.co.kr/news/article.html?no=69283
8626,2020-11-23,대웅제약호이스타정코로나19환자대상임상2상대상자모집완료,http://www.sentv.co.kr/news/view/583332
8627,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시목표로임상가속화,http://www.healthinnews.co.kr/news/articleView.html?idxno=20260
8628,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시목표로임상잰걸음,https://www.fetv.co.kr/news/article.html?no=69292
8629,2020-11-23,대웅제약호이스타정내년초코로나19치료제출시목표,http://www.m-i.kr/news/articleView.html?idxno=767905
8630,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.lcnews.co.kr/news/articleView.html?idxno=10092
8631,2020-11-23,대웅제약호이스타정코로나19국내임상선두,http://www.medisobizanews.com/news/articleView.html?idxno=74382
8632,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료내년1월긴급사용승인목표,https://biz.chosun.com/site/data/html_dir/2020/11/23/2020112301651.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8633,2020-11-23,대웅제약코로나치료제호이스타정출시임박내년1월예상,https://www.ekn.kr/web/view.php?key=20201123010005484
8634,2020-11-23,대웅제약카모스타트코로나19임상2상환자모집완료,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112314094377207
8635,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시목표로임상가속화,http://www.lawissue.co.kr/view.php?ud=202011231414314519204ead0791_12
8636,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://newsbrite.net/143846
8637,2020-11-23,대웅제약호이스타정임상2상시험환자모집완료,http://inthenews.co.kr/article-78669/
8638,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,https://www.hankyung.com/it/article/202011231028i
8639,2020-11-23,대웅제약호이스타정2020년1월코로나19치료제로출시기대,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011231418031760023
8640,2020-11-23,대웅제약호이스타정임상2상시험환자모집완료,http://www.economytalk.kr/news/articleView.html?idxno=209494
8641,2020-11-23,대웅제약코로나치료제호이스타정2상환자모집완료,https://www.ebn.co.kr/news/view/1460409/?sc=Naver
8642,2020-11-23,대웅제약호이스타정이르면내년1월코로나19치료제출시가능,http://www.seoulwire.com/news/articleView.html?idxno=430300
8643,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.fnnews.com/news/202011231420559997
8644,2020-11-23,시지바이오대웅제약과줄기세포치료제CDMO협약체결,https://www.econovill.com/news/articleView.html?idxno=506429
8645,2020-11-23,대웅제약호이스타정21년1월코로나19치료제출시목표임상가속화,http://www.thebigdata.co.kr/view.php?ud=202011231421252132d0a8833aad_23
8646,2020-11-23,대웅제약호이스타정임상가속화,http://www.newsworker.co.kr/news/articleView.html?idxno=92915
8647,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집완료내년1월출시기대,https://www.etoday.co.kr/news/view/1965736
8648,2020-11-23,대웅제약내년1월코로나치료제조건부승인받겠다,http://www.newsis.com/view/?id=NISX20201123_0001243784&cID=13001&pID=13000
8649,2020-11-23,대웅제약호이스타정내년코로나19치료제임상가속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251712
8650,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료1월긴급사용승인목표,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011230268&t=NN
8651,2020-11-23,대웅제약개발중인코로나19치료제호이스타정내년1월출시전망,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123801
8652,2020-11-23,대웅제약내년1월코로나19치료제로호이스타정출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=55571
8653,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,https://www.dailian.co.kr/news/view/939273/?sc=Naver
8654,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시목표로임상가속화,http://www.ftoday.co.kr/news/articleView.html?idxno=208464
8655,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집완료,http://www.youthdaily.co.kr/news/article.html?no=53853
8656,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.newsway.co.kr/news/view?tp=1&ud=2020112314360611589
8657,2020-11-23,대웅제약코로나19치료제임상2상시험환자모집완료내년1월긴급사용승인목표,http://www.newsworks.co.kr/news/articleView.html?idxno=505602
8658,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.metroseoul.co.kr/article/20201123500345
8659,2020-11-23,대웅제약호이스타정임상2상대상자모집완료내년1월코로나19치료제출시기대감,https://www.asiatoday.co.kr/view.php?key=20201123010014843
8660,2020-11-23,대웅제약코로나19치료제호이스타정임상2상대상자모집완료,http://www.upinews.kr/newsView/upi202011230053
8661,2020-11-23,대웅제약췌장염치료제코로나19임상2상시작내년사용목표,http://moneys.mt.co.kr/news/mwView.php?no=2020112314378060598
8662,2020-11-23,대웅제약코로나치료제임상2상시험자모집완료,https://health.chosun.com/site/data/html_dir/2020/11/23/2020112301745.html
8663,2020-11-23,대웅제약코로나19치료제호이스타정임상2상시험환자모집완료,http://www.newsfc.co.kr/news/articleView.html?idxno=43656
8664,2020-11-23,대웅제약호이스타정내년코로나19치료제출시기대,http://www.press9.kr/news/articleView.html?idxno=46366
8665,2020-11-23,대웅제약호이스타정코로나19글로벌1차치료제로개발,http://www.newsprime.co.kr/news/article.html?no=525022
8666,2020-11-23,대웅제약호이스타정국내첫코로나19치료제임상2상환자모집완료,http://www.kpinews.co.kr/news/articleView.html?idxno=131348
8667,2020-11-23,대웅제약코로나치료제임상2상환자모집완료,http://www.koreastocknews.com/news/articleView.html?idxno=59119
8668,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.medigatenews.com/news/1482008960
8669,2020-11-23,코로나19치료제개발기대감↑대웅제약호이스타정임상2상대상자모집완료,http://kpenews.com/View.aspx?No=1345976
8670,2020-11-23,대웅제약호이스타정21년1월코로나19치료제출시기대,http://www.pharmnews.com/news/articleView.html?idxno=101735
8671,2020-11-23,대웅제약코로나치료제2상환자모집완료내년1월출시목표,http://sports.hankooki.com/lpage/economy/202011/sp20201123145545137020.htm?s_ref=nv
8672,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료,http://www.mediapen.com/news/view/576998
8673,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시기대감,http://www.dailysmart.co.kr/news/articleView.html?idxno=36193
8674,2020-11-23,시지바이오자가줄기세포치료제대웅제약에위탁생산,http://www.mkhealth.co.kr/news/articleView.html?idxno=51221
8675,2020-11-23,대웅제약코로나치료제내년1월조건부허가신청”,http://www.viva100.com/main/view.php?key=20201123010005794
8676,2020-11-23,대웅제약내년1월코로나치료제조건부승인목표,https://view.asiae.co.kr/article/2020112315124199068
8677,2020-11-23,대웅제약호이스타정1월코로나19치료제로출시기대,http://medipana.com/news/news_viewer.asp?NewsNum=266270&MainKind=A&NewsKind=5&vCount=12&vKind=1
8678,2020-11-23,대웅제약카모스타트코로나19치료제임상가속감기처럼관리하는의약품으로개발”,https://www.donga.com/news/article/all/20201123/104106054/1
8679,2020-11-23,대웅제약카모스타트코로나19치료제임상가속감기처럼관리하는의약품으로개발”,https://www.donga.com/news/article/all/20201123/104106054/1
8680,2020-11-23,가속도대웅제약호이스타내년1월출시목표,http://www.monews.co.kr/news/articleView.html?idxno=215686
8681,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시목표,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004184764
8682,2020-11-23,대웅제약내년1월코로나19치료제호이스타정출시목표,http://www.seoulfn.com/news/articleView.html?idxno=401934
8683,2020-11-23,대웅제약호이스타정코로나19임상2상모집완료,http://www.mhj21.com/137009
8684,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.nbnnews.co.kr/news/articleView.html?idxno=443443
8685,2020-11-23,대웅제약코로나19임상2상대상자모집완료,http://www.joseilbo.com/news/news_read.php?uid=410969&class=27&grp=
8686,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64741
8687,2020-11-23,대웅제약코로나19치료제빠르면내년1월출시,https://www.nocutnews.co.kr/news/5452018
8688,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.segyebiz.com/newsView/20201123515409?OutUrl=naver
8689,2020-11-23,대웅제약코로나치료제2상환자모집완료내년1월긴급사용승인목표,http://it.chosun.com/site/data/html_dir/2020/11/23/2020112301921.html
8690,2020-11-23,대웅제약호이스타정임상가속화내년코로나19치료제로출시기대,http://www.ceoscoredaily.com/news/article.html?no=75440
8691,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집완료,https://www.news2day.co.kr/article/20201123500137
8692,2020-11-23,대웅제약코로나19치료제호이스타정내년1월출시예상,http://www.paxetv.com/news/articleView.html?idxno=104911
8693,2020-11-23,대웅제약코로나치료제2상환자모집완료내년초출시목표,http://news.mt.co.kr/mtview.php?no=2020112316141667841
8694,2020-11-23,시지바이오대웅제약과줄기세포치료제CDMOMOU체결,http://moneys.mt.co.kr/news/mwView.php?no=2020112316248074492
8695,2020-11-23,대웅제약코로나19치료제내년1월출시가목표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1346198
8696,2020-11-23,코로나19의타미플루로대웅제약췌장염약호이스타정내년1월코로나19치료제로출시기대,http://theviewers.co.kr/View.aspx?No=1346246
8697,2020-11-23,대웅제약1월코로나치료제출시기대,https://www.econovill.com/news/articleView.html?idxno=506439
8698,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시기대,http://www.newstomato.com/ReadNews.aspx?no=1008546
8699,2020-11-23,대웅제약호이스타정내년1월코로나치료제조건부승인목표,https://www.asiatime.co.kr/news/newsview.php?ncode=1065598010778433
8700,2020-11-23,대웅제약코로나치료제개발위한임상2상환자모집완료,http://isplus.live.joins.com/news/article/article.asp?total_id=23927843
8701,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.koreaittimes.com/news/articleView.html?idxno=101987
8702,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료내년1월출시목표”,http://www.mdtoday.co.kr/mdtoday/index.html?no=406698
8703,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약,http://www.mdtoday.co.kr/mdtoday/index.html?no=406695
8704,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=66517
8705,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대”,http://www.ajunews.com/view/20201123170154395
8706,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.thefirstmedia.net/news/articleView.html?idxno=66532
8707,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시목표임상가속화,http://www.thepublic.kr/news/newsview.php?ncode=1065600415173490
8708,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.worktoday.co.kr/news/articleView.html?idxno=11710
8709,2020-11-23,김창수의e뉴스브리핑대웅제약시지바이오자가줄기세포치료제위탁개발생산업무협약체결外,https://www.fetv.co.kr/news/article.html?no=69307
8710,2020-11-23,대웅제약코로나19치료제호이스타정임상2상실시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1430398
8711,2020-11-23,대웅제약호이스타정1월코로나19치료제출시목표,http://kormedi.com/?p=1327982
8712,2020-11-23,대웅제약코로나치료제호이스타정2상피험자모집완료,http://www.consumernews.co.kr/news/articleView.html?idxno=616107
8713,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료내년1월긴급승인목표,https://www.sedaily.com/NewsView/1ZAIQ6DMH5
8714,2020-11-23,금일제약업계주요기사대웅제약코로나19치료제호이스타정임상2상환자모집완료유한양행레이저티닙2차마일스톤723억원수령外,http://www.youthdaily.co.kr/news/article.html?no=53873
8715,2020-11-23,대웅제약코로나19치료제내년1월출시기대,http://www.100ssd.co.kr/news/articleView.html?idxno=72915
8716,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집마쳐,http://www.businesspost.co.kr/BP?command=article_view&num=205646
8717,2020-11-23,대웅제약코로나치료제내년1월승인목표,http://www.dt.co.kr/contents.html?article_no=2020112402100451102002&ref=naver
8718,2020-11-23,대웅제약코로나19치료제9부능선1월출시기대감,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137276&REFERER=NP
8719,2020-11-23,대웅제약2021년1월코로나19경구용1차치료제승인목표,http://www.newsinside.kr/news/articleView.html?idxno=1095592
8720,2020-11-23,대웅제약코로나19치료제호이스타정임상2상대상자모집완료,http://www.thedailypost.kr/news/articleView.html?idxno=77656
8721,2020-11-23,대웅제약호이스타정코로나19임상2상시험환자모두모집,https://www.kpanews.co.kr/article/show.asp?idx=217932&category=D
8722,2020-11-23,시지바이오대웅제약자가줄기세포치료제CDMO업무협약,https://www.kpanews.co.kr/article/show.asp?idx=217933&category=D
8723,2020-11-24,대웅제약2개월후코로나19치료제출시기대,http://www.doctorstimes.com/news/articleView.html?idxno=213158
8724,2020-11-24,대웅제약코로나19치료제호이스타정임상2상모집완료,http://www.g-enews.com/ko-kr/news/article/news_all/2020112318160948212500a1b5d6_1/article.html
8725,2020-11-24,대웅제약펜믹스벨카이라특허회피성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=406712
8726,2020-11-24,대웅제약코로나19치료제이르면내년1월출시가능성,http://kbench.com/?q=node/216127
8727,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업안정적,http://www.businesskorea.co.kr/news/articleView.html?idxno=55609
8728,2020-11-24,대웅제약신규보툴리눔균주입고완료ITC예비결정오류직접입증,http://www.m-i.kr/news/articleView.html?idxno=768197
8729,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.press9.kr/news/articleView.html?idxno=46379
8730,2020-11-24,대웅제약美서신규보툴리눔균주입고완료법적문제없어,https://www.ekn.kr/web/view.php?key=20201124010005679
8731,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://news.mt.co.kr/mtview.php?no=2020112409411441927
8732,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.lawissue.co.kr/view.php?ud=202011240956548864204ead0791_12
8733,2020-11-24,대웅제약새보툴리눔균주입고나보타사업지속성강화,http://medipana.com/news/news_viewer.asp?NewsNum=266316&MainKind=A&NewsKind=5&vCount=12&vKind=1
8734,2020-11-24,대웅제약신규보툴리눔균주입고완료법적문제없어,http://www.medisobizanews.com/news/articleView.html?idxno=74404
8735,2020-11-24,대웅제약나보타위기새균주로극복,http://www.monews.co.kr/news/articleView.html?idxno=215725
8736,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://www.fetv.co.kr/news/article.html?no=69353
8737,2020-11-24,대웅제약신규보툴리눔균주입고완료ITC관계없이나보타강화,http://www.upinews.kr/newsView/upi202011240018
8738,2020-11-24,대웅제약코로나치료제내년1월긴급사용승인목표,http://www.sisaweek.com/news/articleView.html?idxno=139474
8739,2020-11-24,대웅제약新균주로나보타사업지속한다신규보툴리눔균주입고완료”,http://www.viva100.com/main/view.php?key=20201124010005947
8740,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112410115331641
8741,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64759
8742,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.ceoscoredaily.com/news/article.html?no=75454
8743,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011240089&t=NN
8744,2020-11-24,대웅제약신규보툴리눔균주입고완료한∙미정부승인배송절차문제No,http://www.thebigdata.co.kr/view.php?ud=202011241013275603d0a8833aad_23
8745,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화”,http://www.youthdaily.co.kr/news/article.html?no=53940
8746,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.newsis.com/view/?id=NISX20201124_0001244867&cID=13001&pID=13000
8747,2020-11-24,보툴리눔균주신규구매대웅제약ITC최종판결상관없이나보타사업지속,https://www.etoday.co.kr/news/view/1966074
8748,2020-11-24,시지바이오대웅제약과자가줄기세포치료제위탁개발생산MOU체결,http://news.heraldcorp.com/view.php?ud=20201124000304
8749,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.kpinews.co.kr/news/articleView.html?idxno=131423
8750,2020-11-24,균주수입으로여론전나선대웅제약나보타사업지속하겠다,https://www.hankyung.com/it/article/202011244194i
8751,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011241026492270228
8752,2020-11-24,시지바이오대웅제약자가줄기세포치료제CDMO업무협약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=02358326625969000
8753,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://www.segye.com/content/html/2020/11/24/20201124508610.html?OutUrl=naver
8754,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://www.asiatoday.co.kr/view.php?key=20201124010015419
8755,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.thepublic.kr/news/newsview.php?ncode=1065576447310177
8756,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://newsbrite.net/143882
8757,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251740
8758,2020-11-24,대웅제약신규보툴리눔균주입고보톡스사업지속성강화의도,http://www.newsworks.co.kr/news/articleView.html?idxno=505837
8759,2020-11-24,시지바이오대웅제약과자가줄기세포치료제관련업무협약MOU,http://www.dt.co.kr/contents.html?article_no=2020112402109919053002&ref=naver
8760,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.healthinnews.co.kr/news/articleView.html?idxno=20286
8761,2020-11-24,대웅제약보툴리눔균주국내반입완료ITC와무관하게사업지속”,http://daily.hankooki.com/lpage/industry/202011/dh20201124105328148390.htm?s_ref=nv
8762,2020-11-24,대웅제약시지바이오자가줄기세포치료제CDMO업무협약,http://daily.hankooki.com/lpage/economy/202011/dh20201124105830138060.htm?s_ref=nv
8763,2020-11-24,대웅제약신규보툴리눔균주국내입고완료나보타사업강화나서,http://www.newslock.co.kr/news/articleView.html?idxno=33162
8764,2020-11-24,시지바이오대웅제약과자가줄기세포치료제CDMO협약,http://www.segye.com/content/html/2020/11/24/20201124509840.html?OutUrl=naver
8765,2020-11-24,대웅제약신규보툴리눔균주반입완료나보타사업지속성강화,http://www.pinpointnews.co.kr/view.php?ud=2020112411070399072365609d9b_45
8766,2020-11-24,대웅제약미국서신규보툴리눔균주구매아무런법적문제없었다,https://www.dailian.co.kr/news/view/939573/?sc=Naver
8767,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://newsclaim.co.kr/View.aspx?No=1350401
8768,2020-11-24,대웅제약신규보툴리눔균주입고ITC무관나보타사업지속,http://www.medigatenews.com/news/206717619
8769,2020-11-24,대웅제약신규보툴리눔균주입고,https://view.asiae.co.kr/article/2020112411545020746
8770,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://www.newsprime.co.kr/news/article.html?no=525143
8771,2020-11-24,대웅제약소송무관하게보툴리눔톡신사업지속새균주국내반입,http://www.businesspost.co.kr/BP?command=article_view&num=205737
8772,2020-11-24,대웅제약신규보툴리눔균주입고완료,https://www.news2day.co.kr/article/20201124500136
8773,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.updownnews.co.kr/news/articleView.html?idxno=225597
8774,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업이어갈것”,https://health.chosun.com/site/data/html_dir/2020/11/24/2020112401578.html
8775,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=406806
8776,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업이어갈것,https://biz.chosun.com/site/data/html_dir/2020/11/24/2020112401719.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8777,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업강화,https://www.econovill.com/news/articleView.html?idxno=506628
8778,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=443828
8779,2020-11-24,대웅제약신규보툴리눔톡신균주도입완료,http://www.mediapen.com/news/view/577262
8780,2020-11-24,대웅제약신규보툴리눔균주국내반입완료,http://www.whosaeng.com/122713
8781,2020-11-24,대웅제약홀에이하이퍼균주국내반입성공한미정부승인배송절차문제無”,https://www.donga.com/news/article/all/20201124/104124773/1
8782,2020-11-24,코로나19치료제환자모집탄력대웅제약셀트리온완료,http://www.edaily.co.kr/news/newspath.asp?newsid=04063926625969000
8783,2020-11-24,대웅제약보툴리눔균주국내반입절차완료,http://www.shinailbo.co.kr/news/articleView.html?idxno=1346745
8784,2020-11-24,대웅제약홀A하이퍼균주도입ITC판결뒤집을까,http://www.seoulfn.com/news/articleView.html?idxno=402118
8785,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.thefirstmedia.net/news/articleView.html?idxno=66609
8786,2020-11-24,대웅제약코로나19치료제임상2상시험환자모집완료내년1월긴급사용승인목표,http://www.econonews.co.kr/news/articleView.html?idxno=145931
8787,2020-11-25,대웅제약호이스타정코로나19환자대상임상2상대상자모집완료,http://www.kukinews.com/newsView/kuk202011240420
8788,2020-11-25,대웅제약신규보툴리눔균주입고마쳐,https://www.kpanews.co.kr/article/show.asp?idx=217964&category=D
8789,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.press9.kr/news/articleView.html?idxno=46393
8790,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112509013299337
8791,2020-11-25,대웅제약나보타남성형탈모에효과추가임상진행중,http://daily.hankooki.com/lpage/industry/202011/dh20201125090554148390.htm?s_ref=nv
8792,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251792
8793,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=131508
8794,2020-11-25,대웅제약나보타남성형탈모개선효과확인,https://www.ebn.co.kr/news/view/1460730/?sc=Naver
8795,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=266383&MainKind=A&NewsKind=5&vCount=12&vKind=1
8796,2020-11-25,대웅제약나보타남성형탈모에효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2138760
8797,2020-11-25,대웅제약보톡스나보타남성형탈모개선효과입증,https://biz.chosun.com/site/data/html_dir/2020/11/25/2020112500725.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8798,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020112509195982697
8799,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모에효과입증”,http://www.youthdaily.co.kr/news/article.html?no=54056
8800,2020-11-25,보톡스맞았더니머리숱늘었다대웅제약임상서효과입증,http://news.mt.co.kr/mtview.php?no=2020112509213582010
8801,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64788
8802,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.pharmnews.com/news/articleView.html?idxno=101750
8803,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,https://www.fetv.co.kr/news/article.html?no=69443
8804,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.metroseoul.co.kr/article/20201125500059
8805,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,http://www.m-i.kr/news/articleView.html?idxno=768639
8806,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모개선효과입증,http://www.newspim.com/news/view/20201125000221
8807,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.lawissue.co.kr/view.php?ud=202011250943386324204ead0791_12
8808,2020-11-25,대웅제약나보타남성형탈모개선효과입증,http://www.medisobizanews.com/news/articleView.html?idxno=74434
8809,2020-11-25,대웅제약나보타남성형탈모치료기대임상에서효과입증,https://health.chosun.com/site/data/html_dir/2020/11/25/2020112500852.html
8810,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.monews.co.kr/news/articleView.html?idxno=215764
8811,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과,https://www.dailian.co.kr/news/view/939935/?sc=Naver
8812,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://newsbrite.net/143918
8813,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011250955055120511
8814,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://inthenews.co.kr/article-79021/
8815,2020-11-25,대웅제약나보타남성형탈모에효과모발개수유의하게증가,http://www.newsprime.co.kr/news/article.html?no=525259
8816,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.healthinnews.co.kr/news/articleView.html?idxno=20314
8817,2020-11-25,대웅제약나보타남성탈모개선효과,https://www.hankyung.com/it/article/202011258815i
8818,2020-11-25,대웅제약나보타남성형탈모효과입증,http://it.chosun.com/site/data/html_dir/2020/11/25/2020112500932.html
8819,2020-11-25,대웅제약보툴리눔톡신나보타임상서남성형탈모효과확인,http://yna.kr/AKR20201125054800017?did=1195m
8820,2020-11-25,대웅제약보툴리눔톡신나보타탈모개선가능성,http://sports.hankooki.com/lpage/economy/202011/sp20201125101522137020.htm?s_ref=nv
8821,2020-11-25,대웅제약나보타남성형탈모에효과입증임상시험결과,http://www.pinpointnews.co.kr/view.php?ud=2020112510184511432365609d9b_45
8822,2020-11-25,대웅제약보톡스나보타남성형탈모에도효과있다,http://www.getnews.co.kr/news/articleView.html?idxno=501505
8823,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,https://www.ekn.kr/web/view.php?key=20201125010006038
8824,2020-11-25,대웅제약나보타남성형탈모개선에효과,http://www.dailypharm.com/Users/News/NewsView.html?ID=270898&REFERER=NP
8825,2020-11-25,대웅제약나보타남성형탈모치료제되나,http://newsclaim.co.kr/View.aspx?No=1356351
8826,2020-11-25,대웅제약나보타남성형탈모개선효과美SCI저널게재,http://www.newslock.co.kr/news/articleView.html?idxno=33224
8827,2020-11-25,탈모에도보톡스대웅제약나보타남성형탈모임상시험효과입증,http://theviewers.co.kr/View.aspx?No=1356363
8828,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.newsworker.co.kr/news/articleView.html?idxno=93212
8829,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모효과입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123878
8830,2020-11-25,대웅제약나보타남성형탈모효과확인,http://www.newstomato.com/ReadNews.aspx?no=1008932
8831,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.dailymedi.com/detail.php?number=863152&thread=22r05
8832,2020-11-25,대웅제약나보타탈모치료제될까임상시험서남성형탈모에효과,http://www.opinionnews.co.kr/news/articleView.html?idxno=43344
8833,2020-11-25,대웅제약나보타탈모적응증청신호남성형탈모효과입증”,http://www.viva100.com/main/view.php?key=20201125010006331
8834,2020-11-25,대웅제약코로나치료제등신약개발속도낸다,https://www.fetv.co.kr/news/article.html?no=69471
8835,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=36310
8836,2020-11-25,대웅제약나보타남성형탈모관련임상시험결과공개,http://www.asiaa.co.kr/news/articleView.html?idxno=8192
8837,2020-11-25,대웅제약나보타임상서남성형탈모치료효과확인,https://www.econovill.com/news/articleView.html?idxno=506841
8838,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모에효과,https://view.asiae.co.kr/article/2020112511443363365
8839,2020-11-25,대웅제약자체보툴눔톡신의남성형탈모개선효과를학술지에실어,http://www.businesspost.co.kr/BP?command=article_view&num=205917
8840,2020-11-25,대웅제약나보타남성형탈모치료효과확인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=96578
8841,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모에효과,http://www.seoulfn.com/news/articleView.html?idxno=402194
8842,2020-11-25,모발이눈에띄게쑥쑥대웅제약나보타남성형탈모치료효과입증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4352158
8843,2020-11-25,보령제약대웅제약제약주모두급등대웅제약6급등이어보령제약17급등,http://www.econonews.co.kr/news/articleView.html?idxno=146059
8844,2020-11-25,대웅제약대웅낮부터갑작스런급등대웅제약5급등이어대웅8급등,http://www.econonews.co.kr/news/articleView.html?idxno=146060
8845,2020-11-25,대웅제약나보타임상시험서남성형탈모치료효과확인,https://www.etoday.co.kr/news/view/1966647
8846,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.thebigdata.co.kr/view.php?ud=202011251307204233d0a8833aad_23
8847,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모효과입증,http://www.medigatenews.com/news/629564329
8848,2020-11-25,대웅제약나보타임상시험서남성형탈모치료효과,https://www.sedaily.com/NewsView/1ZAJN7NW8I
8849,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.koreaittimes.com/news/articleView.html?idxno=102030
8850,2020-11-25,뉴스투데이L대웅제약나보타임상시험서남성형탈모효과입증,https://www.news2day.co.kr/article/20201125500166
8851,2020-11-25,오늘의제약셀트리온GC녹십자웰빙대웅제약GC녹십자엠에스동화약품,http://www.babytimes.co.kr/news/articleView.html?idxno=41247
8852,2020-11-25,대웅제약나보타남성형탈모치료효과입증,http://www.mhj21.com/137093
8853,2020-11-25,특징주대웅제약나보타임상시험서남성형탈모효과입증6↑,http://moneys.mt.co.kr/news/mwView.php?no=2020112513538082382
8854,2020-11-25,대웅제약나보타남성형탈모에효과입증모발개수유의하게증가”,http://www.mdtoday.co.kr/mdtoday/index.html?no=406937
8855,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과나타나,http://www.economytalk.kr/news/articleView.html?idxno=209549
8856,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=444186
8857,2020-11-25,특징주대웅제약보톡스나보타탈모효과에강세,http://news.heraldcorp.com/view.php?ud=20201125000875
8858,2020-11-25,대웅제약나보타남성형탈모에효과입증,http://www.edaily.co.kr/news/newspath.asp?newsid=03234086625969328
8859,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모효과확인,http://www.mediapen.com/news/view/577678
8860,2020-11-25,나보타보톡스가탈모에효과대웅제약주가↑,http://www.smartfn.co.kr/view.php?ud=202011251353367618d3eee0def8_46
8861,2020-11-25,대웅제약나보타남성형탈모개선효과확인,http://www.koreastocknews.com/news/articleView.html?idxno=59217
8862,2020-11-25,특징주대웅제약보툴리눔톡신나보타탈모효과에강세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004187609
8863,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.lcnews.co.kr/news/articleView.html?idxno=10172
8864,2020-11-25,대웅제약나보타임상1상서남성형탈모치료효과입증,http://weekly.hankooki.com/lpage/life/202011/wk20201125151426147610.htm?s_ref=nv
8865,2020-11-25,대웅제약나보타임상시험에서남성형탈모효과입증,http://www.thepublic.kr/news/newsview.php?ncode=1065590653261782
8866,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011250295&t=NN
8867,2020-11-25,대웅제약나보타효과안전성확인하는임상시험서남성형탈모치료효과확인,http://www.segye.com/content/html/2020/11/25/20201125516873.html?OutUrl=naver
8868,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.thedailypost.kr/news/articleView.html?idxno=77695
8869,2020-11-25,오픈콜라보레이션확대하는대웅제약스핀아웃통한신약개발박차,http://www.updownnews.co.kr/news/articleView.html?idxno=225652
8870,2020-11-25,대웅제약보톡스나보타임상시험서남성형탈모치료효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=506419
8871,2020-11-25,기로선대웅제약메디톡스자구책마련사활,http://www.sporbiz.co.kr/news/articleView.html?idxno=502684
8872,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=66672
8873,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,https://www.asiatoday.co.kr/view.php?key=20201125010016716
8874,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.whosaeng.com/122756
8875,2020-11-25,대웅제약나보타임상시험에서남성형탈모효과입증,http://www.g-enews.com/ko-kr/news/article/news_all/20201125161454334969d76442fa_1/article.html
8876,2020-11-25,의약오늘심기남이대서울병원교수대한소화기내시경연구재단우수논문상수상대웅제약나보타남성형탈모임상시험결과美학술지게재,http://www.sisaon.co.kr/news/articleView.html?idxno=120842
8877,2020-11-25,대웅제약신규보툴리눔균주입고완료ITC결정뒤집어,http://www.thedailypost.kr/news/articleView.html?idxno=77698
8878,2020-11-25,대웅제약나보타임상시험서남성형탈모치료효과확인,http://www.ajunews.com/view/20201125160130665
8879,2020-11-25,대웅제약나보타임상시험서남성형탈모효과,http://www.100ssd.co.kr/news/articleView.html?idxno=72964
8880,2020-11-25,대웅제약나보타남성형탈모개선에효과보여,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005033
8881,2020-11-25,보톡스가탈모치료제로대웅제약나보타남성탈모증상개선효과입증,https://www.donga.com/news/article/all/20201125/104148918/1
8882,2020-11-26,대웅제약내달ITC소송결과에따라주가향방갈릴전망,https://www.asiatoday.co.kr/view.php?key=20201126010016884
8883,2020-11-26,대웅제약ITC최종결론앞두고있어서그결과가중요”,https://www.news2day.co.kr/article/20201126500027
8884,2020-11-26,STOCK대웅제약ICT소송결과에주목승소시주가상향,http://moneys.mt.co.kr/news/mwView.php?no=2020112608458086856
8885,2020-11-26,대웅제약내달ITC최종결론이후접근권고키움증권,https://www.etoday.co.kr/news/view/1966933
8886,2020-11-26,대웅제약4분기실적회복ITC이슈에주가출렁일것”,https://www.hankyung.com/it/article/202011262843i
8887,2020-11-26,대웅제약주식매수의견제시균주소송의최종결과확인뒤투자,http://www.businesspost.co.kr/BP?command=article_view&num=206058
8888,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.sentv.co.kr/news/view/583594
8889,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급맞손,http://www.viva100.com/main/view.php?key=20201126010006533
8890,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251847
8891,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,https://www.fetv.co.kr/news/article.html?no=69554
8892,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.lawissue.co.kr/view.php?ud=202011260922309274204ead0791_12
8893,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약,http://www.newspim.com/news/view/20201126000218
8894,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.press9.kr/news/articleView.html?idxno=46405
8895,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112609193124086
8896,2020-11-26,대웅제약글로벌시장에시선바이오의코로나19진단키트판매키로,http://news.mk.co.kr/newsRead.php?no=1216517&year=2020
8897,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.youthdaily.co.kr/news/article.html?no=54185
8898,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64803
8899,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://newsclaim.co.kr/View.aspx?No=1357963
8900,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급나서,http://medipana.com/news/news_viewer.asp?NewsNum=266444&MainKind=A&NewsKind=5&vCount=12&vKind=1
8901,2020-11-26,대웅제약시선바이오코로나진단키트해외공급계약,http://www.newsis.com/view/?id=NISX20201126_0001247894&cID=13001&pID=13000
8902,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://www.asiatoday.co.kr/view.php?key=20201126010016970
8903,2020-11-26,대웅제약시선바이오와코로나신속진단키트6종글로벌판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=74467
8904,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://inthenews.co.kr/article-79196/
8905,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매맡는다,https://www.etoday.co.kr/news/view/1966988
8906,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://www.ekn.kr/web/view.php?key=20201126010006303
8907,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011260932369830797
8908,2020-11-26,대웅제약시선바이오코로나19진단키트해외판매계약,https://www.hankyung.com/it/article/202011263164i
8909,2020-11-26,대웅제약코로나19원스톱진단플랫폼글로벌판매개시,http://weekly.hankooki.com/lpage/economy/202011/wk20201126094511146380.htm?s_ref=nv
8910,2020-11-26,대웅제약시선바이오코로나진단키트6종해외공급계약,http://sports.hankooki.com/lpage/economy/202011/sp20201126094220137020.htm?s_ref=nv
8911,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.dailysmart.co.kr/news/articleView.html?idxno=36356
8912,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.newsworker.co.kr/news/articleView.html?idxno=93392
8913,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약체결,http://www.ezyeconomy.com/news/articleView.html?idxno=107419
8914,2020-11-26,특징주대웅제약소송비용감소수익성회복,http://www.sisaon.co.kr/news/articleView.html?idxno=120871
8915,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://yna.kr/AKR20201126056500017?did=1195m
8916,2020-11-26,대웅제약시선바이오코로나19진단키트판매계약체결,http://www.monews.co.kr/news/articleView.html?idxno=215805
8917,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=20354
8918,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.segye.com/content/html/2020/11/26/20201126508201.html?OutUrl=naver
8919,2020-11-26,대웅제약시선바이오코로나진단키트글로벌판매계약,http://www.koreastocknews.com/news/articleView.html?idxno=59255
8920,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급계약,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572142848875
8921,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.fnnews.com/news/202011260956558755
8922,2020-11-26,대웅제약코로나19진단키트6종해외판매나선다,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4353134
8923,2020-11-26,대웅제약시선바이오코로나19 진단키트 6종 해외공급계약체결,http://www.greened.kr/news/articleView.html?idxno=277477
8924,2020-11-26,대웅제약시선바이오코로나진단키트해외공급계약,https://www.ebn.co.kr/news/view/1461007/?sc=Naver
8925,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.mhj21.com/137112
8926,2020-11-26,원스톱진단플랫폼대웅제약시선바이오와코로나19진단키트6종해외공급계약,http://theviewers.co.kr/View.aspx?No=1358042
8927,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.thebigdata.co.kr/view.php?ud=20201126094624229d0a8833aad_23
8928,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.kpinews.co.kr/news/articleView.html?idxno=131643
8929,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=407027
8930,2020-11-26,대웅제약코로나19진단키트6종해외공급계약,http://www.bosa.co.kr/news/articleView.html?idxno=2138867
8931,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2020112610205750341
8932,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://newsbrite.net/143983
8933,2020-11-26,대웅제약시선바이오코로나19진단키트6종글로벌공급계약,http://www.lcnews.co.kr/news/articleView.html?idxno=10204
8934,2020-11-26,대웅제약연이은구설수성차별채용공고보톡스로비의혹등논란,http://sports.chosun.com/news/ntype.htm?id=202011270100245120016440&servicedate=20201126
8935,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급,http://www.newsprime.co.kr/news/article.html?no=525416
8936,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약체결,http://www.m-i.kr/news/articleView.html?idxno=769207
8937,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.newslock.co.kr/news/articleView.html?idxno=33311
8938,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.seoulfn.com/news/articleView.html?idxno=402315
8939,2020-11-26,대웅제약시선바이오코로나진단키트6종해외판매계약,http://news.mt.co.kr/mtview.php?no=2020112609470967306
8940,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.insightkorea.co.kr/news/articleView.html?idxno=84850
8941,2020-11-26,대웅제약시선바이오와코로나19PCR진단키트6종글로벌판매계약체결,http://www.marketnews.co.kr/news/articleView.html?idxno=56078
8942,2020-11-26,대웅제약시선바이오진단키트6종해외공급계약,http://www.asiaa.co.kr/news/articleView.html?idxno=8424
8943,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,https://www.sedaily.com/NewsView/1ZAK38GAEK
8944,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급,http://www.newstomato.com/ReadNews.aspx?no=1009208
8945,2020-11-26,대웅제약자체개발보톡스나보타중국서임상3상본격추진,https://www.asiatoday.co.kr/view.php?key=20201126010017306
8946,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약체결,https://www.news2day.co.kr/article/20201126500173
8947,2020-11-26,대웅제약나보타남성형탈모에효과,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137131
8948,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.koreaittimes.com/news/articleView.html?idxno=102075
8949,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.metroseoul.co.kr/article/20201126500255
8950,2020-11-26,대웅제약시선바이오진단키트6종글로벌판권확보,https://health.chosun.com/site/data/html_dir/2020/11/26/2020112601601.html
8951,2020-11-26,대웅제약시선바이오코로나19진단키트판매계약,http://www.dailymedi.com/detail.php?number=863229&thread=22r05
8952,2020-11-26,대웅제약시선바이오머티리얼스의코로나19진단기기해외판매추진,http://www.businesspost.co.kr/BP?command=article_view&num=206105
8953,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.dt.co.kr/contents.html?article_no=2020112602109931102002&ref=naver
8954,2020-11-26,대웅제약시선바이오코로나진단키트6종해외공급계약,http://daily.hankooki.com/lpage/industry/202011/dh20201126141033148390.htm?s_ref=nv
8955,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=444592
8956,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.medigatenews.com/news/1392953050
8957,2020-11-26,대웅제약코로나19진단키트6종해외공급계약체결,http://www.ajunews.com/view/20201126141801234
8958,2020-11-26,대웅제약시선바이오진단키트6종해외공급계약,http://www.bokuennews.com/news/article.html?no=197777
8959,2020-11-26,대웅제약해외에코로나19진단키트공급,http://www.finomy.com/news/articleView.html?idxno=85864
8960,2020-11-26,대웅제약시선바이오코로나진단키트6종글로벌판권확보,http://www.mediapen.com/news/view/578067
8961,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.thedailypost.kr/news/articleView.html?idxno=77729
8962,2020-11-26,대웅제약시선바이오코로나진단키트해외공급계약30분안에진단가능,https://www.econovill.com/news/articleView.html?idxno=507194
8963,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급계약체결,https://www.dailian.co.kr/news/view/940525/?sc=Naver
8964,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결토탈솔루션공급체계확립,http://www.paxetv.com/news/articleView.html?idxno=105199
8965,2020-11-26,대웅제약올로스타우수한효과및독보적인기술력주목,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64821
8966,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.edaily.co.kr/news/newspath.asp?newsid=03890086625969656
8967,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.fntoday.co.kr/news/articleView.html?idxno=241594
8968,2020-11-26,보톡스분쟁ITC최종판결연기대웅제약에호재,http://www.sisaweek.com/news/articleView.html?idxno=139577
8969,2020-11-26,시선바이오대웅제약과코로나19진단키트6종해외판매계약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004189029
8970,2020-11-26,대웅제약호이스타정코로나19치료데드라인은6시간,http://www.thevaluenews.co.kr/news/view.php?idx=161633
8971,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약,https://www.donga.com/news/article/all/20201126/104168086/1
8972,2020-11-26,김창수의e뉴스브리핑대웅제약시선바이오코로나19진단키트6종해외공급계약外,https://www.fetv.co.kr/news/article.html?no=69660
8973,2020-11-26,대웅제약코로나19진단키트6종글로벌공급,http://www.shinailbo.co.kr/news/articleView.html?idxno=1347767
8974,2020-11-26,전승호대웅제약신약개발역량강화해해외시장공략매달려,http://www.businesspost.co.kr/BP?command=article_view&num=206196
8975,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=66780
8976,2020-11-26,대웅제약나보타소송비용감소긍정신호ITC결론지켜봐야,https://www.econovill.com/news/articleView.html?idxno=507258
8977,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급,http://news.kbiz.or.kr/news/articleView.html?idxno=75090
8978,2020-11-27,대웅제약시선바이오코로나19진단키트6종해외공급계약,https://www.kpanews.co.kr/article/show.asp?idx=218038&category=D
8979,2020-11-27,대웅제약코로나19진단키트해외수출나선다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005067
8980,2020-11-27,LG화학한샘대웅제약대학생인재선점겨울인턴모집,http://www.shinailbo.co.kr/news/articleView.html?idxno=1347876
8981,2020-11-27,대웅제약우루사온라인바이럴영상공개,http://www.press9.kr/news/articleView.html?idxno=46417
8982,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64840
8983,2020-11-27,간때문이야로MZ세대어필”대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.fetv.co.kr/news/article.html?no=69704
8984,2020-11-27,대웅제약우루사간때문이야MZ세대시선스틸,http://www.medisobizanews.com/news/articleView.html?idxno=74505
8985,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://medipana.com/news/news_viewer.asp?NewsNum=267516&MainKind=A&NewsKind=5&vCount=12&vKind=1
8986,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.youthdaily.co.kr/news/article.html?no=54329
8987,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.pharmnews.com/news/articleView.html?idxno=101780
8988,2020-11-27,LG화학예금보험公대웅제약한샘유한킴벌리등대학생대졸인턴모집,https://www.news1.kr/articles/?4132248
8989,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.kpinews.co.kr/news/articleView.html?idxno=131747
8990,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.healthinnews.co.kr/news/articleView.html?idxno=20394
8991,2020-11-27,대웅제약우루사노라조온라인바이럴영상∙틱톡챌린지공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251899
8992,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.bosa.co.kr/news/articleView.html?idxno=2138950
8993,2020-11-27,대웅제약간때문이야로MZ세대사로잡는다,http://www.newsis.com/view/?id=NISX20201127_0001249688&cID=13001&pID=13000
8994,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개간때문이야로MZ세대사로잡는다”,http://newsbrite.net/144059
8995,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개가수노라조와협업,http://www.pinpointnews.co.kr/view.php?ud=2020112710475381232365609d9b_45
8996,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.lcnews.co.kr/news/articleView.html?idxno=10252
8997,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011271102164110154
8998,2020-11-27,간때문이야대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://theviewers.co.kr/View.aspx?No=1360053
8999,2020-11-27,대웅제약간때문이야MZ세대사로잡는다,https://www.econovill.com/news/articleView.html?idxno=507358
9000,2020-11-27,영상대웅제약간때문이야로MZ세대사로잡는다,http://www.segye.com/content/html/2020/11/27/20201127509369.html?OutUrl=naver
9001,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개간때문이야로MZ세대사로잡는다,http://www.worktoday.co.kr/news/articleView.html?idxno=11824
9002,2020-11-27,뉴스투데이L대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.news2day.co.kr/article/20201127500160
9003,2020-11-27,대웅제약우루사온라인바이럴영상공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065579036817744
9004,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=407204
9005,2020-11-27,대웅제약나보타중국시장진출가시화글로벌영역확장,http://www.lawissue.co.kr/view.php?ud=202011271247137773204ead0791_12
9006,2020-11-27,대웅제약우루사간때문이야댄스챌린지통해MZ세대공략한다,https://www.asiatoday.co.kr/view.php?key=20201127010017963
9007,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개간때문이야로MZ세대사로잡는다,http://www.nbnnews.co.kr/news/articleView.html?idxno=444933
9008,2020-11-27,시경Today건강대웅제약나보타중국시장진출가시화外,http://www.meconomynews.com/news/articleView.html?idxno=47860
9009,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.newsworker.co.kr/news/articleView.html?idxno=93593
9010,2020-11-27,속도강조하는대웅제약호이스타정임상모집선두맞나,http://www.thevaluenews.co.kr/news/view.php?idx=161650
9011,2020-11-27,대웅제약우루사바이럴영상틱톡챌린지공개,https://www.ebn.co.kr/news/view/1461298/?sc=Naver
9012,2020-11-27,대웅제약우루사온라인바이럴영상공개,https://jhealthmedia.joins.com/article/article_view.asp?pno=22765
9013,2020-11-27,MZ세대사로잡는다대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.updownnews.co.kr/news/articleView.html?idxno=225731
9014,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.metroseoul.co.kr/article/20201127500105
9015,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.pressm.kr/news/articleView.html?idxno=34841
9016,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.thefirstmedia.net/news/articleView.html?idxno=66838
9017,2020-11-27,대웅제약간때문이야댄스챌린지틱톡서진행,http://www.100ssd.co.kr/news/articleView.html?idxno=73057
9018,2020-11-27,대웅제약우루사바이럴영상∙틱톡챌린지공개,http://www.thedailypost.kr/news/articleView.html?idxno=77769
9019,2020-11-28,대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.kpanews.co.kr/article/show.asp?idx=218068&category=D
9020,2020-11-28,대웅제약틱톡서간때문이야댄스챌린지진행MZ세대공략,http://www.updownnews.co.kr/news/articleView.html?idxno=225746
9021,2020-11-29,SK이노베이션대웅제약워라밸기업으로우뚝뭐가달랐나,http://www.segyebiz.com/newsView/20201129509408?OutUrl=naver
9022,2020-11-29,대웅제약나보타임상시험서남성형탈모치료효과입증,http://www.sportsseoul.com/news/read/985905?ref=naver
9023,2020-11-29,대웅제약가수노라조와우루사영상제작,http://www.dailymedi.com/detail.php?number=863321&thread=22r05
9024,2020-11-30,GC녹십자가동률645대제약사중꼴찌대웅제약종근당은110대,http://www.consumernews.co.kr/news/articleView.html?idxno=616333
9025,2020-11-30,대웅제약OTC비만약위드풀공동판매계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=271034&REFERER=NP
9026,2020-11-30,대웅제약12월16일ICT결론이나오면불확실성해소가될듯”,https://www.news2day.co.kr/article/20201130500220
9027,2020-11-30,대웅제약새살연고후시딘마데카솔틈바구니속5년간매출13배증가비결은,http://www.ajunews.com/view/20201130152839996
9028,2020-11-30,인터뷰전승호대웅제약대표ITC최종승소확신끝까지싸워진실밝힐것,http://www.wolyo.co.kr/news/articleView.html?idxno=112555
9029,2020-11-30,대웅제약ITC소송장기화에재정악화순이익률1대PER은363배,http://www.thevaluenews.co.kr/news/view.php?idx=161675
9030,2020-11-30,대웅제약체중감량보조제위드풀공동판매계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=407448
9031,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.fnnews.com/news/202012010947347211
9032,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.fetv.co.kr/news/article.html?no=69986
9033,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.sentv.co.kr/news/view/583870
9034,2020-12-01,대웅제약코로나치료제정부임상지원과제로최종선정,http://news.mt.co.kr/mtview.php?no=2020120109513899338
9035,2020-12-01,대웅제약코로나19올인원치료제DWRX2003정부과제선정,http://www.mhj21.com/137248
9036,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.thebigdata.co.kr/view.php?ud=202012010956092380798818e98b_23
9037,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64902
9038,2020-12-01,대웅제약코로나19치료제정부과제선정내년출시예정,https://www.ekn.kr/web/view.php?key=20201201010000087
9039,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120109493917447
9040,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46446
9041,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46446
9042,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=36606
9043,2020-12-01,대웅제약코로나치료제DWRX2003정부과제선정,https://view.asiae.co.kr/article/2020120110035548543
9044,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정돼”,http://www.youthdaily.co.kr/news/article.html?no=54621
9045,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.hankyung.com/it/article/202012019304i
9046,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.m-i.kr/news/articleView.html?idxno=770821
9047,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=55991
9048,2020-12-01,대웅제약코로나19치료제DWRX2003정부지원과제로선정,http://www.pinpointnews.co.kr/view.php?ud=2020120110031445392365609d9b_45
9049,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020120110015724275
9050,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574635413876
9051,2020-12-01,대웅제약코로나19치료제정부임상지원과제로선정,http://inthenews.co.kr/article-79932/
9052,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.lawissue.co.kr/view.php?ud=202012011012101966204ead0791_12
9053,2020-12-01,특징주대웅대웅제약코로나치료제정부과제선정소식에20급등,https://www.sedaily.com/NewsView/1ZBIJEP6YA
9054,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정내년출시목표,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124104
9055,2020-12-01,대웅제약코로나치료제정부임상지원받아합성의약품중유일,http://moneys.mt.co.kr/news/mwView.php?no=2020120110148068480
9056,2020-12-01,대웅제약코로나19치료제정부과제선정,http://it.chosun.com/site/data/html_dir/2020/12/01/2020120100877.html
9057,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.edaily.co.kr/news/newspath.asp?newsid=02273046625994256
9058,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://daily.hankooki.com/lpage/industry/202012/dh20201201101604148390.htm?s_ref=nv
9059,2020-12-01,특징주대웅제약코로나19치료제정부임상지원사업과제선정에상승세,https://www.etoday.co.kr/news/view/1968740
9060,2020-12-01,대웅제약올인원코로나치료제니클로마사이드정부과제선정,http://www.opinionnews.co.kr/news/articleView.html?idxno=43554
9061,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.newsfc.co.kr/news/articleView.html?idxno=43757
9062,2020-12-01,대웅제약코로나19치료제정부과제선정내년조건부허가추진,https://www.etoday.co.kr/news/view/1968744
9063,2020-12-01,대웅제약니클로사마이드코로나치료제로정부임상지원과제선정,http://www.medisobizanews.com/news/articleView.html?idxno=74597
9064,2020-12-01,대웅제약니클로사마이드코로나19정부과제선정,http://www.biospectator.com/view/news_view.php?varAtcId=11926
9065,2020-12-01,대웅제약코로나19DWRX2003정부과제선정,http://www.wikileaks-kr.org/news/articleView.html?idxno=99478
9066,2020-12-01,특징주대웅제약대웅주가정부코로나치료제임상지원사업선정에가파른상승세,http://www.ccreview.co.kr/news/articleView.html?idxno=296802
9067,2020-12-01,대웅제약코로나19치료제정부과제선정임상50억지원,http://www.ajunews.com/view/20201201102527464
9068,2020-12-01,특징주대웅제약코로나치료제정부임상지원에껑충,http://moneys.mt.co.kr/news/mwView.php?no=2020120110378066978
9069,2020-12-01,대웅제약의DWRX2003코로나19치료제정부과제선정,http://www.monews.co.kr/news/articleView.html?idxno=215962
9070,2020-12-01,대웅제약코로나19치료제정부과제최종선정합성의약품유일,http://www.sisafocus.co.kr/news/articleView.html?idxno=251469
9071,2020-12-01,대웅제약코로나19치료제임상청신호DWRX2003정부과제선정,http://www.viva100.com/main/view.php?key=20201201010000110
9072,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.kpinews.co.kr/news/articleView.html?idxno=131945
9073,2020-12-01,특징주대웅제약코로나19치료제정부임상지원사업과제선정에급등,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004193532
9074,2020-12-01,대웅제약코로나19 치료제정부과제최종선정합성의약품중유일,http://www.greened.kr/news/articleView.html?idxno=278007
9075,2020-12-01,대웅제약코로나19치료제니클로사마이드정부과제선정,http://www.newsprime.co.kr/news/article.html?no=525917
9076,2020-12-01,대웅제약코로나치료제정부과제선정,https://www.ebn.co.kr/news/view/1461778/?sc=Naver
9077,2020-12-01,1일장중코로나주종근당바이오대웅제약파미셀급등,http://www.choicenews.co.kr/news/articleView.html?idxno=76872
9078,2020-12-01,대웅제약코로나19치료제정부과제선정50억원지원,https://health.chosun.com/site/data/html_dir/2020/12/01/2020120101013.html
9079,2020-12-01,특징주대웅제약코로나치료제정부과제선정소식에급등,https://www.ebn.co.kr/news/view/1461779/?sc=Naver
9080,2020-12-01,국내및글로벌임상시험50억원지원대웅제약코로나19치료제DWRX2003정부과제선정,http://www.betanews.net:8080/article/1243157.html
9081,2020-12-01,대웅제약신풍제약오전갑작스런급등대웅제약11급등이어신풍제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=146910
9082,2020-12-01,대웅제약개발중코로나19치료제정부과제선정,http://yna.kr/AKR20201201080700017?did=1195m
9083,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.seoulwire.com/news/articleView.html?idxno=430849
9084,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://kormedi.com/?p=1328374
9085,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.asiaa.co.kr/news/articleView.html?idxno=9235
9086,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://newsbrite.net/144215
9087,2020-12-01,대웅제약개발중코로나19치료제정부과제선정,http://www.startuptoday.co.kr/news/articleView.html?idxno=62714
9088,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=407509
9089,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.thepublic.kr/news/newsview.php?ncode=1065577458348898
9090,2020-12-01,대웅제약나보타글로벌보툴리눔톡신치료시장진출가속,http://www.koreaittimes.com/news/articleView.html?idxno=102160
9091,2020-12-01,특징주대웅대웅제약코로나치료제임상지원에훨훨,http://moneys.mt.co.kr/news/mwView.php?no=2020120111178028439
9092,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://medipana.com/news/news_viewer.asp?NewsNum=267697&MainKind=A&NewsKind=5&vCount=12&vKind=1
9093,2020-12-01,대웅제약코로나치료제로개발중인DWRX2003정부임상지원사업과제로최종선정,http://www.segye.com/content/html/2020/12/01/20201201511291.html?OutUrl=naver
9094,2020-12-01,대웅제약메디톡스보톡스전쟁진행형도용이슈도마위,http://www.enewstoday.co.kr/news/articleView.html?idxno=1432307
9095,2020-12-01,대웅제약대웅주가초반뛰어코로나19치료제개발에정부지원받아,http://www.businesspost.co.kr/BP?command=article_view&num=206734
9096,2020-12-01,대웅제약코로나19치료제정부과제선정50억원지원,http://www.insightkorea.co.kr/news/articleView.html?idxno=84998
9097,2020-12-01,대웅제약코로나치료제정부과제선정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137412&REFERER=NP
9098,2020-12-01,대웅제약코로나19치료제정부임상지원대상선정,https://biz.chosun.com/site/data/html_dir/2020/12/01/2020120101199.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9099,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2139169
9100,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.newsworker.co.kr/news/articleView.html?idxno=93906
9101,2020-12-01,대웅제약등국내제약사코로나19치료제개발잰걸음,http://newsclaim.co.kr/View.aspx?No=1363923
9102,2020-12-01,대웅제약코로나19치료제임상예산50억지원받아,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005179
9103,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=20478
9104,2020-12-01,대웅제약코로나19치료제니클로사마이드정부과제선정,http://www.seoulfn.com/news/articleView.html?idxno=402833
9105,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정50억지원,http://www.medigatenews.com/news/2605800247
9106,2020-12-01,대웅제약코로나19치료제정부과제선정50억지원,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4357828
9107,2020-12-01,대웅제약코로나19 올인원치료제 니클로사마이드DWRX2003정부과제선정,http://www.lcnews.co.kr/news/articleView.html?idxno=10371
9108,2020-12-01,대웅제약대웅오전부터갑작스런급등대웅제약13급등이어대웅23급등,http://www.econonews.co.kr/news/articleView.html?idxno=146951
9109,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.dailian.co.kr/news/view/941829/?sc=Naver
9110,2020-12-01,대웅제약코로나19치료제정부과제선정50억원지원,http://news.tf.co.kr/read/economy/1828234.htm
9111,2020-12-01,코로나19백신치료제제품출시코앞모더나대웅제약의현상황은,http://weekly.hankooki.com/lpage/economy/202012/wk20201201134915146380.htm?s_ref=nv
9112,2020-12-01,대웅제약코로나19치료후보물질DWRX2003정부과제선정,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012010265&t=NN
9113,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.segyebiz.com/newsView/20201201514507?OutUrl=naver
9114,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제로선정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012011121564690798
9115,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.metroseoul.co.kr/article/20201201500332
9116,2020-12-01,대웅제약올인원코로나19치료제정부로부터가치인정임상지원과제최종선정,https://www.donga.com/news/article/all/20201201/104232245/1
9117,2020-12-01,신풍제약대웅제약제약주내내급등이어져특히신풍제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=146961
9118,2020-12-01,대웅제약코로나19치료제정부과제선정50억지원,http://www.newsis.com/view/?id=NISX20201201_0001253921&cID=13001&pID=13000
9119,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.whitepaper.co.kr/news/articleView.html?idxno=199323
9120,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.news2day.co.kr/article/20201201500186
9121,2020-12-01,대웅제약지사제스멕타제네릭스타빅품목허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=407557
9122,2020-12-01,대웅제약코로나19치료후보물질로정부의임상지원대상에뽑혀,http://www.businesspost.co.kr/BP?command=article_view&num=206765
9123,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=445879
9124,2020-12-01,대웅제약코로나치료제정부임상지원대상선정,https://www.sedaily.com/NewsView/1ZBIK0I3C5
9125,2020-12-01,대웅제약코로나19치료제정부과제선정,http://www.mediapen.com/news/view/579499
9126,2020-12-01,대웅제약코로나19치료제정부과제로선정50억원지원,http://www.thedailypost.kr/news/articleView.html?idxno=77834
9127,2020-12-01,대웅제약코로나19치료제DWRX2003정부임상과제선정,http://www.newslock.co.kr/news/articleView.html?idxno=33560
9128,2020-12-01,의약오늘GC녹십자코로나19혈장치료제3차추가생산완료대웅제약코로나19치료제DWRX2003정부과제선정,http://www.sisaon.co.kr/news/articleView.html?idxno=121103
9129,2020-12-01,대웅제약코로나19치료제정부임상지원사업과제로선정50억지원,http://www.newsworks.co.kr/news/articleView.html?idxno=508108
9130,2020-12-01,코로나19올인원치료제대웅제약DWRX2003정부과제선정,http://theviewers.co.kr/View.aspx?No=1364477
9131,2020-12-01,이데일리N대웅제약개발중코로나19치료제정부과제선정外,http://www.edaily.co.kr/news/newspath.asp?newsid=03706406625994256
9132,2020-12-01,대웅제약의코로나19치료후보DWRX2003프로젝트정부과제선정돼,http://news.mk.co.kr/newsRead.php?no=1235666&year=2020
9133,2020-12-01,대웅제약코로나19치료제정부과제선정에날개,http://www.sporbiz.co.kr/news/articleView.html?idxno=503183
9134,2020-12-01,대웅제약코로나19치료제임상지원대상정부과제선정,http://sports.hankooki.com/lpage/economy/202012/sp20201201154713137020.htm?s_ref=nv
9135,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.skyedaily.com/news/news_view.html?ID=117017
9136,2020-12-01,대웅제약코로나19치료제개발에정부지원받는다,http://www.finomy.com/news/articleView.html?idxno=86068
9137,2020-12-01,대웅제약니클로사마이드코로나19치료제정부과제선정,http://www.newstomato.com/ReadNews.aspx?no=1010205
9138,2020-12-01,1일오늘의상한가총정리경보제약대웅제약신풍제약등제약주급등문배철강KG동부제철도상한가,http://www.ccreview.co.kr/news/articleView.html?idxno=296851
9139,2020-12-01,대웅제약코로나19치료제정부로부터50억원지원받는다,http://www.doctorstimes.com/news/articleView.html?idxno=213257
9140,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.econovill.com/news/articleView.html?idxno=507951
9141,2020-12-01,대웅제약코로나19치료제정부임상지원사업선정,http://www.100ssd.co.kr/news/articleView.html?idxno=73110
9142,2020-12-01,대웅제약ITC판결앞두고코로나치료제호재에활짝상승세이어질까,http://www.opinionnews.co.kr/news/articleView.html?idxno=43585
9143,2020-12-01,대웅제약코로나19치료제정부지원사업대상선정임상비용중50억지원,http://www.kdpress.co.kr/news/articleView.html?idxno=99057
9144,2020-12-01,대웅제약코로나19치료제정부임상지원사업대상선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1432665
9145,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제로선정,http://news.kbiz.or.kr/news/articleView.html?idxno=75266
9146,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.thefirstmedia.net/news/articleView.html?idxno=66997
9147,2020-12-02,대웅제약코로나19치료제DWRX2003정부과제뽑혀,https://www.kpanews.co.kr/article/show.asp?idx=218155&category=D
9148,2020-12-02,대웅제약코로나19치료제DWRX2003정부과제뽑혀,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137192
9149,2020-12-02,대웅제약코로나19치료제DWRX2003정부과제선정임상비용50억지원,http://www.paxetv.com/news/articleView.html?idxno=105536
9150,2020-12-02,대웅제약코로나19치료제정부과제선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1349580
9151,2020-12-02,대웅제약DWRX2003올인원코로나19치료제기대감↑정부과제로선정,http://kbench.com/?q=node/216400
9152,2020-12-02,2일장중코로나주신풍제약껑충vs대웅제약파미셀하락,http://www.choicenews.co.kr/news/articleView.html?idxno=76925
9153,2020-12-02,대웅제약나보타허가변경가능할까,https://www.ebn.co.kr/news/view/1462063/?sc=Naver
9154,2020-12-02,美ITC판결결과전승호대웅제약대표거취에영향줄까,http://www.sisajournal-e.com/news/articleView.html?idxno=226530
9155,2020-12-03,대웅제약벨카이라특허남은1건도회피성공,http://www.dailypharm.com/Users/News/NewsView.html?ID=271155&REFERER=NP
9156,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=20541
9157,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120312052363520
9158,2020-12-03,대웅제약펜믹스벨카이라마지막특허까지올클리어,http://medipana.com/news/news_viewer.asp?NewsNum=267844&MainKind=A&NewsKind=5&vCount=12&vKind=1
9159,2020-12-03,대웅제약코로나치료제효과학인국내2상신청,https://www.ebn.co.kr/news/view/1462266/?sc=Naver
9160,2020-12-03,대웅제약코로나19치료제효과입증국내2상신청,https://www.kpanews.co.kr/article/show.asp?idx=218216&category=D
9161,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.lawissue.co.kr/view.php?ud=202012031216172299204ead0791_12
9162,2020-12-03,대웅제약코로나치료제국내임상2상신청신속효과확인,https://www.fetv.co.kr/news/article.html?no=70278
9163,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://medipana.com/news/news_viewer.asp?NewsNum=267854&MainKind=A&NewsKind=5&vCount=12&vKind=1
9164,2020-12-03,대웅제약코로나19치료제임상2상신청연내환자200명임상계획,https://biz.chosun.com/site/data/html_dir/2020/12/03/2020120301443.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9165,2020-12-03,대웅제약코로나치료제2상승인신청초기폐손상억제효과,http://www.medisobizanews.com/news/articleView.html?idxno=74678
9166,2020-12-03,대웅제약식약처에코로나치료제임상2상IND신청,http://news.mt.co.kr/mtview.php?no=2020120312332819510
9167,2020-12-03,대웅제약코로나치료제신속한효과확인2상신청,http://www.newsis.com/view/?id=NISX20201203_0001256970&cID=13001&pID=13000
9168,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청신속한효과확인,http://www.thebigdata.co.kr/view.php?ud=202012031243249237798818e98b_23
9169,2020-12-03,대웅제약코로나19치료제임상2상신청신속한효과확인”,http://www.viva100.com/main/view.php?key=20201203010000862
9170,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.bosa.co.kr/news/articleView.html?idxno=2139371
9171,2020-12-03,대웅제약코로나치료제국내임상2상신청및신속한효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=407788
9172,2020-12-03,대웅제약코로나19치료제신속한효능확인임상2상신청,https://www.sedaily.com/NewsView/1ZBJHC3I52
9173,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.newsworker.co.kr/news/articleView.html?idxno=94251
9174,2020-12-03,대웅제약코로나19치료제임상2상신청,http://www.sentv.co.kr/news/view/584070
9175,2020-12-03,대웅제약코로나19치료제DWRX2003신속한효과확인임상2상신청,http://www.ezyeconomy.com/news/articleView.html?idxno=107660
9176,2020-12-03,대웅제약코로나19치료제국내임상2상신청신속효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252160
9177,2020-12-03,대웅제약코로나19치료제국내임상2상신청신속한효과확인,http://www.m-i.kr/news/articleView.html?idxno=772010
9178,2020-12-03,대웅제약코로나19치료제니클로사마이드국내임상2상신청,http://it.chosun.com/site/data/html_dir/2020/12/03/2020120301608.html
9179,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.newstomato.com/ReadNews.aspx?no=1010678
9180,2020-12-03,대웅제약코로나치료제항바이러스효과확인식약처임상2상신청,http://moneys.mt.co.kr/news/mwView.php?no=2020120313338024117
9181,2020-12-03,대웅제약니클로사마이드임상2상신청항바이러스항염증효과입증,http://www.newsprime.co.kr/news/article.html?no=526293
9182,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://yna.kr/AKR20201203102600017?did=1195m
9183,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://yna.kr/PYH20201203177200017?did=1196m
9184,2020-12-03,대웅제약코로나19치료제햄스터효능시험서효과확인임상2상신청,https://www.asiatoday.co.kr/view.php?key=20201203010002480
9185,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://yna.kr/PYH20201203177000017?did=1196m
9186,2020-12-03,대웅제약코로나19치료제국내임상2상신청연내200명대상진행,https://www.dailian.co.kr/news/view/942686/?sc=Naver
9187,2020-12-03,美국립보건원이주목하는구충제”대웅제약햄스터시험서빠르고강력한코로나19치료효과입증,https://www.donga.com/news/article/all/20201203/104272227/1
9188,2020-12-03,대웅제약코로나19치료제임상2상신청실험효과,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012030247&t=NN
9189,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청생존율개선가능성확인,http://www.newsworks.co.kr/news/articleView.html?idxno=508799
9190,2020-12-03,대웅제약코로나19햄스터모델서DWRX2003효과확인,http://www.press9.kr/news/articleView.html?idxno=46476
9191,2020-12-03,대웅제약코로나19치료제니클로사마이드국내2상신청,https://www.hankyung.com/it/article/202012039575i
9192,2020-12-03,대웅제약DWRX2003코로나19치료제임상2상신청,http://www.medigatenews.com/news/1606128493
9193,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=446672
9194,2020-12-03,대웅제약코로나19치료제니클로사마이드임상2상신청,http://www.seoulfn.com/news/articleView.html?idxno=403165
9195,2020-12-03,대웅제약코로나19치료제DWRX2003효과확인국내2상신청”,http://www.youthdaily.co.kr/news/article.html?no=54880
9196,2020-12-03,대웅제약개발코로나치료제항바이러스항염증효과입증식약처임상2상시험계획신청,http://kpenews.com/View.aspx?No=1367566
9197,2020-12-03,대웅제약코로나치료제항바이러스효능확인임상2상신청,https://www.ekn.kr/web/view.php?key=20201203010000937
9198,2020-12-03,대웅제약코로나19치료제니클로사마이드2상신청,http://www.dailypharm.com/Users/News/NewsView.html?ID=271169&REFERER=NP
9199,2020-12-03,대웅제약개발중인코로나19치료제효과확인2상신청,http://daily.hankooki.com/lpage/industry/202012/dh20201203142212148390.htm?s_ref=nv
9200,2020-12-03,대웅제약코로나19치료제국내임상2상신청햄스터서효과확인,http://www.kpinews.co.kr/news/articleView.html?idxno=132162
9201,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청완료,https://www.news2day.co.kr/article/20201203500180
9202,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124212
9203,2020-12-03,대웅제약코로나치료제치료효과확인임상2상신청,http://www.newspim.com/news/view/20201203000927
9204,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://www.dailysmart.co.kr/news/articleView.html?idxno=36795
9205,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청 ,http://www.pressm.kr/news/articleView.html?idxno=34998
9206,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.edaily.co.kr/news/newspath.asp?newsid=03453846625994912
9207,2020-12-03,대웅제약코로나치료제치료효과확인임상2상신청,http://www.newsway.co.kr/news/view?tp=1&ud=2020120314511022302
9208,2020-12-03,대웅제약니클로사마이드국내코로나치료임상2상신청,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012030215&t=NN
9209,2020-12-03,대웅제약코로나치료제 국내임상2상신청,http://www.koreastocknews.com/news/articleView.html?idxno=59510
9210,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://www.dt.co.kr/contents.html?article_no=2020120302109931102002&ref=naver
9211,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://www.metroseoul.co.kr/article/20201203500373
9212,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청항바이러스효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=33660
9213,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4360683
9214,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및효과확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64983
9215,2020-12-03,대웅제약코로나19치료제임상2상신청효과확인,http://www.getnews.co.kr/news/articleView.html?idxno=502955
9216,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청,https://www.etoday.co.kr/news/view/1969949
9217,2020-12-03,대웅제약코로나19치료제신속한효과확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=56177
9218,2020-12-03,대웅제약코로나19치료제니클로사마이드국내2상신청항바이러스효과확인,http://kbench.com/?q=node/216464
9219,2020-12-03,대웅제약코로나19치료제국내임상2상신청신속한효과확인,https://www.econovill.com/news/articleView.html?idxno=508343
9220,2020-12-03,대웅제약코로나19치료제DWRX2003효과확인국내임상2상신청,https://www.news1.kr/articles/?4138874
9221,2020-12-03,대웅제약코로나19치료제국내임상2상신청및신속효과확인,http://www.koreaittimes.com/news/articleView.html?idxno=102227
9222,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.mediapen.com/news/view/580334
9223,2020-12-03,대웅제약햄스터효력시험확인코로나치료제임상2상신청서제출,http://isplus.live.joins.com/news/article/article.asp?total_id=23936720
9224,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청항바이러스효과입증,https://health.chosun.com/site/data/html_dir/2020/12/03/2020120302253.html
9225,2020-12-03,코로나치료제속도붙나대웅제약국내임상2상신청,http://newsclaim.co.kr/View.aspx?No=1367830
9226,2020-12-03,대웅제약코로나19치료제햄스터효력시험통해신속한항바이러스및항염증효과입증,http://www.paxetv.com/news/articleView.html?idxno=105697
9227,2020-12-03,대웅제약코로나19치료제임상2상신청,http://www.shinailbo.co.kr/news/articleView.html?idxno=1350518
9228,2020-12-03,대웅제약코로나치료제항바이러스항염증효과입증,http://www.wolyo.co.kr/news/articleView.html?idxno=112747
9229,2020-12-03,대웅제약식약처에코로나19치료제임상2상신청,http://www.finomy.com/news/articleView.html?idxno=86199
9230,2020-12-03,대웅제약코로나치료제식약처임상2상IND신청완료,http://www.monews.co.kr/news/articleView.html?idxno=216068
9231,2020-12-03,햄스터효력시험통과대웅제약코로나19치료제후보DWRX2003효과확인,http://theviewers.co.kr/View.aspx?No=1367862
9232,2020-12-03,햄스터실험에서효과확인대웅제약코로나19치료제국내임상2상신청,http://www.betanews.net:8080/article/1243781.html
9233,2020-12-03,대웅제약코로나치료제로개발중인DWRX2003효과입증임상2상준비,http://www.segye.com/content/html/2020/12/03/20201203521382.html?OutUrl=naver
9234,2020-12-03,대웅제약코로나치료제니클로사마이드효능확인임상2상신청,http://www.sporbiz.co.kr/news/articleView.html?idxno=503429
9235,2020-12-03,김창수의e뉴스브리핑대웅제약코로나치료제국내임상2상신청신속효과확인外,https://www.fetv.co.kr/news/article.html?no=70325
9236,2020-12-03,시경Today제약대웅제약코로나치료제DWRX2003국내임상2상신청완료外,http://www.meconomynews.com/news/articleView.html?idxno=48046
9237,2020-12-03,대웅제약코로나19치료제국내임상2상신청,https://www.asiatime.co.kr/news/newsview.php?ncode=1065600394064438
9238,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.joseilbo.com/news/news_read.php?uid=411804&class=27&grp=
9239,2020-12-03,금일제약업계주요기사英화이자코로나19백신세계첫사용승인대웅제약코로나19치료제국내2상신청”外,http://www.youthdaily.co.kr/news/article.html?no=54899
9240,2020-12-03,코로나19백신보다치료제먼저셀트리온종근당대웅제약1호치료제경쟁,http://www.insightkorea.co.kr/news/articleView.html?idxno=85108
9241,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://newsbrite.net/144356
9242,2020-12-03,대웅제약코로나19치료제니클로사마이드효과입증,http://www.100ssd.co.kr/news/articleView.html?idxno=73168
9243,2020-12-03,대웅제약코로나19치료제DWRX2003임상개발성공가능성매우높아급성폐손상에효과적,http://www.lcnews.co.kr/news/articleView.html?idxno=10480
9244,2020-12-03,대웅제약코로나19치료제임상2상신청,http://www.cstimes.com/news/articleView.html?idxno=441552
9245,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청신속한효과확인,http://news.kbiz.or.kr/news/articleView.html?idxno=75327
9246,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.thefirstmedia.net/news/articleView.html?idxno=67148
9247,2020-12-04,대웅제약코로나19치료제DWRX2003국내2상임상신청완료,http://www.g-enews.com/ko-kr/news/article/news_all/20201203165819479469d76442fa_1/article.html
9248,2020-12-04,셀트리온GC녹십자이어대웅제약종근당속도,http://www.dailymedi.com/detail.php?number=863614&thread=22r05
9249,2020-12-04,대웅제약3전3승벨카이라국내후발약시장열리나,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005384
9250,2020-12-04,대웅제약펜믹스벨카이라특허장벽모두깼다,http://www.mdtoday.co.kr/mdtoday/index.html?no=407869
9251,2020-12-04,대웅제약코로나19치료제임상2상신청햄스터실험서효과”,http://www.munhwa.com/news/view.html?no=20201204MW085315313704
9252,2020-12-04,대웅제약경보제약오전부터갑작스런급등대웅제약7급등이어경보제약10급등,http://www.econonews.co.kr/news/articleView.html?idxno=147398
9253,2020-12-04,대웅제약경보제약급등코로나치료제영향,http://www.ajunews.com/view/20201204095410580
9254,2020-12-04,4일장중코로나주셀트리온대웅제약껑충vs제일약품하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77035
9255,2020-12-04,백왕기vs윤재승대웅제약50억손배청구소송17일판결선고불투명,http://www.sisajournal-e.com/news/articleView.html?idxno=226618
9256,2020-12-04,보톡스원조시장은알고있다대웅제약오르는데휴젤뒷걸음,http://news.mk.co.kr/newsRead.php?no=1250177&year=2020
9257,2020-12-06,유한양행대웅제약공동개발약물내년결실대형제약사협업물꼬,https://biz.chosun.com/site/data/html_dir/2020/12/05/2020120501096.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9258,2020-12-06,유한양행대웅제약협업성과내년위궤양신약출시,http://biz.newdaily.co.kr/site/data/html/2020/12/06/2020120600034.html
9259,2020-12-07,대웅제약과참지마요프로젝트대학생교육봉사단3기모집,http://www.metroseoul.co.kr/article/20201207500029
9260,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.medisobizanews.com/news/articleView.html?idxno=74725
9261,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252236
9262,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://medipana.com/news/news_viewer.asp?NewsNum=267951&MainKind=A&NewsKind=5&vCount=12&vKind=1
9263,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.viva100.com/main/view.php?key=20201207010001463
9264,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.youthdaily.co.kr/news/article.html?no=55132
9265,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.press9.kr/news/articleView.html?idxno=46490
9266,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.m-i.kr/news/articleView.html?idxno=772870
9267,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.pharmnews.com/news/articleView.html?idxno=101843
9268,2020-12-07,대웅제약발달장애인돕는참지마요프로젝트3기모집,http://www.asiaa.co.kr/news/articleView.html?idxno=10385
9269,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573055825663
9270,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65017
9271,2020-12-07,대웅제약발달장애인과함께하는참지마요프로젝트대학생교육봉사단3기모집,http://www.pinpointnews.co.kr/view.php?ud=2020120710095883992365609d9b_45
9272,2020-12-07,발달장애인과아름다운동행대웅제약참지마요프로젝트대학생교육봉사단모집,http://kpenews.com/View.aspx?No=1370363
9273,2020-12-07,대웅제약과발달장애인이함께하는아름다운동행참지마요프로젝트대학생교육봉사단3기모집,http://newsbrite.net/144446
9274,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.healthinnews.co.kr/news/articleView.html?idxno=20584
9275,2020-12-07,대웅제약과참지마요프로젝트대학생교육봉사단3기모집,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012071026515760931
9276,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.newsprime.co.kr/news/article.html?no=526567
9277,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.bosa.co.kr/news/articleView.html?idxno=2139515
9278,2020-12-07,대웅제약발달장애인과동행하는대학생교육봉사단모집,http://www.economytalk.kr/news/articleView.html?idxno=209762
9279,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.newsway.co.kr/news/view?tp=1&ud=2020120710450355440
9280,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.enewstoday.co.kr/news/articleView.html?idxno=1433817
9281,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.mhj21.com/137480
9282,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.businesskorea.co.kr/news/articleView.html?idxno=56298
9283,2020-12-07,대웅제약참지마요프로젝트대학생봉사단3기모집,http://www.kpinews.co.kr/news/articleView.html?idxno=132334
9284,2020-12-07,대웅제약발달장애인위한동행프로젝트재시동,http://www.monews.co.kr/news/articleView.html?idxno=216155
9285,2020-12-07,대웅제약과발달장애인의아름다운동행참지마요프로젝트대학생교육봉사단3기모집,http://www.thepublic.kr/news/newsview.php?ncode=1065576252133133
9286,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=408085
9287,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://inthenews.co.kr/article-81025/
9288,2020-12-07,유한양행대웅제약공동개발위궤양치료신약내년2분기출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=408087
9289,2020-12-07,대웅제약참지마요프로젝트대학생봉사단3기모집,https://www.econovill.com/news/articleView.html?idxno=508791
9290,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.dailysmart.co.kr/news/articleView.html?idxno=36917
9291,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.wsobi.com/news/articleView.html?idxno=109734
9292,2020-12-07,봉사단100명모집대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://theviewers.co.kr/View.aspx?No=1370904
9293,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집발달장애인감염병학습지원,http://www.lcnews.co.kr/news/articleView.html?idxno=10582
9294,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.nbnnews.co.kr/news/articleView.html?idxno=447494
9295,2020-12-07,시경Today제약대웅제약참지마요프로젝트대학생교육봉사단3기모집外,http://www.meconomynews.com/news/articleView.html?idxno=48142
9296,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.thedailypost.kr/news/articleView.html?idxno=77946
9297,2020-12-07,대웅제약발달장애인과의아름다운동행참지마요프로젝트3기대학생봉사단모집,http://www.thebigdata.co.kr/view.php?ud=202012071552225448d0a8833aad_23
9298,2020-12-07,대웅제약과발달장애인이함께하는참지마요프로젝트,http://www.pressm.kr/news/articleView.html?idxno=35069
9299,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.segyebiz.com/newsView/20201207517910?OutUrl=naver
9300,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집발달장애인이함께하는아름다운동행,http://www.thefirstmedia.net/news/articleView.html?idxno=67244
9301,2020-12-07,뉴스투데이L대웅제약참지마요프로젝트대학생교육봉사단3기모집,https://www.news2day.co.kr/article/20201207500256
9302,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.100ssd.co.kr/news/articleView.html?idxno=73251
9303,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.lawissue.co.kr/view.php?ud=202012071739153117204ead0791_12
9304,2020-12-07,대웅제약참지마요프로젝트교육봉사단모집,http://www.dailymedi.com/detail.php?number=863731&thread=22r05
9305,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,https://www.kpanews.co.kr/article/show.asp?idx=218303&category=D
9306,2020-12-07,종근당GC녹십자대웅제약코로나19치료제개발현황공개,http://www.newsfreezone.co.kr/news/articleView.html?idxno=280065
9307,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.sentv.co.kr/news/view/584309
9308,2020-12-08,비염치료제라인업강화대웅제약코메키나나잘스프레이출시,http://kpenews.com/View.aspx?No=1371884
9309,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시제형다양화,http://www.medisobizanews.com/news/articleView.html?idxno=74768
9310,2020-12-08,대웅제약코메키나나잘스프레이출시비염치료제라인업확장,https://health.chosun.com/site/data/html_dir/2020/12/08/2020120800818.html
9311,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.fnnews.com/news/202012080933437426
9312,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.press9.kr/news/articleView.html?idxno=46508
9313,2020-12-08,대웅제약코에뿌리는코메키나출시비염치료제강화,http://www.newsis.com/view/?id=NISX20201208_0001261726&cID=13001&pID=13000
9314,2020-12-08,대웅제약코메키나나잘스프레이출시라인업강화나서,http://medipana.com/news/news_viewer.asp?NewsNum=268026&MainKind=A&NewsKind=5&vCount=12&vKind=1
9315,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.mediapen.com/news/view/581386
9316,2020-12-08,대웅제약 코에뿌리는비염치료제 코메키나나잘스프레이 출시 비염치료제라인업강화,http://www.greened.kr/news/articleView.html?idxno=278869
9317,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252288
9318,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.segyebiz.com/newsView/20201208506502?OutUrl=naver
9319,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=20615
9320,2020-12-08,대웅제약코에뿌리는비염치료제출시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120809574221398
9321,2020-12-08,대웅제약비염치료제라인업강화코메키나나잘스프레이출시,http://www.youthdaily.co.kr/news/article.html?no=55288
9322,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.lawissue.co.kr/view.php?ud=202012081002467834204ead0791_12
9323,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=56356
9324,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://news.mt.co.kr/mtview.php?no=2020120810080173999
9325,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137581&REFERER=NP
9326,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시비염치료제라인업강화,http://newsbrite.net/144489
9327,2020-12-08,대웅제약뿌리는비염치료제코메키나나잘스프레이출시,http://www.pinpointnews.co.kr/view.php?ud=2020120810362818312365609d9b_45
9328,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.m-i.kr/news/articleView.html?idxno=773386
9329,2020-12-08,대웅제약코에뿌리는코메키나나잘스프레이출시,http://www.medigatenews.com/news/2706655844
9330,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.bosa.co.kr/news/articleView.html?idxno=2139605
9331,2020-12-08,대웅제약뿌리는비염치료제코메키나나잘스프레이출시,https://www.donga.com/news/article/all/20201208/104338872/1
9332,2020-12-08,대웅제약비염치료제라인업코메키나선보여,http://www.thebigdata.co.kr/view.php?ud=202012081052543490c28f8374b3_23
9333,2020-12-08,제약오늘JW생명과학글로벌진출강화지원사업선정대웅제약비염치료제코메키나나잘스프레이출시,http://www.sisaon.co.kr/news/articleView.html?idxno=121403
9334,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,https://www.asiatoday.co.kr/view.php?key=20201208010005029
9335,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65059
9336,2020-12-08,대웅제약뿌리는비염치료제코메키나나잘스프레이출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=36983
9337,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020120812593737790
9338,2020-12-08,대웅제약코에뿌리는비염치료제출시코메키나나잘스프레이,http://www.lcnews.co.kr/news/articleView.html?idxno=10628
9339,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시스프레이타입,https://www.econovill.com/news/articleView.html?idxno=509037
9340,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.kpinews.co.kr/news/articleView.html?idxno=132451
9341,2020-12-08,대웅제약스프레이타입뿌리는비염치료제 출시,http://www.koreastocknews.com/news/articleView.html?idxno=59631
9342,2020-12-08,대웅제약뿌리는비염치료제코메키나출시,http://www.100ssd.co.kr/news/articleView.html?idxno=73273
9343,2020-12-08,뿌리는비염치료제대웅제약코메키나나잘스프레이출시,http://theviewers.co.kr/View.aspx?No=1372894
9344,2020-12-08,대웅제약코안에뿌리는비염치료제출시코막힘에효과적,http://daily.hankooki.com/lpage/industry/202012/dh20201208153608148390.htm?s_ref=nv
9345,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.dailymedi.com/detail.php?number=863768&thread=22r05
9346,2020-12-08,대웅제약코안에직접비염치료제코메키나나잘스프레이출시,http://www.thedailypost.kr/news/articleView.html?idxno=77990
9347,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.metroseoul.co.kr/article/20201208500397
9348,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=408281
9349,2020-12-08,재계리포트메디톡스대웅제약균주분쟁시작과끝한쪽은치명타,http://www.sejungilbo.com/news/articleView.html?idxno=30349
9350,2020-12-08,뉴스투데이L대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,https://www.news2day.co.kr/article/20201208500271
9351,2020-12-08,대웅제약비염치료제라인업강화비염치료제코메키나나잘스프레이출시,http://www.updownnews.co.kr/news/articleView.html?idxno=226111
9352,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시비염치료제라인업강화,http://www.thepublic.kr/news/newsview.php?ncode=1065593547917010
9353,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.iminju.net/news/articleView.html?idxno=60301
9354,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.thefirstmedia.net/news/articleView.html?idxno=67352
9355,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.thebigdata.co.kr/view.php?ud=202012090906184222798818e98b_23
9356,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://newsclaim.co.kr/View.aspx?No=1373545
9357,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증”,http://www.sentv.co.kr/news/view/584399
9358,2020-12-09,대웅제약나보타대상포진신경통증감소효과입증,http://www.press9.kr/news/articleView.html?idxno=46514
9359,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.ekn.kr/web/view.php?key=20201209010002199
9360,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.fetv.co.kr/news/article.html?no=70722
9361,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,http://www.medisobizanews.com/news/articleView.html?idxno=74798
9362,2020-12-09,대웅제약나보타베트남서대상포진후신경통증감소효과입증”,http://www.youthdaily.co.kr/news/article.html?no=55405
9363,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://news.mt.co.kr/mtview.php?no=2020120909151144531
9364,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,https://view.asiae.co.kr/article/2020120909293600789
9365,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120909214790182
9366,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증”,https://jhealthmedia.joins.com/article/article_view.asp?pno=22824
9367,2020-12-09,대웅제약나보타대상포진신경통증감소가능성확인,http://www.newsis.com/view/?id=NISX20201209_0001263258&cID=13001&pID=13000
9368,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,http://inthenews.co.kr/article-81438/
9369,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.m-i.kr/news/articleView.html?idxno=773855
9370,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1434506
9371,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.dailian.co.kr/news/view/944449/?sc=Naver
9372,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://sports.hankooki.com/lpage/economy/202012/sp20201209094249137020.htm?s_ref=nv
9373,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=132506
9374,2020-12-09,대웅제약나보타대상포진후신경통증효과입증,http://www.newsprime.co.kr/news/article.html?no=526901
9375,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573188810586
9376,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증”,http://it.chosun.com/site/data/html_dir/2020/12/09/2020120900826.html
9377,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.hankyung.com/finance/article/202012099116i
9378,2020-12-09,대웅제약나보타연구결과베트남의학저널에게재,http://www.asiaa.co.kr/news/articleView.html?idxno=10913
9379,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252336
9380,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65074
9381,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.monews.co.kr/news/articleView.html?idxno=216244
9382,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020120909551890551
9383,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.healthinnews.co.kr/news/articleView.html?idxno=20633
9384,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://health.chosun.com/site/data/html_dir/2020/12/09/2020120900907.html
9385,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.metroseoul.co.kr/article/20201209500076
9386,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.pharmnews.com/news/articleView.html?idxno=101863
9387,2020-12-09,대웅제약보툴리눔톡신나보타대상포진신경통증개선효과,http://yna.kr/AKR20201209058500017?did=1195m
9388,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.segye.com/content/html/2020/12/09/20201209509143.html?OutUrl=naver
9389,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=56436
9390,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.wsobi.com/news/articleView.html?idxno=109878
9391,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=268106&MainKind=A&NewsKind=5&vCount=12&vKind=1
9392,2020-12-09,대웅제약나보타대상포진후신경통증에효과입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124394
9393,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2139697
9394,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=408360
9395,2020-12-09,대웅제약나보타대상포진신경통증감소4주지속,http://moneys.mt.co.kr/news/mwView.php?no=2020120911088037762
9396,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=37058
9397,2020-12-09,대웅제약코로나치료제개발한창DWRX2003임상2상신청완료,http://news.heraldcorp.com/view.php?ud=20201209000554
9398,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,http://www.medigatenews.com/news/2298466540
9399,2020-12-09,오늘의제약美아티바유비케어GC녹십자대웅제약동아제약유한건강생활,http://www.babytimes.co.kr/news/articleView.html?idxno=41688
9400,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.thepublic.kr/news/newsview.php?ncode=1065576681750389
9401,2020-12-09,대웅제약호이스타정코로나경증환자대상치료효과입증,https://www.ekn.kr/web/view.php?key=20201209010002284
9402,2020-12-09,제약사훨훨나는데실적곤두박질한미약품대웅제약왜,https://cnbc.sbs.co.kr/article_hub/10001005078?division=NAVER
9403,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,https://www.fetv.co.kr/news/article.html?no=70793
9404,2020-12-09,대웅제약호이스타정코로나19치료효과입증,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137630&REFERER=NP
9405,2020-12-09,대웅제약호이스타정코로나19치료효과입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=56459
9406,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증”,http://www.youthdaily.co.kr/news/article.html?no=55452
9407,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.healthinnews.co.kr/news/articleView.html?idxno=20651
9408,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=268123&MainKind=A&NewsKind=5&vCount=12&vKind=1
9409,2020-12-09,대웅제약호이스타정코로나치료제효과확인연내임상종료1월공급목표,http://news.mt.co.kr/mtview.php?no=2020120912322324829
9410,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증,http://www.press9.kr/news/articleView.html?idxno=46522
9411,2020-12-09,대웅제약호이스타정코로나19환자염증개선등치료효과확인,http://www.medisobizanews.com/news/articleView.html?idxno=74818
9412,2020-12-09,대웅제약나보타대상포진후신경통증개선효과확인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4366354
9413,2020-12-09,삼성제약대웅제약제약주모두급등삼성제약13급등이어대웅제약5급등,http://www.econonews.co.kr/news/articleView.html?idxno=148256
9414,2020-12-09,대웅제약대웅낮부터갑작스런급등대웅10급등이어대웅제약5급등,http://www.econonews.co.kr/news/articleView.html?idxno=148257
9415,2020-12-09,대웅제약대웅낮부터갑작스런급등대웅10급등이어대웅제약5급등,http://www.econonews.co.kr/news/articleView.html?idxno=148257
9416,2020-12-09,대웅제약먹는경증코로나약효과확인내년활용목표,https://www.hankyung.com/it/article/202012090265i
9417,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=408396
9418,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.lawissue.co.kr/view.php?ud=202012091307308413204ead0791_12
9419,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.newsworker.co.kr/news/articleView.html?idxno=94940
9420,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.pressm.kr/news/articleView.html?idxno=35135
9421,2020-12-09,제2의타미플루기대감↑대웅제약호이스타정코로나19환자86염증수치정상,https://www.donga.com/news/article/all/20201209/104361212/1
9422,2020-12-09,대웅제약이지덤뷰티2020올리브영어워즈패치국소케어부문3위수상,https://www.sedaily.com/NewsView/1ZBM7TET08
9423,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.lawissue.co.kr/view.php?ud=202012091324515120204ead0791_12
9424,2020-12-09,대웅제약췌장질환치료제코로나19치료효과확인내년1월공급할것,https://biz.chosun.com/site/data/html_dir/2020/12/09/2020120901559.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9425,2020-12-09,대웅제약호이스타정코로나19환자대상오프라벨처방결과공개,https://www.dailian.co.kr/news/view/944603/?sc=Naver
9426,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과기대,http://www.dailysmart.co.kr/news/articleView.html?idxno=37082
9427,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=132565
9428,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.m-i.kr/news/articleView.html?idxno=774072
9429,2020-12-09,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시비염치료제라인업강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=447916
9430,2020-12-09,대웅제약나보타베트남의학저널에서도우수성인정신경통증감소효과,http://www.lcnews.co.kr/news/articleView.html?idxno=10694
9431,2020-12-09,대웅제약나보타대상포진후신경통증에효과있어,http://www.thedailypost.kr/news/articleView.html?idxno=78000
9432,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과및안전성입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120913405568238
9433,2020-12-09,대웅제약호이스타정경증코로나19환자에게효과,http://www.fnnews.com/news/202012091343581123
9434,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020120913460381050
9435,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://daily.hankooki.com/lpage/industry/202012/dh20201209134912148390.htm?s_ref=nv
9436,2020-12-09,대웅제약호이스타코로나환자대상치료효과확인,http://www.newsis.com/view/?id=NISX20201209_0001263720&cID=13001&pID=13000
9437,2020-12-09,미용이어치료시장넘본다”대웅제약나보타대상포진통증감소효과입증,https://www.donga.com/news/article/all/20201209/104361834/1
9438,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://yna.kr/AKR20201209098500017?did=1195m
9439,2020-12-09,호이스타정코로나치료제1호될까대웅제약연내임상종료1월공급목표,http://moneys.mt.co.kr/news/mwView.php?no=2020120913098022891
9440,2020-12-09,대웅제약주가3증가나보타효과호이스타정효과,http://www.ajunews.com/view/20201209134353256
9441,2020-12-09,대웅제약카모스타트경증코로나19염증반응개선”,http://www.biospectator.com/view/news_view.php?varAtcId=12019
9442,2020-12-09,끝나지않는보툴리눔균도용논란대웅제약메디톡스누가거짓말,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012091158481250608
9443,2020-12-09,대웅제약호이스타정코로나환자대상치료효과입증,http://www.segye.com/content/html/2020/12/09/20201209515152.html?OutUrl=naver
9444,2020-12-09,대웅제약여드름패치이지덤뷰티2020올리브영어워즈수상,https://biz.chosun.com/site/data/html_dir/2020/12/09/2020120901781.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9445,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.metroseoul.co.kr/article/20201209500269
9446,2020-12-09,대웅제약호이스타정코로나19치료효과공개염증개선통해증상악화방지기대,http://kpenews.com/View.aspx?No=1374437
9447,2020-12-09,대웅제약호이스타정코로나19경증환자대상연구에서치료효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=510547
9448,2020-12-09,대웅제약개발코로나19치료제호이스타CRP검사서유효성확인,https://www.asiatoday.co.kr/view.php?key=20201209010006067
9449,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.medigatenews.com/news/1762039024
9450,2020-12-09,대웅제약나보타대상포진후신경통증에효과확인,http://www.koreastocknews.com/news/articleView.html?idxno=59678
9451,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://it.chosun.com/site/data/html_dir/2020/12/09/2020120901834.html
9452,2020-12-09,나보타대상포진도효과대웅제약주가↑,http://www.smartfn.co.kr/view.php?ud=202012091411093616d3eee0def8_46
9453,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=448266
9454,2020-12-09,대웅제약호이스타정코로나19경증치료효과,https://view.asiae.co.kr/article/2020120914441557829
9455,2020-12-09,대웅제약나보타대상포진신경통증감소효과입증,https://www.news2day.co.kr/article/20201209500177
9456,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증안전성도확인,http://www.thebigdata.co.kr/view.php?ud=202012091441325830d0a8833aad_23
9457,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과확인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4366534
9458,2020-12-09,대웅제약호이스타정코로나19치료효과연구결과공개,http://www.newsprime.co.kr/news/article.html?no=526976
9459,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012091440173030658
9460,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과확인,http://sports.hankooki.com/lpage/economy/202012/sp20201209145013137020.htm?s_ref=nv
9461,2020-12-09,대웅제약나보타대상포진신경통증감소효과확인,https://www.econovill.com/news/articleView.html?idxno=509234
9462,2020-12-09,대웅제약호이스타정1월중코로나19관련논문공개,http://weekly.hankooki.com/lpage/economy/202012/wk20201209145451146380.htm?s_ref=nv
9463,2020-12-09,대웅제약호이스타정코로나19경증환자대상치료효과입증,http://www.edaily.co.kr/news/newspath.asp?newsid=03096326625996880
9464,2020-12-09,대웅제약호이스타정코로나경증환자치료효과확인”,https://www.chosun.com/economy/science/2020/12/09/IJYG2NBGC5FN3GB5HJWOW2HOUQ/?utm_source=naver&utm_medium=referral&utm_campaign=naver-news
9465,2020-12-09,대웅제약호이스타정코로나경증환자치료효과확인”,https://www.chosun.com/economy/science/2020/12/09/IJYG2NBGC5FN3GB5HJWOW2HOUQ/?utm_source=naver&utm_medium=referral&utm_campaign=naver-news
9466,2020-12-09,대웅제약호이스타정코로나19치료효과입증됐다,http://news.mk.co.kr/newsRead.php?no=1265735&year=2020
9467,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65079
9468,2020-12-09,대웅제약호이스타정코로나환자대상치료효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2139731
9469,2020-12-09,대웅제약호이스타정코로나환자염증개선효과발표,http://www.monews.co.kr/news/articleView.html?idxno=216255
9470,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://newsbrite.net/144556
9471,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.dt.co.kr/contents.html?article_no=2020120902109931102002&ref=naver
9472,2020-12-09,대웅제약나보타베트남에서대상포진후신경통증감소효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=510614
9473,2020-12-09,뉴스투데이L대웅제약호이스타정코로나19환자치료효과발표,https://www.news2day.co.kr/article/20201209500207
9474,2020-12-09,대웅제약호이스타정코로나경증환자치료효과확인,https://cnbc.sbs.co.kr/article_hub/10001005108?division=NAVER
9475,2020-12-09,대웅제약호이스타정코로나19치료효과1월환자제공목표,http://www.seoulfn.com/news/articleView.html?idxno=403793
9476,2020-12-09,대웅제약나보타대상포진신경통증개선효과,http://www.seoulfn.com/news/articleView.html?idxno=403798
9477,2020-12-09,대웅제약호이스타정코로나19환자대상경구용치료제로효과입증임상2상도속도낸다,http://news.heraldcorp.com/view.php?ud=20201209000915
9478,2020-12-09,대웅제약호이스타코로나19경증환자치료에효과,https://www.sedaily.com/NewsView/1ZBM7UBU1Q
9479,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.pharmnews.com/news/articleView.html?idxno=101866
9480,2020-12-09,대웅제약코로나19치료효과연구결과공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1352639
9481,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.newstomato.com/ReadNews.aspx?no=1011908
9482,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.mediapen.com/news/view/581960
9483,2020-12-09,대웅제약vs메디톡스톡신논란마침표,http://www.whosaeng.com/123143
9484,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.worktoday.co.kr/news/articleView.html?idxno=12123
9485,2020-12-09,통증감소및수면질향상대웅제약나보타대상포진후신경통증감소효과입증,http://theviewers.co.kr/View.aspx?No=1374802
9486,2020-12-09,대웅제약나보타베트남현지연구결과대상포진후신경통증감소효과확인,http://www.k-health.com/news/articleView.html?idxno=51369
9487,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.finomy.com/news/articleView.html?idxno=86442
9488,2020-12-09,김창수의e뉴스브리핑대웅제약호이스타정코로나19환자대상치료효과입증外,https://www.fetv.co.kr/news/article.html?no=70846
9489,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.sporbiz.co.kr/news/articleView.html?idxno=503974
9490,2020-12-09,대웅제약의그약을코로나19환자들에게투여했더니극적인효과가나타났다,https://www.wikitree.co.kr/articles/599587
9491,2020-12-09,대웅제약자체보툴리눔톡신의대상포진신경통증감소효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=207973
9492,2020-12-09,먹는코로나19치료제나오나대웅제약호이스타정경증환자치료효과입증,https://hankookilbo.com/News/Read/A2020120916310000680?did=NA
9493,2020-12-09,금일제약업계주요기사휴젤레티보中수출첫선적대웅제약호이스타정코로나19환자치료효과입증”,http://www.youthdaily.co.kr/news/article.html?no=55507
9494,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,https://www.news1.kr/articles/?4145053
9495,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.asiatoday.co.kr/view.php?key=20201209010006382
9496,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.ezyeconomy.com/news/articleView.html?idxno=107857
9497,2020-12-09,대웅제약호이스타정코로나19경증치료효과확인,http://4th.kr/View.aspx?No=1374932
9498,2020-12-09,대웅제약호이스타정코로나19환자염증억제효과확인,http://www.ajunews.com/view/20201209182204530
9499,2020-12-09,대웅제약호이스타정코로나19환자에서카모스타트의염증개선효과발표,http://www.thefirstmedia.net/news/articleView.html?idxno=67436
9500,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=67448
9501,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4366985
9502,2020-12-10,대웅제약호이스타정코로나19치료효과확인코로나19의타미플루와같은약제,http://www.newsinside.kr/news/articleView.html?idxno=1097303
9503,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=70885
9504,2020-12-10,특징주대상포진후신경통증감소대웅제약12↑,http://moneys.mt.co.kr/news/mwView.php?no=2020121009108027632
9505,2020-12-10,카모스타트코로나19치료제부상대웅제약등관련株들썩,http://news.mk.co.kr/newsRead.php?no=1268060&year=2020
9506,2020-12-10,특징주대웅제약호이스타정코로나치료제효과확인에급등,https://view.asiae.co.kr/article/2020121009195139407
9507,2020-12-10,특징주대웅제약호이스타정코로나19치료효과소식에장초반강세,https://www.sedaily.com/NewsView/1ZBMO5SSI4
9508,2020-12-10,대웅제약코로나치료제기대감이틀째강세,http://news.mt.co.kr/mtview.php?no=2020121009180143055
9509,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=268172&MainKind=A&NewsKind=5&vCount=12&vKind=1
9510,2020-12-10,대웅제약당뇨병성혈관합병증의관리및예방중요성공유”,http://www.youthdaily.co.kr/news/article.html?no=55556
9511,2020-12-10,대웅제약안플원출시5주년4차웹심포지엄,http://www.medisobizanews.com/news/articleView.html?idxno=74844
9512,2020-12-10,대웅제약삼성제약제약주희비엇갈려특히대웅제약갑작스런13급등,http://www.econonews.co.kr/news/articleView.html?idxno=148370
9513,2020-12-10,대웅제약안플원5주년기념웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=46531
9514,2020-12-10,대웅제약호이스타정코로나19치료효과소식에강세,https://www.hankyung.com/finance/article/2020121033626
9515,2020-12-10,특징주대웅제약코로나19치료제효과확인소식에상승세,http://www.inews24.com/view/1325418
9516,2020-12-10,특징주대웅제약코로나치료제기대감에10대급등,https://www.dailian.co.kr/news/view/944928/?sc=Naver
9517,2020-12-10,특징주대웅제약코로나19치료제개발기대감에급등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012100078&t=NN
9518,2020-12-10,특징주대웅제약호이스타정코로나19치료제기대급등,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573042691533
9519,2020-12-10,특징주대웅제약호이스타정코로나치료효과발표에급등,http://news.heraldcorp.com/view.php?ud=20201210000146
9520,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄,http://www.whosaeng.com/123164
9521,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252387
9522,2020-12-10,코스피코스닥동반하락출발무림페이퍼대웅제약베스파급등,http://www.businesspost.co.kr/BP?command=article_view&num=208035
9523,2020-12-10,특징주대웅제약코로나치료제기대감이틀째강세,https://www.econovill.com/news/articleView.html?idxno=509413
9524,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.viva100.com/main/view.php?key=20201210010002498
9525,2020-12-10,코스피미국발악재에273048하락출발대웅제약콜드체인주↑,http://www.opinionnews.co.kr/news/articleView.html?idxno=43913
9526,2020-12-10,특징주대웅제약코로나19치료제기대감에10대상승,http://www.newspim.com/news/view/20201210000215
9527,2020-12-10,특징주대웅제약코로나19치료제기대감에이틀째상승세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004204442
9528,2020-12-10,특징주대웅제약호이스타정코로나19치료제효과에강세,http://www.seoulfn.com/news/articleView.html?idxno=403887
9529,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.healthinnews.co.kr/news/articleView.html?idxno=20663
9530,2020-12-10,특징주대웅제약강세코로나경증환자치료효과,https://www.news1.kr/articles/?4145575
9531,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=132630
9532,2020-12-10,특징주대웅제약코로나19치료제개발기대감에강세,http://www.ajunews.com/view/20201210094613816
9533,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=774373
9534,2020-12-10,특징주대웅제약코로나치료제소식에대웅상승,http://moneys.mt.co.kr/news/mwView.php?no=2020121009498064009
9535,2020-12-10,경보제약대웅제약제약주모두급등경보제약10급등이어대웅제약9급등,http://www.econonews.co.kr/news/articleView.html?idxno=148384
9536,2020-12-10,10일장중코로나주대웅제약엑세스바이오껑충vs제일약품하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77210
9537,2020-12-10,대웅제약안플원출시5주년4차웹심포지엄개최,http://www.newslock.co.kr/news/articleView.html?idxno=33892
9538,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,https://www.ekn.kr/web/view.php?key=20201210010002532
9539,2020-12-10,대웅제약호이스타정코로나19환자상대로치료효과입증”,http://inthenews.co.kr/article-81610/
9540,2020-12-10,특징주대웅제약호이스타정먹는코로나치료제효과기대에급등,http://daily.hankooki.com/lpage/finance/202012/dh20201210100811148310.htm?s_ref=nv
9541,2020-12-10,대웅제약이틀째훨훨왜췌장염치료제호이스타정코로나치료효능호재로,http://www.pinpointnews.co.kr/view.php?ud=202012101012251456861beb2d9d_45
9542,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://news.mt.co.kr/mtview.php?no=2020121009425137680
9543,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://daily.hankooki.com/lpage/industry/202012/dh20201210101641148390.htm?s_ref=nv
9544,2020-12-10,TF특징주대웅제약코로나19치료제효과소식에이틀째강세,http://news.tf.co.kr/read/economy/1830108.htm
9545,2020-12-10,대웅제약항혈전제안플원출시5주년기념4차웹심포지엄개최,http://www.pinpointnews.co.kr/view.php?ud=2020121010382871282365609d9b_45
9546,2020-12-10,대웅제약항혈전제안플원출시5주년기념웹심포지엄진행,https://www.asiatoday.co.kr/view.php?key=20201210010006693
9547,2020-12-10,특징주대웅제약코로나치료효과소식에급등,http://www.skyedaily.com/news/news_view.html?ID=117704
9548,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2139796
9549,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.mediapen.com/news/view/582216
9550,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65100
9551,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=56527
9552,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=202012101100355120204ead0791_12
9553,2020-12-10,대웅제약췌장질환치료제호이스타정코로나치료효과에급등,http://www.whitepaper.co.kr/news/articleView.html?idxno=199580
9554,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=37141
9555,2020-12-10,대웅제약주가초반상승역류성식도염치료제의코로나19치료효과,http://www.businesspost.co.kr/BP?command=article_view&num=208077
9556,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.newsworker.co.kr/news/articleView.html?idxno=95108
9557,2020-12-10,대웅제약겨울철혈류장애및당뇨병성혈관합병증관련웹심포지엄개최,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124442
9558,2020-12-10,대웅제약항혈전제안플원웹심포지엄개최,http://www.100ssd.co.kr/news/articleView.html?idxno=73322
9559,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.thebigdata.co.kr/view.php?ud=202012101221403496798818e98b_23
9560,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.thepublic.kr/news/newsview.php?ncode=1065575814754237
9561,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=408536
9562,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.marketnews.co.kr/news/articleView.html?idxno=57149
9563,2020-12-10,대웅제약이지덤뷰티2020올리브영어워즈서수상,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012100258&t=NN
9564,2020-12-10,대웅대웅제약모두급등대웅15급등이어대웅제약10급등,http://www.econonews.co.kr/news/articleView.html?idxno=148492
9565,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=448647
9566,2020-12-10,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=448655
9567,2020-12-10,대웅제약코로나치료제호이스타정염증개선효과,http://www.thedailypost.kr/news/articleView.html?idxno=78041
9568,2020-12-10,뉴스투데이L대웅제약안플원출시5주년기념4차웹심포지엄개최,https://www.news2day.co.kr/article/20201210500195
9569,2020-12-10,대웅제약안플원출시5주년4차웹심포지엄개최,https://www.econovill.com/news/articleView.html?idxno=509480
9570,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.mhj21.com/137586
9571,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.segyebiz.com/newsView/20201210518815?OutUrl=naver
9572,2020-12-10,10일오늘의상한가총정리남광토건에스씨엠생명과학백금TA상한가대웅대웅제약연이틀급등,http://www.ccreview.co.kr/news/articleView.html?idxno=297880
9573,2020-12-10,호이스타정코로나치료효과대웅제약주가↑,http://www.smartfn.co.kr/view.php?ud=20201210154700502537c00c6b22_46
9574,2020-12-10,대웅제약 호이스타정 경증 코로나19 치료 효과 입증,http://kormedi.com/?p=1328891
9575,2020-12-10,㈜대웅제약이지덤뷰티2020올리브영어워즈수상,http://news.mk.co.kr/newsRead.php?no=1271328&year=2020
9576,2020-12-10,급등락주짚어보기에스씨엠생명과학백혈병치료제효과확인상한가코로나치료효과대웅대웅제약도강세,https://www.etoday.co.kr/news/view/1972651
9577,2020-12-10,대웅주가무려26상승대웅제약은18코로나19치료제기대감영향,http://www.ajunews.com/view/20201210163842236
9578,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.thedailypost.kr/news/articleView.html?idxno=78043
9579,2020-12-10,대웅제약췌장약호이스타코로나치료효과,https://www.hankyung.com/it/article/2020121062681
9580,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=67544
9581,2020-12-10,코스피등돌린외국인매도세에소폭하락마감대웅제약태영건설우남광토건급등,http://www.betanews.net:8080/article/1245047.html
9582,2020-12-10,대웅제약호이스타정코로나19치료효과입증,http://news.kbiz.or.kr/news/articleView.html?idxno=75575
9583,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.newsfreezone.co.kr/news/articleView.html?idxno=281119
9584,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.ajunews.com/view/20201210232025364
9585,2020-12-11,코로나19치료결국엔먹는약”대웅제약등후발주자들먹는약개발경쟁,https://biz.chosun.com/site/data/html_dir/2020/12/10/2020121002607.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9586,2020-12-11,대웅제약나보타 대상포진후신경통증감소에효과,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005600
9587,2020-12-11,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=216322
9588,2020-12-11,대웅제약코로나19환자대상호이스타정치료효과공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005606
9589,2020-12-11,대웅제약호이스타정코로나치료효과확인관련주급등,https://cnbc.sbs.co.kr/article_hub/10001005334?division=NAVER
9590,2020-12-11,신풍제약대웅제약제약주희비엇갈려신풍제약8급락반해대웅제약보합,http://www.econonews.co.kr/news/articleView.html?idxno=148560
9591,2020-12-11,특징주대웅대웅제약주가초관심호이스타정코로나효과입증,http://www.gukjenews.com/news/articleView.html?idxno=2124371
9592,2020-12-11,특징주대웅제약코로나치료제기대감에3거래일째강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02253366625997536
9593,2020-12-11,대웅대웅제약오전갑작스런급등대웅24급등이어대웅제약9급등,http://www.econonews.co.kr/news/articleView.html?idxno=148639
9594,2020-12-11,대웅대웅제약주가초반뛰어코로나19경증환자치료효과부각,http://www.businesspost.co.kr/BP?command=article_view&num=208291
9595,2020-12-11,일양약품대웅제약제약주모두급등일양약품14급등이어대웅제약11급등,http://www.econonews.co.kr/news/articleView.html?idxno=148675
9596,2020-12-11,급등주대웅대웅제약과3일째초강세52주최고가,http://www.itooza.com/common/iview.php?no=2020121113263573237
9597,2020-12-11,대웅제약여드름패치이지덤뷰티2020올리브영어워즈수상,http://www.segye.com/content/html/2020/12/11/20201211511631.html?OutUrl=naver
9598,2020-12-11,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005625
9599,2020-12-11,대웅제약지사제스멕타대신복제약만드나,http://www.mediapen.com/news/view/582734
9600,2020-12-11,단독대웅제약이엑스데이터에시드투자,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012110365&t=NN
9601,2020-12-13,베스트워스트대웅대웅제약호이스타정코로나치료효과발표에급등,https://www.etoday.co.kr/news/view/1973148
9602,2020-12-13,메디톡스대웅제약보톡스분쟁이번주최종판결또연기될까,http://kpenews.com/View.aspx?No=1378671
9603,2020-12-13,메디톡스대웅제약보톡스분쟁최종판결3일뒤예정또미뤄질가능성도,http://theviewers.co.kr/View.aspx?No=1378676
9604,2020-12-13,메디톡스와대웅제약균주소송최종판결16일예정미뤄질가능성도,http://www.businesspost.co.kr/BP?command=article_view&num=208435
9605,2020-12-13,메디톡스대웅제약휴젤보툴리눔균균주출처서면조사자료질병관리청에제출,http://www.econonews.co.kr/news/articleView.html?idxno=148877
9606,2020-12-13,대웅제약메디톡스보톡스분쟁이번주최종판결향후여파는,https://www.asiatoday.co.kr/view.php?key=20201213010008060
9607,2020-12-13,메디톡스대웅제약ITC분쟁이번주결판,http://www.edaily.co.kr/news/newspath.asp?newsid=02145126625998192
9608,2020-12-14,대형제약사소송건수줄어대웅제약소송건가장많고나홀로증가,http://www.consumernews.co.kr/news/articleView.html?idxno=617173
9609,2020-12-14,대웅대웅제약상승에급등까지대웅3상승이어대웅제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=148906
9610,2020-12-14,20번세탁해도기능성유지대웅제약퓨어킷항균마스크출시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121410213363276
9611,2020-12-14,대웅제약기능성마스크퓨어킷항균마스크출시,http://www.viva100.com/main/view.php?key=20201214010003319
9612,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,https://www.fetv.co.kr/news/article.html?no=71261
9613,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65171
9614,2020-12-14,대웅제약20번세탁해도기능성유지퓨어킷항균마스크출시,https://www.asiatoday.co.kr/view.php?key=20201214010008378
9615,2020-12-14,대웅제약20번빨아써도기능유지되는퓨어킷항균마스크출시,http://www.metroseoul.co.kr/article/20201214500130
9616,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://medipana.com/news/news_viewer.asp?NewsNum=268339&MainKind=A&NewsKind=5&vCount=12&vKind=1
9617,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020121410372413416
9618,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시20번세탁후에도기능성유지,http://www.segye.com/content/html/2020/12/14/20201214505369.html?OutUrl=naver
9619,2020-12-14,대웅제약경제적인다회용기능성마스크퓨어킷항균마스크출시,http://www.medisobizanews.com/news/articleView.html?idxno=74929
9620,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크선보여,http://www.asiaa.co.kr/news/articleView.html?idxno=12033
9621,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.fnnews.com/news/202012141046314854
9622,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.press9.kr/news/articleView.html?idxno=46559
9623,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=56698
9624,2020-12-14,대웅제약다회용마스크퓨어킷항균마스크출시,http://www.bosa.co.kr/news/articleView.html?idxno=2140019
9625,2020-12-14,대웅제약퓨어킷항균마스크출시20번세탁해도기능성유지,https://www.econovill.com/news/articleView.html?idxno=509980
9626,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=20747
9627,2020-12-14,대웅제약기능성마스크퓨어킷항균마스크출시,http://inthenews.co.kr/article-82244/
9628,2020-12-14,대웅제약매디톡스보톡스전쟁16일최종결판패소시치명상,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012141100163540526
9629,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=37315
9630,2020-12-14,대웅제약위생용품라인업강화다회용기능성마스크퓨어킷항균마스크출시,http://www.updownnews.co.kr/news/articleView.html?idxno=226268
9631,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252508
9632,2020-12-14,의약오늘대웅제약기능성마스크퓨어킷항균마스크출시동성제약광노화질환치료제이노바에이크림선봬,http://www.sisaon.co.kr/news/articleView.html?idxno=121654
9633,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.lawissue.co.kr/view.php?ud=202012141141489786204ead0791_12
9634,2020-12-14,대웅제약위생용품라인업강화퓨어킷항균마스크출시,http://www.youthdaily.co.kr/news/article.html?no=55955
9635,2020-12-14,대웅제약20번세탁해도기능유지하는마스크출시,http://daily.hankooki.com/lpage/industry/202012/dh20201214114514148390.htm?s_ref=nv
9636,2020-12-14,대웅제약다회용마스크퓨어킷항균마스크출시,http://www.consumuch.com/news/articleView.html?idxno=51534
9637,2020-12-14,대웅제약퓨어킷항균마스크출시,https://www.ebn.co.kr/news/view/1463741/?sc=Naver
9638,2020-12-14,대웅제약다회용기능성마스크출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005686
9639,2020-12-14,뉴스투데이L대웅제약퓨어킷항균마스크출시,https://www.news2day.co.kr/article/20201214500182
9640,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=408838
9641,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.newsworker.co.kr/news/articleView.html?idxno=95518
9642,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.marketnews.co.kr/news/articleView.html?idxno=57463
9643,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.segyebiz.com/newsView/20201214508609?OutUrl=naver
9644,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.kpinews.co.kr/news/articleView.html?idxno=132907
9645,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.koreaittimes.com/news/articleView.html?idxno=102442
9646,2020-12-14,대웅제약20번세탁해도기능성유지퓨어킷항균마스크출시,http://www.thebigdata.co.kr/view.php?ud=202012141339063346798818e98b_23
9647,2020-12-14,대웅제약대웅희비엇갈려특히대웅제약급등서오후고꾸라지는주가,http://www.econonews.co.kr/news/articleView.html?idxno=148999
9648,2020-12-14,경보제약대웅제약제약주희비엇갈려경보제약3상승반해대웅제약6급락,http://www.econonews.co.kr/news/articleView.html?idxno=149000
9649,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.ceoscoredaily.com/news/article.html?no=76194
9650,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=271481&REFERER=NP
9651,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012141435406460661
9652,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.wsobi.com/news/articleView.html?idxno=110316
9653,2020-12-14,대웅제약다회용마스크퓨어킷항균마스크출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1435848
9654,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크선봬,http://news.mt.co.kr/mtview.php?no=2020121415150080306
9655,2020-12-14,16일메디톡스대웅제약보톡스분쟁ITC최종판결패소하면치명상,http://www.getnews.co.kr/news/articleView.html?idxno=504642
9656,2020-12-14,다회용기능성마스크대웅제약퓨어킷향균마스크출시,http://theviewers.co.kr/View.aspx?No=1380170
9657,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.bokuennews.com/news/article.html?no=198421
9658,2020-12-14,대웅제약20번빨아쓰는다회용기능성퓨어킷항균마스크선봬,https://www.kpanews.co.kr/article/show.asp?idx=218520&category=D
9659,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.newstomato.com/ReadNews.aspx?no=1012830
9660,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.ajunews.com/view/20201214163527047
9661,2020-12-14,연봉정밀분석27평균연봉한미약품이400만원높고근속연수는대웅제약이3개월더길어,https://www.news2day.co.kr/article/20201214500283
9662,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.thedailypost.kr/news/articleView.html?idxno=78108
9663,2020-12-14,대웅제약메디톡스5년보톡스분쟁결판날까,http://sports.hankooki.com/lpage/economy/202012/sp20201214164806137020.htm?s_ref=nv
9664,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=449480
9665,2020-12-14,대웅제약기능경제성고려한퓨어킷항균마스크출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1354566
9666,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.dt.co.kr/contents.html?article_no=2020121402109931820008&ref=naver
9667,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.thefirstmedia.net/news/articleView.html?idxno=67709
9668,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.worktoday.co.kr/news/articleView.html?idxno=12231
9669,2020-12-14,대웅제약20번세탁후에도기능성유지되는다회용마스크퓨어킷항균마스크출시,http://www.lcnews.co.kr/news/articleView.html?idxno=10873
9670,2020-12-14,제약RD종근당대웅제약코로나19치료제임상진행내역발표,http://www.newsfreezone.co.kr/news/articleView.html?idxno=282022
9671,2020-12-15,대웅제약대웅하락에급락으로무너져특히대웅가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=149046
9672,2020-12-15,국산1호코로나치료제주인공은셀트리온대웅제약각축전,http://www.viva100.com/main/view.php?key=20201215010003691
9673,2020-12-15,대웅제약vs메디톡스보톡스분쟁美ITC최종판결초읽기,https://www.fetv.co.kr/news/article.html?no=71424
9674,2020-12-15,국내코로나19치료제개발어디까지왔나셀트리온과GC녹십자가선두종근당과대웅제약도추격중,http://topclass.chosun.com/daily/view.asp?idx=738&Newsnumb=202012738
9675,2020-12-15,메디톡스대웅제약ITC결판코앞승기누가잡나,http://www.mediapen.com/news/view/583750
9676,2020-12-15,시경Today건강대웅제약다회용기능성마스크퓨어킷항균마스크출시外,http://www.meconomynews.com/news/articleView.html?idxno=48442
9677,2020-12-15,대웅제약협력사에볼루스美ITC판결앞두고나스닥지수서삭제,http://www.kpinews.co.kr/news/articleView.html?idxno=133032
9678,2020-12-15,콜린알포치매약뭐길래종근당대웅등제약사발동동,https://cnbc.sbs.co.kr/article_hub/10001005827?division=NAVER
9679,2020-12-16,메디톡스vs대웅제약보톡스분쟁판결D1최종결과나오나,http://it.chosun.com/site/data/html_dir/2020/12/15/2020121502655.html
9680,2020-12-16,두차례연기된메디톡스대웅제약최종판결이번엔결판,http://www.youthdaily.co.kr/news/article.html?no=56166
9681,2020-12-16,대웅제약여드름패치이지덤뷰티2020올리브영어워즈수상,http://news.heraldcorp.com/view.php?ud=20201216000108
9682,2020-12-16,미국서보톡스균주소송최종판결앞둔대웅제약덮친악재협력사에볼루스나스닥바이오지수서빠져,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004210828
9683,2020-12-16,제약업계따뜻한손길④대웅제약참지마요ing발달장애인과비대면소통,http://www.wolyo.co.kr/news/articleView.html?idxno=113240
9684,2020-12-16,코로나19치료제임상셀트리온GC녹십자종근당대웅제약앞서,http://www.kpinews.co.kr/news/articleView.html?idxno=133129
9685,2020-12-16,오늘의토막뉴스두차례연기된메디톡스대웅제약최종판결이번엔결판外,http://www.youthdaily.co.kr/news/article.html?no=56268
9686,2020-12-16,퇴근길제약Pin앙숙된대웅제약vs메디톡스보톡스분쟁판결D1外,http://www.pinpointnews.co.kr/view.php?ud=20201216174851797f090c8dbcb_45
9687,2020-12-17,보툴리눔톡신3Q처방시장대웅제약나보타1위,http://www.press9.kr/news/articleView.html?idxno=46589
9688,2020-12-17,메디톡스대웅제약휴젤질병청에균주출처자료제출,http://www.ccreview.co.kr/news/articleView.html?idxno=298480
9689,2020-12-17,속보美ITC메디톡스손들어줘대웅제약21개월간수입금지,http://www.newspim.com/news/view/20201217000039
9690,2020-12-17,속보미ITC메디톡스손들어줘대웅제약21개월간수입금지,http://www.getnews.co.kr/news/articleView.html?idxno=505079
9691,2020-12-17,속보메디톡스손들어준美ITC대웅제약21개월간수입금지,https://view.asiae.co.kr/article/2020121706594110877
9692,2020-12-17,다우지수코로나확진폭발다우지수혼조메디톡스대웅제약셀트리온주가에어떤영향,http://www.pinpointnews.co.kr/view.php?ud=202012170700427134861beb2d9d_45
9693,2020-12-17,속보메디톡스손들어준美ITC대웅제약제품21개월간수입금지,https://www.fetv.co.kr/news/article.html?no=71676
9694,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월간수입금지속보,http://www.edaily.co.kr/news/newspath.asp?newsid=01492406625999504
9695,2020-12-17,속보美ITC메디톡스손들어줘대웅제약21개월수입금지,https://www.etoday.co.kr/news/view/1974773
9696,2020-12-17,속보미ITC메디톡스손들어줬다대웅제약21개월간수입금지,http://www.ccreview.co.kr/news/articleView.html?idxno=298485
9697,2020-12-17,속보메디톡스손들어준미ITC대웅제약21개월간수입금지,http://www.gukjenews.com/news/articleView.html?idxno=2127729
9698,2020-12-17,미ITC메디톡스손들어줘대웅제약21개월간수입금지,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121707214148316
9699,2020-12-17,보톡스분쟁서메디톡스승리美ITC대웅제약21개월수입금지”,https://news.joins.com/article/olink/23542289
9700,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월간수입금지,https://www.ekn.kr/web/view.php?key=20201217010004204
9701,2020-12-17,속보메디톡스손들어준ITC대웅제약21개월수입금지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012170035&t=NN
9702,2020-12-17,메디톡스손들어준ITC대웅제약관세법위반21개월간수입금지1보,http://www.ccreview.co.kr/news/articleView.html?idxno=298487
9703,2020-12-17,보톡스분쟁서메디톡스승소美ITC대웅제약21개월수입금지,http://www.getnews.co.kr/news/articleView.html?idxno=505092
9704,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월수입금지,http://yna.kr/AKR20201217024800017?did=1195m
9705,2020-12-17,美ITC메디톡스에손대웅제약21개월간수입금지,https://www.ebn.co.kr/news/view/1464222/?sc=Naver
9706,2020-12-17,美ITC대웅제약나보타21개월간수입금지,https://www.paxnetnews.com/articles/68669
9707,2020-12-17,속보메디톡스손들어준美ITC대웅제약21개월수입금지,http://news.mt.co.kr/mtview.php?no=2020121707484791349
9708,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월수입금지,https://www.etoday.co.kr/news/view/1974779
9709,2020-12-17,속보美ITC대웅제약나보타21개월수입금지최종결정,http://www.newsis.com/view/?id=NISX20201217_0001273214&cID=13001&pID=13000
9710,2020-12-17,전승호대웅제약대표사실상승리균주도용혐의벗어,https://view.asiae.co.kr/article/2020121707550189093
9711,2020-12-17,보톡스분쟁판결메디톡스승대웅제약21개월수입금지”,https://cnbc.sbs.co.kr/article_hub/10001006039?division=NAVER
9712,2020-12-17,속보메디톡스균주분쟁마무리ITC대웅제약관세법위반21개월간수입금지,http://www.gukjenews.com/news/articleView.html?idxno=2127744
9713,2020-12-17,보톡스분쟁서메디톡스손들어준美ITC대웅제약21개월수입금지,https://www.seoul.co.kr/news/newsView.php?id=20201217500012&wlog_tag3=naver
9714,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월간수입금지”,http://www.newsway.co.kr/news/view?tp=1&ud=2020121707514841233
9715,2020-12-17,속보美ITC보톡스분쟁최종판결대웅제약나보타21개월수입금지,https://www.hankyung.com/it/article/202012177685i
9716,2020-12-17,ITC대웅제약나보타21개월수입금지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1355681
9717,2020-12-17,美ITC보톡스분쟁서메디톡스손들어줬다대웅제약21개월수입금지,https://www.sedaily.com/NewsView/1ZBPVYQU8U
9718,2020-12-17,속보미국ITC대웅제약나보타21개월간수입금지,http://www.fnnews.com/news/202012170757410833
9719,2020-12-17,대웅제약균주전쟁승리ITC결정영향없이글로벌사업지속확대,http://www.thebigdata.co.kr/view.php?ud=202012170803333229798818e98b_23
9720,2020-12-17,ITC나보타21개월수입금지대웅제약美수출길제동,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137774&REFERER=NP
9721,2020-12-17,5년만에결론난보톡스전쟁美ITC대웅제약21개월간수입금지상보,https://view.asiae.co.kr/article/2020121708070232357
9722,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월수입금지,https://news.sbs.co.kr/news/endPage.do?news_id=N1006127285&plink=ORI&cooper=NAVER
9723,2020-12-17,속보美ITC대웅제약나보타21개월수입금지최종결정,http://www.pinpointnews.co.kr/view.php?ud=20201217081015603861beb2d9d_45
9724,2020-12-17,美ITC메디톡스승리판결대웅제약나보타21개월간수입금지,http://www.sisajournal-e.com/news/articleView.html?idxno=227109
9725,2020-12-17,공시대웅제약코로나치료제DWJ1248임상변경계획식약처승인”,http://www.newsway.co.kr/news/view?tp=1&ud=2020121708134467767
9726,2020-12-17,그래픽메디톡스대웅제약보톡스원료분쟁주요일지,http://yna.kr/GYH20201217000400044?did=1363m
9727,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월수입금지,http://news.mt.co.kr/mtview.php?no=2020121707530888891
9728,2020-12-17,대웅제약균주는더이상시비거리아냐ITC위원회예비판결뒤집어,http://www.segye.com/content/html/2020/12/17/20201217503469.html?OutUrl=naver
9729,2020-12-17,美ITC메디톡스손들어줘대웅제약나보타21개월간수입금지,http://www.newspim.com/news/view/20201217000096
9730,2020-12-17,공시대웅제약식약처코로나19치료제DWJ1248임상시험계획변경승인,http://www.fnnews.com/news/202012170817419394
9731,2020-12-17,4년걸친보톡스분쟁메디톡스승리美ITC대웅제약나보타21개월수입금지”,https://www.fetv.co.kr/news/article.html?no=71680
9732,2020-12-17,균주전쟁메디톡스승리ITC대웅제약21개월간수입금지판결상보,http://moneys.mt.co.kr/news/mwView.php?no=2020121708158042232
9733,2020-12-17,보톡스전쟁대웅제약패소ITC21개월수입금지조치”,http://www.thevaluenews.co.kr/news/view.php?idx=161897
9734,2020-12-17,미국ITC대웅제약나보타수입금지10년→21개월판결,https://www.news1.kr/articles/?4152845
9735,2020-12-17,대웅제약균주전쟁승리사실상ITC승소,http://www.medisobizanews.com/news/articleView.html?idxno=75020
9736,2020-12-17,ITC최종판결에메디톡스제조공정도용혐의밝혀진것VS대웅제약예비판결뒤집혀,http://www.segye.com/content/html/2020/12/17/20201217503574.html?OutUrl=naver
9737,2020-12-17,증시키워드메디톡스대웅제약보톡스분쟁종료삼성전자개인vs외인엇갈린투심,https://www.etoday.co.kr/news/view/1974805
9738,2020-12-17,메디톡스미국에서균주소송승리대웅제약21개월간미국수출금지,http://www.businesspost.co.kr/BP?command=article_view&num=209009
9739,2020-12-17,메디톡스보톡스분쟁최종승자미ITC대웅제약21개월수입금지,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4373870
9740,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월간수입금지”상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01649846625999504
9741,2020-12-17,보톡스분쟁서메디톡스승리대웅제약판결뒤집겠다종합,http://it.chosun.com/site/data/html_dir/2020/12/17/2020121700512.html
9742,2020-12-17,대웅제약코로나19치료제임상계획변경승인,http://www.pinpointnews.co.kr/view.php?ud=202012170832468343cd1e7f0bdf_45
9743,2020-12-17,미ITC메디톡스손들어줘대웅제약21개월수입금지,https://www.hankyung.com/economy/article/2020121778037
9744,2020-12-17,대웅제약코로나치료제임상23상시험계획변경승인,http://www.itooza.com/common/iview.php?no=2020121708302808072
9745,2020-12-17,대웅제약코로나치료제임상시험계획변경승인,https://view.asiae.co.kr/article/2020121708394938466
9746,2020-12-17,마침표찍은보톡스전쟁美ITC대웅제약나보타21개월수입금지,http://news.tf.co.kr/read/economy/1832070.htm
9747,2020-12-17,메디톡스보톡스분쟁서승리美ITC대웅제약21개월수입금지,http://www.joynews24.com/view/1327505
9748,2020-12-17,美ITC대웅제약메디톡스최종판결사실상대웅제약승리,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012170823169920401
9749,2020-12-17,美ITC메디톡스손들어줘대웅제약나보타21개월수입금지종합,http://www.newsis.com/view/?id=NISX20201217_0001273295&cID=13001&pID=13000
9750,2020-12-17,메디톡스손들어준美ITC대웅제약나보타21개월수입금지,http://www.viva100.com/main/view.php?key=20201217010004226
9751,2020-12-17,종합보톡스분쟁서메디톡스승소美ITC대웅제약21개월수입금지,http://www.getnews.co.kr/news/articleView.html?idxno=505104
9752,2020-12-17,대웅제약코로나19치료제대규모23상변경승인,https://www.asiatoday.co.kr/view.php?key=20201217010010783
9753,2020-12-17,메디톡스美ITC최종승소대웅제약나보타21개월수입금지,http://www.kpinews.co.kr/news/articleView.html?idxno=133145
9754,2020-12-17,美ITC대웅제약21개월수입금지”,http://www.sentv.co.kr/news/view/584956
9755,2020-12-17,대웅제약코로나19치료제23상변경승인,http://www.press9.kr/news/articleView.html?idxno=46593
9756,2020-12-17,대웅제약코로나치료제호이스타정대규모임상연구개시,https://www.ekn.kr/web/view.php?key=20201217010004238
9757,2020-12-17,보톡스분쟁서메디톡스승대웅제약21개월간수입금지”,https://www.donga.com/news/article/all/20201217/104484775/1
9758,2020-12-17,메디톡스대웅제약분쟁ITC대웅나보타21개월수입금지”,http://www.fnnews.com/news/202012170845475203
9759,2020-12-17,대웅제약코로나19치료제임상3상병합승인획득대규모연구개시”,http://www.youthdaily.co.kr/news/article.html?no=56323
9760,2020-12-17,대웅제약ITC균주는영업비밀아니라고판단사실상승소,http://news.mt.co.kr/mtview.php?no=2020121708460094764
9761,2020-12-17,대웅제약코로나치료제호이스타대규모23상변경승인,http://www.newsis.com/view/?id=NISX20201217_0001273343&cID=13001&pID=13000
9762,2020-12-17,글로벌코로나19치료제개발눈앞대웅제약호이스타정대규모23상변경승인,http://theviewers.co.kr/View.aspx?No=1385693
9763,2020-12-17,대웅제약호이스타정23상변경승인으로코로나19치료제개발눈앞,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65270
9764,2020-12-17,메디톡스승리확신대웅제약의균주와제조공정도용혐의밝혀졌다”,http://www.pinpointnews.co.kr/view.php?ud=202012170905414060f090c8dbcb_45
9765,2020-12-17,대웅제약대웅모두상승세로특히대웅제약가파른상승세로4상승,http://www.econonews.co.kr/news/articleView.html?idxno=149424
9766,2020-12-17,대웅제약호이스타정임상23상병합승인코로나19치료제내년1월출시목표,https://www.etoday.co.kr/news/view/1974840
9767,2020-12-17,대웅제약호이스타정23상병합승인으로연내대규모연구개시,https://www.dailian.co.kr/news/view/947257/?sc=Naver
9768,2020-12-17,대웅제약호이스타정대규모임상23상변경승인,https://www.hankyung.com/it/article/202012177991i
9769,2020-12-17,대웅제약호이스타정23상변경승인코로나19치료제개발눈앞,https://www.fetv.co.kr/news/article.html?no=71692
9770,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252641
9771,2020-12-17,메디톡스대웅제약소송패자없다주가동반강세,http://news.mt.co.kr/mtview.php?no=2020121709145562306
9772,2020-12-17,메디톡스보톡스전쟁승대웅제약사실상승소주장,https://www.paxnetnews.com/articles/68671
9773,2020-12-17,대웅제약코로나치료제호이스타정23상변경승인내년1월출시목표,http://www.viva100.com/main/view.php?key=20201217010004245
9774,2020-12-17,대웅제약균주분쟁승기사실상ITC승소,http://www.press9.kr/news/articleView.html?idxno=46591
9775,2020-12-17,대웅제약ITC명백한오판항소통해최종승리확신,http://www.newspim.com/news/view/20201217000190
9776,2020-12-17,미국ITC대웅제약나보타21개월수입금지,https://www.econovill.com/news/articleView.html?idxno=510632
9777,2020-12-17,미국ITC대웅제약나보타21개월수입금지,https://www.econovill.com/news/articleView.html?idxno=510632
9778,2020-12-17,특징주보톡스전쟁에서패소한대웅제약주가는상승세,https://www.sedaily.com/NewsView/1ZBPW15BIS
9779,2020-12-17,특징주대웅제약보톡스소송戰리스크해소에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01866326625999504
9780,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.lawissue.co.kr/view.php?ud=202012170855214348204ead0791_12
9781,2020-12-17,대웅제약호이스타정코로나192상→23상변경승인대규모임상개시,http://www.medisobizanews.com/news/articleView.html?idxno=75024
9782,2020-12-17,대웅제약코로나치료제호이스타정대규모23상개시내년1월출시목표,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124650
9783,2020-12-17,보톡스전쟁결국메디톡스승ITC대웅제약21개월간수입금지,http://www.whitepaper.co.kr/news/articleView.html?idxno=199766
9784,2020-12-17,메디톡스손들어준美ITC대웅제약나보타21개월수입금지메디톡스주가도훨훨종합,http://www.ccreview.co.kr/news/articleView.html?idxno=298497
9785,2020-12-17,美ITC메디톡스손들어줬다대웅제약21개월수입금지,http://www.metroseoul.co.kr/article/20201217500017
9786,2020-12-17,대웅제약ITC예비판결뒤집어사실상승소,http://www.businesskorea.co.kr/news/articleView.html?idxno=56930
9787,2020-12-17,美ITC보톡스분쟁서메디톡스손대웅제약21개월수입금지,http://www.ezyeconomy.com/news/articleView.html?idxno=108070
9788,2020-12-17,대웅제약코로나치료제호이스타정대규모23상변경승인,http://www.fnnews.com/news/202012170919509034
9789,2020-12-17,대웅제약호이스타정코로나19대규모임상23상승인,http://yna.kr/AKR20201217044200017?did=1195m
9790,2020-12-17,균주전쟁美ITC메디톡스손들어줬다대웅제약끝까지싸워진실밝힐것”,http://www.ajunews.com/view/20201217092359832
9791,2020-12-17,메디톡스손들어준美ITC보톡스소송최종판결후대웅제약이더강세왜,http://news.mk.co.kr/newsRead.php?no=1293486&year=2020
9792,2020-12-17,보톡스분쟁메디톡스승美ITC대웅제약나보타21개월수입금지,http://www.etnews.com/20201217000013
9793,2020-12-17,대웅제약호이스타정대규모23상변경승인코로나19치료제개발눈앞,http://www.thebigdata.co.kr/view.php?ud=202012170926078208798818e98b_23
9794,2020-12-17,공시대웅제약美ITC최종결정집행정지가처분신청법원항소제기예정,http://www.newsway.co.kr/news/view?tp=1&ud=2020121709274010612
9795,2020-12-17,대웅제약메디톡스동반상승5년간의보톡스분쟁끝,https://www.hankyung.com/finance/article/2020121781416
9796,2020-12-17,특징주내가승자”메디톡스대웅제약美ITC판결에개장후급등,http://news.heraldcorp.com/view.php?ud=20201217000134
9797,2020-12-17,대웅제약호이스타정23상병합승인연구연내개시,http://medipana.com/news/news_viewer.asp?NewsNum=268562&MainKind=A&NewsKind=5&vCount=12&vKind=1
9798,2020-12-17,대웅제약호이스타정대규모23상변경승인코로나19치료제개발눈앞,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012170925082250437
9799,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.mhj21.com/137791
9800,2020-12-17,대웅제약코로나치료제호이스타대규모23상변경승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020121709321348235
9801,2020-12-17,특징주보톡스분쟁ITC판결에메디톡스대웅제약동반강세,https://www.news1.kr/articles/?4152976
9802,2020-12-17,보톡스분쟁메디톡스승리대웅제약나보타21개월수입금지,http://www.newsprime.co.kr/news/article.html?no=527827
9803,2020-12-17,ITC나보타21개월수입금지결정대웅제약사실상승소,http://www.medigatenews.com/news/3634299707
9804,2020-12-17,특징주우리가승자대웅제약메디톡스동반강세,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573766742194
9805,2020-12-17,보톡스분쟁대웅제약판결뒤집을것항소하겠다메디톡스승리,http://www.ggilbo.com/news/articleView.html?idxno=816210
9806,2020-12-17,대웅제약코로나치료제호이스타정대규모임상개시,http://www.wolyo.co.kr/news/articleView.html?idxno=113263
9807,2020-12-17,식약처대웅제약코로나치료제호이스타23상변경승인,http://www.beyondpost.co.kr/view.php?ud=20201217094305822246a9e4dd7f_30
9808,2020-12-17,대웅제약호이스타정대규모임상23상변경승인,http://www.dt.co.kr/contents.html?article_no=2020121702109931820006&ref=naver
9809,2020-12-17,미국ITC대웅제약나보타21개월간수입금지,http://www.queen.co.kr/news/articleView.html?idxno=348613
9810,2020-12-17,대웅제약호이스타정임상23상동시에코로나19치료제개발눈앞,http://www.metroseoul.co.kr/article/20201217500057
9811,2020-12-17,나보타21개월수입금지수용못해대웅제약집행정지가처분신청,http://www.wikileaks-kr.org/news/articleView.html?idxno=100479
9812,2020-12-17,대웅제약경구형코로나19치료제개발박차호이스타정대규모23상변경승인,http://kbench.com/?q=node/216881
9813,2020-12-17,美ITC보톡스분쟁메디톡스손들어줘대웅제약항소할것,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572431008429
9814,2020-12-17,대웅제약코로나19치료제대규모임상23상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012170107&t=NN
9815,2020-12-17,美ITC최종판결에메디톡스승리vs대웅제약사실상승리,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005815
9816,2020-12-17,대웅제약코로나19치료제호이스타정대규모23상변경승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=409253
9817,2020-12-17,미국ITC최종판결서대웅제약나보타21개월수입금지종합2보,http://yna.kr/AKR20201217024852017?did=1195m
9818,2020-12-17,코스피2760선출발ITC판결에메디톡스대웅제약출렁,http://www.opinionnews.co.kr/news/articleView.html?idxno=44205
9819,2020-12-17,대웅제약코로나19치료제DWJ1248임상시험계획변경승인,https://www.asiatoday.co.kr/view.php?key=20201217010010876
9820,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.pressm.kr/news/articleView.html?idxno=35344
9821,2020-12-17,美ITC결국메디톡스손들어줘대웅제약21개월수입금지,http://www.sporbiz.co.kr/news/articleView.html?idxno=504629
9822,2020-12-17,美ITC나보타소송메디톡스손들어줘대웅제약21개월수입금지,http://www.wolyo.co.kr/news/articleView.html?idxno=113260
9823,2020-12-17,특징주5년만보톡스분쟁끝대웅제약15급등메디톡스3↑,https://www.asiatoday.co.kr/view.php?key=20201217010010888
9824,2020-12-17,소송결과는메디톡스승하지만주가는대웅제약,https://www.chosun.com/economy/stock-finance/2020/12/17/Y7H3XUHJZRH4ZLZMKPIDON4RF4/?utm_source=naver&utm_medium=referral&utm_campaign=naver-news
9825,2020-12-17,대웅제약글로벌코로나19치료제개발눈앞,http://www.businesskorea.co.kr/news/articleView.html?idxno=56940
9826,2020-12-17,막내린균주논란대웅제약보톡스21개월수입금지,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121709382176088
9827,2020-12-17,ITC보툴리눔균주영업비밀아냐메디톡스대웅제약우리가승리,http://www.segye.com/content/html/2020/12/17/20201217505556.html?OutUrl=naver
9828,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월수입금지,http://www.fntoday.co.kr/news/articleView.html?idxno=244414
9829,2020-12-17,대웅제약개발중코로나치료제호이스타정대규모23상변경승인,https://www.econovill.com/news/articleView.html?idxno=510664
9830,2020-12-17,보톡스분쟁美ITC판결놓고우리가이겼다는메디톡스대웅제약,http://www.getnews.co.kr/news/articleView.html?idxno=505122
9831,2020-12-17,특징주美ITC판결서패소한대웅제약주가왜오르지,http://daily.hankooki.com/lpage/finance/202012/dh20201217100954148310.htm?s_ref=nv
9832,2020-12-17,메디톡스대웅제약과보톡스전쟁승리美ITC나보타21개월수입금지,http://www.newsquest.co.kr/news/articleView.html?idxno=80380
9833,2020-12-17,美ITC보톡스분쟁최종판결서메디톡스손대웅제약사실상승소”,http://www.thepowernews.co.kr/view.php?ud=2020121710025750213c89f9c076_7
9834,2020-12-17,보톡스분쟁메디톡스승리미ITC대웅제약나보타21개월수입금지,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4374054
9835,2020-12-17,특징주메디톡스대웅제약美ITC판결에개장후양사모두급등,http://www.fnnews.com/news/202012171016391138
9836,2020-12-17,美ITC대웅제약나보타21개월수입금지메디톡스손들어줘,http://www.wsobi.com/news/articleView.html?idxno=110555
9837,2020-12-17,대웅제약코로나19치료제호이스타정대규모23상변경승인,http://www.newstomato.com/ReadNews.aspx?no=1013490
9838,2020-12-17,메디톡스보톡스전쟁승리美ITC대웅제약나보타21개월수입금지,http://www.sisafocus.co.kr/news/articleView.html?idxno=252369
9839,2020-12-17,메디톡스대웅제약주가초반다올라균주소송판결에불확실성해소,http://www.businesspost.co.kr/BP?command=article_view&num=209021
9840,2020-12-17,美ITC판결패소에도대웅제약장중급등왜,http://www.choicenews.co.kr/news/articleView.html?idxno=77420
9841,2020-12-17,美ITC대웅제약나보타21개월수입금지명령,http://www.healthinnews.co.kr/news/articleView.html?idxno=20817
9842,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=20818
9843,2020-12-17,보톡스소송메디톡스대웅제약결국상처만진정한승자는변호사들,http://4th.kr/View.aspx?No=1385610
9844,2020-12-17,메디톡스손들어준美ITC대웅제약나보타21개월수입금지,https://www.hankyung.com/it/article/2020121785157
9845,2020-12-17,미국ITC대웅제약나보타21개월수입금지,https://imnews.imbc.com/news/2020/econo/article/6030015_32647.html
9846,2020-12-17,대웅제약나보타10년수입금지→21개월수입금지영업비밀아닌점인정받아사실상승소,http://www.newslock.co.kr/news/articleView.html?idxno=34119
9847,2020-12-17,대웅제약코로나19치료제호이스타정식약처23상변경승인,https://health.chosun.com/site/data/html_dir/2020/12/17/2020121701180.html
9848,2020-12-17,메디톡스대웅제약과의보톡스분쟁승리에도주가는비실비실,http://www.g-enews.com/ko-kr/news/article/news_all/202012170915208298edf69f862c_1/article.html
9849,2020-12-17,나보타수입금지10년→21개월대웅제약보톡스전쟁사실상승리,http://news.tf.co.kr/read/economy/1832113.htm
9850,2020-12-17,대웅제약코로나19치료제대규모23상병합승인,http://sports.hankooki.com/lpage/economy/202012/sp20201217104125137020.htm?s_ref=nv
9851,2020-12-17,특징주대웅제약보톡스분쟁패소에도강세,https://view.asiae.co.kr/article/2020121710483156503
9852,2020-12-17,ITC대웅제약보톡스21개월수입제한명령,https://www.nocutnews.co.kr/news/5466597
9853,2020-12-17,대웅제약보톡스균주도용주장뒤집혔다균주전쟁사실상승소판단”,https://www.donga.com/news/article/all/20201217/104487253/1
9854,2020-12-17,보톡스분쟁서메디톡스승리대웅제약항소할것”,http://www.mdtoday.co.kr/mdtoday/index.html?no=409262
9855,2020-12-17,美ITC최종판결에메디톡스승소vs대웅제약사실상승소,http://www.seoulwire.com/news/articleView.html?idxno=431955
9856,2020-12-17,이데일리N美ITC메디톡스손들어줘대웅제약21개월수입금지外,http://www.edaily.co.kr/news/newspath.asp?newsid=02368166625999504
9857,2020-12-17,美보톡스전쟁서메디톡스승대웅제약나보타21개월수입금지,http://www.sportsseoul.com/news/read/993789?ref=naver
9858,2020-12-17,미국제무역위원회대웅제약보톡스제품21개월수입금지,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202012171105001&code=970100
9859,2020-12-17,주식초고수는지금셀트리온3형제인기여전대웅제약도관심,https://www.sedaily.com/NewsView/1ZBPWIMIAF
9860,2020-12-17,대웅제약코로나19치료제호이스타정대규모23상변경승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574363084732
9861,2020-12-17,부자들은경제신문을읽는다메디톡스승리에도대웅제약동반강세왜,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121711110183456
9862,2020-12-17,대웅제약호이스타정대규모23상변경승인글로벌코로나19치료제개발눈앞,http://www.thepublic.kr/news/newsview.php?ncode=1065574540129046
9863,2020-12-17,1년11개월의싸움미국ITC대웅제약나보타21개월수입금지,https://ilyo.co.kr/?ac=article_view&entry_id=387660
9864,2020-12-17,특징주대웅제약메디톡스와보톡스분쟁패소에도강세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004211805
9865,2020-12-17,8할의성공대웅제약ITC판결여전히불만,http://www.bosa.co.kr/news/articleView.html?idxno=2140370
9866,2020-12-17,대웅제약美파트너스에볼루스합의조건포함해법적문제해결할것”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012171128293930526
9867,2020-12-17,이슈ITC보톡스분쟁메디톡스명분vs대웅제약실리챙겼다,http://www.newspim.com/news/view/20201217000464
9868,2020-12-17,신풍제약대웅제약제약주상승에급등까지신풍제약4상승이어대웅제약14급등,http://www.econonews.co.kr/news/articleView.html?idxno=149512
9869,2020-12-17,국제무역위원회ITC대웅제약나보타21개월수입금지명령,http://www.k-health.com/news/articleView.html?idxno=51509
9870,2020-12-17,대웅제약호이스타정23상변경승인코로나19치료제개발가속도,http://www.sisaweek.com/news/articleView.html?idxno=140188
9871,2020-12-17,대웅제약호이스타코로나임상대규모23상으로변경,http://daily.hankooki.com/lpage/industry/202012/dh20201217114149148390.htm?s_ref=nv
9872,2020-12-17,美ITC판결놓고대웅제약메디톡스동상이몽,http://news.mt.co.kr/mtview.php?no=2020121711270562956
9873,2020-12-17,메디톡스보톡스전쟁승리美ITC대웅제약제품21개월수입금지”,http://www.munhwa.com/news/view.html?no=2020121701072039342001
9874,2020-12-17,균주전쟁메디톡스절반의승리대웅제약최악피했다”,https://cnbc.sbs.co.kr/article_hub/10001006096?division=NAVER
9875,2020-12-17,美ITC대웅제약21개월수입금지대웅제약항소할것,http://www.lawissue.co.kr/view.php?ud=202012171145557942f4ab64559d_12
9876,2020-12-17,특징주보톡스분쟁메디톡스대웅제약장중동반강세,http://yna.kr/AKR20201217089000002?did=1195m
9877,2020-12-17,美ITC대웅제약21개월수입금지메디톡스승리,http://www.obsnews.co.kr/news/articleView.html?idxno=1245310
9878,2020-12-17,미국ITC최종판결서대웅제약나보타21개월수입금지,http://www.seouleconews.com/news/articleView.html?idxno=58245
9879,2020-12-17,美ITC나보타21개월수입금지명령대웅제약사실상승소주장,http://www.newsfc.co.kr/news/articleView.html?idxno=43991
9880,2020-12-17,ITC최종결과두고메디톡스와대웅제약서로승리주장,http://www.monews.co.kr/news/articleView.html?idxno=216541
9881,2020-12-17,대웅제약코로나치료제호이스타정대규모변경승인치료제개발눈앞,http://www.koreaittimes.com/news/articleView.html?idxno=102548
9882,2020-12-17,한미약품종근당대웅제약녹십자HK이노엔,http://www.dailymedi.com/detail.php?number=864119&thread=22r05
9883,2020-12-17,보톡스분쟁서승기잡은메디톡스대웅제약사실상우리의승소,http://kormedi.com/?p=1329320
9884,2020-12-17,대웅제약전승호대표균주사실상기각항소심서999승소할것,http://www.newsis.com/view/?id=NISX20201217_0001273854&cID=13001&pID=13000
9885,2020-12-17,대웅제약코로나19치료제호이스타정23상변경승인받아,http://www.newsfc.co.kr/news/articleView.html?idxno=43995
9886,2020-12-17,메디톡스손들어준ITC판결대웅제약판정승주가급등,http://medipana.com/news/news_viewer.asp?NewsNum=268587&MainKind=A&NewsKind=5&vCount=12&vKind=1
9887,2020-12-17,종합美서결론난보톡스전쟁메디톡스이겼지만대웅제약도절반의성공,http://www.viva100.com/main/view.php?key=20201217010004334
9888,2020-12-17,대웅제약호이스타정코로나19치료제임상23상으로변경,http://www.mkhealth.co.kr/news/articleView.html?idxno=51486
9889,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.wsobi.com/news/articleView.html?idxno=110571
9890,2020-12-17,대웅제약23상변경승인으로코로나19치료제개발가속,http://www.economytalk.kr/news/articleView.html?idxno=209958
9891,2020-12-17,대웅제약ITC최종판정은긍정적이슈KTB證,http://www.itooza.com/common/iview.php?no=2020121711220919092
9892,2020-12-17,대웅제약미국ITC의21개월금지명령즉각가처분신청승리확신,http://www.ceoscoredaily.com/news/article.html?no=76327
9893,2020-12-17,보톡스전쟁ITC판결메디톡스대웅제약동상이몽,http://www.skyedaily.com/news/news_view.html?ID=118271
9894,2020-12-17,메디톡스대웅제약희비엇갈려메디톡스고꾸라지는주가반해대웅제약17급등,http://www.econonews.co.kr/news/articleView.html?idxno=149539
9895,2020-12-17,대웅제약호이스타코로나치료제대규모23상변경승인,http://www.kpinews.co.kr/news/articleView.html?idxno=133203
9896,2020-12-17,대웅제약호이스타정글로벌코로나19치료제개발눈앞,http://www.bosa.co.kr/news/articleView.html?idxno=2140379
9897,2020-12-17,보톡스분쟁진대웅제약그래도주가는날개달았다,http://www.ajunews.com/view/20201217131258037
9898,2020-12-17,오전시황해운제지제약업종강세HMM신풍제지메디콕스대웅제약훨훨이녹스이스타코급등,http://www.pinpointnews.co.kr/view.php?ud=202012171331086047cd1e7f0bdf_45
9899,2020-12-17,메디톡스대웅제약보톡스분쟁종지부국내후발주자엔악재,http://www.mediapen.com/news/view/584479
9900,2020-12-17,대웅제약코로나치료제임상시험계획변경승인,http://www.edaily.co.kr/news/newspath.asp?newsid=02742086625999504
9901,2020-12-17,대웅제약메디톡스와의나보타관련소송판결에항소,http://www.edaily.co.kr/news/newspath.asp?newsid=02748646625999504
9902,2020-12-17,대웅제약호이스타정코로나19임상23상변경승인,http://www.seoulfn.com/news/articleView.html?idxno=404693
9903,2020-12-17,대웅보톡스21개월수입금지”ITC판결에메디톡스대웅제약모두승리주장,http://news.kmib.co.kr/article/view.asp?arcid=0015333830&code=61141411&cp=nv
9904,2020-12-17,대웅제약먹는코로나19치료제임상23상을식약처로부터승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=209080
9905,2020-12-17,대웅제약코로나치료제호이스타정23상변경승인,http://www.koreastocknews.com/news/articleView.html?idxno=59966
9906,2020-12-17,21개월수입금지된나보타대웅제약아메리칸드림향방은,https://www.etoday.co.kr/news/view/1975058
9907,2020-12-17,코로나19치료제개발눈앞대웅제약호이스타정23상변경승인,http://www.thedailypost.kr/news/articleView.html?idxno=78196
9908,2020-12-17,보톡스분쟁메디톡스판정승미ITC대웅제약나보타21개월수입금지명령,http://www.newsworks.co.kr/news/articleView.html?idxno=513007
9909,2020-12-17,대웅제약코로나치료제임상3상대열합류호이스타정임상23상병합승인,https://www.donga.com/news/article/all/20201217/104491277/1
9910,2020-12-17,대웅제약균주도용혐의기각목표가상향할것KTB투자증권,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121714050777622
9911,2020-12-17,미국ITC보톡스분쟁서메디톡스손들어줘대웅제약항소할것 ,http://www.updownnews.co.kr/news/articleView.html?idxno=226417
9912,2020-12-17,ITC메디톡스손들어줬다대웅제약나보타21개월간수입금지,http://www.metroseoul.co.kr/article/20201217500293
9913,2020-12-17,대웅제약코로나19치료제23상병합연내돌입,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137789&REFERER=NP
9914,2020-12-17,대웅제약ITC21개월금지명령에즉각가처분신청ITC결정영향없이글로벌사업지속확대,http://www.thefirstmedia.net/news/articleView.html?idxno=67848
9915,2020-12-17,대웅제약코로나치료제호이스타정대규모23상승인,http://news.mt.co.kr/mtview.php?no=2020121711543666802
9916,2020-12-17,대웅제약코로나19치료제호이스타정23상변경승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=85472
9917,2020-12-17,대웅제약코로나19치료제호이스타정임상23상변경승인,https://www.sedaily.com/NewsView/1ZBPWTBVV8
9918,2020-12-17,메디톡스대웅제약균주전쟁최종판결해석차여전,http://www.newstomato.com/ReadNews.aspx?no=1013575
9919,2020-12-17,보톡스분쟁패소에도대웅제약메디톡스와장중동반강세,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4374442
9920,2020-12-17,대웅제약균주전쟁승리사실상ITC승소,http://www.asiaa.co.kr/news/articleView.html?idxno=12884
9921,2020-12-17,메디톡스대웅제약상대보톡스5년분쟁승리했지만갈등불씨여전,https://www.ekn.kr/web/view.php?key=20201217010004387
9922,2020-12-17,보툴리눔균주공방서웃은메디톡스대웅제약진실밝힐것,http://www.shinailbo.co.kr/news/articleView.html?idxno=1355961
9923,2020-12-17,美ITC대웅제약나보타21개월수입금지메디톡스손들어줘,http://www.thefirstmedia.net/news/articleView.html?idxno=67852
9924,2020-12-17,사실상대웅제약勝소송결과에메디톡스내리고대웅제약오르고,http://news.mt.co.kr/mtview.php?no=2020121714550935351
9925,2020-12-17,대웅제약호이스타정코로나19대규모임상23상승인,http://it.chosun.com/site/data/html_dir/2020/12/17/2020121702042.html
9926,2020-12-17,대웅제약호이스타정식약처로부터23상변경승인코로나19치료제개발속도,https://www.news2day.co.kr/article/20201217500205
9927,2020-12-17,대웅제약주가돌풍왜명신산업에이비프로바이오등급등주관심,http://www.g-enews.com/ko-kr/news/article/news_all/202012171457559211c642673384_1/article.html
9928,2020-12-17,대웅제약폭주막을수없다메디톡스와균주분쟁완화된판결상한가훨훨,http://www.pinpointnews.co.kr/view.php?ud=202012171508397373861beb2d9d_45
9929,2020-12-17,대웅제약호이스타정대규모임상23상변경승인,http://inthenews.co.kr/article-83074/
9930,2020-12-17,대웅제약대웅마감앞두고폭등에상한가까지대웅제약상한가이어대웅28폭등,http://www.econonews.co.kr/news/articleView.html?idxno=149564
9931,2020-12-17,대웅제약균주전쟁승리사실상ITC승소,http://www.nbnnews.co.kr/news/articleView.html?idxno=450762
9932,2020-12-17,미국ITC판결대웅제약나보타21개월수입금지,http://yna.kr/PYH20201217170500013?did=1196m
9933,2020-12-17,미국수입금지명령받은대웅제약,http://yna.kr/PYH20201217170700013?did=1196m
9934,2020-12-17,미국ITC판결대웅제약나보타21개월수입금지,http://yna.kr/PYH20201217170600013?did=1196m
9935,2020-12-17,미국수입금지명령받은대웅제약,http://yna.kr/PYH20201217170800013?did=1196m
9936,2020-12-17,특징주보톡스분쟁패소에도대웅제약상한가종합,http://yna.kr/AKR20201217089051002?did=1195m
9937,2020-12-17,종지부찍은균주분쟁5년메디톡스대웅제약모두의승리냐상처냐,http://www.ajunews.com/view/20201217151655174
9938,2020-12-17,대웅제약코로나19치료제호이스타정글로벌23상승인,http://www.medigatenews.com/news/842802739
9939,2020-12-17,美ITC소송서진대웅제약은上이긴메디톡스는하락왜,http://news.mk.co.kr/newsRead.php?no=1296255&year=2020
9940,2020-12-17,IB토마토대웅제약미국ITC최종판결리스크선반영,http://www.newstomato.com/ReadNews.aspx?no=1013645
9941,2020-12-17,보톡스전쟁3라운드서대웅제약판정패,https://hankookilbo.com/News/Read/A2020121710030001410?did=NA
9942,2020-12-17,대웅제약코로나19치료제개발기대감에상한가,http://sports.hankooki.com/lpage/economy/202012/sp20201217160949137020.htm?s_ref=nv
9943,2020-12-17,급등락주짚어보기메디콕스대웅제약디아이씨삼화페인트상한가기록,https://www.etoday.co.kr/news/view/1975170
9944,2020-12-17,대웅제약호이스타정23상병합승인코로나19치료제개발목전,http://www.lcnews.co.kr/news/articleView.html?idxno=10993
9945,2020-12-17,대웅제약상한가메디톡스5하락반전속에주가희비,https://www.sedaily.com/NewsView/1ZBPWA217D
9946,2020-12-17,대웅제약코로나19치료제호이스타정식약처임상23상변경승인,http://www.getnews.co.kr/news/articleView.html?idxno=505215
9947,2020-12-17,대웅제약호이스타정코로나19임상23상병합승인,https://view.asiae.co.kr/article/2020121716280777298
9948,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.thefirstmedia.net/news/articleView.html?idxno=67879
9949,2020-12-17,코스피277043보합권마감대웅제약상한가,http://www.opinionnews.co.kr/news/articleView.html?idxno=44228
9950,2020-12-17,대웅제약나보타美수출금지에도조용히웃는이유는,https://www.asiatoday.co.kr/view.php?key=20201217010011437
9951,2020-12-17,이인애의뒷담화메디톡스미국에서대웅제약눌렀다국내소송전으로분풀이예고,http://theviewers.co.kr/View.aspx?No=1386863
9952,2020-12-17,17일오늘의상한가총정리대웅제약보톡스분쟁패소불구상한가명신산업3거래일연속강세,http://www.ccreview.co.kr/news/articleView.html?idxno=298548
9953,2020-12-17,메디톡스절반의승리보툴리눔영업비밀아니지만대웅제약관세법위반판결,https://www.news2day.co.kr/article/20201217500250
9954,2020-12-17,백신반도체테마주도대웅대웅제약메디콕스상한가행진이스타코메디포스트새로닉스강세,http://www.pinpointnews.co.kr/view.php?ud=202012171642147124cd1e7f0bdf_45
9955,2020-12-17,모더나화이자아스트라제네카아슬아슬한백신랠리대웅제약신풍제약현대바이오주가가속질주,http://www.pinpointnews.co.kr/view.php?ud=202012171646569760861beb2d9d_45
9956,2020-12-17,대웅제약새벽미국장마감후ITC최종판정공개21개월수입금지명령조치”,https://www.news2day.co.kr/article/20201217500284
9957,2020-12-17,보톡스분쟁서승소한메디톡스대웅제약상대손해배상소송결과주목,http://www.sisajournal-e.com/news/articleView.html?idxno=227140
9958,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.paxetv.com/news/articleView.html?idxno=106694
9959,2020-12-17,보톡스분쟁졌는데상한가간대웅제약왜박해린의뉴스마켓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012170279&t=NNv
9960,2020-12-17,김창수의e뉴스브리핑4년걸친보톡스분쟁메디톡스승리美ITC대웅제약나보타21개월수입금지”外,https://www.fetv.co.kr/news/article.html?no=71827
9961,2020-12-17,메디톡스대웅제약모두절반승리끝나지않은균주전쟁,https://www.sedaily.com/NewsView/1ZBPX7XOXJ
9962,2020-12-17,식약처대웅제약코로나19치료제호이스타정23상임상허가,http://www.newsfreezone.co.kr/news/articleView.html?idxno=283222
9963,2020-12-17,17일특징주대웅제약삼화페인트메디콕스에프앤리퍼블릭등6개종목상한가,http://www.newsworks.co.kr/news/articleView.html?idxno=513120
9964,2020-12-17,대웅제약보톡스분쟁패소에도상한가사실상최종승자,https://www.ajunews.com/view/20201217173223307
9965,2020-12-17,퇴근길제약Pin메디톡스vs대웅제약보톡스전쟁모두가승자外,http://www.pinpointnews.co.kr/view.php?ud=202012171736334853f090c8dbcb_45
9966,2020-12-17,메디톡스vs대웅제약독한전쟁누가이겼나,http://www.wikileaks-kr.org/news/articleView.html?idxno=100541
9967,2020-12-17,대웅제약나보타수입금지가처분신청및항소할것,https://www.news2day.co.kr/article/20201217500304
9968,2020-12-17,대웅제약메디톡스ITC일단락이제는국내소송,http://daily.hankooki.com/lpage/industry/202012/dh20201217181808148390.htm?s_ref=nv
9969,2020-12-17,대웅제약균주소송이어갈태세미국보툴리눔톡신시장포기어려워,http://www.businesspost.co.kr/BP?command=article_view&num=209164
9970,2020-12-17,마감종합기사대웅메디톡스분쟁끝대웅제약과메디콕스모두상한가삼화페인트2연속상한가,http://www.ggilbo.com/news/articleView.html?idxno=816460
9971,2020-12-17,메디톡스대웅제약과기나긴미국균주소송이겨도개운치않다,http://www.businesspost.co.kr/BP?command=article_view&num=209194
9972,2020-12-17,대웅제약호이스타정23상변경승인코로나19치료제개발가속화,http://news.kbiz.or.kr/news/articleView.html?idxno=75802
9973,2020-12-17,대웅제약글로벌코로나19치료제개발눈앞호이스타정대규모23상변경승인,http://www.kdpress.co.kr/news/articleView.html?idxno=99498
9974,2020-12-17,미ITC판결두고엇갈린주장메디톡스대웅의도용혐의밝혀져대웅제약사실상승소,http://www.kdpress.co.kr/news/articleView.html?idxno=99499
9975,2020-12-17,상한가종목대웅제약삼화페인트상한가마감뒤이어디아이씨이녹스메디콕스에프앤리퍼블릭상한가,http://www.econonews.co.kr/news/articleView.html?idxno=149568
9976,2020-12-17,마감한국전력연료비연동제도입급등대웅제약ITC패소에도상한가,https://www.asiatime.co.kr/news/newsview.php?ncode=1065623429898524
9977,2020-12-18,﻿미국ITC판결두고또다시대립대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510939337
9978,2020-12-18,2020년상반기완제의약품생산실적한미약품종근당대웅제약순,http://medicalworldnews.co.kr/news/view.php?idx=1510939340
9979,2020-12-18,대웅제약나보타21개월수입금지”,http://news.kmib.co.kr/article/view.asp?arcid=0924170155&code=11151400&cp=nv
9980,2020-12-18,메디톡스대웅제약상대ITC절반의승리,http://www.edaily.co.kr/news/newspath.asp?newsid=01295606625999832
9981,2020-12-18,코로나확진자폭발모더나도빨리빨리현대바이오대웅제약셀트리온신풍제약주목,http://www.pinpointnews.co.kr/view.php?ud=202012180449143119861beb2d9d_45
9982,2020-12-18,메디톡스손들어줬는데오히려대웅제약30상한가,http://www.dailymedi.com/detail.php?number=864153&thread=22r05
9983,2020-12-18,관심종목ITC판정메디톡스와대웅제약간소송에영향줄수있어하나금융투자,http://www.getnews.co.kr/news/articleView.html?idxno=505296
9984,2020-12-18,증시키워드대웅제약사실상승소”주장에上한국전력연료비연동제소식에강세,https://www.etoday.co.kr/news/view/1975293
9985,2020-12-18,대웅제약대웅모두가파른상승세로급등대웅제약15급등이어대웅6급등,http://www.econonews.co.kr/news/articleView.html?idxno=149603
9986,2020-12-18,특징주대웅제약보톡스분쟁이슈소멸에강세,https://www.etoday.co.kr/news/view/1975334
9987,2020-12-18,특징주대웅제약ITC불확실성해소에이틀째강세,http://www.newspim.com/news/view/20201218000168
9988,2020-12-18,특징주전일상한가찍은대웅제약장초반20대급등,https://www.sedaily.com/NewsView/1ZBQBXKRG6
9989,2020-12-18,기자수첩대웅제약vs메디톡스진정한승자는누구,http://www.seoulwire.com/news/articleView.html?idxno=432021
9990,2020-12-18,특징주대웅제약연일급등세코로나치료제개발순항,http://www.fnnews.com/news/202012180932381957
9991,2020-12-18,시장은대웅제약승리메디톡스소송패소하고도강세,http://news.mt.co.kr/mtview.php?no=2020121809345814040
9992,2020-12-18,특징주대웅제약장중22대상승신고가경신,https://view.asiae.co.kr/article/2020121809495572179
9993,2020-12-18,메디톡스ITC판결전문에대웅제약불법행위공개될것,http://www.kpinews.co.kr/news/articleView.html?idxno=133250
9994,2020-12-18,10년→21개월걱정덜어낸대웅제약에월가도랠리,http://news.mt.co.kr/mtview.php?no=2020121809471167534
9995,2020-12-18,특징주보톡스분쟁마무리대웅제약연일장중급등,http://yna.kr/AKR20201218049100002?did=1195m
9996,2020-12-18,대웅제약소송불확실성해소에주가훨훨이틀째급등,http://www.g-enews.com/ko-kr/news/article/news_all/202012180941146468edf69f862c_1/article.html
9997,2020-12-18,특징주대웅제약코로나19치료제기대감소송종료에이틀째강세,https://www.asiatoday.co.kr/view.php?key=20201218010011725
9998,2020-12-18,메디톡스대웅제약보톨리눔톡신제제사업지속불가능할것,http://www.startuptoday.co.kr/news/articleView.html?idxno=64567
9999,2020-12-18,메디톡스ITC판결전문에대웅제약균주도용명시10일내공개,http://www.getnews.co.kr/news/articleView.html?idxno=505320
10000,2020-12-18,대웅제약보톡스분쟁이슈해소에신고가메디톡스도상승,https://www.hankyung.com/finance/article/2020121829166
10001,2020-12-18,강세업종제약업종상승세대웅제약20↑,http://www.itooza.com/common/iview.php?no=2020121810101991183
10002,2020-12-18,특징주보톡스분쟁마무리대웅제약연일급등,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004212869
10003,2020-12-18,대웅제약왜폭등하나봤더니이거였네소송불확실성해소에매수세몰려,http://www.pinpointnews.co.kr/view.php?ud=202012181034008893861beb2d9d_45
10004,2020-12-18,특징주대웅제약전날상한가이어20올라ITC와다른손든시장,http://www.kdfnews.com/news/articleView.html?idxno=63650
10005,2020-12-18,머니e종목대웅제약소송불확실성해소에급등에볼루스도2153↑,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121810542491059
10006,2020-12-18,대웅제약메디톡스둘다항소끝나도안끝났다,http://www.newsis.com/view/?id=NISX20201218_0001275222&cID=13001&pID=13000
10007,2020-12-18,오전시황백신전기차보톡스테마강세현대바이오대웅제약디아이씨훨훨화신네스엠KMH급등,http://www.pinpointnews.co.kr/view.php?ud=202012181120165546cd1e7f0bdf_45
10008,2020-12-18,특징주대웅제약보톡스분쟁선졌지만증시선연일급등,http://daily.hankooki.com/lpage/finance/202012/dh20201218113122148310.htm?s_ref=nv
10009,2020-12-18,대웅제약아이엔테라퓨틱스포스텍KIURI연구단과MOU,http://www.businesskorea.co.kr/news/articleView.html?idxno=57071
10010,2020-12-18,끝보이지않는보톡스전쟁대웅제약가처분항소할것,http://www.sisaweek.com/news/articleView.html?idxno=140236
10011,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,https://www.fetv.co.kr/news/article.html?no=71906
10012,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=20869
10013,2020-12-18,보톡스전쟁패한대웅제약17일주식상한가가며의문의1승,http://www.enewstoday.co.kr/news/articleView.html?idxno=1437174
10014,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단공동연구협약체결,http://www.asiaa.co.kr/news/articleView.html?idxno=13032
10015,2020-12-18,대웅제약자회사아이엔포스텍과이온채널구조공동연구협약,http://www.medisobizanews.com/news/articleView.html?idxno=75074
10016,2020-12-18,대웅제약ITC최종결정이후이틀연속강세고공행진,http://medipana.com/news/news_viewer.asp?NewsNum=268659&MainKind=A&NewsKind=5&vCount=12&vKind=1
10017,2020-12-18,균주도용판결호재됐나대웅제약이틀새주가60↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=271666&REFERER=NP
10018,2020-12-18,대웅제약주가장중뛰어코로나19치료제개발진척부각,http://www.businesspost.co.kr/BP?command=article_view&num=209269
10019,2020-12-18,대웅제약vs메디톡스소송전현재진행형,http://www.betanews.net:8080/article/1246139.html
10020,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍연구단과공동연구협약,http://www.metroseoul.co.kr/article/20201218500074
10021,2020-12-18,대웅제약자회사포스텍KIURI연구단과공동연구협약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=37605
10022,2020-12-18,메디톡스ITC판결전문에대웅제약도용혐의명시,http://www.cstimes.com/news/articleView.html?idxno=443712
10023,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍연구단과공동연구협약,http://www.edaily.co.kr/news/newspath.asp?newsid=02525606625999832
10024,2020-12-18,대웅제약대웅내내이어지는급등대웅제약19급등이어대웅11급등,http://www.econonews.co.kr/news/articleView.html?idxno=149690
10025,2020-12-18,보톡스분쟁마무리대웅제약장중20대급등,http://www.startuptoday.co.kr/news/articleView.html?idxno=64593
10026,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.lawissue.co.kr/view.php?ud=202012181406371007204ead0791_12
10027,2020-12-18,美ITC보툴리눔균주영업기밀아니다지고도이긴대웅제약,http://www.meconomynews.com/news/articleView.html?idxno=48538
10028,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍과이온채널구조공동연구협약,http://www.newsworks.co.kr/news/articleView.html?idxno=513388
10029,2020-12-18,삼화페인트주가돌풍휴미시스대웅제약등급등주눈길,http://www.g-enews.com/ko-kr/news/article/news_all/202012181430248082c642673384_1/article.html
10030,2020-12-18,먹는코로나치료제나올까대웅제약임상속도낸다,http://www.koreastocknews.com/news/articleView.html?idxno=60018
10031,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍연구진과손잡고신약개발역량강화,https://www.asiatoday.co.kr/view.php?key=20201218010011999
10032,2020-12-18,메디톡스나보타국내허가취소추진대웅제약전승호대표허위주장강력반발,https://www.news2day.co.kr/article/20201218500198
10033,2020-12-18,경보제약대웅제약제약주모두급등특히경보제약오후갑작스런20급등,http://www.econonews.co.kr/news/articleView.html?idxno=149701
10034,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약,http://www.segye.com/content/html/2020/12/18/20201218510036.html?OutUrl=naver
10035,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=451121
10036,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍키우리연구단과공동연구협약체결,https://www.hankyung.com/it/article/202012183829i
10037,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍과공동연구협약,http://www.thedailypost.kr/news/articleView.html?idxno=78240
10038,2020-12-18,TF특징주대웅제약장중20가량상승중신고가경신,http://news.tf.co.kr/read/economy/1832414.htm
10039,2020-12-18,특징주보톡스분쟁마무리대웅제약이틀간57↑종합,http://yna.kr/AKR20201218049151002?did=1195m
10040,2020-12-18,코로나치료제기대감에대웅제약이틀간주가57급등,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4375657
10041,2020-12-18,최악피한대웅제약에볼루스소송국내민사로전선확대되나,http://www.kpinews.co.kr/news/articleView.html?idxno=133325
10042,2020-12-18,대웅제약균주소송관련제조공정도용혐의없어항소통해규명”,https://www.fetv.co.kr/news/article.html?no=71944
10043,2020-12-18,대웅제약균주도용직접적증거없어메디톡스주장반박,http://medipana.com/news/news_viewer.asp?NewsNum=268685&MainKind=A&NewsKind=5&vCount=12&vKind=1
10044,2020-12-18,ITC끝나도균주출처논쟁대웅제약도용증거없다고밝혀져”,http://daily.hankooki.com/lpage/industry/202012/dh20201218164641148390.htm?s_ref=nv
10045,2020-12-18,메디톡스균주는영업비밀vs대웅제약도용증거없어,http://www.seoulwire.com/news/articleView.html?idxno=432081
10046,2020-12-18,메디톡스대웅제약ITC분쟁2회전유감기자의눈,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202012181704001&code=940601
10047,2020-12-18,대웅제약도용의직접적증거없다고이미밝혀졌다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1356490
10048,2020-12-18,대웅제약ITC최종결정서도도용의직접적증거없어반박,http://www.medisobizanews.com/news/articleView.html?idxno=75086
10049,2020-12-18,제지건설제약업종강세국일제지한일홀딩스대웅제약급등명신산업삼화페인트디아이씨동신건설상한가행진,http://www.pinpointnews.co.kr/view.php?ud=202012181707259050cd1e7f0bdf_45
10050,2020-12-18,메디톡스ITC항소대웅제약나보타폐기조치진행할것,https://www.econovill.com/news/articleView.html?idxno=510989
10051,2020-12-18,대웅제약ITC최종결정에서도용증거없어메디톡스주장반박,http://www.viva100.com/main/view.php?key=20201218010004745
10052,2020-12-18,대웅제약자회사아이엔테라퓨틱스이온채널플랫폼정밀도높인다,http://www.medigatenews.com/news/1450128650
10053,2020-12-18,대웅제약ITC판결달리해석하는메디톡스에반박,http://www.businesskorea.co.kr/news/articleView.html?idxno=57103
10054,2020-12-18,대웅제약자회사이온채널구조공동연구협약체결,http://www.100ssd.co.kr/news/articleView.html?idxno=73584
10055,2020-12-18,메디톡스불법행위공개될것VS대웅제약도용직접증거없어,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012180378&t=NN
10056,2020-12-18,대웅제약균주도용직접적증거없다美ITC도인정”,https://www.donga.com/news/article/all/20201218/104513491/1
10057,2020-12-18,대웅제약아이엔테라퓨틱스포스텍과공동연구협약체결민관학民官學협력모델구축,http://www.lcnews.co.kr/news/articleView.html?idxno=11041
10058,2020-12-18,뉴스투데이L대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,https://www.news2day.co.kr/article/20201218500283
10059,2020-12-18,보톡스분쟁신경전계속대웅제약ITC판결균주영업비밀침해없다고명시,https://www.asiatoday.co.kr/view.php?key=20201218010012168
10060,2020-12-18,대웅제약아이엔테라퓨틱스포스텍키우리연구단과공동연구협약,https://www.donga.com/news/article/all/20201218/104513885/1
10061,2020-12-18,혼돈의보톡스시장대웅제약메디톡스다툼에주목받는종근당,http://www.insightkorea.co.kr/news/articleView.html?idxno=85515
10062,2020-12-18,대웅제약VS메디톡스보톡스분쟁계속둘다항소,http://www.wolyo.co.kr/news/articleView.html?idxno=113397
10063,2020-12-18,ITC최종결론나왔지만메디톡스vs대웅제약논쟁ing,http://www.medigatenews.com/news/2283576148
10064,2020-12-18,대웅제약균주도용직접적증거전혀없다메디톡스주장반박,http://www.thebigdata.co.kr/view.php?ud=202012182004506354d0a8833aad_23
10065,2020-12-18,인도아프리카저개발국코로나19관련특허권리무효화요구아스트라제네카존슨앤존슨관련주에이비프로바이오진매트릭스및삼성바이오종근당대웅제약등주목,http://www.econonews.co.kr/news/articleView.html?idxno=149763
10066,2020-12-19,초점극단치닫는대웅제약메디톡스보톡스균주분쟁,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005915
10067,2020-12-19,주간HOT종목보톡스전쟁메디톡스VS대웅제약,https://view.asiae.co.kr/article/2020121914242116240
10068,2020-12-19,메디톡스대웅제약둘다항소균주도용혐의밝혀져vs균주는영업비밀아니다,http://www.econonews.co.kr/news/articleView.html?idxno=149867
10069,2020-12-19,대웅제약vs메디톡스미국ITC위원회최종판결모두항소,http://medicalworldnews.co.kr/news/view.php?idx=1510939370
10070,2020-12-20,ITC메디톡스vs대웅제약판결에주목하는배터리업계,https://www.etoday.co.kr/news/view/1975661
10071,2020-12-21,대웅제약대표호이스타정내달코로나19치료제로출시목표,http://yna.kr/AKR20201218155700017?did=1195m
10072,2020-12-21,메디톡스도대웅제약도아닌앨러간이진정한승자,http://www.bosa.co.kr/news/articleView.html?idxno=2140533
10073,2020-12-21,대웅제약대표호이스타정코로나치료제로출시임박”,http://news.kmib.co.kr/article/view.asp?arcid=0015344070&code=61171911&cp=nv
10074,2020-12-21,대웅제약코로나19치료제임상2상결과연내공개,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012210016&t=NN
10075,2020-12-21,패자는없다메디톡스대웅제약美ITC최종판결두고우리가勝,http://www.youthdaily.co.kr/news/article.html?no=56457
10076,2020-12-21,대웅제약이달중호이스타정임상2상톱라인결과공개,https://www.hankyung.com/it/article/2020122191937
10077,2020-12-21,대웅제약대표호이스타정국내첫알약코로나치료제될것,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4377144
10078,2020-12-21,대웅제약균주전쟁승리나머지오판도바로잡을것,http://www.press9.kr/news/articleView.html?idxno=46616
10079,2020-12-21,대웅제약대표호이스타정코로나19치료제로출시임박”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012210907404170044
10080,2020-12-21,대웅제약코로나치료제1월출시장초반25급등,http://news.mt.co.kr/mtview.php?no=2020122109130728283
10081,2020-12-21,특징주대웅제약코로나치료제개발에3거래일째20대↑,http://www.edaily.co.kr/news/newspath.asp?newsid=01777766626000816
10082,2020-12-21,대웅제약균주전쟁끝났다나머지오판도바로잡겠다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252735
10083,2020-12-21,동화약품대웅제약제약주모두급등대웅제약25급등이어동화약품14급등,http://www.econonews.co.kr/news/articleView.html?idxno=149958
10084,2020-12-21,특징주곰의기운어디까지대웅제약3거래일연속급등,https://www.sedaily.com/NewsView/1ZBRQ2SNCH
10085,2020-12-21,특징주대웅제약코로나19치료제임상결과앞두고상승세,http://www.inews24.com/view/1328423
10086,2020-12-21,대웅제약이달중호이스타정임상2상톱라인결과공개내달출시목표,http://www.getnews.co.kr/news/articleView.html?idxno=505625
10087,2020-12-21,코스피코스닥동반하락출발대웅제약써니전자안랩급등,http://www.businesspost.co.kr/BP?command=article_view&num=209462
10088,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,https://www.ebn.co.kr/news/view/1464738/?sc=Naver
10089,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46621
10090,2020-12-21,코스피277272보합권출발대웅제약급등에단일가로거래중,http://www.opinionnews.co.kr/news/articleView.html?idxno=44320
10091,2020-12-21,대웅제약상한가코로나19치료제임상2상톱라인결과이달공개,http://www.ajunews.com/view/20201221093330696
10092,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252741
10093,2020-12-21,대웅제약일부공정기술침해ITC판결바로잡겠다,http://www.mediapen.com/news/view/585392
10094,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비정부과제선정,http://www.pharmnews.com/news/articleView.html?idxno=101950
10095,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.lawissue.co.kr/view.php?ud=202012210941418072204ead0791_12
10096,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=57150
10097,2020-12-21,대웅제약코로나19치료제임상결과연내공개소식에상한가급등,http://www.g-enews.com/ko-kr/news/article/news_all/202012210935271430edf69f862c_1/article.html
10098,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,https://www.dailian.co.kr/news/view/948365/?sc=Naver
10099,2020-12-21,특징주대웅제약코로나19치료제임상2상결과공개소식에급등,http://www.fnnews.com/news/202012210950546156
10100,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,http://www.youthdaily.co.kr/news/article.html?no=56770
10101,2020-12-21,대웅제약니클로사마이드코로나19치료제정부과제선정,http://www.metroseoul.co.kr/article/20201221500040
10102,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.thebigdata.co.kr/view.php?ud=202012210953442810798818e98b_23
10103,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,https://www.fetv.co.kr/news/article.html?no=72053
10104,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제예비선정,http://news.mt.co.kr/mtview.php?no=2020122109512956472
10105,2020-12-21,대웅제약균주영업비밀가치없다판결논란끝,http://www.wikileaks-kr.org/news/articleView.html?idxno=100677
10106,2020-12-21,특징주대웅제약내달코로나19치료제출시목표기대상한가,https://www.etoday.co.kr/news/view/1976019
10107,2020-12-21,특징주대웅제약급등세코로나19치료제임상2상결과연내공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574889352433
10108,2020-12-21,21일장중코로나주종근당대웅제약껑충vs신풍제약하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77520
10109,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,http://www.newstomato.com/ReadNews.aspx?no=1014052
10110,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.kpinews.co.kr/news/articleView.html?idxno=133373
10111,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020122110024276848
10112,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,http://www.medisobizanews.com/news/articleView.html?idxno=75107
10113,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012210091&t=NN
10114,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,https://www.ekn.kr/web/view.php?key=20201221010005049
10115,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122110093131559
10116,2020-12-21,대웅제약균주전쟁은끝났다나머지오판도바로잡을것,http://www.wolyo.co.kr/news/articleView.html?idxno=113416
10117,2020-12-21,대웅제약메디톡스에연일공세영업비밀국내소송서가리자,http://www.medisobizanews.com/news/articleView.html?idxno=75106
10118,2020-12-21,코로나변종의습격모더나화이자에주목셀트리온헬스케어대웅제약유나이티드제약날라가나,http://www.pinpointnews.co.kr/view.php?ud=202012210957466155861beb2d9d_45
10119,2020-12-21,대웅제약 코로나19치료제 생산장비 구축지원 정부과제 선정,http://kormedi.com/?p=1329572
10120,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://sports.hankooki.com/lpage/economy/202012/sp20201221101705137020.htm?s_ref=nv
10121,2020-12-21,대웅제약코로나19치료제니클로사마이드정부과제예비선정,https://health.chosun.com/site/data/html_dir/2020/12/21/2020122100945.html
10122,2020-12-21,상반기긴급사용승인목표대웅제약니클로사마이드코로나19치료제정부과제선정,http://theviewers.co.kr/View.aspx?No=1389610
10123,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.newspim.com/news/view/20201221000267
10124,2020-12-21,못말리는대웅제약상한가깜짝왜셀트리온종근당유나이티드제약부광약품도훨훨,http://www.pinpointnews.co.kr/view.php?ud=202012211024158204861beb2d9d_45
10125,2020-12-21,대웅제약니클로사마이드 생산장비구축지원예비선정,http://www.koreastocknews.com/news/articleView.html?idxno=60042
10126,2020-12-21,복지부대웅제약코로나치료제생산장비구축에19억원지원,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124743
10127,2020-12-21,대웅제약코로나19치료제생산정부지원예비선정 ,http://www.medical-tribune.co.kr/news/articleView.html?idxno=97273
10128,2020-12-21,대웅제약정부코로나19치료제생산장비구축지원과제예비선정,https://biz.chosun.com/site/data/html_dir/2020/12/21/2020122101002.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10129,2020-12-21,대웅제약균주분쟁은끝vs메디톡스국내승소도자신,http://yna.kr/AKR20201221044200017?did=1195m
10130,2020-12-21,대웅제약호이스타정코로나치료제로출시임박23일임상2상결과공개,http://www.dt.co.kr/contents.html?article_no=2020122102109931102003&ref=naver
10131,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,https://www.etoday.co.kr/news/view/1976062
10132,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,http://www.monews.co.kr/news/articleView.html?idxno=216650
10133,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.asiaa.co.kr/news/articleView.html?idxno=13586
10134,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012211039453620134
10135,2020-12-21,대웅제약코로나19치료제장비구축정부과제예비선정”,https://www.hankyung.com/it/article/202012210177i
10136,2020-12-21,대웅제약개발코로나19치료제정부가생산장비구축지원한다,https://www.asiatoday.co.kr/view.php?key=20201221010012936
10137,2020-12-21,대웅제약균주전쟁끝허위주장지속시단호히응징”,http://www.whosaeng.com/123440
10138,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.seoulwire.com/news/articleView.html?idxno=432163
10139,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.newsis.com/view/?id=NISX20201221_0001277524&cID=13001&pID=13000
10140,2020-12-21,대웅제약코로나19치료제정부과제예비선정,http://it.chosun.com/site/data/html_dir/2020/12/21/2020122101094.html
10141,2020-12-21,대웅제약코로나19치료후보물질생산장비지원정부과제선정,http://yna.kr/AKR20201221062500017?did=1195m
10142,2020-12-21,대웅제약코로나19치료제생산장비구축정부지원예정,http://medipana.com/news/news_viewer.asp?NewsNum=268724&MainKind=A&NewsKind=5&vCount=12&vKind=1
10143,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.newsworker.co.kr/news/articleView.html?idxno=96395
10144,2020-12-21,대웅제약코로나19치료제생산장비구축정부과제선정”,http://www.viva100.com/main/view.php?key=20201221010005124
10145,2020-12-21,대웅제약균주전쟁끝나머지오판도바로잡을것,http://daily.hankooki.com/lpage/industry/202012/dh20201221110010148390.htm?s_ref=nv
10146,2020-12-21,美ITC메디톡스손들어줘대웅제약항소할것”,http://weekly.hankooki.com/lpage/economy/202012/wk20201221111006146380.htm?s_ref=nv
10147,2020-12-21,대웅제약vs메디톡스美ITC최종판결이후에도공방전지속,http://www.startuptoday.co.kr/news/articleView.html?idxno=64709
10148,2020-12-21,특징주대웅제약코로나19치료제기대감에장중상한가,http://yna.kr/AKR20201221065300002?did=1195m
10149,2020-12-21,대웅제약코로나19치료제복지부생산장비구축지원받는다,http://www.ajunews.com/view/20201221102759776
10150,2020-12-21,강세업종제약업종상승세대웅제약상한가,http://www.itooza.com/common/iview.php?no=2020122110542819693
10151,2020-12-21,대웅제약코로나19치료제정부과제예비선정,http://inthenews.co.kr/article-83558/
10152,2020-12-21,특징주대웅제약코로나19치료제개발에상한가,https://www.ebn.co.kr/news/view/1464779/?sc=Naver
10153,2020-12-21,대웅제약코로나19치료제생산장비정부과제선정,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574303871807
10154,2020-12-21,대웅제약코로나19치료제개발생산장비구축비용정부서지원﻿,http://www.pinpointnews.co.kr/view.php?ud=2020122111224175572365609d9b_45
10155,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,http://www.segye.com/content/html/2020/12/21/20201221506500.html?OutUrl=naver
10156,2020-12-21,대웅제약코로나19치료후보물질생산장비지원정부과제선정,http://news.mk.co.kr/newsRead.php?no=1305357&year=2020
10157,2020-12-21,대웅제약주가초반상한가코로나19치료제임상결과에기대커져,http://www.businesspost.co.kr/BP?command=article_view&num=209499
10158,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=409594
10159,2020-12-21,정부가구충제코로나치료제생산지원대웅제약19억원규모설비구축지원과제선정,https://www.donga.com/news/article/all/20201221/104568171/1
10160,2020-12-21,대웅제약이달중호이스타정임상2상톱라인결과공개,http://inthenews.co.kr/article-83504/
10161,2020-12-21,대웅제약ITC결정분석결과발표균주전쟁끝났다단언,http://medipana.com/news/news_viewer.asp?NewsNum=268727&MainKind=A&NewsKind=5&vCount=12&vKind=1
10162,2020-12-21,대웅제약ITC균주침해없다고판단공정기술오판도바로잡을것”,http://www.viva100.com/main/view.php?key=20201221010005142
10163,2020-12-21,대웅제약코로나19치료제정부생산장비지원받는다니클로사마이드정부과제선정,http://www.newslock.co.kr/news/articleView.html?idxno=34242
10164,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=37678
10165,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비정부지원선정,https://view.asiae.co.kr/article/2020122111432966895
10166,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65345
10167,2020-12-21,대웅제약코로나치료제생산장비政지원선정,http://www.whosaeng.com/123452
10168,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://kpenews.com/View.aspx?No=1389820
10169,2020-12-21,대웅제약니클로사마이드코로나19치료정부과제예비선정,http://www.seoulfn.com/news/articleView.html?idxno=405055
10170,2020-12-21,대웅제약코로나19치료제지원정부과제예비선정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005951
10171,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=20899
10172,2020-12-21,대웅제약코로나19치료제3종개발순항중,http://www.bosa.co.kr/news/articleView.html?idxno=2140526
10173,2020-12-21,대웅제약코로나19치료제정부과제예비로뽑혀전승호역량집중,http://www.businesspost.co.kr/BP?command=article_view&num=209496
10174,2020-12-21,대웅제약코로나19치료제정부지원과제예비선정,http://www.mediapen.com/news/view/585520
10175,2020-12-21,대웅제약니클로사마이드코로나19치료제정부지원받는다,http://www.medigatenews.com/news/2237265916
10176,2020-12-21,유나이티드제약대웅제약제약주급등에상한가까지대웅제약상한가이어유나이티드제약16급등,http://www.econonews.co.kr/news/articleView.html?idxno=150052
10177,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제뽑혀,https://www.kpanews.co.kr/article/show.asp?idx=218686&category=D
10178,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.koreaittimes.com/news/articleView.html?idxno=102631
10179,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4377452
10180,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,https://www.econovill.com/news/articleView.html?idxno=511244
10181,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.mhj21.com/137847
10182,2020-12-21,대웅제약코로나치료제개발장비에정부지원금,https://www.sedaily.com/NewsView/1ZBRPWR05R
10183,2020-12-21,대웅제약니클로사마이드코로나19치료제구축지원정부과제선정,http://www.m-i.kr/news/articleView.html?idxno=778099
10184,2020-12-21,대웅제약코로나19치료제니클로사마이드정부과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2140620
10185,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.sporbiz.co.kr/news/articleView.html?idxno=504925
10186,2020-12-21,뉴스투데이L대웅제약코로나19치료제생산장비구축지원정부과제선정,https://www.news2day.co.kr/article/20201221500172
10187,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://news.tf.co.kr/read/economy/1832758.htm
10188,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://daily.hankooki.com/lpage/industry/202012/dh20201221135649148390.htm?s_ref=nv
10189,2020-12-21,코로나19치료제개발기대에대웅제약장중상한가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4377502
10190,2020-12-21,美ITC판결에도진흙탕싸움중인메디톡스대웅제약보톡스논쟁,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012211326409940221
10191,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=451662
10192,2020-12-21,대웅제약엘러간독점을위한소송재판부는반칙허용엘러간은메디톡스이용,http://newsclaim.co.kr/View.aspx?No=1390105
10193,2020-12-21,대웅제약메디톡스균주에대한주장종지부를찍었다,http://www.segye.com/content/html/2020/12/21/20201221510163.html?OutUrl=naver
10194,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비지원정부과제선정,http://www.edaily.co.kr/news/newspath.asp?newsid=03066806626000816
10195,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.hg-times.com/news/articleView.html?idxno=223729
10196,2020-12-21,대웅제약코로나치료제니클로사마이드생산장비구축지원정부과제선정,http://kbench.com/?q=node/216980
10197,2020-12-21,특징주대웅제약코로나19치료제임상결과기대감에상한가,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004215132
10198,2020-12-21,대웅제약균주전쟁은끝났다ITC최종결정이후후속절차박차,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137437
10199,2020-12-21,대웅제약호이스타정내달코로나치료제로출시예정,https://www.ekn.kr/web/view.php?key=20201221010005188
10200,2020-12-21,대웅제약종근당약물재창출로코로나치료제개발박차,http://www.updownnews.co.kr/news/articleView.html?idxno=226512
10201,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.getnews.co.kr/news/articleView.html?idxno=505721
10202,2020-12-21,끝난줄알았더니메디톡스대웅제약보톡스분쟁공방지속,http://www.sisafocus.co.kr/news/articleView.html?idxno=252576
10203,2020-12-21,대웅제약코로나19치료제생산장비지원정부과제선정,http://www.cstimes.com/news/articleView.html?idxno=443952
10204,2020-12-21,특징주대웅제약코로나치료제기대감에3일간104↑종합,http://yna.kr/AKR20201221119800002?did=1195m
10205,2020-12-21,경구형코로나백신치료제기대감에명문삼천당대웅제약상한가,http://www.smartfn.co.kr/view.php?ud=202012211526108400d3eee0def8_46
10206,2020-12-21,급등락주짚어보기대웅제약코로나치료제기대감에상테슬라관련주묶인디아이씨급등,https://www.etoday.co.kr/news/view/1976220
10207,2020-12-21,특징주대웅제약코로나19치료제기대감에사흘간104상승,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004215604
10208,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비지원정부과제선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1437870
10209,2020-12-21,대웅제약코로나치료제기대감에3일간104급등,http://www.paxetv.com/news/articleView.html?idxno=106933
10210,2020-12-21,대웅제약균주전쟁끝메디톡스는기술실체밝혀라,http://www.shinailbo.co.kr/news/articleView.html?idxno=1357272
10211,2020-12-21,대웅제약메디톡스균주영업비밀도용은허구국내소송서드러날것,http://www.whitepaper.co.kr/news/articleView.html?idxno=199854
10212,2020-12-21,대웅제약코로나19치료제생산장비구축지원예비선정,http://www.thedailypost.kr/news/articleView.html?idxno=78296
10213,2020-12-21,김창수의e뉴스브리핑대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정外,https://www.fetv.co.kr/news/article.html?no=72147
10214,2020-12-21,대웅제약코로나치료제생산장비구축지원선정,http://www.skyedaily.com/news/news_view.html?ID=118512
10215,2020-12-21,코로나19치료제기대감대웅제약종근당주가급등,http://www.dailymedi.com/detail.php?number=864278&thread=22r05
10216,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제예비선정,http://www.meconomynews.com/news/articleView.html?idxno=48624
10217,2020-12-21,연기금외인개인제약株동반매수일양약품명문제약대웅제약삼천당제약깜짝상한가행진,http://www.pinpointnews.co.kr/view.php?ud=202012211701168335cd1e7f0bdf_45
10218,2020-12-21,양시장상승마감대웅제약상한가쌍용차하락세,https://imnews.imbc.com/replay/2020/nw1700/article/6034017_32510.html
10219,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.lcnews.co.kr/news/articleView.html?idxno=11114
10220,2020-12-21,신풍제약하락끝은어디개미들속탄다대웅제약박셀바이오일양약품명문제약은폭발,http://www.pinpointnews.co.kr/view.php?ud=202012211718339255861beb2d9d_45
10221,2020-12-21,대웅제약코로나치료제승기잡나상한가랠리시동박해린의뉴스마켓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012210377&t=NNv
10222,2020-12-21,금일제약업계주요기사셀트리온스텔라라바이오시밀러글로벌3상개시대웅제약코로나19치료제정부과제선정外,http://www.youthdaily.co.kr/news/article.html?no=56844
10223,2020-12-21,대웅제약주가3거래일동안104올라코로나치료제기대감반영,http://www.newsfc.co.kr/news/articleView.html?idxno=44049
10224,2020-12-21,21일특징주대웅제약일양약품알체라까뮤이앤씨등12개종목상한가,http://www.newsworks.co.kr/news/articleView.html?idxno=514149
10225,2020-12-21,퇴근길제약Pin대웅제약코로나19치료제생산장비정부지원받나,http://www.pinpointnews.co.kr/view.php?ud=202012211737421564f090c8dbcb_45
10226,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,http://www.100ssd.co.kr/news/articleView.html?idxno=73615
10227,2020-12-21,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=68110
10228,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.thefirstmedia.net/news/articleView.html?idxno=68136
10229,2020-12-21,상한가종목제약주대웅제약일양약품명문제약삼천당제약상한가마감뒤이어디아이씨동신건설까뮤이앤씨알체라등상한가,http://www.econonews.co.kr/news/articleView.html?idxno=150092
10230,2020-12-21,The이슈대웅제약발목잡은ITC의텃새자국산업보호주의결과,http://www.thedailypost.kr/news/articleView.html?idxno=78300
10231,2020-12-22,메디톡스vs대웅제약보톡스분쟁국내소송서시비가리자,http://it.chosun.com/site/data/html_dir/2020/12/22/2020122200319.html
10232,2020-12-22,대웅제약ITC불확실성해소에밸류에이션재조정,http://www.press9.kr/news/articleView.html?idxno=46635
10233,2020-12-22,빅데이터MSI시장심리톱5SK이마트신세계삼성중공업대웅제약,http://www.newsis.com/view/?id=NISX20201222_0001278624&cID=10403&pID=15000
10234,2020-12-22,모더나화이자백신낭보있지만올라탈까왜변이출현긴장대웅제약셀트리온박셀바이오주목,http://www.pinpointnews.co.kr/view.php?ud=202012220754413360861beb2d9d_45
10235,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.fetv.co.kr/news/article.html?no=72187
10236,2020-12-22,동화약품대웅제약제약주상승에급등까지동화약품7급등이어대웅제약4상승,http://www.econonews.co.kr/news/articleView.html?idxno=150135
10237,2020-12-22,대웅제약나보타다양한온도서역가안정성입증”,http://www.youthdaily.co.kr/news/article.html?no=56889
10238,2020-12-22,포털검색상위종목대웅제약코로나치료제개발기대감에4일연속상승,http://www.g-enews.com/ko-kr/news/article/news_all/202012220918493371edf69f862c_1/article.html
10239,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,https://www.ekn.kr/web/view.php?key=20201222010005348
10240,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://medipana.com/news/news_viewer.asp?NewsNum=268800&MainKind=A&NewsKind=5&vCount=12&vKind=1
10241,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.kpinews.co.kr/news/articleView.html?idxno=133465
10242,2020-12-22,타이쿤의차트의기술박셀바이오목표치적중추가전략대웅제약30만원이분기점된다,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122208465185641
10243,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.asiatoday.co.kr/view.php?key=20201222010013608
10244,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증”,http://www.viva100.com/main/view.php?key=20201222010005416
10245,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.m-i.kr/news/articleView.html?idxno=778601
10246,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.dailian.co.kr/news/view/948701/?sc=Naver
10247,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012220934285290410
10248,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.pharmnews.com/news/articleView.html?idxno=101965
10249,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122209444280218
10250,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.press9.kr/news/articleView.html?idxno=46641
10251,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.mhj21.com/137873
10252,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=57226
10253,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252806
10254,2020-12-22,뉴스투데이L대웅제약나보타다양한온도에서역가안정성입증,https://www.news2day.co.kr/article/20201222500075
10255,2020-12-22,대웅제약나보타다양한온도에서안정성지속성입증,http://www.metroseoul.co.kr/article/20201222500108
10256,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012220088&t=NN
10257,2020-12-22,노터스대웅제약코로나19치료제수익2받는다,https://www.etoday.co.kr/news/view/1976490
10258,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,https://www.econovill.com/news/articleView.html?idxno=511446
10259,2020-12-22,대웅제약나보타다양한온도에서효능효과유지,http://news.mt.co.kr/mtview.php?no=2020122209503417698
10260,2020-12-22,대웅제약나보타다양한온도에서안정성입증,https://health.chosun.com/site/data/html_dir/2020/12/22/2020122200927.html
10261,2020-12-22,대웅제약나보타다양한온도조건역가안정성입증,http://www.newsprime.co.kr/news/article.html?no=528305
10262,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://sports.hankooki.com/lpage/economy/202012/sp20201222100822137020.htm?s_ref=nv
10263,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.thebigdata.co.kr/view.php?ud=202012221009207786798818e98b_23
10264,2020-12-22,대웅제약보툴리눔톡신제제나보타다양한온도에서역가안정성입증,http://www.pinpointnews.co.kr/view.php?ud=2020122210101663242365609d9b_45
10265,2020-12-22,대웅제약나보타다양한온도에서효능효과안정적,http://www.healthinnews.co.kr/news/articleView.html?idxno=20925
10266,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.medisobizanews.com/news/articleView.html?idxno=75146
10267,2020-12-22,특징주대웅제약코로나치료제출시기대감에3대상승세,https://www.asiatoday.co.kr/view.php?key=20201222010013698
10268,2020-12-22,대웅제약나보타다양한온도에서안정성입증,http://it.chosun.com/site/data/html_dir/2020/12/22/2020122200968.html
10269,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.asiatime.co.kr/news/newsview.php?ncode=1065576063627193
10270,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=37743
10271,2020-12-22,대웅제약보툴리눔제제나보타다양한온도조건서효능유지,http://yna.kr/AKR20201222062700017?did=1195m
10272,2020-12-22,특징주대웅제약상승세끝10대하락,http://www.edaily.co.kr/news/newspath.asp?newsid=02617446626001144
10273,2020-12-22,대웅제약영진약품제약주급등에급락으로희비엇갈려특히대웅제약급등서갑작스런8급락,http://www.econonews.co.kr/news/articleView.html?idxno=150194
10274,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=57251
10275,2020-12-22,대웅제약후보물질DWP212525코로나19치료제정부과제선정,http://www.mhj21.com/137877
10276,2020-12-22,조필현의시선메디톡스vs대웅제약독한전쟁2라운드시작,http://www.wikileaks-kr.org/news/articleView.html?idxno=100800
10277,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.bosa.co.kr/news/articleView.html?idxno=2140741
10278,2020-12-22,대웅제약나보타온도따라효과달라지지않아,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137868&REFERER=NP
10279,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,http://www.seoulwire.com/news/articleView.html?idxno=432262
10280,2020-12-22,대웅제약비임상연구통해나보타역가안정성입증,http://www.pressm.kr/news/articleView.html?idxno=35512
10281,2020-12-22,대웅제약자가면역치료제신약코로나치료제정부과제선정”,http://www.viva100.com/main/view.php?key=20201222010005514
10282,2020-12-22,특징주대웅제약오전장중최고가찍고하락전환,http://moneys.mt.co.kr/news/mwView.php?no=2020122211228022093
10283,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=20935
10284,2020-12-22,대웅제약자가면역신약후보물질코로나19치료제로정부과제선정,http://www.medisobizanews.com/news/articleView.html?idxno=75157
10285,2020-12-22,대웅제약코로나19치료제정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46650
10286,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.lawissue.co.kr/view.php?ud=202012221114123452204ead0791_12
10287,2020-12-22,대웅제약자가면역치료제신약코로나19치료제정부과제로선정,https://www.asiatoday.co.kr/view.php?key=20201222010013862
10288,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://daily.hankooki.com/lpage/industry/202012/dh20201222113010147950.htm?s_ref=nv
10289,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://www.newsis.com/view/?id=NISX20201222_0001279277&cID=13001&pID=13000
10290,2020-12-22,대웅제약신약후보물질코로나19치료제정부과제선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=37766
10291,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.asiaa.co.kr/news/articleView.html?idxno=13800
10292,2020-12-22,특징주코로나치료제株동반하락대웅제약10대급락,https://www.asiatoday.co.kr/view.php?key=20201222010013878
10293,2020-12-22,대웅제약자가면역치료신약코로나19치료제정부과제선정,http://medipana.com/news/news_viewer.asp?NewsNum=268827&MainKind=A&NewsKind=5&vCount=12&vKind=1
10294,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://www.youthdaily.co.kr/news/article.html?no=56920
10295,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,https://www.news2day.co.kr/article/20201222500174
10296,2020-12-22,22일장중코로나주유나이티드제약명문제약껑충vs대웅제약급락,http://www.choicenews.co.kr/news/articleView.html?idxno=77593
10297,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나치료제정부과제선정,http://www.segye.com/content/html/2020/12/22/20201222508356.html?OutUrl=naver
10298,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65401
10299,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65390
10300,2020-12-22,대웅제약코로나19치료제정부과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2140756
10301,2020-12-22,대웅제약나보타상온냉장냉동서효능유지,http://www.seoulfn.com/news/articleView.html?idxno=405221
10302,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19치료제비임상정부과제선정,http://www.newsprime.co.kr/news/article.html?no=528350
10303,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,https://www.fetv.co.kr/news/article.html?no=72245
10304,2020-12-22,대웅제약자체보툴리눔톡신의다양한온도에서효과유지를입증,http://www.businesspost.co.kr/BP?command=article_view&num=209708
10305,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=409791
10306,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020122212270927538
10307,2020-12-22,대웅제약코로나19치료제정부과제선정,http://www.dailymedi.com/detail.php?number=864318&thread=22r05
10308,2020-12-22,대웅제약자가면역치료제후보물질정부코로나19치료제과제선정,https://biz.chosun.com/site/data/html_dir/2020/12/22/2020122201421.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10309,2020-12-22,대웅제약자가면역치료제후보물질 코로나19 치료제비임상연구개발지원받아,http://www.economytalk.kr/news/articleView.html?idxno=210041
10310,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.koreaittimes.com/news/articleView.html?idxno=102665
10311,2020-12-22,메디톡스vs대웅제약엇갈린ITC최종판결해석끝나지않은국내소송누가웃을까,http://www.thepublic.kr/news/newsview.php?ncode=1065580127084291
10312,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.m-i.kr/news/articleView.html?idxno=778776
10313,2020-12-22,대웅제약자가면역치료제코로나19치료제정부과제선정,http://www.kpinews.co.kr/news/articleView.html?idxno=133520
10314,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.newsworker.co.kr/news/articleView.html?idxno=96597
10315,2020-12-22,대웅제약DWP212525코로나19비임상정부과제선정,https://www.hankyung.com/it/article/202012225298i
10316,2020-12-22,대웅제약자가면역치료제신약정부코로나19치료제비임상과제선정,http://it.chosun.com/site/data/html_dir/2020/12/22/2020122201588.html
10317,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.metroseoul.co.kr/article/20201222500323
10318,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122213505471972
10319,2020-12-22,대웅제약자가면역후보물질코로나치료제정부과제선정,http://news.mt.co.kr/mtview.php?no=2020122213574963177
10320,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.ezyeconomy.com/news/articleView.html?idxno=108249
10321,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제길열리나,http://www.thebigdata.co.kr/view.php?ud=202012221358063569d0a8833aad_23
10322,2020-12-22,대웅제약보톡스나보타다양한온도에서효능효과확인,https://biz.chosun.com/site/data/html_dir/2020/12/22/2020122201668.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10323,2020-12-22,대웅주가18↑자회사대웅제약코로나19생산장비구축지원정부과제선정,http://www.ajunews.com/view/20201222133413780
10324,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,https://www.etoday.co.kr/news/view/1976609
10325,2020-12-22,대웅제약자가면역치료제후보물질정부코로나19치료제과제선정,http://inthenews.co.kr/article-83931/
10326,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,http://www.insightkorea.co.kr/news/articleView.html?idxno=85581
10327,2020-12-22,대웅제약자가면역질환신약물질코로나19비임상정부지원,http://yna.kr/AKR20201222105100017?did=1195m
10328,2020-12-22,대웅제약나보타다양한온도에서안정된효능효과입증,http://www.lcnews.co.kr/news/articleView.html?idxno=11158
10329,2020-12-22,대웅제약자가면역질환신약물질코로나19비임상정부지원받아,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4378555
10330,2020-12-22,코로나19치료제가능성인정대웅제약자가면역치료제신약후보물질정부과제선정,http://theviewers.co.kr/View.aspx?No=1392099
10331,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.getnews.co.kr/news/articleView.html?idxno=505915
10332,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://news.heraldcorp.com/view.php?ud=20201222000765
10333,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012221438452320583
10334,2020-12-22,대웅제약균주전쟁끝났다나머지오판도바로잡을것,http://www.thefirstmedia.net/news/articleView.html?idxno=68172
10335,2020-12-22,대웅제약자가면역치료제후보물질코로나19정부과제선정,http://www.segyebiz.com/newsView/20201222510965?OutUrl=naver
10336,2020-12-22,대웅제약자가면역치료제코로나치료제정부과제선정내년임상1상,http://moneys.mt.co.kr/news/mwView.php?no=2020122214138073964
10337,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.wsobi.com/news/articleView.html?idxno=110930
10338,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=452170
10339,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://daily.hankooki.com/lpage/industry/202012/dh20201222151424148390.htm?s_ref=nv
10340,2020-12-22,대웅제약4번째코로나치료제개발돌입자가면역치료제신약후보물질정부과제선정,https://www.donga.com/news/article/all/20201222/104591469/1
10341,2020-12-22,대웅제약자가면역치료제후보물질코로나19비임상정부지원,https://view.asiae.co.kr/article/2020122215182078022
10342,2020-12-22,큰일치른대웅제약반등노릴까,http://www.sporbiz.co.kr/news/articleView.html?idxno=505042
10343,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.thedailypost.kr/news/articleView.html?idxno=78310
10344,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4378702
10345,2020-12-22,대웅제약자가면역치료제후보물질코로나치료제정부과제선정,http://www.newstomato.com/ReadNews.aspx?no=1014487
10346,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19치료제가능성인정받아,http://kpenews.com/View.aspx?No=1392299
10347,2020-12-22,대웅제약자가면역치료제코로나19치료제정부과제선정,http://sports.hankooki.com/lpage/economy/202012/sp20201222154325137020.htm?s_ref=nv
10348,2020-12-22,대웅제약자가면역치료제후보물질코로나19비임상정부지원,https://www.ajunews.com/view/20201222131105751
10349,2020-12-22,대웅제약자가면역치료후보물질정부과제선정,http://www.mediapen.com/news/view/586018
10350,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.medigatenews.com/news/3462032986
10351,2020-12-22,SCI급국제학술지게재대웅제약나보타다양한온도에서역가안정성입증,http://theviewers.co.kr/View.aspx?No=1392517
10352,2020-12-22,대웅제약DWP212525코로나치료제정부과제선정,http://www.monews.co.kr/news/articleView.html?idxno=216715
10353,2020-12-22,대웅제약자가면역치료후보물질코로나19정부과제선정,http://www.seoulfn.com/news/articleView.html?idxno=405281
10354,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19치료제정부과제선정,http://www.thedailypost.kr/news/articleView.html?idxno=78326
10355,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.lawissue.co.kr/view.php?ud=202012221635149033204ead0791_12
10356,2020-12-22,대웅제약자가면역질환신약물질코로나19치료제정부과제선정,http://news.mk.co.kr/newsRead.php?no=1310919&year=2020
10357,2020-12-22,대웅제약자가면역후보물질코로나치료제정부과제선정비임상연구개발비지원,http://www.updownnews.co.kr/news/articleView.html?idxno=226578
10358,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.thefirstmedia.net/news/articleView.html?idxno=68204
10359,2020-12-22,대웅제약나보타다양한온도에서안정성 입증,http://www.koreastocknews.com/news/articleView.html?idxno=60118
10360,2020-12-22,코로나변이뭐라고모더나화이자관련주어떡하나대웅제약셀트리온신풍제약셀트리온헬스케어휘청,http://www.pinpointnews.co.kr/view.php?ud=202012221649573747861beb2d9d_45
10361,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.thefirstmedia.net/news/articleView.html?idxno=68220
10362,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19비임상정부과제선정,https://www.sedaily.com/NewsView/1ZBS78VH0A
10363,2020-12-22,김창수의e뉴스브리핑대웅제약자가면역치료제후보물질코로나19치료제정부과제선정外,https://www.fetv.co.kr/news/article.html?no=72289
10364,2020-12-22,대웅제약보툴리눔제제나보타다양한온도에서효능유지,http://www.mediapen.com/news/view/586083
10365,2020-12-22,금일제약업계주요기사대웅제약자가면역치료제코로나19정부과제선정제넥신JP모건헬스케어컨퍼런스참가”外,http://www.youthdaily.co.kr/news/article.html?no=56976
10366,2020-12-22,대웅제약코로나19치료제정부과제선정2021년하반기임상1상진입목표,http://www.paxetv.com/news/articleView.html?idxno=107076
10367,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://4th.kr/View.aspx?No=1392658
10368,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제지원과제로뽑혀,http://www.businesspost.co.kr/BP?command=article_view&num=209785
10369,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://news.kbiz.or.kr/news/articleView.html?idxno=75983
10370,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.newsfreezone.co.kr/news/articleView.html?idxno=285107
10371,2020-12-23,대웅제약자가면역치료제DWP212525코로나19치료제정부과제선정,https://www.kpanews.co.kr/article/show.asp?idx=218745&category=D
10372,2020-12-23,대웅제약나보타다양한온도서역가안정성입증,https://www.kpanews.co.kr/article/show.asp?idx=218752&category=D
10373,2020-12-23,종목PICK이달130뛴대웅제약상승끝호재더있나,https://www.asiatoday.co.kr/view.php?key=20201222010014279
10374,2020-12-23,1호메이드인코리아코로나치료제셀트리온대웅제약누가빠를까,https://biz.chosun.com/site/data/html_dir/2020/12/22/2020122202470.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10375,2020-12-23,대웅제약자가면역치료후보물질코로나19치료제정부과제선정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006041
10376,2020-12-23,뉴욕증시코로나변이에다우지수휘청대웅제약셀트리온현대약품유나이티드제약주목을,http://www.pinpointnews.co.kr/view.php?ud=202012230647168143861beb2d9d_45
10377,2020-12-23,고공행진대웅제약주가조정접어드나2일차급락마감,http://medipana.com/news/news_viewer.asp?NewsNum=268847&MainKind=A&NewsKind=5&vCount=12&vKind=1
10378,2020-12-23,대웅제약ITC패소에도훨훨코로나치료제기대감,http://www.cstimes.com/news/articleView.html?idxno=444187
10379,2020-12-23,대웅제약신약후보물질코로나19치료제정부과제선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1357996
10380,2020-12-23,대웅제약동화약품제약주하락에급락으로무너져대웅제약6급락이어동화약품1하락,http://www.econonews.co.kr/news/articleView.html?idxno=150320
10381,2020-12-23,현대약품대웅제약제약주급등에급락으로희비엇갈려현대약품14급등반해대웅제약6급락,http://www.econonews.co.kr/news/articleView.html?idxno=150331
10382,2020-12-23,국내1호코로나치료제언제나오나셀트리온대웅제약GC녹십자,https://news.imaeil.com/Society/2020122310035192486
10383,2020-12-23,대웅제약뉴트로감성더한한정판대웅우루사360캡슐출시,https://www.ekn.kr/web/view.php?key=20201223010005729
10384,2020-12-23,23일장중코로나주강스템바이오텍껑충vs대웅제약신풍제약하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77625
10385,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://sports.hankooki.com/lpage/economy/202012/sp20201223102749136980.htm?s_ref=nv
10386,2020-12-23,대웅제약연말맞아대웅우루사360캡슐한정판출시,https://biz.chosun.com/site/data/html_dir/2020/12/23/2020122301103.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10387,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://medipana.com/news/news_viewer.asp?NewsNum=268886&MainKind=A&NewsKind=5&vCount=12&vKind=1
10388,2020-12-23,대웅제약뉴트로한정판대웅우루사360캡슐출시,http://news.mt.co.kr/mtview.php?no=2020122310325754483
10389,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.kpinews.co.kr/news/articleView.html?idxno=133612
10390,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65411
10391,2020-12-23,대웅제약대웅우루사360캡슐한정판출시,http://www.medisobizanews.com/news/articleView.html?idxno=75189
10392,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.youthdaily.co.kr/news/article.html?no=57043
10393,2020-12-23,소중한분에게선물하세요대웅제약대웅우루사360캡슐뉴트로한정판출시,https://www.asiatoday.co.kr/view.php?key=20201223010014692
10394,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=57327
10395,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=20968
10396,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://news.mk.co.kr/newsRead.php?no=1312935&year=2020
10397,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.mhj21.com/137940
10398,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.koreaittimes.com/news/articleView.html?idxno=102697
10399,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=271826&REFERER=NP
10400,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=37829
10401,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.lawissue.co.kr/view.php?ud=202012231200476018204ead0791_12
10402,2020-12-23,대웅제약DWP212525코로나19치료제정부과제선정,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137487
10403,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.thebigdata.co.kr/view.php?ud=202012231252377063d0a8833aad_23
10404,2020-12-23,대웅제약뉴트로열풍따라대웅우루사360캡슐한정판출시,http://www.lcnews.co.kr/news/articleView.html?idxno=11203
10405,2020-12-23,유나이티드제약대웅제약제약주하락에급락으로무너져특히유나이티드제약급등서오후갑작스런4하락반전,http://www.econonews.co.kr/news/articleView.html?idxno=150430
10406,2020-12-23,대웅제약연말맞이대웅우루사360캡슐한정판출시,http://www.marketnews.co.kr/news/articleView.html?idxno=58128
10407,2020-12-23,대웅제약복고풍대웅우루사360캡슐한정판출시,http://www.sportsseoul.com/news/read/995617?ref=naver
10408,2020-12-23,대웅제약우루사의변신은계속된다”,http://www.whosaeng.com/123566
10409,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인,http://www.mhj21.com/137947
10410,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.lawissue.co.kr/view.php?ud=202012231428005950204ead0791_12
10411,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.thebigdata.co.kr/view.php?ud=202012231428556889798818e98b_23
10412,2020-12-23,대웅제약코로나19치료제임상2a상서효과확인대규모임상신속진행,http://www.fnnews.com/news/202012231427022865
10413,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인,http://www.press9.kr/news/articleView.html?idxno=46662
10414,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인”,http://www.youthdaily.co.kr/news/article.html?no=57086
10415,2020-12-23,트렌드쫓는건기식대웅제약대웅우루사360캡슐뉴트로한정판출시,http://theviewers.co.kr/View.aspx?No=1393767
10416,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료효과확인,https://www.etoday.co.kr/news/view/1977165
10417,2020-12-23,대웅제약호이스타정임상2a상서코로나치료가능성확인,http://medipana.com/news/news_viewer.asp?NewsNum=268916&MainKind=A&NewsKind=5&vCount=12&vKind=1
10418,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.metroseoul.co.kr/article/20201223500374
10419,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.bosa.co.kr/news/articleView.html?idxno=2140879
10420,2020-12-23,대웅제약임상2a상서호이스타정코로나19치료효과확인,http://it.chosun.com/site/data/html_dir/2020/12/23/2020122302166.html
10421,2020-12-23,대웅제약호이스타정2a상서코로나치료제효과확인”,http://www.viva100.com/main/view.php?key=20201223010005955
10422,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.medisobizanews.com/news/articleView.html?idxno=75203
10423,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65426
10424,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인바이러스진입차단,http://www.paxetv.com/news/articleView.html?idxno=107146
10425,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인,http://daily.hankooki.com/lpage/industry/202012/dh20201223144711148390.htm?s_ref=nv
10426,2020-12-23,대웅제약호이스타정임상2a상서코로나치료제가능성확인,https://www.ekn.kr/web/view.php?key=20201223010005851
10427,2020-12-23,대웅제약호이스타2a상서코로나치료제가능성확인,http://www.newsis.com/view/?id=NISX20201223_0001281239&cID=13001&pID=13000
10428,2020-12-23,코로나19치료제가능성확인대웅제약호이스타정임상2a상결과발표계획,http://theviewers.co.kr/View.aspx?No=1393795
10429,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료효과확인,http://yna.kr/AKR20201223113900017?did=1195m
10430,2020-12-23,대웅제약호이스타정임상2a상톱라인결과공개코로나19치료제가능성확인,http://kpenews.com/View.aspx?No=1393919
10431,2020-12-23,호이스타정코로나치료제가능성확인대웅제약임상2상발표,http://www.wikileaks-kr.org/news/articleView.html?idxno=100899
10432,2020-12-23,대웅제약호이스타정2a상서코로나19치료제가능성확인,https://www.hankyung.com/finance/article/202012230279i
10433,2020-12-23,대웅제약대웅폭락에하한가로무너져대웅제약하한가이어대웅26폭락,http://www.econonews.co.kr/news/articleView.html?idxno=150454
10434,2020-12-23,대웅제약상대손해배상소송업체들시점따져소가올릴듯,http://www.sisajournal-e.com/news/articleView.html?idxno=227352
10435,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122315130939276
10436,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.m-i.kr/news/articleView.html?idxno=779396
10437,2020-12-23,대웅제약호이스타정코로나19치료효과확인,https://view.asiae.co.kr/article/2020122315214590509
10438,2020-12-23,대웅제약호이스타정코로나치료제로가능성확인,https://www.dailian.co.kr/news/view/949282/?sc=Naver
10439,2020-12-23,현대바이오대웅대웅제약폭락투자자들어쩌나,http://www.nbnnews.co.kr/news/articleView.html?idxno=452660
10440,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=20979
10441,2020-12-23,코로나변이백신두달안생산이렇게나빨리현대바이오하한가충격대웅제약셀트리온주가어디로,http://www.pinpointnews.co.kr/view.php?ud=202012231510503718861beb2d9d_45
10442,2020-12-23,대웅제약호이스타정2a임상서코로나19치료효과확인,http://www.seoulfn.com/news/articleView.html?idxno=405427
10443,2020-12-23,의약오늘이대서울병원우수내시경실인증획득대웅제약호이스타정임상2a상결과공개,http://www.sisaon.co.kr/news/articleView.html?idxno=122038
10444,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료효과확인,http://inthenews.co.kr/article-84203/
10445,2020-12-23,대웅제약호이스타정임상결과코로나19치료제가능성확인,http://www.joseilbo.com/news/news_read.php?uid=413301&class=27&grp=
10446,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.finomy.com/news/articleView.html?idxno=87067
10447,2020-12-23,대웅제약 호이스타정 임상 2a상에서 코로나19 치료 효과 확인,http://kormedi.com/?p=1329727
10448,2020-12-23,대웅제약호이스타정임상결과코로나19치료제가능성확인,https://www.fetv.co.kr/news/article.html?no=72383
10449,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=452625
10450,2020-12-23,대웅제약호이스타정2a상주평가변수미충족2b3상진행,https://www.econovill.com/news/articleView.html?idxno=511781
10451,2020-12-23,대웅제약임상2a상서호이스타정코로나19치료효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=34395
10452,2020-12-23,대웅제약호이스타정코로나19치료효과임상2a상확인,https://www.news2day.co.kr/article/20201223500271
10453,2020-12-23,우루사의변신은무죄”대웅제약대웅우루사360캡슐뉴트로한정판출시,https://www.fetv.co.kr/news/article.html?no=72388
10454,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.mediapen.com/news/view/586451
10455,2020-12-23,대웅제약호이스타정2a상임상결과통계적으로유의하지않아,http://www.koreastocknews.com/news/articleView.html?idxno=60159
10456,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제로가능성확인,http://news.kbiz.or.kr/news/articleView.html?idxno=76024
10457,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.medigatenews.com/news/3568144681
10458,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.thedailypost.kr/news/articleView.html?idxno=78347
10459,2020-12-23,대웅제약호이스타정코로나치료효과보였다는데하한가왜,http://moneys.mt.co.kr/news/mwView.php?no=2020122315268079507
10460,2020-12-23,대웅제약알약코로나치료제호이스타정효과확인,http://news.mt.co.kr/mtview.php?no=2020122315500798037
10461,2020-12-23,대웅제약코로나치료제2상실패인데도3상진행,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137902&REFERER=NP
10462,2020-12-23,너무올랐나대웅제약3일간104급등뒤이틀째급락,http://yna.kr/AKR20201223137600002?did=1195m
10463,2020-12-23,대웅제약이틀연속급락차익실현물량대거쏟아져,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4379840
10464,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.ceoscoredaily.com/news/article.html?no=76553
10465,2020-12-23,대웅제약코로나치료제주평가변수통계적으로유의하지않아,http://www.edaily.co.kr/news/newspath.asp?newsid=03758886626001472
10466,2020-12-23,대웅제약호이스타정2a임상Topline결과발표,http://www.whosaeng.com/123574
10467,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,https://cnbc.sbs.co.kr/article_hub/10001006887?division=NAVER
10468,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,http://www.newsworks.co.kr/news/articleView.html?idxno=514882
10469,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.g-enews.com/ko-kr/news/article/news_all/2020122315583398769d76442fa_1/article.html
10470,2020-12-23,대웅제약대웅우루사360캡슐한정판출시,http://www.mediapen.com/news/view/586497
10471,2020-12-23,대웅제약코로나19치료제임상유효성확인,http://www.skyedaily.com/news/news_view.html?ID=118751
10472,2020-12-23,현대바이오대웅대웅제약하한가종근당바이오에이비프로바이오인바이오폭락투자경고바이오株,http://www.pinpointnews.co.kr/view.php?ud=202012231646329609cd1e7f0bdf_45
10473,2020-12-23,대웅제약호이스타정코로나치료제임상2a상서주평가변수충족못해,http://www.newspim.com/news/view/20201223001145
10474,2020-12-23,지놈앤컴퍼니석경에이티주가치솟았지만대웅제약현대바이오와르르셀트리온신풍제약은,http://www.pinpointnews.co.kr/view.php?ud=202012231653073813861beb2d9d_45
10475,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.dailymedi.com/detail.php?number=864397&thread=22r05
10476,2020-12-23,대웅제약호이스타정임상2상중간결과발표코로나치료제가능성확인”,https://www.donga.com/news/article/all/20201223/104613670/1
10477,2020-12-23,대웅제약3일간급등뒤이틀연속급락,http://www.startuptoday.co.kr/news/articleView.html?idxno=65088
10478,2020-12-23,대웅제약호이스타정임상에서코로나19치료제가능성확인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065600178296803
10479,2020-12-23,대웅제약임상2상서효과확인국산치료제가시화,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012230256&t=NNv
10480,2020-12-23,대웅제약호이스타정코로나19제거빨랐으나통계적유의성없어종합,http://yna.kr/AKR20201223113951017?did=1195m
10481,2020-12-23,대웅제약호이스타정2a상서코로나19치료가능성확인”,https://www.kpanews.co.kr/article/show.asp?idx=218777&category=D
10482,2020-12-23,대웅제약호이스타2a상서코로나치료제가능성확인,https://www.ajunews.com/view/20201223165336857
10483,2020-12-23,대웅제약호이스타정임상2a상코로나19치료제가능성확인,http://www.ajunews.com/view/20201223164112848
10484,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.worktoday.co.kr/news/articleView.html?idxno=12484
10485,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제로가능성확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=410005
10486,2020-12-23,대웅제약호이스타정임상서통계적유의성확보실패대웅측가능성확인주장,http://news.mk.co.kr/newsRead.php?no=1315421&year=2020
10487,2020-12-23,대웅제약호이스타정코로나19치료제임상서주평가변수충족못해,http://www.kpinews.co.kr/news/articleView.html?idxno=133670
10488,2020-12-23,대웅제약호이스타정2a상서코로나19치료제가능성확인,http://www.bokuennews.com/news/article.html?no=198829
10489,2020-12-23,대웅제약호이스타정임상2a상서코로나치료제가능성확인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1438709
10490,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.thepublic.kr/news/newsview.php?ncode=1065599035054024
10491,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.cstimes.com/news/articleView.html?idxno=444428
10492,2020-12-23,23일특징주LG전자세방전지등10개종목상한가대웅제약등3개하한가,http://www.newsworks.co.kr/news/articleView.html?idxno=514952
10493,2020-12-23,대웅제약먹는코로나19치료제임상2a상에서가능성확인,http://www.businesspost.co.kr/BP?command=article_view&num=210005
10494,2020-12-23,코로나19치료제개발어디쯤왔나셀트리온GC녹십자대웅제약주목,http://www.businesspost.co.kr/BP?command=article_view&num=209919
10495,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=410035
10496,2020-12-23,코로나확진빛의속도모더나화이자가구원의손길대웅제약현대바이오왜이러나,http://www.pinpointnews.co.kr/view.php?ud=202012231939191741861beb2d9d_45
10497,2020-12-23,마감종합기사LG전자등LG그룹주급등자율주행관련주강세계속돼대웅대웅제약현대바이오하한가,http://www.ggilbo.com/news/articleView.html?idxno=817748
10498,2020-12-23,대웅제약호이스타정코로나19치료가능성확인,http://www.newsfreezone.co.kr/news/articleView.html?idxno=285599
10499,2020-12-23,마감LG전자마그나와전기차부품합작사상한가대웅대웅제약하한가,https://www.asiatime.co.kr/news/newsview.php?ncode=1065615894288705
10500,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4380175
10501,2020-12-24,대웅제약대웅우루사360캡슐뉴트로한정판선봬,https://www.kpanews.co.kr/article/show.asp?idx=218799&category=D
10502,2020-12-24,뉴욕증시코로나변이충격끝났나다우지수상승니콜라폭락대웅제약현대바이오주가도주목,http://www.pinpointnews.co.kr/view.php?ud=202012240643306695861beb2d9d_45
10503,2020-12-24,대웅제약특별한악재도없는데급락에멘붕이틀연속장대음봉당분간먹구름,http://www.pinpointnews.co.kr/view.php?ud=202012240657195685861beb2d9d_45
10504,2020-12-24,대웅제약우루사360캡슐뉴트로한정판출시,http://www.ajunews.com/view/20201223184625929
10505,2020-12-24,전파력훨씬강한코로나변이또출연어떡해에이비프로바이오대웅제약셀트리온현대바이오주목,http://www.pinpointnews.co.kr/view.php?ud=202012240802587425861beb2d9d_45
10506,2020-12-24,증시키워드LG전자마그나와합작법인설립소식에상대웅제약코로나19치료제효능논란에하,https://www.etoday.co.kr/news/view/1977393
10507,2020-12-24,특징주전일하한가맞은대웅제약이틀만에주가44빠져,https://www.sedaily.com/NewsView/1ZBT3XDY4K
10508,2020-12-24,뉴투분석실적하락굴욕맞은한미약품과대웅제약의서로다른속사정,https://www.news2day.co.kr/article/20201223500367
10509,2020-12-24,특징주대웅제약반등시도호이스타정효능논란,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012240924019510136
10510,2020-12-24,대웅제약대웅하락에폭락으로무너져대웅제약4하락이어대웅10폭락,http://www.econonews.co.kr/news/articleView.html?idxno=150520
10511,2020-12-24,코로나19알약치료제나올까대웅제약호이스타정임상2a상서치료제가능성확인,http://kbench.com/?q=node/217102
10512,2020-12-24,단독전승호대웅제약대표호이스타코로나치료제개발자신적극해명,http://moneys.mt.co.kr/news/mwView.php?no=2020122411348013737
10513,2020-12-24,대웅제약호이스타정임상2a상코로나치료제가능성확인,http://www.monews.co.kr/news/articleView.html?idxno=216805
10514,2020-12-24,대웅제약코로나19치료제개발잰걸음,http://www.g-enews.com/ko-kr/news/article/news_all/20201224115231839069d76442fa_1/article.html
10515,2020-12-24,대웅제약대웅급락에폭락까지대웅제약7급락이어대웅14폭락,http://www.econonews.co.kr/news/articleView.html?idxno=150617
10516,2020-12-24,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.thefirstmedia.net/news/articleView.html?idxno=68322
10517,2020-12-24,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.thefirstmedia.net/news/articleView.html?idxno=68324
10518,2020-12-24,대웅제약호이스타정코로나19치료제로통계적유의성확보실패,http://www.mkhealth.co.kr/news/articleView.html?idxno=51570
10519,2020-12-24,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=453008
10520,2020-12-24,올라타기겁나는삼성전자폭풍랠리대웅제약현대바이오휘청신풍제약에이비프로바이오상승,http://www.pinpointnews.co.kr/view.php?ud=202012241652385182861beb2d9d_45
10521,2020-12-24,대웅제약호이스타정임상2a상결과코로나19치료제가능성UP,http://www.thedailypost.kr/news/articleView.html?idxno=78398
10522,2020-12-25,대웅제약˝호이스타2a상서코로나치료제가능성확인˝,http://www.kbsm.net/default/index_view_page.php?idx=297374&part_idx=318
10523,2020-12-25,코로나빛의속도화이자모더나백신효능글쎄셀트리온대웅제약현대바이오등급등락,http://www.g-enews.com/ko-kr/news/article/news_all/2020122507500649294e4869c120_1/article.html
10524,2020-12-26,대웅제약공포의장대음봉출연외국인기관도매도전환긴숨고르기들어가나,http://www.pinpointnews.co.kr/view.php?ud=202012260925599668861beb2d9d_45
10525,2020-12-26,주간e종목대웅제약주가보톡스에웃고코로나19에울다,http://www.sisajournal-e.com/news/articleView.html?idxno=227431
10526,2020-12-26,3일천하대웅제약아찔한주가등락또다른반전있을까,http://www.opinionnews.co.kr/news/articleView.html?idxno=44524
10527,2020-12-26,코로나변종확산막아낼수있나대웅제약현대바이오신풍제약등급등락속출,http://www.pinpointnews.co.kr/view.php?ud=202012261106039914861beb2d9d_45
10528,2020-12-28,대웅제약동화약품제약주모두하락흐름대웅제약3하락이어동화약품역시3하락,http://www.econonews.co.kr/news/articleView.html?idxno=150991
10529,2020-12-28,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,http://www.wsobi.com/news/articleView.html?idxno=111209
10530,2020-12-28,대웅제약호이스타임상운이없게20대위약군많았다,http://www.kpinews.co.kr/news/articleView.html?idxno=133860
10531,2020-12-28,단독대웅제약배보다배꼽올영업이익보다훨씬많은소송비용지출,http://www.newsfc.co.kr/news/articleView.html?idxno=44123
10532,2020-12-28,코로나백신믿었지만변이출연에제약주맥빠지네셀트리온대웅제약박셀바이오신풍제약등급등락봇물,http://www.pinpointnews.co.kr/view.php?ud=202012281729547892861beb2d9d_45
10533,2020-12-29,화이자백신과다투여이런실수를독감처럼유한양행박셀바이오대웅제약셀트리온촉각,http://www.pinpointnews.co.kr/view.php?ud=202012290505341495861beb2d9d_45
10534,2020-12-29,동화약품대웅제약제약주모두상승흐름대웅제약2상승이어동화약품역시2상승,http://www.econonews.co.kr/news/articleView.html?idxno=151194
10535,2020-12-29,대웅제약대웅모두가파른상승세로급등대웅제약8급등이어대웅6급등,http://www.econonews.co.kr/news/articleView.html?idxno=151268
10536,2020-12-30,대웅제약펙수프라잔13상임상시험계획승인,http://www.pinpointnews.co.kr/view.php?ud=202012300900586608cd1e7f0bdf_45
10537,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인,http://www.sentv.co.kr/news/view/585715
10538,2020-12-30,대웅제약위식도역류질환신약중국3상승인,http://www.press9.kr/news/articleView.html?idxno=46704
10539,2020-12-30,대웅제약위식도역류질환치료제신약中3상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=38104
10540,2020-12-30,대웅제약펙수프라잔중국13상임상시험계획승인,https://view.asiae.co.kr/article/2020123009120312261
10541,2020-12-30,대웅제약펙수프라잔中임상3상직행2022년완료목표,http://www.viva100.com/main/view.php?key=20201230010007145
10542,2020-12-30,대웅제약펙수프라잔13상임상시험계획승인,http://www.edaily.co.kr/news/newspath.asp?newsid=01853206626003768
10543,2020-12-30,대웅제약위식도역류질환신약중국임상3상승인받아,http://yna.kr/AKR20201230038500017?did=1195m
10544,2020-12-30,대웅제약펙수프라잔중국임상3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020123009044034628
10545,2020-12-30,대웅제약역류성식도염질환치료제펙수프라잔中3상승인,https://www.fetv.co.kr/news/article.html?no=72853
10546,2020-12-30,대웅제약펙수프라잔중국3상직행,http://www.medisobizanews.com/news/articleView.html?idxno=75333
10547,2020-12-30,대웅제약위식도역류질환신약펙수프라잔中3상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2141273
10548,2020-12-30,대웅제약중국서펙수프라잔임상3상돌입,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012300063&t=NN
10549,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인,https://www.ekn.kr/web/view.php?key=20201230010007046
10550,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인획득,http://www.youthdaily.co.kr/news/article.html?no=57692
10551,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://inthenews.co.kr/article-85127/
10552,2020-12-30,대웅제약신약펙수프라잔中임상3상승인3조5000억규모중국시장공략박차”,https://www.donga.com/news/article/all/20201230/104694523/1
10553,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,http://www.mediapen.com/news/view/588141
10554,2020-12-30,대웅제약위식도역류질환신약中서임상3상승인,https://www.asiatoday.co.kr/view.php?key=20201230010018190
10555,2020-12-30,대웅제약펙수프라잔中임상3상승인,http://www.cstimes.com/news/articleView.html?idxno=445118
10556,2020-12-30,대웅제약펙수프라잔中임상3상승인,http://www.cstimes.com/news/articleView.html?idxno=445118
10557,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,https://health.chosun.com/site/data/html_dir/2020/12/30/2020123000802.html
10558,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,http://medipana.com/news/news_viewer.asp?NewsNum=269154&MainKind=A&NewsKind=5&vCount=12&vKind=1
10559,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.getnews.co.kr/news/articleView.html?idxno=507142
10560,2020-12-30,대웅제약위식도역류신약중국3상승인,http://www.newsis.com/view/?id=NISX20201230_0001288042&cID=13001&pID=13000
10561,2020-12-30,대웅제약위식도역류질환치료제신약 펙수프라잔 중국 3상승인,http://www.greened.kr/news/articleView.html?idxno=282222
10562,2020-12-30,대웅제약펙수프라잔중국3상승인,https://www.ebn.co.kr/news/view/1465961/?sc=Naver
10563,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.m-i.kr/news/articleView.html?idxno=781090
10564,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.sisaweek.com/news/articleView.html?idxno=140485
10565,2020-12-30,대웅제약위식도역류질환치료제중국3상임상승인,https://biz.chosun.com/site/data/html_dir/2020/12/30/2020123000869.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10566,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004223846
10567,2020-12-30,대웅제약동화약품제약주모두상승흐름대웅제약1상승이어동화약품역시1상승,http://www.econonews.co.kr/news/articleView.html?idxno=151325
10568,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中임상3상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=410550
10569,2020-12-30,대웅제약위식도역류질환치료제중국3상임상승인,https://cnbc.sbs.co.kr/article_hub/10001007582?division=NAVER
10570,2020-12-30,대웅제약위식도역류질환치료제신약중국3상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=57633
10571,2020-12-30,대웅제약펙수프라잔 中3상승인2022년완료계획,http://www.koreastocknews.com/news/articleView.html?idxno=60292
10572,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=21065
10573,2020-12-30,대웅제약위식도역류질환신약중국임상3상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573653803958
10574,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.asiaa.co.kr/news/articleView.html?idxno=15222
10575,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.newspim.com/news/view/20201230000216
10576,2020-12-30,대웅제약위식도역류질환치료제中서3상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=134036
10577,2020-12-30,대웅제약위식도역류질환신약중국서3상승인,https://www.econovill.com/news/articleView.html?idxno=512543
10578,2020-12-30,대웅제약펙수프라잔중국서3상임상시험계획승인,https://www.etoday.co.kr/news/view/1979050
10579,2020-12-30,2상건너뛰고곧바로3상승인대웅제약위식도역류질환약펙수프라잔중국3상승인,http://theviewers.co.kr/View.aspx?No=1400063
10580,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253034
10581,2020-12-30,대웅제약위식도역류질환치료제중국3상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137981&REFERER=NP
10582,2020-12-30,대웅제약위식도역류질환신약펙수프라잔中3상승인,https://www.hankyung.com/it/article/202012300719i
10583,2020-12-30,대웅제약펙수프라잔中임상3상승인받아,http://www.finomy.com/news/articleView.html?idxno=87276
10584,2020-12-30,대웅제약 위식도역류질환치료제 신약 중국 3상 승인,http://kormedi.com/?p=1330174
10585,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인,http://www.mhj21.com/138066
10586,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국임상3상승인,https://www.dailian.co.kr/news/view/951005/?sc=Naver
10587,2020-12-30,대웅제약펙수프라잔3상中승인받아,http://www.wikileaks-kr.org/news/articleView.html?idxno=101215
10588,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=218920&category=D
10589,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,https://daily.hankooki.com/lpage/industry/202012/dh20201230104251148390.htm?s_ref=nv
10590,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.thebigdata.co.kr/view.php?ud=20201230104916862798818e98b_23
10591,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012301045253540208
10592,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국서3개월만에3상승인,http://www.lcnews.co.kr/news/articleView.html?idxno=11433
10593,2020-12-30,대웅제약위식도역류질환치료제신약 중국 3상승인,http://www.economytalk.kr/news/articleView.html?idxno=210168
10594,2020-12-30,대웅제약위식도역류질환신약중국3상승인,https://sports.hankooki.com/lpage/economy/202012/sp20201230105819137020.htm?s_ref=nv
10595,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.wsobi.com/news/articleView.html?idxno=111410
10596,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인,http://www.pressm.kr/news/articleView.html?idxno=35727
10597,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의브랜드가치증대,https://www.fetv.co.kr/news/article.html?no=72893
10598,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼출시,http://www.viva100.com/main/view.php?key=20201230010007230
10599,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.thebigdata.co.kr/view.php?ud=202012301110389068798818e98b_23
10600,2020-12-30,대웅제약 액상형진통제 이지엔6 리뉴얼소비자편의브랜드가치증대,http://www.lcnews.co.kr/news/articleView.html?idxno=11438
10601,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.businesskorea.co.kr/news/articleView.html?idxno=57650
10602,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004223986
10603,2020-12-30,대웅제약신약펙수프라잔3상中승인주가반등할까,http://www.smartfn.co.kr/view.php?ud=20201230105546623737c00c6b22_46
10604,2020-12-30,대웅제약액상형진통제리뉴얼편의증대,http://www.newsis.com/view/?id=NISX20201230_0001288336&cID=13001&pID=13000
10605,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.medisobizanews.com/news/articleView.html?idxno=75351
10606,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼제형축소등,http://medipana.com/news/news_viewer.asp?NewsNum=269182&MainKind=A&NewsKind=5&vCount=12&vKind=1
10607,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼소비자편의브랜드가치증대”,http://www.youthdaily.co.kr/news/article.html?no=57718
10608,2020-12-30,소비자편의↑대웅제약액상형진통제이지엔6리뉴얼,http://www.koreaittimes.com/news/articleView.html?idxno=102816
10609,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.healthinnews.co.kr/news/articleView.html?idxno=21084
10610,2020-12-30,대웅제약펙수프라잔中3상승인,http://www.whosaeng.com/123673
10611,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.whosaeng.com/123669
10612,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인,http://www.newsprime.co.kr/news/article.html?no=529059
10613,2020-12-30,대웅제약이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65511
10614,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65507
10615,2020-12-30,공시대웅제약위식도역류질환치료제중국3상임상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020123011412981172
10616,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020123011431964125
10617,2020-12-30,제약브리핑대웅제약JW중외제약유유제약,http://4th.kr/View.aspx?No=1400364
10618,2020-12-30,대웅제약이지엔6제형축소기존대비23작게,https://www.asiatoday.co.kr/view.php?key=20201230010018499
10619,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.asiaa.co.kr/news/articleView.html?idxno=15273
10620,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.newslock.co.kr/news/articleView.html?idxno=34621
10621,2020-12-30,대웅제약위식도역류질환치료제의중국임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=210764
10622,2020-12-30,대웅제약액상형진통제이지엔6새단장,https://www.ekn.kr/web/view.php?key=20201230010007146
10623,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.metroseoul.co.kr/article/20201230500196
10624,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.updownnews.co.kr/news/articleView.html?idxno=226804
10625,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.medigatenews.com/news/1653707750
10626,2020-12-30,대웅제약이지엔6리뉴얼소비자편의브랜드가치증대,http://www.thedailypost.kr/news/articleView.html?idxno=78473
10627,2020-12-30,대웅제약펙수프라잔중국3상승인,http://www.newstomato.com/ReadNews.aspx?no=1015904
10628,2020-12-30,대웅제약이지엔6제형축소및패키지변경,http://www.consumuch.com/news/articleView.html?idxno=51667
10629,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,https://jhealthmedia.joins.com/article/article_view.asp?pno=22924
10630,2020-12-30,대웅제약위식도역류질환치료제중국3상승인2022년임상완료목표,http://news.mt.co.kr/mtview.php?no=2020123013442749934
10631,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.thedailypost.kr/news/articleView.html?idxno=78476
10632,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=454475
10633,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.nbnnews.co.kr/news/articleView.html?idxno=454462
10634,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,https://www.econovill.com/news/articleView.html?idxno=512609
10635,2020-12-30,대웅제약위식도역류질환신약중국임상3상승인,http://www.whitepaper.co.kr/news/articleView.html?idxno=200081
10636,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼소비자편의증대,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012301400420180322
10637,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://news.mk.co.kr/newsRead.php?no=1335298&year=2020
10638,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼복용편의성↑,http://news.mt.co.kr/mtview.php?no=2020123014381024032
10639,2020-12-30,대웅제약개발위식도역류질환신약중국임상3상승인,http://www.seoulfn.com/news/articleView.html?idxno=406109
10640,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.mdtoday.co.kr/mdtoday/index.html?no=410622
10641,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=12619
10642,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼브랜드이미지강화,http://www.m-i.kr/news/articleView.html?idxno=781360
10643,2020-12-30,복용편의성증대대웅제약액상형진통제이지엔6리뉴얼,http://theviewers.co.kr/View.aspx?No=1400903
10644,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.thefirstmedia.net/news/articleView.html?idxno=68581
10645,2020-12-30,대웅제약위식도역류치료제중국서임상3상승인,https://www.hankyung.com/it/article/2020123028781
10646,2020-12-30,대웅제약위식도역류질환치료제신약중국3상승인,http://www.ajunews.com/view/20201230160735321
10647,2020-12-30,대웅제약중국서위식도역류질환치료제펙수프라잔3상임상시험승인,http://www.g-enews.com/ko-kr/news/article/news_all/20201230170719190669d76442fa_1/article.html
10648,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=68596
10649,2020-12-30,김창수의e뉴스브리핑대웅제약역류성식도염질환치료제펙수프라잔中3상승인外,https://www.fetv.co.kr/news/article.html?no=72962
10650,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼출시,http://www.mediapen.com/news/view/588452
10651,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.consumernews.co.kr/news/articleView.html?idxno=618125
10652,2020-12-30,대웅제약신약펙수프라잔중국3상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=73800
10653,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.newsfarm.co.kr/news/articleView.html?idxno=62525
10654,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.enewstoday.co.kr/news/articleView.html?idxno=1440313
10655,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔中임상3상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1440326
10656,2020-12-30,대웅제약소화기관치료제中3상승인,http://www.dt.co.kr/contents.html?article_no=2020123102101031102001&ref=naver
10657,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.medigatenews.com/news/1772400347
10658,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.wolyo.co.kr/news/articleView.html?idxno=113950
10659,2020-12-30,대웅제약펙수프라잔中임상3상계획승인취득2022년완료계획,http://www.newsfreezone.co.kr/news/articleView.html?idxno=287472
10660,2020-12-31,대웅제약액상형진통제이지엔6리뉴얼,http://www.bosa.co.kr/news/articleView.html?idxno=2141356
10661,2020-12-31,기업공시12월30일대웅제약위식도역류질환신약중국임상3상승인등,https://www.sedaily.com/NewsView/1ZBWAQJ5M0
10662,2020-12-31,대웅제약액상형진통제이지엔6리뉴얼공개,http://www.monews.co.kr/news/articleView.html?idxno=216931
10663,2020-12-31,대웅제약펙수프라잔중국3상승인완료,http://www.monews.co.kr/news/articleView.html?idxno=216927
10664,2020-12-31,대웅제약위식도역류신약펙수프라잔중국3상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1361076
10665,2020-12-31,대웅제약액상형진통제이지엔6리뉴얼소비자편의증대,http://www.segyebiz.com/newsView/20201231505281?OutUrl=naver
10666,2020-12-31,대웅제약이지엔6리뉴얼로소비자편의증대,http://www.wsobi.com/news/articleView.html?idxno=111526
10667,2020-12-31,대웅제약펙수프라잔글로벌시장본격도전,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137592
10668,2020-12-31,대웅제약메디톡스법정다툼소송비용에초라한성적표기록,http://www.todaykorea.co.kr/news/articleView.html?idxno=281723
10669,2020-12-31,대웅제약코로나치료제호이스타정임상3상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=272070&REFERER=NP
10670,2020-12-31,대웅제약코로나치료제호이스타병용임상3상승인,https://www.econovill.com/news/articleView.html?idxno=512846
10671,2021-01-02,대웅제약호이스타정국내서코로나중증환자임상3상시작,http://moneys.mt.co.kr/news/mwView.php?no=2021010208588058839
10672,2021-01-03,지난주제약업계주요이슈솔젠트코스닥직상장추진4일이사회대웅제약펙수프라잔中3상승인外,http://www.youthdaily.co.kr/news/article.html?no=57966
10673,2021-01-04,대웅제약췌장염약호이스타정중증코로나19임상3상승인,http://yna.kr/AKR20210103044300017?did=1195m
10674,2021-01-04,대웅제약나보타주이상반응사지경직추가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253084
10675,2021-01-04,대웅제약호이스타정중증코로나치료제임상3상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101040025&t=NN
10676,2021-01-04,대웅제약호이스타정중증코로나임상3상승인,https://view.asiae.co.kr/article/2021010407334990348
10677,2021-01-04,대웅제약코로나19중증환자대상임상3상시험계획승인,http://www.edaily.co.kr/news/newspath.asp?newsid=01479286628914440
10678,2021-01-04,대웅제약췌장염약호이스타정중증코로나19임상3상승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101040809070390815
10679,2021-01-04,대웅제약중증환자대상DWJ1248임상3상시험계획승인,http://www.itooza.com/common/iview.php?no=2021010408142595446
10680,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2021010408103947101
10681,2021-01-04,대웅제약코로나치료제호이스타정국내임상3상승인,https://www.hankyung.com/it/article/202101042298i
10682,2021-01-04,대웅제약코로나치료제DWJ1248임상3상시험계획승인,http://www.pinpointnews.co.kr/view.php?ud=202101040817435786cd1e7f0bdf_45
10683,2021-01-04,대웅제약코로나19치료제DWJ1248임상3상시험계획승인,https://www.asiatoday.co.kr/view.php?key=20210104010000546
10684,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,http://www.getnews.co.kr/news/articleView.html?idxno=507726
10685,2021-01-04,공시대웅제약코로나19치료제호이스타정국내임상3상승인,http://www.fnnews.com/news/202101040829036867
10686,2021-01-04,대웅제약코로나19중증환자대상임상3상시험계획승인,http://news.heraldcorp.com/view.php?ud=20210104000044
10687,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021010408265134373
10688,2021-01-04,대웅제약코로나19치료제중증대상임상3상승인,https://www.sedaily.com/NewsView/22H4HUAEMX
10689,2021-01-04,대웅제약췌장염약호이스타정중증코로나19임상3상승인,https://cnbc.sbs.co.kr/article_hub/10001008005?division=NAVER
10690,2021-01-04,대웅제약코로나19중증환자치료제임상3상시험계획승인,https://view.asiae.co.kr/article/2021010408430947465
10691,2021-01-04,대웅제약호이스타정먹는중증코로나19치료제로임상3상승인,http://www.greened.kr/news/articleView.html?idxno=282728
10692,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,http://www.cstimes.com/news/articleView.html?idxno=445545
10693,2021-01-04,대웅제약췌장염약코로나19치료제임상3상승인,https://biz.chosun.com/site/data/html_dir/2021/01/04/2021010400444.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10694,2021-01-04,대웅제약호이스타정중증코로나19환자대상3상승인획득,https://www.youthdaily.co.kr/news/article.html?no=58050
10695,2021-01-04,대웅제약호이스타정코로나19임상3상승인중증환자1072명목표,http://www.dt.co.kr/contents.html?article_no=2021010402109931102001&ref=naver
10696,2021-01-04,대웅제약코로나치료제중증환자대상임상3상승인,http://news.mt.co.kr/mtview.php?no=2021010408474818670
10697,2021-01-04,대웅제약코로나19치료제호이스타정국내임상3상승인,https://www.dailian.co.kr/news/view/951896/?sc=Naver
10698,2021-01-04,대웅제약호이스타정중증환자대상임상3상시작,http://isplus.live.joins.com/news/article/article.asp?total_id=23961178
10699,2021-01-04,대웅제약호이스타정중증환자대상코로나치료제임상3상승인,http://www.newspim.com/news/view/20210104000058
10700,2021-01-04,대웅제약DWJ1248정국내임상3상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=410853
10701,2021-01-04,대웅제약호이스타정코로나19중증임상3상승인,http://news.tf.co.kr/read/economy/1834925.htm
10702,2021-01-04,대웅제약호이스타정코로나19국내3상돌입,https://www.kpanews.co.kr/article/show.asp?idx=218988&category=D
10703,2021-01-04,대웅제약호이스타정중증코로나치료제임상3상승인,http://news.kmib.co.kr/article/view.asp?arcid=0015387748&code=61171911&cp=nv
10704,2021-01-04,대웅제약호이스타정중증코로나19치료제임상3상승인,http://www.newstomato.com/ReadNews.aspx?no=1016223
10705,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,https://cnbc.sbs.co.kr/article_hub/10001008009?division=NAVER
10706,2021-01-04,대웅제약코로나19치료제호이스타정임상3상승인,http://www.mediapen.com/news/view/589403
10707,2021-01-04,대웅제약코로나19치료제중증환자대상임상3상시험계획승인,https://www.etoday.co.kr/news/view/1980252
10708,2021-01-04,대웅제약호이스타코로나19치료제임상3상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=134230
10709,2021-01-04,대웅제약호이스타정코로나19중증환자대상3상승인,http://www.press9.kr/news/articleView.html?idxno=46719
10710,2021-01-04,대웅제약코로나19치료제호이스타정임상3상돌입,http://www.ezyeconomy.com/news/articleView.html?idxno=108539
10711,2021-01-04,대웅제약호이스타정이번엔중증코로나19환자대상임상3상시험,http://www.medisobizanews.com/news/articleView.html?idxno=75411
10712,2021-01-04,대웅제약호이스타정중증환자대상국내임상3상승인,http://it.chosun.com/site/data/html_dir/2021/01/04/2021010400574.html
10713,2021-01-04,대웅제약코로나치료제임상3상시험시작주가↑,http://news.mt.co.kr/mtview.php?no=2021010410031757348
10714,2021-01-04,대웅제약호이스타정중증코로나치료제임상3상승인,http://www.whitepaper.co.kr/news/articleView.html?idxno=200160
10715,2021-01-04,특징주대웅제약코로나치료제임상3상승인소식에9대강세,https://www.dailian.co.kr/news/view/951993/?sc=Naver
10716,2021-01-04,특징주대웅제약중증코로나치료제임상3상승인소식에급등,http://www.edaily.co.kr/news/newspath.asp?newsid=02263206628914440
10717,2021-01-04,대웅제약1091상승18만3000원대로시작치료제3상영향,http://www.ajunews.com/view/20210104084910832
10718,2021-01-04,대웅제약과전면전준비메디톡스검사출신부사장영입,http://www.wikileaks-kr.org/news/articleView.html?idxno=101417
10719,2021-01-04,대웅제약대웅모두갑작스런급등대웅제약12급등이어대웅14급등,http://www.econonews.co.kr/news/articleView.html?idxno=152042
10720,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.greened.kr/news/articleView.html?idxno=282807
10721,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,https://www.youthdaily.co.kr/news/article.html?no=58081
10722,2021-01-04,신년사전승호대웅제약대표끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.newsway.co.kr/news/view?tp=1&ud=2021010410132295095
10723,2021-01-04,신년사전승호대웅제약대표2021년신약개발성과가시화되는한해가될것,https://www.ekn.kr/web/view.php?key=20210104010000282
10724,2021-01-04,신년사전승호대웅제약사장포스트코로나시대선도해나갈것”,http://kpenews.com/View.aspx?No=1403595
10725,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.press9.kr/news/articleView.html?idxno=46721
10726,2021-01-04,특징주대웅제약코로나19치료제임상3상승인에강세,http://www.inews24.com/view/1331838
10727,2021-01-04,특징주대웅제약세계최초경구용코로나19치료제임상3상시험승인소식에상승세,https://www.etoday.co.kr/news/view/1980321
10728,2021-01-04,전승호대웅제약사장끊임없는혁신으로포스트코로나선도할것”,http://news.mt.co.kr/mtview.php?no=2021010410071258621
10729,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.asiaa.co.kr/news/articleView.html?idxno=15932
10730,2021-01-04,대웅제약코로나19치료제혁신신약등글로벌신약성과가시화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253100
10731,2021-01-04,특징주대웅제약코로나치료제임상3상승인소식에강세,http://www.newspim.com/news/view/20210104000252
10732,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나선도할것,http://www.mediapen.com/news/view/589478
10733,2021-01-04,이종목버핏이라면대웅제약코로나19치료제임상3상승인에급등,https://www.news2day.co.kr/article/20210104500065
10734,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101041009255400893
10735,2021-01-04,대웅제약코로나19치료제중증대상임상3상승인,https://sports.hankooki.com/lpage/economy/202101/sp20210104102300137020.htm?s_ref=nv
10736,2021-01-04,특징주대웅제약중증코로나치료제3상승인에상승세,https://www.news1.kr/articles/?4169658
10737,2021-01-04,특징주대웅제약코로나19치료제임상3상승인에강세,http://www.ajunews.com/view/20210104102625020
10738,2021-01-04,2021신년사전승호대웅제약사장올해신약개발성과본격가시화될것,https://www.asiatoday.co.kr/view.php?key=20210104010000760
10739,2021-01-04,전승호대웅제약사장코로나위기돌파에전사역량집중,http://www.newsis.com/view/?id=NISX20210104_0001292469&cID=13001&pID=13000
10740,2021-01-04,대웅제약코로나치료제임상3상승인소식에강세,https://biz.chosun.com/site/data/html_dir/2021/01/04/2021010401025.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10741,2021-01-04,대웅제약올해는신약개발성과가시화되는한해,http://www.medisobizanews.com/news/articleView.html?idxno=75412
10742,2021-01-04,대웅제약주가초반뛰어코로나19치료제임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=211194
10743,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도”,http://www.bokuennews.com/news/article.html?no=199110
10744,2021-01-04,2021신년사전승호대웅제약사장혁신통해포스트코로나시대선도할것,http://www.m-i.kr/news/articleView.html?idxno=782124
10745,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도해나갈것”,https://www.fetv.co.kr/news/article.html?no=73151
10746,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도,http://www.newstomato.com/ReadNews.aspx?no=1016265
10747,2021-01-04,신년메시지전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.ceoscoredaily.com/news/article.html?no=76891
10748,2021-01-04,신년사대웅제약혁신과도전으로포스트코로나시대이끌것,https://www.etoday.co.kr/news/view/1980336
10749,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65564
10750,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.segye.com/content/html/2021/01/04/20210104505319.html?OutUrl=naver
10751,2021-01-04,전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도,http://www.upinews.kr/newsView/upi202101040027
10752,2021-01-04,특징주대웅제약5대강세호이스타정중증환자대상임상승인,https://www.ebn.co.kr/news/view/1466421/?sc=Naver
10753,2021-01-04,대웅제약혁신으로포스트코로나시대선도,http://www.bosa.co.kr/news/articleView.html?idxno=2141547
10754,2021-01-04,대웅제약전승호사장끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.thebigdata.co.kr/view.php?ud=202101041050286995798818e98b_23
10755,2021-01-04,대웅제약포스트코로나시대선도할것”,http://www.mhj21.com/138153
10756,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.segyebiz.com/newsView/20210104505606?OutUrl=naver
10757,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도,https://www.econovill.com/news/articleView.html?idxno=513036
10758,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나선도할것,http://www.getnews.co.kr/news/articleView.html?idxno=507780
10759,2021-01-04,2021신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.seoulwire.com/news/articleView.html?idxno=432908
10760,2021-01-04,대웅제약혁신통해포스트코로나시대선도”,http://www.whosaeng.com/123730
10761,2021-01-04,전승호대웅제약사장끊임없는혁신포스트코로나시대선도할것”,http://www.viva100.com/main/view.php?key=20210104010000385
10762,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도,http://www.insightkorea.co.kr/news/articleView.html?idxno=85794
10763,2021-01-04,대웅제약코로나19치료제의중증환자대상임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=211212
10764,2021-01-04,대웅제약호이스타정코로나19중환자대상임상3상돌입,http://inthenews.co.kr/article-85838/
10765,2021-01-04,전승호대웅제약대표올해신약개발성과가본격적으로가시화되는한해가될것,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021010411091889804
10766,2021-01-04,대웅제약끊임없는혁신통해포스트코로나시대선도,http://medipana.com/news/news_viewer.asp?NewsNum=269311&MainKind=A&NewsKind=5&vCount=12&vKind=1
10767,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101040196&t=NN
10768,2021-01-04,대웅제약호이스타정렘데시비르병용치료제로임상3상,http://news.mt.co.kr/mtview.php?no=2021010410241308944
10769,2021-01-04,신년사전승호대웅제약사장올해신약개발성과가시화,https://biz.chosun.com/site/data/html_dir/2021/01/04/2021010401353.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10770,2021-01-04,대웅제약신년사전승호대표글로벌혁신신약개발로K팜글로벌리더도약,http://www.g-enews.com/ko-kr/news/article/news_all/2021010411340937862500a1b5d6_1/article.html
10771,2021-01-04,신년사전승호대웅제약사장혁신으로포스트코로나시대선도”,http://www.edaily.co.kr/news/newspath.asp?newsid=03050406628914440
10772,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.pressm.kr/news/articleView.html?idxno=35816
10773,2021-01-04,전승호대웅제약대표뛰어난약효안전성확보제약회사최우선가치,http://www.newsprime.co.kr/news/article.html?no=529337
10774,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.dailysmart.co.kr/news/articleView.html?idxno=38277
10775,2021-01-04,대웅제약전승호사장올해신약개발성과가시화될것,http://www.consumuch.com/news/articleView.html?idxno=51687
10776,2021-01-04,대웅제약코로나치료제호이스타정임상3상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004228063
10777,2021-01-04,특징주대웅제약중증코로나19치료제임상3상승인소식에강세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004228061
10778,2021-01-04,2021신년사전승호대웅제약사장한국형글로벌기업도약할것,http://www.newslock.co.kr/news/articleView.html?idxno=34777
10779,2021-01-04,전승호대웅제약사장코로나위기돌파에전사역량집중,http://www.wsobi.com/news/articleView.html?idxno=111624
10780,2021-01-04,대웅제약2021신년사끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.paxetv.com/news/articleView.html?idxno=107793
10781,2021-01-04,이데일리N대웅제약코로나19중증환자대상임상3상시험계획승인外,http://www.edaily.co.kr/news/newspath.asp?newsid=03384966628914440
10782,2021-01-04,2021년대웅제약온라인시무식,http://yna.kr/PYH20210104116500017?did=1196m
10783,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.nbnnews.co.kr/news/articleView.html?idxno=455435
10784,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도할것,http://www.medigatenews.com/news/612336739
10785,2021-01-04,전승호대웅제약사장급격한변화속끊임없는혁신이뤄야,http://www.100ssd.co.kr/news/articleView.html?idxno=73852
10786,2021-01-04,대웅제약끊임없는혁신약효와안전성최우선가치”,http://www.biospectator.com/view/news_view.php?varAtcId=12199
10787,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로한국대표제약사자리매김,https://www.dailian.co.kr/news/view/952106/?sc=Naver
10788,2021-01-04,대웅제약과소송메디톡스부장검사출신부사장으로영입,http://4th.kr/View.aspx?No=1404198
10789,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.pharmnews.com/news/articleView.html?idxno=102066
10790,2021-01-04,2021신년사전승호대웅제약사장혁신으로포스트코로나시대선도할것,https://daily.hankooki.com/lpage/industry/202101/dh20210104150617148390.htm?s_ref=nv
10791,2021-01-04,신년사GC녹십자한미약품대웅제약보령제약,https://www.ajunews.com/view/20210104145817335
10792,2021-01-04,전승호대웅제약사장올해코로나19치료제등신약개발성과가시화”,https://www.donga.com/news/article/all/20210104/104760956/1
10793,2021-01-04,전승호대웅제약사장혁신으로포스트코로나시대선도”,http://www.mdtoday.co.kr/mdtoday/index.html?no=410937
10794,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.businesskorea.co.kr/news/articleView.html?idxno=57846
10795,2021-01-04,대웅제약코로나19치료제호이스타정중증환자대상임상3상승인,http://kbench.com/?q=node/217272
10796,2021-01-04,신년사전승호대웅제약대표끊임없는혁신으로포스트코로나시대선도해나갈것”,http://theviewers.co.kr/View.aspx?No=1404433
10797,2021-01-04,전승호대웅제약사장혁신으로포스트코로나시대선도,http://www.finomy.com/news/articleView.html?idxno=87430
10798,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.thedailypost.kr/news/articleView.html?idxno=78546
10799,2021-01-04,대웅제약온라인신년시무식개최포스트코로나시대선도해나갈것,http://www.lcnews.co.kr/news/articleView.html?idxno=11565
10800,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.thepublic.kr/news/newsview.php?ncode=1065592352849821
10801,2021-01-04,대웅제약올해펙수프라잔등글로벌신약개발성과가시화될것,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=125053
10802,2021-01-04,전승호대웅제약대표호이스타정연구지속할것,http://www.mdtoday.co.kr/mdtoday/index.html?no=410955
10803,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.dt.co.kr/contents.html?article_no=2021010402109931102006&ref=naver
10804,2021-01-04,대웅제약전사적역량집중해위기돌파할것신년사밝혀,http://www.sportsseoul.com/news/read/998986?ref=naver
10805,2021-01-04,신년사전승호대웅제약사장코로나19위기돌파에역량집중,http://www.newsworks.co.kr/news/articleView.html?idxno=517444
10806,2021-01-04,신년사전승호대웅제약사장혁신으로포스트코로나시대선도,http://it.chosun.com/site/data/html_dir/2021/01/04/2021010402306.html
10807,2021-01-04,대웅제약온라인신년시무식진행,http://www.lawissue.co.kr/view.php?ud=202101041649459852204ead0791_12
10808,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.newsworker.co.kr/news/articleView.html?idxno=97928
10809,2021-01-04,대웅제약혁신으로포스트코로나선도”,http://www.thevaluenews.co.kr/news/view.php?idx=162103
10810,2021-01-04,대웅제약한미녹십자등온택트시무식으로새해첫근무시작,http://www.ajunews.com/view/20210104171803536
10811,2021-01-04,금일제약업계주요기사대웅제약호이스타정중증코로나19환자대상3상승인한국유나이티드제약NASH치료제임상2상진입外,http://www.youthdaily.co.kr/news/article.html?no=58146
10812,2021-01-04,대웅제약끊임없는혁신포스트코로나시대선도할것,http://www.shinailbo.co.kr/news/articleView.html?idxno=1362273
10813,2021-01-04,시무식대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.thefirstmedia.net/news/articleView.html?idxno=68731
10814,2021-01-04,대웅제약2021년온라인시무식혁신강조,https://www.kpanews.co.kr/article/show.asp?idx=219019&category=D
10815,2021-01-05,유가증권기업공시4일대웅제약등,https://www.hankyung.com/finance/article/2021010564811
10816,2021-01-05,대웅제약엔트레스토성분약생동성시험돌입복제약개발나서,http://www.ceoscoredaily.com/news/article.html?no=76947
10817,2021-01-05,전승호대웅제약대표끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.bizwnews.com/news/articleView.html?idxno=22598
10818,2021-01-05,대웅제약대웅가파른하락세로무너져대웅제약5하락이어대웅역시5하락,http://www.econonews.co.kr/news/articleView.html?idxno=152203
10819,2021-01-05,대웅제약대웅오후갑작스런급등대웅제약19급등이어대웅24급등,http://www.econonews.co.kr/news/articleView.html?idxno=152297
10820,2021-01-05,대웅제약주가장중급등코로나19치료제임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=211524
10821,2021-01-05,이종목버핏이라면코로나임상3상승인대웅제약나비효과에대웅도급등,https://www.news2day.co.kr/article/20210105500204
10822,2021-01-05,신년사전승호대웅제약사장신약개발성과가시화되는시기,http://www.meconomynews.com/news/articleView.html?idxno=49050
10823,2021-01-05,특징주대웅제약코로나치료제임상3상승인소식에강세,http://www.fnnews.com/news/202101051431026736
10824,2021-01-05,특징주노터스대웅제약이버멕틴코로나치료제가능성에주가급등,http://www.ccreview.co.kr/news/articleView.html?idxno=301156
10825,2021-01-05,코스피마감시황동학개미외인기관꺽었다삼성제약한솔로지스틱스대웅제약삼성제약,http://www.smartfn.co.kr/view.php?ud=202101051543511254260ddb1f94_46
10826,2021-01-06,백신접종시작했지만사망자폭발화들짝박셀바이오현대바이오삼성제약대웅제약주목,http://www.pinpointnews.co.kr/view.php?ud=202101060517068748861beb2d9d_45
10827,2021-01-06,휴젤강세속대웅제약메디톡스장기소송전종료변수,http://www.dailymedi.com/detail.php?number=864789&thread=22r05
10828,2021-01-06,대웅제약식약처3상승인1년간9건국내사중최다,http://www.press9.kr/news/articleView.html?idxno=46745
10829,2021-01-06,메디톡스대웅제약넘어이번엔식약처행정처분피할까,https://daily.hankooki.com/lpage/industry/202101/dh20210106071515148390.htm?s_ref=nv
10830,2021-01-06,투자경고동신건설셀젠텍박셀바이오대웅제약초강세투자주의오킨스전자글로스퍼랩스선바이오급등시장경보株훨훨,http://www.pinpointnews.co.kr/view.php?ud=202101060723309594cd1e7f0bdf_45
10831,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.thebigdata.co.kr/view.php?ud=202101060926177605798818e98b_23
10832,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253214
10833,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인”,https://www.youthdaily.co.kr/news/article.html?no=58309
10834,2021-01-06,대웅제약올로스타국제학술지심장학저널등재,http://www.asiaa.co.kr/news/articleView.html?idxno=16265
10835,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,https://www.ekn.kr/web/view.php?key=20210106010000887
10836,2021-01-06,대웅제약올로스타우수한효과확인,http://www.press9.kr/news/articleView.html?idxno=46751
10837,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.fetv.co.kr/news/article.html?no=73395
10838,2021-01-06,대웅제약올로스타개별약제병용보다효과우수,http://www.medisobizanews.com/news/articleView.html?idxno=75487
10839,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.pharmnews.com/news/articleView.html?idxno=102097
10840,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.mediapen.com/news/view/590374
10841,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인”,http://www.viva100.com/main/view.php?key=20210106010000993
10842,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.m-i.kr/news/articleView.html?idxno=783046
10843,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과,http://medipana.com/news/news_viewer.asp?NewsNum=269442&MainKind=A&NewsKind=5&vCount=12&vKind=1
10844,2021-01-06,대웅제약고혈압복합제개별약제병용때보다우수,http://www.newsis.com/view/?id=NISX20210106_0001295343&cID=13001&pID=13000
10845,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.metroseoul.co.kr/article/20210106500080
10846,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.newsway.co.kr/news/view?tp=1&ud=2021010609564277854
10847,2021-01-06,대웅제약올로스타개별약제병용요법대비효과확인,http://www.kpinews.co.kr/news/articleView.html?idxno=134455
10848,2021-01-06,대웅제약올로스타개별약제병용요법보다효과우수,https://daily.hankooki.com/lpage/industry/202101/dh20210106100239148390.htm?s_ref=nv
10849,2021-01-06,대웅제약올로스타혈압강하및이상지질혈증개선효과확인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=125126
10850,2021-01-06,대웅제약올로스타개별약제병용요법대비효과우수,http://www.pressm.kr/news/articleView.html?idxno=35901
10851,2021-01-06,대웅제약올로스타개별약제병용요법효과확인,http://www.mhj21.com/138251
10852,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101061007160020533
10853,2021-01-06,대웅제약복합제올로스타개별약제병용요법보다우수한효과확인,https://www.etoday.co.kr/news/view/1981334
10854,2021-01-06,대웅제약 올로스타 개별약제 병용 요법 대비 효과 뛰어나,http://kormedi.com/?p=1330614
10855,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.hankyung.com/it/article/202101061991i
10856,2021-01-06,대웅제약올로스타혈압강하이상지질혈증개선우수확인,http://news.mt.co.kr/mtview.php?no=2021010610043838078
10857,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=38410
10858,2021-01-06,오늘의제약SK바이오사이언스유비케어대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=42460
10859,2021-01-06,대웅제약올로스타개별약제병용대비저밀도지단백콜레스테롤감소,http://www.newsprime.co.kr/news/article.html?no=529651
10860,2021-01-06,현대약품대웅제약제약주희비엇갈려현대약품15급등반해대웅제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=152389
10861,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=21183
10862,2021-01-06,대웅제약올로스타병용요법대비효과우수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1138075&REFERER=NP
10863,2021-01-06,대웅제약올로스타개별약제병용요법대비효과우수,http://www.bosa.co.kr/news/articleView.html?idxno=2141760
10864,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.asiatoday.co.kr/view.php?key=20210106010002631
10865,2021-01-06,대웅제약올로스타심장학저널CardiologyJournal12월호등재,http://www.businesskorea.co.kr/news/articleView.html?idxno=57973
10866,2021-01-06,대웅제약올로스타개별약제병용보다효과우수,https://view.asiae.co.kr/article/2021010610543204694
10867,2021-01-06,대웅제약올로스타개별약제병용군대비우수효과,https://sports.hankooki.com/lpage/economy/202101/sp20210106105308137020.htm?s_ref=nv
10868,2021-01-06,대웅제약올로스타혈압이상지질혈증개선효과확인,https://health.chosun.com/site/data/html_dir/2021/01/06/2021010601325.html
10869,2021-01-06,대웅제약올로스타개별약제병용대비우수효과,http://www.dailypharm.com/Users/News/NewsView.html?ID=272223&REFERER=NP
10870,2021-01-06,대웅제약올로스타개별약제병용대비효과우수,https://www.econovill.com/news/articleView.html?idxno=513480
10871,2021-01-06,대웅제약올로스타개별약제병용요법대비우수,https://www.ebn.co.kr/news/view/1466840/?sc=Naver
10872,2021-01-06,대웅제약올로스타개선효과국제학술지등재,http://www.wikileaks-kr.org/news/articleView.html?idxno=101576
10873,2021-01-06,제약오늘대웅제약올로스타개별약제병용요법대비효과확인JW중외제약기업미디어플랫폼으로홈페이지리뉴얼,http://www.sisaon.co.kr/news/articleView.html?idxno=122599
10874,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=517976
10875,2021-01-06,대웅제약올로스타연구국제학술지심장학저널등재,http://www.100ssd.co.kr/news/articleView.html?idxno=73917
10876,2021-01-06,뉴스투데이L대웅제약올로스타우수한혈압강하이상지질혈증개선효과확인,https://www.news2day.co.kr/article/20210106500115
10877,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.thepublic.kr/news/newsview.php?ncode=1065576568106159
10878,2021-01-06,대웅제약올로스타개별약제병용요법대비효과우수,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006466
10879,2021-01-06,대웅제약고혈압과이상지질혈증복합제효능을국제학술지에실어,http://www.businesspost.co.kr/BP?command=article_view&num=211678
10880,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572996881131
10881,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.lcnews.co.kr/news/articleView.html?idxno=11627
10882,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=411136
10883,2021-01-06,대웅제약올로스타우수한복약순응도혈압강하효과확인,http://www.thedailypost.kr/news/articleView.html?idxno=78602
10884,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=456272
10885,2021-01-06,대웅제약올로스타개별약제병용요법比효과우수,http://www.upinews.kr/newsView/upi202101060067
10886,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004230603
10887,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65623
10888,2021-01-06,대웅제약고혈압약올로스타개별약제병용요법대비우수효과입증,http://www.kukinews.com/newsView/kuk202101060243
10889,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.dailian.co.kr/news/view/953042/?sc=Naver
10890,2021-01-06,대웅제약올로스타LDLC감소치병용군대비3배,http://www.skyedaily.com/news/news_view.html?ID=119776
10891,2021-01-06,대웅제약올로스타혈압강하이상지질혈증개선효과확인,http://www.sporbiz.co.kr/news/articleView.html?idxno=506418
10892,2021-01-06,대웅제약올로스타병용요법대비우수한효과확인,http://www.medigatenews.com/news/870021021
10893,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.newstomato.com/ReadNews.aspx?no=1016999
10894,2021-01-06,제약업계소식JW중외제약기업미디어플랫폼으로홈페이지리뉴얼대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.bizwnews.com/news/articleView.html?idxno=22639
10895,2021-01-06,심장학저널에등재대웅제약올로스타혈압강하및이상지질혈증개선효과확인,http://theviewers.co.kr/View.aspx?No=1407530
10896,2021-01-06,대웅제약올로스타연구국제학술지등재,http://www.shinailbo.co.kr/news/articleView.html?idxno=1363293
10897,2021-01-06,브리핑JW중외제약대웅제약보령제약,http://4th.kr/View.aspx?No=1407256
10898,2021-01-06,대웅제약복합개량신약올로스타개별약제병용요법대비우수한효능확인,https://www.donga.com/news/article/all/20210106/104801403/1
10899,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.thefirstmedia.net/news/articleView.html?idxno=68864
10900,2021-01-06,대웅제약올로스타임상결과SCI급학술지등재,http://www.newsfreezone.co.kr/news/articleView.html?idxno=288873
10901,2021-01-07,30대제약사CEO15명3월임기만료대웅제약등실적부진에연임물음표,http://www.consumernews.co.kr/news/articleView.html?idxno=618354
10902,2021-01-07,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://jhealthmedia.joins.com/article/article_view.asp?pno=22951
10903,2021-01-07,여의도주식왕대웅제약vs드림시큐리티여의도를달굴종목은,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021010621002130430
10904,2021-01-07,대웅제약올로스타연구국제학술지심장학저널등재,http://www.wolyo.co.kr/news/articleView.html?idxno=114161
10905,2021-01-07,대웅제약동화약품제약주희비엇갈려대웅제약2하락반해동화약품소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=152557
10906,2021-01-08,대웅제약동화약품제약주모두하락세로대웅제약3하락이어동화약품역시3하락,http://www.econonews.co.kr/news/articleView.html?idxno=152743
10907,2021-01-08,대웅대웅제약하락에급락으로무너져대웅9급락이어대웅제약4하락,http://www.econonews.co.kr/news/articleView.html?idxno=152795
10908,2021-01-11,동화약품대웅제약제약주가파른하락세로급락대웅제약6급락이어동화약품5급락,http://www.econonews.co.kr/news/articleView.html?idxno=153195
10909,2021-01-12,이낙연셀트리온GC녹십자대웅제약등국내제약사와코로나19치료제개발상황점검,http://www.topstarnews.net/news/articleView.html?idxno=855526
10910,2021-01-12,특징주코로나19치료제기대감↑셀트리온대웅제약등강세,http://www.newspim.com/news/view/20210112000166
10911,2021-01-12,대웅제약동화약품제약주모두상승세로돌아서대웅제약3상승이어동화약품소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=153314
10912,2021-01-12,녹십자셀트리온대웅제약불러모은與K치료제중요,https://biz.chosun.com/site/data/html_dir/2021/01/12/2021011201177.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10913,2021-01-12,대웅대웅제약상승에급등까지대웅7급등이어대웅제약5상승,http://www.econonews.co.kr/news/articleView.html?idxno=153371
10914,2021-01-12,이낙연셀트리온대웅제약GC녹십자등코로나19치료제개발점검,http://www.topstarnews.net/news/articleView.html?idxno=855594
10915,2021-01-12,경남제약대웅제약제약주상승에급등까지특히경남제약오후갑작스런24급등,http://www.econonews.co.kr/news/articleView.html?idxno=153403
10916,2021-01-12,치료제개발어디까지왔나셀트리온대웅제약GC녹십자각축전,http://www.ajunews.com/view/20210112152800743
10917,2021-01-12,아주경제오늘의뉴스종합치료제개발어디까지왔나셀트리온대웅제약GC녹십자각축전外,http://www.ajunews.com/view/20210112221309989
10918,2021-01-13,대웅제약동화약품제약주모두하락세로특히대웅제약3낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=153473
10919,2021-01-13,경남제약대웅제약제약주상승에급등까지특히경남제약가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=153595
10920,2021-01-14,대웅제약ITC균주논쟁종결균주영업비밀성부정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253457
10921,2021-01-14,ITC최종결정전문공개대웅제약균주논쟁종결선언,http://www.bosa.co.kr/news/articleView.html?idxno=2142248
10922,2021-01-14,코로나K치료제셀트리온다음은어디부광약품엔키켐생명과학신풍제약종근당대웅제약제넥신주목,http://www.pinpointnews.co.kr/view.php?ud=202101140642176381861beb2d9d_45
10923,2021-01-14,대웅제약ITC균주논쟁종결균주는영업비밀아니다,http://www.medisobizanews.com/news/articleView.html?idxno=75659
10924,2021-01-14,ITC최종판결전문공개에대웅제약메디톡스엇갈린해석,http://medipana.com/news/news_viewer.asp?NewsNum=269801&MainKind=A&NewsKind=5&vCount=12&vKind=1
10925,2021-01-14,곧K코로나치료제나오나관련주셀트리온대웅제약녹십자종근당주가는,http://www.ajunews.com/view/20210114072727918
10926,2021-01-14,메디톡스대웅제약보톡스분쟁최종판결문공개후2차전,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101140040&t=NN
10927,2021-01-14,국산코로나19치료제셀트리온이어GC녹십자대웅제약종근당도허가신청채비,http://www.topstarnews.net/news/articleView.html?idxno=855894
10928,2021-01-14,메디톡스대웅제약보톡스분쟁ITC판결문공개균주는영업비밀아니다”,https://www.fetv.co.kr/news/article.html?no=73924
10929,2021-01-14,美ITC보톡스판결문놓고대웅제약vs메디톡스아전인수해석,https://www.ekn.kr/web/view.php?key=20210114010002836
10930,2021-01-14,국산코로나19치료제셀트리온이어GC녹십자대웅제약종근당줄이어개발,http://www.kwnews.co.kr/nview.asp?aid=221011300149
10931,2021-01-14,보톡스분쟁ITC판결문공개됐지만대웅제약메디톡스갈등지속,http://www.greened.kr/news/articleView.html?idxno=284397
10932,2021-01-14,보톡스분쟁ITC최종판결전문공개대웅제약메디톡스또엇갈린해석,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021011408543676139
10933,2021-01-14,메디톡스美ITC최종판결전문공개대웅제약이부정하게균주취득,http://www.pinpointnews.co.kr/view.php?ud=20210114090422468f090c8dbcb_45
10934,2021-01-14,ITC최종판결전문공개대웅제약메디톡스여전히엇갈린해석,http://www.newstomato.com/ReadNews.aspx?no=1018488
10935,2021-01-14,대웅제약이훔쳤다”메디톡스가거짓말”계속되는보톡스전쟁,https://news.joins.com/article/olink/23564842
10936,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.press9.kr/news/articleView.html?idxno=46814
10937,2021-01-14,대웅제약메디톡스ITC최종판결전문공개에온도차,http://www.cstimes.com/news/articleView.html?idxno=446984
10938,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004238292
10939,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101140067&t=NN
10940,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.sentv.co.kr/news/view/586589
10941,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65738
10942,2021-01-14,대웅제약CDMO사업돌입첨단바이오의약품제조업허가취득,https://www.fetv.co.kr/news/article.html?no=73938
10943,2021-01-14,대웅제약CDMO신사업진출첨단바이오의약품제조업허가,http://www.viva100.com/main/view.php?key=20210114010003034
10944,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격돌입,https://www.ekn.kr/web/view.php?key=20210114010002874
10945,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thebigdata.co.kr/view.php?ud=202101140929599116798818e98b_23
10946,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253462
10947,2021-01-14,대웅제약첨단바이오의약품제조업허가CDMO사업돌입,http://medipana.com/news/news_viewer.asp?NewsNum=269810&MainKind=A&NewsKind=5&vCount=12&vKind=1
10948,2021-01-14,대웅제약메디톡스보톡스분쟁ITC판결문공개,https://www.ebn.co.kr/news/view/1467888/?sc=Naver
10949,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격진출,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021011409330435566
10950,2021-01-14,대웅제약첨단바이오의약품제조허가취득CDMO사업돌입,https://www.hankyung.com/it/article/202101141017i
10951,2021-01-14,대웅제약의약품위탁생산사업진출식약처제조업허가취득,https://health.chosun.com/site/data/html_dir/2021/01/14/2021011400860.html
10952,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업시작,http://www.medisobizanews.com/news/articleView.html?idxno=75669
10953,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,http://www.metroseoul.co.kr/article/20210114500039
10954,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101140938277630440
10955,2021-01-14,대웅제약의약품위탁생산사업진출허가취득,https://biz.sbs.co.kr/article_hub/20000000341?division=NAVER
10956,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572775786692
10957,2021-01-14,美ITC메디톡스대웅제약균주분쟁판결문공개균주는영업비밀아냐,https://www.sedaily.com/NewsView/22H94HIZKF
10958,2021-01-14,대웅제약균주논쟁종결ITC영업비밀성완전부정,http://www.press9.kr/news/articleView.html?idxno=46818
10959,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,https://www.etoday.co.kr/news/view/1984295
10960,2021-01-14,전문대웅제약균주논쟁종결선언메디톡스향별도고소방침,http://www.thevaluenews.co.kr/news/view.php?idx=162206
10961,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.medigatenews.com/news/2750202155
10962,2021-01-14,美ITC전문공개대웅제약도용입증vs영업비밀아냐,https://biz.sbs.co.kr/article_hub/20000000332?division=NAVER
10963,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2021011409434230980
10964,2021-01-14,ITC최종결정전문공개대웅제약vs메디톡스2차전,http://it.chosun.com/site/data/html_dir/2021/01/14/2021011400900.html
10965,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,https://www.kpanews.co.kr/article/show.asp?idx=219268&category=D
10966,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,https://sports.hankooki.com/lpage/economy/202101/sp20210114094913137020.htm?s_ref=nv
10967,2021-01-14,대웅제약첨단바이오의약품제조업허가CDMO사업,http://www.biospectator.com/view/news_view.php?varAtcId=12292
10968,2021-01-14,보톡스논란또시작이야메디톡스훔쳐갔다Vs대웅제약분석법오류있다,http://moneys.mt.co.kr/news/mwView.php?no=2021011409438085571
10969,2021-01-14,보톡스분쟁메디톡스대웅제약ITC판결문두고여전히입장차,http://www.mediapen.com/news/view/592733
10970,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://yna.kr/AKR20210114057400017?did=1195m
10971,2021-01-14,대웅제약바이오의약품위탁개발생산사업진출,https://biz.chosun.com/site/data/html_dir/2021/01/14/2021011400959.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10972,2021-01-14,대웅제약균주영업비밀성부정논쟁종결vs메디톡스도용행위명백,http://www.consumernews.co.kr/news/articleView.html?idxno=618787
10973,2021-01-14,대웅제약균주도용맞고메디톡스균주영업기밀틀리다,http://www.wikileaks-kr.org/news/articleView.html?idxno=102043
10974,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입”,https://www.youthdaily.co.kr/news/article.html?no=59175
10975,2021-01-14,대웅제약ITC균주논쟁종결메디톡스허위증언고소할것,http://newsclaim.co.kr/View.aspx?No=1416209
10976,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.ceoscoredaily.com/news/article.html?no=77403
10977,2021-01-14,대웅제약첨단바이오의약품제조업허가취득쾌거,http://www.pressm.kr/news/articleView.html?idxno=36083
10978,2021-01-14,대웅제약첨단바이오의약품제조업허가획득CDMO사업본격화,http://www.pinpointnews.co.kr/view.php?ud=2021011410061536182365609d9b_45
10979,2021-01-14,대웅제약바이오의약품위탁개발생산사업진출CDMO관련제조업허가취득,https://www.donga.com/news/article/all/20210114/104917277/1
10980,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,http://www.fnnews.com/news/202101141015584478
10981,2021-01-14,대웅제약메디톡스美ITC최종판결전문놓고설왕설래,https://www.hankyung.com/it/article/202101140583i
10982,2021-01-14,대웅제약첨단바이오의약품CDMO사업진출,https://www.ebn.co.kr/news/view/1467921/?sc=Naver
10983,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.bokuennews.com/news/article.html?no=199494
10984,2021-01-14,메디톡스VS대웅제약보톡스전쟁다시불붙나ITC최종판결놓고서로비난,https://www.etoday.co.kr/news/view/1984355
10985,2021-01-14,메디톡스대웅제약ITC판결나왔지만또해석전쟁,http://www.newsis.com/view/?id=NISX20210114_0001304893&cID=13001&pID=13000
10986,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://it.chosun.com/site/data/html_dir/2021/01/14/2021011401097.html
10987,2021-01-14,대웅제약첨단바이오의약품제조업취득CDMO사업돌입,http://www.economytalk.kr/news/articleView.html?idxno=210453
10988,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.newslock.co.kr/news/articleView.html?idxno=35229
10989,2021-01-14,ITC최종결정문에대웅제약오판승소할뜻밝혀,http://www.businesskorea.co.kr/news/articleView.html?idxno=58459
10990,2021-01-14,대웅제약동화약품제약주모두상승세로대웅제약3상승이어동화약품1상승,http://www.econonews.co.kr/news/articleView.html?idxno=153683
10991,2021-01-14,대웅제약첨단바이오의약품제조업허가취득세포치료제제조개발판매올인원패키지,http://www.paxetv.com/news/articleView.html?idxno=108607
10992,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.businesskorea.co.kr/news/articleView.html?idxno=58465
10993,2021-01-14,제이엘케이대웅제약과플랫폼기술개발공급계약체결,http://www.pinpointnews.co.kr/view.php?ud=20210114103726340cd1e7f0bdf_45
10994,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://news.mt.co.kr/mtview.php?no=2021011410010652708
10995,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMP사업돌입,http://www.mhj21.com/138425
10996,2021-01-14,대웅제약바이오의약품제조업허가취득CDMO본격진출,https://www.econovill.com/news/articleView.html?idxno=514702
10997,2021-01-14,대웅제약첨바법힘입어바이오사업도전장,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1138230&REFERER=NP
10998,2021-01-14,美ITC최종판결공개메디톡스대웅제약엇갈린해석,http://www.newsprime.co.kr/news/article.html?no=530614
10999,2021-01-14,더벨대웅제약세포치료제CDMO사업본격화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202101141009304160107590
11000,2021-01-14,대웅제약바이오의약품제조업허가취득CDMO사업돌입,http://www.healthinnews.co.kr/news/articleView.html?idxno=21327
11001,2021-01-14,대웅대웅제약모두가파른상승세로급등대웅8급등이어대웅제약5급등,http://www.econonews.co.kr/news/articleView.html?idxno=153699
11002,2021-01-14,대웅제약균주도용美ITC판결전문공개,https://www.paxnetnews.com/articles/69794
11003,2021-01-14,대웅제약의약품위탁개발생산사업진출식약처허가취득,http://www.sisaweek.com/news/articleView.html?idxno=140901
11004,2021-01-14,대웅제약메디톡스ITC최종판결전문공개에엇갈린해석,http://www.seoulwire.com/news/articleView.html?idxno=433871
11005,2021-01-14,셀트리온이어GC녹십자대웅제약코로나19치료제줄섰다,http://www.kyeongin.com/main/view.php?key=20210114010002607
11006,2021-01-14,대웅제약첨단바이오의약품제조업자격취득CDMO사업진출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=97884
11007,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.whosaeng.com/124022
11008,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.bosa.co.kr/news/articleView.html?idxno=2142282
11009,2021-01-14,대웅제약에호재CDMO사업뭐길래,http://www.todaykorea.co.kr/news/articleView.html?idxno=282427
11010,2021-01-14,대웅제약첨단바이오제조업허가CDMO사업돌입,http://www.newsis.com/view/?id=NISX20210114_0001305112&cID=13001&pID=13000
11011,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.dailysmart.co.kr/news/articleView.html?idxno=38804
11012,2021-01-14,메디톡스대웅제약균주도용여부로2차전예상,http://www.k-health.com/news/articleView.html?idxno=51918
11013,2021-01-14,美ITC대웅제약메디톡스균주도용해유전적증거가입증,http://www.thepowernews.co.kr/view.php?ud=2021011411281944547a517a52c2_7
11014,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.dt.co.kr/contents.html?article_no=2021011402109931102009&ref=naver
11015,2021-01-14,ITC전문공개에도대웅제약메디톡스엇갈린주장논란지속,http://isplus.live.joins.com/news/article/article.asp?total_id=23970378
11016,2021-01-14,대웅제약도의약품위탁개발생산사업진출,http://www.dailymedi.com/detail.php?number=865204&thread=22r05
11017,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.onews.tv/news/articleView.html?idxno=44907
11018,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,http://www.lawissue.co.kr/view.php?ud=202101141136451184204ead0791_12
11019,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.segyebiz.com/newsView/20210114509115?OutUrl=naver
11020,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.smartfn.co.kr/view.php?ud=202101141147502799d5d29c6899_46
11021,2021-01-14,대웅제약바이오의약품제조업허가CDMO사업도전장,http://www.seoulfn.com/news/articleView.html?idxno=407533
11022,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.koreaittimes.com/news/articleView.html?idxno=103094
11023,2021-01-14,대웅제약식약처로부터첨단바이오의약품제조업허가받아,http://www.businesspost.co.kr/BP?command=article_view&num=212816
11024,2021-01-14,보폭넓히는대웅제약바이오의약품위탁생산사업진출,http://www.skyedaily.com/news/news_view.html?ID=120573
11025,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.newsworker.co.kr/news/articleView.html?idxno=99088
11026,2021-01-14,대웅제약균주영업비밀아냐”메디톡스대웅이제조기술도용,http://www.fnnews.com/news/202101141221314562
11027,2021-01-14,대웅제약균주논쟁종결”쐐기,http://www.whosaeng.com/124026
11028,2021-01-14,ITC최종판결문대웅제약메디톡스또다시엇갈리는해석,http://www.medigatenews.com/news/1374414101
11029,2021-01-14,제이엘케이대웅제약과1억규모AIDB플랫폼기술개발공급계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=411888
11030,2021-01-14,대웅제약바이오의약품위탁개발생산사업본격진출,http://news.mk.co.kr/newsRead.php?no=44532&year=2021
11031,2021-01-14,네버엔딩보톡스분쟁메디톡스대웅제약판결문정반대해석,http://www.upinews.kr/newsView/upi202101140043
11032,2021-01-14,대웅제약첨단바이오의약품제조업허가취득세포치료제제조개발판매,http://www.lcnews.co.kr/news/articleView.html?idxno=11862
11033,2021-01-14,메디톡스대웅제약ITC최종판결전문공개서로다른해석,http://www.mdtoday.co.kr/mdtoday/index.html?no=411878
11034,2021-01-14,메디톡스대웅제약ITC최종판결전문엇갈린해석2차전예고,https://www.asiatime.co.kr/news/newsview.php?ncode=1065581428546524
11035,2021-01-14,같은판결다른해석대웅제약vs메디톡스계속되는증거논쟁,http://www.newsquest.co.kr/news/articleView.html?idxno=80956
11036,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thepublic.kr/news/newsview.php?ncode=1065574504865641
11037,2021-01-14,판결문도입맛대로메디톡스vs대웅제약계속된신경전,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006750
11038,2021-01-14,대웅제약메디톡스균주공방계속최종판결전문놓고도해석제각각,http://www.businesspost.co.kr/BP?command=article_view&num=212860
11039,2021-01-14,보톡스분쟁메디톡스대웅제약ITC판결문두고도설전,http://www.finomy.com/news/articleView.html?idxno=87876
11040,2021-01-14,대웅제약vs메디톡스ITC판결문공개에도입장차여전,http://www.shinailbo.co.kr/news/articleView.html?idxno=1366130
11041,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=459055
11042,2021-01-14,대웅제약첨단바이오의약품제조업정부허가취득,http://www.100ssd.co.kr/news/articleView.html?idxno=74064
11043,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.m-i.kr/news/articleView.html?idxno=786084
11044,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=411901
11045,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thedailypost.kr/news/articleView.html?idxno=78781
11046,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입ㅍ,http://www.worktoday.co.kr/news/articleView.html?idxno=12907
11047,2021-01-14,대웅제약CDMO진출첨단바이오의약품제조업허가,https://view.asiae.co.kr/article/2021011415203448107
11048,2021-01-14,미국ITC최종판결전문공개대웅제약메디톡스이번엔해석전쟁,http://www.insightkorea.co.kr/news/articleView.html?idxno=86062
11049,2021-01-14,美ITC최종판결대웅제약부정하게균주도용했다,https://www.thepublic.kr/news/newsview.php?ncode=1065594702964499
11050,2021-01-14,美ITC최종판결공개대웅제약메디톡스균주뺏었다,http://www.kihoilbo.co.kr/news/articleView.html?idxno=906406
11051,2021-01-14,美ITC최종판결발표대웅제약메디톡스균주훔쳐,http://www.kgdm.co.kr/news/articleView.html?idxno=734500
11052,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,https://www.lkp.news/news/article.html?no=11807
11053,2021-01-14,美ITC대웅제약메디톡스균주도용”,http://www.beyondpost.co.kr/view.php?ud=2021011415525859796cf2d78c68_30
11054,2021-01-14,대웅제약첨단바이오의약품위탁개발사업본격진출,http://www.joseilbo.com/news/news_read.php?uid=414784&class=27&grp=
11055,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.monews.co.kr/news/articleView.html?idxno=300461
11056,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.thereport.co.kr/news/articleView.html?idxno=8553
11057,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://www.newspim.com/news/view/20210114000904
11058,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.newsfarm.co.kr/news/articleView.html?idxno=63187
11059,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.whitepaper.co.kr/news/articleView.html?idxno=200657
11060,2021-01-14,공매도대웅제약이틀간공매도174건공매잔고12억원,http://www.pinpointnews.co.kr/view.php?ud=202101141631283288f090c8dbcb_45
11061,2021-01-14,셀트리온국산1호코로나19치료제초읽기2호쟁탈전나선대웅제약녹십자종근당,https://biz.chosun.com/site/data/html_dir/2021/01/14/2021011402338.html?utm_source=naver&utm_medium=original&utm_campaign=biz
11062,2021-01-14,대웅제약바이오의약품위탁개발생산사업시작,http://www.finomy.com/news/articleView.html?idxno=87893
11063,2021-01-14,대웅제약CDMO사업진출바이오의약품제조업허가받아,https://www.hankyung.com/it/article/2021011437171
11064,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.newstomato.com/ReadNews.aspx?no=1018728
11065,2021-01-14,시경Today제약대웅제약첨단바이오의약품제조업허가취득外,http://www.meconomynews.com/news/articleView.html?idxno=49391
11066,2021-01-14,김창수의e뉴스브리핑메디톡스대웅제약보톡스분쟁ITC판결문공개균주는영업비밀아니다”外,https://www.fetv.co.kr/news/article.html?no=73986
11067,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://www.consumernews.co.kr/news/articleView.html?idxno=618841
11068,2021-01-14,퇴근길제약Pin메디톡스ITC최종판결전문공개대웅제약겨냥外,http://www.pinpointnews.co.kr/view.php?ud=202101141728185449f090c8dbcb_45
11069,2021-01-14,금일제약업계주요기사종근당나파벨탄코로나19환자치료”美ITC대웅제약메디톡스균주戰서균주는영업비밀아니다外,http://www.youthdaily.co.kr/news/article.html?no=59248
11070,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=69240
11071,2021-01-14,대웅제약美ITC균주는 영업비밀아니라고판단,http://www.thefirstmedia.net/news/articleView.html?idxno=69249
11072,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,http://news.kbiz.or.kr/news/articleView.html?idxno=76720
11073,2021-01-14,국산코로나치료제쏟아진다셀트리온이어종근당대웅제약등도허가대기,http://4th.kr/View.aspx?No=1417399
11074,2021-01-14,대웅제약바이오의약품위탁개발생산사업진출,http://www.newsfreezone.co.kr/news/articleView.html?idxno=290884
11075,2021-01-14,메디톡스대웅제약보톡스전쟁최종판결양사우리가이겼다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1444276
11076,2021-01-15,뉴욕증시바이든경기부양기대다우지수상승출발박셀바이오현대바이오대웅제약삼성제약등촉각,http://www.pinpointnews.co.kr/view.php?ud=202101150153377846861beb2d9d_45
11077,2021-01-15,대웅제약첨단바이오의약품제조업허가취득,http://www.segye.com/content/html/2021/01/14/20210114504984.html?OutUrl=naver
11078,2021-01-15,대웅제약ITC최종판결전문분석논쟁종결선언,http://www.monews.co.kr/news/articleView.html?idxno=300477
11079,2021-01-15,대웅제약첨단바이오의약품CDMO사업본격화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1366345
11080,2021-01-15,대웅제약ITC최종판결인정못해”메디톡스끝까지책임물을것,http://theviewers.co.kr/View.aspx?No=1417965
11081,2021-01-15,대웅제약동화약품제약주지지부진대웅제약소폭상승이어동화약품2하락,http://www.econonews.co.kr/news/articleView.html?idxno=153847
11082,2021-01-15,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격돌입,http://kormedi.com/?p=1331323
11083,2021-01-15,대웅대웅제약모두가파른상승세대웅5상승이어대웅제약역시5상승,http://www.econonews.co.kr/news/articleView.html?idxno=153930
11084,2021-01-15,대웅제약메디톡스보톡스전쟁진행중추가소송도불사,http://www.enewstoday.co.kr/news/articleView.html?idxno=1444437
11085,2021-01-15,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.wsobi.com/news/articleView.html?idxno=112395
11086,2021-01-15,셀트리온이어국산코로나2호치료제누가될까GC녹십자이어대웅제약종근당가시권진입,http://www.newswatch.kr/news/articleView.html?idxno=53020
11087,2021-01-15,대웅제약호이스타정서울성모병원서코로나19치료제사용추진,https://www.donga.com/news/article/all/20210115/104943977/1
11088,2021-01-15,오늘Who대웅제약바이오의약품위탁개발전승호줄기세포주믿어,http://www.businesspost.co.kr/BP?command=article_view&num=213122
11089,2021-01-15,1000대기업매출1500조돌파대웅제약종근당셀트리온헬스케어에스엘파트론파워로직스등매출1조클럽가입,http://www.econonews.co.kr/news/articleView.html?idxno=153945
11090,2021-01-16,대웅제약1415일공매도328건공매잔고119억원규모,http://www.pinpointnews.co.kr/view.php?ud=202101160952024570f090c8dbcb_45
11091,2021-01-16,대웅제약호이스타정서울성모병원서사용할까공매도잔고12억육박,http://www.thekpm.com/view.php?ud=2021011614542438087addc4692d_17
11092,2021-01-17,길어지는조정대웅제약언제반등외국인기관뚜렷한매수없어개미들초조,http://www.pinpointnews.co.kr/view.php?ud=202101171114454394861beb2d9d_45
11093,2021-01-17,대웅제약올로스타임상결과美치료학저널등재”,http://www.dailymedi.com/detail.php?number=865291&thread=22r05
11094,2021-01-18,제약사비장의무기⑧신약에기대거는대웅제약사업다각화사활,http://www.cstimes.com/news/articleView.html?idxno=447220
11095,2021-01-18,공정위ICT독과점남용잡는다구글브로드컴대웅제약타깃,http://www.edaily.co.kr/news/newspath.asp?newsid=02394406628919032
11096,2021-01-18,공정위구글사건전담조직가동돌비대웅제약도조만간제재,http://news.mt.co.kr/mtview.php?no=2021011809491440211
11097,2021-01-18,동화약품대웅제약제약주모두하락세로특히동화약품가파른하락세로4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=154248
11098,2021-01-18,공정위지식재산권남용행위로대웅제약제재하나,http://www.dailypharm.com/Users/News/NewsView.html?ID=272569&REFERER=NP
11099,2021-01-19,상대적소외제약바이오주언제반등박셀바이오대웅제약삼성제약한국파마주목,http://www.pinpointnews.co.kr/view.php?ud=202101190513561528861beb2d9d_45
11100,2021-01-19,코로나19치료제부터CDMO까지대웅제약세포치료제기지개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006871
11101,2021-01-19,대웅제약이틀간공매도257건공매잔고118억규모,http://www.pinpointnews.co.kr/view.php?ud=202101190754008310cd1e7f0bdf_45
11102,2021-01-19,대웅제약동화약품제약주모두가파른하락세대웅제약4낙폭이어동화약품역시4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=154427
11103,2021-01-19,질병청대웅제약보툴리눔균주현장조사대상포함,http://www.kpinews.co.kr/news/articleView.html?idxno=135495
11104,2021-01-20,코로나타격이후추가불황삼성전자박셀바이오한국파마대웅제약씨젠필룩스는,http://www.pinpointnews.co.kr/view.php?ud=202101200640015143861beb2d9d_45
11105,2021-01-20,대웅제약BMS스프라이셀특허에도전장,http://www.mdtoday.co.kr/mdtoday/index.html?no=412375
11106,2021-01-20,보령제약대웅제약제약주상승에급등까지특히보령제약오전갑작스런8급등,http://www.econonews.co.kr/news/articleView.html?idxno=154615
11107,2021-01-20,과기부코로나19치료제후보종근당대웅제약,http://www.dailymedi.com/detail.php?number=865440&thread=22r01
11108,2021-01-20,백신접종에도코로나확산여전씨젠GC녹십자대웅제약한미약품주목을,http://www.pinpointnews.co.kr/view.php?ud=202101201544439549861beb2d9d_45
11109,2021-01-20,동학개미나흘만에폭풍매수삼성전자LG화학삼성SDI박셀바이오대웅제약상승,http://www.pinpointnews.co.kr/view.php?ud=202101201714393139861beb2d9d_45
